,protein_name,pubmed_id,title,authors,mesh_terms,paper_url
0,ADRB1,37731001,The beta(1)-adrenergic receptor links sympathetic nerves to T cell exhaustion.,"['Globig AM', 'Zhao S', 'Roginsky J', 'Maltez VI', 'Guiza J', 'Avina-Ochoa N', 'Heeg M', 'Araujo Hoffmann F', 'Chaudhary O', 'Wang J', 'Senturk G', 'Chen D', ""O'Connor C"", 'Pfaff S', 'Germain RN', 'Schalper KA', 'Emu B', 'Kaech SM']","['Humans', 'Antigens/immunology/metabolism', '*Catecholamines/metabolism', '*CD8-Positive T-Lymphocytes/cytology/immunology/metabolism', 'Cell Proliferation', 'Immune Checkpoint Inhibitors/therapeutic use', 'Melanoma/immunology/metabolism/therapy', 'Memory T Cells/cytology/immunology', 'Pancreatic Neoplasms/immunology/metabolism/therapy', '*Receptors, Adrenergic, beta-1/metabolism', '*Sympathetic Nervous System/immunology/physiology', '*T-Cell Exhaustion', 'Stress, Physiological']",https://pubmed.ncbi.nlm.nih.gov/37731001/
1,ADRB1,36600052,beta-adrenoreceptor-triggered PKA activation negatively regulates the innate antiviral response.,"['Guo Y', 'Zhang XN', 'Su S', 'Ruan ZL', 'Hu MM', 'Shu HB']","['Humans', 'Antiviral Agents', 'Epinephrine/pharmacology', 'Immunity, Innate/genetics', '*Membrane Proteins/genetics', 'Norepinephrine/pharmacology', '*Virus Diseases', 'Receptors, Adrenergic, beta-1/metabolism', 'Receptors, Adrenergic, beta-2/metabolism', 'Enzyme Activation', 'Cyclic AMP-Dependent Protein Kinases/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36600052/
2,ADRB1,32755608,Human Brown Adipocyte Thermogenesis Is Driven by beta2-AR Stimulation.,"['Blondin DP', 'Nielsen S', 'Kuipers EN', 'Severinsen MC', 'Jensen VH', 'Miard S', 'Jespersen NZ', 'Kooijman S', 'Boon MR', 'Fortin M', 'Phoenix S', 'Frisch F', 'Guerin B', 'Turcotte EE', 'Haman F', 'Richard D', 'Picard F', 'Rensen PCN', 'Scheele C', 'Carpentier AC']","['Adipocytes, Brown/*metabolism', 'Adolescent', 'Adult', 'Animals', 'Humans', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Middle Aged', 'Receptors, Adrenergic, beta-2/*metabolism', '*Thermogenesis', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/32755608/
3,ADRB1,31473062,A Rare Mutation of beta(1)-Adrenergic Receptor Affects Sleep/Wake Behaviors.,"['Shi G', 'Xing L', 'Wu D', 'Bhattacharyya BJ', 'Jones CR', 'McMahon T', 'Chong SYC', 'Chen JA', 'Coppola G', 'Geschwind D', 'Krystal A', 'Ptacek LJ', 'Fu YH']","['Animals', 'Gene Knock-In Techniques', 'Humans', 'Mice', 'Mutation', 'Neurons/metabolism', 'Pedigree', 'Pontine Tegmentum/cytology/metabolism', 'Receptors, Adrenergic, beta-1/*genetics', 'Sleep/*genetics', 'Sleep Wake Disorders/genetics', 'Sleep, REM/genetics', 'Wakefulness/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31473062/
4,ADRB1,35113855,Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.,"['Yarmolinsky J', 'Diez-Obrero V', 'Richardson TG', 'Pigeyre M', 'Sjaarda J', 'Pare G', 'Walker VM', 'Vincent EE', 'Tan VY', 'Obon-Santacana M', 'Albanes D', 'Hampe J', 'Gsur A', 'Hampel H', 'Pai RK', 'Jenkins M', 'Gallinger S', 'Casey G', 'Zheng W', 'Amos CI', 'Smith GD', 'Martin RM', 'Moreno V']","['Antihypertensive Agents/*adverse effects', 'Blood Pressure/drug effects/genetics', 'Female', 'Genome-Wide Association Study/methods', 'Humans', 'Male', 'Mendelian Randomization Analysis/*methods', 'Neoplasms/chemically induced/epidemiology/*genetics', 'Peptidyl-Dipeptidase A/*genetics', 'Polymorphism, Single Nucleotide/drug effects/genetics', 'Receptors, Adrenergic, beta-1/*genetics', 'Risk Factors', 'Solute Carrier Family 12, Member 3/genetics']",https://pubmed.ncbi.nlm.nih.gov/35113855/
5,ADRB1,38951961,"Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy.","['Duarte JD', 'Thomas CD', 'Lee CR', 'Huddart R', 'Agundez JAG', 'Baye JF', 'Gaedigk A', 'Klein TE', 'Lanfear DE', 'Monte AA', 'Nagy M', 'Schwab M', 'Stein CM', 'Uppugunduri CRS', 'van Schaik RHN', 'Donnelly RS', 'Caudle KE', 'Luzum JA']","['Humans', '*Adrenergic beta-Antagonists/pharmacokinetics/therapeutic use', '*Cytochrome P-450 CYP2D6/genetics/metabolism', '*G-Protein-Coupled Receptor Kinase 5/genetics', '*Genotype', 'Metoprolol/pharmacokinetics', '*Pharmacogenetics/methods/standards', 'Pharmacogenomic Variants', 'Receptors, Adrenergic, alpha-2/genetics', '*Receptors, Adrenergic, beta-1/genetics', '*Receptors, Adrenergic, beta-2/genetics']",https://pubmed.ncbi.nlm.nih.gov/38951961/
6,ADRB1,31624248,Chronic stress promotes gastric cancer progression and metastasis: an essential role for ADRB2.,"['Zhang X', 'Zhang Y', 'He Z', 'Yin K', 'Li B', 'Zhang L', 'Xu Z']","['Animals', 'Cell Movement/physiology', 'Cell Proliferation/physiology', 'Disease Progression', 'Female', 'Heterografts', 'Humans', 'MAP Kinase Signaling System', 'Male', 'Mice', 'Mice, Inbred BALB C', 'Mice, Nude', 'NF-kappa B/metabolism', 'Neoplasm Metastasis', 'RNA, Messenger/biosynthesis/genetics', 'Receptors, Adrenergic, beta-2/biosynthesis/genetics/*metabolism', 'STAT3 Transcription Factor/metabolism', 'Signal Transduction', 'Stomach Neoplasms/*metabolism/*pathology', 'Stress, Physiological/*physiology']",https://pubmed.ncbi.nlm.nih.gov/31624248/
7,ADRB1,39114924,Genome-Wide Mendelian Randomization Study Reveals Druggable Genes for Cerebral Small Vessel Disease.,"['Yang XZ', 'Huang MY', 'Han F', 'Ni J', 'Zhou LX', 'Yao M', 'Zhang DD', 'Zhu YC']","['*Cerebral Small Vessel Diseases/genetics', 'Humans', '*Mendelian Randomization Analysis', '*Genome-Wide Association Study', 'Magnetic Resonance Imaging', 'Brain/diagnostic imaging']",https://pubmed.ncbi.nlm.nih.gov/39114924/
8,ADRB1,39190310,Genetic Insights Into Perinatal Outcomes of Maternal Antihypertensive Therapy During Pregnancy.,"['Barry CS', 'Walker VM', 'Burden C', 'Havdahl A', 'Davies NM']","['Humans', 'Pregnancy', 'Female', '*Antihypertensive Agents/therapeutic use', 'Adult', 'Pregnancy Outcome/epidemiology', 'Infant, Newborn', 'Norway/epidemiology', 'Mendelian Randomization Analysis', 'Male', 'Polymorphism, Single Nucleotide', 'Hypertension/drug therapy/epidemiology', 'Blood Pressure/genetics/drug effects']",https://pubmed.ncbi.nlm.nih.gov/39190310/
9,ADRB1,25823457,Associations between ADRB1 and CYP2D6 gene polymorphisms and the response to beta-blocker therapy in hypertension.,"['Wu D', 'Li G', 'Deng M', 'Song W', 'Huang X', 'Guo X', 'Wu Z', 'Wu S', 'Xu J']","['Adrenergic beta-Antagonists/therapeutic use', 'Adult', 'Aged', 'Antihypertensive Agents/therapeutic use', 'Blood Pressure/drug effects', 'China', 'Cytochrome P-450 CYP2D6/*genetics', 'Essential Hypertension', 'Gene Frequency/genetics', 'Humans', 'Hypertension/*drug therapy/*genetics/physiopathology', 'Metoprolol/*therapeutic use', 'Middle Aged', 'Polymorphism, Single Nucleotide', 'Receptors, Adrenergic, beta-1/*genetics', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/25823457/
10,ADRB1,27638020,Genetics of Takotsubo Syndrome.,"['Limongelli G', 'Masarone D', 'Maddaloni V', 'Rubino M', 'Fratta F', 'Cirillo A', 'Ludovica SB', 'Pacileo R', 'Fusco A', 'Coppola GR', 'Pisacane F', 'Bossone E', 'Calabro P', 'Calabro R', 'Russo MG', 'Pacileo G']","['G-Protein-Coupled Receptor Kinase 5/genetics', 'Genetic Predisposition to Disease', 'Humans', 'Polymorphism, Genetic', 'Receptors, Adrenergic, alpha-1/genetics', 'Receptors, Adrenergic, beta-1/genetics', 'Receptors, Adrenergic, beta-2/genetics', 'Takotsubo Cardiomyopathy/*genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/27638020/
11,ADRB1,34470728,Pharmacogenetic polymorphisms affecting bisoprolol response.,"['Castano-Amores C', 'Diaz-Villamarin X', 'Perez-Gutierrez AM', 'Antunez-Rodriguez A', 'Pozo-Agundo A', 'Moreno-Escobar E', 'Sanchez-Ramos JG', 'Martinez-Gonzalez LJ', 'Davila-Fajardo CL']","['Adrenergic beta-1 Receptor Antagonists/*pharmacology', 'Bisoprolol/*pharmacology', 'Blood Pressure/drug effects', 'Cardiovascular Diseases/drug therapy/genetics/physiopathology', 'Humans', '*Pharmacogenetics', 'Polymorphism, Single Nucleotide', 'Receptors, Adrenergic, beta-1/genetics', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/34470728/
12,ADRB1,38326723,Risk Factors of Depression Screened by Two-Sample Mendelian Randomization Analysis: A Systematic Review.,"['Wang HL', 'Xue YF', 'Cui BQ', 'Liu H', 'Shen XX']","['Humans', '*Depressive Disorder, Major/genetics', 'Depression', 'Genome-Wide Association Study', 'Mendelian Randomization Analysis', 'Risk Factors', 'Serotonin Plasma Membrane Transport Proteins']",https://pubmed.ncbi.nlm.nih.gov/38326723/
13,ADRB1,38450887,"Exploring the causal relationship between antihypertensive drugs and glioblastoma by combining drug target Mendelian randomization study, eQTL colocalization, and single-cell RNA sequencing.","['Zhao S', 'Xie Y', 'Ding X', 'Zheng C', 'Chen J', 'Zhao N', 'Ji Y', 'Wang Q', 'Liu Y', 'Cheng C']","['*Glioblastoma/genetics/drug therapy', 'Humans', '*Mendelian Randomization Analysis', '*Antihypertensive Agents/therapeutic use', '*Polymorphism, Single Nucleotide', '*Genome-Wide Association Study', '*Receptors, Adrenergic, beta-1/genetics', 'Quantitative Trait Loci', 'Blood Pressure/drug effects', 'Sequence Analysis, RNA', 'Single-Cell Analysis', 'Adrenergic beta-Antagonists/therapeutic use', 'Brain Neoplasms/genetics/drug therapy']",https://pubmed.ncbi.nlm.nih.gov/38450887/
14,ADRB1,37952358,"Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome.","['Castano-Amores C', 'Antunez-Rodriguez A', 'Pozo-Agundo A', 'Garcia-Rodriguez S', 'Martinez-Gonzalez LJ', 'Davila-Fajardo CL']","['Humans', 'Cytochrome P-450 CYP2D6/genetics', '*Acute Coronary Syndrome/drug therapy/genetics', 'Bisoprolol/therapeutic use', '*Percutaneous Coronary Intervention', 'Adrenergic beta-Antagonists/therapeutic use', 'Genotype', 'Polymorphism, Single Nucleotide/genetics', '*Hypotension', 'Receptors, Adrenergic, beta-1/genetics', 'Receptors, Adrenergic, beta-2/genetics']",https://pubmed.ncbi.nlm.nih.gov/37952358/
15,ADRB1,36812890,Stimulation of the beta-2-adrenergic receptor with salbutamol activates human brown adipose tissue.,"['Straat ME', 'Hoekx CA', 'van Velden FHP', 'Pereira Arias-Bouda LM', 'Dumont L', 'Blondin DP', 'Boon MR', 'Martinez-Tellez B', 'Rensen PCN']","['Male', 'Humans', '*Albuterol/pharmacology', '*Adipose Tissue, Brown', 'Propranolol/pharmacology', 'Glucose/pharmacology', 'Receptors, Adrenergic', 'Receptors, Adrenergic, beta-3']",https://pubmed.ncbi.nlm.nih.gov/36812890/
16,ADRB1,38138160,Associations between Selected ADRB1 and CYP2D6 Gene Polymorphisms in Children with Ventricular and Supraventricular Arrhythmias.,"['Moric-Janiszewska E', 'Smolik S', 'Szydlowski L', 'Kapral M']","['Child', 'Female', 'Humans', '*Adrenergic beta-Antagonists/therapeutic use', 'Arrhythmias, Cardiac/genetics', '*Cytochrome P-450 CYP2D6/genetics', 'DNA', 'Polymorphism, Genetic/genetics', 'Receptors, Adrenergic, beta-1/genetics']",https://pubmed.ncbi.nlm.nih.gov/38138160/
17,ADRB1,32726152,Pharmacogenetic factors affecting beta-blocker metabolism and response.,"['Thomas CD', 'Johnson JA']","['Adrenergic beta-Antagonists/*administration & dosage/pharmacokinetics/pharmacology', 'Cardiovascular Diseases/*drug therapy/genetics', 'G-Protein-Coupled Receptor Kinase 5/genetics', 'Genotype', 'Humans', '*Pharmacogenetics', 'Pharmacogenomic Testing', 'Receptors, Adrenergic, beta-1/genetics']",https://pubmed.ncbi.nlm.nih.gov/32726152/
18,ADRB1,38769606,Utilizing genetics and proteomics to assess the role of antihypertensive drugs in human longevity and the underlying pathways: a Mendelian randomization study.,"['Fan B', 'Zhao JV']","['Humans', '*Mendelian Randomization Analysis', '*Antihypertensive Agents/therapeutic use', '*Longevity/drug effects/genetics', 'Male', 'Female', '*Genome-Wide Association Study', '*Blood Pressure/drug effects/genetics', '*Proteomics', '*Hypertension/drug therapy/genetics/physiopathology', '*Pharmacogenomic Variants', 'Aged', 'Middle Aged', 'Risk Factors', 'Vasodilator Agents/therapeutic use', 'Phenotype', 'Treatment Outcome', 'Calcium Channel Blockers/therapeutic use', 'Age Factors', 'Adrenergic beta-Antagonists/therapeutic use', 'Risk Assessment', 'Sex Factors']",https://pubmed.ncbi.nlm.nih.gov/38769606/
19,ADRB1,22713143,Advancing management of hypertension through pharmacogenomics.,['Johnson JA'],"['Blood Pressure/drug effects/genetics', 'Calcium Channels, L-Type/genetics', 'Endosomal Sorting Complexes Required for Transport/genetics', 'Humans', 'Hypertension/*drug therapy/*genetics', 'Nedd4 Ubiquitin Protein Ligases', '*Pharmacogenetics', 'Polymorphism, Genetic', 'Receptors, Adrenergic, beta-1/genetics', 'Ubiquitin-Protein Ligases/genetics']",https://pubmed.ncbi.nlm.nih.gov/22713143/
20,HRH1,34822775,The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1.,"['Li H', 'Xiao Y', 'Li Q', 'Yao J', 'Yuan X', 'Zhang Y', 'Yin X', 'Saito Y', 'Fan H', 'Li P', 'Kuo WL', 'Halpin A', 'Gibbons DL', 'Yagita H', 'Zhao Z', 'Pang D', 'Ren G', 'Yee C', 'Lee JJ', 'Yu D']","['Cell Line, Tumor/drug effects', 'Histamine/*metabolism', 'Humans', 'Immune Tolerance/immunology', '*Immunotherapy/methods', 'Macrophages/immunology', 'Neoplasms/*drug therapy/immunology', 'Receptors, Histamine/immunology/metabolism', 'Tumor Microenvironment/*drug effects/immunology']",https://pubmed.ncbi.nlm.nih.gov/34822775/
21,HRH1,38458750,Function of mast cell and bile-cholangiocarcinoma interplay in cholangiocarcinoma microenvironment.,"['Shi A', 'Liu Z', 'Fan Z', 'Li K', 'Liu X', 'Tang Y', 'Hu J', 'Li X', 'Shu L', 'Zhao L', 'Huang L', 'Zhang Z', 'Lv G', 'Zhang Z', 'Xu Y']","['*Cholangiocarcinoma/metabolism/pathology/genetics', '*Mast Cells/metabolism', '*Bile Duct Neoplasms/metabolism/pathology/genetics', 'Animals', 'Humans', '*Tumor Microenvironment', 'Mice', 'Bile/metabolism', 'Receptors, G-Protein-Coupled/metabolism/genetics', 'Receptors, Histamine/metabolism', 'Histamine/metabolism', 'Cell Proliferation', 'Cancer-Associated Fibroblasts/metabolism/pathology', 'Cell Degranulation']",https://pubmed.ncbi.nlm.nih.gov/38458750/
22,HRH1,19450133,Histamine pharmacogenomics.,"['Garcia-Martin E', 'Ayuso P', 'Martinez C', 'Blanca M', 'Agundez JA']","['Amine Oxidase (Copper-Containing)/*genetics', 'Amino Acid Substitution', 'Genetic Variation', 'Histamine/*genetics', 'Histamine N-Methyltransferase/*genetics', 'Histidine Decarboxylase/*genetics', 'Humans', 'Pharmacogenetics/methods', '*Polymorphism, Genetic', 'Promoter Regions, Genetic/genetics', 'Receptors, Histamine/*genetics']",https://pubmed.ncbi.nlm.nih.gov/19450133/
23,HRH1,38715057,Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells.,"['Zhong P', 'Nakata K', 'Oyama K', 'Higashijima N', 'Sagara A', 'Date S', 'Luo H', 'Hayashi M', 'Kubo A', 'Wu C', 'He S', 'Yamamoto T', 'Koikawa K', 'Iwamoto C', 'Abe T', 'Ikenaga N', 'Ohuchida K', 'Morisaki T', 'Oda Y', 'Kuba K', 'Nakamura M']","['Humans', '*Pancreatic Neoplasms/drug therapy/metabolism/pathology/genetics', '*Immune Checkpoint Inhibitors/pharmacology/therapeutic use', 'Mice', 'Animals', 'Receptors, Histamine H1/metabolism/genetics', 'Histocompatibility Antigens Class I/metabolism/genetics', 'Cell Line, Tumor', 'Female', 'Histamine H1 Antagonists/pharmacology/therapeutic use', 'Male']",https://pubmed.ncbi.nlm.nih.gov/38715057/
24,HRH1,38953634,The histamine receptor H1 acts as an alternative receptor for SARS-CoV-2.,"['Yu F', 'Liu X', 'Ou H', 'Li X', 'Liu R', 'Lv X', 'Xiao S', 'Hu M', 'Liang T', 'Chen T', 'Wei X', 'Zhang Z', 'Liu S', 'Liu H', 'Zhu Y', 'Liu G', 'Tu T', 'Li P', 'Zhang H', 'Pan T', 'Ma X']","['Humans', '*SARS-CoV-2/drug effects/physiology', 'Animals', '*Angiotensin-Converting Enzyme 2/metabolism', 'Mice', '*Virus Internalization/drug effects', '*Receptors, Histamine H1/metabolism', '*Spike Glycoprotein, Coronavirus/metabolism/genetics', 'COVID-19/virology/metabolism', 'HEK293 Cells', 'COVID-19 Drug Treatment', 'Receptors, Virus/metabolism', 'Protein Binding', 'Histamine Antagonists/pharmacology', 'Antiviral Agents/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/38953634/
25,HRH1,38955315,Pathophysiological role of histamine signaling and its implications in glioblastoma.,"['Yadav P', 'Vengoji R', 'Jain M', 'Batra SK', 'Shonka N']","['Humans', '*Glioblastoma/pathology/metabolism/drug therapy', '*Histamine/metabolism', '*Brain Neoplasms/pathology/metabolism/drug therapy', '*Signal Transduction', '*Tumor Microenvironment', 'Animals', 'Histamine Antagonists/therapeutic use/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/38955315/
26,HRH1,37474883,"The Roles of Histamine Receptor 1 (hrh1) in Neurotransmitter System Regulation, Behavior, and Neurogenesis in Zebrafish.","['Yao Y', 'Baronio D', 'Chen YC', 'Jin C', 'Panula P']","['Animals', 'Humans', 'Histamine/metabolism', '*Neurogenesis', 'Neurotransmitter Agents/metabolism', 'Orexins/metabolism', '*Receptors, Histamine H1/genetics/metabolism', '*Zebrafish/growth & development']",https://pubmed.ncbi.nlm.nih.gov/37474883/
27,HRH1,39462031,Histamine stimulates human microglia to alter cellular prion protein expression via the HRH2 histamine receptor.,"['Pehar M', 'Hewitt M', 'Wagner A', 'Sandhu JK', 'Khalili A', 'Wang X', 'Cho JY', 'Sim VL', 'Kulka M']","['Humans', '*Microglia/metabolism/drug effects', '*Histamine/pharmacology/metabolism', 'Cell Line', '*Receptors, Histamine H2/metabolism/genetics', '*Calcium/metabolism', 'PrPC Proteins/metabolism/genetics', 'Cytokines/metabolism', 'Gene Expression Regulation/drug effects', 'Receptors, Histamine/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39462031/
28,HRH1,31406237,Human H1 receptor (HRH1) gene polymorphism is associated with the severity of side effects after desloratadine treatment in Chinese patients with chronic spontaneous uticaria.,"['Li J', 'Chen W', 'Peng C', 'Zhu W', 'Liu Z', 'Zhang W', 'Su J', 'Li J', 'Chen X']","['Adult', 'China/epidemiology', 'Chronic Disease', 'Drug-Related Side Effects and Adverse Reactions/diagnosis/epidemiology/*genetics', 'Female', 'Histamine H1 Antagonists, Non-Sedating/*adverse effects', 'Humans', 'Loratadine/adverse effects/*analogs & derivatives', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide/*genetics', 'Receptors, Histamine H1/*genetics', 'Severity of Illness Index', 'Sleepiness', 'Treatment Outcome', 'Urticaria/drug therapy/epidemiology/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31406237/
29,HRH1,29523718,Potential negative effects of anti-histamines on male reproductive function.,"['Mondillo C', 'Varela ML', 'Abiuso AMB', 'Vazquez R']","['Animals', 'Fertility/drug effects/physiology', 'Histamine Antagonists/*pharmacology', 'Humans', 'Leydig Cells/drug effects/metabolism', 'Male', 'Reproduction/*drug effects/physiology', 'Spermatozoa/*drug effects', 'Testis/*drug effects/metabolism', 'Testosterone/metabolism']",https://pubmed.ncbi.nlm.nih.gov/29523718/
30,HRH1,27855565,Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain.,"['Tiwari AK', 'Zhang D', 'Pouget JG', 'Zai CC', 'Chowdhury NI', 'Brandl EJ', 'Qin L', 'Freeman N', 'Lieberman JA', 'Meltzer HY', 'Kennedy JL', 'Muller DJ']","['Adult', 'Antipsychotic Agents/*adverse effects', 'Clozapine/adverse effects', 'Female', 'Humans', 'Male', 'Olanzapine/adverse effects', 'Polymorphism, Single Nucleotide', 'Psychotic Disorders/*drug therapy', 'Receptors, Histamine H1/*genetics', 'Receptors, Histamine H3/*genetics', 'Schizophrenia/*drug therapy', 'Weight Gain/*drug effects/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27855565/
31,HRH1,36000734,Mycobacterium tuberculosis Utilizes Host Histamine Receptor H1 to Modulate Reactive Oxygen Species Production and Phagosome Maturation via the p38MAPK-NOX2 Axis.,"['Mo S', 'Guo J', 'Ye T', 'Zhang X', 'Zeng J', 'Xu Y', 'Peng B', 'Dai Y', 'Xiao W', 'Zhang P', 'Deng G', 'Xu D', 'Long X', 'Cai Y', 'Chen X']","['Humans', '*Mycobacterium tuberculosis/genetics', 'Reactive Oxygen Species/metabolism', 'p38 Mitogen-Activated Protein Kinases/metabolism', 'Histamine', '*Tuberculosis/microbiology', 'Antitubercular Agents', 'Phagosomes/microbiology', 'Nitrogen/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36000734/
32,HRH1,36732336,Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration.,"['Park C', 'Lee JW', 'Kim K', 'Seen DS', 'Jeong JY', 'Huh WK']","['Humans', '*Receptors, CXCR4/metabolism', 'Histamine/pharmacology/metabolism', 'Calcium Signaling', 'HeLa Cells', 'Calcium/metabolism', 'Chemokine CXCL12/metabolism', 'Cell Movement', 'Receptors, Histamine H1/metabolism', 'Cell Line, Tumor', '*Neoplasms/genetics']",https://pubmed.ncbi.nlm.nih.gov/36732336/
33,HRH1,35587368,Combined impacts of histamine receptor H1 gene polymorphisms and an environmental carcinogen on the susceptibility to and progression of oral squamous cell carcinoma.,"['Ding YF', 'Lin YW', 'Chiu WK', 'Lin CW', 'Yang YC', 'Chang LC', 'Chang J', 'Yang SF', 'Chien MH']","['*Carcinogens, Environmental', '*Carcinoma, Squamous Cell/genetics/pathology', 'Case-Control Studies', 'Genetic Predisposition to Disease', '*Head and Neck Neoplasms', 'Humans', '*Mouth Neoplasms/genetics/pathology', 'Polymorphism, Single Nucleotide', 'Receptors, Histamine/genetics', 'Squamous Cell Carcinoma of Head and Neck/genetics']",https://pubmed.ncbi.nlm.nih.gov/35587368/
34,HRH1,25295384,Genetic variation within the histamine pathway among patients with asthma--a pilot study.,"['Raje N', 'Vyhlidal CA', 'Dai H', 'Jones BL']","['Adult', 'Black or African American', 'Amine Oxidase (Copper-Containing)/genetics', 'Asthma/*genetics', 'Child', 'Female', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Genetic Variation', 'Genotype', 'Haplotypes', 'Histamine/*metabolism', 'Humans', 'Male', 'Pilot Projects', 'Polymorphism, Single Nucleotide', 'RNA, Messenger', 'Racial Groups', 'Receptors, G-Protein-Coupled/genetics', 'Receptors, Histamine/genetics', 'Receptors, Histamine H4', 'Sex Factors', 'White People', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/25295384/
35,HRH1,35234502,Clemastine Inhibits the Biofilm and Hemolytic of Staphylococcus aureus through the GdpP Protein.,"['Shang Y', 'Guo J', 'Zhao Y', 'Chen J', 'Meng Q', 'Qu D', 'Zheng J', 'Yu Z', 'Wu Y', 'Deng Q']","['Anti-Bacterial Agents/pharmacology/therapeutic use', 'Biofilms', 'Clemastine/pharmacology/therapeutic use', 'Hemolysis', 'Humans', '*Methicillin-Resistant Staphylococcus aureus/genetics', 'Microbial Sensitivity Tests', 'Molecular Docking Simulation', 'Oxacillin/pharmacology/therapeutic use', '*Staphylococcal Infections/microbiology', 'Staphylococcus aureus']",https://pubmed.ncbi.nlm.nih.gov/35234502/
36,HRH1,31500698,MRGPRX4 is a bile acid receptor for human cholestatic itch.,"['Yu H', 'Zhao T', 'Liu S', 'Wu Q', 'Johnson O', 'Wu Z', 'Zhuang Z', 'Shi Y', 'Peng L', 'He R', 'Yang Y', 'Sun J', 'Wang X', 'Xu H', 'Zeng Z', 'Zou P', 'Lei X', 'Luo W', 'Li Y']","['Bile Acids and Salts/*metabolism', 'Ganglia, Spinal/cytology', 'Humans', 'Pruritus/*chemically induced', 'Receptors, Cell Surface/*metabolism', 'Receptors, G-Protein-Coupled/*metabolism', 'Receptors, Histamine H4/metabolism', 'Sensory Receptor Cells/*drug effects/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/31500698/
37,HRH1,34378323,Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis.,"['Herranz C', 'Mateo F', 'Baiges A', 'Ruiz de Garibay G', 'Junza A', 'Johnson SR', 'Miller S', 'Garcia N', 'Capellades J', 'Gomez A', 'Vidal A', 'Palomero L', 'Espin R', 'Extremera AI', 'Blommaert E', 'Revilla-Lopez E', 'Saez B', 'Gomez-Olles S', 'Ancochea J', 'Valenzuela C', 'Alonso T', 'Ussetti P', 'Laporta R', 'Xaubet A', 'Rodriguez-Portal JA', 'Montes-Worboys A', 'Machahua C', 'Bordas J', 'Menendez JA', 'Cruzado JM', 'Guiteras R', 'Bontoux C', 'La Motta C', 'Noguera-Castells A', 'Mancino M', 'Lastra E', 'Rigo-Bonnin R', 'Perales JC', 'Vinals F', 'Lahiguera A', 'Zhang X', 'Cuadras D', 'van Moorsel CHM', 'van der Vis JJ', 'Quanjel MJR', 'Filippakis H', 'Hakem R', 'Gorrini C', 'Ferrer M', 'Ugun-Klusek A', 'Billett E', 'Radzikowska E', 'Casanova A', 'Molina-Molina M', 'Roman A', 'Yanes O', 'Pujana MA']","['Biomarkers', 'Histamine', 'Humans', '*Lung Neoplasms/drug therapy', '*Lymphangioleiomyomatosis/drug therapy', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/34378323/
38,HRH1,24236486,"Variability in histamine receptor genes HRH1, HRH2 and HRH4 in patients with hypersensitivity to NSAIDs.","['Ayuso P', 'Blanca M', 'Cornejo-Garcia JA', 'Torres MJ', 'Dona I', 'Salas M', 'Blanca-Lopez N', 'Canto G', 'Rondon C', 'Campo P', 'Laguna JJ', 'Fernandez J', 'Martinez C', 'Agundez JA', 'Garcia-Martin E']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Anti-Inflammatory Agents, Non-Steroidal/*adverse effects', 'Case-Control Studies', 'Child', 'Child, Preschool', 'DNA Copy Number Variations/*genetics', 'Drug Hypersensitivity/*genetics', 'Female', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide/*genetics', 'Receptors, G-Protein-Coupled/*genetics', 'Receptors, Histamine/*genetics', 'Receptors, Histamine H1/*genetics', 'Receptors, Histamine H2/*genetics', 'Receptors, Histamine H4', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/24236486/
39,HRH1,39037273,Identification of HRH1 as an alternative receptor for SARS-CoV-2: insights from viral inhibition by repurposable antihistamines.,"['Zhong G', 'Li J', 'Wang H']","['*SARS-CoV-2/drug effects', 'Humans', '*Drug Repositioning', '*Virus Internalization/drug effects', 'COVID-19 Drug Treatment', 'Histamine Antagonists/pharmacology', 'Spike Glycoprotein, Coronavirus/metabolism/genetics/antagonists & inhibitors', 'Antiviral Agents/pharmacology', 'Receptors, Histamine H1/metabolism/genetics', 'COVID-19/virology', 'Receptors, Virus/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39037273/
40,ADORA2B,36720042,CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer.,"['Faraoni EY', 'Singh K', 'Chandra V', 'Le Roux O', 'Dai Y', 'Sahin I', ""O'Brien BJ"", 'Strickland LN', 'Li L', 'Vucic E', 'Warner AN', 'Pruski M', 'Clark T', 'Van Buren G', 'Thosani NC', 'Bynon JS', 'Wray CJ', 'Bar-Sagi D', 'Poulsen KL', 'Vornik LA', 'Savage MI', 'Sei S', 'Mohammed A', 'Zhao Z', 'Brown PH', 'Mills T', 'Eltzschig HK', 'McAllister F', 'Bailey-Lundberg JM']","['Animals', 'Humans', 'Mice', 'Adenosine', '*Cancer Vaccines', '*Carcinoma, Pancreatic Ductal/pathology', 'Immunosuppression Therapy', 'Immunotherapy', '*Pancreatic Neoplasms/pathology', 'Tumor Microenvironment', ""5'-Nucleotidase/immunology""]",https://pubmed.ncbi.nlm.nih.gov/36720042/
41,ADORA2B,36943408,IL-6 in the infarcted heart is preferentially formed by fibroblasts and modulated by purinergic signaling.,"['Alter C', 'Henseler AS', 'Owenier C', 'Hesse J', 'Ding Z', 'Lautwein T', 'Bahr J', 'Hayat S', 'Kramann R', 'Kostenis E', 'Scheller J', 'Schrader J']","['Animals', 'Humans', 'Mice', 'Adenosine/metabolism', '*Fibroblasts/metabolism', '*Interleukin-6/genetics/metabolism', 'Mice, Inbred C57BL', '*Myocardial Infarction/genetics/metabolism', '*T-Lymphocytes/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36943408/
42,ADORA2B,39366386,Stress triggers irritable bowel syndrome with diarrhea through a spermidine-mediated decline in type I interferon.,"['Zhang L', 'Wang HL', 'Zhang YF', 'Mao XT', 'Wu TT', 'Huang ZH', 'Jiang WJ', 'Fan KQ', 'Liu DD', 'Yang B', 'Zhuang MH', 'Huang GM', 'Liang Y', 'Zhu SJ', 'Zhong JY', 'Xu GY', 'Li XM', 'Cao Q', 'Li YY', 'Jin J']","['*Irritable Bowel Syndrome/metabolism', '*Diarrhea/metabolism', '*Spermidine/pharmacology/metabolism', 'Animals', 'Humans', 'Male', 'Stress, Psychological/complications/metabolism', 'Mice, Inbred C57BL', 'Interferon Type I/metabolism', 'Mice', 'Dendritic Cells/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39366386/
43,ADORA2B,38874549,Targeting Adenosine A2b Receptor Promotes Penile Rehabilitation of Refractory Erectile Dysfunction.,"['Xiong Y', 'Qin F', 'Wei S', 'Yang X', 'Li J', 'Wu C', 'Zhang F', 'Yuan J']","['Animals', 'Humans', 'Male', 'Mice', 'Rats', 'Adenosine/metabolism', '*Disease Models, Animal', '*Erectile Dysfunction/metabolism/rehabilitation/drug therapy/genetics', 'Mice, Knockout', 'Penile Erection/drug effects/physiology', 'Penis/metabolism/physiopathology', 'Rats, Sprague-Dawley', '*Receptor, Adenosine A2B/metabolism/genetics']",https://pubmed.ncbi.nlm.nih.gov/38874549/
44,ADORA2B,37187740,The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer.,"['Strickland LN', 'Faraoni EY', 'Ruan W', 'Yuan X', 'Eltzschig HK', 'Bailey-Lundberg JM']","['Humans', 'Adenosine/metabolism', '*CD8-Positive T-Lymphocytes/metabolism', 'Hypoxia', 'Immunotherapy', '*Pancreatic Neoplasms/therapy', 'Tumor Microenvironment', '*Receptor, Adenosine A2B/drug effects/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37187740/
45,ADORA2B,32294028,A Role for the Adenosine ADORA2B Receptor in Midazolam Induced Cognitive Dysfunction.,"['Gile J', 'Oyama Y', 'Shuff S', 'Eckle T']","['Adenosine', 'Animals', '*Cognitive Dysfunction', 'Hippocampus/metabolism', 'Humans', 'Mice', 'Mice, Inbred C57BL', 'Midazolam', '*Receptor, Adenosine A2B/metabolism']",https://pubmed.ncbi.nlm.nih.gov/32294028/
46,ADORA2B,23540714,Attenuating myocardial ischemia by targeting A2B adenosine receptors.,"['Eltzschig HK', 'Bonney SK', 'Eckle T']","['Adenosine/metabolism', 'Animals', 'Humans', 'Myocardial Ischemia/drug therapy/genetics/*metabolism', 'Receptor, Adenosine A2B/genetics/*metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/23540714/
47,ADORA2B,25318478,Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension.,"['Karmouty-Quintana H', 'Philip K', 'Acero LF', 'Chen NY', 'Weng T', 'Molina JG', 'Luo F', 'Davies J', 'Le NB', 'Bunge I', 'Volcik KA', 'Le TT', 'Johnston RA', 'Xia Y', 'Eltzschig HK', 'Blackburn MR']","['Animals', 'Bleomycin/toxicity', 'Disease Models, Animal', 'Humans', 'Hypertension, Pulmonary/*etiology/pathology/physiopathology', 'Idiopathic Pulmonary Fibrosis/*etiology/pathology/physiopathology', 'Macrophage Activation', 'Mice', 'Mice, Inbred C57BL', 'Mice, Knockout', 'Myeloid Cells/physiology', 'Receptor, Adenosine A2B/*deficiency/genetics/physiology']",https://pubmed.ncbi.nlm.nih.gov/25318478/
48,ADORA2B,38848865,GPCR Function in Autophagy Control: A Systematic Approach of Chemical Intervention.,"['Sanz-Martinez P', 'Tascher G', 'Cano-Franco S', 'Cabrerizo-Poveda P', 'Munch C', 'Homan EJ', 'Stolz A']","['*Autophagy/drug effects', 'Humans', '*Receptors, G-Protein-Coupled/metabolism', 'Signal Transduction/drug effects', 'Small Molecule Libraries/pharmacology', 'Ligands']",https://pubmed.ncbi.nlm.nih.gov/38848865/
49,ADORA2B,28701304,HIF1A up-regulates the ADORA2B receptor on alternatively activated macrophages and contributes to pulmonary fibrosis.,"['Philip K', 'Mills TW', 'Davies J', 'Chen NY', 'Karmouty-Quintana H', 'Luo F', 'Molina JG', 'Amione-Guerra J', 'Sinha N', 'Guha A', 'Eltzschig HK', 'Blackburn MR']","['Adult', 'Aged', 'Animals', 'Bleomycin/adverse effects/pharmacology', 'Cell Hypoxia/drug effects/genetics', 'Cells, Cultured', 'Female', 'Humans', 'Hypoxia-Inducible Factor 1, alpha Subunit/genetics/*metabolism', 'Interleukin-6/biosynthesis/genetics', 'Macrophages/*metabolism/pathology', '*Macrophages, Alveolar', 'Male', 'Mice', 'Mice, Transgenic', 'Middle Aged', 'Pulmonary Fibrosis/chemically induced/genetics/*metabolism/pathology', 'Receptor, Adenosine A2B/*biosynthesis/genetics', '*Up-Regulation']",https://pubmed.ncbi.nlm.nih.gov/28701304/
50,ADORA2B,30664911,Involvement of A(2B) adenosine receptors as anti-inflammatory in gestational diabesity.,"['Cabalin C', 'Villalobos-Labra R', 'Toledo F', 'Sobrevia L']","['Adenosine/metabolism', 'Cell Hypoxia', 'Diabetes, Gestational/genetics/*metabolism', 'Female', 'Humans', 'Hyperglycemia/genetics/*metabolism', 'Oxidative Stress', 'Pregnancy', 'Receptor, Adenosine A2B/genetics/*metabolism', 'Signal Transduction', '*Up-Regulation']",https://pubmed.ncbi.nlm.nih.gov/30664911/
51,ADORA2B,22531331,Adora2b signaling on bone marrow derived cells dampens myocardial ischemia-reperfusion injury.,"['Koeppen M', 'Harter PN', 'Bonney S', 'Bonney M', 'Reithel S', 'Zachskorn C', 'Mittelbronn M', 'Eckle T']","['Adenosine A2 Receptor Agonists/*pharmacology', 'Aminopyridines/*pharmacology', 'Animals', 'Bone Marrow Cells/*drug effects/physiology', 'Cell Transplantation', 'Enzyme-Linked Immunosorbent Assay', 'Humans', 'Immunohistochemistry', 'Mice', 'Mice, Inbred C57BL', 'Mice, Knockout', 'Mutant Chimeric Proteins', 'Myocardial Ischemia/physiopathology', 'Myocardial Reperfusion Injury/*drug therapy/physiopathology', 'Myocardium/enzymology', 'Neutrophils/physiology', 'Peroxidase/metabolism', 'Receptor, Adenosine A2B/drug effects/genetics/*physiology', 'Signal Transduction/*drug effects/physiology', 'Tumor Necrosis Factor-alpha/metabolism', 'Xanthines/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/22531331/
52,ADORA2B,39285466,Assessing the causal effect of inflammation-related genes on myocarditis: A Mendelian randomization study.,"['Xiao H', 'Chen H', 'Liang W', 'Liu Y', 'Lin K', 'Guo Y']","['Humans', '*Myocarditis/genetics/metabolism/epidemiology', '*Mendelian Randomization Analysis', '*Genome-Wide Association Study', '*Polymorphism, Single Nucleotide', 'Genetic Predisposition to Disease', 'Inflammation/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39285466/
53,ADORA2B,37068869,Novel Potential Mechanisms of Regulatory B Cell-Mediated Immunosuppression.,"['Zheremyan EA', 'Ustiugova AS', 'Radko AI', 'Stasevich EM', 'Uvarova AN', 'Mitkin NA', 'Kuprash DV', 'Korneev KV']","['Humans', '*B-Lymphocytes, Regulatory/metabolism/pathology', 'Immune Tolerance', 'Immunosuppressive Agents/metabolism', 'Immunosuppression Therapy', 'L-Amino Acid Oxidase/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37068869/
54,ADORA2B,23994158,The role of the adenosinergic system in lung fibrosis.,"['Della Latta V', 'Cabiati M', 'Rocchiccioli S', 'Del Ry S', 'Morales MA']","['Adenosine/*immunology/metabolism', 'Animals', 'Humans', 'Lung/drug effects/immunology/metabolism/*pathology', 'Mice', 'Pulmonary Fibrosis/drug therapy/immunology/metabolism/*pathology', 'Purinergic P1 Receptor Antagonists/pharmacology/therapeutic use', 'Receptors, Purinergic P1/*immunology/metabolism']",https://pubmed.ncbi.nlm.nih.gov/23994158/
55,ADORA2B,32141895,Erythrocyte adaptive metabolic reprogramming under physiological and pathological hypoxia.,"[""D'Alessandro A"", 'Xia Y']","['Altitude Sickness/*metabolism/pathology', 'Anemia, Sickle Cell/*metabolism/pathology', 'Animals', 'Cell Hypoxia', '*Cellular Reprogramming', 'Erythrocytes/*metabolism/pathology', 'Humans', 'Mice', 'Oxygen/metabolism', 'Renal Insufficiency, Chronic/*metabolism/pathology']",https://pubmed.ncbi.nlm.nih.gov/32141895/
56,ADORA2B,38367982,Adenosine metabolic signature in circulating CD4+ T cells predicts remission in rheumatoid arthritis.,"['Brown PM', 'Anderson AE', 'Naamane N', 'Lendrem DW', 'Morgan AW', 'Isaacs JD', 'Pratt AG']","['Humans', '*Antirheumatic Agents/therapeutic use', 'CD4-Positive T-Lymphocytes/metabolism', 'Adenosine/therapeutic use', 'Treatment Outcome', '*Arthritis, Rheumatoid/diagnosis/drug therapy', 'Methotrexate/therapeutic use', 'Biomarkers', 'C-Reactive Protein/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38367982/
57,ADORA2B,26228921,Adenosine A2b receptor promotes progression of human oral cancer.,"['Kasama H', 'Sakamoto Y', 'Kasamatsu A', 'Okamoto A', 'Koyama T', 'Minakawa Y', 'Ogawara K', 'Yokoe H', 'Shiiba M', 'Tanzawa H', 'Uzawa K']","['Aged', 'Carcinoma, Squamous Cell/*genetics/metabolism/*pathology', 'Cell Hypoxia', 'Cell Line, Tumor', 'Cell Proliferation', 'Female', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Hypoxia-Inducible Factor 1, alpha Subunit/*metabolism', 'Male', 'Middle Aged', 'Mouth Neoplasms/*genetics/metabolism/*pathology', 'Receptor, Adenosine A2B/*genetics/metabolism', 'Up-Regulation']",https://pubmed.ncbi.nlm.nih.gov/26228921/
58,ADORA2B,31494223,Differential role of adenosine signaling cascade in acute and chronic pain.,"['Adebiyi MG', 'Manalo J', 'Kellems RE', 'Xia Y']","['Acute Pain/*metabolism', 'Adenosine/*metabolism', 'Animals', 'Chronic Pain/*metabolism', 'Humans', 'Signal Transduction/*physiology']",https://pubmed.ncbi.nlm.nih.gov/31494223/
59,ADORA2B,22634345,Adenosine signaling in normal and sickle erythrocytes and beyond.,"['Zhang Y', 'Xia Y']","['2,3-Diphosphoglycerate/metabolism', 'Adenosine/*metabolism', 'Anemia, Sickle Cell/*physiopathology', 'Animals', 'Erythrocytes/*physiology', 'Erythrocytes, Abnormal/*physiology', 'Humans', 'Hypoxia', 'Killer Cells, Natural/immunology', 'Mice', 'Mice, Knockout', 'Receptor, Adenosine A2A/metabolism', 'Receptor, Adenosine A2B/metabolism', '*Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/22634345/
60,CYP1A2,33397254,Metabolism and Mechanism of Human Cytochrome P450 Enzyme 1A2.,"['Guo J', 'Zhu X', 'Badawy S', 'Ihsan A', 'Liu Z', 'Xie C', 'Wang X']","['Animals', 'Cytochrome P-450 CYP1A2/*metabolism', 'Cytochrome P-450 CYP1A2 Inhibitors/*pharmacology', 'Enzyme Inhibitors/pharmacology', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/33397254/
61,CYP1A2,32616876,EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency.,"['Baumgartner-Parzer S', 'Witsch-Baumgartner M', 'Hoeppner W']","['Adrenal Hyperplasia, Congenital/diagnosis/*genetics', 'Consensus Development Conferences as Topic', 'Cytochrome P-450 CYP1A2/*deficiency/genetics', 'Databases, Factual/standards', 'Europe', 'Genetic Testing/methods/*standards', 'Humans', '*Practice Guidelines as Topic', 'Quality Assurance, Health Care/standards']",https://pubmed.ncbi.nlm.nih.gov/32616876/
62,CYP1A2,10493258,Human cytochrome P4501A2.,"['Landi MT', 'Sinha R', 'Lang NP', 'Kadlubar FF']","['Biotransformation/*genetics', 'Carcinogens/*metabolism', 'Cytochrome P-450 CYP1A2/*genetics/*physiology', 'Enzyme Induction/drug effects', 'Female', 'Genetic Predisposition to Disease/classification/*genetics', 'Genetic Variation', '*Genetics, Population', 'Genotype', 'Humans', 'Liver/enzymology', 'Male', 'Neoplasms/*genetics', 'Phenotype', 'Polymorphism, Genetic/*genetics', 'Smoking/adverse effects']",https://pubmed.ncbi.nlm.nih.gov/10493258/
63,CYP1A2,29282363,The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis.,"['Koonrungsesomboon N', 'Khatsri R', 'Wongchompoo P', 'Teekachunhatean S']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Caffeine/*metabolism', 'Cytochrome P-450 CYP1A2/biosynthesis/*genetics', 'Female', 'Heterozygote', 'Homozygote', 'Humans', 'Male', 'Middle Aged', 'Pharmacogenetics', '*Pharmacogenomic Variants', 'Phenotype', '*Polymorphism, Genetic', 'Risk Factors', 'Smokers', 'Smoking/adverse effects/genetics/metabolism', 'Substrate Specificity', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/29282363/
64,CYP1A2,33484438,"Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes.","['Kwon YJ', 'Shin S', 'Chun YJ']","['Animals', 'Cytochrome P-450 CYP1A1/genetics/*metabolism', 'Cytochrome P-450 CYP1A2/genetics/*metabolism', 'Cytochrome P-450 CYP1B1/genetics/*metabolism', 'Disease Models, Animal', 'Genetic Predisposition to Disease', 'Humans', 'Ligands', 'Receptors, Aryl Hydrocarbon/metabolism', 'Xenobiotics/*pharmacokinetics']",https://pubmed.ncbi.nlm.nih.gov/33484438/
65,CYP1A2,37683226,Will ChatGPT3 Substitute for us as Clozapine Experts?,"['de Leon J', 'De Las Cuevas C']","['Humans', '*Clozapine', '*Antipsychotic Agents', 'Cytochrome P-450 CYP1A2/metabolism', 'Artificial Intelligence', 'Black or African American']",https://pubmed.ncbi.nlm.nih.gov/37683226/
66,CYP1A2,34590872,Inflammation Suppresses Patients' Ability to Metabolize Cytochrome P450 Substrate Drugs.,['White CM'],"['*Cytochrome P-450 CYP1A2/metabolism', 'Cytochrome P-450 CYP2C19', 'Cytochrome P-450 CYP2D6', '*Cytochrome P-450 CYP3A', 'Cytochrome P-450 Enzyme System/metabolism', 'Drug Interactions', 'Humans', 'Inflammation/drug therapy']",https://pubmed.ncbi.nlm.nih.gov/34590872/
67,CYP1A2,36065858,[Smoking cessation and drug interactions].,"['Madsen HKL', 'Gullov M', 'Farver-Vestergaard I', 'Hjort P', 'Nielsen LP', 'Lokke A', 'Haastrup MB']","['*Clozapine/adverse effects', 'Cytochrome P-450 CYP1A2/metabolism/pharmacology', 'Drug Interactions', 'Humans', 'Olanzapine', '*Smoking Cessation']",https://pubmed.ncbi.nlm.nih.gov/36065858/
68,CYP1A2,22724322,[Smoking and drug interactions].,"['Rouhos A', 'Raaska K']","['Cytochrome P-450 CYP1A2/*metabolism', '*Drug Interactions', 'Enzyme Induction', 'Humans', 'Smoking/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/22724322/
69,CYP1A2,36623673,Genic-intergenic polymorphisms of CYP1A genes and their clinical impact.,"['Kukal S', 'Thakran S', 'Kanojia N', 'Yadav S', 'Mishra MK', 'Guin D', 'Singh P', 'Kukreti R']","['Caffeine', '*Cytochrome P-450 CYP1A1/genetics', '*Cytochrome P-450 CYP1A2/genetics/metabolism', 'Mixed Function Oxygenases/genetics', 'Polymorphism, Single Nucleotide', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/36623673/
70,CYP1A2,36823774,Effects of xenobiotics on CYP1 enzyme-mediated biotransformation and bioactivation of estradiol.,"['Mao X', 'Li H', 'Zheng J']","['Humans', '*Cytochrome P-450 CYP1A2/genetics/metabolism', 'Cytochrome P-450 CYP1A1/genetics/metabolism', 'Cytochrome P450 Family 1/metabolism', 'Xenobiotics/pharmacology', 'Estradiol/pharmacology/metabolism', '*Neoplasms', 'Biotransformation']",https://pubmed.ncbi.nlm.nih.gov/36823774/
71,CYP1A2,35995710,"Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate Cancer.","['Gregg JR', 'Kim J', 'Logothetis C', 'Hanash S', 'Zhang X', 'Manyam G', 'Muir K', 'Giles GG', 'Stanford JL', 'Berndt SI', 'Kogevinas M', 'Brenner H', 'Eeles RA', 'Wei P', 'Daniel CR']","['Male', 'Humans', '*Caffeine/metabolism', 'Coffee', 'Cytochrome P-450 CYP1A2/genetics/metabolism', 'Risk Factors', 'Australia', 'Genotype', '*Prostatic Neoplasms/genetics']",https://pubmed.ncbi.nlm.nih.gov/35995710/
72,CYP1A2,37898643,CYP1A2 expression rather than genotype is associated with olanzapine concentration in psychiatric patients.,"['Fekete F', 'Menus A', 'Toth K', 'Kiss AF', 'Minus A', 'Sirok D', 'Belic A', 'Poti A', 'Csukly G', 'Monostory K']","['Humans', 'Olanzapine/adverse effects', '*Cytochrome P-450 CYP1A2/genetics/metabolism', 'Cytochrome P-450 CYP2D6/genetics/metabolism', '*Antipsychotic Agents/adverse effects', 'Genotype', 'RNA, Messenger']",https://pubmed.ncbi.nlm.nih.gov/37898643/
73,CYP1A2,37029915,Genetics of caffeine and brain-related outcomes - a systematic review of observational studies and randomized trials.,"['Kapellou A', 'King A', 'Graham CAM', 'Pilic L', 'Mavrommatis Y']","['Adult', 'Humans', '*Caffeine/metabolism', 'Cytochrome P-450 CYP1A2/genetics/metabolism', '*Sleep Initiation and Maintenance Disorders', 'Genome-Wide Association Study', 'Randomized Controlled Trials as Topic', 'Brain/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37029915/
74,CYP1A2,15199661,Some aspects of genetic polymorphism in the biotransformation of antidepressants.,['Brosen K'],"['Animals', 'Antidepressive Agents/*pharmacokinetics', 'Biotransformation/genetics', 'Cytochrome P-450 CYP1A2/genetics/metabolism', 'Cytochrome P-450 CYP2D6/genetics/metabolism', 'Cytochrome P-450 Enzyme System/genetics/metabolism', 'Humans', 'Polymorphism, Genetic/*genetics', 'Selective Serotonin Reuptake Inhibitors/pharmacokinetics']",https://pubmed.ncbi.nlm.nih.gov/15199661/
75,CYP1A2,33403509,"Novel insights on caffeine supplementation, CYP1A2 genotype, physiological responses and exercise performance.","['Barreto G', 'Grecco B', 'Merola P', 'Reis CEG', 'Gualano B', 'Saunders B']","['Athletic Performance/*physiology', 'Caffeine/*administration & dosage', 'Central Nervous System Stimulants/*administration & dosage', 'Cytochrome P-450 CYP1A2/*genetics', '*Exercise', 'Humans', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/33403509/
76,CYP1A2,16684659,The role of trace metals in cytochrome P4501 regulation.,['Kaminsky L'],"['Animals', 'Aryl Hydrocarbon Hydroxylases/biosynthesis/genetics/*metabolism', 'Cytochrome P-450 CYP1A1/biosynthesis/genetics/*metabolism', 'Cytochrome P-450 CYP1A2/biosynthesis/genetics/*metabolism', 'Cytochrome P-450 CYP1B1', 'Enzyme Induction', 'Gene Expression Regulation, Enzymologic', 'Humans', 'Protein Processing, Post-Translational', 'Trace Elements/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/16684659/
77,CYP1A2,30248915,The Role of Genetics in Moderating the Inter-Individual Differences in the Ergogenicity of Caffeine.,"['Southward K', 'Rutherfurd-Markwick K', 'Badenhorst C', 'Ali A']","['Anxiety/genetics', 'Athletes/psychology', 'Athletic Performance/psychology', 'Caffeine/*pharmacology', 'Central Nervous System Stimulants/*pharmacology', 'Cytochrome P-450 CYP1A2/*genetics/metabolism', 'Dietary Supplements', 'Doping in Sports', 'Exercise/*physiology/psychology', 'Humans', 'Individuality', 'Performance-Enhancing Substances/*pharmacology', 'Physical Endurance/drug effects/*genetics', 'Precision Medicine', 'Receptor, Adenosine A2A/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/30248915/
78,CYP1A2,38862812,Circadian time-dependent effects of experimental colitis on theophylline disposition and toxicity.,"['Yang Y', 'Wu P', 'Guo J', 'Pan Z', 'Lin S', 'Zeng W', 'Wang C', 'Dong Z', 'Wang S']","['*Theophylline/pharmacokinetics', 'Animals', '*Colitis/chemically induced/metabolism', 'Mice', '*Mice, Inbred C57BL', '*Circadian Rhythm/drug effects', 'Male', 'Dextran Sulfate', 'Cytochrome P-450 CYP1A2/metabolism/genetics', 'Humans', 'Microsomes, Liver/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38862812/
79,CYP1A2,38877514,METTL3-induced circ_0008345 contributes to the progression of colorectal cancer via the microRNA-182-5p/CYP1A2 pathway.,"['Hou C', 'Liu J', 'Liu J', 'Yao D', 'Liang F', 'Qin C', 'Ma Z']","['*MicroRNAs/genetics/metabolism', '*Colorectal Neoplasms/genetics/pathology/metabolism', '*RNA, Circular/genetics/metabolism', 'Humans', 'Animals', 'Mice', '*Methyltransferases/metabolism/genetics', '*Disease Progression', '*Cytochrome P-450 CYP1A2/genetics/metabolism', 'Gene Expression Regulation, Neoplastic', 'Cell Proliferation', 'Cell Line, Tumor', 'Male', 'Female', 'Signal Transduction', 'Mice, Nude']",https://pubmed.ncbi.nlm.nih.gov/38877514/
80,DHODH,33981038,DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer.,"['Mao C', 'Liu X', 'Zhang Y', 'Lei G', 'Yan Y', 'Lee H', 'Koppula P', 'Wu S', 'Zhuang L', 'Fang B', 'Poyurovsky MV', 'Olszewski K', 'Gan B']","['Animals', 'Biphenyl Compounds/pharmacology', 'Cell Line, Tumor', 'Dihydroorotate Dehydrogenase/genetics/*metabolism', 'Female', '*Ferroptosis', 'Gene Deletion', 'Humans', 'Lipid Peroxidation', 'Metabolomics', 'Mice, Nude', 'Mitochondria/*metabolism', 'Neoplasms/*enzymology', 'Phospholipid Hydroperoxide Glutathione Peroxidase/antagonists & inhibitors/genetics', 'Xenograft Model Antitumor Assays', 'Mice']",https://pubmed.ncbi.nlm.nih.gov/33981038/
81,DHODH,36368321,Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma.,"['Gwynne WD', 'Suk Y', 'Custers S', 'Mikolajewicz N', 'Chan JK', 'Zador Z', 'Chafe SC', 'Zhai K', 'Escudero L', 'Zhang C', 'Zaslaver O', 'Chokshi C', 'Shaikh MV', 'Bakhshinyan D', 'Burns I', 'Chaudhry I', 'Nachmani O', 'Mobilio D', 'Maich WT', 'Mero P', 'Brown KR', 'Quaile AT', 'Venugopal C', 'Moffat J', 'Montenegro-Burke JR', 'Singh SK']","['Child', 'Humans', '*Medulloblastoma/drug therapy/genetics/metabolism', 'Dihydroorotate Dehydrogenase', 'Cell Line, Tumor', 'Neoplasm Recurrence, Local', 'Pyrimidines/therapeutic use', '*Cerebellar Neoplasms/drug therapy/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36368321/
82,DHODH,34855504,Fumarate is a terminal electron acceptor in the mammalian electron transport chain.,"['Spinelli JB', 'Rosen PC', 'Sprenger HG', 'Puszynska AM', 'Mann JL', 'Roessler JM', 'Cangelosi AL', 'Henne A', 'Condon KJ', 'Zhang T', 'Kunchok T', 'Lewis CA', 'Chandel NS', 'Sabatini DM']","['Animals', 'Cell Hypoxia', 'Cell Line', 'Cell Line, Tumor', 'Dihydroorotate Dehydrogenase/metabolism', '*Electron Transport', 'Electron Transport Complex I/metabolism', 'Electron Transport Complex III/metabolism', 'Electron Transport Complex IV/metabolism', '*Electrons', 'Female', 'Fumarates/*metabolism', 'Humans', 'Mice', 'Mice, Inbred C57BL', 'Mitochondria/metabolism', 'Oxidation-Reduction', 'Oxygen/metabolism', 'Succinate Dehydrogenase/metabolism', 'Ubiquinone/analogs & derivatives/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34855504/
83,DHODH,37497000,"Effects of DNA, RNA, and Protein Methylation on the Regulation of Ferroptosis.","['Wang X', 'Kong X', 'Feng X', 'Jiang DS']","['Humans', 'Animals', 'Methylation', '*Ferroptosis', 'DNA/metabolism', 'RNA/metabolism', 'Proteins/metabolism', 'Iron/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37497000/
84,DHODH,32641834,Mitochondrial ubiquinol oxidation is necessary for tumour growth.,"['Martinez-Reyes I', 'Cardona LR', 'Kong H', 'Vasan K', 'McElroy GS', 'Werner M', 'Kihshen H', 'Reczek CR', 'Weinberg SE', 'Gao P', 'Steinert EM', 'Piseaux R', 'Budinger GRS', 'Chandel NS']","['Animals', 'Cell Line, Tumor', 'Cell Proliferation', 'Ciona intestinalis/enzymology', 'Citric Acid Cycle', 'Cytosol/metabolism', 'Dihydroorotate Dehydrogenase', 'Electron Transport', 'Electron Transport Complex I/metabolism', 'Electron Transport Complex II/metabolism', 'Electron Transport Complex III/deficiency/metabolism', 'Humans', 'Levilactobacillus brevis/enzymology', 'Male', 'Mice', 'Mitochondria/enzymology/*metabolism', 'Mitochondrial Proteins/genetics/metabolism', 'Multienzyme Complexes/genetics/metabolism', 'NAD/metabolism', 'NADH, NADPH Oxidoreductases/genetics/metabolism', 'Neoplasms/enzymology/*metabolism/*pathology', 'Oxidative Phosphorylation', 'Oxidoreductases/genetics/metabolism', 'Oxidoreductases Acting on CH-CH Group Donors/metabolism', 'Plant Proteins/genetics/metabolism', 'Ubiquinone/*analogs & derivatives/metabolism']",https://pubmed.ncbi.nlm.nih.gov/32641834/
85,DHODH,36078133,Molecular Mechanisms of Ferroptosis and Relevance to Cardiovascular Disease.,"['Xie LH', 'Fefelova N', 'Pamarthi SH', 'Gwathmey JK']","['*COVID-19', '*Cardiovascular Diseases', '*Ferroptosis', 'Humans', 'Iron/metabolism', 'Lipid Peroxidation', '*Reperfusion Injury']",https://pubmed.ncbi.nlm.nih.gov/36078133/
86,DHODH,27641501,Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia.,"['Sykes DB', 'Kfoury YS', 'Mercier FE', 'Wawer MJ', 'Law JM', 'Haynes MK', 'Lewis TA', 'Schajnovitz A', 'Jain E', 'Lee D', 'Meyer H', 'Pierce KA', 'Tolliday NJ', 'Waller A', 'Ferrara SJ', 'Eheim AL', 'Stoeckigt D', 'Maxcy KL', 'Cobert JM', 'Bachand J', 'Szekely BA', 'Mukherjee S', 'Sklar LA', 'Kotz JD', 'Clish CB', 'Sadreyev RI', 'Clemons PA', 'Janzer A', 'Schreiber SL', 'Scadden DT']","['Animals', 'Antineoplastic Agents/chemistry/isolation & purification/*therapeutic use', 'Cell Differentiation', 'Dihydroorotate Dehydrogenase', 'Enzyme Inhibitors/chemistry/isolation & purification/*therapeutic use', 'High-Throughput Screening Assays', 'Homeodomain Proteins/genetics', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy/genetics/*pathology', 'Mice', '*Molecular Targeted Therapy', 'Myeloid Cells/pathology', 'Oxidoreductases Acting on CH-CH Group Donors/*antagonists & inhibitors/metabolism', 'Pyrimidines/metabolism', 'Small Molecule Libraries/chemistry/isolation & purification/therapeutic use', 'Xenograft Model Antitumor Assays']",https://pubmed.ncbi.nlm.nih.gov/27641501/
87,DHODH,38838551,A targetable PRR11-DHODH axis drives ferroptosis- and temozolomide-resistance in glioblastoma.,"['Miao Z', 'Xu L', 'Gu W', 'Ren Y', 'Li R', 'Zhang S', 'Chen C', 'Wang H', 'Ji J', 'Chen J']","['Humans', '*Ferroptosis/drug effects/genetics', '*Glioblastoma/metabolism/drug therapy/genetics/pathology', '*Temozolomide/pharmacology', '*Drug Resistance, Neoplasm/genetics', 'Cell Line, Tumor', 'Mice', '*Dihydroorotate Dehydrogenase/metabolism', 'Animals', 'Gene Expression Regulation, Neoplastic/drug effects', 'Brain Neoplasms/drug therapy/metabolism/pathology/genetics']",https://pubmed.ncbi.nlm.nih.gov/38838551/
88,DHODH,38805974,Redistribution of defective mitochondria-mediated dihydroorotate dehydrogenase imparts 5-fluorouracil resistance in colorectal cancer.,"['Dong S', 'Zhang M', 'Cheng Z', 'Zhang X', 'Liang W', 'Li S', 'Li L', 'Xu Q', 'Song S', 'Liu Z', 'Yang G', 'Zhao X', 'Tao Z', 'Liang S', 'Wang K', 'Zhang G', 'Hu S']","['*Dihydroorotate Dehydrogenase/metabolism', '*Fluorouracil/pharmacology', 'Humans', '*Colorectal Neoplasms/drug therapy/metabolism/genetics/pathology', '*Mitochondria/metabolism/drug effects', '*Drug Resistance, Neoplasm', '*Oxidoreductases Acting on CH-CH Group Donors/metabolism/genetics', 'Mice', 'Animals', 'Cell Line, Tumor', 'Xenograft Model Antitumor Assays', 'Lipid Peroxidation/drug effects']",https://pubmed.ncbi.nlm.nih.gov/38805974/
89,DHODH,38423231,A novel mitochondria-targeting DHODH inhibitor induces robust ferroptosis and alleviates immune suppression.,"['Hai Y', 'Fan R', 'Zhao T', 'Lin R', 'Zhuang J', 'Deng A', 'Meng S', 'Hou Z', 'Wei G']","['Humans', 'Animals', 'Mice', 'Dihydroorotate Dehydrogenase', '*Oxidoreductases Acting on CH-CH Group Donors', '*Melanoma/drug therapy', '*Ferroptosis', 'Enzyme Inhibitors/pharmacology', 'Mitochondria']",https://pubmed.ncbi.nlm.nih.gov/38423231/
90,DHODH,38646934,Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia.,"['Elgamal OA', 'Fobare S', 'Vibhute S', 'Mehmood A', 'Vroom DC', 'Johnson ML', 'Stearns B', 'Lerma JR', 'Truxall J', 'Stahl E', 'Carmichael B', 'Orwick SJ', 'Mims AS', 'Curran E', 'Santhanam R', 'Tridandapani S', 'Phelps MA', 'Xie Z', 'Coss CC', 'Baker SD', 'Patrick J', 'Ezzell JK', 'Rai J', 'Pan J', 'Rai SN', 'Stillwell C', 'Wunderlich M', 'Abdulrahim M', 'Goodwin TE', 'Hilinski G', 'Bennett CE', 'Hertlein E', 'Byrd JC']","['*Leukemia, Myeloid, Acute/drug therapy/immunology', 'Humans', '*Pyrimidines/therapeutic use', 'Mice', 'Animals', 'Dihydroorotate Dehydrogenase', 'Immunotherapy/methods', 'Cell Line, Tumor', 'Xenograft Model Antitumor Assays', 'Female']",https://pubmed.ncbi.nlm.nih.gov/38646934/
91,DHODH,33986176,Cell-specific transcriptional control of mitochondrial metabolism by TIF1gamma drives erythropoiesis.,"['Rossmann MP', 'Hoi K', 'Chan V', 'Abraham BJ', 'Yang S', 'Mullahoo J', 'Papanastasiou M', 'Wang Y', 'Elia I', 'Perlin JR', 'Hagedorn EJ', 'Hetzel S', 'Weigert R', 'Vyas S', 'Nag PP', 'Sullivan LB', 'Warren CR', 'Dorjsuren B', 'Greig EC', 'Adatto I', 'Cowan CA', 'Schreiber SL', 'Young RA', 'Meissner A', 'Haigis MC', 'Hekimi S', 'Carr SA', 'Zon LI']","['Animals', 'Citric Acid Cycle', 'DNA Methylation', 'Dihydroorotate Dehydrogenase', 'Electron Transport', 'Embryo, Nonmammalian/metabolism', 'Enzyme Inhibitors/pharmacology', '*Erythropoiesis', 'Gene Expression Regulation', 'Histones/metabolism', 'Leflunomide/pharmacology', 'Metabolic Networks and Pathways', 'Methylation', 'Mitochondria/*metabolism', 'Oxidoreductases Acting on CH-CH Group Donors/antagonists & inhibitors', 'Oxygen Consumption', 'Transcription Factors/genetics/*metabolism', '*Transcription, Genetic', 'Ubiquinone/metabolism', 'Zebrafish/embryology/genetics', 'Zebrafish Proteins/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/33986176/
92,DHODH,21801113,Leflunomide: dermatologic perspective.,"['Sehgal VN', 'Verma P']","['Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use', 'Antirheumatic Agents/*therapeutic use', 'Dermatologic Agents/*therapeutic use', 'Dihydroorotate Dehydrogenase', 'Enzyme Inhibitors/therapeutic use', 'Humans', 'Isoxazoles/*therapeutic use', 'Leflunomide', 'Oxidoreductases Acting on CH-CH Group Donors/antagonists & inhibitors', 'Skin Diseases/*drug therapy']",https://pubmed.ncbi.nlm.nih.gov/21801113/
93,DHODH,36399287,Targeting lipid metabolism for ferroptotic cancer therapy.,"['Luo M', 'Yan J', 'Hu X', 'Li H', 'Li H', 'Liu Q', 'Chen Y', 'Zou Z']","['Humans', 'Apoptosis', 'Lipid Metabolism', 'Lipid Peroxidation', '*Ferroptosis', '*Neoplasms/metabolism', 'Iron/metabolism', 'Adaptor Proteins, Signal Transducing/metabolism', 'Apoptosis Regulatory Proteins/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36399287/
94,DHODH,34111397,"Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors ""leflunomide"" and ""teriflunomide"" in Covid-19: A narrative review.","['Kaur H', 'Sarma P', 'Bhattacharyya A', 'Sharma S', 'Chhimpa N', 'Prajapat M', 'Prakash A', 'Kumar S', 'Singh A', 'Singh R', 'Avti P', 'Thota P', 'Medhi B']","['Animals', 'Antiviral Agents/adverse effects/*pharmacology/therapeutic use', 'Crotonates/adverse effects/*pharmacology/therapeutic use', 'Dihydroorotate Dehydrogenase', 'Drug Repositioning', 'Enzyme Inhibitors/adverse effects/*pharmacology/therapeutic use', 'Humans', 'Hydroxybutyrates/adverse effects/*pharmacology/therapeutic use', 'Leflunomide/adverse effects/*pharmacology/therapeutic use', 'Nitriles/adverse effects/*pharmacology/therapeutic use', 'Oxidoreductases Acting on CH-CH Group Donors/*antagonists & inhibitors', 'Toluidines/adverse effects/*pharmacology/therapeutic use', '*COVID-19 Drug Treatment']",https://pubmed.ncbi.nlm.nih.gov/34111397/
95,DHODH,34348625,DHODH Hot Spots: An Underexplored Source to Guide Drug Development Efforts.,"['Froes TQ', 'Zapata LCC', 'Akamine JS', 'Castilho MS', 'Nonato MC']","['Antiviral Agents', 'Dihydroorotate Dehydrogenase/*antagonists & inhibitors/*chemistry/metabolism', 'Drug Development/*trends', 'Humans', 'Trypanosoma cruzi/enzymology']",https://pubmed.ncbi.nlm.nih.gov/34348625/
96,DHODH,38575587,POLQ inhibition attenuates the stemness and ferroptosis resistance in gastric cancer cells via downregulation of dihydroorotate dehydrogenase.,"['Peng Y', 'Zheng W', 'Chen Y', 'Lei X', 'Yang Z', 'Yang Y', 'Liang W', 'Sun K', 'Li G', 'Yu J']","['Humans', 'Cell Line, Tumor', 'Dihydroorotate Dehydrogenase', 'Down-Regulation/genetics', '*Ferroptosis/genetics', 'Novobiocin', '*Stomach Neoplasms/drug therapy/genetics']",https://pubmed.ncbi.nlm.nih.gov/38575587/
97,DHODH,28666740,The dihydroorotate dehydrogenases: Past and present.,"['Reis RAG', 'Calil FA', 'Feliciano PR', 'Pinheiro MP', 'Nonato MC']","['Animals', 'Bacterial Infections/drug therapy/enzymology', 'Dihydroorotate Dehydrogenase', 'Drug Discovery', 'Enzyme Inhibitors/chemistry/therapeutic use', '*Flavoproteins/antagonists & inhibitors/chemistry/metabolism', 'Humans', 'Immune System Diseases/drug therapy/enzymology', 'Neoplasms/drug therapy/enzymology', '*Oxidoreductases Acting on CH-CH Group Donors/antagonists & inhibitors/chemistry/metabolism', 'Parasitic Diseases/drug therapy/enzymology', 'Pyrimidines/chemistry/metabolism', 'Virus Diseases/drug therapy/enzymology']",https://pubmed.ncbi.nlm.nih.gov/28666740/
98,DHODH,23452331,On dihydroorotate dehydrogenases and their inhibitors and uses.,"['Munier-Lehmann H', 'Vidalain PO', 'Tangy F', 'Janin YL']","['Animals', 'Bacteria/enzymology', 'Coccidia/enzymology', 'Coccidiostats/therapeutic use', 'Dihydroorotate Dehydrogenase', 'Enzyme Inhibitors/*therapeutic use', 'Humans', 'Oxidoreductases Acting on CH-CH Group Donors/*antagonists & inhibitors/chemistry/genetics']",https://pubmed.ncbi.nlm.nih.gov/23452331/
99,PTGS2,35908547,Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment.,"['Gong Z', 'Li Q', 'Shi J', 'Wei J', 'Li P', 'Chang CH', 'Shultz LD', 'Ren G']","['Cyclooxygenase 2/genetics', 'Fibroblasts/pathology', 'Humans', 'Lung/pathology', '*Lung Neoplasms/pathology', '*Receptors, Prostaglandin E, EP2 Subtype', 'Receptors, Prostaglandin E, EP4 Subtype/genetics', 'Tumor Microenvironment']",https://pubmed.ncbi.nlm.nih.gov/35908547/
100,PTGS2,37705740,The PTGS2/COX2-PGE(2) signaling cascade in inflammation: Pro or anti? A case study with type 1 diabetes mellitus.,"['Martin-Vazquez E', 'Cobo-Vuilleumier N', 'Lopez-Noriega L', 'Lorenzo PI', 'Gauthier BR']","['Humans', '*Dinoprostone', 'Cyclooxygenase 2/genetics', '*Diabetes Mellitus, Type 1', 'Signal Transduction', 'Inflammation']",https://pubmed.ncbi.nlm.nih.gov/37705740/
101,PTGS2,33974977,Verification of ferroptosis and pyroptosis and identification of PTGS2 as the hub gene in human coronary artery atherosclerosis.,"['Zhou Y', 'Zhou H', 'Hua L', 'Hou C', 'Jia Q', 'Chen J', 'Zhang S', 'Wang Y', 'He S', 'Jia E']","['*Atherosclerosis/genetics', 'Coronary Vessels', 'Cyclooxygenase 2/genetics', '*Ferroptosis', 'Humans', 'Pyroptosis']",https://pubmed.ncbi.nlm.nih.gov/33974977/
102,PTGS2,36757813,Stabilization of E-cadherin adhesions by COX-2/GSK3beta signaling is a targetable pathway in metastatic breast cancer.,"['Balamurugan K', 'Poria DK', 'Sehareen SW', 'Krishnamurthy S', 'Tang W', 'McKennett L', 'Padmanaban V', 'Czarra K', 'Ewald AJ', 'Ueno NT', 'Ambs S', 'Sharan S', 'Sterneck E']","['Humans', 'Cadherins/genetics/metabolism', 'Celecoxib/pharmacology/therapeutic use', 'Cell Line, Tumor', 'Cyclooxygenase 2/genetics/metabolism', '*Dinoprostone', 'Glycogen Synthase Kinase 3 beta/metabolism', 'Signal Transduction/genetics', '*Triple Negative Breast Neoplasms/drug therapy/genetics', 'Female']",https://pubmed.ncbi.nlm.nih.gov/36757813/
103,PTGS2,32184095,COX-2 in liver fibrosis.,"['Yang H', 'Xuefeng Y', 'Shandong W', 'Jianhua X']","['Animals', '*Cyclooxygenase 2/genetics/metabolism', 'Humans', 'Liver Cirrhosis/*metabolism', 'Signal Transduction/genetics']",https://pubmed.ncbi.nlm.nih.gov/32184095/
104,PTGS2,38762541,Endothelial ROBO4 suppresses PTGS2/COX-2 expression and inflammatory diseases.,"['Tanaka M', 'Shirakura K', 'Takayama Y', 'Muatsui M', 'Watanabe Y', 'Yamamoto T', 'Takahashi J', 'Tanaka S', 'Hino N', 'Doi T', 'Obana M', 'Fujio Y', 'Takayama K', 'Okada Y']","['*Cyclooxygenase 2/metabolism/genetics', 'Animals', 'Mice', '*Inflammation/metabolism/genetics', 'Humans', '*Receptors, Cell Surface/metabolism/genetics', 'Mice, Knockout', 'Mice, Inbred C57BL', 'Male', 'Endothelial Cells/metabolism', 'Roundabout Proteins']",https://pubmed.ncbi.nlm.nih.gov/38762541/
105,PTGS2,38413694,Apomorphine is a potent inhibitor of ferroptosis independent of dopaminergic receptors.,"['Miyauchi A', 'Watanabe C', 'Yamada N', 'Jimbo EF', 'Kobayashi M', 'Ohishi N', 'Nagayoshi A', 'Aoki S', 'Kishita Y', 'Ohtake A', 'Ohno N', 'Takahashi M', 'Yamagata T', 'Osaka H']","['Humans', 'Apomorphine/pharmacology', '*Ferroptosis', 'Cyclooxygenase 2/genetics', 'Receptors, Dopamine D2/metabolism', 'Dopamine Agonists/pharmacology', '*Mitochondrial Diseases']",https://pubmed.ncbi.nlm.nih.gov/38413694/
106,PTGS2,29076197,Gestational tissue inflammatory biomarkers at term labor: A systematic review of literature.,"['Hadley EE', 'Richardson LS', 'Torloni MR', 'Menon R']","['Animals', 'Antimicrobial Cationic Peptides', 'Biomarkers/*metabolism', 'Cathelicidins/genetics/metabolism', 'Cyclooxygenase 2/genetics/metabolism', 'Female', 'Humans', 'Inflammation/*immunology', 'Inflammation Mediators/*metabolism', 'Metalloporphyrins/genetics/*metabolism', 'Parturition/*immunology', 'Pregnancy/*immunology', 'Uterus/*physiology']",https://pubmed.ncbi.nlm.nih.gov/29076197/
107,PTGS2,20876365,Cyclooxygenase-2 expression in animal cancers.,['Dore M'],"['Animals', 'Cyclooxygenase 2/genetics/*metabolism', 'Gene Expression Regulation, Enzymologic/*physiology', 'Gene Expression Regulation, Neoplastic/*physiology', 'Humans', 'Neoplasms/*enzymology/metabolism']",https://pubmed.ncbi.nlm.nih.gov/20876365/
108,PTGS2,23810915,PTGS2 (Cyclooxygenase-2) expression and survival among colorectal cancer patients: a systematic review.,"['Kunzmann AT', 'Murray LJ', 'Cardwell CR', 'McShane CM', 'McMenamin UC', 'Cantwell MM']","['Colorectal Neoplasms/*enzymology/genetics/*mortality', 'Cyclooxygenase 2/*biosynthesis/genetics/metabolism', 'Disease-Free Survival', 'Humans', 'Prognosis', 'Survival Analysis']",https://pubmed.ncbi.nlm.nih.gov/23810915/
109,PTGS2,22385680,Thiamine and Parkinson's disease.,"[""Lu'o'ng Kv"", 'Nguyen LT']","['Animals', 'Biomarkers/blood', 'Cyclooxygenase 2/genetics/metabolism', 'Humans', 'Oxidative Stress/genetics', 'Parkinson Disease/*blood/*drug therapy/genetics', 'Reactive Oxygen Species/metabolism', 'Thiamine/*blood/genetics/*therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/22385680/
110,PTGS2,16469511,"Aspirin ""resistance"".","['Schror K', 'Weber AA', 'Hohlfeld T']","['Aspirin/*pharmacology', 'Blood Platelets/*drug effects', 'Cyclooxygenase 2/genetics/physiology', '*Drug Resistance', 'Humans', 'Isoenzymes/physiology', 'Membrane Proteins/genetics/physiology']",https://pubmed.ncbi.nlm.nih.gov/16469511/
111,PTGS2,26685098,"Cyclooxygenase 2: its regulation, role and impact in airway inflammation.","['Rumzhum NN', 'Ammit AJ']","['Animals', 'Anti-Inflammatory Agents/pharmacology/therapeutic use', 'Cyclooxygenase 2/*genetics/*metabolism', 'Cyclooxygenase 2 Inhibitors/pharmacology/therapeutic use', 'Cytokines/metabolism', 'Gene Expression Regulation', 'Humans', 'Inflammation/drug therapy/*etiology/*metabolism', 'Inflammation Mediators/metabolism', 'Respiratory Tract Diseases/drug therapy/*etiology/*metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/26685098/
112,PTGS2,20179228,Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward.,"['Menter DG', 'Schilsky RL', 'DuBois RN']","['Animals', 'Antineoplastic Agents/pharmacology', 'Cyclooxygenase 2/genetics/*metabolism', 'Humans', 'Neoplasms/drug therapy/*enzymology', 'Prostaglandins/metabolism', 'Risk', 'Signal Transduction/physiology']",https://pubmed.ncbi.nlm.nih.gov/20179228/
113,PTGS2,30622375,Post-translational modifications of prostaglandin-endoperoxide synthase 2 in colorectal cancer: An update.,"['Jaen RI', 'Prieto P', 'Casado M', 'Martin-Sanz P', 'Bosca L']","['Biomarkers, Tumor/analysis', 'Colorectal Neoplasms/drug therapy/*pathology', 'Cyclooxygenase 2/genetics/*metabolism', 'Cyclooxygenase 2 Inhibitors/*pharmacology/therapeutic use', 'Glycosylation/drug effects', 'Humans', 'Phosphorylation/drug effects', 'Prostaglandins/*biosynthesis', 'Protein Processing, Post-Translational/*drug effects', 'RNA, Messenger/metabolism']",https://pubmed.ncbi.nlm.nih.gov/30622375/
114,PTGS2,29578814,Mechanisms of Phytonutrient Modulation of Cyclooxygenase-2 (COX-2) and Inflammation Related to Cancer.,"['Desai SJ', 'Prickril B', 'Rasooly A']","['Animals', 'Anti-Inflammatory Agents, Non-Steroidal/pharmacology', 'Cyclooxygenase 2/genetics/*metabolism', 'Cyclooxygenase 2 Inhibitors/pharmacology', 'Gene Expression Regulation, Enzymologic', 'Humans', 'Inflammation/complications/*diet therapy/metabolism', 'NF-kappa B/genetics/metabolism', 'Neoplasms/*etiology/metabolism', 'Phytochemicals/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/29578814/
115,PTGS2,34920330,PTGES3 is a Putative Prognostic Marker in Breast Cancer.,"['Adekeye A', 'Agarwal D', 'Nayak A', 'Tchou J']","['Biomarkers, Tumor/metabolism', '*Breast Neoplasms/enzymology/pathology', 'Cyclooxygenase 2/genetics/metabolism', 'Dinoprostone/metabolism', 'Female', 'Humans', 'Prognosis', '*Prostaglandin-E Synthases/metabolism', 'Proteomics', 'Tumor Microenvironment']",https://pubmed.ncbi.nlm.nih.gov/34920330/
116,PTGS2,33539521,Prostaglandin-Endoperoxide Synthase 2 (PTGS2) in the Oviduct: Roles in Fertilization and Early Embryo Development.,"['Anamthathmakula P', 'Winuthayanon W']","['Animals', 'Cyclooxygenase 2/genetics/*metabolism', '*Embryonic Development', 'Fallopian Tubes/*enzymology', 'Female', 'Fertilization', 'Humans', 'Ovary/enzymology/metabolism', 'Prostaglandins/metabolism']",https://pubmed.ncbi.nlm.nih.gov/33539521/
117,PTGS2,34355717,"Different approaches to synthesising cerium oxide nanoparticles and their corresponding physical characteristics, and ROS scavenging and anti-inflammatory capabilities.","['Wu Y', 'Ta HT']","['Animals', 'Anti-Inflammatory Agents/*chemistry/pharmacology', 'Antioxidants/chemistry', 'Cerium/*chemistry', 'Cyclooxygenase 2/genetics/metabolism', 'Cytokines/metabolism', 'Humans', 'Metal Nanoparticles/*chemistry', 'Micelles', 'Reactive Oxygen Species/*chemistry/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34355717/
118,PTGS2,36094838,HIF-1alpha is essential for the augmentation of myometrial contractility during labordagger.,"['Wen B', 'Zheng Z', 'Wang L', 'Qian X', 'Wang X', 'Chen Y', 'Bao J', 'Jiang Y', 'Ji K', 'Liu H']","['Female', 'Humans', 'Pregnancy', 'Cell Hypoxia', 'Cyclooxygenase 2/genetics/metabolism', '*Hypoxia-Inducible Factor 1, alpha Subunit/genetics/metabolism', '*Myometrium/metabolism', '*Postpartum Hemorrhage/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36094838/
119,CYP2C9,34109627,PharmVar GeneFocus: CYP2C9.,"['Sangkuhl K', 'Claudio-Campos K', 'Cavallari LH', 'Agundez JAG', 'Whirl-Carrillo M', 'Duconge J', 'Del Tredici AL', 'Wadelius M', 'Rodrigues Botton M', 'Woodahl EL', 'Scott SA', 'Klein TE', 'Pratt VM', 'Daly AK', 'Gaedigk A']","['Alleles', 'Cytochrome P-450 CYP2C9/*genetics', 'Haplotypes/genetics', 'Humans', 'Knowledge Bases', 'Pharmaceutical Preparations/administration & dosage', 'Pharmacogenetics/methods', 'Polymorphism, Genetic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/34109627/
120,CYP2C9,32189324,Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.,"['Theken KN', 'Lee CR', 'Gong L', 'Caudle KE', 'Formea CM', 'Gaedigk A', 'Klein TE', 'Agundez JAG', 'Grosser T']","['Anti-Inflammatory Agents, Non-Steroidal/adverse effects/*pharmacokinetics', 'Clinical Decision-Making', 'Consensus', 'Cytochrome P-450 CYP2C9/*genetics/metabolism', 'Drug Interactions', 'Drug-Related Side Effects and Adverse Reactions/enzymology/*genetics', 'Genotype', 'Humans', 'Pharmacogenetics/*standards', 'Pharmacogenomic Testing/*standards', '*Pharmacogenomic Variants', 'Phenotype', 'Predictive Value of Tests', 'Risk Assessment', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/32189324/
121,CYP2C9,25282448,Warfarin pharmacogenetics.,"['Johnson JA', 'Cavallari LH']","['Anticoagulants/*administration & dosage', 'Cytochrome P-450 CYP2C9/*genetics', 'Genotype', 'Humans', '*Pharmacogenetics', 'Vitamin K Epoxide Reductases/*genetics', 'Warfarin/*administration & dosage']",https://pubmed.ncbi.nlm.nih.gov/25282448/
122,CYP2C9,35380455,Pharmacogenetics of clopidogrel and warfarin in the treatment of cardiovascular diseases: an overview of reviews.,"['de Lara DV', 'de Melo DO', 'Araujo Silva LC', 'Goncalves TS', 'Junior Lima Santos PC']","['Anticoagulants/therapeutic use', '*Cardiovascular Diseases/drug therapy/genetics', 'Clopidogrel/therapeutic use', 'Cytochrome P-450 CYP2C9/genetics', 'Genotype', 'Humans', 'Pharmacogenetics', 'Review Literature as Topic', 'Vitamin K Epoxide Reductases/genetics', '*Warfarin/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/35380455/
123,CYP2C9,26595139,Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes.,"['Cespedes-Garro C', 'Fricke-Galindo I', 'Naranjo ME', 'Rodrigues-Soares F', 'Farinas H', 'de Andres F', 'Lopez-Lopez M', 'Penas-Lledo EM', 'LLerena A']","['Cytochrome P-450 CYP2C9/*genetics', '*Gene Frequency', 'Genotype', 'Humans', 'Phenotype', 'Racial Groups/*genetics']",https://pubmed.ncbi.nlm.nih.gov/26595139/
124,CYP2C9,32813781,Nurse empowerment through Pharmacogenetics.,"['Moraes JC', 'Nunes FDD', 'Coeli-Lacchini FB', 'Miyazaki AHL', 'Floria-Santos M', 'Lacchini R']","['*Aryl Hydrocarbon Hydroxylases', 'Brazil', 'Cross-Sectional Studies', 'Cytochrome P-450 CYP2C9/genetics', 'Empowerment', 'Humans', '*Pharmacogenetics']",https://pubmed.ncbi.nlm.nih.gov/32813781/
125,CYP2C9,30989645,Enantiospecific Pharmacogenomics of Fluvastatin.,"['Hirvensalo P', 'Tornio A', 'Neuvonen M', 'Kiander W', 'Kidron H', 'Paile-Hyvarinen M', 'Tapaninen T', 'Backman JT', 'Niemi M']","['Anticholesteremic Agents/*chemistry/*pharmacokinetics', 'Area Under Curve', 'Cytochrome P-450 CYP2C9/*genetics', 'Fluvastatin/*chemistry/*pharmacokinetics', 'Half-Life', 'Humans', 'Liver-Specific Organic Anion Transporter 1/*genetics', 'Pharmacogenetics', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/30989645/
126,CYP2C9,25282474,Is personalized medicine achievable in obstetrics?,"['Quinney SK', 'Patil AS', 'Flockhart DA']","['Antihypertensive Agents/metabolism/therapeutic use', 'Cytochrome P-450 CYP2C9/genetics/metabolism', 'Cytochrome P-450 CYP2D6/genetics/metabolism', 'Cytochrome P-450 CYP3A/genetics/metabolism', 'Female', 'Glucuronosyltransferase/genetics/metabolism', 'Humans', 'Hypertension/drug therapy', 'Narcotics/metabolism/therapeutic use', 'Obstetric Labor, Premature/drug therapy', '*Obstetrics', 'Pain/drug therapy', '*Pharmacogenetics', '*Precision Medicine', 'Pregnancy', 'Pregnancy Complications, Cardiovascular/drug therapy', 'Tocolytic Agents/metabolism/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/25282474/
127,CYP2C9,29119932,Relevance of CYP2C9 Function in Valproate Therapy.,"['Monostory K', 'Nagy A', 'Toth K', 'Budi T', 'Kiss A', 'Deri M', 'Csukly G']","['Adult', 'Age Factors', 'Anticonvulsants/blood/pharmacokinetics/therapeutic use', 'Biosynthetic Pathways', 'Child', 'Cytochrome P-450 CYP2C9/genetics/*metabolism', 'Epilepsy/drug therapy/metabolism', 'Genotype', 'Humans', 'Phenotype', 'Polymorphism, Genetic', 'Valproic Acid/blood/pharmacokinetics/*therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/29119932/
128,CYP2C9,37318060,"Associations between SLCO1B1, APOE and CYP2C9 and lipid-lowering efficacy and pharmacokinetics of fluvastatin: a meta-analysis.","['Zhang ZH', 'Yue Sun LC', 'Gu HY', 'Jiang C', 'Yi ZM']","['Humans', 'Fluvastatin', 'Cytochrome P-450 CYP2C9/genetics', 'Genotype', '*Cholesterol', 'Apolipoproteins E', '*Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use/pharmacokinetics', 'Liver-Specific Organic Anion Transporter 1/genetics']",https://pubmed.ncbi.nlm.nih.gov/37318060/
129,CYP2C9,24908449,VKORC1 and CYP2C9 genotype distribution in Asian countries.,"['Gaikwad T', 'Ghosh K', 'Shetty S']","['Anticoagulants/pharmacokinetics', 'Asia/epidemiology', 'Asian People/*genetics', 'Cytochrome P-450 CYP2C9/*genetics/metabolism', 'Gene Frequency', 'Genotype', 'Humans', 'Pharmacogenetics', 'Phenotype', '*Polymorphism, Genetic', 'Vitamin K Epoxide Reductases/*genetics/metabolism', 'Warfarin/pharmacokinetics']",https://pubmed.ncbi.nlm.nih.gov/24908449/
130,CYP2C9,34821506,The importance of including African populations in pharmacogenetics studies of warfarin response.,"['Dandara C', 'Ndadza A', 'Soko N']","['Africa', 'Anticoagulants/*pharmacology', 'Cytochrome P-450 CYP2C9/genetics', 'Humans', '*Pharmacogenetics', 'Polymorphism, Single Nucleotide', 'Vitamin K Epoxide Reductases/genetics', 'Warfarin/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/34821506/
131,CYP2C9,24825094,Molecular functionality of CYP2C9 polymorphisms and their influence on drug therapy.,"['Jarrar YB', 'Lee SJ']","['Animals', 'Cytochrome P-450 CYP2C9/*genetics/metabolism', '*Drug Therapy/trends', 'Genetic Variation/*genetics', 'Humans', 'Pharmacogenetics/*methods/trends', 'Polymorphism, Single Nucleotide/*genetics']",https://pubmed.ncbi.nlm.nih.gov/24825094/
132,CYP2C9,35953159,Cytochrome P450s in chimeric mice with humanized liver.,"['Uehara S', 'Suemizu H', 'Yamazaki H']","['Animals', 'Chimera/metabolism', 'Cytochrome P-450 CYP2C9/metabolism/pharmacology', '*Cytochrome P-450 Enzyme System/genetics/metabolism', 'Drug Interactions', 'Humans', '*Liver/metabolism', 'Mice']",https://pubmed.ncbi.nlm.nih.gov/35953159/
133,CYP2C9,25185986,Warfarin pharmacogenomics: recommendations with available patented clinical technologies.,"['Borkowski AA', 'Kardani A', 'Mastorides SM', 'Thomas LB']","['Anticoagulants/metabolism/*therapeutic use', 'Cytochrome P-450 CYP2C9/genetics/metabolism', 'Genotyping Techniques', 'Hemorrhage/etiology', 'Humans', 'Patents as Topic', '*Pharmacogenetics', 'Polymorphism, Single Nucleotide', 'Thromboembolism/drug therapy/genetics/pathology', 'Vitamin K Epoxide Reductases/genetics/metabolism', 'Warfarin/metabolism/*therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/25185986/
134,CYP2C9,34060344,A meta-analysis of effects of CYP2C9 and CYP2C19 polymorphisms on phenytoin pharmacokinetic parameters.,"['Kanjanasilp J', 'Sawangjit R', 'Phanthaisong S', 'Borihanthanawuth W']","['Anticonvulsants/*pharmacokinetics', 'Cytochrome P-450 CYP2C19/*genetics', 'Cytochrome P-450 CYP2C9/*genetics', 'Epilepsy/drug therapy/*genetics/metabolism', 'Humans', 'Observational Studies as Topic/methods', 'Phenytoin/*pharmacokinetics', 'Polymorphism, Genetic/drug effects/*genetics']",https://pubmed.ncbi.nlm.nih.gov/34060344/
135,CYP2C9,34149005,Sulfamethoxazole-trimethoprim-induced liver injury and genetic polymorphisms of NAT2 and CYP2C9 in Taiwan.,"['Huang YS', 'Tseng SY', 'Chang TE', 'Perng CL', 'Huang YH']","['*Arylamine N-Acetyltransferase/genetics', '*Chemical and Drug Induced Liver Injury, Chronic', 'Cytochrome P-450 CYP2C9/genetics', 'Genotype', 'Humans', 'Polymorphism, Genetic', 'Taiwan', 'Trimethoprim, Sulfamethoxazole Drug Combination']",https://pubmed.ncbi.nlm.nih.gov/34149005/
136,CYP2C9,32406758,Inhibition of CYP2C9 by natural products: insight into the potential risk of herb-drug interactions.,"['Wang K', 'Gao Q', 'Zhang T', 'Rao J', 'Ding L', 'Qiu F']","['Animals', 'Biological Products/*pharmacology', 'Cytochrome P-450 CYP2C9/metabolism', 'Cytochrome P-450 CYP2C9 Inhibitors/*pharmacology', 'Herb-Drug Interactions', 'Humans', 'Plant Extracts/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/32406758/
137,CYP2C9,38487942,A physiologically-based pharmacokinetic/pharmacodynamic modeling approach for drug-drug-gene interaction evaluation of S-warfarin with fluconazole.,"['Geng K', 'Shen C', 'Wang X', 'Wang X', 'Shao W', 'Wang W', 'Chen T', 'Sun H', 'Xie H']","['*Warfarin/pharmacokinetics/pharmacology/administration & dosage', 'Humans', '*Fluconazole/pharmacology/pharmacokinetics', '*Drug Interactions', '*Cytochrome P-450 CYP2C9/genetics/metabolism', '*Anticoagulants/pharmacokinetics/pharmacology/administration & dosage', '*Models, Biological', '*Vitamin K Epoxide Reductases/genetics/metabolism', 'Polymorphism, Genetic', 'International Normalized Ratio']",https://pubmed.ncbi.nlm.nih.gov/38487942/
138,CYP2C9,29105855,"Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro.","['Stage TB', 'Graff M', 'Wong S', 'Rasmussen LL', 'Nielsen F', 'Pottegard A', 'Brosen K', 'Kroetz DL', 'Khojasteh SC', 'Damkier P']","['Adult', 'Anti-Bacterial Agents/pharmacology', 'Area Under Curve', 'Chromatography, Liquid', 'Cross-Over Studies', 'Cytochrome P-450 CYP2C19/biosynthesis/*drug effects', 'Cytochrome P-450 CYP2C9/biosynthesis/*drug effects', 'Cytochrome P-450 CYP3A/biosynthesis/*drug effects', 'Cytochrome P-450 Enzyme System/biosynthesis/drug effects', 'Dicloxacillin/*pharmacology', 'Drug Interactions', 'Enzyme Induction/drug effects', 'Female', 'Hepatocytes/drug effects/enzymology', 'Humans', 'Male', 'Mass Spectrometry', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/29105855/
139,CYP2B6,37032427,"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.","['Bousman CA', 'Stevenson JM', 'Ramsey LB', 'Sangkuhl K', 'Hicks JK', 'Strawn JR', 'Singh AB', 'Ruano G', 'Mueller DJ', 'Tsermpini EE', 'Brown JT', 'Bell GC', 'Leeder JS', 'Gaedigk A', 'Scott SA', 'Klein TE', 'Caudle KE', 'Bishop JR']","['Humans', '*Selective Serotonin Reuptake Inhibitors', 'Cytochrome P-450 CYP2D6/genetics/metabolism', 'Cytochrome P-450 CYP2B6/genetics', 'Pharmacogenetics', '*Depressive Disorder, Major/drug therapy/genetics', 'Cytochrome P-450 CYP2C19/genetics/metabolism', 'Serotonin Plasma Membrane Transport Proteins/genetics', 'Serotonin', 'Antidepressive Agents/therapeutic use', 'Citalopram/therapeutic use', 'Genotype']",https://pubmed.ncbi.nlm.nih.gov/37032427/
140,CYP2B6,37267048,The clinical toxicology of ketamine.,"['Schep LJ', 'Slaughter RJ', 'Watts M', 'Mackenzie E', 'Gee P']","['Animals', 'Humans', 'Cytochrome P-450 CYP2B6', '*Ketamine', 'Analgesics', '*Anesthetics']",https://pubmed.ncbi.nlm.nih.gov/37267048/
141,CYP2B6,33448339,PharmVar GeneFocus: CYP2B6.,"['Desta Z', 'El-Boraie A', 'Gong L', 'Somogyi AA', 'Lauschke VM', 'Dandara C', 'Klein K', 'Miller NA', 'Klein TE', 'Tyndale RF', 'Whirl-Carrillo M', 'Gaedigk A']","['Alleles', 'Cytochrome P-450 CYP2B6/*genetics/metabolism', '*Genetic Variation', 'Haplotypes', 'Humans', 'Knowledge Bases', '*Pharmacogenetics']",https://pubmed.ncbi.nlm.nih.gov/33448339/
142,CYP2B6,38863207,Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy.,"['Robinson KM', 'Eum S', 'Desta Z', 'Tyndale RF', 'Gaedigk A', 'Crist RC', 'Haidar CE', 'Myers AL', 'Samer CF', 'Somogyi AA', 'Zubiaur P', 'Iwuchukwu OF', 'Whirl-Carrillo M', 'Klein TE', 'Caudle KE', 'Donnelly RS', 'Kharasch ED']","['Humans', '*Analgesics, Opioid/pharmacokinetics/adverse effects', '*Cytochrome P-450 CYP2B6/genetics/metabolism', '*Genotype', '*Methadone/pharmacokinetics/adverse effects', 'Opiate Substitution Treatment/methods', '*Opioid-Related Disorders/drug therapy/genetics', 'Pharmacogenetics', 'Pharmacogenomic Variants']",https://pubmed.ncbi.nlm.nih.gov/38863207/
143,CYP2B6,36001223,The Role of Pharmacogenomics in Opioid Prescribing.,"['Wong AK', 'Somogyi AA', 'Rubio J', 'Philip J']","['*Analgesics, Opioid/administration & dosage', 'Codeine/administration & dosage', 'Cytochrome P-450 CYP2B6/genetics', 'Cytochrome P-450 CYP2D6/genetics', 'Humans', 'Methadone/administration & dosage', 'Oxycodone/administration & dosage', '*Pharmacogenetics', ""Practice Patterns, Physicians'"", 'Tramadol/administration & dosage']",https://pubmed.ncbi.nlm.nih.gov/36001223/
144,CYP2B6,27712845,Pharmacogenetic Optimization of Smoking Cessation Treatment.,"['Chenoweth MJ', 'Tyndale RF']","['Cytochrome P-450 CYP2A6/genetics', 'Cytochrome P-450 CYP2B6/genetics', 'Genetic Variation', 'Humans', 'Nicotine/metabolism', 'Organic Cation Transport Proteins/genetics', 'Organic Cation Transporter 2', '*Pharmacogenetics', 'Polymorphism, Single Nucleotide', 'Receptors, Dopamine D4/genetics', 'Receptors, Nicotinic/genetics', '*Smoking Cessation/methods']",https://pubmed.ncbi.nlm.nih.gov/27712845/
145,CYP2B6,37264909,Association Between CYP2B6 Polymorphisms and Efficacy of Clopidogrel in Minor Stroke or Transient Ischemic Attack.,"['Qiu X', 'Zhang Y', 'Gu H', 'Jiang Y', 'Pan Y', 'Jiang Y', 'Meng X', 'Wang Y', 'Zhao X', 'Li H', 'Wang X', 'Wang Y', 'Li Z']","['*Clopidogrel/administration & dosage', 'Humans', 'Middle Aged', '*Aspirin/administration & dosage', '*Cytochrome P-450 CYP2B6/genetics', '*Platelet Aggregation Inhibitors/administration & dosage', 'Male', 'Female', '*Stroke/drug therapy/prevention & control', 'Recurrence']",https://pubmed.ncbi.nlm.nih.gov/37264909/
146,CYP2B6,36162369,Association between CYP2C19 and CYP2B6 phenotypes and the pharmacokinetics and safety of diazepam.,"['Zubiaur P', 'Figueiredo-Tor L', 'Villapalos-Garcia G', 'Soria-Chacartegui P', 'Navares-Gomez M', 'Novalbos J', 'Matas M', 'Calleja S', 'Mejia-Abril G', 'Roman M', 'Ochoa D', 'Abad-Santos F']","['*Cytochrome P-450 CYP2B6/genetics', '*Cytochrome P-450 CYP2C19/genetics', '*Diazepam/adverse effects/pharmacokinetics', 'Phenotype', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/36162369/
147,CYP2B6,35194103,CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme function.,"['Mango K', 'Kiss AF', 'Fekete F', 'Erdos R', 'Monostory K']","['*Alleles', 'Cytochrome P-450 CYP2B6/*genetics/*physiology', 'Gene Expression', 'Genotype', 'Humans', 'Liver/enzymology', 'Phenotype', '*Polymorphism, Genetic', 'RNA, Messenger/genetics/metabolism', 'White People']",https://pubmed.ncbi.nlm.nih.gov/35194103/
148,CYP2B6,29402634,A CYP2B6-humanized mouse model and its potential applications.,"['Li L', 'Zhang QY', 'Ding X']","['Animals', 'Cytochrome P-450 CYP2B6/*genetics/*metabolism', 'Humans', 'Liver/enzymology', 'Mice', 'Mice, Knockout', 'Mice, Transgenic', '*Models, Animal', 'Receptors, Cytoplasmic and Nuclear/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/29402634/
149,CYP2B6,27278961,Biotransformation and Rearrangement of Laromustine.,"['Nassar AE', 'Wisnewski AV', 'King I']","['Animals', 'Antineoplastic Agents, Alkylating/chemistry/*metabolism/toxicity', 'Biotransformation', 'Cytochrome P-450 CYP2B6/metabolism', 'Cytochrome P-450 CYP3A/metabolism', 'Dogs', 'Haplorhini', 'Humans', 'Hydrazines/chemistry/*metabolism/toxicity', 'Hydroxylation', 'Microsomes, Liver/*enzymology', 'Molecular Structure', 'Rats', 'Substrate Specificity', 'Sulfonamides/chemistry/*metabolism/toxicity']",https://pubmed.ncbi.nlm.nih.gov/27278961/
150,CYP2B6,32960272,CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz.,"['Griesel R', 'Maartens G', 'Chirehwa M', 'Sokhela S', 'Akpomiemie G', 'Moorhouse M', 'Venter F', 'Sinxadi P']","['Female', 'Humans', 'Male', 'Alkynes/adverse effects', '*Anti-HIV Agents/adverse effects', 'Benzoxazines/adverse effects', 'Cyclopropanes/adverse effects', 'Cytochrome P-450 CYP2B6/genetics', 'Genotype', 'Heterocyclic Compounds, 3-Ring/adverse effects', '*HIV Infections/drug therapy/genetics', 'Oxazines/adverse effects', 'Piperazines/adverse effects', 'Pyridones/adverse effects', '*Weight Gain/genetics']",https://pubmed.ncbi.nlm.nih.gov/32960272/
151,CYP2B6,31324697,Efavirenz Metabolism: Influence of Polymorphic CYP2B6 Variants and Stereochemistry.,"['Wang PF', 'Neiner A', 'Kharasch ED']","['Alkynes', 'Animals', 'Benzoxazines/administration & dosage/chemistry/*metabolism/*pharmacokinetics/toxicity', 'Cell Line', 'Cyclopropanes', 'Cytochrome P-450 CYP2B6/*genetics/metabolism', 'HIV Infections/*drug therapy/genetics', 'Humans', 'Insecta', 'Polymorphism, Single Nucleotide', 'Recombinant Proteins/genetics/metabolism', 'Reverse Transcriptase Inhibitors/administration & dosage/chemistry/*pharmacokinetics/toxicity', 'Stereoisomerism']",https://pubmed.ncbi.nlm.nih.gov/31324697/
152,CYP2B6,36320932,"Frequency of CYP2B6 Alleles in Major Iranian Ethnicities, Affecting Response to Efavirenz.","['Mardi P', 'Tavakoli-Far B', 'Sheibani Nia S', 'Jazayeri R', 'Houshmand M']","['Humans', 'Cytochrome P-450 CYP2B6/genetics', 'Iran', 'Alleles', '*HIV Infections/genetics', 'Polymorphism, Single Nucleotide', 'Gene Frequency']",https://pubmed.ncbi.nlm.nih.gov/36320932/
153,CYP2B6,34752647,Association of CYP2B6 genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta-analysis.,"['Eum S', 'Sayre F', 'Lee AM', 'Stingl JC', 'Bishop JR']","['Bupropion/*analogs & derivatives/therapeutic use', '*Cytochrome P-450 CYP2B6/genetics', 'Genotype', 'Humans', 'Polymorphism, Genetic/genetics']",https://pubmed.ncbi.nlm.nih.gov/34752647/
154,CYP2B6,34505542,Could pharmacogenetics aid the prediction of nevirapine pharmacokinetics and allow individualized treatment?,['Kwara A'],"['Anti-HIV Agents/*pharmacokinetics/therapeutic use', 'Cytochrome P-450 CYP2B6/genetics/metabolism', 'HIV Infections/drug therapy/*genetics/*metabolism', 'Humans', 'Nevirapine/*pharmacokinetics/therapeutic use', 'Pharmacogenetics/*methods', 'Precision Medicine/*methods', 'Predictive Value of Tests']",https://pubmed.ncbi.nlm.nih.gov/34505542/
155,CYP2B6,30578565,Role of CYP2B6 pharmacogenomics in bupropion-mediated smoking cessation.,"['Tran AX', 'Ho TT', 'Varghese Gupta S']","['Bupropion/*administration & dosage/adverse effects/pharmacokinetics', 'Cytochrome P-450 CYP2B6/*genetics', 'Genetic Variation', 'Humans', 'Pharmacogenetics', 'Smoking Cessation/*methods', 'Smoking Cessation Agents/administration & dosage/adverse effects/pharmacokinetics']",https://pubmed.ncbi.nlm.nih.gov/30578565/
156,CYP2B6,24413215,The pharmacogenetics of drug metabolizing enzymes in the Lebanese population.,"['Ossaily S', 'Zgheib NK']","['Arabs/*genetics', 'Cytochrome P-450 CYP2B6/*genetics', 'Glutathione Transferase/*genetics', 'Humans', 'Inactivation, Metabolic', 'Lebanon', 'Pharmaceutical Preparations/*metabolism', 'Pharmacogenetics', 'Vitamin K Epoxide Reductases/*genetics']",https://pubmed.ncbi.nlm.nih.gov/24413215/
157,CYP2B6,36255213,PharmaKoVariome database for supporting genetic testing.,"['Kim J', 'Choi JP', 'Kim MS', 'Bhak J']","['Humans', '*Cytochrome P-450 CYP2D6/genetics', 'Cytochrome P-450 CYP2B6/genetics', '*Pharmacogenetics', 'Genotype', 'Genetic Testing', 'Pharmaceutical Preparations', 'Nucleotides']",https://pubmed.ncbi.nlm.nih.gov/36255213/
158,CYP2B6,39724708,Relationships among CYP2B6 genetic variants and serum levels of multiple polychlorinated biphenyls and hydroxylated metabolites in a Japanese population.,"['Lyu Z', 'Kobayashi H', 'Iwase K', 'Haraguchi K', 'Fujii Y', 'Harada KH']","['*Cytochrome P-450 CYP2B6/genetics/metabolism', '*Polychlorinated Biphenyls/blood', 'Humans', 'Hydroxylation', 'Female', '*Polymorphism, Single Nucleotide', 'Male', 'Japan', 'Adult', 'Middle Aged', 'Environmental Pollutants/blood', 'Asian People/genetics', 'Aged', 'Haplotypes', 'East Asian People']",https://pubmed.ncbi.nlm.nih.gov/39724708/
159,CYP2C19,30998396,Clopidogrel Pharmacogenetics.,"['Pereira NL', 'Rihal CS', 'So DYF', 'Rosenberg Y', 'Lennon RJ', 'Mathew V', 'Goodman SG', 'Weinshilboum RM', 'Wang L', 'Baudhuin LM', 'Lerman A', 'Hasan A', 'Iturriaga E', 'Fu YP', 'Geller N', 'Bailey K', 'Farkouh ME']","['Clinical Decision-Making', 'Clopidogrel/administration & dosage/adverse effects/*pharmacokinetics', 'Cytochrome P-450 CYP2C19/*genetics/metabolism', 'Drug Labeling', '*Drug Resistance', 'Genotype', 'Humans', 'Patient Selection', '*Pharmacogenomic Variants', 'Phenotype', 'Platelet Aggregation/*drug effects', 'Platelet Aggregation Inhibitors/administration & dosage/adverse effects/*pharmacokinetics', 'Purinergic P2Y Receptor Antagonists/administration & dosage/adverse effects/*pharmacokinetics', 'Risk Assessment']",https://pubmed.ncbi.nlm.nih.gov/30998396/
160,CYP2C19,37032427,"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.","['Bousman CA', 'Stevenson JM', 'Ramsey LB', 'Sangkuhl K', 'Hicks JK', 'Strawn JR', 'Singh AB', 'Ruano G', 'Mueller DJ', 'Tsermpini EE', 'Brown JT', 'Bell GC', 'Leeder JS', 'Gaedigk A', 'Scott SA', 'Klein TE', 'Caudle KE', 'Bishop JR']","['Humans', '*Selective Serotonin Reuptake Inhibitors', 'Cytochrome P-450 CYP2D6/genetics/metabolism', 'Cytochrome P-450 CYP2B6/genetics', 'Pharmacogenetics', '*Depressive Disorder, Major/drug therapy/genetics', 'Cytochrome P-450 CYP2C19/genetics/metabolism', 'Serotonin Plasma Membrane Transport Proteins/genetics', 'Serotonin', 'Antidepressive Agents/therapeutic use', 'Citalopram/therapeutic use', 'Genotype']",https://pubmed.ncbi.nlm.nih.gov/37032427/
161,CYP2C19,24550106,Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update.,"['Wedemeyer RS', 'Blume H']","['Cytochrome P-450 CYP2C19/metabolism', 'Cytochrome P-450 CYP3A/metabolism', 'Drug Interactions/*physiology', 'Humans', 'Proton Pump Inhibitors/*pharmacokinetics']",https://pubmed.ncbi.nlm.nih.gov/24550106/
162,CYP2C19,29620484,Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine.,"['El Rouby N', 'Lima JJ', 'Johnson JA']","['Cytochrome P-450 CYP2C19/*genetics', 'Dose-Response Relationship, Drug', 'Genotype', 'Humans', '*Pharmacogenetics', 'Precision Medicine/methods', 'Proton Pump Inhibitors/*administration & dosage/adverse effects/pharmacokinetics']",https://pubmed.ncbi.nlm.nih.gov/29620484/
163,CYP2C19,35146797,Night-time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole.,"['Yang E', 'Kim S', 'Kim B', 'Kim B', 'Kim Y', 'Park SS', 'Song GS', 'Yu KS', 'Jang IJ', 'Lee S']","['Benzene Derivatives', 'Cross-Over Studies', 'Cytochrome P-450 CYP2C19/genetics', '*Esomeprazole/pharmacology', '*Gastric Acid', 'Humans', 'Hydrogen-Ion Concentration', 'Imidazoles', 'Proton Pump Inhibitors/pharmacology', 'Pyrroles', 'Sulfonamides']",https://pubmed.ncbi.nlm.nih.gov/35146797/
164,CYP2C19,32602114,PharmVar GeneFocus: CYP2C19.,"['Botton MR', 'Whirl-Carrillo M', 'Del Tredici AL', 'Sangkuhl K', 'Cavallari LH', 'Agundez JAG', 'Duconge J', 'Lee MTM', 'Woodahl EL', 'Claudio-Campos K', 'Daly AK', 'Klein TE', 'Pratt VM', 'Scott SA', 'Gaedigk A']","['Alleles', 'Cytochrome P-450 CYP2C19/*genetics', 'Genetic Variation/genetics', 'Genotype', 'Haplotypes/genetics', 'Humans', 'Knowledge Bases', 'Pharmacogenetics/methods']",https://pubmed.ncbi.nlm.nih.gov/32602114/
165,CYP2C19,38899464,CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association.,"['Pereira NL', 'Cresci S', 'Angiolillo DJ', 'Batchelor W', 'Capers Q 4th', 'Cavallari LH', 'Leifer D', 'Luzum JA', 'Roden DM', 'Stellos K', 'Turrise SL', 'Tuteja S']","['Humans', '*Cytochrome P-450 CYP2C19/genetics/metabolism', '*Purinergic P2Y Receptor Antagonists/therapeutic use', 'Administration, Oral', 'American Heart Association', 'United States', 'Platelet Aggregation Inhibitors/therapeutic use', 'Clopidogrel/therapeutic use', 'Genetic Testing/methods', 'Prasugrel Hydrochloride/therapeutic use', 'Pharmacogenomic Testing', 'Ticagrelor/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/38899464/
166,CYP2C19,38343077,Precision medicine in cardiovascular therapeutics: Evaluating the role of pharmacogenetic analysis prior to drug treatment.,"['Ingelman-Sundberg M', 'Pirmohamed M']","['Humans', '*Precision Medicine', 'Warfarin/therapeutic use', 'Pharmacogenomic Testing', 'Clopidogrel/therapeutic use', 'Cytochrome P-450 CYP2C19/genetics/therapeutic use', '*Cardiovascular Diseases/drug therapy/genetics/diagnosis', 'Anticoagulants/therapeutic use', 'Pharmacogenetics', 'Liver-Specific Organic Anion Transporter 1/genetics', 'Vitamin K Epoxide Reductases/genetics']",https://pubmed.ncbi.nlm.nih.gov/38343077/
167,CYP2C19,25974703,Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.,"['Hicks JK', 'Bishop JR', 'Sangkuhl K', 'Muller DJ', 'Ji Y', 'Leckband SG', 'Leeder JS', 'Graham RL', 'Chiulli DL', 'LLerena A', 'Skaar TC', 'Scott SA', 'Stingl JC', 'Klein TE', 'Caudle KE', 'Gaedigk A']","['Biotransformation', 'Cytochrome P-450 CYP2C19/*genetics/metabolism', 'Cytochrome P-450 CYP2D6/*genetics/metabolism', '*Drug Dosage Calculations', 'Genotype', 'Humans', 'Patient Safety', 'Pharmacogenetics/*standards', 'Phenotype', '*Polymorphism, Genetic', 'Risk Assessment', 'Risk Factors', 'Selective Serotonin Reuptake Inhibitors/*administration & dosage/adverse effects/pharmacokinetics']",https://pubmed.ncbi.nlm.nih.gov/25974703/
168,CYP2C19,28835093,Voriconazole-refractory invasive aspergillosis.,"['Park SY', 'Yoon JA', 'Kim SH']","['Antifungal Agents/adverse effects/pharmacokinetics/*therapeutic use', 'Aspergillus/*drug effects/pathogenicity', 'Biopsy', 'Coinfection', 'Cytochrome P-450 CYP2C19/genetics/metabolism', 'Diagnosis, Differential', 'Diagnostic Errors', 'Drug Monitoring', '*Drug Resistance, Fungal', 'Female', 'Humans', 'Immunocompromised Host', 'Invasive Pulmonary Aspergillosis/diagnosis/*drug therapy/immunology/microbiology', 'Male', 'Middle Aged', 'Pharmacogenetics', 'Pharmacogenomic Variants', 'Predictive Value of Tests', 'Tomography, X-Ray Computed', 'Voriconazole/adverse effects/pharmacokinetics/*therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/28835093/
169,CYP2C19,35914768,Pharmacogenetics of Antiplatelet Therapy.,"['Castrichini M', 'Luzum JA', 'Pereira N']","['Humans', '*Platelet Aggregation Inhibitors/adverse effects', 'Clopidogrel/therapeutic use', '*Pharmacogenetics', 'Cytochrome P-450 CYP2C19/genetics/metabolism', 'Prospective Studies', 'Reproducibility of Results', 'Genotype', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/35914768/
170,CYP2C19,37531788,Patient understanding of pharmacogenomic test results in clinical care.,"['Doyle TA', 'Schmidt KK', 'Halverson CME', 'Olivera J', 'Garcia A', 'Shugg TA', 'Skaar TC', 'Schwartz PH']","['Humans', '*Pharmacogenetics', '*Pharmacogenomic Testing', 'Cytochrome P-450 CYP2C19/genetics']",https://pubmed.ncbi.nlm.nih.gov/37531788/
171,CYP2C19,38631139,Influence of CYP2C19 and CYP2D6 on side effects of aripiprazole and risperidone: A systematic review.,"['de Brabander E', 'Kleine Schaars K', 'van Amelsvoort T', 'van Westrhenen R']","['Humans', '*Antipsychotic Agents/adverse effects/pharmacokinetics', '*Aripiprazole/adverse effects/pharmacokinetics', '*Cytochrome P-450 CYP2C19/genetics/metabolism', '*Cytochrome P-450 CYP2D6/genetics/metabolism', '*Risperidone/adverse effects/pharmacokinetics']",https://pubmed.ncbi.nlm.nih.gov/38631139/
172,CYP2C19,35953160,Polymorphic cytochromes P450 in non-human primates.,"['Uno Y', 'Uehara S', 'Yamazaki H']","['Animals', '*Callithrix/metabolism', 'Cytochrome P-450 CYP2C19/metabolism', '*Cytochrome P-450 Enzyme System/genetics/metabolism', 'Humans', 'Liver/metabolism', 'Macaca fascicularis/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35953160/
173,CYP2C19,25696877,Pharmacogenomics of antiplatelet drugs.,"['Sabatine MS', 'Mega JL']","['Clinical Trials as Topic', 'Clopidogrel', 'Cytochrome P-450 CYP2C19/genetics', 'Humans', '*Pharmacogenetics', 'Platelet Aggregation Inhibitors/*therapeutic use', 'Practice Guidelines as Topic', 'Ticlopidine/analogs & derivatives/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/25696877/
174,CYP2C19,36588476,Pharmacogenetics of P2Y(12) receptor inhibitors.,"['Thomas CD', 'Williams AK', 'Lee CR', 'Cavallari LH']","['Humans', 'Clopidogrel/therapeutic use', 'Platelet Aggregation Inhibitors/adverse effects', 'Ticagrelor/therapeutic use', 'Prasugrel Hydrochloride', 'Pharmacogenetics', '*Percutaneous Coronary Intervention/adverse effects', '*Acute Coronary Syndrome/drug therapy/genetics', 'Cytochrome P-450 CYP2C19/genetics/therapeutic use', 'Purinergic P2Y Receptor Antagonists/adverse effects', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/36588476/
175,CYP2C19,37619481,Safety analysis of co-administering tacrolimus and omeprazole in renal transplant recipients - A review.,"['Miedziaszczyk M', 'Idasiak-Piechocka I']","['Humans', '*Omeprazole/adverse effects', 'Tacrolimus/adverse effects', 'Cytochrome P-450 CYP3A/genetics', 'Cytochrome P-450 CYP2C19/genetics', '*Kidney Transplantation', 'Kidney']",https://pubmed.ncbi.nlm.nih.gov/37619481/
176,CYP2C19,27886818,Genetic Determinants of P2Y(12) Inhibitors and Clinical Implications.,"['Cavallari LH', 'Obeng AO']","['Acute Coronary Syndrome/metabolism/*therapy', 'Alleles', 'Clopidogrel', 'Cytochrome P-450 CYP2C19/drug effects/*genetics/metabolism', 'Genotype', 'Humans', '*Percutaneous Coronary Intervention', '*Polymorphism, Single Nucleotide', 'Purinergic P2Y Receptor Antagonists/therapeutic use', 'Thrombosis/*genetics/metabolism/prevention & control', 'Ticlopidine/*analogs & derivatives/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/27886818/
177,CYP2C19,35449399,Point of care CYP2C19 genotyping after percutaneous coronary intervention.,"['Baudhuin LM', 'Train LJ', 'Goodman SG', 'Lane GE', 'Lennon RJ', 'Mathew V', 'Murthy V', 'Nazif TM', 'So DYF', 'Sweeney JP', 'Wu AHB', 'Rihal CS', 'Farkouh ME', 'Pereira NL']","['Humans', 'Cytochrome P-450 CYP2C19/genetics', '*Percutaneous Coronary Intervention', 'Platelet Aggregation Inhibitors/therapeutic use', 'Point-of-Care Systems', 'Prospective Studies', 'Genotype', 'Randomized Controlled Trials as Topic', 'Multicenter Studies as Topic']",https://pubmed.ncbi.nlm.nih.gov/35449399/
178,CYP2C19,35138719,[Genotype-guided antithrombotic therapy].,"['van den Broek WWA', 'Azzahhafi J', 'van Schaik RHN', 'Ten Berg JM']","['*Acute Coronary Syndrome/therapy', 'Cytochrome P-450 CYP2C19/genetics/therapeutic use', 'Fibrinolytic Agents/therapeutic use', 'Genotype', 'Humans', '*Percutaneous Coronary Intervention/adverse effects', 'Platelet Aggregation Inhibitors/therapeutic use', 'Ticagrelor/adverse effects', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/35138719/
179,PDE5A,38332893,Network pharmacology combined with Mendelian randomization analysis to identify the key targets of renin-angiotensin-aldosterone system inhibitors in the treatment of diabetic nephropathy.,"['Zhou D', 'Zhou T', 'Tang S', 'Li Q', 'Li W', 'Gan G', 'Li M', 'Chen Q']","['Humans', '*Diabetic Nephropathies/drug therapy/genetics/metabolism', 'Renin-Angiotensin System/genetics', 'Molecular Docking Simulation', 'Mendelian Randomization Analysis', 'Network Pharmacology', 'Cyclooxygenase 2/metabolism', '*Acute Kidney Injury/complications', 'Anti-Inflammatory Agents, Non-Steroidal/pharmacology', 'Diphenhydramine/pharmacology/therapeutic use', '*Diabetes Mellitus/drug therapy']",https://pubmed.ncbi.nlm.nih.gov/38332893/
180,PDE5A,37605207,Phosphodiesterase and psychiatric disorders: a two-sample Mendelian randomization study.,"['Jiang M', 'Yan W', 'Zhang Y', 'Lu Z', 'Lu T', 'Zhang D', 'Li J', 'Wang L']","['Humans', '*Depressive Disorder, Major/genetics', '*Autism Spectrum Disorder', 'Genome-Wide Association Study', 'Mendelian Randomization Analysis', '*Mental Disorders/genetics', ""3',5'-Cyclic-AMP Phosphodiesterases""]",https://pubmed.ncbi.nlm.nih.gov/37605207/
181,PDE5A,12387708,Vardenafil.,['Young JM'],"[""3',5'-Cyclic-GMP Phosphodiesterases"", 'Animals', 'Clinical Trials as Topic/statistics & numerical data', 'Cyclic Nucleotide Phosphodiesterases, Type 5', 'Erectile Dysfunction/drug therapy/enzymology', 'Humans', 'Imidazoles/chemistry/*pharmacology/*therapeutic use', 'Male', 'Phosphodiesterase Inhibitors/chemistry/pharmacology/therapeutic use', 'Phosphoric Diester Hydrolases/metabolism', 'Piperazines/chemistry/*pharmacology/*therapeutic use', 'Sulfones', 'Triazines', 'Vardenafil Dihydrochloride']",https://pubmed.ncbi.nlm.nih.gov/12387708/
182,PDE5A,35767715,Protein tyrosine phosphatase PTPN22 negatively modulates platelet function and thrombus formation.,"['Wang X', 'Wei G', 'Ding Y', 'Gui X', 'Tong H', 'Xu X', 'Zhang S', 'Sun Z', 'Ju W', 'Li Y', 'Yao R', 'Wu Q', 'Lu Z', 'Fu C', 'Li Z', 'Zhang S', 'Gardiner EE', 'Andrews RK', 'Hu H', 'Zeng L', 'Xu K', 'Qiao J']","['Animals', 'Blood Platelets/metabolism', '*Hemostasis', 'Humans', 'Mice', 'Mice, Knockout', 'Platelet Activation', 'Platelet Aggregation', 'Platelet Function Tests', '*Protein Tyrosine Phosphatase, Non-Receptor Type 22/metabolism', '*Thrombosis/genetics']",https://pubmed.ncbi.nlm.nih.gov/35767715/
183,PDE5A,14498756,Tadalafil.,"['Curran M', 'Keating G']","[""3',5'-Cyclic-GMP Phosphodiesterases"", 'Carbolines/adverse effects/pharmacokinetics/*therapeutic use', 'Clinical Trials as Topic', 'Cyclic Nucleotide Phosphodiesterases, Type 5', 'Diabetes Complications', 'Dose-Response Relationship, Drug', 'Drug Interactions', 'Erectile Dysfunction/complications/*drug therapy', 'Humans', 'Male', 'Phosphodiesterase Inhibitors/adverse effects/pharmacokinetics/*therapeutic use', 'Phosphoric Diester Hydrolases/*metabolism', 'Tadalafil', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/14498756/
184,PDE5A,16402111,Phosphodiesterase inhibitors.,"['Boswell-Smith V', 'Spina D', 'Page CP']","[""3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors"", ""3',5'-Cyclic-GMP Phosphodiesterases/antagonists & inhibitors"", 'Animals', 'Asthma/drug therapy/enzymology', 'Cyclic Nucleotide Phosphodiesterases, Type 3', 'Cyclic Nucleotide Phosphodiesterases, Type 4', 'Cyclic Nucleotide Phosphodiesterases, Type 5', 'Erectile Dysfunction/drug therapy/enzymology', 'Heart Failure/drug therapy/enzymology', 'Humans', 'Inflammation/drug therapy/enzymology', 'Male', 'Phosphodiesterase Inhibitors/*pharmacology/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/16402111/
185,PDE5A,37737266,MicroRNA-1 protects the endothelium in acute lung injury.,"['Korde A', 'Haslip M', 'Pednekar P', 'Khan A', 'Chioccioli M', 'Mehta S', 'Lopez-Giraldez F', 'Bermejo S', 'Rojas M', 'Dela Cruz C', 'Matthay MA', 'Pober JS', 'Pierce RW', 'Takyar SS']","['Humans', 'Animals', 'Mice', '*MicroRNAs/genetics', 'Vascular Endothelial Growth Factor A', '*Acute Lung Injury/genetics', '*Respiratory Distress Syndrome/genetics', 'Endothelium']",https://pubmed.ncbi.nlm.nih.gov/37737266/
186,PDE5A,38565536,Mex-3 RNA binding family member A (MEX3A)/circMPP6 complex promotes colorectal cancer progression by inhibiting autophagy.,"['Chen RX', 'Xu SD', 'Deng MH', 'Hao SH', 'Chen JW', 'Ma XD', 'Zhuang WT', 'Cao JH', 'Lv YR', 'Lin JL', 'Li SY', 'Qiao GB', 'Xie D', 'Wang FW']","['Humans', 'Autophagy/genetics', '*Colorectal Neoplasms/metabolism', 'Family', 'Phosphoproteins/metabolism', 'Proteins/metabolism', 'RNA/genetics', '*RNA, Circular/genetics', 'RNA-Binding Proteins/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38565536/
187,PDE5A,32860248,The NO-cGMP-PKG pathway in skeletal remodeling.,"['Kim SM', 'Yuen T', 'Iqbal J', 'Rubin MR', 'Zaidi M']","['Animals', 'Bone Remodeling/*physiology', 'Bone and Bones/physiology', 'Cyclic GMP/*metabolism', 'Cyclic GMP-Dependent Protein Kinases/*metabolism', 'Cyclic Nucleotide Phosphodiesterases, Type 5/physiology', 'Humans', 'Mice', 'Nitric Oxide/*metabolism', 'Signal Transduction/physiology']",https://pubmed.ncbi.nlm.nih.gov/32860248/
188,PDE5A,28196297,Targeting invasive properties of melanoma cells.,"['Arozarena I', 'Wellbrock C']","['Animals', 'Antineoplastic Agents/*therapeutic use', 'Cell Differentiation', 'Gene Expression Regulation, Neoplastic/drug effects', 'Humans', 'Melanoma/*drug therapy/metabolism/*pathology', '*Molecular Targeted Therapy', 'Neoplasm Invasiveness', 'Neoplasm Metastasis', 'Neoplasm Proteins/*antagonists & inhibitors', 'Phenotype', 'Signal Transduction/drug effects', 'Skin Neoplasms/*drug therapy/metabolism/*pathology']",https://pubmed.ncbi.nlm.nih.gov/28196297/
189,PDE5A,37517510,"The Triple Crown: NO, CO, and H(2)S in cancer cell biology.","['Oza PP', 'Kashfi K']","['Humans', 'Nitric Oxide/metabolism', '*Gasotransmitters/metabolism', '*Hydrogen Sulfide/metabolism', '*Neoplasms/drug therapy/metabolism', 'Carbon Monoxide/metabolism/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/37517510/
190,PDE5A,38762700,Potential drug targets for tumors identified through Mendelian randomization analysis.,"['Song N', 'Shi P', 'Cui K', 'Zeng L', 'Wang Z', 'Di W', 'Li J', 'Fan Y', 'Li Z', 'Zhang J', 'Su W', 'Wang H']","['Humans', '*Mendelian Randomization Analysis', '*Neoplasms/genetics', '*Genome-Wide Association Study', 'Quantitative Trait Loci', 'Antineoplastic Agents/therapeutic use/pharmacology', 'Polymorphism, Single Nucleotide', 'Genetic Predisposition to Disease']",https://pubmed.ncbi.nlm.nih.gov/38762700/
191,PDE5A,35405093,Approach and management to patients with neurological disorders reporting sexual dysfunction.,"['Hentzen C', 'Musco S', 'Amarenco G', 'Del Popolo G', 'Panicker JN']","['Ejaculation/physiology', '*Erectile Dysfunction/diagnosis/drug therapy', 'Female', 'Humans', 'Male', '*Nervous System Diseases/complications/therapy', '*Sexual Dysfunction, Physiological/diagnosis/etiology/therapy']",https://pubmed.ncbi.nlm.nih.gov/35405093/
192,PDE5A,29601927,Genetic alterations in the NO-cGMP pathway and cardiovascular risk.,"['Wobst J', 'Schunkert H', 'Kessler T']","['Animals', 'Cardiovascular Diseases/*genetics/*metabolism', 'Cyclic GMP/*metabolism', 'Genetic Variation/genetics', 'Humans', 'Nitric Oxide/*metabolism', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/29601927/
193,PDE5A,12166544,Pharmacology of phosphodiesterase-5 inhibitors.,"['Corbin JD', 'Francis SH']","['1-Methyl-3-isobutylxanthine/pharmacokinetics', ""3',5'-Cyclic-GMP Phosphodiesterases"", 'Area Under Curve', 'Carbolines', 'Cyclic Nucleotide Phosphodiesterases, Type 5', 'Erectile Dysfunction/drug therapy', 'Humans', 'Imidazoles/pharmacokinetics/therapeutic use', 'Male', 'Muscle, Smooth, Vascular/drug effects', 'Phosphodiesterase Inhibitors/*pharmacokinetics/therapeutic use', '*Phosphoric Diester Hydrolases', 'Piperazines/pharmacokinetics/therapeutic use', 'Purines', 'Purinones/pharmacokinetics/therapeutic use', 'Sildenafil Citrate', 'Sulfones', 'Tadalafil', 'Theophylline/pharmacokinetics', 'Triazines', 'Vardenafil Dihydrochloride']",https://pubmed.ncbi.nlm.nih.gov/12166544/
194,PDE5A,38179743,"Metabolism-Related Prognostic Biomarkers, Purine Metabolism and Anti-Tumor Immunity in Colon Adenocarcinoma.","['Liu H', 'Zhang Y', 'Zhang Q', 'Zhang T', 'Lu T']","['Humans', '*Colonic Neoplasms/genetics', '*Adenocarcinoma/genetics', 'Prognosis', 'Carcinogenesis', 'Biomarkers', 'Purines', 'Tumor Microenvironment/genetics', '*Arylamine N-Acetyltransferase']",https://pubmed.ncbi.nlm.nih.gov/38179743/
195,PDE5A,38601164,Genetic insight into putative causes of xanthelasma palpebrarum: a Mendelian randomization study.,"['Hu W', 'Liu Y', 'Lian C', 'Lu H']","['Humans', '*Diabetes Mellitus, Type 2', 'Genome-Wide Association Study', 'Mendelian Randomization Analysis', 'Cholesterol', '*Xanthomatosis/genetics/epidemiology', 'Membrane Proteins']",https://pubmed.ncbi.nlm.nih.gov/38601164/
196,PDE5A,39006834,Integrated Bioinformatics Analysis Reveals the Aberrantly Methylated Differentially Expressed Genes in Dilated Cardiomyopathy.,"['Li N', 'Wang J', 'Wang X', 'Zha L']","['*Cardiomyopathy, Dilated/genetics', '*DNA Methylation/genetics', 'Humans', '*Computational Biology', 'Animals', 'Mice', '*Gene Expression Profiling', 'Epigenesis, Genetic', 'Transcriptome/genetics', 'Male', 'Gene Expression Regulation/genetics']",https://pubmed.ncbi.nlm.nih.gov/39006834/
197,PDE5A,39206778,miR-30d Attenuates Pulmonary Arterial Hypertension via Targeting MTDH and PDE5A and Modulates the Beneficial Effect of Sildenafil.,"['Liang X', 'Zhou J', 'Wang H', 'Zhang Z', 'Yin M', 'Zhu Y', 'Li L', 'Chen C', 'Wei M', 'Hu M', 'Zhao C', 'Yao J', 'Li G', 'Dinh-Xuan AT', 'Xiao J', 'Bei Y']","['Animals', 'Humans', 'Male', 'Rats', '*Cell Adhesion Molecules/metabolism/genetics', 'Cyclic Nucleotide Phosphodiesterases, Type 5/metabolism/genetics', 'Disease Models, Animal', '*Membrane Proteins/metabolism/genetics', '*MicroRNAs/genetics/metabolism', 'Phosphodiesterase 5 Inhibitors/pharmacology', 'Pulmonary Arterial Hypertension/drug therapy/metabolism/genetics', 'Rats, Sprague-Dawley', 'Rats, Transgenic', '*RNA-Binding Proteins/metabolism/genetics', '*Sildenafil Citrate/pharmacology', 'Vascular Remodeling/drug effects/genetics']",https://pubmed.ncbi.nlm.nih.gov/39206778/
198,PDE5A,12525671,Erectile dysfunction.,"['Shabsigh R', 'Anastasiadis AG']","[""3',5'-Cyclic-GMP Phosphodiesterases"", 'Alprostadil/physiology', 'Apomorphine/therapeutic use', 'Brain/physiopathology', 'Cyclic Nucleotide Phosphodiesterases, Type 5', 'Erectile Dysfunction/etiology/physiopathology/*therapy', 'Humans', 'Male', 'Penile Prosthesis', 'Penis/blood supply/innervation', 'Phosphodiesterase Inhibitors/therapeutic use', 'Phosphoric Diester Hydrolases/physiology', 'Piperazines/therapeutic use', 'Purines', 'Sildenafil Citrate', 'Sulfones']",https://pubmed.ncbi.nlm.nih.gov/12525671/
199,GSR,36635256,SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase.,"['Xu FL', 'Wu XH', 'Chen C', 'Wang K', 'Huang LY', 'Xia J', 'Liu Y', 'Shan XF', 'Tang N']","['Humans', '*Carcinoma, Hepatocellular/drug therapy/genetics/metabolism', 'Sorafenib/pharmacology/therapeutic use', 'Glutathione Reductase/metabolism/pharmacology/therapeutic use', '*Liver Neoplasms/drug therapy/genetics/metabolism', '*Ferroptosis', 'NF-E2-Related Factor 2/genetics/metabolism', 'Drug Resistance, Neoplasm/genetics', 'Cell Line, Tumor', '*Antineoplastic Agents/pharmacology/therapeutic use', 'Fatty Acid Transport Proteins']",https://pubmed.ncbi.nlm.nih.gov/36635256/
200,GSR,24621793,The Marble-Hand Illusion.,"['Senna I', 'Maravita A', 'Bolognini N', 'Parise CV']","['Adult', '*Calcium Carbonate', 'Hand/*physiology', 'Humans', 'Illusions/*physiology', 'Male', 'Mechanical Phenomena', 'Skin', 'Surveys and Questionnaires', 'Touch Perception', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/24621793/
201,GSR,37819772,Notopterol Inhibits the NF-kappaB Pathway and Activates the PI3K/Akt/Nrf2 Pathway in Periodontal Tissue.,"['Zhou J', 'Shi P', 'Ma R', 'Xie X', 'Zhao L', 'Wang J']","['Humans', '*NF-kappa B/metabolism', 'Proto-Oncogene Proteins c-akt/metabolism', 'NF-E2-Related Factor 2/metabolism', 'Phosphatidylinositol 3-Kinases/metabolism', 'Lipopolysaccharides/pharmacology', 'Anti-Inflammatory Agents/pharmacology', 'Antioxidants', '*Periodontitis', 'Heme Oxygenase-1/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37819772/
202,GSR,38563353,Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation.,"['Mulholland M', 'Depuydt MAC', 'Jakobsson G', 'Ljungcrantz I', 'Grentzmann A', 'To F', 'Bengtsson E', 'Jaensson Gyllenback E', 'Gronberg C', 'Rattik S', 'Liberg D', 'Schiopu A', 'Bjorkbacka H', 'Kuiper J', 'Bot I', 'Slutter B', 'Engelbertsen D']","['Animals', 'Female', 'Humans', 'Male', 'Mice', 'Anti-Inflammatory Agents/pharmacology', '*Atherosclerosis/genetics/pathology', 'Disease Models, Animal', '*Inflammation/genetics/pathology', '*Interleukin-1 Receptor Accessory Protein/antagonists & inhibitors/genetics/metabolism', 'Macrophages/metabolism/immunology/pathology', 'Mice, Inbred C57BL', 'Mice, Knockout, ApoE', '*Plaque, Atherosclerotic/genetics/pathology', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/38563353/
203,GSR,28543548,Fate and Behavior of Gunshot Residue-A Review.,"['Blakey LS', 'Sharples GP', 'Chana K', 'Birkett JW']","['Antimony/*analysis', 'Barium/*analysis', 'Clothing', 'Equipment and Supplies', 'Firearms', '*Forensic Ballistics', 'Hand', 'Humans', 'Lead/*analysis', 'Skin/chemistry', '*Wounds, Gunshot']",https://pubmed.ncbi.nlm.nih.gov/28543548/
204,GSR,32109199,A Bio-Physio-Psychological Investigation of Athletes' Burnout.,"['Monfared SS', 'Lebeau JC', 'Mason J', 'Cho SK', 'Basevitch I', 'Perry I', 'Baur DA', 'Tenenbaum G']","['Adolescent', 'Athletes/*psychology', 'Blood Volume', 'Burnout, Psychological/*psychology', 'Emotions', 'Female', 'Galvanic Skin Response', 'Humans', 'Hydrocortisone/metabolism', 'Male', 'Respiratory Rate', 'Saliva/metabolism', 'Self Concept', 'Youth Sports/psychology']",https://pubmed.ncbi.nlm.nih.gov/32109199/
205,GSR,33396021,Advances and limitations in the determination and assessment of gunshot residue in the environment.,"['Black O', 'Smith SC', 'Roper C']","['Animals', 'Antimony/analysis', '*Environmental Pollutants/analysis/chemistry', 'Environmental Pollution/*analysis/prevention & control', 'Environmental Restoration and Remediation/*methods', '*Firearms', 'Humans', 'Lead/analysis', 'Organic Chemicals/analysis']",https://pubmed.ncbi.nlm.nih.gov/33396021/
206,GSR,23796488,Stabilising cysteinyl thiol oxidation and nitrosation for proteomic analysis.,"['Ratnayake S', 'Dias IH', 'Lattman E', 'Griffiths HR']","['Animals', 'Cysteine/chemistry/*metabolism', 'Humans', 'Mass Spectrometry', 'Nitroso Compounds/chemistry/*metabolism', 'Protein Processing, Post-Translational/*physiology', 'Proteomics/*methods', 'Sulfhydryl Compounds']",https://pubmed.ncbi.nlm.nih.gov/23796488/
207,GSR,30819542,Autonomic biofeedback therapy in epilepsy.,['Nagai Y'],"['Autonomic Nervous System/*physiology', 'Biofeedback, Psychology/*methods', 'Double-Blind Method', 'Epilepsy/*therapy', 'Galvanic Skin Response/physiology', 'Humans', 'Randomized Controlled Trials as Topic']",https://pubmed.ncbi.nlm.nih.gov/30819542/
208,GSR,38701300,Identification and validation of oxidative stress-related genes in sepsis-induced myopathy.,"['Zhang N', 'Huang D', 'Li X', 'Yan J', 'Yan Q', 'Ge W', 'Zhou J']","['Humans', '*Oxidative Stress/genetics', '*Sepsis/genetics', '*Muscular Diseases/genetics', 'Computational Biology', 'Protein Interaction Maps/genetics', 'MicroRNAs/genetics', 'ROC Curve', 'Biomarkers/metabolism', 'Gene Expression Profiling', 'Gene Regulatory Networks', 'Gene Ontology', 'Databases, Genetic']",https://pubmed.ncbi.nlm.nih.gov/38701300/
209,GSR,35644278,Evoking stress reactivity in virtual reality: A systematic review and meta-analysis.,"['Dammen LV', 'Finseth TT', 'McCurdy BH', 'Barnett NP', 'Conrady RA', 'Leach AG', 'Deick AF', 'Van Steenis AL', 'Gardner R', 'Smith BL', 'Kay A', 'Shirtcliff EA']","['Blood Pressure', 'Galvanic Skin Response', 'Heart Rate/physiology', 'Humans', '*Hydrocortisone/analysis', '*Virtual Reality']",https://pubmed.ncbi.nlm.nih.gov/35644278/
210,GSR,26507443,Historical perspective on the DNA damage response.,['Hanawalt PC'],"['Animals', 'Bacteria/metabolism', 'Biochemistry/history', 'DNA/metabolism', '*DNA Damage', '*DNA Repair', 'DNA Replication', 'Eukaryota/metabolism', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Signal Transduction', 'Stress, Physiological']",https://pubmed.ncbi.nlm.nih.gov/26507443/
211,GSR,26736585,Annotation and prediction of stress and workload from physiological and inertial signals.,"['Ghosh A', 'Danieli M', 'Riccardi G']","['Accelerometry', 'Adult', 'Blood Volume/physiology', 'Emotions', 'Female', 'Galvanic Skin Response/physiology', 'Heart Rate/physiology', 'Humans', 'Interviews as Topic', 'Male', 'Middle Aged', 'Signal Processing, Computer-Assisted', 'Skin Temperature/physiology', '*Stress, Psychological', 'Workload/*psychology']",https://pubmed.ncbi.nlm.nih.gov/26736585/
212,GSR,35723136,Measuring emotional variables in occupational performance: A scoping review.,"['Park H', 'Kim J', 'Jo S', 'Kim H', 'Jo Y', 'Kim S', 'Yoo I']","['Anxiety', '*Emotions/physiology', 'Galvanic Skin Response', 'Heart Rate/physiology', 'Humans', '*Occupational Stress/complications/psychology']",https://pubmed.ncbi.nlm.nih.gov/35723136/
213,GSR,34866404,Polymorphisms of genes related to phase II metabolism and resistance to clopidogrel.,"['Alkattan A', 'Alkhalifah A', 'Alsalameen E', 'Alghanim F', 'Radwan N']","['Carrier Proteins/genetics', 'Clopidogrel/metabolism/*pharmacology', 'Drug Resistance', 'Glucosephosphate Dehydrogenase/genetics', 'Glutamate-Cysteine Ligase/genetics', 'Glutathione Synthase/genetics', 'Glutathione Transferase/genetics', 'Hexokinase/genetics', 'Humans', 'Platelet Aggregation Inhibitors/*pharmacology', '*Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/34866404/
214,GSR,38036067,Pharmacological and genetic increases in liver NADPH levels ameliorate NASH progression in female mice.,"['Rodriguez-Ramiro I', 'Pastor-Fernandez A', 'Lopez-Aceituno JL', 'Garcia-Dominguez E', 'Sierra-Ramirez A', 'Valverde AM', 'Martinez-Pastor B', 'Efeyan A', 'Gomez-Cabrera MC', 'Vina J', 'Fernandez-Marcos PJ']","['Female', 'Mice', 'Humans', 'Animals', '*Non-alcoholic Fatty Liver Disease/drug therapy/genetics/metabolism', 'NADP/metabolism', 'Antioxidants/metabolism', 'Liver/metabolism', 'Inflammation/metabolism', 'Choline/metabolism', 'Methionine/metabolism', 'Mice, Inbred C57BL', 'Disease Models, Animal']",https://pubmed.ncbi.nlm.nih.gov/38036067/
215,GSR,33394302,Concluding Notes and Future Directions.,"['Bucci W', 'Maskit B']","['Arousal/physiology', '*Biomedical Research', '*Communication', 'Computer Simulation', 'Humans', 'Language', '*Psychotherapy']",https://pubmed.ncbi.nlm.nih.gov/33394302/
216,GSR,28162895,The Brain Basis for Misophonia.,"['Kumar S', 'Tansley-Hancock O', 'Sedley W', 'Winston JS', 'Callaghan MF', 'Allen M', 'Cope TE', 'Gander PE', 'Bamiou DE', 'Griffiths TD']","['Adult', 'Anger/*physiology', 'Anxiety Disorders/diagnostic imaging/*physiopathology', 'Brain/diagnostic imaging/*physiopathology', 'Cerebral Cortex/diagnostic imaging/*physiology', 'Emotions/physiology', 'Female', 'Galvanic Skin Response', 'Humans', 'Magnetic Resonance Imaging', 'Male', 'Middle Aged', 'Sound/*adverse effects', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/28162895/
217,GSR,24373791,Soy isoflavones and prostate cancer: a review of molecular mechanisms.,"['Mahmoud AM', 'Yang W', 'Bosland MC']","['Angiogenesis Inhibitors/pharmacology', 'Animals', 'Antioxidants/metabolism', 'Apoptosis/drug effects', 'Autophagy/drug effects', 'Cell Cycle/drug effects', 'Cell Differentiation/drug effects', 'DNA Repair', 'Epigenesis, Genetic', 'Humans', 'Insulin-Like Growth Factor I/physiology', 'Isoflavones/*therapeutic use', 'Male', 'MicroRNAs/metabolism', 'Neoplasm Metastasis/drug therapy', 'Neoplastic Stem Cells/drug effects', 'Prostaglandins/physiology', 'Prostatic Neoplasms/drug therapy/*prevention & control', 'Protein-Tyrosine Kinases/antagonists & inhibitors', 'Radiation-Sensitizing Agents/pharmacology', 'Receptors, Androgen/drug effects', 'Receptors, Estrogen/drug effects', 'Signal Transduction', 'Glycine max/*chemistry', 'Transforming Growth Factor beta/physiology', 'Wnt Signaling Pathway/drug effects']",https://pubmed.ncbi.nlm.nih.gov/24373791/
218,GSR,39742810,The human zinc-binding cysteine proteome.,"['Burger N', 'Mittenbuhler MJ', 'Xiao H', 'Shin S', 'Wei SM', 'Henze EK', 'Schindler S', 'Mehravar S', 'Wood DM', 'Petrocelli JJ', 'Sun Y', 'Sprenger HG', 'Latorre-Muro P', 'Smythers AL', 'Bozi LHM', 'Darabedian N', 'Zhu Y', 'Seo HS', 'Dhe-Paganon S', 'Che J', 'Chouchani ET']","['Humans', '*Zinc/metabolism', '*Cysteine/metabolism', '*Proteome/metabolism', 'Glutathione Reductase/metabolism', 'Protein Binding', 'Lung Neoplasms/metabolism/pathology', 'Cell Line, Tumor', 'Animals']",https://pubmed.ncbi.nlm.nih.gov/39742810/
219,SLC6A4,33400193,Genetics of primary congenital hypothyroidism-a review.,"['Kostopoulou E', 'Miliordos K', 'Spiliotis B']","['*Congenital Hypothyroidism/genetics', 'Dual Oxidases/genetics', 'Forkhead Transcription Factors', 'Humans', 'Infant, Newborn', 'Iodides', 'Mutation', 'Serotonin Plasma Membrane Transport Proteins', '*Thyroid Dysgenesis/genetics', 'Thyroid Hormones']",https://pubmed.ncbi.nlm.nih.gov/33400193/
220,SLC6A4,21835681,Genetics of emotion.,"['Bevilacqua L', 'Goldman D']","['Catechol O-Methyltransferase/genetics', 'Emotions/*physiology', 'Genetic Predisposition to Disease/*genetics', '*Genetics', 'Genome-Wide Association Study', 'Humans', 'Mood Disorders/*genetics', 'Neuroimaging', 'Neuropeptide Y/genetics', 'Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I/genetics', 'Serotonin Plasma Membrane Transport Proteins/genetics', 'Tacrolimus Binding Proteins/genetics']",https://pubmed.ncbi.nlm.nih.gov/21835681/
221,SLC6A4,37481134,Palmitoylation of solute carriers.,"['Villanueva CE', 'Hagenbuch B']","['Humans', '*Palmitic Acid/metabolism', '*Lipoylation/physiology', 'Protein Processing, Post-Translational', 'Phosphorylation', 'Membrane Proteins/metabolism', 'Serotonin Plasma Membrane Transport Proteins/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37481134/
222,SLC6A4,27350097,Genetic influences on conduct disorder.,"['Salvatore JE', 'Dick DM']","['Conduct Disorder/*genetics', 'Gene-Environment Interaction', 'Genetic Association Studies', 'Genetic Predisposition to Disease/*genetics', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/27350097/
223,SLC6A4,27191890,Molecular factors in migraine.,"['Kowalska M', 'Prendecki M', 'Kozubski W', 'Lianeri M', 'Dorszewska J']","['Genetic Association Studies', 'Genetic Markers/genetics', 'Genetic Predisposition to Disease', 'Humans', 'Inflammation', 'Migraine Disorders/*genetics/physiopathology', 'Orexin Receptors/genetics', 'Orexins/genetics', 'Oxidative Stress', 'Polymorphism, Genetic', 'Risk Factors', 'Serotonin Plasma Membrane Transport Proteins/genetics', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/27191890/
224,SLC6A4,37537371,The serotonin transporter sustains human brown adipose tissue thermogenesis.,"['Suchacki KJ', 'Ramage LE', 'Kwok TC', 'Kelman A', 'McNeill BT', 'Rodney S', 'Keegan M', 'Gray C', 'MacNaught G', 'Patel D', 'Fletcher AM', 'Simpson JP', 'Carter RN', 'Semple RK', 'Homer NZM', 'Morton NM', 'van Beek EJR', 'Wakelin SJ', 'Stimson RH']","['Humans', 'Mice', 'Animals', '*Adipose Tissue, Brown/metabolism', 'Serotonin/metabolism', 'Sertraline/metabolism/pharmacology', 'Serotonin Plasma Membrane Transport Proteins/genetics/metabolism/pharmacology', 'Obesity/metabolism', 'Thermogenesis/physiology', '*Metabolic Diseases/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37537371/
225,SLC6A4,24385047,"SLC6A4 polymorphism, population genetics, and psychiatric traits.",['Gelernter J'],"['*Genetics, Population', 'Humans', 'Mental Disorders/*genetics/psychology', '*Polymorphism, Genetic', 'Serotonin Plasma Membrane Transport Proteins/*genetics']",https://pubmed.ncbi.nlm.nih.gov/24385047/
226,SLC6A4,36555276,"Interplay between Serotonin, Immune Response, and Intestinal Dysbiosis in Inflammatory Bowel Disease.","['Gonzalez Delgado S', 'Garza-Veloz I', 'Trejo-Vazquez F', 'Martinez-Fierro ML']","['Humans', '*Serotonin', 'Serotonin Plasma Membrane Transport Proteins/genetics', 'Dysbiosis/genetics', '*Inflammatory Bowel Diseases/genetics', 'Selective Serotonin Reuptake Inhibitors', 'Immunity']",https://pubmed.ncbi.nlm.nih.gov/36555276/
227,SLC6A4,38408804,Serotonin and the serotonin transporter in the adrenal gland.,"['Bauer MB', 'Currie KPM']","['Animals', 'Humans', '*Serotonin/metabolism', '*Serotonin Plasma Membrane Transport Proteins/genetics/metabolism', 'Aldosterone/metabolism', 'Hydrocortisone', 'Adrenal Glands', 'Mammals']",https://pubmed.ncbi.nlm.nih.gov/38408804/
228,SLC6A4,29930222,The Role of Microbiota in Depression - a brief review.,"['Zalar B', 'Haslberger A', 'Peterlin B']","['3-Hydroxybutyric Acid/physiology', 'Acylation/physiology', 'Brain/*physiopathology', 'Butyrates/metabolism', 'DNA Methylation/physiology', 'Depressive Disorder/genetics/*physiopathology', 'Emotions/physiology', 'Epigenesis, Genetic/physiology', 'Gastrointestinal Microbiome/*physiology', 'Gene Expression Regulation/physiology', 'Histones/physiology', 'Homeostasis/physiology', 'Humans', 'Neurotransmitter Agents/*physiology', 'Serotonin Plasma Membrane Transport Proteins/physiology', 'gamma-Aminobutyric Acid/physiology']",https://pubmed.ncbi.nlm.nih.gov/29930222/
229,SLC6A4,28645747,A review of DNA methylation in depression.,"['Chen D', 'Meng L', 'Pei F', 'Zheng Y', 'Leng J']","['Brain-Derived Neurotrophic Factor/genetics/metabolism', '*DNA Methylation', 'Depression/*genetics', '*Epigenesis, Genetic', 'Humans', 'Receptors, Glucocorticoid/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/28645747/
230,SLC6A4,29086036,SLC6 Transporter Folding Diseases and Pharmacochaperoning.,"['Freissmuth M', 'Stockner T', 'Sucic S']","['Animals', 'Dopamine Plasma Membrane Transport Proteins/chemistry/genetics/physiology', 'Drug Discovery', 'Humans', 'Molecular Chaperones/pharmacology/*therapeutic use', 'Mutation', 'Protein Folding', 'Proteostasis Deficiencies/*drug therapy', 'Serotonin Plasma Membrane Transport Proteins/chemistry/genetics/physiology', 'Solute Carrier Proteins/chemistry/genetics/*physiology']",https://pubmed.ncbi.nlm.nih.gov/29086036/
231,SLC6A4,21439906,Human serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional GxG and GxE differences in health and disease.,"['Murphy DL', 'Moya PR']","[""3' Untranslated Regions"", 'Animals', 'Environment', 'Gene Expression Regulation', 'Genomic Structural Variation', 'Humans', 'Pharmacogenetics', 'Receptors, Serotonin/genetics/metabolism', 'Serotonin/genetics/metabolism', 'Serotonin Plasma Membrane Transport Proteins/*genetics']",https://pubmed.ncbi.nlm.nih.gov/21439906/
232,SLC6A4,30806160,Epigenetic alterations associated with childhood trauma and adult mental health outcomes: A systematic review.,"['Nothling J', 'Malan-Muller S', 'Abrahams N', 'Hemmings SMJ', 'Seedat S']","['Adult', 'Child', '*Child Abuse', 'DNA Methylation', 'Epigenesis, Genetic', 'Humans', '*Mental Disorders/genetics', 'Mental Health', 'Receptors, Glucocorticoid/metabolism', 'Serotonin Plasma Membrane Transport Proteins']",https://pubmed.ncbi.nlm.nih.gov/30806160/
233,SLC6A4,27565518,SLC6A4 methylation as an epigenetic marker of life adversity exposures in humans: A systematic review of literature.,"['Provenzi L', 'Giorda R', 'Beri S', 'Montirosso R']","['DNA Methylation', 'Depression', '*Epigenesis, Genetic', 'Epigenomics', 'Genetic Markers', 'Humans', 'Serotonin Plasma Membrane Transport Proteins/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27565518/
234,SLC6A4,24368617,Neurogenetics of aggressive behavior: studies in primates.,"['Barr CS', 'Driscoll C']","['Aggression/*physiology', 'Animals', 'Behavior, Animal', '*Gene-Environment Interaction', 'Genetic Variation', '*Genetics', 'Humans', 'Impulsive Behavior/genetics', 'Primates', 'Reward']",https://pubmed.ncbi.nlm.nih.gov/24368617/
235,SLC6A4,22920216,Toward an integration of cognitive and genetic models of risk for depression.,"['Gibb BE', 'Beevers CG', 'McGeary JE']","['Attention', 'Cognition/*physiology', 'Depression/*genetics/*psychology', 'Epigenesis, Genetic', '*Gene-Environment Interaction', 'Humans', '*Models, Genetic', 'Models, Psychological', 'Risk Factors', 'Serotonin Plasma Membrane Transport Proteins/genetics']",https://pubmed.ncbi.nlm.nih.gov/22920216/
236,SLC6A4,37453823,Effects of serotonin transporter and receptor polymorphisms on depression.,"['Lopez-Echeverri YP', 'Cardona-Londono KJ', 'Garcia-Aguirre JF', 'Orrego-Cardozo M']","['Humans', '*Serotonin Plasma Membrane Transport Proteins/genetics', '*Depression/genetics', 'Polymorphism, Genetic', 'Serotonin/genetics', 'Alleles']",https://pubmed.ncbi.nlm.nih.gov/37453823/
237,SLC6A4,36114180,Maternal and infant NR3C1 and SLC6A4 epigenetic signatures of the COVID-19 pandemic lockdown: when timing matters.,"['Nazzari S', 'Grumi S', 'Mambretti F', 'Villa M', 'Giorda R', 'Provenzi L']","['*COVID-19/epidemiology/prevention & control', 'Child', 'Communicable Disease Control', '*Epigenesis, Genetic/genetics', 'Female', 'Humans', 'Infant', 'Mouth Mucosa/metabolism', 'Pandemics/prevention & control', 'Pregnancy', '*Quarantine/psychology', '*Receptors, Glucocorticoid/genetics/metabolism', '*Serotonin Plasma Membrane Transport Proteins/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36114180/
238,SLC6A4,38419374,Breaking the rules of SLC6 transporters: Export of the human creatine transporter-1 from the endoplasmic reticulum is supported by its N-terminus.,"['Un D', 'Kovalchuk V', 'El-Kasaby A', 'Kasture A', 'Koban F', 'Kudlacek O', 'Freissmuth M', 'Sucic S']","['Humans', '*Endoplasmic Reticulum/metabolism', 'Protein Transport/physiology', 'Vesicular Transport Proteins/metabolism/genetics', 'HEK293 Cells', 'Membrane Transport Proteins/metabolism/genetics', 'Plasma Membrane Neurotransmitter Transport Proteins/metabolism/genetics', 'Mutation/genetics', 'Animals', 'Nerve Tissue Proteins']",https://pubmed.ncbi.nlm.nih.gov/38419374/
239,SLC6A2,38750358,Dimerization and antidepressant recognition at noradrenaline transporter.,"['Zhang H', 'Yin YL', 'Dai A', 'Zhang T', 'Zhang C', 'Wu C', 'Hu W', 'He X', 'Pan B', 'Jin S', 'Yuan Q', 'Wang MW', 'Yang D', 'Xu HE', 'Jiang Y']","['Humans', '*Antidepressive Agents/chemistry/metabolism/pharmacology', 'Apoproteins/chemistry/metabolism/ultrastructure', 'Aspartic Acid/chemistry/metabolism', 'Binding Sites', 'Cholesterol/metabolism/chemistry', '*Cryoelectron Microscopy', 'Models, Molecular', '*Norepinephrine/metabolism/chemistry', '*Norepinephrine Plasma Membrane Transport Proteins/antagonists & inhibitors/chemistry/metabolism/ultrastructure', 'Protein Binding', '*Protein Multimerization', 'Substrate Specificity']",https://pubmed.ncbi.nlm.nih.gov/38750358/
240,SLC6A2,29035364,Sympathetic neuron-associated macrophages contribute to obesity by importing and metabolizing norepinephrine.,"['Pirzgalska RM', 'Seixas E', 'Seidman JS', 'Link VM', 'Sanchez NM', 'Mahu I', 'Mendes R', 'Gres V', 'Kubasova N', 'Morris I', 'Arus BA', 'Larabee CM', 'Vasques M', 'Tortosa F', 'Sousa AL', 'Anandan S', 'Tranfield E', 'Hahn MK', 'Iannacone M', 'Spann NJ', 'Glass CK', 'Domingos AI']","['Animals', 'CX3C Chemokine Receptor 1/metabolism', 'Gene Expression Profiling', 'Homeostasis', 'Macrophages/*metabolism', 'Mice', 'Mice, Inbred C57BL', 'Mice, Transgenic', 'Neurons/*metabolism', 'Norepinephrine/*metabolism', 'Norepinephrine Plasma Membrane Transport Proteins/genetics', 'Obesity/genetics/*pathology', 'Sympathetic Nervous System/*pathology']",https://pubmed.ncbi.nlm.nih.gov/29035364/
241,SLC6A2,39085602,Transport and inhibition mechanisms of the human noradrenaline transporter.,"['Hu T', 'Yu Z', 'Zhao J', 'Meng Y', 'Salomon K', 'Bai Q', 'Wei Y', 'Zhang J', 'Xu S', 'Dai Q', 'Yu R', 'Yang B', 'Loland CJ', 'Zhao Y']","['Humans', 'Allosteric Regulation/drug effects', '*Apoproteins/antagonists & inhibitors/chemistry/metabolism', 'Binding Sites', 'Biological Transport', '*Bupropion/chemistry/metabolism/pharmacology', 'Chlorides/chemistry/metabolism', 'Conotoxins/chemistry/metabolism/pharmacology', 'Models, Molecular', '*Norepinephrine/chemistry/metabolism', '*Norepinephrine Plasma Membrane Transport Proteins/metabolism/chemistry/antagonists & inhibitors', '*Piperazines/chemistry/metabolism/pharmacology', 'Protein Binding', 'Protein Conformation/drug effects', 'Sodium/chemistry/metabolism', '*Thiazoles/chemistry/metabolism/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/39085602/
242,SLC6A2,39143211,Substrate binding and inhibition mechanism of norepinephrine transporter.,"['Ji W', 'Miao A', 'Liang K', 'Liu J', 'Qi Y', 'Zhou Y', 'Duan X', 'Sun J', 'Lai L', 'Wu JX']","['Humans', 'Binding Sites', 'Cryoelectron Microscopy', 'Models, Molecular', 'Norepinephrine/metabolism', '*Norepinephrine Plasma Membrane Transport Proteins/antagonists & inhibitors/chemistry/metabolism/ultrastructure', 'Protein Binding', 'Substrate Specificity', '3-Iodobenzylguanidine/metabolism', 'Apoproteins']",https://pubmed.ncbi.nlm.nih.gov/39143211/
243,SLC6A2,14566196,Neuropharmacology of paroxetine.,"['Nemeroff CB', 'Owens MJ']","['Animals', 'Antidepressive Agents, Second-Generation/*pharmacology', 'Carrier Proteins/metabolism', 'Humans', 'Membrane Glycoproteins/metabolism', '*Membrane Transport Proteins', '*Nerve Tissue Proteins', 'Norepinephrine Plasma Membrane Transport Proteins', 'Paroxetine/*pharmacology', 'Serotonin Plasma Membrane Transport Proteins', 'Selective Serotonin Reuptake Inhibitors/*pharmacology', 'Symporters/metabolism']",https://pubmed.ncbi.nlm.nih.gov/14566196/
244,SLC6A2,37481134,Palmitoylation of solute carriers.,"['Villanueva CE', 'Hagenbuch B']","['Humans', '*Palmitic Acid/metabolism', '*Lipoylation/physiology', 'Protein Processing, Post-Translational', 'Phosphorylation', 'Membrane Proteins/metabolism', 'Serotonin Plasma Membrane Transport Proteins/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37481134/
245,SLC6A2,39048818,Molecular basis of human noradrenaline transporter reuptake and inhibition.,"['Tan J', 'Xiao Y', 'Kong F', 'Zhang X', 'Xu H', 'Zhu A', 'Liu Y', 'Lei J', 'Tian B', 'Yuan Y', 'Yan C']","['Humans', 'Allosteric Site', '*Antidepressive Agents/chemistry/metabolism', 'Apoproteins/chemistry/metabolism', 'Atomoxetine Hydrochloride/chemistry/pharmacology/metabolism', 'Binding Sites', 'Bupropion/chemistry/metabolism/pharmacology', 'Citalopram/chemistry/pharmacology/metabolism', '*Cryoelectron Microscopy', 'Desipramine/pharmacology/chemistry', '*Dopamine/metabolism/chemistry', 'Escitalopram/chemistry/metabolism', 'Models, Molecular', '*Norepinephrine/metabolism/chemistry', '*Norepinephrine Plasma Membrane Transport Proteins/antagonists & inhibitors/chemistry/metabolism/ultrastructure', 'Potassium/metabolism', 'Potassium Chloride/pharmacology', 'Protein Conformation', 'Sodium/metabolism', 'Substrate Specificity']",https://pubmed.ncbi.nlm.nih.gov/39048818/
246,SLC6A2,36628952,Pharmacogenetics of anxiety and depression in Alzheimer's disease.,"['Cacabelos R', 'Carril JC', 'Corzo L', 'Pego R', 'Cacabelos N', 'Alcaraz M', 'Muniz A', 'Martinez-Iglesias O', 'Naidoo V']","['Humans', '*Alzheimer Disease/drug therapy/genetics', 'Pharmacogenetics/methods', 'Depression/drug therapy/genetics', 'Cytochrome P-450 CYP2D6/genetics', 'Anxiety/drug therapy/genetics', 'Liver-Specific Organic Anion Transporter 1', '*Arylamine N-Acetyltransferase', 'Carrier Proteins', 'Nerve Tissue Proteins', 'Serotonin Plasma Membrane Transport Proteins']",https://pubmed.ncbi.nlm.nih.gov/36628952/
247,SLC6A2,39158690,Evaluation of SLC6A2 and CYP2D6 polymorphisms' effects on atomoxetine treatment in attention deficit and hyperactivity disorder.,"['Kole IH', 'Vural P', 'Yurdacan B', 'Alemdar A', 'Mutlu C']","['Humans', '*Atomoxetine Hydrochloride/therapeutic use/adverse effects', '*Attention Deficit Disorder with Hyperactivity/drug therapy/genetics', '*Cytochrome P-450 CYP2D6/genetics', 'Male', 'Female', '*Polymorphism, Single Nucleotide', '*Adrenergic Uptake Inhibitors/therapeutic use/adverse effects', 'Child', '*Genotype', 'Adolescent', 'Norepinephrine Plasma Membrane Transport Proteins/genetics', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/39158690/
248,SLC6A2,11803442,"Cocaine, reward, movement and monoamine transporters.","['Uhl GR', 'Hall FS', 'Sora I']","['Animals', 'Brain/drug effects/pathology', 'Carrier Proteins/antagonists & inhibitors/genetics/physiology', 'Cocaine/*pharmacology', 'Cocaine-Related Disorders/genetics/metabolism', 'Dopamine/physiology', 'Dopamine Plasma Membrane Transport Proteins', 'Genetic Predisposition to Disease', 'Genetic Variation', 'Humans', 'Membrane Glycoproteins/antagonists & inhibitors/deficiency/genetics/physiology', 'Membrane Transport Modulators', 'Membrane Transport Proteins/antagonists & inhibitors/deficiency/genetics/*physiology', 'Mice', 'Mice, Knockout', 'Models, Neurological', 'Models, Psychological', 'Motor Activity/*drug effects', 'Nerve Tissue Proteins/antagonists & inhibitors/deficiency/genetics/*physiology', 'Norepinephrine/physiology', 'Norepinephrine Plasma Membrane Transport Proteins', '*Reward', 'Serotonin/physiology', 'Serotonin Plasma Membrane Transport Proteins', 'Symporters/antagonists & inhibitors/deficiency/genetics/physiology']",https://pubmed.ncbi.nlm.nih.gov/11803442/
249,SLC6A2,29480512,[Side effects of methylphenidate in children and the young].,"['Espadas M', 'Insa I', 'Chamorro M', 'Alda-Diez JA']","['Adolescent', 'Anorexia/chemically induced', 'Attention Deficit Disorder with Hyperactivity/*drug therapy', 'Bone Diseases, Developmental/chemically induced', 'Central Nervous System Stimulants/*adverse effects/pharmacokinetics/therapeutic use', 'Child', 'Child, Preschool', 'Clinical Trials as Topic', 'Dopamine Agonists/*adverse effects/pharmacokinetics/therapeutic use', 'Growth Disorders/chemically induced', 'Humans', 'Hypertension/chemically induced', 'Mental Disorders/chemically induced', 'Meta-Analysis as Topic', 'Methylphenidate/*adverse effects/pharmacokinetics/therapeutic use', 'Norepinephrine Plasma Membrane Transport Proteins/antagonists & inhibitors', 'Observational Studies as Topic', 'Prospective Studies', 'Psychoses, Substance-Induced/etiology', 'Sleep Wake Disorders/chemically induced', 'Tachycardia/chemically induced', 'Tics/chemically induced']",https://pubmed.ncbi.nlm.nih.gov/29480512/
250,SLC6A2,10584970,Endocrine regulation of neurotransmitter transporters.,['Figlewicz DP'],"['Animals', 'Carrier Proteins/drug effects/*metabolism', 'Dopamine Plasma Membrane Transport Proteins', 'Epilepsy/drug therapy', 'GABA Plasma Membrane Transport Proteins', 'Humans', 'Hydrocortisone/*blood/pharmacology', 'Insulin/*blood/pharmacology', 'Ketone Bodies/*metabolism', '*Membrane Glycoproteins', 'Membrane Proteins/drug effects/metabolism', '*Membrane Transport Proteins', '*Nerve Tissue Proteins', 'Neurotransmitter Agents/*metabolism/physiology', 'Norepinephrine Plasma Membrane Transport Proteins', '*Organic Anion Transporters', '*Symporters']",https://pubmed.ncbi.nlm.nih.gov/10584970/
251,SLC6A2,32012861,The Relationship between DNA Methylation and Antidepressant Medications: A Systematic Review.,"['Webb LM', 'Phillips KE', 'Ho MC', 'Veldic M', 'Blacker CJ']","['Antidepressive Agents/pharmacology/*therapeutic use', '*DNA Methylation', 'Depressive Disorder, Major/*drug therapy/genetics', 'Epigenesis, Genetic', 'Humans', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/32012861/
252,SLC6A2,29588275,Differential ubiquitination in NETs regulates macrophage responses in systemic lupus erythematosus.,"['Barrera-Vargas A', 'Gomez-Martin D', 'Carmona-Rivera C', 'Merayo-Chalico J', 'Torres-Ruiz J', 'Manna Z', 'Hasni S', 'Alcocer-Varela J', 'Kaplan MJ']","['Adult', 'Autoantibodies/biosynthesis', 'Calcium/metabolism', 'Case-Control Studies', 'Cells, Cultured', 'Cytokines/biosynthesis', 'Extracellular Traps/immunology/*metabolism', 'Female', 'Humans', 'Lupus Erythematosus, Systemic/immunology/*metabolism', 'Macrophages/*metabolism', 'Male', 'Norepinephrine Plasma Membrane Transport Proteins/immunology/metabolism', 'Receptors, CXCR4/metabolism', 'Ubiquitin/metabolism', 'Ubiquitination/immunology/physiology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/29588275/
253,SLC6A2,33340618,Association between genetic variants of the norepinephrine transporter gene (SLC6A2) and bipolar I disorder.,"['Kim SY', 'Kim HN', 'Jeon SW', 'Lim WJ', 'Kim SI', 'Lee YJ', 'Kim SY', 'Kim YK']","['Adult', 'Bipolar Disorder/diagnosis/*epidemiology/*genetics', 'Female', 'Genetic Association Studies/*methods', 'Genetic Variation/*genetics', 'Humans', 'Male', 'Middle Aged', 'Norepinephrine Plasma Membrane Transport Proteins/*genetics', 'Republic of Korea/epidemiology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/33340618/
254,SLC6A2,19405789,Treatment strategies for hot flushes.,"['Shen W', 'Stearns V']","['*Estrogen Replacement Therapy', 'Evidence-Based Medicine', 'Female', 'Hot Flashes/*drug therapy', 'Humans', 'Norepinephrine Plasma Membrane Transport Proteins/*metabolism', 'Quality of Life', 'Selective Serotonin Reuptake Inhibitors/*therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/19405789/
255,SLC6A2,20145962,Molecular genetics of attention-deficit/hyperactivity disorder: an overview.,"['Banaschewski T', 'Becker K', 'Scherag S', 'Franke B', 'Coghill D']","['Adolescent', 'Cell Division/genetics', 'Child', 'Genetic Markers/*genetics', 'Genetic Predisposition to Disease/*genetics', 'Genome-Wide Association Study', 'Humans', 'Malformations of Cortical Development, Group II/genetics', 'Neurotransmitter Agents/genetics', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/20145962/
256,SLC6A2,24655776,Association between norepinephrine transporter gene (SLC6A2) polymorphisms and suicide in patients with major depressive disorder.,"['Kim YK', 'Hwang JA', 'Lee HJ', 'Yoon HK', 'Ko YH', 'Lee BH', 'Jung HY', 'Hahn SW', 'Na KS']","['Adult', 'Case-Control Studies', 'Depressive Disorder, Major/*genetics/*psychology', 'Female', 'Humans', 'Male', 'Middle Aged', 'Norepinephrine Plasma Membrane Transport Proteins/*genetics', '*Polymorphism, Single Nucleotide', 'Risk Assessment', 'Suicide, Attempted/*statistics & numerical data', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/24655776/
257,SLC6A2,18839161,Chronic heart failure: beta-blockers and pharmacogenetics.,"['Azuma J', 'Nonen S']","['Adrenergic beta-Antagonists/adverse effects/pharmacokinetics/*therapeutic use', 'Animals', 'Chronic Disease', 'Cytochrome P-450 Enzyme System/genetics', 'G-Protein-Coupled Receptor Kinases/genetics', 'Heart Failure/*drug therapy/enzymology/genetics', 'Humans', 'Norepinephrine Plasma Membrane Transport Proteins/genetics', 'Patient Selection', 'Peptidyl-Dipeptidase A/genetics', '*Pharmacogenetics', '*Polymorphism, Genetic', 'Practice Guidelines as Topic', 'Receptors, Adrenergic, beta/drug effects/genetics', 'Risk Assessment', 'Risk Factors', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/18839161/
258,SLC6A2,39653825,Dynamic behavior and lineage plasticity of the pulmonary venous endothelium.,"['Wong J', 'Zhao G', 'Adams-Tzivelekidis S', 'Wen H', 'Chandrasekaran P', 'Michki SN', 'Gentile ME', 'Singh M', 'Kass-Gergi S', 'Mendoza M', 'Holcomb NP', 'Li X', 'Tang AT', 'Negretti NM', 'Sucre JMS', 'Frank DB', 'Vaughan AE']","['Animals', '*Pulmonary Veins', '*Cell Lineage', 'Cell Proliferation', 'Endothelial Cells/physiology', 'Disease Models, Animal', 'Mice, Transgenic', 'Cell Plasticity/physiology', 'Mice', 'Orthomyxoviridae Infections/virology', 'Regeneration/physiology', 'Hyperoxia/physiopathology', 'Neovascularization, Physiologic/physiology', 'Capillaries/physiology', 'Endothelium, Vascular/cytology', 'Cell Differentiation', 'Mice, Inbred C57BL', 'Lung Injury/pathology/physiopathology', 'Endothelial Progenitor Cells/physiology/metabolism', 'Lung/blood supply']",https://pubmed.ncbi.nlm.nih.gov/39653825/
259,SLC6A3,27217152,"Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.","['Bonvicini C', 'Faraone SV', 'Scassellati C']","['Adult', 'Alleles', 'Attention Deficit Disorder with Hyperactivity/*genetics/*metabolism', 'Biomarkers/blood', 'Docosahexaenoic Acids/blood/genetics/metabolism', 'Dopamine Plasma Membrane Transport Proteins/*genetics/metabolism', 'Female', 'Gene Frequency/genetics', 'Genetic Association Studies/methods', 'Genotype', 'Humans', 'Male', 'Methylphenidate/therapeutic use', 'Minisatellite Repeats/genetics', 'Nerve Tissue Proteins/*genetics/metabolism', 'Pharmacogenetics', 'Polymorphism, Genetic', 'Receptors, Dopamine D4/genetics']",https://pubmed.ncbi.nlm.nih.gov/27217152/
260,SLC6A3,37481134,Palmitoylation of solute carriers.,"['Villanueva CE', 'Hagenbuch B']","['Humans', '*Palmitic Acid/metabolism', '*Lipoylation/physiology', 'Protein Processing, Post-Translational', 'Phosphorylation', 'Membrane Proteins/metabolism', 'Serotonin Plasma Membrane Transport Proteins/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37481134/
261,SLC6A3,34264428,Tremor in Primary Monogenic Dystonia.,"['Pandey S', 'Bhattad S', 'Dinesh S']","['Anoctamins', 'Apoptosis Regulatory Proteins/genetics', 'DNA-Binding Proteins/genetics', 'Dopamine Plasma Membrane Transport Proteins', '*Dystonia/epidemiology/genetics', '*Dystonic Disorders/epidemiology/genetics', 'Humans', 'Molecular Chaperones', 'Mutation/genetics', 'Tremor/epidemiology/genetics']",https://pubmed.ncbi.nlm.nih.gov/34264428/
262,SLC6A3,28766921,The dopamine transporter role in psychiatric phenotypes.,"['Salatino-Oliveira A', 'Rohde LA', 'Hutz MH']","['Animals', 'Disease Models, Animal', 'Dopamine/genetics/metabolism', 'Dopamine Plasma Membrane Transport Proteins/*genetics/*metabolism', 'Humans', 'Mental Disorders/genetics/*metabolism', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/28766921/
263,SLC6A3,29086036,SLC6 Transporter Folding Diseases and Pharmacochaperoning.,"['Freissmuth M', 'Stockner T', 'Sucic S']","['Animals', 'Dopamine Plasma Membrane Transport Proteins/chemistry/genetics/physiology', 'Drug Discovery', 'Humans', 'Molecular Chaperones/pharmacology/*therapeutic use', 'Mutation', 'Protein Folding', 'Proteostasis Deficiencies/*drug therapy', 'Serotonin Plasma Membrane Transport Proteins/chemistry/genetics/physiology', 'Solute Carrier Proteins/chemistry/genetics/*physiology']",https://pubmed.ncbi.nlm.nih.gov/29086036/
264,SLC6A3,26593110,Meta-analysis of the association of the SLC6A3 3'-UTR VNTR with cognition.,"['Ettinger U', 'Merten N', 'Kambeitz J']","['*Cognition', 'Dopamine Plasma Membrane Transport Proteins/*genetics', 'Humans', '*Minisatellite Repeats', '*Polymorphism, Genetic']",https://pubmed.ncbi.nlm.nih.gov/26593110/
265,SLC6A3,27898587,Maternal epigenetics and fetal and neonatal growth.,"['Kitsiou-Tzeli S', 'Tzetis M']","['DNA Methylation', 'Environment', '*Epigenesis, Genetic', 'Female', 'Fetal Development/*genetics', 'Fetal Growth Retardation/genetics', 'Gene Expression', 'Genomic Imprinting/genetics', 'Histones/metabolism', 'Humans', 'Hypothalamo-Hypophyseal System/metabolism/physiology', 'Infant, Low Birth Weight/growth & development', 'Infant, Newborn/*growth & development', 'Maternal Nutritional Physiological Phenomena/*genetics', 'Pituitary-Adrenal System/physiology', 'Pregnancy']",https://pubmed.ncbi.nlm.nih.gov/27898587/
266,SLC6A3,27520881,Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.,"['Lohr KM', 'Masoud ST', 'Salahpour A', 'Miller GW']","['Animals', 'Dopamine/*metabolism', 'Dopamine Plasma Membrane Transport Proteins/*metabolism', 'Dopaminergic Neurons/*metabolism', 'Humans', 'Mesencephalon/metabolism', 'Presynaptic Terminals/*metabolism', 'Synaptic Transmission/physiology']",https://pubmed.ncbi.nlm.nih.gov/27520881/
267,SLC6A3,28097908,Common and specific genes and peripheral biomarkers in children and adults with attention-deficit/hyperactivity disorder.,"['Bonvicini C', 'Faraone SV', 'Scassellati C']","['Adult', 'Attention Deficit Disorder with Hyperactivity/*genetics/*metabolism', '*Biomarkers', 'Child', '*Genomics', 'Humans', '*Metabolomics']",https://pubmed.ncbi.nlm.nih.gov/28097908/
268,SLC6A3,34650206,The dopamine transporter gene SLC6A3: multidisease risks.,"['Reith MEA', 'Kortagere S', 'Wiers CE', 'Sun H', 'Kurian MA', 'Galli A', 'Volkow ND', 'Lin Z']","['*Attention Deficit Disorder with Hyperactivity/genetics', '*Dopamine Plasma Membrane Transport Proteins/genetics/metabolism', 'Haplotypes', 'Humans', 'Mutation', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/34650206/
269,SLC6A3,11803442,"Cocaine, reward, movement and monoamine transporters.","['Uhl GR', 'Hall FS', 'Sora I']","['Animals', 'Brain/drug effects/pathology', 'Carrier Proteins/antagonists & inhibitors/genetics/physiology', 'Cocaine/*pharmacology', 'Cocaine-Related Disorders/genetics/metabolism', 'Dopamine/physiology', 'Dopamine Plasma Membrane Transport Proteins', 'Genetic Predisposition to Disease', 'Genetic Variation', 'Humans', 'Membrane Glycoproteins/antagonists & inhibitors/deficiency/genetics/physiology', 'Membrane Transport Modulators', 'Membrane Transport Proteins/antagonists & inhibitors/deficiency/genetics/*physiology', 'Mice', 'Mice, Knockout', 'Models, Neurological', 'Models, Psychological', 'Motor Activity/*drug effects', 'Nerve Tissue Proteins/antagonists & inhibitors/deficiency/genetics/*physiology', 'Norepinephrine/physiology', 'Norepinephrine Plasma Membrane Transport Proteins', '*Reward', 'Serotonin/physiology', 'Serotonin Plasma Membrane Transport Proteins', 'Symporters/antagonists & inhibitors/deficiency/genetics/physiology']",https://pubmed.ncbi.nlm.nih.gov/11803442/
270,SLC6A3,20631684,"Neurogenetics and pharmacology of learning, motivation, and cognition.","['Frank MJ', 'Fossella JA']","['Animals', 'Cognition/physiology', 'Corpus Striatum/chemistry/*physiology', 'Dopamine/deficiency/genetics/*metabolism', 'Dopamine Plasma Membrane Transport Proteins/genetics', 'Dopamine and cAMP-Regulated Phosphoprotein 32/genetics', 'Genetic Variation/genetics', 'Humans', 'Learning/physiology', 'Motivation/genetics', 'Polymorphism, Genetic', 'Prefrontal Cortex/chemistry/*physiology', 'Receptors, Dopamine D2/genetics', 'Receptors, Dopamine D4/genetics']",https://pubmed.ncbi.nlm.nih.gov/20631684/
271,SLC6A3,34797406,SLC gene mutations and pediatric neurological disorders: diverse clinical phenotypes in a Saudi Arabian population.,"['Mir A', 'Almudhry M', 'Alghamdi F', 'Albaradie R', 'Ibrahim M', 'Aldurayhim F', 'Alhedaithy A', 'Alamr M', 'Bawazir M', 'Mohammad S', 'Abdelhay S', 'Bashir S', 'Housawi Y']","['Adolescent', 'Asian People/genetics', 'Autism Spectrum Disorder/*genetics', 'Brain/metabolism', 'Bulbar Palsy, Progressive/genetics', 'Child', 'Child, Preschool', 'Epilepsy/*genetics', 'Female', '*Genetic Predisposition to Disease', 'Hearing Loss, Sensorineural/genetics', 'Humans', 'Infant', 'Intellectual Disability/*genetics', 'Male', 'Membrane Transport Proteins/genetics', 'Mutation', 'Phenotype', 'Saudi Arabia', 'Solute Carrier Proteins/*genetics']",https://pubmed.ncbi.nlm.nih.gov/34797406/
272,SLC6A3,37628576,"LRP5, SLC6A3, and SOX10 Expression in Conventional Ameloblastoma.","['Correa-Arzate L', 'Portilla-Robertson J', 'Ramirez-Jarquin JO', 'Jacinto-Aleman LF', 'Mejia-Velazquez CP', 'Villanueva-Sanchez FG', 'Rodriguez-Vazquez M']","['Humans', '*Ameloblastoma/genetics', 'Vorinostat', 'Cell Proliferation/genetics', 'Computational Biology', 'SOXE Transcription Factors/genetics', 'Low Density Lipoprotein Receptor-Related Protein-5', 'Dopamine Plasma Membrane Transport Proteins']",https://pubmed.ncbi.nlm.nih.gov/37628576/
273,SLC6A3,19450132,Polymorphisms in the dopamine transporter gene (SLC6A3/DAT1) and alcohol dependence in humans: a systematic review.,"['van der Zwaluw CS', 'Engels RC', 'Buitelaar J', 'Verkes RJ', 'Franke B', 'Scholte RH']","['Alcohol Withdrawal Delirium/*genetics', 'Alcoholism/epidemiology/*genetics/metabolism', 'Case-Control Studies', 'DNA, Complementary/genetics', 'Dopamine Plasma Membrane Transport Proteins/*genetics', 'Environment', 'Family', 'Female', 'Genetic Variation', 'Humans', 'Male', 'Minisatellite Repeats/genetics', 'Racial Groups/genetics', 'Risk Factors', 'Sex Characteristics', 'Tandem Repeat Sequences']",https://pubmed.ncbi.nlm.nih.gov/19450132/
274,SLC6A3,16722244,ADHD and the dopamine transporter: are there reasons to pay attention?,"['Mazei-Robinson MS', 'Blakely RD']","['Adult', 'Animals', 'Attention Deficit Disorder with Hyperactivity/drug therapy/*genetics/metabolism', 'Base Sequence', 'Brain/drug effects/metabolism', 'Child', 'Disease Models, Animal', 'Dopamine Plasma Membrane Transport Proteins/chemistry/*genetics/metabolism', 'Dopamine Uptake Inhibitors/pharmacology/therapeutic use', 'Female', 'Gene Expression Regulation', 'Humans', 'Male', 'Methylphenidate/pharmacology/therapeutic use', 'Mice', 'Mice, Knockout', 'Minisatellite Repeats/genetics', 'Molecular Sequence Data', 'Mutation']",https://pubmed.ncbi.nlm.nih.gov/16722244/
275,SLC6A3,20206707,Imaging genetics in ADHD.,['Durston S'],"['Attention Deficit Disorder with Hyperactivity/*genetics', 'Child', 'Diagnostic Imaging/*methods', 'Dopamine Plasma Membrane Transport Proteins/genetics', '*Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Phenotype', 'Receptors, Dopamine D4/genetics']",https://pubmed.ncbi.nlm.nih.gov/20206707/
276,SLC6A3,20164768,Dopamine: what's new in migraine?,"['Charbit AR', 'Akerman S', 'Goadsby PJ']","['Animals', 'Dopamine/*metabolism', 'Dopamine Antagonists/pharmacology/therapeutic use', 'Dopamine Plasma Membrane Transport Proteins/metabolism', 'Dopamine beta-Hydroxylase/metabolism', 'Genetic Predisposition to Disease/genetics', 'Humans', 'Hypothalamus/*metabolism/*physiopathology', 'Migraine Disorders/drug therapy/*metabolism/*physiopathology', 'Neural Pathways/metabolism/physiopathology', 'Nociceptors/drug effects/metabolism', 'Trigeminal Nuclei/metabolism/physiopathology']",https://pubmed.ncbi.nlm.nih.gov/20164768/
277,SLC6A3,31185047,Presence of recombination hotspots throughout SLC6A3.,"['Zhao J', 'Zhou Y', 'Xiong N', 'Qing H', 'Wang T', 'Lin Z']","['Black or African American', 'Cohort Studies', 'Dopamine Plasma Membrane Transport Proteins/*genetics', 'Female', 'Genetic Markers', '*Genome, Human', 'Humans', 'Male', '*Recombination, Genetic', 'Substance-Related Disorders/*genetics', 'White People']",https://pubmed.ncbi.nlm.nih.gov/31185047/
278,SLC6A3,30259411,Intragenic Transcriptional cis-Antagonism Across SLC6A3.,"['Zhao Y', 'Yu J', 'Zhao J', 'Chen X', 'Xiong N', 'Wang T', 'Qing H', 'Lin Z']","['Adult', 'Animals', 'Cell Line, Tumor', 'Dopamine Plasma Membrane Transport Proteins/*genetics', 'Enhancer Elements, Genetic', 'Haplotypes/genetics', 'Humans', 'Male', 'Mice, Inbred C57BL', 'Minisatellite Repeats/genetics', 'Models, Biological', '*Promoter Regions, Genetic', 'Transcription Factors/metabolism', '*Transcription, Genetic']",https://pubmed.ncbi.nlm.nih.gov/30259411/
279,COMT,21095465,Catechol-O-methyltransferase and pain.,"['Kambur O', 'Mannisto PT']","['Animals', 'Catechol O-Methyltransferase/genetics/*metabolism', 'Humans', 'Pain/genetics/*metabolism', 'Pain Threshold/physiology']",https://pubmed.ncbi.nlm.nih.gov/21095465/
280,COMT,35590332,"Connecting DCX, COMT and FMR1 in social behavior and cognitive impairment.","['Delprato A', 'Xiao E', 'Manoj D']","['Catechol O-Methyltransferase/metabolism', '*Cognitive Dysfunction', 'Fragile X Mental Retardation Protein/genetics/metabolism', 'Hippocampus/metabolism', 'Humans', '*Intellectual Disability/genetics/metabolism', 'Neurogenesis/genetics', 'Social Behavior']",https://pubmed.ncbi.nlm.nih.gov/35590332/
281,COMT,25732148,Imaging genetics and psychiatric disorders.,"['Hashimoto R', 'Ohi K', 'Yamamori H', 'Yasuda Y', 'Fujimoto M', 'Umeda-Yano S', 'Watanabe Y', 'Fukunaga M', 'Takeda M']","['Bipolar Disorder/diagnosis/*genetics/pathology/physiopathology', 'Brain-Derived Neurotrophic Factor/genetics/metabolism', 'Catechol O-Methyltransferase/genetics/metabolism', 'Chromosomes, Human, Pair 12/chemistry/ultrastructure', 'Cooperative Behavior', 'Gene Expression', 'Genetics, Medical/instrumentation/*methods', 'Genome-Wide Association Study', 'Genotype', 'Hippocampus/*metabolism/pathology/physiopathology', 'Humans', 'Kruppel-Like Transcription Factors/genetics/metabolism', 'Neuroimaging/instrumentation/*methods', 'Phenotype', 'Polymorphism, Single Nucleotide', 'Schizophrenia/diagnosis/*genetics/pathology/physiopathology']",https://pubmed.ncbi.nlm.nih.gov/25732148/
282,COMT,29231139,"Catechol-O-methyltransferase, Cognition and Alzheimer's Disease.","['Perkovic MN', 'Strac DS', 'Tudor L', 'Konjevod M', 'Erjavec GN', 'Pivac N']","['Alzheimer Disease/*enzymology/*genetics/psychology', 'Catechol O-Methyltransferase/*genetics/*metabolism', 'Cognition/*physiology', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/29231139/
283,COMT,26696755,The Function and Roles of ADAMTS-7 in Inflammatory Diseases.,"['Zhang Y', 'Lin J', 'Wei F']","['ADAM Proteins/chemistry/genetics/*physiology', 'ADAMTS Proteins', 'ADAMTS7 Protein', 'Arthritis/etiology', 'Atherosclerosis/etiology', 'Catechol O-Methyltransferase/metabolism', 'Humans', 'Inflammation/*etiology']",https://pubmed.ncbi.nlm.nih.gov/26696755/
284,COMT,30550356,Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality.,"['Tamburini E', 'Dallatomasina A', 'Quartararo J', 'Cortelazzi B', 'Mangieri D', 'Lazzaretti M', 'Perris R']","['Amino Acid Sequence', 'Animals', 'Antigens/*chemistry/genetics/metabolism', 'Cell Membrane/metabolism', 'Chondroitin Sulfate Proteoglycans/chemistry/genetics/metabolism', 'Evolution, Molecular', 'Humans', 'Membrane Proteins/chemistry/genetics/metabolism', 'Models, Molecular', 'Nerve Regeneration/physiology', 'Neurites/metabolism', 'Phylogeny', 'Protein Interaction Domains and Motifs', 'Proteoglycans/*chemistry/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/30550356/
285,COMT,37218669,Dopaminergic signalling and behavioural alterations by Comt-Dtnbp1 genetic interaction and their clinical relevance.,"['Manago F', 'Scheggia D', 'Pontillo M', 'Mereu M', 'Mastrogiacomo R', 'Udayan G', 'Valentini P', 'Tata MC', 'Weinberger DR', 'Weickert CS', 'Pompa PP', 'De Luca MA', 'Vicari S', 'Papaleo F']","['Humans', 'Mice', 'Animals', '*DiGeorge Syndrome/genetics', 'Catechol O-Methyltransferase/genetics/metabolism', 'Dopamine/metabolism', 'Genetic Predisposition to Disease', 'Clinical Relevance', 'Polymorphism, Single Nucleotide', 'Dysbindin/genetics']",https://pubmed.ncbi.nlm.nih.gov/37218669/
286,COMT,38532008,Sex dimorphism controls dysbindin-related cognitive dysfunctions in mice and humans with the contribution of COMT.,"['Geraci F', 'Passiatore R', 'Penzel N', 'Laudani S', 'Bertolino A', 'Blasi G', 'Graziano ACE', 'Kikidis GC', 'Mazza C', 'Parihar M', 'Rampino A', 'Sportelli L', 'Trevisan N', 'Drago F', 'Papaleo F', 'Sambataro F', 'Pergola G', 'Leggio GM']","['*Catechol O-Methyltransferase/genetics/metabolism', '*Dysbindin/metabolism/genetics', 'Animals', 'Male', 'Female', 'Humans', '*Sex Characteristics', 'Mice', '*Memory, Short-Term/physiology', '*Schizophrenia/genetics/metabolism', '*Cognitive Dysfunction/metabolism/genetics/physiopathology', 'Adult', '*Prefrontal Cortex/metabolism', 'Magnetic Resonance Imaging/methods', 'Epistasis, Genetic', 'Cognition/physiology', 'Estrogens/metabolism', 'Middle Aged', 'Mice, Inbred C57BL', 'Carrier Proteins/genetics/metabolism', 'Dystrophin-Associated Proteins/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38532008/
287,COMT,25466290,"Catechol-O-methyltransferase, dopamine, and sleep-wake regulation.","['Dauvilliers Y', 'Tafti M', 'Landolt HP']","['Arousal/*physiology', 'Catechol O-Methyltransferase/genetics/*physiology', 'Dopamine/*physiology', 'Frontal Lobe/enzymology/physiology', 'Humans', 'Narcolepsy/enzymology/etiology', 'Sleep/*physiology', 'Sleep Wake Disorders/enzymology/etiology']",https://pubmed.ncbi.nlm.nih.gov/25466290/
288,COMT,20631684,"Neurogenetics and pharmacology of learning, motivation, and cognition.","['Frank MJ', 'Fossella JA']","['Animals', 'Cognition/physiology', 'Corpus Striatum/chemistry/*physiology', 'Dopamine/deficiency/genetics/*metabolism', 'Dopamine Plasma Membrane Transport Proteins/genetics', 'Dopamine and cAMP-Regulated Phosphoprotein 32/genetics', 'Genetic Variation/genetics', 'Humans', 'Learning/physiology', 'Motivation/genetics', 'Polymorphism, Genetic', 'Prefrontal Cortex/chemistry/*physiology', 'Receptors, Dopamine D2/genetics', 'Receptors, Dopamine D4/genetics']",https://pubmed.ncbi.nlm.nih.gov/20631684/
289,COMT,34893161,Insights into S-adenosyl-l-methionine (SAM)-dependent methyltransferase related diseases and genetic polymorphisms.,"['Li J', 'Sun C', 'Cai W', 'Li J', 'Rosen BP', 'Chen J']","['Animals', 'Humans', 'Metabolism, Inborn Errors/*genetics/metabolism', 'Methyltransferases/chemistry/*genetics/metabolism', '*Polymorphism, Single Nucleotide', 'S-Adenosylmethionine/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/34893161/
290,COMT,21860037,Neurobiology of aggression and violence in schizophrenia.,['Soyka M'],"['Aggression/*physiology', 'Catechol O-Methyltransferase/genetics', 'Humans', '*Schizophrenia/enzymology/genetics', 'Violence/*psychology']",https://pubmed.ncbi.nlm.nih.gov/21860037/
291,COMT,22138198,Effects of COMT polymorphisms on brain function and behavior in health and disease.,"['Witte AV', 'Floel A']","['Animals', 'Brain Chemistry/*genetics/physiology', 'Catechol O-Methyltransferase/chemistry/*genetics', '*Health Status', 'Humans', 'Mental Disorders/*enzymology/*genetics/physiopathology', 'Methionine/genetics', 'Polymorphism, Single Nucleotide/*genetics', 'Valine/genetics']",https://pubmed.ncbi.nlm.nih.gov/22138198/
292,COMT,18329779,"Brain imaging, genetics and emotion.","['Aleman A', 'Swart M', 'van Rijn S']","['Animals', 'Brain/*anatomy & histology/physiology', 'Brain Chemistry/genetics', 'Emotions/*physiology', 'Genetic Variation', 'Humans', '*Molecular Biology', 'Neurotransmitter Agents/metabolism/physiology', 'Polymorphism, Genetic/physiology']",https://pubmed.ncbi.nlm.nih.gov/18329779/
293,COMT,36623778,Catechol-O-Methyltransferase Loss Drives Cell-Specific Nociceptive Signaling via the Enteric Catechol-O-Methyltransferase/microRNA-155/Tumor Necrosis Factor alpha Axis.,"['Zhou Q', 'Yang L', 'Verne ML', 'Zhang BB', 'Fields J', 'Verne GN']","['Humans', 'Mice', 'Animals', '*Irritable Bowel Syndrome/metabolism', 'Tumor Necrosis Factor-alpha/metabolism', 'Catechol O-Methyltransferase/genetics/metabolism', 'Nociception', 'Tumor Necrosis Factor Inhibitors', 'Colon/metabolism', 'Abdominal Pain/genetics/metabolism', '*MicroRNAs/genetics/metabolism', 'Trinitrobenzenes/metabolism', 'Sulfonic Acids/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36623778/
294,COMT,29883709,"Fearfulness, neuroticism/anxiety, and COMT Val158Met in long-term fear conditioning and extinction.","['Panitz C', 'Sperl MFJ', 'Hennig J', 'Klucken T', 'Hermann C', 'Mueller EM']","['Adolescent', 'Adult', 'Anxiety/genetics/*physiopathology', 'Bradycardia/*physiopathology', 'Catechol O-Methyltransferase/*genetics', 'Conditioning, Classical/*physiology', 'Electrocardiography', 'Electroencephalography', 'Evoked Potentials/*physiology', 'Extinction, Psychological/*physiology', 'Fear/*physiology', 'Galvanic Skin Response/physiology', 'Humans', 'Male', 'Mental Recall/physiology', 'Neuroticism/*physiology', 'Personality/genetics/*physiology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/29883709/
295,COMT,26888414,Physical and verbal aggressive behavior and COMT genotype: Sensitivity to the environment.,"['Tuvblad C', 'Narusyte J', 'Comasco E', 'Andershed H', 'Andershed AK', 'Colins OF', 'Fanti KA', 'Nilsson KW']","['Adult', 'Aggression/*physiology/psychology', 'Alleles', 'Catechol O-Methyltransferase/*genetics/metabolism', 'Environment', 'Female', 'Gene-Environment Interaction', 'Genetic Predisposition to Disease/genetics', 'Genotype', 'Homozygote', 'Humans', 'Male', 'Parent-Child Relations', 'Polymorphism, Single Nucleotide/genetics', 'Risk Factors', 'Valine/genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/26888414/
296,COMT,37684514,Dysregulated COMT Expression in Fragile X Syndrome.,"['Utami KH', 'Yusof NABM', 'Garcia-Miralles M', 'Skotte NH', 'Nama S', 'Sampath P', 'Langley SR', 'Pouladi MA']","['Animals', 'Humans', 'Mice', '*Catechol O-Methyltransferase/genetics', 'Dopamine/metabolism', 'Fragile X Mental Retardation Protein/genetics/metabolism', '*Fragile X Syndrome/genetics/metabolism', 'Mice, Knockout', 'Neurons/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37684514/
297,COMT,34587154,Suppressor effect of catechol-O-methyltransferase gene in prostate cancer.,"['Hashimoto Y', 'Shiina M', 'Maekawa S', 'Kato T', 'Shahryari V', 'Kulkarni P', 'Dasgupta P', 'Yamamura S', 'Saini S', 'Tabatabai ZL', 'Dahiya R', 'Tanaka Y']","['Animals', 'Apoptosis', 'Biomarkers, Tumor/genetics/*metabolism', 'Case-Control Studies', 'Catechol O-Methyltransferase/genetics/*metabolism', 'Cell Movement', 'Cell Proliferation', '*Gene Expression Regulation, Neoplastic', 'Humans', 'Male', 'Mice', 'Mice, Inbred BALB C', 'Mice, Nude', 'MicroRNAs/*genetics', 'Prognosis', 'Prostatic Neoplasms/genetics/metabolism/*pathology', 'Survival Rate', 'Tumor Cells, Cultured', 'Xenograft Model Antitumor Assays']",https://pubmed.ncbi.nlm.nih.gov/34587154/
298,COMT,8906471,Purification methods of mammalian catechol-O-methyltransferases.,"['Tilgmann C', 'Ulmanen I']","['Amino Acid Sequence', 'Animals', 'Blotting, Western', 'Catechol O-Methyltransferase/analysis/chemistry/genetics/*isolation & purification', 'Chromatography, Liquid/methods', 'Electrophoresis, Polyacrylamide Gel', 'Gene Expression/*genetics', 'Humans', 'Liver/enzymology', 'Molecular Sequence Data', 'Placenta/enzymology', 'Rats', 'Recombinant Proteins/genetics/isolation & purification']",https://pubmed.ncbi.nlm.nih.gov/8906471/
299,CHRM1,30185628,Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness.,"['Renz BW', 'Tanaka T', 'Sunagawa M', 'Takahashi R', 'Jiang Z', 'Macchini M', 'Dantes Z', 'Valenti G', 'White RA', 'Middelhoff MA', 'Ilmer M', 'Oberstein PE', 'Angele MK', 'Deng H', 'Hayakawa Y', 'Westphalen CB', 'Werner J', 'Remotti H', 'Reichert M', 'Tailor YH', 'Nagar K', 'Friedman RA', 'Iuga AC', 'Olive KP', 'Wang TC']","['Animals', 'Carcinoma, Pancreatic Ductal/metabolism/pathology/*prevention & control', 'Cell Transformation, Neoplastic/*drug effects/metabolism/pathology', 'Cholinergic Agents/*pharmacology', 'Genes, ras', 'Humans', 'Mice', 'Mice, Inbred C57BL', 'Mice, Inbred NOD', 'Mice, Knockout', 'Mice, SCID', 'Neoplastic Stem Cells/*drug effects/metabolism/pathology', 'Pancreatic Neoplasms/metabolism/pathology/*prevention & control', 'Receptor, Muscarinic M1/*physiology', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/30185628/
300,CHRM1,37994870,Muscarinic M1 and M4 receptor agonists for schizophrenia: promising candidates for the therapeutic arsenal.,['Dean B'],"['Humans', '*Schizophrenia/drug therapy', 'Muscarinic Agonists/pharmacology/therapeutic use', 'Receptor, Muscarinic M4/agonists/genetics/therapeutic use', '*Antipsychotic Agents/pharmacology/therapeutic use', 'Receptors, Dopamine D2/therapeutic use', 'Receptor, Muscarinic M1']",https://pubmed.ncbi.nlm.nih.gov/37994870/
301,CHRM1,38262412,Cholinergic signaling via muscarinic M1 receptor confers resistance to docetaxel in prostate cancer.,"['Wang J', 'Wei J', 'Pu T', 'Zeng A', 'Karthikeyan V', 'Bechtold B', 'Vo K', 'Chen J', 'Lin TP', 'Chang AP', 'Corey E', 'Puhr M', 'Klocker H', 'Culig Z', 'Bland T', 'Wu BJ']","['Male', 'Humans', 'Docetaxel/pharmacology/therapeutic use', '*Receptor, Muscarinic M1/genetics', '*Prostatic Neoplasms, Castration-Resistant/drug therapy/genetics/metabolism', 'Cell Line, Tumor', 'Cholinergic Agents/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/38262412/
302,CHRM1,38674857,Mendelian Randomization Analysis Identifies Inverse Causal Relationship between External Eating and Metabolic Phenotypes.,"['Timasheva Y', 'Balkhiyarova Z', 'Avzaletdinova D', 'Morugova T', 'Korytina GF', 'Nouwen A', 'Prokopenko I', 'Kochetova O']","['Humans', '*Mendelian Randomization Analysis', '*Phenotype', '*Diabetes Mellitus, Type 2/genetics/etiology', '*Feeding Behavior', 'Female', 'Male', 'Metabolic Syndrome/genetics/etiology', 'tRNA Methyltransferases/genetics', 'Glycated Hemoglobin/metabolism/analysis', 'Middle Aged', 'Body Mass Index', 'Adenylyl Cyclases/genetics', 'Genome-Wide Association Study', 'Polymorphism, Single Nucleotide', 'Adult', 'Waist Circumference', 'Genetic Variation', '*Ghrelin']",https://pubmed.ncbi.nlm.nih.gov/38674857/
303,CHRM1,36475335,"Sex, Age, and Regional Differences in CHRM1 and CHRM3 Genes Expression Levels in the Human Brain Biopsies: Potential Targets for Alzheimer's Disease-related Sleep Disturbances.","['Sanfilippo C', 'Giuliano L', 'Castrogiovanni P', 'Imbesi R', 'Ulivieri M', 'Fazio F', 'Blennow K', 'Zetterberg H', 'Di Rosa M']","['Male', 'Female', 'Humans', '*Alzheimer Disease/genetics', 'Sleep', 'Brain', 'Biopsy', 'Receptor, Muscarinic M1/genetics', 'Receptor, Muscarinic M3']",https://pubmed.ncbi.nlm.nih.gov/36475335/
304,CHRM1,30157420,Muscarinic Acetylcholine Receptors Chrm1 and Chrm3 Are Essential for REM Sleep.,"['Niwa Y', 'Kanda GN', 'Yamada RG', 'Shi S', 'Sunagawa GA', 'Ukai-Tadenuma M', 'Fujishima H', 'Matsumoto N', 'Masumoto KH', 'Nagano M', 'Kasukawa T', 'Galloway J', 'Perrin D', 'Shigeyoshi Y', 'Ukai H', 'Kiyonari H', 'Sumiyama K', 'Ueda HR']","['Acetylcholine/*metabolism', 'Animals', 'HEK293 Cells', 'Humans', 'Male', 'Mice', 'Mice, Inbred BALB C', 'Mice, Inbred C57BL', 'Mice, Knockout', 'Receptor, Muscarinic M1/*metabolism', 'Receptor, Muscarinic M3/*metabolism', 'Sleep, REM/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30157420/
305,CHRM1,30564629,Evolution of the Muscarinic Acetylcholine Receptors in Vertebrates.,"['Pedersen JE', 'Bergqvist CA', 'Larhammar D']","['Animals', 'Humans', 'Phylogeny', 'Receptor, Muscarinic M1/*metabolism', 'Receptor, Muscarinic M3/*metabolism', 'Receptor, Muscarinic M4/metabolism', 'Receptors, Cholinergic/*metabolism', 'Receptors, Muscarinic/*metabolism', 'Vertebrates/metabolism']",https://pubmed.ncbi.nlm.nih.gov/30564629/
306,CHRM1,21557953,Mouse models of genetic effects on cognition: relevance to schizophrenia.,"['Papaleo F', 'Lipska BK', 'Weinberger DR']","['Animals', 'Cognition', 'Cognition Disorders/*genetics/psychology', '*Disease Models, Animal', 'Humans', 'Mice', 'Reelin Protein', 'Schizophrenia/*genetics', 'Schizophrenic Psychology', 'Species Specificity']",https://pubmed.ncbi.nlm.nih.gov/21557953/
307,CHRM1,36155524,"Loss of Cholinergic Receptor Muscarinic 1 (CHRM1) Protein in the Hippocampus and Temporal Cortex of a Subset of Individuals with Alzheimer's Disease, Parkinson's Disease, or Frontotemporal Dementia: Implications for Patient Survival.","['Sabbir MG', 'Speth RC', 'Albensi BC']","['Humans', '*Alzheimer Disease/metabolism', '*Parkinson Disease/metabolism', '*Frontotemporal Dementia', 'Hippocampus/metabolism', 'Temporal Lobe/metabolism', 'Cholinergic Agents', 'Receptors, Cholinergic/metabolism', 'Receptor, Muscarinic M1/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36155524/
308,CHRM1,24430298,CHRM2 but not CHRM1 or CHRM3 polymorphisms are associated with asthma susceptibility in Mexican patients.,"['Jimenez-Morales S', 'Jimenez-Ruiz JL', 'Del Rio-Navarro BE', 'Navarro-Olivos E', 'Escamilla-Guerrero G', 'Savan R', 'Dean M', 'Orozco L']","['Adolescent', 'Alleles', 'Asthma/diagnosis/*genetics', 'Case-Control Studies', 'Child', 'Female', 'Gene Frequency', 'Gene Order', 'Genetic Association Studies', '*Genetic Predisposition to Disease', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Male', 'Mexico', 'Odds Ratio', '*Polymorphism, Single Nucleotide', 'Receptor, Muscarinic M1/*genetics', 'Receptor, Muscarinic M2/*genetics', 'Receptor, Muscarinic M3/*genetics']",https://pubmed.ncbi.nlm.nih.gov/24430298/
309,CHRM1,25037527,An investigation of the factors that regulate muscarinic receptor expression in schizophrenia.,"['Seo MS', 'Scarr E', 'Dean B']","['Adult', 'Blotting, Western', 'Brain/metabolism', 'Cohort Studies', 'Humans', 'Middle Aged', 'Piperidines', 'Pirenzepine', 'Polymerase Chain Reaction', 'RNA, Messenger/metabolism', 'Radioligand Assay', 'Receptor, Muscarinic M1', 'Receptor, Muscarinic M3', 'Receptor, Muscarinic M4', 'Receptors, Muscarinic/*metabolism', 'Schizophrenia/*metabolism', 'Sp1 Transcription Factor/*metabolism', 'Sp3 Transcription Factor/*metabolism', 'Tritium']",https://pubmed.ncbi.nlm.nih.gov/25037527/
310,CHRM1,39605182,Chemogenomic Screening in a Patient-Derived 3D Fatty Liver Disease Model Reveals the CHRM1-TRPM8 Axis as a Novel Module for Targeted Intervention.,"['Youhanna S', 'Kemas AM', 'Wright SC', 'Zhong Y', 'Klumpp B', 'Klein K', 'Motso A', 'Michel M', 'Ziegler N', 'Shang M', 'Sabatier P', 'Kannt A', 'Sheng H', 'Oliva-Vilarnau N', 'Buttner FA', 'Seashore-Ludlow B', 'Schreiner J', 'Windbergs M', 'Cornillet M', 'Bjorkstrom NK', 'Hulsmeier AJ', 'Hornemann T', 'Olsen JV', 'Wang Y', 'Gramignoli R', 'Sundstrom M', 'Lauschke VM']","['Humans', '*TRPM Cation Channels/genetics/metabolism', 'Receptor, Muscarinic M1/genetics/metabolism', 'Fatty Liver/metabolism/genetics/drug therapy', 'Hepatocytes/metabolism/drug effects', 'Signal Transduction/drug effects/genetics']",https://pubmed.ncbi.nlm.nih.gov/39605182/
311,CHRM1,34806612,Muscarinic Receptors Expression in the Peripheral Blood Cells Differentiate Dementia with Lewy Bodies from Alzheimer's Disease.,"['Reale M', 'Carrarini C', 'Russo M', 'Dono F', 'Ferri L', 'Di Pietro M', 'Costantini E', 'Porreca A', 'Di Nicola M', 'Onofrj M', 'Bonanni L']","['Aged', 'Aged, 80 and over', 'Alzheimer Disease/genetics/*metabolism', 'Case-Control Studies', 'Diagnosis, Differential', 'Female', 'Humans', 'Lewy Body Disease/genetics/*metabolism', 'Logistic Models', 'Male', 'ROC Curve', 'Receptor, Muscarinic M1/genetics/*metabolism', 'Receptor, Muscarinic M4/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/34806612/
312,CHRM1,26818859,The Cholinergic System: An Emerging Drug Target for Schizophrenia.,"['Gibbons A', 'Dean B']","['Animals', 'Cholinergic Agents/chemistry/*pharmacology', 'Humans', 'Schizophrenia/*drug therapy/metabolism', 'alpha7 Nicotinic Acetylcholine Receptor/*agonists/metabolism']",https://pubmed.ncbi.nlm.nih.gov/26818859/
313,CHRM1,36068422,Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndrome.,"['Qiao G', 'Xing J', 'Luo X', 'Zhang C', 'Yi J']","['Humans', 'Female', '*Computational Biology', '*Polycystic Ovary Syndrome/drug therapy', 'Gene Regulatory Networks', 'Gene Expression Profiling', 'Ligands', 'Receptor, Muscarinic M1/genetics', 'p21-Activated Kinases/genetics']",https://pubmed.ncbi.nlm.nih.gov/36068422/
314,CHRM1,39558340,Exercise-conditioned plasma ameliorates postoperative cognitive dysfunction by activating hippocampal cholinergic circuit and enhancing BDNF/TrkB signaling.,"['Lu X', 'Xiong W', 'Chen Z', 'Li Y', 'Xu F', 'Yang X', 'Long M', 'Guo W', 'Wu S', 'Sun L', 'Wang G']","['Animals', '*Brain-Derived Neurotrophic Factor/metabolism/genetics', '*Hippocampus/metabolism/pathology', 'Male', '*Postoperative Cognitive Complications/metabolism', '*Mice, Inbred C57BL', '*Signal Transduction', 'Mice', '*Physical Conditioning, Animal', '*Receptor, trkB/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39558340/
315,CHRM1,30623717,Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors.,"['Boiko AS', 'Ivanova SA', 'Pozhidaev IV', 'Freidin MB', 'Osmanova DZ', 'Fedorenko OY', 'Semke AV', 'Bokhan NA', 'Wilffert B', 'Loonen AJM']","['Adult', 'Alleles', 'Antipsychotic Agents/*adverse effects', 'Dyskinesia, Drug-Induced/complications/*genetics', 'Female', 'Genetic Predisposition to Disease', 'Hospitals, Psychiatric', 'Humans', 'Logistic Models', 'Male', 'Middle Aged', 'Pharmacogenetics', 'Polymorphism, Single Nucleotide', 'Receptor, Muscarinic M1/*genetics', 'Receptor, Muscarinic M2/*genetics', 'Schizophrenia/complications/drug therapy/*genetics', 'Severity of Illness Index']",https://pubmed.ncbi.nlm.nih.gov/30623717/
316,CHRM1,19404243,Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotype.,"['Salah-Uddin H', 'Scarr E', 'Pavey G', 'Harris K', 'Hagan JJ', 'Dean B', 'Challiss RA', 'Watson JM']","['Adult', 'Aged', 'Cell Membrane/drug effects/metabolism', 'Female', 'GTP-Binding Protein alpha Subunits, Gq-G11/metabolism', ""Guanosine 5'-O-(3-Thiotriphosphate)/metabolism"", 'Humans', 'Male', 'Middle Aged', 'Muscarinic Agonists/pharmacology', 'Muscarinic Antagonists/pharmacology', 'Oxotremorine/analogs & derivatives/pharmacology', 'Phenotype', 'Piperidines/pharmacology', 'Pirenzepine/pharmacology', 'Prefrontal Cortex/drug effects/*metabolism', 'Protein Binding/drug effects', 'Receptor, Muscarinic M1', 'Receptors, Muscarinic/*metabolism', 'Schizophrenia/drug therapy/*metabolism', 'Sulfur Radioisotopes', 'Tritium', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/19404243/
317,CHRM1,31428788,Widespread Changes in Positive Allosteric Modulation of the Muscarinic M1 Receptor in Some Participants With Schizophrenia.,"['Hopper S', 'Pavey GM', 'Gogos A', 'Dean B']","['*Allosteric Regulation', 'Autoradiography', 'Case-Control Studies', 'Cerebral Cortex/metabolism', 'Corpus Striatum/metabolism', 'Female', 'Hippocampus/metabolism', 'Humans', 'Male', 'Middle Aged', 'N-Methylscopolamine/metabolism', 'Protein Binding/drug effects', 'Quinolones/metabolism', 'Radioligand Assay/methods', 'Receptor, Muscarinic M1/*agonists/deficiency', 'Schizophrenia/*metabolism', 'Tritium/metabolism']",https://pubmed.ncbi.nlm.nih.gov/31428788/
318,CHRM3,35429253,The role of bile acids in carcinogenesis.,"['Rezen T', 'Rozman D', 'Kovacs T', 'Kovacs P', 'Sipos A', 'Bai P', 'Miko E']","['*Bile Acids and Salts/metabolism', 'Carcinogenesis/pathology', '*Esophageal Neoplasms/metabolism', 'Humans', 'Liver/metabolism', 'Male']",https://pubmed.ncbi.nlm.nih.gov/35429253/
319,CHRM3,36475335,"Sex, Age, and Regional Differences in CHRM1 and CHRM3 Genes Expression Levels in the Human Brain Biopsies: Potential Targets for Alzheimer's Disease-related Sleep Disturbances.","['Sanfilippo C', 'Giuliano L', 'Castrogiovanni P', 'Imbesi R', 'Ulivieri M', 'Fazio F', 'Blennow K', 'Zetterberg H', 'Di Rosa M']","['Male', 'Female', 'Humans', '*Alzheimer Disease/genetics', 'Sleep', 'Brain', 'Biopsy', 'Receptor, Muscarinic M1/genetics', 'Receptor, Muscarinic M3']",https://pubmed.ncbi.nlm.nih.gov/36475335/
320,CHRM3,34314386,Pancreas-specific CHRM3 activation causes pancreatitis in mice.,"['Wan J', 'Wang J', 'Wagner LE 2nd', 'Wang OH', 'Gui F', 'Chen J', 'Zhu X', 'Haddock AN', 'Edenfield BH', 'Haight B', 'Mukhopadhyay D', 'Wang Y', 'Yule DI', 'Bi Y', 'Ji B']","['Acinar Cells/*metabolism/pathology', 'Animals', 'Cells, Cultured', 'Disease Models, Animal', '*Gene Expression Regulation', 'Mice', 'Mice, Mutant Strains', 'Mice, Transgenic', 'Pancreatitis/*genetics/metabolism/pathology', 'RNA/*genetics', 'Receptor, Muscarinic M3/biosynthesis/*genetics', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/34314386/
321,CHRM3,35876633,Smooth Muscle Insulin Receptor Deletion Causes Voiding Dysfunction: A Mechanism for Diabetic Bladder Dysfunction.,"['Chen H', 'Wu A', 'Zeidel ML', 'Yu W']","['Adiponectin/metabolism', 'Animals', 'Blood Glucose/metabolism', '*Diabetes Mellitus/metabolism', 'Humans', '*Insulins/metabolism', 'Mice', 'Muscle Contraction/genetics', 'Muscle, Smooth/metabolism/pathology', 'Receptor, Insulin/genetics/metabolism', 'Receptor, Muscarinic M3/metabolism', 'TOR Serine-Threonine Kinases/metabolism', 'Urinary Bladder/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35876633/
322,CHRM3,39081703,Tongxieyaofang Decotion Alleviates IBS by Modulating CHRM3 and Gut Barrier.,"['Feng T', 'Zhou Y', 'Lv B', 'Cai L']","['*Irritable Bowel Syndrome/drug therapy/metabolism', '*Drugs, Chinese Herbal/pharmacology/chemistry', 'Animals', '*Molecular Docking Simulation', '*Receptor, Muscarinic M3/metabolism/antagonists & inhibitors', 'Humans', 'Male', 'Rats', 'Intestinal Mucosa/metabolism/drug effects', 'Rats, Sprague-Dawley', 'Network Pharmacology']",https://pubmed.ncbi.nlm.nih.gov/39081703/
323,CHRM3,30157420,Muscarinic Acetylcholine Receptors Chrm1 and Chrm3 Are Essential for REM Sleep.,"['Niwa Y', 'Kanda GN', 'Yamada RG', 'Shi S', 'Sunagawa GA', 'Ukai-Tadenuma M', 'Fujishima H', 'Matsumoto N', 'Masumoto KH', 'Nagano M', 'Kasukawa T', 'Galloway J', 'Perrin D', 'Shigeyoshi Y', 'Ukai H', 'Kiyonari H', 'Sumiyama K', 'Ueda HR']","['Acetylcholine/*metabolism', 'Animals', 'HEK293 Cells', 'Humans', 'Male', 'Mice', 'Mice, Inbred BALB C', 'Mice, Inbred C57BL', 'Mice, Knockout', 'Receptor, Muscarinic M1/*metabolism', 'Receptor, Muscarinic M3/*metabolism', 'Sleep, REM/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30157420/
324,CHRM3,31692054,Chrm3 protects against acinar cell necrosis by stabilizing caspase-8 expression in severe acute pancreatitis mice model.,"['Huang N', 'Murtaza G', 'Wang L', 'Luan J', 'Wang X', 'Sun Y', 'Wu X', 'Tao Y', 'Shi S', 'Cao P', 'Qiao Y', 'Han D', 'Kou J', 'Ma N', 'Gao X']","['Acinar Cells/metabolism/*pathology', 'Animals', 'Arginine/toxicity', 'Caspase 8/chemistry/genetics/*metabolism', 'Cell Proliferation', 'Cells, Cultured', 'Disease Models, Animal', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Mice, Knockout', '*Necrosis', 'Pancreatitis/chemically induced/pathology/*prevention & control', 'Protective Agents/*pharmacology', 'Receptor, Muscarinic M3/*physiology', '*Transcriptome']",https://pubmed.ncbi.nlm.nih.gov/31692054/
325,CHRM3,31740666,A regulatory variant of CHRM3 is associated with cannabis-induced hallucinations in European Americans.,"['Cheng Z', 'Phokaew C', 'Chou YL', 'Lai D', 'Meyers JL', 'Agrawal A', 'Farrer LA', 'Kranzler HR', 'Gelernter J']","['Black or African American', 'Alleles', 'Animals', 'Cannabis', 'Female', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Hallucinations/*chemically induced', 'Humans', 'Male', 'Marijuana Abuse/complications/*genetics', 'Mice', 'Polymorphism, Single Nucleotide', 'Receptor, Muscarinic M3/*genetics', 'White People/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31740666/
326,CHRM3,36017844,Exploring the Target and Mechanism of Radix Paeoniae Alba on Sjogren's Syndrome.,"['Wu F', 'Wu G', 'Li T', 'Lu W', 'Fu T', 'Zhang Z']","['Humans', '*Drugs, Chinese Herbal/chemistry', ""*Sjogren's Syndrome/drug therapy"", 'Molecular Docking Simulation', '*Paeonia', 'Medicine, Chinese Traditional', 'Receptor, Muscarinic M3']",https://pubmed.ncbi.nlm.nih.gov/36017844/
327,CHRM3,29357811,Targeting M3 Muscarinic Receptors for Colon Cancer Therapy.,"['Felton J', 'Hu S', 'Raufman JP']","['Colonic Neoplasms/pathology/*therapy', 'Humans', 'Matrix Metalloproteinases/metabolism', '*Molecular Targeted Therapy', 'Receptor, Muscarinic M3/*antagonists & inhibitors/metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/29357811/
328,CHRM3,24430298,CHRM2 but not CHRM1 or CHRM3 polymorphisms are associated with asthma susceptibility in Mexican patients.,"['Jimenez-Morales S', 'Jimenez-Ruiz JL', 'Del Rio-Navarro BE', 'Navarro-Olivos E', 'Escamilla-Guerrero G', 'Savan R', 'Dean M', 'Orozco L']","['Adolescent', 'Alleles', 'Asthma/diagnosis/*genetics', 'Case-Control Studies', 'Child', 'Female', 'Gene Frequency', 'Gene Order', 'Genetic Association Studies', '*Genetic Predisposition to Disease', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Male', 'Mexico', 'Odds Ratio', '*Polymorphism, Single Nucleotide', 'Receptor, Muscarinic M1/*genetics', 'Receptor, Muscarinic M2/*genetics', 'Receptor, Muscarinic M3/*genetics']",https://pubmed.ncbi.nlm.nih.gov/24430298/
329,CHRM3,38641412,The M3 Muscarinic Acetylcholine Receptor Can Signal through Multiple G Protein Families.,"['Smith JS', 'Hilibrand AS', 'Skiba MA', 'Dates AN', 'Calvillo-Miranda VG', 'Kruse AC']","['Animals', 'Humans', 'CHO Cells', 'Cricetulus', 'GTP-Binding Protein alpha Subunits, Gq-G11/metabolism', '*GTP-Binding Proteins/metabolism', 'HEK293 Cells', '*Receptor, Muscarinic M3/metabolism', '*Signal Transduction/physiology']",https://pubmed.ncbi.nlm.nih.gov/38641412/
330,CHRM3,32371828,Genetic variability in postoperative nausea and vomiting: A systematic review.,"['Klenke S', 'Frey UH']","['*Antiemetics', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Humans', 'Polymorphism, Single Nucleotide/genetics', '*Postoperative Nausea and Vomiting/diagnosis/epidemiology/genetics', 'Receptor, Muscarinic M3']",https://pubmed.ncbi.nlm.nih.gov/32371828/
331,CHRM3,37342032,High-Throughput Sequencing Data Reveal an Antiangiogenic Role of HNF4A-Mediated CACNA1A/VEGFA Axis in Proliferative Diabetic Retinopathy.,"['Yin Y', 'Wu S', 'Niu L', 'Huang S']","['Humans', '*Diabetic Retinopathy', 'Vascular Endothelial Growth Factor A/genetics/metabolism', 'Vitreous Body/metabolism', 'Retina', 'Retinal Vessels', '*Diabetes Mellitus/metabolism', 'Calcium Channels/metabolism', 'Hepatocyte Nuclear Factor 4/genetics/metabolism', 'Receptor, Muscarinic M3']",https://pubmed.ncbi.nlm.nih.gov/37342032/
332,CHRM3,35977679,A Genomic Instability-Associated Prognostic Signature for Glioblastoma Patients.,"['Chen X', 'Tian F', 'Wu Z']","['Adult', 'Humans', '*Glioblastoma/genetics', 'Prognosis', '*Glioma', 'Nomograms', 'Algorithms', 'Gene Expression Regulation, Neoplastic/genetics', 'Receptor, Muscarinic M3']",https://pubmed.ncbi.nlm.nih.gov/35977679/
333,CHRM3,35955642,Functional Characterization of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells.,"['Fan X', 'Cyganek L', 'Nitschke K', 'Uhlig S', 'Nuhn P', 'Bieback K', 'Duerschmied D', 'El-Battrawy I', 'Zhou X', 'Akin I']","['Biomarkers/metabolism', 'Cell Differentiation/genetics', 'Endothelial Cells', 'Fibroblasts/metabolism', 'Human Umbilical Vein Endothelial Cells/metabolism', 'Humans', '*Induced Pluripotent Stem Cells/metabolism', 'RNA, Messenger/metabolism', 'Receptor, Muscarinic M3/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35955642/
334,CHRM3,31077873,Genetic contribution to PONV risk.,"['Klenke S', 'de Vries GJ', 'Schiefer L', 'Seyffert N', 'Bachmann HS', 'Peters J', 'Frey UH']","['Adult', 'Aged', 'Demography', 'Female', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Odds Ratio', 'Polymorphism, Single Nucleotide/genetics', 'Postoperative Nausea and Vomiting/*epidemiology/*genetics', 'Retrospective Studies', 'Risk Assessment/*methods', 'Risk Factors', 'Treatment Outcome', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/31077873/
335,CHRM3,27584968,New Etiology of Cholinergic Urticaria.,['Tokura Y'],"['Acetylcholine/metabolism', 'Histamine/*immunology/metabolism', 'Humans', 'Hypersensitivity/*immunology/metabolism/physiopathology', 'Hypohidrosis/immunology/metabolism/physiopathology', 'Immunoglobulin E/immunology', 'Inflammation', 'Mast Cells/*immunology/metabolism', 'Receptor, Muscarinic M3/metabolism', 'Receptors, IgE/immunology', 'Sweat/immunology', 'Sweat Glands/metabolism', '*Sweating', 'T-Lymphocytes/immunology', 'Urticaria/*immunology/metabolism/physiopathology']",https://pubmed.ncbi.nlm.nih.gov/27584968/
336,CHRM3,39614664,Bone marrow mesenchymal stem cell-derived exosomal miR-181a-5p promotes M2 macrophage polarization to alleviate acute pancreatitis through ZEB2-mediated RACK1 ubiquitination.,"['Li H', 'Du R', 'Xiang A', 'Liu Y', 'Guan M', 'He H']","['*Mesenchymal Stem Cells/metabolism', '*Receptors for Activated C Kinase/metabolism/genetics', '*Zinc Finger E-box Binding Homeobox 2/metabolism/genetics', '*MicroRNAs/genetics/metabolism', '*Exosomes/metabolism', 'Animals', '*Ubiquitination', 'Humans', '*Macrophages/metabolism', 'Male', '*Pancreatitis/metabolism/genetics', 'Apoptosis', 'Mice', 'Rats', 'Neoplasm Proteins']",https://pubmed.ncbi.nlm.nih.gov/39614664/
337,KCNH2,20544339,HERG1 channelopathies.,['Sanguinetti MC'],"['Animals', 'Channelopathies/*genetics', 'ERG1 Potassium Channel', 'Epilepsy/genetics', 'Ether-A-Go-Go Potassium Channels/chemistry/*genetics/physiology', 'Humans', 'Long QT Syndrome/genetics/physiopathology', 'Muscular Atrophy/genetics', 'Up-Regulation']",https://pubmed.ncbi.nlm.nih.gov/20544339/
338,KCNH2,23426162,Primary aldosteronism and potassium channel mutations.,['Stowasser M'],"['Amino Acid Substitution', 'Animals', 'ERG1 Potassium Channel', 'Ether-A-Go-Go Potassium Channels/genetics/metabolism', 'G Protein-Coupled Inwardly-Rectifying Potassium Channels/genetics/metabolism', 'Humans', 'Hyperaldosteronism/*genetics/metabolism/physiopathology', '*Mutation', 'Potassium Channels/chemistry/*genetics/metabolism', 'Severity of Illness Index']",https://pubmed.ncbi.nlm.nih.gov/23426162/
339,KCNH2,36626562,KCNH2 encodes a nuclear-targeted polypeptide that mediates hERG1 channel gating and expression.,"['Jain A', 'Stack O', 'Ghodrati S', 'Sanchez-Conde FG', 'Ukachukwu CU', 'Salwi S', 'Jimenez-Vazquez EN', 'Jones DK']","['Animals', 'Humans', 'Rats', '*ERG1 Potassium Channel/genetics/metabolism', '*Ether-A-Go-Go Potassium Channels/genetics/metabolism', 'HEK293 Cells', '*Myocytes, Cardiac/metabolism', 'Peptides/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36626562/
340,KCNH2,36252106,Suppression and Replacement Gene Therapy for KCNH2-Mediated Arrhythmias.,"['Bains S', 'Zhou W', 'Dotzler SM', 'Martinez K', 'Kim CJ', 'Tester DJ', 'Ye D', 'Ackerman MJ']","['Humans', 'ERG1 Potassium Channel/genetics', '*Arrhythmias, Cardiac/genetics/therapy', '*Long QT Syndrome/genetics/therapy', 'Genetic Therapy']",https://pubmed.ncbi.nlm.nih.gov/36252106/
341,KCNH2,35806392,Mutation-Specific Differences in Kv7.1 (KCNQ1) and Kv11.1 (KCNH2) Channel Dysfunction and Long QT Syndrome Phenotypes.,"['Kekenes-Huskey PM', 'Burgess DE', 'Sun B', 'Bartos DC', 'Rozmus ER', 'Anderson CL', 'January CT', 'Eckhardt LL', 'Delisle BP']","['ERG1 Potassium Channel/genetics', 'Electrocardiography', 'Humans', '*KCNQ1 Potassium Channel/genetics', 'Mutation', 'Phenotype', '*Romano-Ward Syndrome/genetics']",https://pubmed.ncbi.nlm.nih.gov/35806392/
342,KCNH2,29758301,Lipid roles in hERG function and interactions with drugs.,"['Kudaibergenova M', 'Perissinotti LL', 'Noskov SY']","['Ceramides/metabolism/pharmacology', 'ERG1 Potassium Channel/agonists/antagonists & inhibitors/chemistry/*physiology', 'Fatty Acids, Unsaturated/metabolism/pharmacology', 'Humans', 'Lipids/*physiology', 'Long QT Syndrome/etiology', 'Membrane Lipids/physiology', 'Molecular Docking Simulation', 'Signal Transduction', 'Steroids/metabolism/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/29758301/
343,KCNH2,38000475,"Escitalopram-induced QTc prolongation and its relationship with KCNQ1, KCNE1, and KCNH2 gene polymorphisms.","['Chen Z', 'Xu Z', 'Gao C', 'Chen L', 'Tan T', 'Jiang W', 'Chen B', 'Yuan Y', 'Zhang Z']","['Humans', 'Escitalopram', 'Retrospective Studies', 'KCNQ1 Potassium Channel/genetics', 'Electrocardiography', 'Polymorphism, Single Nucleotide', '*Long QT Syndrome/chemically induced/genetics', '*Potassium Channels, Voltage-Gated/genetics/adverse effects', 'ERG1 Potassium Channel/genetics']",https://pubmed.ncbi.nlm.nih.gov/38000475/
344,KCNH2,11343409,I(Kr): the hERG channel.,['Tseng GN'],"['Action Potentials', 'Alternative Splicing', 'Amino Acid Sequence', 'Animals', 'Arrhythmias, Cardiac/metabolism', '*Cation Transport Proteins', '*DNA-Binding Proteins', 'ERG1 Potassium Channel', 'Ether-A-Go-Go Potassium Channels', 'Heart/physiology', 'Humans', 'Ions', 'Molecular Sequence Data', 'Mutation', 'Myocardium/metabolism', 'Potassium/metabolism', 'Potassium Channels/*chemistry/metabolism/*physiology', '*Potassium Channels, Voltage-Gated', 'Sequence Homology, Amino Acid', 'Structure-Activity Relationship', '*Trans-Activators', 'Transcriptional Regulator ERG']",https://pubmed.ncbi.nlm.nih.gov/11343409/
345,KCNH2,18991593,hERG (KCNH2 or Kv11.1) K+ channels: screening for cardiac arrhythmia risk.,"['Bowlby MR', 'Peri R', 'Zhang H', 'Dunlop J']","['Animals', 'Arrhythmias, Cardiac/*chemically induced/*genetics', 'Drug Evaluation, Preclinical/*methods', '*Drug-Related Side Effects and Adverse Reactions', 'ERG1 Potassium Channel', 'Electrocardiography', 'Electrophysiology', 'Ether-A-Go-Go Potassium Channels/*drug effects/*genetics', 'Humans', 'Predictive Value of Tests', 'Radioligand Assay', 'Rubidium/metabolism']",https://pubmed.ncbi.nlm.nih.gov/18991593/
346,KCNH2,32135169,HERG channel and cancer: A mechanistic review of carcinogenic processes and therapeutic potential.,"['He S', 'Moutaoufik MT', 'Islam S', 'Persad A', 'Wu A', 'Aly KA', 'Fonge H', 'Babu M', 'Cayabyab FS']","['Antineoplastic Agents/pharmacology/therapeutic use', 'Apoptosis/drug effects', 'Benzimidazoles/pharmacology/therapeutic use', 'Carcinogenesis/drug effects/*pathology', 'Cell Movement/drug effects', 'Cell Proliferation/drug effects', 'ERG1 Potassium Channel/antagonists & inhibitors/chemistry/genetics/*metabolism', 'Epigenesis, Genetic/drug effects', 'Fluoxetine/pharmacology/therapeutic use', 'Gene Expression Regulation, Neoplastic/drug effects', 'Humans', 'Integrin beta1/*metabolism', 'Long QT Syndrome/genetics', 'Membrane Potentials/drug effects', 'Molecular Docking Simulation', 'Mutation', 'Myocytes, Cardiac/metabolism', 'Neoplasms/drug therapy/genetics/*pathology', 'Piperidines/pharmacology/therapeutic use', 'Protein Conformation, alpha-Helical', 'Protein Interaction Mapping', 'Protein Structure, Quaternary', 'Pyridines/pharmacology/therapeutic use', 'STAT1 Transcription Factor/*metabolism', 'Signal Transduction/drug effects', 'Sulfanilamides/pharmacology/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/32135169/
347,KCNH2,23459091,hERG channel function: beyond long QT.,"['Babcock JJ', 'Li M']","['Animals', 'ERG1 Potassium Channel', 'Ether-A-Go-Go Potassium Channels/biosynthesis/genetics/*physiology', '*Gene Expression', 'Humans', 'Long QT Syndrome/genetics/*metabolism', 'Neoplasms/genetics/*metabolism', 'Organ Specificity']",https://pubmed.ncbi.nlm.nih.gov/23459091/
348,KCNH2,39128897,Potassium voltage-gated channel subfamily H member 2 (KCNH2) is a promising target for incretin secretagogue therapies.,"['Yuan YC', 'Wang H', 'Jiang ZJ', 'Liu C', 'Li Q', 'Zhou SR', 'Yang JK']","['Animals', 'Mice', '*Incretins/pharmacology', '*Enteroendocrine Cells/metabolism/drug effects', '*Glucagon-Like Peptide 1/genetics/metabolism', 'Humans', 'Gastric Inhibitory Polypeptide/genetics', 'Diabetes Mellitus, Type 2/genetics/metabolism/drug therapy/pathology', 'Secretagogues/pharmacology', 'Mice, Knockout', 'ERG1 Potassium Channel']",https://pubmed.ncbi.nlm.nih.gov/39128897/
349,KCNH2,21700951,Phenotypic manifestations of mutations in genes encoding subunits of cardiac potassium channels.,"['Shimizu W', 'Horie M']","['Action Potentials', 'Animals', 'Atrial Fibrillation/genetics', 'Brugada Syndrome/genetics', 'Genetic Association Studies', 'Heart/physiology', 'Heart Diseases/*genetics', 'Humans', 'Long QT Syndrome/genetics/therapy', '*Mutation', 'Phenotype', 'Potassium Channels/chemistry/*genetics/physiology', 'Protein Subunits']",https://pubmed.ncbi.nlm.nih.gov/21700951/
350,KCNH2,28334543,[Functional impact of hERG: from physiological role to target of anticancer therapy].,"['Satkova J', 'Bebarova M']","['Animals', 'Apoptosis/*genetics', 'Arrhythmias, Cardiac/*genetics', 'Cell Proliferation/*genetics', 'ERG1 Potassium Channel/*genetics', 'Humans', 'Molecular Targeted Therapy', 'Muscle Contraction/*genetics', 'Muscle, Smooth', 'Mutation', 'Neoplasms/*genetics/therapy']",https://pubmed.ncbi.nlm.nih.gov/28334543/
351,KCNH2,36421807,Analysis of CACNA1C and KCNH2 Risk Variants on Cardiac Autonomic Function in Patients with Schizophrenia.,"['Refisch A', 'Komatsuzaki S', 'Ungelenk M', 'Schumann A', 'Chung HY', 'Schilling SS', 'Jantzen W', 'Schroder S', 'Nothen MM', 'Muhleisen TW', 'Hubner CA', 'Bar KJ']","['Humans', '*Schizophrenia/drug therapy', 'Calcium Channels, L-Type/genetics', 'Polymorphism, Single Nucleotide', '*Antipsychotic Agents/therapeutic use', 'Genotype', 'ERG1 Potassium Channel/genetics']",https://pubmed.ncbi.nlm.nih.gov/36421807/
352,KCNH2,34990074,"Celebrities in the heart, strangers in the pancreatic beta cell: Voltage-gated potassium channels K(v) 7.1 and K(v) 11.1 bridge long QT syndrome with hyperinsulinaemia as well as type 2 diabetes.","['Lubberding AF', 'Juhl CR', 'Skovhoj EZ', 'Kanters JK', 'Mandrup-Poulsen T', 'Torekov SS']","['*Diabetes Mellitus, Type 2/genetics', '*ERG1 Potassium Channel/genetics', 'Genome-Wide Association Study', 'Humans', '*Hyperinsulinism/genetics', '*Hypoglycemia/genetics', '*Insulin-Secreting Cells/metabolism', '*KCNQ1 Potassium Channel/genetics/metabolism', '*Long QT Syndrome/genetics/metabolism', 'Mutation']",https://pubmed.ncbi.nlm.nih.gov/34990074/
353,KCNH2,35798139,The N-linker region of hERG1a upregulates hERG1b potassium channels.,"['Johnson AA', 'Crawford TR', 'Trudeau MC']","['Alanine/chemistry/genetics', 'Biotin/chemistry', '*Ether-A-Go-Go Potassium Channels/chemistry/genetics/metabolism', 'Humans', '*Long QT Syndrome/genetics/metabolism', 'Mutagenesis', 'Protein Domains', 'Up-Regulation']",https://pubmed.ncbi.nlm.nih.gov/35798139/
354,KCNH2,32759882,Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2 KCNH2 (hERG) Mutations and Identifying New Patients.,"['Ono M', 'Burgess DE', 'Schroder EA', 'Elayi CS', 'Anderson CL', 'January CT', 'Sun B', 'Immadisetty K', 'Kekenes-Huskey PM', 'Delisle BP']","['ERG1 Potassium Channel/chemistry/*genetics/metabolism', 'Genetic Testing/methods', 'Humans', 'Long QT Syndrome/diagnosis/*genetics/therapy', 'Loss of Function Mutation']",https://pubmed.ncbi.nlm.nih.gov/32759882/
355,KCNH2,35635995,New insights of the role of the KCNH2 gene in schizophrenia: An fMRI case-control study.,"['Guardiola-Ripoll M', 'Almodovar-Paya C', 'Lubeiro A', 'Salvador R', 'Salgado-Pineda P', 'Gomar JJ', 'Guerrero-Pedraza A', 'Sarro S', 'Maristany T', 'Fernandez-Linsenbarth I', 'Hernandez-Garcia M', 'Papiol S', 'Molina V', 'Pomarol-Clotet E', 'Fatjo-Vilas M']","['Brain/metabolism', 'Case-Control Studies', 'ERG1 Potassium Channel/genetics/metabolism', 'Humans', 'Magnetic Resonance Imaging', 'Prefrontal Cortex/metabolism', '*Schizophrenia/complications/diagnostic imaging/genetics']",https://pubmed.ncbi.nlm.nih.gov/35635995/
356,KCNH2,37386841,Mechanisms of fever-induced QT prolongation and torsades de pointes in patients with KCNH2 mutation.,"['Usuda K', 'Hayashi K', 'Nakajima T', 'Kurata Y', 'Cui S', 'Kusayama T', 'Tsuda T', 'Tada H', 'Kato T', 'Sakata K', 'Usui S', 'Fujino N', 'Tanaka Y', 'Kaneko Y', 'Kurabayashi M', 'Tange S', 'Saito T', 'Ohta K', 'Yamagishi M', 'Takamura M']","['Humans', '*Torsades de Pointes/diagnosis/genetics', 'Computer Simulation', '*Long QT Syndrome/diagnosis/genetics', 'Mutation', 'DNA-Binding Proteins', 'ERG1 Potassium Channel/genetics']",https://pubmed.ncbi.nlm.nih.gov/37386841/
357,HTR2B,38037454,Neurotransmitter Receptor HTR2B Regulates Lipid Metabolism to Inhibit Ferroptosis in Gastric Cancer.,"['Tu RH', 'Wu SZ', 'Huang ZN', 'Zhong Q', 'Ye YH', 'Zheng CH', 'Xie JW', 'Wang JB', 'Lin JX', 'Chen QY', 'Huang CM', 'Lin M', 'Lu J', 'Cao LL', 'Li P']","['Humans', '*Adenocarcinoma', 'Cell Line, Tumor', 'Cell Proliferation/genetics', '*Ferroptosis', 'Lipid Metabolism', 'Phosphatidylinositol 3-Kinases/metabolism', 'Proto-Oncogene Proteins c-akt/metabolism', 'Receptors, Neurotransmitter/metabolism', 'Serotonin/metabolism/pharmacology', '*Stomach Neoplasms/pathology', 'TOR Serine-Threonine Kinases/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38037454/
358,HTR2B,28315323,Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.,"['Jiang SH', 'Li J', 'Dong FY', 'Yang JY', 'Liu DJ', 'Yang XM', 'Wang YH', 'Yang MW', 'Fu XL', 'Zhang XX', 'Li Q', 'Pang XF', 'Huo YM', 'Li J', 'Zhang JF', 'Lee HY', 'Lee SJ', 'Qin WX', 'Gu JR', 'Sun YW', 'Zhang ZG']","['Aged', 'Animals', 'Apoptosis/drug effects', 'Carcinoma, Pancreatic Ductal/chemistry/drug therapy/*metabolism', 'Cell Line, Tumor', 'Cell Proliferation/drug effects', 'Cell Survival/drug effects', 'Female', 'Gene Silencing', 'Glucose/metabolism', 'Glycolysis/drug effects', 'Humans', 'Indoles/therapeutic use', 'Lactic Acid/biosynthesis', 'Male', 'Mice', 'Middle Aged', 'Monoamine Oxidase/analysis', 'Neoplasm Transplantation', 'Pancreas/chemistry', 'Pancreatic Neoplasms/chemistry/drug therapy/*metabolism', 'Phosphatidylinositol 3-Kinase/metabolism', 'Proto-Oncogene Proteins c-akt/metabolism', 'Proto-Oncogene Proteins c-myc/metabolism', 'Receptor, Serotonin, 5-HT2B/genetics/*metabolism', 'Serotonin/analysis/*metabolism/pharmacology', 'Serotonin 5-HT2 Receptor Agonists/pharmacology', 'Serotonin 5-HT2 Receptor Antagonists/pharmacology/therapeutic use', 'Signal Transduction', 'Stress, Physiological', 'TOR Serine-Threonine Kinases/metabolism', 'Tissue Array Analysis', 'Transcriptome', 'Tryptophan Hydroxylase/analysis', 'Urea/analogs & derivatives/therapeutic use', 'src-Family Kinases/metabolism']",https://pubmed.ncbi.nlm.nih.gov/28315323/
359,HTR2B,34618686,Inhibiting serotonin signaling through HTR2B in visceral adipose tissue improves obesity-related insulin resistance.,"['Choi WG', 'Choi W', 'Oh TJ', 'Cha HN', 'Hwang I', 'Lee YK', 'Lee SY', 'Shin H', 'Lim A', 'Ryu D', 'Suh JM', 'Park SY', 'Choi SH', 'Kim H']","['Adipocytes/cytology', 'Adipocytes, White', 'Adipose Tissue', 'Adipose Tissue, White/metabolism', 'Adult', 'Animals', 'Diet, High-Fat', 'Epididymis', 'Female', 'Glycerol/metabolism', 'Humans', 'Inflammation', 'Insulin/metabolism', '*Insulin Resistance', 'Intra-Abdominal Fat/*metabolism', 'Lipolysis', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Mice, Knockout', 'Middle Aged', 'Obesity/*metabolism', 'Phosphorylation', 'Receptor, Serotonin, 5-HT2B/*metabolism', 'Serotonin/*metabolism', 'Signal Transduction', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/34618686/
360,HTR2B,27615133,beta-Cell adaptation in pregnancy.,"['Baeyens L', 'Hindi S', 'Sorenson RL', 'German MS']","['*Adaptation, Physiological', 'Animals', '*Cell Proliferation', 'Diabetes, Gestational/metabolism', 'Female', 'Glucose/*metabolism', 'Humans', 'Insulin/*metabolism', 'Insulin Resistance', 'Insulin Secretion', 'Insulin-Secreting Cells/cytology/*metabolism', 'Mice', 'Placental Lactogen/metabolism', 'Postpartum Period', 'Pregnancy/*metabolism', 'Rats', 'Serotonin/metabolism']",https://pubmed.ncbi.nlm.nih.gov/27615133/
361,HTR2B,30223085,Evolutionary considerations on 5-HT(2) receptors.,"['Moutkine I', 'Collins EL', 'Bechade C', 'Maroteaux L']","['Animals', 'Evolution, Molecular', 'Genomics', 'Humans', 'Proteasome Endopeptidase Complex/physiology', 'Receptors, Serotonin/*physiology', 'Serotonin/metabolism']",https://pubmed.ncbi.nlm.nih.gov/30223085/
362,HTR2B,38381131,Serotonin Receptor HTR2B Facilitates Colorectal Cancer Metastasis via CREB1-ZEB1 Axis-Mediated Epithelial-Mesenchymal Transition.,"['Li T', 'Wei L', 'Zhang X', 'Fu B', 'Zhou Y', 'Yang M', 'Cao M', 'Chen Y', 'Tan Y', 'Shi Y', 'Wu L', 'Xuan C', 'Du Q', 'Hu R']","['*Epithelial-Mesenchymal Transition', 'Humans', '*Colorectal Neoplasms/pathology/genetics/metabolism', '*Cyclic AMP Response Element-Binding Protein/metabolism', 'Animals', 'Mice', '*Zinc Finger E-box-Binding Homeobox 1/metabolism/genetics', '*Receptor, Serotonin, 5-HT2B/metabolism/genetics', 'Cell Line, Tumor', 'Cell Movement', 'Neoplasm Metastasis', 'Signal Transduction', 'Gene Expression Regulation, Neoplastic', 'Male', 'Female']",https://pubmed.ncbi.nlm.nih.gov/38381131/
363,HTR2B,31806625,Serotonin Regulates Adult beta-Cell Mass by Stimulating Perinatal beta-Cell Proliferation.,"['Moon JH', 'Kim YG', 'Kim K', 'Osonoi S', 'Wang S', 'Saunders DC', 'Wang J', 'Yang K', 'Kim H', 'Lee J', 'Jeong JS', 'Banerjee RR', 'Kim SK', 'Wu Y', 'Mizukami H', 'Powers AC', 'German MS', 'Kim H']","['Animals', 'Animals, Newborn', 'Cell Proliferation', 'Female', 'Glucose/*metabolism', 'Growth Hormone/metabolism', 'Humans', 'Infant', 'Insulin-Secreting Cells/*physiology', 'Mice', 'Mice, Knockout', 'Pregnancy', 'Propafenone/metabolism', 'RNA, Messenger/genetics/metabolism', 'Receptors, Prolactin/genetics/metabolism', 'Serotonin/*metabolism', 'Tryptophan Hydroxylase/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/31806625/
364,HTR2B,39255737,Inhibition of HTR2B-mediated serotonin signaling in colorectal cancer suppresses tumor growth through ERK signaling.,"['Lee JY', 'Park S', 'Park EJ', 'Pagire HS', 'Pagire SH', 'Choi BW', 'Park M', 'Fang S', 'Ahn JH', 'Oh CM']","['Animals', '*Colorectal Neoplasms/pathology/drug therapy/metabolism', 'Humans', '*Cell Proliferation/drug effects', '*Receptor, Serotonin, 5-HT2B/metabolism', 'Cell Line, Tumor', '*Serotonin/metabolism/pharmacology', '*Cell Movement/drug effects', '*MAP Kinase Signaling System/drug effects', 'Mice', 'Xenograft Model Antitumor Assays', 'Mice, Nude', 'Mice, Inbred BALB C', 'Serotonin 5-HT2 Receptor Antagonists/pharmacology', 'Signal Transduction/drug effects', 'Gene Expression Regulation, Neoplastic/drug effects']",https://pubmed.ncbi.nlm.nih.gov/39255737/
365,HTR2B,38989697,Targeting HTR2B suppresses nonfunctioning pituitary adenoma growth and sensitizes cabergoline treatment via inhibiting Galphaq/PLC/PKCgamma/STAT3 axis.,"['Lin S', 'Wang L', 'Han C', 'Dai Y', 'Li C', 'Liu Y', 'Zhang B', 'Huang N', 'Zhang A', 'Zhang T', 'Wang Y', 'Xie J', 'Tang H', 'Cheng Y', 'Yao H', 'Lou M', 'Xue L', 'Wu ZB']","['*Pituitary Neoplasms/drug therapy/pathology/metabolism', 'Humans', 'Animals', '*STAT3 Transcription Factor/metabolism/antagonists & inhibitors', '*Cabergoline/pharmacology', 'Mice', '*Receptor, Serotonin, 5-HT2B/metabolism', '*Xenograft Model Antitumor Assays', '*Cell Proliferation/drug effects', '*Adenoma/drug therapy/pathology/metabolism', 'Mice, Nude', 'Signal Transduction/drug effects', 'Protein Kinase C/metabolism/antagonists & inhibitors', 'Tumor Cells, Cultured', 'Gene Expression Regulation, Neoplastic/drug effects', 'Cell Line, Tumor', 'Apoptosis/drug effects', 'Male']",https://pubmed.ncbi.nlm.nih.gov/38989697/
366,HTR2B,38477756,CHD7 regulates craniofacial cartilage development via controlling HTR2B expression.,"['Breuer M', 'Rummler M', 'Singh J', 'Maher S', 'Zaouter C', 'Jamadagni P', 'Pilon N', 'Willie BM', 'Patten SA']","['Animals', 'Humans', '*Cartilage/metabolism', 'CHARGE Syndrome/genetics/metabolism/pathology', 'Chondrocytes/metabolism', 'Chondrogenesis/genetics', 'Collagen Type II/metabolism/genetics', '*DNA Helicases', 'DNA-Binding Proteins/metabolism/genetics', 'Gene Expression Regulation, Developmental', 'Skull/metabolism', '*Zebrafish/metabolism/genetics/embryology', '*Zebrafish Proteins/metabolism/genetics']",https://pubmed.ncbi.nlm.nih.gov/38477756/
367,HTR2B,36049541,miRNA-203b-3p Induces Acute and Chronic Pruritus through 5-HTR2B and TRPV4.,"['De Logu F', 'Maglie R', 'Titiz M', 'Poli G', 'Landini L', 'Marini M', 'Souza Monteiro de Araujo D', 'De Siena G', 'Montini M', 'Cabrini DA', 'Otuki MF', 'Pawloski PL', 'Antiga E', 'Tuccinardi T', 'Calixto JB', 'Geppetti P', 'Nassini R', 'Andre E']","['Animals', 'Humans', 'Mice', 'Computer Simulation', 'Ganglia, Spinal', 'Mice, Inbred C57BL', '*MicroRNAs/genetics/metabolism', '*Pruritus/chemically induced/genetics/metabolism', '*TRPV Cation Channels/genetics/metabolism', '*Receptor, Serotonin, 5-HT2B/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36049541/
368,HTR2B,38851806,HTR2B as a novel biomarker of chronic obstructive pulmonary disease with lung squamous cell carcinoma.,"['Li Y', 'Wang Y', 'Wu R', 'Li P', 'Cheng Z']","['Humans', '*Pulmonary Disease, Chronic Obstructive/genetics/metabolism', '*Lung Neoplasms/genetics/pathology/metabolism', '*Biomarkers, Tumor/genetics/metabolism', '*Carcinoma, Squamous Cell/genetics/pathology/metabolism', '*Epithelial-Mesenchymal Transition/genetics', 'Receptor, Serotonin, 5-HT2B/genetics/metabolism', 'Gene Expression Regulation, Neoplastic', 'Cell Proliferation/genetics', 'Cell Line, Tumor']",https://pubmed.ncbi.nlm.nih.gov/38851806/
369,HTR2B,21836641,Association of variations in TPH1 and HTR2B with gestational weight gain and measures of obesity.,"['Kwak SH', 'Park BL', 'Kim H', 'German MS', 'Go MJ', 'Jung HS', 'Koo BK', 'Cho YM', 'Choi SH', 'Cho YS', 'Shin HD', 'Jang HC', 'Park KS']","['Adult', 'Animals', 'Asian People/*genetics', 'Female', 'Humans', 'Mice', 'Obesity/epidemiology/*genetics', '*Polymorphism, Single Nucleotide', 'Pregnancy', 'Pregnancy Complications/*genetics', 'Receptor, Serotonin, 5-HT2B/*genetics', 'Republic of Korea/epidemiology', 'Serotonin/genetics', 'Tryptophan Hydroxylase/*genetics', 'Weight Gain/*genetics']",https://pubmed.ncbi.nlm.nih.gov/21836641/
370,HTR2B,36264865,Molecular and clinicopathological differences between depressed and protruded T2 colorectal cancer.,"['Mochizuki K', 'Kudo SE', 'Kato K', 'Kudo K', 'Ogawa Y', 'Kouyama Y', 'Takashina Y', 'Ichimasa K', 'Tobo T', 'Toshima T', 'Hisamatsu Y', 'Yonemura Y', 'Masuda T', 'Miyachi H', 'Ishida F', 'Nemoto T', 'Mimori K']","['Humans', 'Biomarkers, Tumor/genetics', '*Colorectal Neoplasms/pathology', 'Prognosis', 'Retrospective Studies', 'Transcriptome']",https://pubmed.ncbi.nlm.nih.gov/36264865/
371,HTR2B,25038996,Serotonin modulation of macrophage polarization: inflammation and beyond.,"['de Las Casas-Engel M', 'Corbi AL']","['Animals', 'Gene Expression Regulation/*immunology', 'Homeostasis/*immunology', 'Humans', 'Inflammation/immunology/metabolism/pathology', 'Macrophages/*immunology/metabolism/pathology', 'Receptors, Serotonin/*immunology', 'Serotonin/*immunology/metabolism']",https://pubmed.ncbi.nlm.nih.gov/25038996/
372,HTR2B,36260369,Quantification of changes in human islet G protein-coupled receptor mRNA expression in obesity.,"['Lyu Z', 'Zhao M', 'Atanes P', 'Persaud SJ']","['Humans', '*Islets of Langerhans/metabolism', 'Insulin Secretion', 'Receptors, G-Protein-Coupled/genetics/metabolism', 'Obesity/genetics/metabolism', 'RNA, Messenger/metabolism', 'Insulin/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36260369/
373,HTR2B,25238823,[Role of peripheral serotonin in the insulin secretion and glucose homeostasis].,"['Cataldo LR', 'Cortes VA', 'Galgani JE', 'Olmos PR', 'Santos JL']","['Glucose/*physiology', '*Homeostasis', 'Humans', 'Insulin/*metabolism', 'Insulin Secretion', 'Insulin-Secreting Cells/physiology', 'Peripheral Nervous System/physiology', 'Serotonin/*physiology']",https://pubmed.ncbi.nlm.nih.gov/25238823/
374,HTR2B,23355731,Serotonin skews human macrophage polarization through HTR2B and HTR7.,"['de las Casas-Engel M', 'Dominguez-Soto A', 'Sierra-Filardi E', 'Bragado R', 'Nieto C', 'Puig-Kroger A', 'Samaniego R', 'Loza M', 'Corcuera MT', 'Gomez-Aguado F', 'Bustos M', 'Sanchez-Mateos P', 'Corbi AL']","['Animals', 'Biomarkers/*metabolism', 'Cell Differentiation/*drug effects', 'Cell Lineage', 'Cells, Cultured', 'Gene Expression Regulation/drug effects/immunology', 'Genes, Reporter', 'Humans', 'Inflammation/chemically induced/immunology/metabolism', 'Interleukin-10/biosynthesis/immunology', 'Kupffer Cells/cytology/drug effects/immunology', 'Lipopolysaccharides', 'Luciferases', 'Macrophages/cytology/*drug effects/immunology', 'Mice', 'Mice, Inbred C57BL', 'Receptor, Serotonin, 5-HT2B/genetics/*immunology', 'Receptors, Serotonin/genetics/*immunology', 'Serotonin/immunology/*pharmacology', 'Signal Transduction/drug effects']",https://pubmed.ncbi.nlm.nih.gov/23355731/
375,HTR2B,32920046,Improved visual discrimination learning in mice with partial 5-HT2B gene deletion.,"['Radke AK', 'Piantadosi PT', 'Uhl GR', 'Hall FS', 'Holmes A']","['Animals', 'Cognition/physiology', 'Conditioning, Operant/physiology', 'Discrimination Learning/*physiology', 'Discrimination, Psychological/physiology', '*Gene Deletion', 'Male', 'Mice', 'Receptor, Serotonin, 5-HT2B/*genetics', '*Reversal Learning', 'Visual Perception/*genetics']",https://pubmed.ncbi.nlm.nih.gov/32920046/
376,HTR2B,31478179,Serotonin and Dopamine Receptor Expression in Solid Tumours Including Rare Cancers.,"['Peters MAM', 'Meijer C', 'Fehrmann RSN', 'Walenkamp AME', 'Kema IP', 'de Vries EGE', 'Hollema H', 'Oosting SF']","['Biomarkers, Tumor/analysis/metabolism', 'Humans', 'Neoplasms/*metabolism', 'Receptors, Dopamine/*biosynthesis', 'Receptors, Serotonin/*biosynthesis']",https://pubmed.ncbi.nlm.nih.gov/31478179/
377,HTR1A,38906512,Targeting 5-Hydroxytryptamine Receptor 1A in the Portal Vein to Decrease Portal Hypertension.,"['Zhu CP', 'Liu SQ', 'Wang KQ', 'Xiong HL', 'Aristu-Zabalza P', 'Boyer-Diaz Z', 'Feng JF', 'Song SH', 'Luo C', 'Chen WS', 'Zhang X', 'Dong WH', 'Gracia-Sancho J', 'Xie WF']","['Animals', 'Female', 'Humans', 'Male', 'Mice', 'Rats', '8-Hydroxy-2-(di-n-propylamino)tetralin/pharmacology', 'Cyclic AMP/metabolism', 'Disease Models, Animal', '*Hypertension, Portal/metabolism/genetics/physiopathology/etiology', 'Ligation', 'Liver Cirrhosis/metabolism/genetics/pathology', 'Liver Cirrhosis, Experimental/metabolism/genetics/pathology/chemically induced/physiopathology', 'Mice, Inbred C57BL', '*Mice, Knockout', 'Muscle, Smooth, Vascular/metabolism/drug effects/pathology', 'Myocytes, Smooth Muscle/metabolism/drug effects/pathology', 'Piperazines/pharmacology', '*Portal Pressure/drug effects', '*Portal Vein/metabolism', 'Pyridines/pharmacology', 'Rats, Sprague-Dawley', 'Rats, Wistar', '*Receptor, Serotonin, 5-HT1A/metabolism/genetics', 'Serotonin/metabolism/pharmacology', '*Serotonin 5-HT1 Receptor Agonists/pharmacology', 'Serotonin 5-HT1 Receptor Antagonists/pharmacology', 'Signal Transduction', 'Thioacetamide/toxicity']",https://pubmed.ncbi.nlm.nih.gov/38906512/
378,HTR1A,36214900,Association between the HTR1A rs6295 gene polymorphism and suicidal behavior: an updated meta-analysis.,"['Hernandez-Diaz Y', 'Tovilla-Zarate CA', 'Castillo-Avila RG', 'Juarez-Rojop IE', 'Genis-Mendoza AD', 'Lopez-Narvaez ML', 'Villar-Juarez GE', 'Gonzalez-Castro TB']","['Humans', '*Suicidal Ideation', '*Polymorphism, Single Nucleotide', 'Case-Control Studies', 'Odds Ratio', 'Genetic Predisposition to Disease', 'Receptor, Serotonin, 5-HT1A/genetics']",https://pubmed.ncbi.nlm.nih.gov/36214900/
379,HTR1A,26568455,HTR1A Polymorphisms and Clinical Efficacy of Antipsychotic Drug Treatment in Schizophrenia: A Meta-Analysis.,"['Takekita Y', 'Fabbri C', 'Kato M', 'Koshikawa Y', 'Tajika A', 'Kinoshita T', 'Serretti A']","['Antipsychotic Agents/*therapeutic use', 'Chi-Square Distribution', 'Gene Frequency', 'Humans', 'Pharmacogenetics', '*Pharmacogenomic Variants', '*Polymorphism, Genetic', 'Receptor, Serotonin, 5-HT1A/*genetics', 'Remission Induction', 'Schizophrenia/diagnosis/*drug therapy/genetics', '*Schizophrenic Psychology', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/26568455/
380,HTR1A,26575296,Novel developments in genetic and epigenetic mechanisms of anxiety.,"['Gottschalk MG', 'Domschke K']","['Acid Sensing Ion Channels/genetics', 'Anxiety/*genetics', 'Anxiety Disorders/*genetics', '*Epigenesis, Genetic', 'Humans', 'Monoamine Oxidase/genetics', 'Neuroimaging', 'Panic Disorder/genetics', 'Phenotype', 'Phobic Disorders', 'RGS Proteins/genetics', 'Receptor, Serotonin, 5-HT1A/genetics', 'Receptors, Corticotropin-Releasing Hormone/genetics', 'Receptors, G-Protein-Coupled/genetics', 'Receptors, Oxytocin/genetics', 'Serotonin Plasma Membrane Transport Proteins/genetics', 'CRF Receptor, Type 1']",https://pubmed.ncbi.nlm.nih.gov/26575296/
381,HTR1A,25106036,Are there depression and anxiety genetic markers and mutations? A systematic review.,"['Lacerda-Pinheiro SF', 'Pinheiro Junior RF', 'Pereira de Lima MA', 'Lima da Silva CG', 'Vieira dos Santos Mdo S', 'Teixeira Junior AG', 'Lima de Oliveira PN', 'Ribeiro KD', 'Rolim-Neto ML', 'Bianco BA']","['Alleles', 'Anxiety/*genetics', 'Anxiety Disorders/*genetics', 'Depression/*genetics', 'Depressive Disorder/*genetics', '*Genetic Markers', '*Genetic Predisposition to Disease', 'Humans', 'Mutation', 'Polymorphism, Genetic', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/25106036/
382,HTR1A,18715570,Serotonin receptor HTR1A and HTR2C variants and personality traits in suicide attempters and controls.,"['Serretti A', 'Calati R', 'Giegling I', 'Hartmann AM', 'Moller HJ', 'Rujescu D']","['Adult', 'Analysis of Variance', 'Female', 'Genetic Markers/genetics', 'Genetic Predisposition to Disease/epidemiology/genetics', 'Germany/epidemiology', 'Humans', 'Italy/epidemiology', 'Male', 'Middle Aged', 'Mood Disorders/epidemiology/genetics/psychology', 'Personality/*genetics', 'Personality Disorders/epidemiology/*genetics/psychology', 'Personality Inventory/statistics & numerical data', 'Polymorphism, Genetic/*genetics', 'Receptor, Serotonin, 5-HT1A/*genetics', 'Receptor, Serotonin, 5-HT2C/*genetics', 'Receptors, Serotonin/genetics', 'Socioeconomic Factors', 'Suicide/psychology/*statistics & numerical data', 'Temperament']",https://pubmed.ncbi.nlm.nih.gov/18715570/
383,HTR1A,29689343,Leveraging genetics to enhance the efficacy of PTSD pharmacotherapies.,['Miller MW'],"['Animals', 'Antidepressive Agents/*therapeutic use', 'Humans', 'Pharmacogenetics/*methods/trends', 'Selective Serotonin Reuptake Inhibitors/*therapeutic use', 'Stress Disorders, Post-Traumatic/*drug therapy/*genetics', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/29689343/
384,HTR1A,22826341,Transcriptional regulation of the 5-HT1A receptor: implications for mental illness.,['Albert PR'],"['Alleles', 'Animals', 'Antidepressive Agents/pharmacology', 'Anxiety/drug therapy/genetics/metabolism/physiopathology', 'Autoreceptors/genetics/metabolism', 'Depression/drug therapy/genetics/metabolism/*physiopathology', 'Gene Expression Regulation', 'Gene Frequency', 'Gene-Environment Interaction', 'Genotype', 'Humans', 'Promoter Regions, Genetic', 'Receptor, Serotonin, 5-HT1A/genetics/*metabolism', 'Synaptic Transmission', 'Transcription Factors/genetics/metabolism', '*Transcription, Genetic']",https://pubmed.ncbi.nlm.nih.gov/22826341/
385,HTR1A,22791347,Fluoxetine pharmacogenetics in child and adult populations.,"['Blazquez A', 'Mas S', 'Plana MT', 'Lafuente A', 'Lazaro L']","['Adolescent', 'Adult', 'Child', 'Depressive Disorder/drug therapy/*genetics', 'Drug Resistance/*genetics', 'Fluoxetine/pharmacology/*therapeutic use', 'Gene Frequency', 'Humans', 'Membrane Glycoproteins/genetics', 'Membrane Transport Proteins/genetics', '*Pharmacogenetics', 'Polymorphism, Single Nucleotide/*drug effects', 'Receptors, Serotonin/*genetics/metabolism', 'Serotonin/genetics', 'Selective Serotonin Reuptake Inhibitors/pharmacology/*therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/22791347/
386,HTR1A,22392387,No association between the HTR1A gene and suicidal behavior: a meta-analysis.,"['Angles MR', 'Ocana DB', 'Medellin BC', 'Tovilla-Zarate C']","['Case-Control Studies', 'Genome-Wide Association Study', 'Humans', 'Polymorphism, Single Nucleotide/*genetics', 'Receptor, Serotonin, 5-HT1A/*genetics', '*Suicidal Ideation', 'Suicide/*psychology']",https://pubmed.ncbi.nlm.nih.gov/22392387/
387,HTR1A,34773671,The impact of HTR1A and HTR1B methylation combined with stress/genotype on early antidepressant efficacy.,"['Xu Z', 'Chen Z', 'Shen T', 'Chen L', 'Tan T', 'Gao C', 'Chen B', 'Yuan Y', 'Zhang Z']","['*Antidepressive Agents/pharmacology', 'Case-Control Studies', 'DNA Methylation', '*Depressive Disorder, Major/drug therapy/genetics', 'Genotype', 'Humans', 'Polymorphism, Single Nucleotide/genetics', 'Receptor, Serotonin, 5-HT1A/genetics', 'Receptor, Serotonin, 5-HT1B/genetics', 'Stress, Psychological/genetics', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/34773671/
388,HTR1A,35019025,Polymorphisms of the serotonin receptors genes in patients with bruxism: a systematic review.,"['Campello CP', 'Moraes SLD', 'Vasconcelos BCDE', 'Lima ELS', 'Pellizzer EP', 'Lemos CAA', 'Muniz MTC']","['Humans', 'Polymorphism, Single Nucleotide', 'Receptor, Serotonin, 5-HT1A/*genetics', '*Sleep Bruxism/genetics']",https://pubmed.ncbi.nlm.nih.gov/35019025/
389,HTR1A,38573820,Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia.,"['Zhou L', 'Ni C', 'Liao R', 'Tang X', 'Yi T', 'Ran M', 'Huang M', 'Liao R', 'Zhou X', 'Qin D', 'Wang L', 'Huang F', 'Xie X', 'Wan Y', 'Luo J', 'Wang Y', 'Wu J']","['Mice', 'Animals', '*Vilazodone Hydrochloride/adverse effects/metabolism', 'Zebrafish', 'Receptor, Serotonin, 5-HT1A/metabolism', 'Blood Platelets/metabolism', '*Thrombocytopenia/drug therapy/metabolism', 'Megakaryocytes/metabolism', 'Thrombopoiesis']",https://pubmed.ncbi.nlm.nih.gov/38573820/
390,HTR1A,30124346,5-HT1A receptor ligands and their therapeutic applications: review of new patents.,"['Staron J', 'Bugno R', 'Hogendorf AS', 'Bojarski AJ']","['Animals', 'Drug Design', 'Humans', 'Ligands', 'Patents as Topic', 'Receptor, Serotonin, 5-HT1A/*drug effects/metabolism', 'Serotonin 5-HT1 Receptor Agonists/*pharmacology', 'Serotonin 5-HT1 Receptor Antagonists/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/30124346/
391,HTR1A,35899365,"Whole-transcriptome sequencing identifies neuroinflammation, metabolism and blood-brain barrier related processes in the hippocampus of aged mice during perioperative period.","['Suo Z', 'Yang J', 'Zhou B', 'Qu Y', 'Xu W', 'Li M', 'Xiao T', 'Zheng H', 'Ni C']","['Animals', '*Blood-Brain Barrier', 'Gene Expression Profiling', 'Hippocampus/metabolism', 'Humans', 'Mice', 'Mice, Inbred C57BL', 'Neuroinflammatory Diseases', 'Perioperative Period', '*Transcriptome']",https://pubmed.ncbi.nlm.nih.gov/35899365/
392,HTR1A,20942817,Pharmacogenetics of new analgesics.,"['Lotsch J', 'Geisslinger G']","['Amidohydrolases/genetics', 'Analgesia/*methods', 'Analgesics/*pharmacology/therapeutic use', 'Genotype', 'Humans', 'Ion Channels/genetics', 'Molecular Targeted Therapy', 'Pain/*drug therapy/metabolism', 'Pharmacogenetics', 'Receptors, G-Protein-Coupled/genetics', 'Signal Transduction/genetics']",https://pubmed.ncbi.nlm.nih.gov/20942817/
393,HTR1A,27328783,Concordance and incongruence in preclinical anxiety models: Systematic review and meta-analyses.,"['Mohammad F', 'Ho J', 'Woo JH', 'Lim CL', 'Poon DJJ', 'Lamba B', 'Claridge-Chang A']","['*Anxiety', 'Anxiety Disorders', 'Corticotropin-Releasing Hormone', 'Humans', 'Receptors, Corticotropin-Releasing Hormone', 'Social Isolation']",https://pubmed.ncbi.nlm.nih.gov/27328783/
394,HTR1A,18639564,Transcriptional regulation at a HTR1A polymorphism associated with mental illness.,"['Le Francois B', 'Czesak M', 'Steubl D', 'Albert PR']","['Animals', 'Antidepressive Agents/pharmacology', 'Brain/drug effects/metabolism', 'Gene Expression Regulation/*physiology/radiation effects', '*Genetic Predisposition to Disease', 'Humans', 'Mental Disorders/*genetics/pathology', 'Polymorphism, Genetic/*genetics', 'Receptor, Serotonin, 5-HT1A/*genetics']",https://pubmed.ncbi.nlm.nih.gov/18639564/
395,HTR1A,37788276,Antioxioxidant and antiapoptotic effects of Thymosin beta4 in Abeta-induced SH-SY5Y cells via the 5-HTR1A/ERK axis.,"['Zhang GH', 'Chin KL', 'Yan SY', 'Pare R']","['Aged', 'Humans', '*Alzheimer Disease/drug therapy', 'Apoptosis', 'Cell Line, Tumor', '*Neuroblastoma/pathology', 'Oxidative Stress', 'Receptor, Serotonin, 5-HT1A/metabolism', 'Signal Transduction', '*Thymosin/metabolism', 'Neuroprotection']",https://pubmed.ncbi.nlm.nih.gov/37788276/
396,HTR1A,23644029,"Systematic review, structural analysis, and new theoretical perspectives on the role of serotonin and associated genes in the etiology of psychopathy and sociopathy.","['Yildirim BO', 'Derksen JJ']","['Amygdala/physiopathology', 'Antisocial Personality Disorder/*etiology/genetics/physiopathology', 'Gene-Environment Interaction', 'Humans', 'Hypothalamo-Hypophyseal System/physiopathology', 'Mental Disorders/*etiology/genetics/physiopathology', 'Pituitary-Adrenal System/physiopathology', 'Polymorphism, Genetic', 'Serotonin/biosynthesis/*physiology']",https://pubmed.ncbi.nlm.nih.gov/23644029/
397,HTR2C,36373384,Depressive patient-derived GABA interneurons reveal abnormal neural activity associated with HTR2C.,"['Lu K', 'Hong Y', 'Tao M', 'Shen L', 'Zheng Z', 'Fang K', 'Yuan F', 'Xu M', 'Wang C', 'Zhu D', 'Guo X', 'Liu Y']","['Humans', '*Depressive Disorder, Major/metabolism', 'Interneurons/metabolism', 'Neurons/metabolism', 'Cell Differentiation', 'gamma-Aminobutyric Acid/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36373384/
398,HTR2C,34367066,Central 5-HTR2C in the Control of Metabolic Homeostasis.,"['Yao T', 'He J', 'Cui Z', 'Wang R', 'Bao K', 'Huang Y', 'Wang R', 'Liu T']","['Animals', 'Brain/metabolism/*physiology', 'Energy Metabolism/*genetics', 'Estrogens/physiology', 'Ghrelin/physiology', 'Homeostasis/genetics', 'Humans', 'Hypothalamus/metabolism/physiology', 'Insulin/physiology', 'Leptin/physiology', 'Nerve Net/physiology', 'Receptor, Serotonin, 5-HT2C/metabolism/*physiology', 'Signal Transduction/genetics']",https://pubmed.ncbi.nlm.nih.gov/34367066/
399,HTR2C,24897292,Pharmacogenetics of second-generation antipsychotics.,['Brennan MD'],"['Alleles', 'Antipsychotic Agents/*adverse effects', 'Biomarkers/metabolism', 'Drug-Related Side Effects and Adverse Reactions/genetics', 'Genome-Wide Association Study/methods', 'Humans', 'Pharmacogenetics/*methods', 'Polymorphism, Genetic/genetics']",https://pubmed.ncbi.nlm.nih.gov/24897292/
400,HTR2C,38941473,Neural circuits expressing the serotonin 2C receptor regulate memory in mice and humans.,"['Liu H', 'He Y', 'Liu H', 'Brouwers B', 'Yin N', 'Lawler K', 'Keogh JM', 'Henning E', 'Lee DK', 'Yu M', 'Tu L', 'Zhang N', 'Conde KM', 'Han J', 'Yan Z', 'Scarcelli NA', 'Liao L', 'Xu J', 'Tong Q', 'Zheng H', 'Sun Z', 'Yang Y', 'Wang C', 'He Y', 'Farooqi IS', 'Xu Y']","['Animals', 'Humans', '*Receptor, Serotonin, 5-HT2C/metabolism/genetics', '*Memory/drug effects/physiology', 'Mice', '*Mice, Transgenic', '*Neuronal Plasticity/drug effects', '*Alzheimer Disease/metabolism', 'Hippocampus/metabolism/drug effects', 'Serotonin/metabolism', 'Disease Models, Animal', 'CA1 Region, Hippocampal/metabolism/drug effects', 'Neurons/metabolism/drug effects', 'Serotonin 5-HT2 Receptor Agonists/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/38941473/
401,HTR2C,29528898,New findings in pharmacogenetics of schizophrenia.,"['Zai CC', 'Tiwari AK', 'Zai GC', 'Maes MS', 'Kennedy JL']","['*Antipsychotic Agents/adverse effects/classification/pharmacokinetics', 'Drug Resistance/genetics', 'Humans', '*Pharmacogenetics/methods/trends', '*Schizophrenia/drug therapy/genetics', 'Tardive Dyskinesia/chemically induced/genetics/prevention & control', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/29528898/
402,HTR2C,38674857,Mendelian Randomization Analysis Identifies Inverse Causal Relationship between External Eating and Metabolic Phenotypes.,"['Timasheva Y', 'Balkhiyarova Z', 'Avzaletdinova D', 'Morugova T', 'Korytina GF', 'Nouwen A', 'Prokopenko I', 'Kochetova O']","['Humans', '*Mendelian Randomization Analysis', '*Phenotype', '*Diabetes Mellitus, Type 2/genetics/etiology', '*Feeding Behavior', 'Female', 'Male', 'Metabolic Syndrome/genetics/etiology', 'tRNA Methyltransferases/genetics', 'Glycated Hemoglobin/metabolism/analysis', 'Middle Aged', 'Body Mass Index', 'Adenylyl Cyclases/genetics', 'Genome-Wide Association Study', 'Polymorphism, Single Nucleotide', 'Adult', 'Waist Circumference', 'Genetic Variation', '*Ghrelin']",https://pubmed.ncbi.nlm.nih.gov/38674857/
403,HTR2C,36628952,Pharmacogenetics of anxiety and depression in Alzheimer's disease.,"['Cacabelos R', 'Carril JC', 'Corzo L', 'Pego R', 'Cacabelos N', 'Alcaraz M', 'Muniz A', 'Martinez-Iglesias O', 'Naidoo V']","['Humans', '*Alzheimer Disease/drug therapy/genetics', 'Pharmacogenetics/methods', 'Depression/drug therapy/genetics', 'Cytochrome P-450 CYP2D6/genetics', 'Anxiety/drug therapy/genetics', 'Liver-Specific Organic Anion Transporter 1', '*Arylamine N-Acetyltransferase', 'Carrier Proteins', 'Nerve Tissue Proteins', 'Serotonin Plasma Membrane Transport Proteins']",https://pubmed.ncbi.nlm.nih.gov/36628952/
404,HTR2C,18802918,Focus on HTR2C: A possible suggestion for genetic studies of complex disorders.,"['Drago A', 'Serretti A']","['Animals', 'Base Sequence', 'Brain/anatomy & histology/metabolism/physiology/physiopathology', 'Genetics, Population', 'Humans', 'Mental Disorders/*genetics/physiopathology', 'Molecular Sequence Data', 'Protein Processing, Post-Translational/physiology', 'Receptor, Serotonin, 5-HT2C/genetics/metabolism/*physiology']",https://pubmed.ncbi.nlm.nih.gov/18802918/
405,HTR2C,29502799,Genetics of tardive dyskinesia: Promising leads and ways forward.,"['Zai CC', 'Maes MS', 'Tiwari AK', 'Zai GC', 'Remington G', 'Kennedy JL']","['Animals', 'Antipsychotic Agents/adverse effects', 'Dopamine Antagonists/adverse effects', 'Humans', 'Tardive Dyskinesia/*genetics']",https://pubmed.ncbi.nlm.nih.gov/29502799/
406,HTR2C,26100432,Weight Gain and Metabolic Changes During Treatment with Antipsychotics and Antidepressants.,"['Himmerich H', 'Minkwitz J', 'Kirkby KC']","['Animals', 'Antidepressive Agents/*adverse effects', 'Antipsychotic Agents/*adverse effects', 'Drug Monitoring', 'Genetic Predisposition to Disease', 'Glucose Intolerance/*chemically induced/genetics/metabolism', 'Humans', 'Hyperlipidemias/*chemically induced/genetics/metabolism', 'Overweight/*chemically induced/genetics/metabolism', 'Polymorphism, Genetic', 'Weight Gain/drug effects']",https://pubmed.ncbi.nlm.nih.gov/26100432/
407,HTR2C,28499663,Htr2c Splice Variants and 5HT(2C)R-Mediated Appetite.,['Isles AR'],"['Alternative Splicing/genetics/*physiology', 'Animals', 'Appetite/*genetics', 'Appetite Regulation/*genetics', 'Disease Models, Animal', 'Humans', 'Mice', 'Mice, Transgenic', 'Prader-Willi Syndrome/genetics/pathology', 'Protein Isoforms/genetics', 'Receptor, Serotonin, 5-HT2C/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28499663/
408,HTR2C,23370274,The pharmacogenetics of antipsychotic-induced adverse events.,"['Muller DJ', 'Chowdhury NI', 'Zai CC']","['Antipsychotic Agents/*adverse effects/pharmacology', 'Humans', 'Mental Disorders/*drug therapy/*genetics', 'Movement Disorders/*etiology', 'Polymorphism, Single Nucleotide', 'Weight Gain/*drug effects']",https://pubmed.ncbi.nlm.nih.gov/23370274/
409,HTR2C,30607769,Pharmacogenetic Correlates of Antipsychotic-Induced Weight Gain in the Chinese Population.,"['Luo C', 'Liu J', 'Wang X', 'Mao X', 'Zhou H', 'Liu Z']","['Antipsychotic Agents/*adverse effects', 'Asian People/genetics', 'China', 'Genome-Wide Association Study', 'Genotype', 'Humans', 'Lipid Metabolism/genetics', 'Neurosecretory Systems/drug effects', '*Pharmacogenomic Testing', 'Polymorphism, Single Nucleotide', 'Receptors, Adrenergic/genetics', 'Receptors, Dopamine/genetics', 'Receptors, Histamine/genetics', 'Receptors, Serotonin/genetics', 'Weight Gain/*drug effects/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30607769/
410,HTR2C,38652060,The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational study.,"['Fernandez-Egea E', 'Chen S', 'Sanguesa E', 'Gasso P', 'Biria M', 'Plaistow J', 'Jarratt-Barnham I', 'Segarra N', 'Mas S', 'Ribate MP', 'Garcia CB', 'Fineberg NA', 'Worbe Y', 'Cardinal RN', 'Robbins TW']","['Humans', '*Clozapine/adverse effects/therapeutic use', 'Male', 'Female', 'Adult', '*Antipsychotic Agents/adverse effects', 'Longitudinal Studies', '*Psychotic Disorders/drug therapy', '*Schizophrenia, Treatment-Resistant/drug therapy/genetics', 'Middle Aged', 'Compulsive Behavior/chemically induced', 'Obsessive-Compulsive Disorder/drug therapy/chemically induced', 'Schizophrenia/drug therapy']",https://pubmed.ncbi.nlm.nih.gov/38652060/
411,HTR2C,28576508,A review of the role of serotonin system genes in obsessive-compulsive disorder.,"['Sinopoli VM', 'Burton CL', 'Kronenberg S', 'Arnold PD']","['Animals', 'Genetic Predisposition to Disease', 'Humans', 'Obsessive-Compulsive Disorder/diagnostic imaging/drug therapy/*genetics/*metabolism', 'Serotonin/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/28576508/
412,HTR2C,35121849,Adverse maternal environment affects hippocampal HTR2c variant expression and epigenetic characteristics in mouse offspring.,"['Ke X', 'Huang Y', 'Fu Q', 'Majnik A', 'Lane RH']","['Animals', 'Female', 'Male', 'Mice', 'Pregnancy', 'DNA Methylation', '*Epigenesis, Genetic', '*Hippocampus/metabolism', '*Prenatal Exposure Delayed Effects/metabolism', 'RNA, Messenger/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35121849/
413,HTR2C,23742855,Serotonergic genes and suicide: a systematic review.,"['Antypa N', 'Serretti A', 'Rujescu D']","['Alleles', 'Animals', 'Brain/enzymology/metabolism', 'Case-Control Studies', 'Endophenotypes', '*Evidence-Based Medicine', 'Gene-Environment Interaction', 'Genetic Association Studies', 'Genetic Predisposition to Disease', '*Genetic Variation', 'Humans', 'Monoamine Oxidase/*genetics/metabolism', 'Nerve Tissue Proteins/genetics/metabolism', 'Neurons/enzymology/metabolism', 'Protein Isoforms/genetics/metabolism', 'Receptors, Serotonin/*genetics/metabolism', 'Self-Injurious Behavior/etiology/*genetics/metabolism/prevention & control', 'Serotonin Plasma Membrane Transport Proteins/*genetics/metabolism', 'Tryptophan Hydroxylase/*genetics/metabolism', 'Suicide Prevention']",https://pubmed.ncbi.nlm.nih.gov/23742855/
414,HTR2C,21894153,Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.,"['Lett TA', 'Wallace TJ', 'Chowdhury NI', 'Tiwari AK', 'Kennedy JL', 'Muller DJ']","['Antipsychotic Agents/*adverse effects/classification/pharmacokinetics', 'Appetite/genetics', 'Biogenic Monoamines/metabolism', 'Biological Transport/genetics', 'Biotransformation/genetics', 'Cardiovascular Diseases/etiology', 'Epigenesis, Genetic', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Humans', 'Lipid Metabolism/genetics', 'Meta-Analysis as Topic', 'Metabolic Syndrome/etiology', 'Neurotransmitter Agents/metabolism', 'Obesity/chemically induced/complications/genetics', 'Patient Compliance', 'Precision Medicine', 'Receptors, Neurotransmitter/genetics/metabolism', 'Weight Gain/*drug effects/genetics']",https://pubmed.ncbi.nlm.nih.gov/21894153/
415,HTR2C,25138234,"Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed.","['Shams TA', 'Muller DJ']","['Antipsychotic Agents/*adverse effects/therapeutic use', 'Epigenomics', 'Genetic Markers', '*Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Polymorphism, Single Nucleotide', 'Weight Gain/*drug effects/genetics']",https://pubmed.ncbi.nlm.nih.gov/25138234/
416,HTR2C,19411841,"Serotonin receptor 2C and mental disorders: genetic, expression and RNA editing studies.","['Iwamoto K', 'Bundo M', 'Kato T']","['Adenosine Deaminase/genetics', 'Animals', 'Gene Expression Regulation', 'Genetic Variation', 'Humans', 'Mental Disorders/*genetics/metabolism', '*RNA Editing', 'RNA-Binding Proteins', 'Receptor, Serotonin, 5-HT2C/chemistry/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/19411841/
417,ADRA2C,38951961,"Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy.","['Duarte JD', 'Thomas CD', 'Lee CR', 'Huddart R', 'Agundez JAG', 'Baye JF', 'Gaedigk A', 'Klein TE', 'Lanfear DE', 'Monte AA', 'Nagy M', 'Schwab M', 'Stein CM', 'Uppugunduri CRS', 'van Schaik RHN', 'Donnelly RS', 'Caudle KE', 'Luzum JA']","['Humans', '*Adrenergic beta-Antagonists/pharmacokinetics/therapeutic use', '*Cytochrome P-450 CYP2D6/genetics/metabolism', '*G-Protein-Coupled Receptor Kinase 5/genetics', '*Genotype', 'Metoprolol/pharmacokinetics', '*Pharmacogenetics/methods/standards', 'Pharmacogenomic Variants', 'Receptors, Adrenergic, alpha-2/genetics', '*Receptors, Adrenergic, beta-1/genetics', '*Receptors, Adrenergic, beta-2/genetics']",https://pubmed.ncbi.nlm.nih.gov/38951961/
418,ADRA2C,11001792,Molecular heterosis: a review.,"['Comings DE', 'MacMurray JP']","['Alleles', 'Animals', 'Female', 'Genetic Linkage', '*Heterozygote', 'Homozygote', 'Humans', 'Male', 'Models, Genetic', 'Phenotype', 'Polymorphism, Genetic']",https://pubmed.ncbi.nlm.nih.gov/11001792/
419,ADRA2C,34930904,Differential brain ADRA2A and ADRA2C gene expression and epigenetic regulation in schizophrenia. Effect of antipsychotic drug treatment.,"['Brocos-Mosquera I', 'Miranda-Azpiazu P', 'Muguruza C', 'Corzo-Monje V', 'Morentin B', 'Meana JJ', 'Callado LF', 'Rivero G']","['Animals', '*Antipsychotic Agents/pharmacology', 'Brain', 'Dorsolateral Prefrontal Cortex', 'Epigenesis, Genetic', 'Gene Expression', 'Gene Expression Regulation', 'Rats', '*Schizophrenia/drug therapy/genetics']",https://pubmed.ncbi.nlm.nih.gov/34930904/
420,ADRA2C,36926933,Impact of Neuroeffector Adrenergic Receptor Polymorphisms on Incident Ventricular Fibrillation During Acute Myocardial Ischemia.,"['Chevalier P', 'Roy P', 'Bessiere F', 'Morel E', 'Ankou B', 'Morgan G', 'Halder I', 'London B', 'Minobe WA', 'Slavov D', 'Deliniere A', 'Bochaton T', 'Paganelli F', 'Lesavre N', 'Boiteux C', 'Mansourati J', 'Maury P', 'Clerici G', 'Winum PF', 'Huebler SP', 'Carroll IA', 'Bristow MR']","['Humans', '*Ventricular Fibrillation/diagnosis/epidemiology/genetics', 'Case-Control Studies', 'Polymorphism, Genetic', 'Receptors, Adrenergic/genetics', '*ST Elevation Myocardial Infarction', 'Norepinephrine']",https://pubmed.ncbi.nlm.nih.gov/36926933/
421,ADRA2C,35982177,Maternal anxiety affects embryo implantation via impairing adrenergic receptor signaling in decidual cells.,"['Wu J', 'Lin S', 'Huang P', 'Qiu L', 'Jiang Y', 'Zhang Y', 'Meng N', 'Meng M', 'Wang L', 'Deng W', 'Liu Z', 'Guo C', 'Lu J', 'Wang H', 'Kong S']","['Animals', 'Anxiety', '*Embryo Implantation/physiology', 'Epinephrine/pharmacology', 'Female', 'Humans', 'Mice', '*Phosphatidylinositol 3-Kinases', 'Pregnancy', 'Receptors, Adrenergic']",https://pubmed.ncbi.nlm.nih.gov/35982177/
422,ADRA2C,35258481,Genetic biomarkers of life-threatening pheochromocytoma-induced cardiomyopathy.,"['Amar J', 'Brunel J', 'Cardot Bauters C', 'Jacques V', 'Delmas C', 'Odou MF', 'Savagner F']","['*Adrenal Gland Neoplasms/genetics', 'Biomarkers', '*Cardiomyopathies', 'Catecholamines', 'Genotype', 'Humans', '*Paraganglioma', '*Pheochromocytoma/genetics', 'Polymorphism, Single Nucleotide', '*Receptors, Adrenergic, alpha-2/genetics', '*Receptors, Adrenergic, beta-1/genetics', '*Receptors, Adrenergic, beta-2/genetics']",https://pubmed.ncbi.nlm.nih.gov/35258481/
423,ADRA2C,24322971,Cardiovascular pharmacogenomics: expectations and practical benefits.,"['Turner RM', 'Pirmohamed M']","['Adrenergic beta-Antagonists/administration & dosage/pharmacokinetics', 'Animals', 'Anti-Arrhythmia Agents/administration & dosage/pharmacokinetics', 'Anticoagulants/administration & dosage/pharmacokinetics', 'Cardiovascular Diseases/*drug therapy/*genetics', 'Clopidogrel', 'Humans', 'Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage/pharmacokinetics', '*Pharmacogenetics/trends', 'Platelet Aggregation Inhibitors/administration & dosage/pharmacokinetics', 'Renin-Angiotensin System/drug effects', 'Ticlopidine/administration & dosage/analogs & derivatives/pharmacokinetics', 'Warfarin/administration & dosage/pharmacokinetics']",https://pubmed.ncbi.nlm.nih.gov/24322971/
424,ADRA2C,20145962,Molecular genetics of attention-deficit/hyperactivity disorder: an overview.,"['Banaschewski T', 'Becker K', 'Scherag S', 'Franke B', 'Coghill D']","['Adolescent', 'Cell Division/genetics', 'Child', 'Genetic Markers/*genetics', 'Genetic Predisposition to Disease/*genetics', 'Genome-Wide Association Study', 'Humans', 'Malformations of Cortical Development, Group II/genetics', 'Neurotransmitter Agents/genetics', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/20145962/
425,ADRA2C,30277919,The association of an alpha2C adrenoreceptor gene polymorphism with vasomotor symptoms in African American women.,"['Aharon DA', 'Friedman EG', 'Overbey JR', 'McLaughlin M', 'Langaee T', 'Thurston RC']","['Adult', 'Black or African American', 'Case-Control Studies', 'Cross-Sectional Studies', 'Female', 'Hot Flashes/ethnology/*genetics', 'Humans', 'Longitudinal Studies', 'Menopause/*physiology', 'Middle Aged', 'Polymorphism, Genetic', '*Receptors, Adrenergic, alpha-2', 'Surveys and Questionnaires', 'Sweating/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30277919/
426,ADRA2C,31218733,Prognostic significance of alpha- and beta2-adrenoceptor gene expression in breast cancer patients.,"['Rivero EM', 'Martinez LM', 'Bruque CD', 'Gargiulo L', 'Bruzzone A', 'Luthy IA']","['Biomarkers, Tumor/analysis/*metabolism', 'Breast/pathology', 'Breast Neoplasms/mortality/*pathology', 'Datasets as Topic', 'Disease-Free Survival', 'Female', 'Follow-Up Studies', 'Gene Expression Profiling', 'Humans', 'Middle Aged', 'Neoplasm Recurrence, Local', 'Oligonucleotide Array Sequence Analysis', 'Prognosis', 'Receptors, Adrenergic, alpha-2/analysis/*metabolism', 'Receptors, Adrenergic, beta-2/analysis/metabolism']",https://pubmed.ncbi.nlm.nih.gov/31218733/
427,ADRA2C,35533547,Sex-dependent host-microbiome dynamics in zebrafish: Implications for toxicology and gastrointestinal physiology.,"['Martyniuk CJ', 'Buerger AN', 'Vespalcova H', 'Rudzanova B', 'Sohag SR', 'Hanlon AT', 'Ginn PE', 'Craft SL', 'Smetanova S', 'Budinska E', 'Bisesi JH Jr', 'Adamovsky O']","['Animals', 'Apoptosis Regulatory Proteins', 'Bacteria', 'Female', '*Gastrointestinal Microbiome/genetics', 'Gastrointestinal Tract/microbiology', 'Male', '*Microbiota', 'Zebrafish/genetics']",https://pubmed.ncbi.nlm.nih.gov/35533547/
428,ADRA2C,29672586,Selection on the regulation of sympathetic nervous activity in humans and chimpanzees.,"['Lee KS', 'Chatterjee P', 'Choi EY', 'Sung MK', 'Oh J', 'Won H', 'Park SM', 'Kim YJ', 'Yi SV', 'Choi JK']","['Alleles', 'Animals', 'Biological Evolution', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Gene Editing', 'Gene Expression Regulation', 'Humans', 'Pan troglodytes/genetics/*physiology', 'Receptors, Adrenergic, alpha-2/genetics/physiology', 'Sympathetic Nervous System/*physiology']",https://pubmed.ncbi.nlm.nih.gov/29672586/
429,ADRA2C,11462757,Clinical and molecular genetics of ADHD and Tourette syndrome. Two related polygenic disorders.,['Comings DE'],"['Attention Deficit Disorder with Hyperactivity/diagnosis/epidemiology/*genetics', 'Comorbidity', 'Dopamine/*genetics', 'Female', 'Genetic Linkage', 'Humans', 'Male', 'Mental Disorders/epidemiology', 'Molecular Biology/*methods', 'Pedigree', 'Psychiatric Status Rating Scales', 'Serotonin/genetics', 'Tourette Syndrome/diagnosis/epidemiology/*genetics', 'Twins/genetics']",https://pubmed.ncbi.nlm.nih.gov/11462757/
430,ADRA2C,11317218,An in-frame deletion in the alpha(2C) adrenergic receptor is common in African--Americans.,"['Feng J', 'Zheng J', 'Gelernter J', 'Kranzler H', 'Cook E', 'Goldman D', 'Jones IR', 'Craddock N', 'Heston LL', 'Delisi L', 'Peltonen L', 'Bennett WP', 'Sommer SS']","['Black People/*genetics', 'Case-Control Studies', 'Female', '*Gene Deletion', 'Humans', 'Male', 'Polymorphism, Genetic', 'RNA Splice Sites/genetics', 'Receptors, Adrenergic, alpha-2/*genetics', 'Schizophrenia/*ethnology/*genetics', 'Black or African American']",https://pubmed.ncbi.nlm.nih.gov/11317218/
431,ADRA2C,30354340,Dose Response of beta-Blockers in Adrenergic Receptor Polymorphism Genotypes.,"['Parikh KS', 'Fiuzat M', 'Davis G', 'Neely M', 'Blain-Nelson P', 'Whellan DJ', 'Abraham WT', 'Adams KF Jr', 'Felker GM', 'Liggett SB', ""O'Connor CM"", 'Bristow MR']","['Adrenergic beta-1 Receptor Antagonists/administration & dosage/pharmacokinetics', 'Adrenergic beta-Antagonists/*administration & dosage/pharmacokinetics', 'Adult', 'Aged', 'Amino Acid Substitution/genetics', 'Carvedilol/administration & dosage/pharmacokinetics', 'Cause of Death', 'Clinical Trials as Topic', 'Cohort Studies', 'Dose-Response Relationship, Drug', 'Female', 'Genotype', 'Heart Failure/*drug therapy/*genetics/mortality', 'Humans', 'Male', 'Middle Aged', 'Mortality', 'Pharmacogenetics', 'Pharmacogenomic Testing', '*Polymorphism, Genetic', 'Propanolamines/administration & dosage/pharmacokinetics', 'Receptors, Adrenergic/*genetics', 'Receptors, Adrenergic, alpha-2/genetics', 'Receptors, Adrenergic, beta-1/genetics', 'Retrospective Studies']",https://pubmed.ncbi.nlm.nih.gov/30354340/
432,ADRA2C,18835330,Association between the alpha-2C-adrenergic receptor gene and attention deficit hyperactivity disorder in a Korean sample.,"['Cho SC', 'Kim JW', 'Kim BN', 'Hwang JW', 'Shin MS', 'Park M', 'Kim SA', 'Cho DY', 'Yoo HJ', 'Chung US', 'Son JW', 'Park TW']","['Asian People', 'Attention Deficit Disorder with Hyperactivity/ethnology/*genetics/metabolism', 'Brain Chemistry/*genetics', 'Child', 'DNA Mutational Analysis', 'Exploratory Behavior/physiology', 'Female', 'Gene Frequency/genetics', 'Genetic Markers/genetics', 'Genetic Predisposition to Disease/*genetics', 'Genetic Testing', 'Genotype', 'Humans', 'Inheritance Patterns/genetics', 'Korea', 'Male', 'Mutation/genetics', 'Norepinephrine/*metabolism', 'Polymorphism, Genetic/*genetics', 'Receptors, Adrenergic, alpha-2/*genetics', 'Temperament/physiology']",https://pubmed.ncbi.nlm.nih.gov/18835330/
433,ADRA2C,7623774,Targeted inactivation of the gene encoding the mouse alpha 2c-adrenoceptor homolog.,"['Link RE', 'Stevens MS', 'Kulatunga M', 'Scheinin M', 'Barsh GS', 'Kobilka BK']","['Animals', 'Base Sequence', 'Binding Sites', 'Crosses, Genetic', 'DNA Primers', 'Gene Expression Regulation', 'Mice', 'Mice, Inbred C57BL', 'Mice, Inbred DBA', 'Mice, Knockout', 'Molecular Sequence Data', 'RNA, Messenger/genetics/metabolism', 'Radioligand Assay', 'Receptors, Adrenergic, alpha-2/*genetics/metabolism', 'Stem Cells/metabolism']",https://pubmed.ncbi.nlm.nih.gov/7623774/
434,ADRA2C,16636200,Do allelic variants in alpha2A and alpha2C adrenergic receptors predispose to hypertension in blacks?,"['Li JL', 'Canham RM', 'Vongpatanasin W', 'Leonard D', 'Auchus RJ', 'Victor RG']","['Adult', 'Aged', '*Alleles', 'Black People/*genetics', 'Blood Pressure', 'Female', '*Genetic Predisposition to Disease', '*Genetic Variation', 'Heart Ventricles', 'Humans', 'Hypertension/diagnosis/*genetics/physiopathology', 'Logistic Models', 'Magnetic Resonance Imaging', 'Male', 'Middle Aged', 'Myocardium/pathology', 'Receptors, Adrenergic, alpha-2/*genetics']",https://pubmed.ncbi.nlm.nih.gov/16636200/
435,ADRA2C,32958803,Distribution and relative expression of vasoactive receptors on arteries.,"['Liu X', 'Luo D', 'Zhang J', 'Du L']","['Adult', 'Arteries/*metabolism', 'Endothelin-1/metabolism', 'Endothelium/metabolism', 'Female', 'Humans', 'Male', 'Middle Aged', 'Myocardium/metabolism', 'Receptors, Adrenergic, alpha-2/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/32958803/
436,ADRA2C,17644825,Genetic variation associated with ischemic heart failure: a HuGE review and meta-analysis.,"['Kitsios G', 'Zintzaras E']","['Case-Control Studies', '*Genetic Predisposition to Disease', '*Genetic Variation', 'Genotype', 'Heart Failure/epidemiology/*genetics/physiopathology', 'Humans', 'Myocardial Ischemia/epidemiology/*genetics/physiopathology', 'Polymorphism, Genetic', 'Prognosis', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/17644825/
437,ADRA2A,31462402,Single-Cell Transcriptomic Map of the Human and Mouse Bladders.,"['Yu Z', 'Liao J', 'Chen Y', 'Zou C', 'Zhang H', 'Cheng J', 'Liu D', 'Li T', 'Zhang Q', 'Li J', 'Yang X', 'Ye Y', 'Huang Z', 'Long X', 'Yang R', 'Mo Z']","['Animals', 'Female', 'Humans', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Rats', 'Rats, Sprague-Dawley', 'Receptors, Adrenergic, alpha-2/analysis', 'Receptors, Histamine H2/analysis', 'Sequence Analysis, RNA', '*Single-Cell Analysis', '*Transcriptome', 'Troponin T/analysis', 'Urinary Bladder/*cytology/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/31462402/
438,ADRA2A,38788722,Enterococcus-derived tyramine hijacks alpha(2A)-adrenergic receptor in intestinal stem cells to exacerbate colitis.,"['Li C', 'Zhang P', 'Xie Y', 'Wang S', 'Guo M', 'Wei X', 'Zhang K', 'Cao D', 'Zhou R', 'Wang S', 'Song X', 'Zhu S', 'Pan W']","['Animals', '*Tyramine/metabolism/pharmacology', '*Colitis/microbiology/chemically induced/metabolism', 'Mice', '*Receptors, Adrenergic, alpha-2/metabolism', '*Mice, Knockout', '*Stem Cells/metabolism', 'Humans', 'Mice, Inbred C57BL', 'Tyrosine Decarboxylase/metabolism', 'Enterococcus faecalis/metabolism', 'Gastrointestinal Microbiome', 'Intestinal Mucosa/microbiology/metabolism/pathology', 'Yohimbine/pharmacology', 'Disease Models, Animal', 'Enterococcus/metabolism', 'Intestines/microbiology/pathology', 'Cell Proliferation', 'Inflammatory Bowel Diseases/microbiology/metabolism', 'Dextran Sulfate']",https://pubmed.ncbi.nlm.nih.gov/38788722/
439,ADRA2A,37286594,Tumour immune rejection triggered by activation of alpha2-adrenergic receptors.,"['Zhu J', 'Naulaerts S', 'Boudhan L', 'Martin M', 'Gatto L', 'Van den Eynde BJ']","['Animals', 'Humans', 'Mice', 'CD4-Positive T-Lymphocytes/drug effects/immunology', 'CD8-Positive T-Lymphocytes/drug effects/immunology', '*Neoplasms/drug therapy/immunology', 'Signal Transduction/drug effects', 'Tumor Microenvironment', '*Receptors, Adrenergic, alpha-2/metabolism', '*Adrenergic alpha-2 Receptor Agonists/pharmacology/therapeutic use', 'Adrenergic alpha-2 Receptor Antagonists/pharmacology', 'Macrophages/drug effects/immunology', 'Mice, Knockout', 'Single-Cell Gene Expression Analysis']",https://pubmed.ncbi.nlm.nih.gov/37286594/
440,ADRA2A,20504254,Pharmacogenomics of suicidal events.,"['Brent D', 'Melhem N', 'Turecki G']","['Antidepressive Agents/*adverse effects', 'Depression/drug therapy/genetics/metabolism', 'Humans', '*Pharmacogenetics', 'Polymorphism, Genetic', '*Suicide', 'Suicide, Attempted']",https://pubmed.ncbi.nlm.nih.gov/20504254/
441,ADRA2A,20081858,New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.,"['Dupuis J', 'Langenberg C', 'Prokopenko I', 'Saxena R', 'Soranzo N', 'Jackson AU', 'Wheeler E', 'Glazer NL', 'Bouatia-Naji N', 'Gloyn AL', 'Lindgren CM', 'Magi R', 'Morris AP', 'Randall J', 'Johnson T', 'Elliott P', 'Rybin D', 'Thorleifsson G', 'Steinthorsdottir V', 'Henneman P', 'Grallert H', 'Dehghan A', 'Hottenga JJ', 'Franklin CS', 'Navarro P', 'Song K', 'Goel A', 'Perry JR', 'Egan JM', 'Lajunen T', 'Grarup N', 'Sparso T', 'Doney A', 'Voight BF', 'Stringham HM', 'Li M', 'Kanoni S', 'Shrader P', 'Cavalcanti-Proenca C', 'Kumari M', 'Qi L', 'Timpson NJ', 'Gieger C', 'Zabena C', 'Rocheleau G', 'Ingelsson E', 'An P', ""O'Connell J"", 'Luan J', 'Elliott A', 'McCarroll SA', 'Payne F', 'Roccasecca RM', 'Pattou F', 'Sethupathy P', 'Ardlie K', 'Ariyurek Y', 'Balkau B', 'Barter P', 'Beilby JP', 'Ben-Shlomo Y', 'Benediktsson R', 'Bennett AJ', 'Bergmann S', 'Bochud M', 'Boerwinkle E', 'Bonnefond A', 'Bonnycastle LL', 'Borch-Johnsen K', 'Bottcher Y', 'Brunner E', 'Bumpstead SJ', 'Charpentier G', 'Chen YD', 'Chines P', 'Clarke R', 'Coin LJ', 'Cooper MN', 'Cornelis M', 'Crawford G', 'Crisponi L', 'Day IN', 'de Geus EJ', 'Delplanque J', 'Dina C', 'Erdos MR', 'Fedson AC', 'Fischer-Rosinsky A', 'Forouhi NG', 'Fox CS', 'Frants R', 'Franzosi MG', 'Galan P', 'Goodarzi MO', 'Graessler J', 'Groves CJ', 'Grundy S', 'Gwilliam R', 'Gyllensten U', 'Hadjadj S', 'Hallmans G', 'Hammond N', 'Han X', 'Hartikainen AL', 'Hassanali N', 'Hayward C', 'Heath SC', 'Hercberg S', 'Herder C', 'Hicks AA', 'Hillman DR', 'Hingorani AD', 'Hofman A', 'Hui J', 'Hung J', 'Isomaa B', 'Johnson PR', 'Jorgensen T', 'Jula A', 'Kaakinen M', 'Kaprio J', 'Kesaniemi YA', 'Kivimaki M', 'Knight B', 'Koskinen S', 'Kovacs P', 'Kyvik KO', 'Lathrop GM', 'Lawlor DA', 'Le Bacquer O', 'Lecoeur C', 'Li Y', 'Lyssenko V', 'Mahley R', 'Mangino M', 'Manning AK', 'Martinez-Larrad MT', 'McAteer JB', 'McCulloch LJ', 'McPherson R', 'Meisinger C', 'Melzer D', 'Meyre D', 'Mitchell BD', 'Morken MA', 'Mukherjee S', 'Naitza S', 'Narisu N', 'Neville MJ', 'Oostra BA', 'Orru M', 'Pakyz R', 'Palmer CN', 'Paolisso G', 'Pattaro C', 'Pearson D', 'Peden JF', 'Pedersen NL', 'Perola M', 'Pfeiffer AF', 'Pichler I', 'Polasek O', 'Posthuma D', 'Potter SC', 'Pouta A', 'Province MA', 'Psaty BM', 'Rathmann W', 'Rayner NW', 'Rice K', 'Ripatti S', 'Rivadeneira F', 'Roden M', 'Rolandsson O', 'Sandbaek A', 'Sandhu M', 'Sanna S', 'Sayer AA', 'Scheet P', 'Scott LJ', 'Seedorf U', 'Sharp SJ', 'Shields B', 'Sigurethsson G', 'Sijbrands EJ', 'Silveira A', 'Simpson L', 'Singleton A', 'Smith NL', 'Sovio U', 'Swift A', 'Syddall H', 'Syvanen AC', 'Tanaka T', 'Thorand B', 'Tichet J', 'Tonjes A', 'Tuomi T', 'Uitterlinden AG', 'van Dijk KW', 'van Hoek M', 'Varma D', 'Visvikis-Siest S', 'Vitart V', 'Vogelzangs N', 'Waeber G', 'Wagner PJ', 'Walley A', 'Walters GB', 'Ward KL', 'Watkins H', 'Weedon MN', 'Wild SH', 'Willemsen G', 'Witteman JC', 'Yarnell JW', 'Zeggini E', 'Zelenika D', 'Zethelius B', 'Zhai G', 'Zhao JH', 'Zillikens MC', 'Borecki IB', 'Loos RJ', 'Meneton P', 'Magnusson PK', 'Nathan DM', 'Williams GH', 'Hattersley AT', 'Silander K', 'Salomaa V', 'Smith GD', 'Bornstein SR', 'Schwarz P', 'Spranger J', 'Karpe F', 'Shuldiner AR', 'Cooper C', 'Dedoussis GV', 'Serrano-Rios M', 'Morris AD', 'Lind L', 'Palmer LJ', 'Hu FB', 'Franks PW', 'Ebrahim S', 'Marmot M', 'Kao WH', 'Pankow JS', 'Sampson MJ', 'Kuusisto J', 'Laakso M', 'Hansen T', 'Pedersen O', 'Pramstaller PP', 'Wichmann HE', 'Illig T', 'Rudan I', 'Wright AF', 'Stumvoll M', 'Campbell H', 'Wilson JF', 'Bergman RN', 'Buchanan TA', 'Collins FS', 'Mohlke KL', 'Tuomilehto J', 'Valle TT', 'Altshuler D', 'Rotter JI', 'Siscovick DS', 'Penninx BW', 'Boomsma DI', 'Deloukas P', 'Spector TD', 'Frayling TM', 'Ferrucci L', 'Kong A', 'Thorsteinsdottir U', 'Stefansson K', 'van Duijn CM', 'Aulchenko YS', 'Cao A', 'Scuteri A', 'Schlessinger D', 'Uda M', 'Ruokonen A', 'Jarvelin MR', 'Waterworth DM', 'Vollenweider P', 'Peltonen L', 'Mooser V', 'Abecasis GR', 'Wareham NJ', 'Sladek R', 'Froguel P', 'Watanabe RM', 'Meigs JB', 'Groop L', 'Boehnke M', 'McCarthy MI', 'Florez JC', 'Barroso I']","['Adolescent', 'Adult', 'Alleles', 'Blood Glucose/*genetics/*metabolism', 'Child', 'DNA Copy Number Variations/genetics', 'Databases, Genetic', 'Delta-5 Fatty Acid Desaturase', 'Diabetes Mellitus, Type 2/*genetics', 'Fasting/*blood', 'Gene Expression Regulation', 'Genetic Loci/*genetics', '*Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Homeostasis/*genetics', 'Humans', 'Meta-Analysis as Topic', 'Polymorphism, Single Nucleotide/genetics', 'Quantitative Trait Loci/genetics', 'Quantitative Trait, Heritable', 'Reproducibility of Results']",https://pubmed.ncbi.nlm.nih.gov/20081858/
442,ADRA2A,36628952,Pharmacogenetics of anxiety and depression in Alzheimer's disease.,"['Cacabelos R', 'Carril JC', 'Corzo L', 'Pego R', 'Cacabelos N', 'Alcaraz M', 'Muniz A', 'Martinez-Iglesias O', 'Naidoo V']","['Humans', '*Alzheimer Disease/drug therapy/genetics', 'Pharmacogenetics/methods', 'Depression/drug therapy/genetics', 'Cytochrome P-450 CYP2D6/genetics', 'Anxiety/drug therapy/genetics', 'Liver-Specific Organic Anion Transporter 1', '*Arylamine N-Acetyltransferase', 'Carrier Proteins', 'Nerve Tissue Proteins', 'Serotonin Plasma Membrane Transport Proteins']",https://pubmed.ncbi.nlm.nih.gov/36628952/
443,ADRA2A,38664626,Germline genetic regulation of the colorectal tumor immune microenvironment.,"['Schmit SL', 'Tsai YY', 'Bonner JD', 'Sanz-Pamplona R', 'Joshi AD', 'Ugai T', 'Lindsey SS', 'Melas M', 'McDonnell KJ', 'Idos GE', 'Walker CP', 'Qu C', 'Kast WM', 'Da Silva DM', 'Glickman JN', 'Chan AT', 'Giannakis M', 'Nowak JA', 'Rennert HS', 'Robins HS', 'Ogino S', 'Greenson JK', 'Moreno V', 'Rennert G', 'Gruber SB']","['Humans', '*Colorectal Neoplasms/genetics/immunology', '*Tumor Microenvironment/genetics/immunology', '*Polymorphism, Single Nucleotide', 'Male', 'Female', '*Genome-Wide Association Study', 'Middle Aged', 'Quantitative Trait Loci', 'Aged', 'Lymphocytes, Tumor-Infiltrating/immunology', 'Germ-Line Mutation', 'RNA-Binding Proteins/genetics', 'Genotype', 'Germ Cells/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38664626/
444,ADRA2A,37828025,ADRA2A and IRX1 are putative risk genes for Raynaud's phenomenon.,"['Hartmann S', 'Yasmeen S', 'Jacobs BM', 'Denaxas S', 'Pirmohamed M', 'Gamazon ER', 'Caulfield MJ', 'Hemingway H', 'Pietzner M', 'Langenberg C']","['Humans', '*Genome-Wide Association Study', 'Ulcer', '*Raynaud Disease/genetics/complications', 'Pain/complications', 'Transcription Factors/genetics', 'Homeodomain Proteins', 'Receptors, Adrenergic, alpha-2/genetics']",https://pubmed.ncbi.nlm.nih.gov/37828025/
445,ADRA2A,39142284,Genetic and functional analysis of Raynaud's syndrome implicates loci in vasculature and immunity.,"['Tervi A', 'Ramste M', 'Abner E', 'Cheng P', 'Lane JM', 'Maher M', 'Valliere J', 'Lammi V', 'Strausz S', 'Riikonen J', 'Nguyen T', 'Martyn GE', 'Sheth MU', 'Xia F', 'Docampo ML', 'Gu W', 'Esko T', 'Saxena R', 'Pirinen M', 'Palotie A', 'Ripatti S', 'Sinnott-Armstrong N', 'Daly M', 'Engreitz JM', 'Rabinovitch M', 'Heckman CA', 'Quertermous T', 'Jones SE', 'Ollila HM']","['*Raynaud Disease/genetics/immunology', 'Humans', '*Quantitative Trait Loci', '*Genome-Wide Association Study', 'Nitric Oxide Synthase Type III/genetics/metabolism', 'Female', 'Male']",https://pubmed.ncbi.nlm.nih.gov/39142284/
446,ADRA2A,34930904,Differential brain ADRA2A and ADRA2C gene expression and epigenetic regulation in schizophrenia. Effect of antipsychotic drug treatment.,"['Brocos-Mosquera I', 'Miranda-Azpiazu P', 'Muguruza C', 'Corzo-Monje V', 'Morentin B', 'Meana JJ', 'Callado LF', 'Rivero G']","['Animals', '*Antipsychotic Agents/pharmacology', 'Brain', 'Dorsolateral Prefrontal Cortex', 'Epigenesis, Genetic', 'Gene Expression', 'Gene Expression Regulation', 'Rats', '*Schizophrenia/drug therapy/genetics']",https://pubmed.ncbi.nlm.nih.gov/34930904/
447,ADRA2A,26458049,Genes associated with diabetes: potential for novel therapeutic targets?,"['Hara K', 'Kadowaki T', 'Odawara M']","['Animals', 'Diabetes Mellitus, Type 2/*drug therapy/genetics/physiopathology', 'Drug Design', 'Genome-Wide Association Study', 'Humans', 'Hypoglycemic Agents/*pharmacology', '*Molecular Targeted Therapy', 'Precision Medicine']",https://pubmed.ncbi.nlm.nih.gov/26458049/
448,ADRA2A,34309518,beta2-adrenoreceptors control human skin microvascular reactivity.,"['Morell A', 'Milara J', 'Gozalbes L', 'Gavalda A', 'Tarrason G', 'Godessart N', 'Marin S', 'Navalon P', 'Cortijo J']","['Adolescent', 'Adult', 'Arteries/*metabolism', 'Arterioles/*metabolism', 'Foreskin/*blood supply/*metabolism', 'Humans', 'Male', 'RNA, Messenger/metabolism', 'Receptors, Adrenergic, alpha-2/genetics/*metabolism', 'Receptors, Adrenergic, beta-2/genetics/*metabolism', 'Vasodilation', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/34309518/
449,ADRA2A,34948773,The Predictive Role of ADRA2A rs1800544 and HTR3B rs3758987 Polymorphisms in Motion Sickness Susceptibility.,"['Zhang X', 'Sun Y']","['Genetic Predisposition to Disease', 'Genotype', 'Heterozygote', 'Humans', '*Motion Sickness/genetics', '*Polymorphism, Single Nucleotide', 'Receptors, Adrenergic, alpha-2', '*Receptors, Serotonin, 5-HT3']",https://pubmed.ncbi.nlm.nih.gov/34948773/
450,ADRA2A,33171772,Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease.,"['Silvestro S', 'Schepici G', 'Bramanti P', 'Mazzon E']","['Animals', 'Anti-Anxiety Agents/therapeutic use', 'Anticonvulsants/therapeutic use', 'Antidepressive Agents/therapeutic use', 'Antipsychotic Agents/therapeutic use', 'Cannabidiol/*therapeutic use', 'Cannabinoids/therapeutic use', 'Female', 'Humans', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Nervous System Diseases/*drug therapy', 'Neuroprotective Agents/therapeutic use', 'PPAR gamma/metabolism', 'Rats', 'Rats, Wistar', 'Receptor, Serotonin, 5-HT1A/metabolism', 'Receptors, Adrenergic, alpha-2/metabolism', 'Receptors, Cannabinoid/metabolism', 'TRPV Cation Channels/metabolism']",https://pubmed.ncbi.nlm.nih.gov/33171772/
451,ADRA2A,20145962,Molecular genetics of attention-deficit/hyperactivity disorder: an overview.,"['Banaschewski T', 'Becker K', 'Scherag S', 'Franke B', 'Coghill D']","['Adolescent', 'Cell Division/genetics', 'Child', 'Genetic Markers/*genetics', 'Genetic Predisposition to Disease/*genetics', 'Genome-Wide Association Study', 'Humans', 'Malformations of Cortical Development, Group II/genetics', 'Neurotransmitter Agents/genetics', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/20145962/
452,ADRA2A,38091635,Dexmedetomidine post-treatment exacerbates metabolic disturbances in septic cardiomyopathy via alpha(2A)-adrenoceptor.,"['Xu Y', 'Zhang X', 'Tang X', 'Zhang C', 'Cahoon JG', 'Wang Y', 'Li H', 'Lv X', 'Wang Y', 'Wang Z', 'Wang H', 'Yang D']","['Humans', 'Mice', 'Animals', '*Dexmedetomidine/pharmacology/therapeutic use', '*Cardiomyopathies/drug therapy', '*Heart Diseases/drug therapy', '*Sepsis/drug therapy', 'Glucose/therapeutic use', 'Fatty Acids']",https://pubmed.ncbi.nlm.nih.gov/38091635/
453,ADRA2A,38635307,Yeast Platforms for Production and Screening of Bioactive Derivatives of Rauwolscine.,"['Bradley SA', 'Hansson FG', 'Lehka BJ', 'Rago D', 'Pinho P', 'Peng H', 'Adhikari KB', 'Haidar AK', 'Hansen LG', 'Volkova D', 'Holtz M', 'Muyo Abad S', 'Ma X', 'Koudounas K', 'Besseau S', 'Gautron N', 'Melin C', 'Marc J', 'Birer Williams C', 'Courdavault V', 'Jensen ED', 'Keasling JD', 'Zhang J', 'Jensen MK']","['*Saccharomyces cerevisiae/metabolism', 'Humans', 'Biosynthetic Pathways', 'Yohimbine/metabolism/pharmacology', 'Secologanin Tryptamine Alkaloids/metabolism', 'Indole Alkaloids/metabolism', 'Drug Discovery/methods']",https://pubmed.ncbi.nlm.nih.gov/38635307/
454,ADRA2A,39136088,ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer.,"['Moreno P', 'Ohara Y', 'Craig AJ', 'Liu H', 'Yang S', 'Dorsey TH', 'Zhang L', 'Panigrahi G', 'Cawley H', 'Azizian A', 'Gaedcke J', 'Ghadimi M', 'Hanna N', 'Hussain SP']","['Humans', '*Pancreatic Neoplasms/pathology/genetics/metabolism', '*Carcinoma, Pancreatic Ductal/pathology/genetics/metabolism', '*Receptors, Adrenergic, alpha-2/genetics/metabolism', '*Gene Expression Regulation, Neoplastic', 'Cell Line, Tumor', 'Male', 'Female', 'Carnitine/analogs & derivatives/metabolism', 'Transcriptome', 'Neoplasm Invasiveness', 'Metabolome', 'Lymphatic Metastasis', 'Middle Aged', 'Prognosis']",https://pubmed.ncbi.nlm.nih.gov/39136088/
455,ADRA2A,37140276,Identification of key genes and molecular pathways in type 2 diabetes mellitus and polycystic ovary syndrome via bioinformatics analyses.,"['Zhang J', 'Zhang FJ', 'Zhang L', 'Xian DX', 'Wang SA', 'Peng M', 'Liu Y']","['Female', 'Humans', '*Polycystic Ovary Syndrome/metabolism', '*Diabetes Mellitus, Type 2/genetics/complications', 'Gene Regulatory Networks', '*MicroRNAs/genetics', 'Computational Biology', 'Kruppel-Like Transcription Factors/genetics', 'Intracellular Signaling Peptides and Proteins/genetics']",https://pubmed.ncbi.nlm.nih.gov/37140276/
456,ADRA2A,38411331,Dexmedetomidine activates the PKA/CREB pathway and inhibits proinflammatory factor expression through beta2 adrenergic receptors.,"['Zhang B', 'Shen J']","['Humans', '*NF-kappa B/metabolism', '*Dexmedetomidine/pharmacology', 'Lipopolysaccharides/toxicity', 'Molecular Docking Simulation', 'Cytokines/metabolism', 'RNA, Small Interfering', 'Receptors, Adrenergic']",https://pubmed.ncbi.nlm.nih.gov/38411331/
457,AR,21633166,Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.,"['Lehmann BD', 'Bauer JA', 'Chen X', 'Sanders ME', 'Chakravarthy AB', 'Shyr Y', 'Pietenpol JA']","['Animals', 'Antineoplastic Agents/therapeutic use', 'Breast Neoplasms/classification/*drug therapy/*genetics/physiopathology', 'Cell Line, Tumor', 'Female', 'Gene Expression Profiling', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Kaplan-Meier Estimate', 'Mice', 'Mice, Nude', 'Phenotype', 'Signal Transduction/physiology', 'Transplantation, Heterologous']",https://pubmed.ncbi.nlm.nih.gov/21633166/
458,AR,33277366,KIF15-Mediated Stabilization of AR and AR-V7 Contributes to Enzalutamide Resistance in Prostate Cancer.,"['Gao L', 'Zhang W', 'Zhang J', 'Liu J', 'Sun F', 'Liu H', 'Hu J', 'Wang X', 'Wang X', 'Su P', 'Chen S', 'Qu S', 'Shi B', 'Xiong X', 'Chen W', 'Dong X', 'Han B']","['Animals', 'Benzamides/*therapeutic use', 'Cell Line, Tumor', 'Disease Progression', 'Drug Resistance, Neoplasm/*genetics', 'HEK293 Cells', 'Humans', 'Kinesins/genetics/*physiology', 'Male', 'Mice', 'Mice, Nude', 'Nitriles/*therapeutic use', 'PC-3 Cells', 'Phenylthiohydantoin/*therapeutic use', 'Prostatic Neoplasms/*drug therapy/genetics/metabolism/pathology', 'Protein Domains/genetics', 'Protein Isoforms/genetics/metabolism', 'Protein Stability', 'Proteolysis', 'Receptors, Androgen/chemistry/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/33277366/
459,AR,38788686,What comes next in glycobiology.,"['Seeberger PH', 'Ge Y', 'Szymanski CM', 'Kolarich D', 'Thaysen-Andersen M', 'Packer NH', 'Fadda E', 'Davis B', 'Nishihara S', 'Rabinovich GA', 'Kwong PD', 'Strasser R']","['Animals', 'Humans', '*Glycomics', '*Polysaccharides/metabolism/chemistry']",https://pubmed.ncbi.nlm.nih.gov/38788686/
460,AR,8500595,The link proteins.,"['Neame PJ', 'Barry FP']","['Aggrecans', 'Amino Acid Sequence', 'Animals', 'Chondroitin Sulfate Proteoglycans/chemistry', 'Exons', '*Extracellular Matrix Proteins', 'Gene Expression', 'Genes', 'Humans', 'Hyaluronic Acid/metabolism', 'Lectins, C-Type', 'Molecular Sequence Data', 'Peptide Fragments', 'Protein Structure, Tertiary', 'Proteins/classification/*physiology', 'Proteoglycans/chemistry/classification/*physiology', 'RNA, Messenger/genetics', 'Sequence Alignment', 'Structure-Activity Relationship', 'Terminology as Topic', 'Versicans']",https://pubmed.ncbi.nlm.nih.gov/8500595/
461,AR,28258575,Aquaporins in Fetal Development.,"['Martinez N', 'Damiano AE']","['Amniotic Fluid/chemistry/metabolism', 'Animals', 'Aquaporin 1/genetics/*metabolism', 'Blastocyst/*metabolism', 'Chorionic Gonadotropin/genetics/metabolism', 'Extraembryonic Membranes/growth & development/*metabolism', 'Female', 'Fetal Development/*physiology', 'Fetus', 'Gene Expression Regulation', 'Humans', 'Insulin/genetics/metabolism', 'Placenta/*metabolism', 'Pregnancy', 'Protein Isoforms/genetics/metabolism', 'Water/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/28258575/
462,AR,15368346,Offbeat mice.,['Gaussin V'],"['Animals', 'Arrhythmias, Cardiac/metabolism/*pathology', 'Connexins/genetics/*physiology', 'Death, Sudden, Cardiac/etiology', 'Gene Expression Regulation, Developmental', 'Heart Block/*metabolism', '*Heart Conduction System/embryology/physiology', 'Humans', 'Models, Animal', 'Myocytes, Cardiac/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/15368346/
463,AR,33246268,Intermediate filaments as effectors of differentiation.,"['Redmond CJ', 'Coulombe PA']","['Animals', '*Cell Differentiation', 'Humans', 'Intermediate Filament Proteins/chemistry/genetics/metabolism', 'Intermediate Filaments/chemistry/*physiology', '*Mechanotransduction, Cellular']",https://pubmed.ncbi.nlm.nih.gov/33246268/
464,AR,31601481,Na(+)/H(+) exchanger and cardiac hypertrophy.,"['Yeves AM', 'Ennis IL']","['Animals', 'Cardiomegaly/*physiopathology', 'Cardiomegaly, Exercise-Induced/physiology', 'Cardiovascular Diseases/physiopathology', 'Heart Failure/*physiopathology', 'Humans', 'Myocardial Reperfusion Injury/physiopathology', 'Risk Factors', 'Sodium-Hydrogen Exchanger 1/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/31601481/
465,AR,25472532,Prolactin (PRL) in adipose tissue: regulation and functions.,"['Ben-Jonathan N', 'Hugo E']","['Adipogenesis/physiology', 'Adipose Tissue/*metabolism', 'Animals', 'Gene Expression Regulation', 'Growth Hormone/physiology', 'Humans', 'Lipid Metabolism', 'Placental Lactogen/physiology', 'Prolactin/*genetics/*physiology', 'Receptors, Prolactin/chemistry/physiology']",https://pubmed.ncbi.nlm.nih.gov/25472532/
466,AR,24492849,Epigenetic regulation of epidermal differentiation.,"['Perdigoto CN', 'Valdes VJ', 'Bardot ES', 'Ezhkova E']","['Acetylation', 'Animals', 'Cell Differentiation/*genetics', 'Chromatin/chemistry/genetics/metabolism', 'Chromatin Assembly and Disassembly/genetics', 'DNA Methylation/genetics', 'Epigenesis, Genetic/*physiology', 'Histone Acetyltransferases/genetics', 'Histone-Lysine N-Methyltransferase/genetics', 'Histones/metabolism', 'Humans', 'Jumonji Domain-Containing Histone Demethylases/genetics', 'Skin/*cytology', 'Skin Diseases, Genetic/genetics', 'Stem Cells/physiology']",https://pubmed.ncbi.nlm.nih.gov/24492849/
467,AR,16200644,Cortical complexity in cetacean brains.,"['Hof PR', 'Chanis R', 'Marino L']","['Animals', 'Cerebral Cortex/*anatomy & histology/physiology', 'Cetacea/*anatomy & histology/physiology']",https://pubmed.ncbi.nlm.nih.gov/16200644/
468,AR,14699636,Adult stem cells.,"['Young HE', 'Black AC Jr']","['Adult', 'Animals', 'Cell Lineage/physiology', 'Humans', 'Mesenchymal Stem Cells/*cytology/*physiology', 'Pluripotent Stem Cells/*cytology/*physiology']",https://pubmed.ncbi.nlm.nih.gov/14699636/
469,AR,15200142,Extracellular Ca2+-sensing receptors--an overview.,"['Chang W', 'Shoback D']","['Amino Acid Sequence', 'Animals', 'Calcium/*metabolism', 'Cations/chemistry/metabolism', 'Extracellular Space/metabolism', 'Homeostasis/genetics/physiology', 'Humans', 'Ligands', 'Mice', 'Mice, Knockout', 'Models, Biological', 'Molecular Sequence Data', 'Phylogeny', 'Receptors, Calcium-Sensing/agonists/genetics/*physiology', 'Receptors, G-Protein-Coupled/genetics/physiology', 'Sequence Homology, Amino Acid']",https://pubmed.ncbi.nlm.nih.gov/15200142/
470,AR,31077689,Consideration of breast cancer subtype in targeting the androgen receptor.,"['Venema CM', 'Bense RD', 'Steenbruggen TG', 'Nienhuis HH', 'Qiu SQ', 'van Kruchten M', 'Brown M', 'Tamimi RM', 'Hospers GAP', 'Schroder CP', 'Fehrmann RSN', 'de Vries EGE']","['Animals', 'Breast Neoplasms/drug therapy/genetics/*metabolism', 'Female', 'Humans', 'Male', 'Molecular Targeted Therapy', 'Prostatic Neoplasms/drug therapy/metabolism', 'RNA, Messenger/metabolism', 'Receptors, Androgen/genetics/*metabolism/physiology']",https://pubmed.ncbi.nlm.nih.gov/31077689/
471,AR,15382016,Hepatic nervous system development.,"['Delalande JM', 'Milla PJ', 'Burns AJ']","['Animals', 'Autonomic Nervous System/*embryology/physiology', 'Axons/metabolism/*physiology', 'Gallbladder/innervation', '*Gene Expression Regulation, Developmental', 'Humans', 'Liver/*embryology/*innervation', 'Mice/*anatomy & histology']",https://pubmed.ncbi.nlm.nih.gov/15382016/
472,AR,30821186,Androgen receptor: A promising therapeutic target in breast cancer.,"['Vasiliou SK', 'Diamandis EP']","['Androgens/metabolism/therapeutic use', 'Antineoplastic Agents/metabolism/therapeutic use', 'Breast/chemistry/metabolism', '*Breast Neoplasms/chemistry/drug therapy/metabolism', 'Drug Discovery', 'Female', 'Humans', '*Receptors, Androgen', 'Receptors, Estrogen/genetics', 'Receptors, Progesterone/genetics', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/30821186/
473,AR,14699631,Smooth muscle stem cells.,"['Hirschi KK', 'Majesky MW']","['Animals', 'Humans', 'Multipotent Stem Cells/*cytology/physiology', 'Muscle, Smooth, Vascular/*cytology/physiology', 'Neural Crest/cytology']",https://pubmed.ncbi.nlm.nih.gov/14699631/
474,AR,21270519,MicroRNAs in skeletal myogenesis.,"['Ge Y', 'Chen J']","['Animals', 'Cell Differentiation/genetics', 'Gene Expression Regulation, Developmental', 'Humans', 'Mice', 'MicroRNAs/genetics/metabolism/*physiology', 'Muscle Development/*genetics', 'Muscle, Skeletal/*growth & development']",https://pubmed.ncbi.nlm.nih.gov/21270519/
475,AR,22406839,The hinge region in androgen receptor control.,"['Clinckemalie L', 'Vanderschueren D', 'Boonen S', 'Claessens F']","['Acetylation', 'Animals', 'DNA-Binding Proteins/*physiology', 'Humans', 'Methylation', 'Peptides/*metabolism', 'Phosphorylation', '*Protein Interaction Domains and Motifs', 'Receptors, Androgen/*chemistry/genetics/*metabolism', 'Response Elements', 'Transcriptional Activation', 'Ubiquitination']",https://pubmed.ncbi.nlm.nih.gov/22406839/
476,AR,27269735,Engineered matrices for skeletal muscle satellite cell engraftment and function.,"['Han WM', 'Jang YC', 'Garcia AJ']","['Alginates/administration & dosage/chemistry', 'Animals', 'Biocompatible Materials/administration & dosage/*chemistry', 'Cell- and Tissue-Based Therapy/*methods', 'Cells, Immobilized/*cytology/metabolism/transplantation', 'Collagen/administration & dosage/chemistry', 'Gene Expression', 'Glucuronic Acid/administration & dosage/chemistry', 'Hexuronic Acids/administration & dosage/chemistry', 'Humans', 'Hydrogels/administration & dosage/chemistry', 'Muscle, Skeletal/metabolism/pathology', 'Muscular Diseases/metabolism/pathology/therapy', 'MyoD Protein/genetics/metabolism', 'PAX7 Transcription Factor/genetics/metabolism', 'Regeneration/physiology', 'Satellite Cells, Skeletal Muscle/*cytology/metabolism/transplantation', 'Tissue Engineering/*methods', 'Tissue Scaffolds']",https://pubmed.ncbi.nlm.nih.gov/27269735/
477,HTR1B,15950004,Molecular genetics of attention-deficit/hyperactivity disorder.,"['Faraone SV', 'Perlis RH', 'Doyle AE', 'Smoller JW', 'Goralnick JJ', 'Holmgren MA', 'Sklar P']","['Adoption/psychology', 'Animals', 'Attention Deficit Disorder with Hyperactivity/*etiology/*genetics', 'Dopamine Plasma Membrane Transport Proteins', 'Dopamine beta-Hydroxylase/genetics', 'Family', 'Humans', 'Membrane Glycoproteins/genetics', 'Membrane Proteins/genetics', 'Membrane Transport Proteins/genetics', 'Molecular Biology', 'Nerve Tissue Proteins/genetics', 'Receptor, Serotonin, 5-HT1B/genetics', 'Receptors, Dopamine D1/genetics', 'Receptors, Dopamine D2/genetics', 'Receptors, Dopamine D4', 'Receptors, Dopamine D5', 'Serotonin Plasma Membrane Transport Proteins', 'Synaptosomal-Associated Protein 25', '*Twin Studies as Topic']",https://pubmed.ncbi.nlm.nih.gov/15950004/
478,HTR1B,35853382,HTR1B genotype and psychopathy: Main effect and interaction with paternal maltreatment.,"['Palumbo S', 'Mariotti V', 'Vellucci S', 'Antonelli K', 'Anderson N', 'Harenski C', 'Pietrini P', 'Kiehl KA', 'Pellegrini S']","['Adolescent', 'Adult', 'Alleles', '*Antisocial Personality Disorder/genetics/psychology', '*Emotions', 'Genotype', 'Humans', 'Male', 'Parenting', 'Receptor, Serotonin, 5-HT1B/genetics']",https://pubmed.ncbi.nlm.nih.gov/35853382/
479,HTR1B,37453823,Effects of serotonin transporter and receptor polymorphisms on depression.,"['Lopez-Echeverri YP', 'Cardona-Londono KJ', 'Garcia-Aguirre JF', 'Orrego-Cardozo M']","['Humans', '*Serotonin Plasma Membrane Transport Proteins/genetics', '*Depression/genetics', 'Polymorphism, Genetic', 'Serotonin/genetics', 'Alleles']",https://pubmed.ncbi.nlm.nih.gov/37453823/
480,HTR1B,31112844,Antidepressant pharmacogenetics in children and young adults: A systematic review.,"['Maruf AA', 'Greenslade A', 'Arnold PD', 'Bousman C']","['Adolescent', 'Amitriptyline', 'Antidepressive Agents/*adverse effects', 'Child', 'Citalopram/adverse effects', 'Cytochrome P-450 CYP2C19/genetics', 'Cytochrome P-450 CYP2D6/genetics', 'Female', 'Fluoxetine/adverse effects', 'Fluvoxamine', 'Humans', 'Male', 'Mental Disorders/*drug therapy/*genetics', 'Nortriptyline', 'Paroxetine/adverse effects', '*Pharmacogenetics', 'Serotonin Plasma Membrane Transport Proteins/genetics', 'Sertraline', 'Tryptophan Hydroxylase/genetics', 'Venlafaxine Hydrochloride', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/31112844/
481,HTR1B,19831843,The genetics of attention-deficit/hyperactivity disorder.,"['Coghill D', 'Banaschewski T']","['Attention Deficit Disorder with Hyperactivity/etiology/*genetics', 'Dopamine Plasma Membrane Transport Proteins/genetics', 'Environment', '*Genetic Predisposition to Disease', '*Genetics', 'Genome-Wide Association Study/methods', 'Humans', 'Polymorphism, Single Nucleotide', 'Receptors, Dopamine/genetics/metabolism', 'Receptors, Serotonin, 5-HT1/genetics', 'Synaptosomal-Associated Protein 25/genetics']",https://pubmed.ncbi.nlm.nih.gov/19831843/
482,HTR1B,25600112,The molecular genetic architecture of attention deficit hyperactivity disorder.,"['Hawi Z', 'Cummins TD', 'Tong J', 'Johnson B', 'Lau R', 'Samarrai W', 'Bellgrove MA']","['Attention Deficit Disorder with Hyperactivity/*genetics', 'DNA Copy Number Variations/*genetics', 'Genetic Predisposition to Disease/*genetics', 'Genome-Wide Association Study', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/25600112/
483,HTR1B,19809810,HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory.,"['Drago A', 'Alboni S', 'Brunello N', 'De Ronchi D', 'Serretti A']","['Genetic Variation', 'Humans', '*Memory', 'Mental Disorders/*genetics', '*Motivation', '*Polymorphism, Single Nucleotide', 'Receptor, Serotonin, 5-HT1B/*genetics', 'Risk']",https://pubmed.ncbi.nlm.nih.gov/19809810/
484,HTR1B,34773671,The impact of HTR1A and HTR1B methylation combined with stress/genotype on early antidepressant efficacy.,"['Xu Z', 'Chen Z', 'Shen T', 'Chen L', 'Tan T', 'Gao C', 'Chen B', 'Yuan Y', 'Zhang Z']","['*Antidepressive Agents/pharmacology', 'Case-Control Studies', 'DNA Methylation', '*Depressive Disorder, Major/drug therapy/genetics', 'Genotype', 'Humans', 'Polymorphism, Single Nucleotide/genetics', 'Receptor, Serotonin, 5-HT1A/genetics', 'Receptor, Serotonin, 5-HT1B/genetics', 'Stress, Psychological/genetics', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/34773671/
485,HTR1B,38760456,"Association of OPRM1 rs1799971, HTR1B rs6296 and COMT rs4680 polymorphisms with clinical phenotype among women with fibromyalgia.","['Fernandez-de-Las-Penas C', 'Ambite-Quesada S', 'Fernandez-Mendez LM', 'Jimenez-Antona C', 'Gomez-Calero C', 'Pocinho R', 'Valera-Calero JA', 'Cigaran-Mendez M', 'Arendt-Nielsen L']","['Adult', 'Female', 'Humans', '*Catechol O-Methyltransferase/genetics', '*Fibromyalgia/genetics', 'Genetic Predisposition to Disease', 'Genotype', 'Phenotype', '*Polymorphism, Single Nucleotide', 'Quality of Life', '*Receptor, Serotonin, 5-HT1B/genetics', '*Receptors, Opioid, mu/genetics']",https://pubmed.ncbi.nlm.nih.gov/38760456/
486,HTR1B,36980888,Single-Nucleotide Polymorphisms as Biomarkers of Antipsychotic-Induced Akathisia: Systematic Review.,"['Nasyrova RF', 'Vaiman EE', 'Repkina VV', 'Khasanova AK', 'Asadullin AR', 'Shipulin GA', 'Altynbekov KS', 'Al-Zamil M', 'Petrova MM', 'Shnayder NA']","['Humans', '*Antipsychotic Agents/adverse effects', 'Psychomotor Agitation/drug therapy', 'Polymorphism, Single Nucleotide', '*Schizophrenia/drug therapy/genetics', 'Biomarkers']",https://pubmed.ncbi.nlm.nih.gov/36980888/
487,HTR1B,28576508,A review of the role of serotonin system genes in obsessive-compulsive disorder.,"['Sinopoli VM', 'Burton CL', 'Kronenberg S', 'Arnold PD']","['Animals', 'Genetic Predisposition to Disease', 'Humans', 'Obsessive-Compulsive Disorder/diagnostic imaging/drug therapy/*genetics/*metabolism', 'Serotonin/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/28576508/
488,HTR1B,23742855,Serotonergic genes and suicide: a systematic review.,"['Antypa N', 'Serretti A', 'Rujescu D']","['Alleles', 'Animals', 'Brain/enzymology/metabolism', 'Case-Control Studies', 'Endophenotypes', '*Evidence-Based Medicine', 'Gene-Environment Interaction', 'Genetic Association Studies', 'Genetic Predisposition to Disease', '*Genetic Variation', 'Humans', 'Monoamine Oxidase/*genetics/metabolism', 'Nerve Tissue Proteins/genetics/metabolism', 'Neurons/enzymology/metabolism', 'Protein Isoforms/genetics/metabolism', 'Receptors, Serotonin/*genetics/metabolism', 'Self-Injurious Behavior/etiology/*genetics/metabolism/prevention & control', 'Serotonin Plasma Membrane Transport Proteins/*genetics/metabolism', 'Tryptophan Hydroxylase/*genetics/metabolism', 'Suicide Prevention']",https://pubmed.ncbi.nlm.nih.gov/23742855/
489,HTR1B,20392224,Lrp5 and bone formation : A serotonin-dependent pathway.,"['Yadav VK', 'Ducy P']","['Animals', 'Gene Silencing', 'Humans', 'Intestinal Mucosa/metabolism', 'LDL-Receptor Related Proteins/genetics/metabolism/*physiology', 'Low Density Lipoprotein Receptor-Related Protein-5', 'Mice', 'Mice, Knockout', 'Models, Biological', 'Osteogenesis/*genetics', 'Serotonin/metabolism/physiology', 'Signal Transduction/genetics']",https://pubmed.ncbi.nlm.nih.gov/20392224/
490,HTR1B,36272053,Role of Sonic Hedgehog Signaling Activation in the Prevention of Neurological Abnormalities Associated with Obsessive-Compulsive Disorder.,"['Gupta R', 'Mehan S', 'Chhabra S', 'Giri A', 'Sherawat K']","['Humans', '*Hedgehog Proteins/genetics/metabolism/pharmacology', 'Signal Transduction', 'Neurons', '*Obsessive-Compulsive Disorder/drug therapy/metabolism', 'Cell Differentiation', 'Serotonin Plasma Membrane Transport Proteins']",https://pubmed.ncbi.nlm.nih.gov/36272053/
491,HTR1B,20159345,Molecular genetics of attention deficit hyperactivity disorder.,"['Faraone SV', 'Mick E']","['Attention Deficit Disorder with Hyperactivity/*diagnosis/epidemiology/*genetics', 'Gene Expression/genetics', 'Genome-Wide Association Study', 'Humans', 'Molecular Biology/*methods', 'Prevalence', 'Twins/genetics']",https://pubmed.ncbi.nlm.nih.gov/20159345/
492,HTR1B,28493018,Emerging role of miRNA in attention deficit hyperactivity disorder: a systematic review.,"['Srivastav S', 'Walitza S', 'Grunblatt E']","['Animals', 'Attention Deficit Disorder with Hyperactivity/*genetics/*metabolism', 'Biomarkers/metabolism', 'Gene Expression Regulation/genetics', 'Humans', 'MicroRNAs/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/28493018/
493,HTR1B,29680514,"Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia.","['Mohammadi A', 'Rashidi E', 'Amooeian VG']","['Biomarkers/blood/cerebrospinal fluid/metabolism', 'Brain/*metabolism', 'Brain-Derived Neurotrophic Factor/blood/cerebrospinal fluid/metabolism', 'Catechol O-Methyltransferase/blood/cerebrospinal fluid/metabolism', 'Cell Adhesion Molecules, Neuronal/blood/cerebrospinal fluid/metabolism', 'Dysbindin/blood/cerebrospinal fluid/metabolism', 'Extracellular Matrix Proteins/blood/cerebrospinal fluid/metabolism', 'Humans', 'Nerve Growth Factors/blood/cerebrospinal fluid/metabolism', 'Nerve Tissue Proteins/blood/cerebrospinal fluid/metabolism', 'Neurotrophin 3', 'Prefrontal Cortex/metabolism', 'Reelin Protein', 'Schizophrenia/*blood/*cerebrospinal fluid/diagnostic imaging', 'Serine Endopeptidases/blood/cerebrospinal fluid/metabolism', 'Vascular Endothelial Growth Factor A']",https://pubmed.ncbi.nlm.nih.gov/29680514/
494,HTR1B,16961425,Candidate gene studies of attention-deficit/hyperactivity disorder.,"['Faraone SV', 'Khan SA']","['Attention Deficit Disorder with Hyperactivity/*genetics', 'Case-Control Studies', 'Dopamine Plasma Membrane Transport Proteins/genetics', 'Dopamine beta-Hydroxylase/genetics', 'Genetic Markers', 'Genetic Variation', 'Humans', 'Meta-Analysis as Topic', 'Pharmacogenetics', 'Receptors, Dopamine D4/genetics', 'Receptors, Dopamine D5/genetics', 'Receptors, Serotonin/genetics', 'Serotonin Plasma Membrane Transport Proteins/genetics', 'Synaptosomal-Associated Protein 25/genetics']",https://pubmed.ncbi.nlm.nih.gov/16961425/
495,HTR1B,11008065,Oligomerization of dopamine and serotonin receptors.,"['Lee SP', 'Xie Z', 'Varghese G', 'Nguyen T', ""O'Dowd BF"", 'George SR']","['Animals', 'Dimerization', 'Dopamine Agonists/pharmacology', 'GTP-Binding Proteins/*metabolism', 'Humans', 'Receptor, Serotonin, 5-HT1B', 'Receptor, Serotonin, 5-HT1D', 'Receptors, Dopamine/chemistry/drug effects/*metabolism', 'Receptors, Dopamine D2/chemistry/genetics/metabolism', 'Receptors, Dopamine D3', 'Receptors, Serotonin/chemistry/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/11008065/
496,HTR1B,35046097,Subversion of Serotonin Receptor Signaling in Osteoblasts by Kynurenine Drives Acute Myeloid Leukemia.,"['Galan-Diez M', 'Borot F', 'Ali AM', 'Zhao J', 'Gil-Iturbe E', 'Shan X', 'Luo N', 'Liu Y', 'Huang XP', 'Bisikirska B', 'Labella R', 'Kurland I', 'Roth BL', 'Quick M', 'Mukherjee S', 'Rabadan R', 'Carroll M', 'Raza A', 'Kousteni S']","['Animals', 'Humans', '*Kynurenine/metabolism/therapeutic use', '*Leukemia, Myeloid, Acute/drug therapy', 'Mice', 'Osteoblasts/metabolism', 'Signal Transduction', 'Tumor Microenvironment']",https://pubmed.ncbi.nlm.nih.gov/35046097/
497,CACNA1C,36598608,CACNA1C-Related Channelopathies.,"['Herold KG', 'Hussey JW', 'Dick IE']","['Syndactyly', 'Calcium Channels, L-Type/genetics', 'Humans', 'Autistic Disorder', '*Long QT Syndrome/genetics', 'Mutation', '*Channelopathies/genetics']",https://pubmed.ncbi.nlm.nih.gov/36598608/
498,CACNA1C,33985586,Calcium channelopathies and intellectual disability: a systematic review.,"['Kessi M', 'Chen B', 'Peng J', 'Yan F', 'Yang L', 'Yin F']","['Calcium', 'Calcium Channels, L-Type', '*Channelopathies/genetics', 'Child', 'DNA Copy Number Variations', 'Developmental Disabilities', 'Humans', '*Intellectual Disability/genetics']",https://pubmed.ncbi.nlm.nih.gov/33985586/
499,CACNA1C,38658687,Antisense oligonucleotide therapeutic approach for Timothy syndrome.,"['Chen X', 'Birey F', 'Li MY', 'Revah O', 'Levy R', 'Thete MV', 'Reis N', 'Kaganovsky K', 'Onesto M', 'Sakai N', 'Hudacova Z', 'Hao J', 'Meng X', 'Nishino S', 'Huguenard J', 'Pasca SP']","['Animals', 'Female', 'Humans', 'Male', 'Mice', 'Alternative Splicing/drug effects/genetics', '*Autistic Disorder/drug therapy/genetics', 'Calcium/metabolism', 'Calcium Channels, L-Type/metabolism/genetics', 'Cell Movement/drug effects', 'Dendrites/metabolism', 'Exons/genetics', '*Long QT Syndrome/drug therapy/genetics', 'Neurons/metabolism/drug effects', '*Oligonucleotides, Antisense/pharmacology/therapeutic use', 'Organoids/drug effects/metabolism', 'Prosencephalon/metabolism/cytology', '*Syndactyly/drug therapy/genetics', 'Interneurons/cytology/drug effects']",https://pubmed.ncbi.nlm.nih.gov/38658687/
500,CACNA1C,34163037,Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations.,"['Rodan LH', 'Spillmann RC', 'Kurata HT', 'Lamothe SM', 'Maghera J', 'Jamra RA', 'Alkelai A', 'Antonarakis SE', 'Atallah I', 'Bar-Yosef O', 'Bilan F', 'Bjorgo K', 'Blanc X', 'Van Bogaert P', 'Bolkier Y', 'Burrage LC', 'Christ BU', 'Granadillo JL', 'Dickson P', 'Donald KA', 'Dubourg C', 'Eliyahu A', 'Emrick L', 'Engleman K', 'Gonfiantini MV', 'Good JM', 'Kalser J', 'Kloeckner C', 'Lachmeijer G', 'Macchiaiolo M', 'Nicita F', 'Odent S', ""O'Heir E"", 'Ortiz-Gonzalez X', 'Pacio-Miguez M', 'Palomares-Bralo M', 'Pena L', 'Platzer K', 'Quinodoz M', 'Ranza E', 'Rosenfeld JA', 'Roulet-Perez E', 'Santani A', 'Santos-Simarro F', 'Pode-Shakked B', 'Skraban C', 'Slaugh R', 'Superti-Furga A', 'Thiffault I', 'van Jaabrsveld RH', 'Vincent M', 'Wang HG', 'Zacher P', 'Rush E', 'Pitt GS', 'Au PYB', 'Shashi V']","['*Autistic Disorder/genetics', '*Calcium Channels, L-Type/genetics', 'Humans', '*Long QT Syndrome', 'Phenotype', '*Syndactyly']",https://pubmed.ncbi.nlm.nih.gov/34163037/
501,CACNA1C,31983240,"An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome.","['Adler A', 'Novelli V', 'Amin AS', 'Abiusi E', 'Care M', 'Nannenberg EA', 'Feilotter H', 'Amenta S', 'Mazza D', 'Bikker H', 'Sturm AC', 'Garcia J', 'Ackerman MJ', 'Hershberger RE', 'Perez MV', 'Zareba W', 'Ware JS', 'Wilde AAM', 'Gollob MH']","['Atrioventricular Block/*genetics', 'Evidence-Based Medicine', 'Female', 'Genetic Diseases, Inborn/*genetics', '*Genetic Predisposition to Disease', 'Humans', 'Long QT Syndrome/*genetics', 'Male', 'Multicenter Studies as Topic']",https://pubmed.ncbi.nlm.nih.gov/31983240/
502,CACNA1C,32629111,Timothy syndrome iPSC modeling.,"['Bekdash R', 'Klein AD', 'Yazawa M']","['Animals', 'Autistic Disorder/genetics/*metabolism', 'Calcium Channels, L-Type/genetics/*metabolism', 'Humans', 'Induced Pluripotent Stem Cells/*metabolism', 'Long QT Syndrome/genetics/*metabolism', 'Mutation/genetics', 'Phenotype', 'Syndactyly/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/32629111/
503,CACNA1C,37972591,Structural basis for human Ca(v)1.2 inhibition by multiple drugs and the neurotoxin calciseptine.,"['Gao S', 'Yao X', 'Chen J', 'Huang G', 'Fan X', 'Xue L', 'Li Z', 'Wu T', 'Zheng Y', 'Huang J', 'Jin X', 'Wang Y', 'Wang Z', 'Yu Y', 'Liu L', 'Pan X', 'Song C', 'Yan N']","['Humans', '*Calcium Channels, L-Type/chemistry/metabolism', '*Elapid Venoms', 'Neurotoxins', 'Protein Domains', 'Cryoelectron Microscopy']",https://pubmed.ncbi.nlm.nih.gov/37972591/
504,CACNA1C,39186314,Visceral Adipocyte-Derived Extracellular Vesicle miR-27a-5p Elicits Glucose Intolerance by Inhibiting Pancreatic beta-Cell Insulin Secretion.,"['Zhang Y', 'Qian B', 'Yang Y', 'Niu F', 'Lin C', 'Yuan H', 'Wang J', 'Wu T', 'Shao Y', 'Shao S', 'Liu A', 'Wu J', 'Sun P', 'Chang X', 'Bi Y', 'Tang W', 'Zhu Y', 'Chen F', 'Su D', 'Han X']","['Animals', '*MicroRNAs/metabolism/genetics', '*Insulin-Secreting Cells/metabolism', '*Glucose Intolerance/metabolism/genetics', 'Mice', '*Extracellular Vesicles/metabolism', '*Insulin Secretion/physiology', '*Intra-Abdominal Fat/metabolism', 'Insulin/metabolism', 'Male', 'Obesity/metabolism/genetics', 'Mice, Inbred C57BL', 'Mice, Obese']",https://pubmed.ncbi.nlm.nih.gov/39186314/
505,CACNA1C,31953567,Genetic Intersections of Language and Neuropsychiatric Conditions.,"['Koomar T', 'Michaelson JJ']","['*Communication', 'Humans', '*Language', 'Mental Disorders/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31953567/
506,CACNA1C,38776078,Key Roles of CACNA1C/Cav1.2 and CALB1/Calbindin in Prefrontal Neurons Altered in Cognitive Disorders.,"['Datta D', 'Yang S', 'Joyce MKP', 'Woo E', 'McCarroll SA', 'Gonzalez-Burgos G', 'Perone I', 'Uchendu S', 'Ling E', 'Goldman M', 'Berretta S', 'Murray J', 'Morozov Y', 'Arellano J', 'Duque A', 'Rakic P', ""O'Dell R"", 'van Dyck CH', 'Lewis DA', 'Wang M', 'Krienen FM', 'Arnsten AFT']","['*Calcium Channels, L-Type/genetics/metabolism', 'Humans', 'Animals', '*Pyramidal Cells/physiology/metabolism', 'Male', 'Cognition Disorders/physiopathology/genetics', 'Prefrontal Cortex/metabolism/physiopathology', 'Dorsolateral Prefrontal Cortex/physiology', 'Macaca mulatta', 'Memory, Short-Term/physiology', 'Female', 'Transcriptome']",https://pubmed.ncbi.nlm.nih.gov/38776078/
507,CACNA1C,33106102,Voltage-Gated Calcium Channels in Nonexcitable Tissues.,"['Pitt GS', 'Matsui M', 'Cao C']","['Action Potentials/physiology', 'Animals', 'Autistic Disorder/metabolism', 'Calcium/*metabolism', 'Calcium Channels/*metabolism', 'Calcium Signaling/*physiology', 'Humans', 'Long QT Syndrome/metabolism', 'Signal Transduction/physiology', 'Syndactyly/metabolism']",https://pubmed.ncbi.nlm.nih.gov/33106102/
508,CACNA1C,26210959,Molecular neurobiological clues to the pathogenesis of bipolar disorder.,['Harrison PJ'],"['Animals', 'Ankyrins/*genetics/metabolism', 'Bipolar Disorder/*genetics/metabolism', 'Calcium Channels, L-Type/*genetics/metabolism', 'Calcium Signaling/*genetics', 'Cell Adhesion/genetics', 'Cell Differentiation/genetics', 'Circadian Rhythm/genetics', 'Disease Models, Animal', 'Gene Expression Regulation', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Humans', 'Phenotype', 'Transcriptome/genetics']",https://pubmed.ncbi.nlm.nih.gov/26210959/
509,CACNA1C,29697308,Emerging therapeutic targets in the short QT syndrome.,"['Hancox JC', 'Whittaker DG', 'Du C', 'Stuart AG', 'Zhang H']","['Animals', 'Anti-Arrhythmia Agents/*pharmacology', 'Arrhythmias, Cardiac/*drug therapy/genetics/physiopathology', 'Drug Design', 'Genotype', 'Humans', '*Molecular Targeted Therapy', 'Potassium Channel Blockers/pharmacology', 'Potassium Channels/drug effects/metabolism', 'Sodium Channel Blockers/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/29697308/
510,CACNA1C,30384889,Genetic Basis of Severe Childhood-Onset Cardiomyopathies.,"['Vasilescu C', 'Ojala TH', 'Brilhante V', 'Ojanen S', 'Hinterding HM', 'Palin E', 'Alastalo TP', 'Koskenvuo J', 'Hiippala A', 'Jokinen E', 'Jahnukainen T', 'Lohi J', 'Pihkala J', 'Tyni TA', 'Carroll CJ', 'Suomalainen A']","['Adolescent', 'Age of Onset', 'Cardiomyopathies/diagnosis/*epidemiology/*genetics', 'Child', 'Child, Preschool', 'Cohort Studies', 'Female', 'Finland/epidemiology', 'Genetic Testing/*methods', 'Humans', 'Infant', 'Infant, Newborn', 'Male', 'Pedigree', 'Protein Structure, Secondary', '*Severity of Illness Index']",https://pubmed.ncbi.nlm.nih.gov/30384889/
511,CACNA1C,37816059,Pairwise biosynthesis of ion channels stabilizes excitability and mitigates arrhythmias.,"['Jameson MB', 'Rios-Perez EB', 'Liu F', 'Eichel CA', 'Robertson GA']","['Humans', '*KCNQ1 Potassium Channel/genetics', 'ERG1 Potassium Channel/genetics', 'In Situ Hybridization, Fluorescence', '*Arrhythmias, Cardiac/genetics/metabolism', 'RNA, Messenger/genetics/metabolism', 'RNA, Small Interfering', 'NAV1.5 Voltage-Gated Sodium Channel/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37816059/
512,CACNA1C,39420001,Multiple beta cell-independent mechanisms drive hypoglycemia in Timothy syndrome.,"['Matsui M', 'Lynch LE', 'Distefano I', 'Galante A', 'Gade AR', 'Wang HG', 'Gomez-Banoy N', 'Towers P', 'Sinden DS', 'Wei EQ', 'Barnett AS', 'Johnson K', 'Lima R', 'Rubio-Navarro A', 'Li AK', 'Marx SO', 'McGraw TE', 'Thornton PS', 'Timothy KW', 'Lo JC', 'Pitt GS']","['Animals', '*Calcium Channels, L-Type/metabolism/genetics', '*Hypoglycemia/metabolism/genetics', '*Insulin-Secreting Cells/metabolism', '*Syndactyly/genetics/metabolism/pathology', '*Long QT Syndrome/genetics/metabolism', '*Autistic Disorder/genetics/metabolism', 'Mice', 'Humans', '*Disease Models, Animal', 'Male', 'Glucagon/metabolism', 'Female', 'Mutation', 'Glucose/metabolism', 'Calcium/metabolism', 'Gene Knock-In Techniques', 'Hyperinsulinism/genetics/metabolism', 'Insulin/metabolism', 'Homeostasis', 'Hypothalamus/metabolism', 'Blood Glucose/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39420001/
513,CACNA1C,36154842,CACNA1C (Ca(V)1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders: Advances from functional genomics and pharmacoepidemiology.,"['Harrison PJ', 'Husain SM', 'Lee H', 'Los Angeles A', 'Colbourne L', 'Mould A', 'Hall NAL', 'Haerty W', 'Tunbridge EM']","['Animals', 'Calcium', 'Calcium Channel Blockers/pharmacology/therapeutic use', '*Calcium Channels, L-Type/genetics', 'Genomics', 'Humans', '*Mental Disorders/drug therapy/genetics', 'Mice', 'Pharmacoepidemiology', 'Protein Isoforms']",https://pubmed.ncbi.nlm.nih.gov/36154842/
514,CACNA1C,28497380,From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms.,"['Kabir ZD', 'Martinez-Rivera A', 'Rajadhyaksha AM']","['Animals', 'Calcium Channels, L-Type/*genetics/*metabolism', 'Genetic Variation', 'Humans', 'Mental Disorders/*genetics/*metabolism', 'Social Behavior']",https://pubmed.ncbi.nlm.nih.gov/28497380/
515,CACNA1C,34072954,Mechanisms and Regulation of Cardiac Ca(V)1.2 Trafficking.,"['Westhoff M', 'Dixon RE']","['Animals', 'Calcium/*metabolism', 'Calcium Channels, L-Type/*physiology', '*Calcium Signaling', 'Cell Line', 'Heart Ventricles/cytology/*metabolism', 'Humans', '*Myocardial Contraction', 'Myocytes, Cardiac/cytology/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/34072954/
516,CACNA1C,30264490,Observational fear behavior in rodents as a model for empathy.,"['Kim A', 'Keum S', 'Shin HS']","['Animals', 'Brain/*metabolism/physiology', '*Empathy', '*Fear', 'Gene-Environment Interaction', 'Rodentia', 'Social Environment']",https://pubmed.ncbi.nlm.nih.gov/30264490/
517,CACNA1D,35139664,Genetics of Primary Aldosteronism.,['Scholl UI'],"['*Adenoma/metabolism', '*Adrenal Cortex Neoplasms/metabolism', '*Adrenocortical Adenoma/metabolism', 'Aldosterone/metabolism', 'G Protein-Coupled Inwardly-Rectifying Potassium Channels/genetics/metabolism', 'Humans', '*Hyperaldosteronism/metabolism', 'Mutation', 'Sodium-Potassium-Exchanging ATPase/genetics/metabolism', 'Steroid 11-beta-Hydroxylase/genetics']",https://pubmed.ncbi.nlm.nih.gov/35139664/
518,CACNA1D,33985586,Calcium channelopathies and intellectual disability: a systematic review.,"['Kessi M', 'Chen B', 'Peng J', 'Yan F', 'Yang L', 'Yin F']","['Calcium', 'Calcium Channels, L-Type', '*Channelopathies/genetics', 'Child', 'DNA Copy Number Variations', 'Developmental Disabilities', 'Humans', '*Intellectual Disability/genetics']",https://pubmed.ncbi.nlm.nih.gov/33985586/
519,CACNA1D,32401642,Autophagy in the physiological endometrium and cancer.,"['Devis-Jauregui L', 'Eritja N', 'Davis ML', 'Matias-Guiu X', 'Llobet-Navas D']","['Apoptosis Regulatory Proteins/metabolism', 'Autophagy/*physiology', 'Endometrium/*metabolism', 'Female', 'Humans', 'Hyperplasia/metabolism', 'Neoplasms/*metabolism', 'Placenta/*metabolism', 'Pregnancy']",https://pubmed.ncbi.nlm.nih.gov/32401642/
520,CACNA1D,34547194,"Congenital hyperinsulinism: recent updates on molecular mechanisms, diagnosis and management.","['Giri D', 'Hawton K', 'Senniappan S']","['Child', 'Child, Preschool', '*Congenital Hyperinsulinism/diagnosis/genetics/therapy', 'Humans', '*Hyperinsulinism/metabolism', 'Infant, Newborn', 'Insulin/therapeutic use', 'Insulin Secretion', '*Insulin-Secreting Cells/metabolism', 'Mutation']",https://pubmed.ncbi.nlm.nih.gov/34547194/
521,CACNA1D,38884729,Human Genetics of Ventricular Septal Defect.,"['Perrot A', 'Rickert-Sperling S']","['Humans', 'Chromosome Aberrations', 'DNA Copy Number Variations/genetics', 'Genetic Predisposition to Disease/genetics', '*Heart Septal Defects, Ventricular/genetics', 'Mutation', 'Transcription Factors/genetics']",https://pubmed.ncbi.nlm.nih.gov/38884729/
522,CACNA1D,32185602,Hyperinsulinemic hypoglycemia in children and adolescents: Recent advances in understanding of pathophysiology and management.,"['Gupsilonemes M', 'Rahman SA', 'Kapoor RR', 'Flanagan S', 'Houghton JAL', 'Misra S', 'Oliver N', 'Dattani MT', 'Shah P']","['Adolescent', 'Child', 'Child, Preschool', 'Congenital Hyperinsulinism/*diagnosis/genetics/metabolism/*therapy', 'Humans', 'Infant']",https://pubmed.ncbi.nlm.nih.gov/32185602/
523,CACNA1D,31969708,Mechanism of adrenergic Ca(V)1.2 stimulation revealed by proximity proteomics.,"['Liu G', 'Papa A', 'Katchman AN', 'Zakharov SI', 'Roybal D', 'Hennessey JA', 'Kushner J', 'Yang L', 'Chen BX', 'Kushnir A', 'Dangas K', 'Gygi SP', 'Pitt GS', 'Colecraft HM', 'Ben-Johny M', 'Kalocsay M', 'Marx SO']","['Animals', 'Calcium Channels, L-Type/chemistry/*metabolism', 'Calcium Channels, N-Type/metabolism', 'Cellular Microenvironment', 'Cyclic AMP/metabolism', 'Cyclic AMP-Dependent Protein Kinases/metabolism', 'Female', 'HEK293 Cells', 'Heterotrimeric GTP-Binding Proteins/metabolism', 'Humans', 'Male', 'Mice', 'Monomeric GTP-Binding Proteins/metabolism', 'Myocardium/metabolism', 'Phosphorylation', 'Protein Domains', 'Protein Subunits/chemistry/metabolism', '*Proteomics', 'Receptors, Adrenergic, beta/*metabolism', 'Signal Transduction', 'ras Proteins/chemistry/metabolism']",https://pubmed.ncbi.nlm.nih.gov/31969708/
524,CACNA1D,36484990,Whole-Exome Sequencing Among Chinese Patients With Hereditary Diffuse Gastric Cancer.,"['Liu ZX', 'Zhang XL', 'Zhao Q', 'Chen Y', 'Sheng H', 'He CY', 'Sun YT', 'Lai MY', 'Wu MQ', 'Zuo ZX', 'Wang W', 'Zhou ZW', 'Wang FH', 'Li YH', 'Xu RH', 'Qiu MZ']","['Adult', 'Female', 'Humans', 'Male', '*Adenocarcinoma', 'Adenosine Triphosphatases/genetics', 'Cohort Studies', 'East Asian People', 'Exome Sequencing', 'Genetic Predisposition to Disease/genetics', '*MicroRNAs', 'Pedigree', 'Retrospective Studies', 'RNA-Binding Proteins/genetics', '*Stomach Neoplasms/epidemiology/genetics', 'Transcription Factors/genetics', 'Ubiquitin-Protein Ligases/genetics', 'Young Adult', 'Middle Aged', 'Aged']",https://pubmed.ncbi.nlm.nih.gov/36484990/
525,CACNA1D,27485459,Genetics of primary hyperaldosteronism.,"['Dutta RK', 'Soderkvist P', 'Gimm O']","['Adrenal Cortex Neoplasms/*genetics/metabolism', 'Adrenal Glands/*pathology', 'Adrenocortical Adenoma/*genetics/metabolism', 'Aldosterone/genetics/metabolism', 'Animals', 'Genetic Predisposition to Disease', 'Humans', 'Hyperaldosteronism/*genetics', 'Hyperplasia/genetics']",https://pubmed.ncbi.nlm.nih.gov/27485459/
526,CACNA1D,36592224,CACNA1D-Related Channelopathies: From Hypertension to Autism.,['Ortner NJ'],"['Humans', '*Autistic Disorder/genetics', '*Channelopathies/genetics', '*Hypertension/genetics', 'Calcium Channels, L-Type/genetics']",https://pubmed.ncbi.nlm.nih.gov/36592224/
527,CACNA1D,31695023,Genetic causes of primary aldosteronism.,"['Seidel E', 'Schewe J', 'Scholl UI']","['Adrenal Gland Diseases/etiology/genetics', 'Animals', 'Calcium Channels, L-Type/genetics/metabolism', 'G Protein-Coupled Inwardly-Rectifying Potassium Channels/genetics/metabolism', 'Humans', 'Hyperaldosteronism/*etiology/*genetics', 'Hypertension/etiology/genetics', 'Sodium-Potassium-Exchanging ATPase/genetics/metabolism', 'beta Catenin/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/31695023/
528,CACNA1D,32583268,De novo CACNA1D Ca(2+) channelopathies: clinical phenotypes and molecular mechanism.,"['Ortner NJ', 'Kaserer T', 'Copeland JN', 'Striessnig J']","['Animals', 'Calcium/*metabolism', 'Calcium Channels, L-Type/*genetics/*metabolism', 'Channelopathies/*genetics/*metabolism', 'Humans', 'Mutation/genetics', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/32583268/
529,CACNA1D,31207362,Genomics of benign adrenocortical tumors.,"['Jouinot A', 'Armignacco R', 'Assie G']","['Adrenal Cortex Neoplasms/*genetics', 'Genomics', 'Humans', 'Exome Sequencing']",https://pubmed.ncbi.nlm.nih.gov/31207362/
530,CACNA1D,35813615,Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome.,"['Santana LS', 'Guimaraes AG', 'Almeida MQ']","['*Adrenocortical Adenoma/complications/genetics/metabolism', 'Aldosterone/metabolism', 'Cytochrome P-450 CYP11B2/genetics/metabolism', 'G Protein-Coupled Inwardly-Rectifying Potassium Channels/genetics/metabolism', 'Humans', '*Hyperaldosteronism/complications/genetics', '*Hypertension/etiology', 'Sodium-Potassium-Exchanging ATPase/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35813615/
531,CACNA1D,26842699,Ca(v) 1.3 (CACNA1D) L-type Ca(2+) channel dysfunction in CNS disorders.,"['Pinggera A', 'Striessnig J']","['Animals', 'Calcium Channels, L-Type/*genetics/*metabolism', 'Central Nervous System Diseases/*genetics/*metabolism', 'Epilepsy/genetics/metabolism', 'Humans', 'Mutation, Missense/genetics', 'Neurons/metabolism']",https://pubmed.ncbi.nlm.nih.gov/26842699/
532,CACNA1D,35778363,Familial forms and molecular profile of primary hyperaldosteronism.,"['Araujo-Castro M', 'Martin Rojas-Marcos P', 'Parra Ramirez P']","['Humans', '*Aldosterone/metabolism', 'Steroid 11-beta-Hydroxylase/metabolism', 'Cytochrome P-450 CYP11B2/metabolism', 'Angiotensin II/metabolism', 'Sodium-Potassium-Exchanging ATPase/genetics/metabolism', '*Hyperaldosteronism/genetics', 'Adrenocorticotropic Hormone/metabolism', 'G Protein-Coupled Inwardly-Rectifying Potassium Channels/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35778363/
533,CACNA1D,39502033,Evolutionary Characteristics in Primary Aldosteronism Patients.,"['Gao Y', 'Wang Y', 'Zhou Y', 'Chang X', 'Zhang Y', 'Nie M', 'Tong A']","['*Hyperaldosteronism/genetics', 'Humans', '*Mutation', '*Aldosterone/metabolism', 'Male', 'Calcium Channels, L-Type/genetics', 'Hyperplasia/genetics', 'G Protein-Coupled Inwardly-Rectifying Potassium Channels/genetics', 'Female', 'Exome Sequencing/methods', 'Middle Aged', 'Phylogeny', 'Adrenal Cortex/metabolism/pathology']",https://pubmed.ncbi.nlm.nih.gov/39502033/
534,CACNA1D,32507359,Adrenocortical tumorigenesis: Lessons from genetics.,"['Kamilaris CDC', 'Hannah-Shmouni F', 'Stratakis CA']","['Adrenal Cortex/metabolism/*pathology', 'Adrenal Cortex Neoplasms/*genetics/metabolism/pathology', 'Aldosterone/analysis/blood', 'Carcinogenesis/*genetics', 'DNA Mutational Analysis', '*Genetic Techniques/trends', 'Humans', 'Hyperplasia/genetics', 'Mutation', 'Signal Transduction/genetics']",https://pubmed.ncbi.nlm.nih.gov/32507359/
535,CACNA1D,38174562,"Multifocal, Asymmetric Bilateral Primary Aldosteronism Cannot be Excluded by Strong Adrenal Vein Sampling Lateralization: An International Retrospective Cohort Study.","['Turcu AF', 'Tezuka Y', 'Lim JS', 'Salman Z', 'Sehgal K', 'Liu H', 'Larose S', 'Parksook WW', 'Williams TA', 'Cohen DL', 'Wachtel H', 'Zhang J', 'Dorwal P', 'Satoh F', 'Yang J', 'Lacroix A', 'Reincke M', 'Giordano TJ', 'Udager AM', 'Vaidya A', 'Rainey WE']","['Humans', '*Hyperaldosteronism/diagnosis/genetics/surgery', 'Retrospective Studies', 'Aldosterone', 'Cosyntropin', 'Cohort Studies', 'Cytochrome P-450 CYP11B2', 'Adrenal Glands/surgery/blood supply', 'Adrenalectomy']",https://pubmed.ncbi.nlm.nih.gov/38174562/
536,CACNA1D,30086874,Diagnosis and management of hyperinsulinaemic hypoglycaemia.,"['Galcheva S', 'Al-Khawaga S', 'Hussain K']","['Child', 'Congenital Hyperinsulinism/blood/*diagnosis/drug therapy/genetics', 'Hepatocyte Nuclear Factor 1-alpha/genetics', 'Humans', 'Infant, Newborn', 'Insulin Secretion/*genetics', 'Mutation', 'Octreotide/therapeutic use', 'Positron Emission Tomography Computed Tomography']",https://pubmed.ncbi.nlm.nih.gov/30086874/
537,CACNA1S,26238698,Malignant hyperthermia: a review.,"['Rosenberg H', 'Pollock N', 'Schiemann A', 'Bulger T', 'Stowell K']","['Genetic Counseling', 'Humans', '*Malignant Hyperthermia/diagnosis/epidemiology/genetics/physiopathology']",https://pubmed.ncbi.nlm.nih.gov/26238698/
538,CACNA1S,30236257,Genetic epidemiology of malignant hyperthermia in the UK.,"['Miller DM', 'Daly C', 'Aboelsaod EM', 'Gardner L', 'Hobson SJ', 'Riasat K', 'Shepherd S', 'Robinson RL', 'Bilmen JG', 'Gupta PK', 'Shaw MA', 'Hopkins PM']","['Adaptor Proteins, Signal Transducing/genetics', 'Calcium Channels/genetics', 'Calcium Channels, L-Type', 'Cohort Studies', 'Computer Simulation', 'Exome', 'Family', 'Genetic Predisposition to Disease', 'Genetic Testing', 'Genetic Variation', 'Humans', 'Malignant Hyperthermia/*epidemiology/*genetics', 'Ryanodine Receptor Calcium Release Channel/genetics', 'United Kingdom/epidemiology']",https://pubmed.ncbi.nlm.nih.gov/30236257/
539,CACNA1S,33985586,Calcium channelopathies and intellectual disability: a systematic review.,"['Kessi M', 'Chen B', 'Peng J', 'Yan F', 'Yang L', 'Yin F']","['Calcium', 'Calcium Channels, L-Type', '*Channelopathies/genetics', 'Child', 'DNA Copy Number Variations', 'Developmental Disabilities', 'Humans', '*Intellectual Disability/genetics']",https://pubmed.ncbi.nlm.nih.gov/33985586/
540,CACNA1S,39174253,Periodic paralysis.,['Cannon SC'],"['Humans', '*Paralyses, Familial Periodic/genetics/diagnosis/therapy', 'Mutation/genetics', 'Ion Channels/genetics', 'Muscle, Skeletal/physiopathology']",https://pubmed.ncbi.nlm.nih.gov/39174253/
541,CACNA1S,33060286,"Neurogenetic fetal akinesia and arthrogryposis: genetics, expanding genotype-phenotypes and functional genomics.","['Ravenscroft G', 'Clayton JS', 'Faiz F', 'Sivadorai P', 'Milnes D', 'Cincotta R', 'Moon P', 'Kamien B', 'Edwards M', 'Delatycki M', 'Lamont PJ', 'Chan SH', 'Colley A', 'Ma A', 'Collins F', 'Hennington L', 'Zhao T', 'McGillivray G', 'Ghedia S', 'Chao K', ""O'Donnell-Luria A"", 'Laing NG', 'Davis MR']","['Alleles', 'Amino Acid Sequence', 'Amino Acid Substitution', 'Arthrogryposis/*diagnosis/*genetics', 'Chromosome Mapping', 'Female', '*Genetic Association Studies', '*Genetic Predisposition to Disease', '*Genomics/methods', 'Genotype', 'High-Throughput Nucleotide Sequencing', 'Humans', 'Magnetic Resonance Imaging', 'Male', 'Mutation', 'Pedigree', '*Phenotype', 'Sequence Analysis, DNA', 'Exome Sequencing']",https://pubmed.ncbi.nlm.nih.gov/33060286/
542,CACNA1S,29478596,Periodic paralysis.,"['Fialho D', 'Griggs RC', 'Matthews E']","['Genetic Predisposition to Disease/*genetics', 'Humans', 'Ion Channels/*genetics', 'Mutation/*genetics', 'Paralyses, Familial Periodic/*genetics/physiopathology']",https://pubmed.ncbi.nlm.nih.gov/29478596/
543,CACNA1S,38884729,Human Genetics of Ventricular Septal Defect.,"['Perrot A', 'Rickert-Sperling S']","['Humans', 'Chromosome Aberrations', 'DNA Copy Number Variations/genetics', 'Genetic Predisposition to Disease/genetics', '*Heart Septal Defects, Ventricular/genetics', 'Mutation', 'Transcription Factors/genetics']",https://pubmed.ncbi.nlm.nih.gov/38884729/
544,CACNA1S,34602496,A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort.,"['Megarbane A', 'Bizzari S', 'Deepthi A', 'Sabbagh S', 'Mansour H', 'Chouery E', 'Hmaimess G', 'Jabbour R', 'Mehawej C', 'Alame S', 'Hani A', 'Hasbini D', 'Ghanem I', 'Koussa S', 'Al-Ali MT', 'Obeid M', 'Talea DB', 'Lefranc G', 'Levy N', 'Leturcq F', 'El Hayek S', 'Delague V', 'Urtizberea JA']","['Adolescent', 'Adult', 'Charcot-Marie-Tooth Disease/epidemiology/genetics', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Lebanon/epidemiology', 'Male', 'Middle Aged', 'Motor Neuron Disease/*epidemiology/*genetics', 'Muscular Atrophy, Spinal/epidemiology/genetics', 'Muscular Dystrophies/*epidemiology/*genetics', 'Muscular Dystrophies, Limb-Girdle/epidemiology/genetics', 'Muscular Dystrophy, Duchenne/epidemiology/genetics', 'Retrospective Studies', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/34602496/
545,CACNA1S,38081835,"Epilepsy-linked kinase CDKL5 phosphorylates voltage-gated calcium channel Cav2.3, altering inactivation kinetics and neuronal excitability.","['Sampedro-Castaneda M', 'Baltussen LL', 'Lopes AT', 'Qiu Y', 'Sirvio L', 'Mihaylov SR', 'Claxton S', 'Richardson JC', 'Lignani G', 'Ultanir SK']","['Animals', 'Child', 'Humans', 'Mice', 'Calcium Channels/genetics', '*Epilepsy/genetics', '*Epileptic Syndromes/genetics', 'Protein Serine-Threonine Kinases/genetics', '*Spasms, Infantile/genetics']",https://pubmed.ncbi.nlm.nih.gov/38081835/
546,CACNA1S,39163158,What is in the Myopathy Literature?,"['Isfort M', 'Lacomis D']","['Humans', '*Muscular Diseases/diagnosis/genetics/therapy']",https://pubmed.ncbi.nlm.nih.gov/39163158/
547,CACNA1S,38637617,Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder.,"['Nievergelt CM', 'Maihofer AX', 'Atkinson EG', 'Chen CY', 'Choi KW', 'Coleman JRI', 'Daskalakis NP', 'Duncan LE', 'Polimanti R', 'Aaronson C', 'Amstadter AB', 'Andersen SB', 'Andreassen OA', 'Arbisi PA', 'Ashley-Koch AE', 'Austin SB', 'Avdibegovic E', 'Babic D', 'Bacanu SA', 'Baker DG', 'Batzler A', 'Beckham JC', 'Belangero S', 'Benjet C', 'Bergner C', 'Bierer LM', 'Biernacka JM', 'Bierut LJ', 'Bisson JI', 'Boks MP', 'Bolger EA', 'Brandolino A', 'Breen G', 'Bressan RA', 'Bryant RA', 'Bustamante AC', 'Bybjerg-Grauholm J', 'Baekvad-Hansen M', 'Borglum AD', 'Borte S', 'Cahn L', 'Calabrese JR', 'Caldas-de-Almeida JM', 'Chatzinakos C', 'Cheema S', 'Clouston SAP', 'Colodro-Conde L', 'Coombes BJ', 'Cruz-Fuentes CS', 'Dale AM', 'Dalvie S', 'Davis LK', 'Deckert J', 'Delahanty DL', 'Dennis MF', 'Desarnaud F', 'DiPietro CP', 'Disner SG', 'Docherty AR', 'Domschke K', 'Dyb G', 'Kulenovic AD', 'Edenberg HJ', 'Evans A', 'Fabbri C', 'Fani N', 'Farrer LA', 'Feder A', 'Feeny NC', 'Flory JD', 'Forbes D', 'Franz CE', 'Galea S', 'Garrett ME', 'Gelaye B', 'Gelernter J', 'Geuze E', 'Gillespie CF', 'Goleva SB', 'Gordon SD', 'Goci A', 'Grasser LR', 'Guindalini C', 'Haas M', 'Hagenaars S', 'Hauser MA', 'Heath AC', 'Hemmings SMJ', 'Hesselbrock V', 'Hickie IB', 'Hogan K', 'Hougaard DM', 'Huang H', 'Huckins LM', 'Hveem K', 'Jakovljevic M', 'Javanbakht A', 'Jenkins GD', 'Johnson J', 'Jones I', 'Jovanovic T', 'Karstoft KI', 'Kaufman ML', 'Kennedy JL', 'Kessler RC', 'Khan A', 'Kimbrel NA', 'King AP', 'Koen N', 'Kotov R', 'Kranzler HR', 'Krebs K', 'Kremen WS', 'Kuan PF', 'Lawford BR', 'Lebois LAM', 'Lehto K', 'Levey DF', 'Lewis C', 'Liberzon I', 'Linnstaedt SD', 'Logue MW', 'Lori A', 'Lu Y', 'Luft BJ', 'Lupton MK', 'Luykx JJ', 'Makotkine I', 'Maples-Keller JL', 'Marchese S', 'Marmar C', 'Martin NG', 'Martinez-Levy GA', 'McAloney K', 'McFarlane A', 'McLaughlin KA', 'McLean SA', 'Medland SE', 'Mehta D', 'Meyers J', 'Michopoulos V', 'Mikita EA', 'Milani L', 'Milberg W', 'Miller MW', 'Morey RA', 'Morris CP', 'Mors O', 'Mortensen PB', 'Mufford MS', 'Nelson EC', 'Nordentoft M', 'Norman SB', 'Nugent NR', ""O'Donnell M"", 'Orcutt HK', 'Pan PM', 'Panizzon MS', 'Pathak GA', 'Peters ES', 'Peterson AL', 'Peverill M', 'Pietrzak RH', 'Polusny MA', 'Porjesz B', 'Powers A', 'Qin XJ', 'Ratanatharathorn A', 'Risbrough VB', 'Roberts AL', 'Rothbaum AO', 'Rothbaum BO', 'Roy-Byrne P', 'Ruggiero KJ', 'Rung A', 'Runz H', 'Rutten BPF', 'de Viteri SS', 'Salum GA', 'Sampson L', 'Sanchez SE', 'Santoro M', 'Seah C', 'Seedat S', 'Seng JS', 'Shabalin A', 'Sheerin CM', 'Silove D', 'Smith AK', 'Smoller JW', 'Sponheim SR', 'Stein DJ', 'Stensland S', 'Stevens JS', 'Sumner JA', 'Teicher MH', 'Thompson WK', 'Tiwari AK', 'Trapido E', 'Uddin M', 'Ursano RJ', 'Valdimarsdottir U', 'Van Hooff M', 'Vermetten E', 'Vinkers CH', 'Voisey J', 'Wang Y', 'Wang Z', 'Waszczuk M', 'Weber H', 'Wendt FR', 'Werge T', 'Williams MA', 'Williamson DE', 'Winsvold BS', 'Winternitz S', 'Wolf C', 'Wolf EJ', 'Xia Y', 'Xiong Y', 'Yehuda R', 'Young KA', 'Young RM', 'Zai CC', 'Zai GC', 'Zervas M', 'Zhao H', 'Zoellner LA', 'Zwart JA', 'deRoon-Cassini T', 'van Rooij SJH', 'van den Heuvel LL', 'Stein MB', 'Ressler KJ', 'Koenen KC']","['Humans', 'Genetic Loci', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Neurobiology', 'Polymorphism, Single Nucleotide', '*Stress Disorders, Post-Traumatic/genetics', 'White People/genetics', 'White', 'Black or African American', 'American Indian or Alaska Native']",https://pubmed.ncbi.nlm.nih.gov/38637617/
548,CACNA1S,37315111,Increased PDGFRB and NF-kappaB signaling caused by highly prevalent somatic mutations in intracranial aneurysms.,"['Shima Y', 'Sasagawa S', 'Ota N', 'Oyama R', 'Tanaka M', 'Kubota-Sakashita M', 'Kawakami H', 'Kobayashi M', 'Takubo N', 'Ozeki AN', 'Sun X', 'Kim YJ', 'Kamatani Y', 'Matsuda K', 'Maejima K', 'Fujita M', 'Noda K', 'Kamiyama H', 'Tanikawa R', 'Nagane M', 'Shibahara J', 'Tanaka T', 'Rikitake Y', 'Mataga N', 'Takahashi S', 'Kosaki K', 'Okano H', 'Furihata T', 'Nakaki R', 'Akimitsu N', 'Wada Y', 'Ohtsuka T', 'Kurihara H', 'Kamiguchi H', 'Okabe S', 'Nakafuku M', 'Kato T', 'Nakagawa H', 'Saito N', 'Nakatomi H']","['Animals', 'Mice', '*Intracranial Aneurysm/genetics', 'Mutation/genetics', '*NF-kappa B', 'Receptor, Platelet-Derived Growth Factor beta/genetics', 'Signal Transduction/genetics', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/37315111/
549,CACNA1S,28011884,Pharmacogenetics and pathophysiology of CACNA1S mutations in malignant hyperthermia.,"['Beam TA', 'Loudermilk EF', 'Kisor DF']","['Calcium Channels/*genetics', 'Calcium Channels, L-Type', 'Genetic Predisposition to Disease', 'Humans', 'Malignant Hyperthermia/*genetics/*physiopathology', 'Mutation/*genetics', 'Pharmacogenetics', 'Ryanodine Receptor Calcium Release Channel/genetics']",https://pubmed.ncbi.nlm.nih.gov/28011884/
550,CACNA1S,32222817,Skeletal muscle Ca(V)1.1 channelopathies.,['Flucher BE'],"['Adaptor Proteins, Signal Transducing/genetics/metabolism', 'Animals', 'Calcium Channels, L-Type/*genetics/*metabolism', 'Channelopathies/*genetics/*metabolism/pathology', 'Humans', 'Muscle, Skeletal/*metabolism/pathology', 'Mutation/genetics']",https://pubmed.ncbi.nlm.nih.gov/32222817/
551,CACNA1S,30343943,"De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias.","['Helbig KL', 'Lauerer RJ', 'Bahr JC', 'Souza IA', 'Myers CT', 'Uysal B', 'Schwarz N', 'Gandini MA', 'Huang S', 'Keren B', 'Mignot C', 'Afenjar A', 'Billette de Villemeur T', 'Heron D', 'Nava C', 'Valence S', 'Buratti J', 'Fagerberg CR', 'Soerensen KP', 'Kibaek M', 'Kamsteeg EJ', 'Koolen DA', 'Gunning B', 'Schelhaas HJ', 'Kruer MC', 'Fox J', 'Bakhtiari S', 'Jarrar R', 'Padilla-Lopez S', 'Lindstrom K', 'Jin SC', 'Zeng X', 'Bilguvar K', 'Papavasileiou A', 'Xing Q', 'Zhu C', 'Boysen K', 'Vairo F', 'Lanpher BC', 'Klee EW', 'Tillema JM', 'Payne ET', 'Cousin MA', 'Kruisselbrink TM', 'Wick MJ', 'Baker J', 'Haan E', 'Smith N', 'Sadeghpour A', 'Davis EE', 'Katsanis N', 'Corbett MA', 'MacLennan AH', 'Gecz J', 'Biskup S', 'Goldmann E', 'Rodan LH', 'Kichula E', 'Segal E', 'Jackson KE', 'Asamoah A', 'Dimmock D', 'McCarrier J', 'Botto LD', 'Filloux F', 'Tvrdik T', 'Cascino GD', 'Klingerman S', 'Neumann C', 'Wang R', 'Jacobsen JC', 'Nolan MA', 'Snell RG', 'Lehnert K', 'Sadleir LG', 'Anderlid BM', 'Kvarnung M', 'Guerrini R', 'Friez MJ', 'Lyons MJ', 'Leonhard J', 'Kringlen G', 'Casas K', 'El Achkar CM', 'Smith LA', 'Rotenberg A', 'Poduri A', 'Sanchis-Juan A', 'Carss KJ', 'Rankin J', 'Zeman A', 'Raymond FL', 'Blyth M', 'Kerr B', 'Ruiz K', 'Urquhart J', 'Hughes I', 'Banka S', 'Hedrich UBS', 'Scheffer IE', 'Helbig I', 'Zamponi GW', 'Lerche H', 'Mefford HC']","['Adolescent', 'Adult', 'Calcium Channels, R-Type/*genetics', 'Cation Transport Proteins/*genetics', 'Child', 'Child, Preschool', 'Contracture/*genetics', 'Dyskinesias/*genetics', 'Epilepsy/*genetics', 'Female', 'Genetic Variation/*genetics', 'Humans', 'Infant', 'Male', 'Megalencephaly/*genetics', 'Neurodevelopmental Disorders/genetics', 'Spasms, Infantile/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30343943/
552,CACNA1S,37930228,Two zebrafish cacna1s loss-of-function variants provide models of mild and severe CACNA1S-related myopathy.,"['Endo Y', 'Groom L', 'Wang SM', 'Pannia E', 'Griffiths NW', 'Van Gennip JLM', 'Ciruna B', 'Laporte J', 'Dirksen RT', 'Dowling JJ']","['Animals', 'Humans', '*Calcium Channels, L-Type/genetics/metabolism', 'Muscle, Skeletal/metabolism', '*Muscular Diseases/pathology', 'Mutation', '*Zebrafish/genetics/metabolism', '*Zebrafish Proteins/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37930228/
553,CACNA1S,29970176,Whole-exome sequencing identifies novel pathogenic mutations and putative phenotype-influencing variants in Polish limb-girdle muscular dystrophy patients.,"['Fichna JP', 'Macias A', 'Piechota M', 'Korostynski M', 'Potulska-Chromik A', 'Redowicz MJ', 'Zekanowski C']","['Adolescent', 'Adult', 'Aged', 'Calcium Channels/genetics', 'Calcium Channels, L-Type', 'Calpain/*genetics', 'Cardiac Myosins/*genetics', 'Child', 'Child, Preschool', 'Collagen Type VI/genetics', 'Dysferlin/*genetics', 'Exome/genetics', 'Female', 'Genetic Predisposition to Disease', 'Genetic Testing', 'Humans', 'Male', 'Middle Aged', 'Muscle Proteins/*genetics', 'Muscular Dystrophies, Limb-Girdle/*genetics/pathology', 'Mutation/genetics', 'Myosin Heavy Chains/*genetics', 'Phenotype', 'Poland', 'Sequence Analysis, DNA', 'Exome Sequencing/methods', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/29970176/
554,CACNA1S,25989378,"Malignant hyperthermia, a Scandinavian update.","['Broman M', 'Islander G', 'Muller CR']","['Anesthesia/*methods', 'Humans', 'Malignant Hyperthermia/*diagnosis/physiopathology/*therapy', 'Registries', 'Sweden']",https://pubmed.ncbi.nlm.nih.gov/25989378/
555,CACNA1S,18031562,Primary periodic paralyses.,['Finsterer J'],"['Calcium Channels/genetics', 'Calcium Channels, L-Type', 'Chromosomes, Human, Pair 17/genetics', 'Chromosomes, Human, X', 'Genetic Counseling', 'Glycogen Storage Disease Type IV/diagnosis/genetics/physiopathology', 'Humans', 'Hypokalemic Periodic Paralysis/diagnosis/genetics/physiopathology', 'Myotonic Disorders/diagnosis/genetics/physiopathology', 'Paralyses, Familial Periodic/diagnosis/*genetics/*physiopathology', 'Point Mutation/genetics']",https://pubmed.ncbi.nlm.nih.gov/18031562/
556,CACNA1S,38148504,Epidemiological and clinical features of malignant hyperthermia: A scoping review.,"['Cong Z', 'Wan T', 'Wang J', 'Feng L', 'Cao C', 'Li Z', 'Wang X', 'Han Y', 'Zhou Y', 'Gao Y', 'Zhang J', 'Qu Y', 'Guo X']","['Humans', '*Malignant Hyperthermia/diagnosis/epidemiology/genetics', 'Ryanodine Receptor Calcium Release Channel/genetics', 'Risk Factors', 'Risk Assessment']",https://pubmed.ncbi.nlm.nih.gov/38148504/
557,FLT3,31821677,FLT3 mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development.,"['Kiyoi H', 'Kawashima N', 'Ishikawa Y']","['Clinical Trials as Topic', 'Drug Resistance, Neoplasm', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy/genetics', 'Point Mutation', 'Protein Domains', 'Protein Kinase Inhibitors/pharmacology/*therapeutic use', 'Segmental Duplications, Genomic', 'Sequence Deletion', 'Signal Transduction/drug effects', 'fms-Like Tyrosine Kinase 3/chemistry/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31821677/
558,FLT3,31066629,FMS-like Tyrosine Kinase 3/FLT3: From Basic Science to Clinical Implications.,"['Kazi JU', 'Ronnstrand L']","['Animals', 'Antineoplastic Agents/pharmacology', 'Hematopoietic Stem Cells/physiology', 'Humans', 'Membrane Proteins/genetics/physiology', 'Signal Transduction', 'fms-Like Tyrosine Kinase 3/antagonists & inhibitors/genetics/*physiology']",https://pubmed.ncbi.nlm.nih.gov/31066629/
559,FLT3,37246158,Mutation spectrum of FLT3 and significance of non-canonical FLT3 mutations in haematological malignancy.,"['Ge SS', 'Qiu QC', 'Dai HP', 'Shen XD', 'Wu TM', 'Du JH', 'Wan CL', 'Shen HJ', 'Wu DP', 'Xue SL', 'Liu SB']","['Humans', 'fms-Like Tyrosine Kinase 3/genetics', 'Mutation', '*Leukemia, Myeloid, Acute/genetics', 'Point Mutation', '*Hematologic Neoplasms']",https://pubmed.ncbi.nlm.nih.gov/37246158/
560,FLT3,30692594,Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis.,"['Loberg MA', 'Bell RK', 'Goodwin LO', 'Eudy E', 'Miles LA', 'SanMiguel JM', 'Young K', 'Bergstrom DE', 'Levine RL', 'Schneider RK', 'Trowbridge JJ']","['Animals', 'Biomarkers, Tumor/genetics', 'Cell Transformation, Neoplastic/genetics/*pathology', '*Clonal Evolution', 'DNA (Cytosine-5-)-Methyltransferases/*genetics/physiology', 'DNA Methyltransferase 3A', '*Disease Models, Animal', 'Disease Progression', 'Female', 'Hematopoiesis', 'Leukemia, Myeloid, Acute/*etiology/metabolism/pathology', 'Mice', 'Mice, Inbred C57BL', 'Mice, Transgenic', '*Mutation', 'Myeloid Progenitor Cells/pathology/transplantation', 'Myeloproliferative Disorders/genetics/*pathology', 'Nuclear Proteins/*genetics/physiology', 'Nucleophosmin']",https://pubmed.ncbi.nlm.nih.gov/30692594/
561,FLT3,37794183,Rare variant associations with plasma protein levels in the UK Biobank.,"['Dhindsa RS', 'Burren OS', 'Sun BB', 'Prins BP', 'Matelska D', 'Wheeler E', 'Mitchell J', 'Oerton E', 'Hristova VA', 'Smith KR', 'Carss K', 'Wasilewski S', 'Harper AR', 'Paul DS', 'Fabre MA', 'Runz H', 'Viollet C', 'Challis B', 'Platt A', 'Vitsios D', 'Ashley EA', 'Whelan CD', 'Pangalos MN', 'Wang Q', 'Petrovski S']","['Humans', 'Alleles', '*Biological Specimen Banks', 'Biomarkers/blood', '*Blood Proteins/analysis/genetics', 'Databases, Factual', 'Exome/genetics', '*Genetic Association Studies', '*Genomics', 'Hematopoiesis', 'Mutation', 'Plasma/chemistry', '*Proteomics', 'United Kingdom']",https://pubmed.ncbi.nlm.nih.gov/37794183/
562,FLT3,31387917,"circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression.","['Sun YM', 'Wang WT', 'Zeng ZC', 'Chen TQ', 'Han C', 'Pan Q', 'Huang W', 'Fang K', 'Sun LY', 'Zhou YF', 'Luo XQ', 'Luo C', 'Du X', 'Chen YQ']","['Animals', 'Cell Cycle Proteins/*genetics', 'Cell Line, Tumor', 'Disease Progression', 'Heterogeneous-Nuclear Ribonucleoproteins/*metabolism', 'Heterografts', 'Humans', 'Leukemia, Myeloid, Acute/*genetics/pathology', 'Mice', 'Mice, Inbred NOD', 'Mice, SCID', 'Polypyrimidine Tract-Binding Protein/*metabolism', 'Protein Biosynthesis', 'RNA, Circular/*genetics', 'Tandem Repeat Sequences', 'Trans-Activators/*genetics', 'fms-Like Tyrosine Kinase 3/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31387917/
563,FLT3,30997851,FLT3 inhibitor quizartinib (AC220).,"['Naqvi K', 'Ravandi F']","['Animals', 'Antineoplastic Agents/chemistry/*pharmacology/therapeutic use', 'Antineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic use', 'Benzothiazoles/chemistry/*pharmacology/therapeutic use', 'Biomarkers, Tumor', 'Clinical Studies as Topic', 'Combined Modality Therapy', 'Drug Development', 'Drug Discovery', 'Drug Evaluation, Preclinical', 'Drug Resistance, Neoplasm', 'Humans', 'Leukemia, Myeloid, Acute/genetics/metabolism/therapy', 'Molecular Targeted Therapy', 'Phenylurea Compounds/chemistry/*pharmacology/therapeutic use', 'Protein Kinase Inhibitors/chemistry/*pharmacology/therapeutic use', 'Treatment Outcome', 'fms-Like Tyrosine Kinase 3/*antagonists & inhibitors']",https://pubmed.ncbi.nlm.nih.gov/30997851/
564,FLT3,17652007,Pediatric oncology.,"['Kurmasheva RT', 'Houghton PJ']","['Animals', 'Antineoplastic Agents/chemistry/therapeutic use', 'Child', 'Chromosomes, Human/genetics', 'Gene Expression Regulation', 'Humans', 'Intercellular Signaling Peptides and Proteins/metabolism', 'Neoplasms/drug therapy/genetics/metabolism/*pathology', 'Signal Transduction/drug effects']",https://pubmed.ncbi.nlm.nih.gov/17652007/
565,FLT3,39392050,In silico and in vitro study of FLT3 inhibitors and their application in acute myeloid leukemia.,"['Carranza-Aranda AS', 'Jave-Suarez LF', 'Flores-Hernandez FY', 'Huizar-Lopez MDR', 'Herrera-Rodriguez SE', 'Santerre A']","['Humans', 'Aniline Compounds/pharmacology', 'Antineoplastic Agents/pharmacology/chemistry', 'Apoptosis/drug effects', 'Benzothiazoles/pharmacology', 'Cell Line, Tumor', 'Cell Proliferation/drug effects', 'Cell Survival/drug effects', 'Computer Simulation', '*fms-Like Tyrosine Kinase 3/antagonists & inhibitors/genetics/metabolism/chemistry', '*Leukemia, Myeloid, Acute/drug therapy/metabolism/genetics', 'Molecular Docking Simulation', 'Mutation', 'Phenylurea Compounds/pharmacology', '*Protein Kinase Inhibitors/pharmacology', 'Pyrazines/pharmacology', 'Sorafenib/pharmacology', '*Staurosporine/analogs & derivatives/pharmacology', 'Triazines/pharmacology/chemistry']",https://pubmed.ncbi.nlm.nih.gov/39392050/
566,FLT3,38950330,Alkynyl nicotinamides show antileukemic activity in drug-resistant acute myeloid leukemia.,"['Ramdas B', 'Dayal N', 'Pandey R', 'Larocque E', 'Kanumuri R', 'Pasupuleti SK', 'Liu S', 'Kanellopoulou C', 'Chu EFY', 'Mohallem R', 'Virani S', 'Chopra G', 'Aryal UK', 'Lapidus R', 'Wan J', 'Emadi A', 'Haneline LS', 'Holtsberg FW', 'Aman MJ', 'Sintim HO', 'Kapur R']","['Humans', '*Leukemia, Myeloid, Acute/drug therapy/genetics/pathology/metabolism', '*fms-Like Tyrosine Kinase 3/genetics/antagonists & inhibitors/metabolism', '*Drug Resistance, Neoplasm/drug effects/genetics', 'Animals', 'Mice', '*Niacinamide/analogs & derivatives/pharmacology', 'Cell Line, Tumor', 'Xenograft Model Antitumor Assays', 'Female', 'Antineoplastic Agents/pharmacology/chemistry', 'Mutation', 'Mice, SCID', 'Mice, Inbred NOD']",https://pubmed.ncbi.nlm.nih.gov/38950330/
567,FLT3,28538663,The Cytokine Flt3-Ligand in Normal and Malignant Hematopoiesis.,"['Tsapogas P', 'Mooney CJ', 'Brown G', 'Rolink A']","['Animals', 'Drug Discovery', 'Gene Expression Regulation, Leukemic', '*Hematopoiesis', 'Hematopoietic Stem Cells/metabolism/pathology', 'Humans', 'Leukemia, Myeloid/drug therapy/genetics/*metabolism/pathology', 'Membrane Proteins/genetics/*metabolism', 'Mutation', 'fms-Like Tyrosine Kinase 3/antagonists & inhibitors/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/28538663/
568,FLT3,36550214,Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling.,"['Anderson NR', 'Sheth V', 'Li H', 'Harris MW', 'Qiu S', 'Crossman DK', 'Kumar H', 'Agarwal P', 'Nagasawa T', 'Paterson AJ', 'Welner RS', 'Bhatia R']","['Animals', 'Humans', 'Mice', 'Chemokine CXCL12/genetics/metabolism', '*fms-Like Tyrosine Kinase 3/metabolism', '*Leukemia, Myeloid, Acute/drug therapy/genetics', 'MAP Kinase Signaling System', 'Mutation', 'Signal Transduction', 'Stem Cells/metabolism', 'Tumor Microenvironment', 'p38 Mitogen-Activated Protein Kinases']",https://pubmed.ncbi.nlm.nih.gov/36550214/
569,FLT3,15583855,Normal and oncogenic FLT3.,"['Naoe T', 'Kiyoi H']","['Animals', 'COS Cells', 'Cell Differentiation', 'Cell Proliferation', 'Humans', 'Leukemia/metabolism', 'Leukemia, Myeloid, Acute/metabolism', 'Ligands', 'Mice', 'Mice, Transgenic', 'Models, Molecular', 'Mutation', 'Neoplasms/*metabolism', 'Phenotype', 'Point Mutation', 'Prognosis', 'Protein Structure, Tertiary', 'Protein-Tyrosine Kinases/antagonists & inhibitors', 'Proto-Oncogene Proteins/metabolism/*physiology', 'RNA, Messenger/metabolism', 'Receptor Protein-Tyrosine Kinases/metabolism/*physiology', 'Stem Cells', 'Transfection', 'fms-Like Tyrosine Kinase 3']",https://pubmed.ncbi.nlm.nih.gov/15583855/
570,FLT3,39666851,Overcoming Resistance to FLT3-ITD Therapeutics.,['McInnes C'],"['*fms-Like Tyrosine Kinase 3/antagonists & inhibitors/genetics/metabolism', 'Humans', '*Drug Resistance, Neoplasm/drug effects', '*Protein Kinase Inhibitors/pharmacology/therapeutic use/chemistry', '*Leukemia, Myeloid, Acute/drug therapy/genetics', 'Animals', 'Antineoplastic Agents/pharmacology/therapeutic use/chemistry', 'Tandem Repeat Sequences']",https://pubmed.ncbi.nlm.nih.gov/39666851/
571,FLT3,39300221,Selective degradation of mutant FMS-like tyrosine kinase-3 requires BIM-dependent depletion of heat shock proteins.,"['Halilovic M', 'Abdelsalam M', 'Zabkiewicz J', 'Lazenby M', 'Alvares C', 'Schmidt M', 'Brenner W', 'Najafi S', 'Oehme I', 'Hieber C', 'Zeyn Y', 'Bros M', 'Sippl W', 'Kramer OH']","['Humans', '*fms-Like Tyrosine Kinase 3/genetics/metabolism', 'Animals', '*Bcl-2-Like Protein 11/metabolism/genetics', '*Leukemia, Myeloid, Acute/pathology/genetics/metabolism/drug therapy', '*Proteolysis', '*Zebrafish', '*Heat-Shock Proteins/genetics/metabolism', 'Mutation', 'Apoptosis', 'Cell Line, Tumor']",https://pubmed.ncbi.nlm.nih.gov/39300221/
572,FLT3,15253381,FLT3: receptor and ligand.,"['Drexler HG', 'Quentmeier H']","['Animals', 'Growth Substances/metabolism', 'Humans', 'Leukemia, Myeloid, Acute/metabolism', 'Membrane Proteins/chemistry/*physiology', 'Mutation', 'Proto-Oncogene Proteins/chemistry/*physiology', 'Receptor Protein-Tyrosine Kinases/chemistry/*physiology', 'Signal Transduction', 'Stem Cells/metabolism', 'fms-Like Tyrosine Kinase 3']",https://pubmed.ncbi.nlm.nih.gov/15253381/
573,FLT3,9720755,FLT3: receptor and ligand. Biology and potential clinical application.,"['Shurin MR', 'Esche C', 'Lotze MT']","['Animals', 'Humans', 'Ligands', 'Membrane Proteins/genetics/*physiology/therapeutic use', 'Proto-Oncogene Proteins/genetics/*physiology', 'Receptor Protein-Tyrosine Kinases/genetics/*physiology', 'fms-Like Tyrosine Kinase 3']",https://pubmed.ncbi.nlm.nih.gov/9720755/
574,FLT3,32314599,Recent advances in FLT3 inhibitors for acute myeloid leukemia.,"['Tong L', 'Li X', 'Hu Y', 'Liu T']","['Antineoplastic Agents/chemistry/*pharmacology', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy/metabolism', 'Molecular Structure', 'Protein Kinase Inhibitors/chemistry/*pharmacology', 'fms-Like Tyrosine Kinase 3/*antagonists & inhibitors/metabolism']",https://pubmed.ncbi.nlm.nih.gov/32314599/
575,FLT3,24682858,FLT3 inhibitors in AML: are we there yet?,"['Sudhindra A', 'Smith CC']","['Antineoplastic Agents/*therapeutic use', 'Clinical Trials as Topic', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy/genetics/physiopathology', 'Molecular Targeted Therapy/*methods', 'Protein Kinase Inhibitors/*therapeutic use', 'fms-Like Tyrosine Kinase 3/*antagonists & inhibitors/genetics/physiology']",https://pubmed.ncbi.nlm.nih.gov/24682858/
576,FLT3,33213500,Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia.,"['Gebru MT', 'Wang HG']","['Animals', 'Antineoplastic Agents/*pharmacology/therapeutic use', '*Drug Resistance, Neoplasm/drug effects', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy/genetics/metabolism', 'Molecular Targeted Therapy', 'Mutation/drug effects', 'Protein Kinase Inhibitors/*pharmacology/therapeutic use', 'Signal Transduction/drug effects', 'fms-Like Tyrosine Kinase 3/*antagonists & inhibitors/chemistry/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/33213500/
577,FLT1,15294883,Vascular endothelial growth factor: basic science and clinical progress.,['Ferrara N'],"['Animals', 'Gene Expression Regulation', 'Humans', 'Neoplasms/blood supply', 'Neovascularization, Pathologic/metabolism/prevention & control', '*Vascular Endothelial Growth Factor A/antagonists & inhibitors/genetics/physiology']",https://pubmed.ncbi.nlm.nih.gov/15294883/
578,FLT1,37331163,H3K27me3-modulated Hofbauer cell BMP2 signalling enhancement compensates for shallow trophoblast invasion in preeclampsia.,"['Deng J', 'Zhao HJ', 'Zhong Y', 'Hu C', 'Meng J', 'Wang C', 'Lan X', 'Wang X', 'Chen ZJ', 'Yan J', 'Wang W', 'Li Y']","['Pregnancy', 'Humans', 'Female', 'Rats', 'Animals', '*Trophoblasts/metabolism', 'Histones/metabolism', '*Pre-Eclampsia/metabolism', 'Bone Morphogenetic Protein 2/genetics/metabolism/pharmacology', 'Placenta/metabolism', 'Cell Movement']",https://pubmed.ncbi.nlm.nih.gov/37331163/
579,FLT1,38141889,SOD3 regulates FLT1 to affect bone metabolism by promoting osteogenesis and inhibiting adipogenesis through PI3K/AKT and MAPK pathways.,"['Xu K', 'Fei W', 'Gao W', 'Fan C', 'Li Y', 'Hong Y', 'Cui R']","['Humans', 'Mice', 'Animals', 'Aged', '*Adipogenesis/physiology', 'Osteogenesis/physiology', 'Proto-Oncogene Proteins c-akt/genetics/metabolism', 'Phosphatidylinositol 3-Kinases/genetics/metabolism', 'Quality of Life', 'Cell Differentiation/physiology', '*Osteoporosis/metabolism', 'Osteoblasts/metabolism', 'Superoxide Dismutase/genetics/metabolism', 'Vascular Endothelial Growth Factor Receptor-1']",https://pubmed.ncbi.nlm.nih.gov/38141889/
580,FLT1,38971545,IGF1R and FLT1 in female endothelial cells and CHD2 in male microglia play important roles in Alzheimer's disease based on gender difference analysis.,"['He R', 'Cheng J', 'Qiu Y', 'Hu Y', 'Liu J', 'Wang TH', 'Cao X']","['*Alzheimer Disease/genetics/metabolism', 'Female', 'Animals', 'Male', '*Microglia/metabolism', 'Humans', '*Receptor, IGF Type 1/genetics/metabolism', 'Mice', '*Endothelial Cells/metabolism', '*Vascular Endothelial Growth Factor Receptor-1/genetics/metabolism', 'Sex Factors', 'DNA-Binding Proteins/genetics/metabolism', 'Prefrontal Cortex/metabolism', 'Mice, Inbred C57BL']",https://pubmed.ncbi.nlm.nih.gov/38971545/
581,FLT1,37789414,Identification of methylation-regulated genes modulating microglial phagocytosis in hyperhomocysteinemia-exacerbated Alzheimer's disease.,"['Wang X', 'Liu L', 'Jiang X', 'Saredy J', 'Xi H', 'Cueto R', 'Sigler D', 'Khan M', 'Wu S', 'Ji Y', 'Snyder NW', 'Hu W', 'Yang X', 'Wang H']","['Mice', 'Animals', 'Humans', '*Alzheimer Disease/metabolism', 'Amyloid beta-Peptides/metabolism', 'Microglia/metabolism', '*Hyperhomocysteinemia/complications/genetics/metabolism', 'Methylation', 'Phagocytosis', 'Disease Models, Animal', 'Mice, Transgenic']",https://pubmed.ncbi.nlm.nih.gov/37789414/
582,FLT1,22908198,PlGF: a multitasking cytokine with disease-restricted activity.,"['Dewerchin M', 'Carmeliet P']","['Animals', 'Arthritis, Rheumatoid/drug therapy', 'Cardiovascular Diseases/drug therapy/etiology', 'Colitis/etiology', 'Cytokines/antagonists & inhibitors/deficiency/genetics/*physiology', 'Growth and Development/physiology', 'Hematologic Diseases/drug therapy/etiology', 'Humans', 'Hypersensitivity, Delayed/drug therapy', 'Liver Cirrhosis/drug therapy', 'Mice', 'Neoplasms/drug therapy/etiology', 'Obesity/drug therapy', 'Placenta Growth Factor', 'Pregnancy Proteins/antagonists & inhibitors/deficiency/genetics/*physiology', 'Pulmonary Emphysema/drug therapy', 'Sepsis/etiology', 'Signal Transduction/physiology', 'Vascular Endothelial Growth Factor Receptor-1/physiology', 'Wound Healing/physiology']",https://pubmed.ncbi.nlm.nih.gov/22908198/
583,FLT1,12965085,Regulation of embryonic implantation.,"['Krussel JS', 'Bielfeld P', 'Polan ML', 'Simon C']","['Animals', 'Blastocyst/chemistry/physiology', 'Embryo Implantation/*physiology', 'Embryonic and Fetal Development', 'Endometrium/physiology', 'Female', 'Gene Expression', 'Humans', 'Interleukin-1/genetics/physiology', 'Mice', 'Mice, Knockout', 'Neovascularization, Physiologic', 'Pregnancy', 'Receptors, Interleukin-1/physiology', 'Vascular Endothelial Growth Factor A/genetics/physiology']",https://pubmed.ncbi.nlm.nih.gov/12965085/
584,FLT1,36922327,Wnt5a-Flt1 activation contributes to preterm altered cerebral angiogenesis after prenatal inflammation.,"['Jiangxue H', 'Liling Y', 'Fang X', 'Shumei Y', 'Gengying L', 'Xuejun R', 'Yao Y', 'Chuan N', 'Jie Y', 'Zhuxiao R']","['Animals', 'Female', 'Humans', 'Pregnancy', 'Rats', '*Cerebral Hemorrhage/genetics/metabolism', '*Chorioamnionitis/genetics/metabolism', '*Inflammation/complications/genetics/metabolism', 'Lipopolysaccharides', '*Prenatal Exposure Delayed Effects', 'Vascular Endothelial Growth Factor A', '*Wnt-5a Protein/genetics/metabolism', '*Vascular Endothelial Growth Factor Receptor-1/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36922327/
585,FLT1,35711030,A systematic review of molecular alterations in invasive non-functioning pituitary adenoma.,"['Hosseinkhan N', 'Honardoost M', 'Emami Z', 'Cheraghi S', 'Hashemi-Madani N', 'Khamseh ME']","['*Adenoma/genetics/metabolism', 'Humans', 'Hypoxia', '*MicroRNAs/genetics', 'Phosphatidylinositol 3-Kinases', '*Pituitary Neoplasms/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35711030/
586,FLT1,35981547,MiR-30a-3p Targeting FLT1 Modulates Trophoblast Cell Proliferation in the Pathogenesis of Preeclampsia.,"['Wang Y', 'Wang L', 'Yu X', 'Gong W']","[""3' Untranslated Regions/genetics"", 'Cell Movement', 'Cell Proliferation', 'Female', 'Humans', '*MicroRNAs/genetics/metabolism', 'Placenta/metabolism', '*Pre-Eclampsia/genetics/metabolism', 'Pregnancy', 'Trophoblasts/*cytology/metabolism', 'Vascular Endothelial Growth Factor Receptor-1/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35981547/
587,FLT1,30199611,Anti-Flt1 peptide and cyanine-conjugated gold nanoparticles for the concurrent antiangiogenic and endothelial cell proton treatment.,"['Seo SJ', 'Lee SH', 'Kim KH', 'Kim JK']","['*Angiogenesis Inhibitors/chemistry/pharmacology', 'Endothelial Cells/*metabolism/pathology', '*Gold/chemistry/pharmacology', 'Humans', 'Metal Nanoparticles/*chemistry', '*Peptides/chemistry/pharmacology', '*Protons', 'Retinal Vessels/*metabolism/pathology', 'Vascular Endothelial Growth Factor Receptor-1/*antagonists & inhibitors']",https://pubmed.ncbi.nlm.nih.gov/30199611/
588,FLT1,37215144,The transcriptional control of the VEGFA-VEGFR1 (FLT1) axis in alternatively polarized murine and human macrophages.,"['Domokos A', 'Varga Z', 'Jambrovics K', 'Caballero-Sanchez N', 'Szabo E', 'Nagy G', 'Scholtz B', 'Halasz L', 'Varadi E', 'Bene KP', 'Mazlo A', 'Bacsi A', 'Jeney V', 'Szebeni GJ', 'Nagy L', 'Czimmerer Z']","['Humans', 'Mice', 'Animals', '*Interleukin-4/metabolism', '*Vascular Endothelial Growth Factor A/genetics/metabolism', 'Macrophages/metabolism', 'Signal Transduction', 'Gene Expression Regulation', 'Vascular Endothelial Growth Factor Receptor-1/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37215144/
589,FLT1,10709867,Angiogenic growth factor expression in placenta.,"['Smith SK', 'He Y', 'Clark DE', 'Charnock-Jones DS']","['Angiogenesis Inducing Agents/*biosynthesis/genetics', 'Animals', 'Female', 'Gene Expression Regulation/physiology', 'Humans', 'Multigene Family', 'Placenta/*metabolism', 'Pregnancy', 'Pregnancy Proteins/*biosynthesis/genetics']",https://pubmed.ncbi.nlm.nih.gov/10709867/
590,FLT1,10865839,"Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction.","['Sato Y', 'Kanno S', 'Oda N', 'Abe M', 'Ito M', 'Shitara K', 'Shibuya M']","['Endothelial Growth Factors/pharmacology/*physiology', 'Endothelium, Vascular/cytology/*physiology', 'Gene Expression Regulation/drug effects', 'Humans', 'Lymphokines/pharmacology/*physiology', 'Matrix Metalloproteinase 1/genetics', 'Proto-Oncogene Protein c-ets-1', 'Proto-Oncogene Proteins/genetics/*physiology', 'Proto-Oncogene Proteins c-ets', 'Receptor Protein-Tyrosine Kinases/*physiology', 'Receptors, Growth Factor/*physiology', 'Receptors, Vascular Endothelial Growth Factor', 'Signal Transduction/*physiology', 'Transcription Factors/genetics', 'Vascular Endothelial Growth Factor A', 'Vascular Endothelial Growth Factor Receptor-1', 'Vascular Endothelial Growth Factors']",https://pubmed.ncbi.nlm.nih.gov/10865839/
591,FLT1,34663835,A simple detection method for the serum sFLT1 protein in preeclampsia.,"['Shibuya M', 'Matsui H', 'Sasagawa T', 'Nagamatsu T']","['Adult', 'Enzyme-Linked Immunosorbent Assay/*methods', 'Female', 'Humans', 'Placenta/metabolism', 'Pre-Eclampsia/blood/genetics/*metabolism', 'Pregnancy', 'Vascular Endothelial Growth Factor Receptor-1/*analysis/blood/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34663835/
592,FLT1,35289275,Potential biomarkers and the molecular mechanism associated with DLL4 during renal cell carcinoma progression.,"['Wang X', 'Zhang J', 'Wang Y', 'Wang Y', 'Yu W', 'Shi G']","['Adaptor Proteins, Signal Transducing', 'Biomarkers', 'Calcium-Binding Proteins/genetics', '*Carcinoma, Renal Cell/metabolism', 'Gene Expression Profiling', 'Humans', '*Kidney Neoplasms/metabolism', '*MicroRNAs/genetics', 'Neovascularization, Pathologic']",https://pubmed.ncbi.nlm.nih.gov/35289275/
593,FLT1,33656845,Synthesis and Antitumor Application of Antiangiogenetic Gold Nanoclusters.,"['Li Q', 'Zhou R', 'Sun Y', 'Xiao D', 'Liu M', 'Zhao D', 'Peng S', 'Chen Y', 'Lin Y']","['Angiogenesis Inhibitors/*administration & dosage/therapeutic use', 'Animals', 'Cell Line, Tumor', 'Drug Carriers/chemistry', 'Glutathione/metabolism', 'Gold/*chemistry', 'Human Umbilical Vein Endothelial Cells', 'Humans', 'Metal Nanoparticles/*chemistry', 'Mice, Inbred BALB C', 'Mice, Nude', 'Neoplasms/*drug therapy/metabolism', 'Peptides/*administration & dosage/therapeutic use', 'Vascular Endothelial Growth Factor Receptor-1/antagonists & inhibitors/metabolism', 'Mice']",https://pubmed.ncbi.nlm.nih.gov/33656845/
594,FLT1,24041258,FLT1 kinase is a mediator of radioresistance and survival in head and neck squamous cell carcinoma.,"['Van Limbergen EJ', 'Zabrocki P', 'Porcu M', 'Hauben E', 'Cools J', 'Nuyts S']","['Biomarkers, Tumor/analysis', 'Blotting, Western', 'Carcinoma, Squamous Cell/*enzymology/mortality/radiotherapy', 'Cell Line, Tumor', 'Head and Neck Neoplasms/*enzymology/mortality/radiotherapy', 'Humans', 'Immunohistochemistry', 'Kaplan-Meier Estimate', 'Microscopy, Confocal', 'Radiation Tolerance/*physiology', 'Real-Time Polymerase Chain Reaction', 'Squamous Cell Carcinoma of Head and Neck', 'Vascular Endothelial Growth Factor Receptor-1/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/24041258/
595,FLT1,24778014,Fluorescent resonance energy transfer imaging of VEGFR dimerization.,"['Ahmadova Z', 'Yagublu V', 'Forg T', 'Hajiyeva Y', 'Jesenofsky R', 'Hafner M', 'Keese M']","['Animals', 'CHO Cells', 'Cricetinae', 'Cricetulus', 'Fluorescence Resonance Energy Transfer/*methods', 'Humans', 'Protein Multimerization/*physiology', 'Vascular Endothelial Growth Factor Receptor-1/*chemistry/metabolism', 'Vascular Endothelial Growth Factor Receptor-2/*chemistry/metabolism']",https://pubmed.ncbi.nlm.nih.gov/24778014/
596,FLT1,27251772,Flt1/VEGFR1 heterozygosity causes transient embryonic edema.,"['Otowa Y', 'Moriwaki K', 'Sano K', 'Shirakabe M', 'Yonemura S', 'Shibuya M', 'Rossant J', 'Suda T', 'Kakeji Y', 'Hirashima M']","['Adaptor Proteins, Signal Transducing/genetics', 'Animals', 'Capillary Permeability', 'Cell Membrane/metabolism', 'Edema/*genetics/metabolism', '*Embryonic Development', 'Endothelial Cells', 'Genetic Heterogeneity', 'Mice', 'Mutation', 'Nuchal Translucency Measurement', 'Phosphorylation', 'Vascular Endothelial Growth Factor A/*metabolism', 'Vascular Endothelial Growth Factor Receptor-1/*genetics/*metabolism', 'Vascular Endothelial Growth Factor Receptor-2/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/27251772/
597,FLT4,30173249,Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis.,"['Melincovici CS', 'Bosca AB', 'Susman S', 'Marginean M', 'Mihu C', 'Istrate M', 'Moldovan IM', 'Roman AL', 'Mihu CM']","['Angiogenesis Inhibitors/*pharmacology', 'Animals', 'Humans', 'Neoplasms/*blood supply/*drug therapy', 'Neovascularization, Pathologic/drug therapy/metabolism', 'Vascular Endothelial Growth Factor A/*antagonists & inhibitors/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/30173249/
598,FLT4,28991257,"Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands.","['Jin SC', 'Homsy J', 'Zaidi S', 'Lu Q', 'Morton S', 'DePalma SR', 'Zeng X', 'Qi H', 'Chang W', 'Sierant MC', 'Hung WC', 'Haider S', 'Zhang J', 'Knight J', 'Bjornson RD', 'Castaldi C', 'Tikhonoa IR', 'Bilguvar K', 'Mane SM', 'Sanders SJ', 'Mital S', 'Russell MW', 'Gaynor JW', 'Deanfield J', 'Giardini A', 'Porter GA Jr', 'Srivastava D', 'Lo CW', 'Shen Y', 'Watkins WS', 'Yandell M', 'Yost HJ', 'Tristani-Firouzi M', 'Newburger JW', 'Roberts AE', 'Kim R', 'Zhao H', 'Kaltman JR', 'Goldmuntz E', 'Chung WK', 'Seidman JG', 'Gelb BD', 'Seidman CE', 'Lifton RP', 'Brueckner M']","['Adult', 'Autistic Disorder/*genetics/pathology', 'Cardiac Myosins/*genetics', 'Case-Control Studies', 'Child', 'Exome', 'Female', 'Gene Expression', '*Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Growth Differentiation Factor 1/*genetics', 'Heart Defects, Congenital/*genetics/pathology', 'Heterozygote', 'High-Throughput Nucleotide Sequencing', 'Homozygote', 'Humans', 'Male', 'Mutation', 'Myosin Heavy Chains/*genetics', 'Pedigree', 'Risk', 'Vascular Endothelial Growth Factor Receptor-3/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28991257/
599,FLT4,34632918,FLT4/VEGFR3 activates AMPK to coordinate glycometabolic reprogramming with autophagy and inflammasome activation for bacterial elimination.,"['Ma L', 'Li W', 'Zhang Y', 'Qi L', 'Zhao Q', 'Li N', 'Lu Y', 'Zhang L', 'Zhou F', 'Wu Y', 'He Y', 'Yu H', 'He Y', 'Wei B', 'Wang H']","['AMP-Activated Protein Kinases/metabolism', 'Adenosine Monophosphate', '*Autophagy/physiology', 'Bacteria/metabolism', 'Caspase 1', 'Humans', '*Inflammasomes/metabolism', 'Ligands', 'Lipopolysaccharides', 'Vascular Endothelial Growth Factor C', 'Vascular Endothelial Growth Factor Receptor-3']",https://pubmed.ncbi.nlm.nih.gov/34632918/
600,FLT4,34755131,Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma.,"['Liu S', 'Knochelmann HM', 'Lomeli SH', 'Hong A', 'Richardson M', 'Yang Z', 'Lim RJ', 'Wang Y', 'Dumitras C', 'Krysan K', 'Timmers C', 'Romeo MJ', 'Krieg C', ""O'Quinn EC"", 'Horton JD', 'Dubinett SM', 'Paulos CM', 'Neskey DM', 'Lo RS']","['Antineoplastic Agents, Immunological/therapeutic use', 'Carcinoma, Squamous Cell/*drug therapy/genetics/immunology/surgery', 'Cyclin-Dependent Kinase Inhibitor p16/genetics/immunology', 'Gene Expression Profiling', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Immune Checkpoint Inhibitors/therapeutic use', 'Janus Kinase 2/genetics/immunology', 'Mouth Neoplasms/*drug therapy/genetics/immunology/surgery', 'Mutation', 'Neoadjuvant Therapy/methods', 'Neoplasm Recurrence, Local/*drug therapy/genetics/immunology/surgery', 'Nivolumab/*therapeutic use', 'PTEN Phosphohydrolase/genetics/immunology', 'Programmed Cell Death 1 Receptor/antagonists & inhibitors/*genetics/immunology', 'Receptors, Antigen, T-Cell, alpha-beta/genetics/immunology', 'Survival Analysis', 'T-Lymphocytes, Regulatory/drug effects/immunology/pathology', 'Th17 Cells/drug effects/immunology/pathology', 'Treatment Outcome', 'Vascular Endothelial Growth Factor Receptor-3/*genetics/immunology', 'YAP-Signaling Proteins/genetics/immunology']",https://pubmed.ncbi.nlm.nih.gov/34755131/
601,FLT4,29680577,Cytokines regulating lymphangiogenesis.,"['Sainz-Jaspeado M', 'Claesson-Welsh L']","['Animals', 'Carcinogenesis', 'Cell Differentiation', 'Cytokines/*metabolism', 'Endothelial Cells/*physiology', 'Humans', '*Lymphangiogenesis', 'Lymphatic Vessels/*physiology', 'Neoplasms/*immunology', 'Vascular Endothelial Growth Factor C/*metabolism', 'Vascular Endothelial Growth Factor Receptor-3/*metabolism', 'Wound Healing']",https://pubmed.ncbi.nlm.nih.gov/29680577/
602,FLT4,37353784,m(6)A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma.,"['Fang H', 'Sun Q', 'Zhou J', 'Zhang H', 'Song Q', 'Zhang H', 'Yu G', 'Guo Y', 'Huang C', 'Mou Y', 'Jia C', 'Song Y', 'Liu A', 'Song K', 'Lu C', 'Tian R', 'Wei S', 'Yang D', 'Chen Y', 'Li T', 'Wang K', 'Yu Y', 'Lv Y', 'Mo K', 'Sun P', 'Yu X', 'Song X']","['Humans', 'Methylation', 'Ecosystem', 'Endothelial Cells', 'Phosphatidylinositol 3-Kinases', 'Neoplasm Recurrence, Local', '*Adenocarcinoma of Lung/genetics', '*Lung Neoplasms/genetics', 'Tumor Microenvironment', 'RNA-Binding Proteins/genetics']",https://pubmed.ncbi.nlm.nih.gov/37353784/
603,FLT4,24384851,Malignant vascular tumors--an update.,['Antonescu C'],"['Biomarkers, Tumor/analysis/genetics', 'Diagnosis, Differential', 'Genetic Predisposition to Disease', '*Hemangioendothelioma, Epithelioid/chemistry/genetics/pathology', '*Hemangiosarcoma/chemistry/genetics/pathology', 'Humans', 'Phenotype', 'Predictive Value of Tests', 'Prognosis']",https://pubmed.ncbi.nlm.nih.gov/24384851/
604,FLT4,39557830,EphrinB2-mediated CDK5/ISL1 pathway enhances cardiac lymphangiogenesis and alleviates ischemic injury by resolving post-MI inflammation.,"['Bai Y', 'Chen L', 'Guo F', 'Zhang J', 'Hu J', 'Tao X', 'Lu Q', 'Li W', 'Chen X', 'Gong T', 'Qiu N', 'Jin Y', 'Yang L', 'Lei Y', 'Ruan C', 'Jing Q', 'Cooke JP', 'Wang S', 'Zou Y', 'Ge J']","['Animals', '*Lymphangiogenesis/genetics', 'Mice', '*Ephrin-B2/genetics/metabolism', '*Myocardial Infarction/genetics/pathology/metabolism', '*Cyclin-Dependent Kinase 5/genetics/metabolism', 'Inflammation/genetics/pathology/metabolism', 'Signal Transduction/genetics', 'Humans', 'Mice, Knockout', 'Transcription Factors/genetics/metabolism', 'Vascular Endothelial Growth Factor Receptor-3/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39557830/
605,FLT4,38888964,The Alzheimer's disease-linked protease BACE2 cleaves VEGFR3 and modulates its signaling.,"['Schmidt A', 'Hrupka B', 'van Bebber F', 'Sunil Kumar S', 'Feng X', 'Tschirner SK', 'Assfalg M', 'Muller SA', 'Hilger LS', 'Hofmann LI', 'Pigoni M', 'Jocher G', 'Voytyuk I', 'Self EL', 'Ito M', 'Hyakkoku K', 'Yoshimura A', 'Horiguchi N', 'Feederle R', 'De Strooper B', 'Schulte-Merker S', 'Lammert E', 'Moechars D', 'Schmid B', 'Lichtenthaler SF']","['Animals', 'Humans', 'Mice', '*Alzheimer Disease/metabolism/genetics/pathology/enzymology', '*Amyloid Precursor Protein Secretases/metabolism/genetics/antagonists & inhibitors', '*Aspartic Acid Endopeptidases/metabolism/genetics/antagonists & inhibitors', 'Endothelial Cells/metabolism/enzymology/pathology', '*Signal Transduction', '*Vascular Endothelial Growth Factor Receptor-3/metabolism/genetics', '*Zebrafish/metabolism/genetics', 'Zebrafish Proteins/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38888964/
606,FLT4,24276893,A fisheye view on lymphangiogenesis.,"['van Impel A', 'Schulte-Merker S']","['Animals', 'Calcium-Binding Proteins/*metabolism', '*Lymphangiogenesis', 'Lymphatic Vessels/*embryology/metabolism', 'Lymphedema/genetics', 'Mice', 'Tumor Suppressor Proteins/*metabolism', 'Vascular Endothelial Growth Factor C/*metabolism', 'Vascular Endothelial Growth Factor Receptor-3/*metabolism', 'Zebrafish']",https://pubmed.ncbi.nlm.nih.gov/24276893/
607,FLT4,38614964,Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses.,"['Cao M', 'Cui B']","['Humans', '*Adiposity/genetics', 'Proteome', 'Genome-Wide Association Study', 'Mendelian Randomization Analysis', 'Obesity', '*Cardiovascular Diseases', 'Membrane Proteins', 'Molecular Chaperones', 'HSP40 Heat-Shock Proteins']",https://pubmed.ncbi.nlm.nih.gov/38614964/
608,FLT4,38713105,FLT4 causes developmental disorders of the cardiovascular and lymphovascular systems via pleiotropic molecular mechanisms.,"['Monaghan RM', 'Naylor RW', 'Flatman D', 'Kasher PR', 'Williams SG', 'Keavney BD']","['Animals', 'Humans', 'Cells, Cultured', 'Endoplasmic Reticulum/metabolism/pathology/genetics', 'Endothelial Cells/metabolism/pathology', 'Gene Expression Regulation, Developmental', 'Genetic Predisposition to Disease', 'Human Umbilical Vein Endothelial Cells/metabolism/pathology', 'Lymphedema/genetics/metabolism/pathology/physiopathology', 'Mutation', 'Phenotype', '*Signal Transduction', '*Tetralogy of Fallot/genetics/pathology/metabolism', '*Vascular Endothelial Growth Factor Receptor-3/metabolism/genetics', '*Zebrafish/genetics', '*Zebrafish Proteins/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38713105/
609,FLT4,28192087,Endothelial cell markers from clinician's perspective.,"['Rakocevic J', 'Orlic D', 'Mitrovic-Ajtic O', 'Tomasevic M', 'Dobric M', 'Zlatic N', 'Milasinovic D', 'Stankovic G', 'Ostojic M', 'Labudovic-Borovic M']","['Antigens, CD34/genetics/metabolism', '*Biomarkers', 'Cardiovascular Diseases/diagnosis/*genetics', 'Endoglin/genetics/metabolism', 'Endothelial Cells/*metabolism', 'Humans', 'Neovascularization, Pathologic/genetics/metabolism', 'Platelet Endothelial Cell Adhesion Molecule-1/genetics/metabolism', 'Randomized Controlled Trials as Topic', 'Receptors, Vascular Endothelial Growth Factor/genetics/metabolism', 'Vascular Endothelial Growth Factor A/genetics/metabolism', 'Vascular Endothelial Growth Factor Receptor-3/genetics/metabolism', 'von Willebrand Factor/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/28192087/
610,FLT4,28129845,The lymphatic vasculature revisited-new developments in the zebrafish.,"['Padberg Y', 'Schulte-Merker S', 'van Impel A']","['Animals', 'Arthritis, Rheumatoid/diagnostic imaging/physiopathology', 'Disease Models, Animal', 'Endothelial Cells/pathology/*ultrastructure', 'Humans', '*Lymphangiogenesis', 'Lymphatic Vessels/*diagnostic imaging/physiopathology', 'Lymphedema/diagnostic imaging/physiopathology', 'Molecular Imaging/*methods', 'Obesity/diagnostic imaging/physiopathology', 'Zebrafish/physiology']",https://pubmed.ncbi.nlm.nih.gov/28129845/
611,FLT4,33067626,The physiological and pathological functions of VEGFR3 in cardiac and lymphatic development and related diseases.,"['Monaghan RM', 'Page DJ', 'Ostergaard P', 'Keavney BD']","['Animals', 'Cardiovascular System/*metabolism/pathology/physiopathology', 'Disease Models, Animal', 'Gene Expression Regulation, Developmental', 'Heart Defects, Congenital/genetics/*metabolism/pathology/physiopathology', 'Humans', 'Lymphatic System/*metabolism/pathology/physiopathology', 'Lymphedema/genetics/*metabolism/pathology/physiopathology', 'Mice, Transgenic', 'Morphogenesis', 'Mutation', 'Signal Transduction', 'Vascular Endothelial Growth Factor Receptor-3/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/33067626/
612,FLT4,39596293,Molecules That Have Rarely Been Studied in Lymphatic Endothelial Cells.,"['Becker J', 'Wilting J']","['Humans', '*Endothelial Cells/metabolism', 'Vascular Endothelial Growth Factor Receptor-3/metabolism/genetics', 'Lymphatic Vessels/metabolism/cytology', 'Homeodomain Proteins/metabolism/genetics', 'Membrane Glycoproteins/metabolism/genetics', 'Vesicular Transport Proteins/metabolism/genetics', 'Tumor Suppressor Proteins/metabolism/genetics', 'Platelet Endothelial Cell Adhesion Molecule-1/metabolism/genetics', 'Prospero-Related Homeobox 1 Protein']",https://pubmed.ncbi.nlm.nih.gov/39596293/
613,FLT4,30142879,Roles of the TGF-beta(-)VEGF-C Pathway in Fibrosis-Related Lymphangiogenesis.,"['Kinashi H', 'Ito Y', 'Sun T', 'Katsuno T', 'Takei Y']","['Animals', 'Connective Tissue Growth Factor/genetics/metabolism', 'Epithelial Cells/metabolism/pathology', 'Gene Expression Regulation', 'Humans', 'Lymphangiogenesis/*genetics', 'Lymphatic Vessels/metabolism/pathology', 'Macrophages/metabolism/pathology', 'Nephrogenic Fibrosing Dermopathy/genetics/*metabolism/pathology', 'Peritoneal Fibrosis/genetics/*metabolism/pathology', 'Renal Insufficiency, Chronic/genetics/*metabolism/pathology', 'Signal Transduction', 'Transforming Growth Factor beta/genetics/*metabolism', 'Vascular Endothelial Growth Factor C/genetics/*metabolism', 'Vascular Endothelial Growth Factor D/genetics/metabolism', 'Vascular Endothelial Growth Factor Receptor-3/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/30142879/
614,FLT4,37779428,RETooling the RET Inhibitor Pralsetinib for ESR1 Fusion-Positive Breast Cancer and Beyond.,"['Wu J', 'Subbiah V']","['Humans', 'Female', '*Breast Neoplasms/drug therapy/genetics/metabolism', 'Estrogen Receptor alpha/metabolism', '*Carcinoma, Non-Small-Cell Lung', '*Lung Neoplasms', 'Proto-Oncogene Proteins c-ret/genetics']",https://pubmed.ncbi.nlm.nih.gov/37779428/
615,FLT4,23945394,Tbx1 regulates brain vascularization.,"['Cioffi S', 'Martucciello S', 'Fulcoli FG', 'Bilio M', 'Ferrentino R', 'Nusco E', 'Illingworth E']","['Animals', 'Brain/*blood supply/pathology', 'DiGeorge Syndrome/*genetics/*pathology', 'Disease Models, Animal', 'Gene Expression Regulation', 'Gene Knockdown Techniques', 'Human Umbilical Vein Endothelial Cells', 'Humans', 'Intracellular Signaling Peptides and Proteins/*metabolism', 'Membrane Proteins/*metabolism', 'Mice', 'Mice, Transgenic', 'Mutation', 'Neovascularization, Pathologic/genetics', 'Phenotype', 'T-Box Domain Proteins/genetics/*physiology', 'Vascular Endothelial Growth Factor Receptor-3/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/23945394/
616,KDR,15294883,Vascular endothelial growth factor: basic science and clinical progress.,['Ferrara N'],"['Animals', 'Gene Expression Regulation', 'Humans', 'Neoplasms/blood supply', 'Neovascularization, Pathologic/metabolism/prevention & control', '*Vascular Endothelial Growth Factor A/antagonists & inhibitors/genetics/physiology']",https://pubmed.ncbi.nlm.nih.gov/15294883/
617,KDR,38029740,VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis.,"['Rizvi F', 'Lee YR', 'Diaz-Aragon R', 'Bawa PS', 'So J', 'Florentino RM', 'Wu S', 'Sarjoo A', 'Truong E', 'Smith AR', 'Wang F', 'Everton E', 'Ostrowska A', 'Jung K', 'Tam Y', 'Muramatsu H', 'Pardi N', 'Weissman D', 'Soto-Gutierrez A', 'Shin D', 'Gouon-Evans V']","['Animals', 'Mice', 'Humans', '*Zebrafish', 'RNA, Messenger/genetics', 'COVID-19 Vaccines', 'Nucleosides', 'Hepatocytes', 'Liver', 'Epithelial Cells', '*Liver Diseases/pathology', 'Fibrosis', 'Liver Regeneration', 'Vascular Endothelial Growth Factor A/genetics']",https://pubmed.ncbi.nlm.nih.gov/38029740/
618,KDR,24909742,Hypoxia-inducible hydrogels.,"['Park KM', 'Gerecht S']","['Angiopoietin-1/genetics/metabolism', 'Basic Helix-Loop-Helix Transcription Factors/genetics/metabolism', 'Biocompatible Materials', '*Cellular Microenvironment', 'Computer Simulation', 'Coumaric Acids', 'Endothelial Cells/*metabolism', 'Gelatin/chemistry', 'Gene Expression Profiling', 'Humans', 'Hydrogels/*metabolism', 'Hypoxia-Inducible Factor 1, alpha Subunit/genetics/metabolism', 'Laccase', 'Matrix Metalloproteinases/genetics/metabolism', 'Neovascularization, Physiologic/*genetics/physiology', 'Oxygen/*metabolism', 'Oxygen Consumption', 'Vascular Endothelial Growth Factor A/genetics/metabolism', 'Vascular Endothelial Growth Factor Receptor-2/genetics/metabolism', 'Wound Healing/genetics']",https://pubmed.ncbi.nlm.nih.gov/24909742/
619,KDR,38918393,The tyrosine kinase KDR is essential for the survival of HTLV-1-infected T cells by stabilizing the Tax oncoprotein.,"['Mohanty S', 'Suklabaidya S', 'Lavorgna A', 'Ueno T', 'Fujisawa JI', 'Ngouth N', 'Jacobson S', 'Harhaj EW']","['Humans', '*Gene Products, tax/metabolism/genetics', '*Human T-lymphotropic virus 1/pathogenicity/genetics/physiology', '*Vascular Endothelial Growth Factor Receptor-2/metabolism/genetics', '*NF-kappa B/metabolism', '*Paraparesis, Tropical Spastic/virology/metabolism', '*Cell Survival', 'Apoptosis', 'HTLV-I Infections/virology/metabolism', 'CD4-Positive T-Lymphocytes/virology/metabolism', 'T-Lymphocytes/metabolism/virology', 'Leukemia-Lymphoma, Adult T-Cell/virology/metabolism/genetics/pathology', 'Phosphorylation', 'HEK293 Cells']",https://pubmed.ncbi.nlm.nih.gov/38918393/
620,KDR,37610648,"PDGFRA, KIT, and KDR Gene Amplification in Glioblastoma: Heterogeneity and Clinical Significance.","['Carlotto BS', 'Trevisan P', 'Provenzi VO', 'Soares FP', 'Rosa RFM', 'Varella-Garcia M', 'Zen PRG']","['Humans', 'Middle Aged', 'Central Nervous System', 'Chromosome Aberrations', 'Clinical Relevance', 'Gene Amplification', '*Glioblastoma/genetics', 'Receptor Protein-Tyrosine Kinases', 'Vascular Endothelial Growth Factor Receptor-2/genetics', 'Receptor, Platelet-Derived Growth Factor alpha/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37610648/
621,KDR,25987223,Pyrethroid resistance in Culex pipiens mosquitoes.,"['Scott JG', 'Yoshimizu MH', 'Kasai S']","['Animals', 'Culex/*drug effects/genetics/physiology', 'Humans', 'Insect Vectors', '*Insecticide Resistance/genetics', 'Insecticides/*toxicity', 'Pyrethrins/*toxicity']",https://pubmed.ncbi.nlm.nih.gov/25987223/
622,KDR,22382862,Anti-angiogenic effect of alpha-mangostin.,"['Shiozaki T', 'Fukai M', 'Hermawati E', 'Juliawaty LD', 'Syah YM', 'Hakim EH', 'Puthongking P', 'Suzuki T', 'Kinoshita K', 'Takahashi K', 'Koyama K']","['Angiogenesis Inhibitors/chemistry/*pharmacology', 'Garcinia mangostana/chemistry', 'Phosphorylation/drug effects', 'Receptor Protein-Tyrosine Kinases/metabolism', 'Xanthones/chemistry/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/22382862/
623,KDR,36601864,AMG232 inhibits angiogenesis in glioma through the p53-RBM4-VEGFR2 pathway.,"['Xiao Y', 'Li M', 'Ma T', 'Ning H', 'Liu L']","['Humans', 'Cell Movement', 'Cell Proliferation/physiology', '*Endothelial Cells/metabolism', '*Glioma/drug therapy/genetics', 'Neovascularization, Pathologic/drug therapy/metabolism', 'RNA-Binding Proteins/metabolism', 'Tumor Suppressor Protein p53/genetics/metabolism', 'Vascular Endothelial Growth Factor A/metabolism', 'Vascular Endothelial Growth Factor Receptor-2/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36601864/
624,KDR,9839443,Vascular endothelial growth factor.,['Zachary I'],"['Animals', 'Endothelial Growth Factors/chemistry/metabolism/*physiology', 'Endothelium, Vascular/*embryology', 'Gene Expression Regulation, Developmental', 'Humans', 'Hypoxia/genetics/*metabolism', 'Lymphokines/chemistry/metabolism/*physiology', '*Neovascularization, Physiologic', 'Proto-Oncogene Proteins/metabolism', 'Receptor Protein-Tyrosine Kinases/metabolism', 'Receptors, Growth Factor/metabolism', 'Receptors, Vascular Endothelial Growth Factor', 'Vascular Endothelial Growth Factor A', 'Vascular Endothelial Growth Factor Receptor-1', 'Vascular Endothelial Growth Factors']",https://pubmed.ncbi.nlm.nih.gov/9839443/
625,KDR,23171577,Quantification of circulating CD34+/KDR+/CD45dim endothelial progenitor cells: analytical considerations.,"['Van Craenenbroeck EM', 'Van Craenenbroeck AH', 'van Ierssel S', 'Bruyndonckx L', 'Hoymans VY', 'Vrints CJ', 'Conraads VM']","['Animals', 'Antigens, CD34/*blood', 'Cardiovascular Diseases/blood/immunology/pathology', 'Cell Movement/immunology', 'Endothelial Cells/chemistry/*metabolism/pathology', 'Flow Cytometry/*methods/standards', 'Humans', 'Leukocyte Common Antigens/*blood', 'Neovascularization, Physiologic', 'Stem Cells/chemistry/*metabolism/pathology', 'Vascular Endothelial Growth Factor Receptor-2/*blood']",https://pubmed.ncbi.nlm.nih.gov/23171577/
626,KDR,30956148,Complex Formation between VEGFR2 and the beta(2)-Adrenoceptor.,"['Kilpatrick LE', 'Alcobia DC', 'White CW', 'Peach CJ', 'Glenn JR', 'Zimmerman K', 'Kondrashov A', 'Pfleger KDG', 'Ohana RF', 'Robers MB', 'Wood KV', 'Sloan EK', 'Woolard J', 'Hill SJ']","['Bioluminescence Resonance Energy Transfer Techniques', 'Cells, Cultured', 'Fluorescent Dyes/chemistry', 'HEK293 Cells', 'Humans', 'Ligands', 'Luciferases/chemistry/metabolism', 'Protein Binding', 'Receptors, Adrenergic, beta-2/chemistry/*metabolism', 'Vascular Endothelial Growth Factor Receptor-2/chemistry/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/30956148/
627,KDR,39665142,Extracellular Vesicles From Preeclampsia Disrupt the Blood-Brain Barrier by Reducing CLDN5.,"['Sandoval H', 'Ibanez B', 'Contreras M', 'Troncoso F', 'Castro FO', 'Caamano D', 'Mendez L', 'Escudero-Guevara E', 'Nualart F', 'Mistry HD', 'Kurlak LO', 'Vatish M', 'Acurio J', 'Escudero C']","['*Pre-Eclampsia/metabolism/physiopathology/blood', 'Female', '*Claudin-5/metabolism/genetics', 'Animals', 'Pregnancy', 'Humans', '*Blood-Brain Barrier/metabolism', '*Extracellular Vesicles/metabolism', '*Mice, Inbred C57BL', '*Endothelial Cells/metabolism/pathology', '*Vascular Endothelial Growth Factor A/metabolism', '*Placenta/metabolism', '*Vascular Endothelial Growth Factor Receptor-2/metabolism', 'Disease Models, Animal', 'Cell Line', 'Adult', 'Case-Control Studies', 'Mice', 'Capillary Permeability', 'Down-Regulation', 'Signal Transduction', 'Cell Hypoxia']",https://pubmed.ncbi.nlm.nih.gov/39665142/
628,KDR,37298503,Deciphering the Cardiovascular Potential of Human CD34(+) Stem Cells.,"['Aries A', 'Zanetti C', 'Henon P', 'Drenou B', 'Lahlil R']","['Humans', '*Stem Cells/metabolism', 'Myocardium/metabolism', 'Antigens, CD34/metabolism', 'Myocytes, Cardiac/metabolism', '*Myocardial Infarction/metabolism', 'Cell Differentiation/physiology', 'Cell Adhesion Molecules/metabolism', 'Frizzled Receptors/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37298503/
629,KDR,11166270,Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.,"['Zachary I', 'Gliki G']","['Animals', 'Capillary Permeability', 'Cell Division', 'Cell Movement', '*Collateral Circulation', 'DNA-Binding Proteins/genetics', 'Early Growth Response Protein 1', 'Endothelial Growth Factors/*metabolism', 'Endothelium, Vascular/*metabolism/pathology', 'Epoprostenol/metabolism', 'Gene Expression Regulation', 'Humans', '*Immediate-Early Proteins', 'Lymphokines/*metabolism', '*Milk Proteins', 'Myocardial Ischemia/*metabolism/pathology/physiopathology', 'NFATC Transcription Factors', '*Neovascularization, Physiologic', 'Nitric Oxide/metabolism', '*Nuclear Proteins', 'Proto-Oncogene Proteins/genetics/metabolism', 'Proto-Oncogene Proteins c-ets', 'Receptor Protein-Tyrosine Kinases/metabolism', 'Receptors, Growth Factor/metabolism', 'Receptors, Vascular Endothelial Growth Factor', 'STAT3 Transcription Factor', 'STAT5 Transcription Factor', 'Signal Transduction/genetics/*physiology', 'Trans-Activators/genetics', 'Transcription Factors/genetics', 'Vascular Endothelial Growth Factor A', 'Vascular Endothelial Growth Factor Receptor-1', 'Vascular Endothelial Growth Factor Receptor-3', 'Vascular Endothelial Growth Factors']",https://pubmed.ncbi.nlm.nih.gov/11166270/
630,KDR,33370709,Dihydroartemisinin inhibits the tumorigenesis and invasion of gastric cancer by regulating STAT1/KDR/MMP9 and P53/BCL2L1/CASP3/7 pathways.,"['Liang R', 'Chen W', 'Chen XY', 'Fan HN', 'Zhang J', 'Zhu JS']","['Animals', 'Antineoplastic Agents/*pharmacology', 'Apoptosis Regulatory Proteins/genetics/*metabolism', 'Artemisinins/*pharmacology', 'Caspase 3/genetics/metabolism', 'Caspase 7/genetics/metabolism', 'Cell Line, Tumor', 'Cell Movement/drug effects', 'Cell Proliferation/drug effects', 'Databases, Genetic', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Matrix Metalloproteinase 9/genetics/*metabolism', 'Mice, Nude', 'Neoplasm Invasiveness', 'STAT1 Transcription Factor/genetics/*metabolism', 'Signal Transduction', 'Stomach Neoplasms/*drug therapy/genetics/metabolism/pathology', 'Tumor Suppressor Protein p53/genetics/*metabolism', 'Vascular Endothelial Growth Factor Receptor-2/genetics/*metabolism', 'Xenograft Model Antitumor Assays', 'bcl-X Protein/genetics/metabolism', 'Mice']",https://pubmed.ncbi.nlm.nih.gov/33370709/
631,KDR,30816803,DKK3 (Dikkopf-3) Transdifferentiates Fibroblasts Into Functional Endothelial Cells-Brief Report.,"['Chen T', 'Karamariti E', 'Hong X', 'Deng J', 'Wu Y', 'Gu W', 'Simpson R', 'Wong MM', 'Yu B', 'Hu Y', 'Qu A', 'Xu Q', 'Zhang L']","['Adaptor Proteins, Signal Transducing/*physiology', 'Animals', 'Bioreactors', 'Cell Transdifferentiation/*physiology', 'Cells, Cultured', 'Culture Media', 'Endothelial Cells/*cytology', 'Epithelial-Mesenchymal Transition/physiology', 'Fibroblasts/cytology/*drug effects', 'Humans', 'Mice', 'Mice, Inbred NOD', 'MicroRNAs/physiology', 'Neovascularization, Physiologic', 'Recombinant Proteins/biosynthesis', 'STAT3 Transcription Factor/physiology', 'Vascular Endothelial Growth Factor Receptor-2/genetics']",https://pubmed.ncbi.nlm.nih.gov/30816803/
632,KDR,30332959,Utilization of Apatinib-Loaded Nanoparticles for the Treatment of Ocular Neovascularization.,"['Halasz K', 'Kelly SJ', 'Iqbal MT', 'Pathak Y', 'Sutariya V']","['Antineoplastic Agents/*administration & dosage/chemistry', 'Cell Line', 'Drug Carriers/*administration & dosage/chemistry', 'Eye Diseases/drug therapy', 'Humans', 'Nanoparticles/*administration & dosage/chemistry', 'Neovascularization, Pathologic/drug therapy', 'Protein Kinase Inhibitors/*administration & dosage/chemistry', 'Pyridines/*administration & dosage/chemistry', 'Vascular Endothelial Growth Factor A/metabolism', 'Vascular Endothelial Growth Factor Receptor-2/metabolism']",https://pubmed.ncbi.nlm.nih.gov/30332959/
633,KDR,34000264,Network pharmacology-based evaluation of natural compounds with paclitaxel for the treatment of metastatic breast cancer.,"['Rathaur P', 'Soni MN', 'Gelat B', 'Rawal R', 'Pandya HA', 'Johar K']","['Animals', 'Antineoplastic Agents, Phytogenic/administration & dosage/*metabolism', 'Biological Products/administration & dosage/chemistry/*metabolism', 'Breast Neoplasms/drug therapy/*metabolism/pathology', 'Cell Line, Tumor', 'Cell Survival/drug effects/physiology', 'Chick Embryo', 'Dose-Response Relationship, Drug', 'Drug Evaluation, Preclinical/methods', 'Female', 'Humans', 'Molecular Docking Simulation/methods', 'Paclitaxel/administration & dosage/*metabolism', 'Protein Structure, Secondary', 'Protein Structure, Tertiary', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/34000264/
634,KDR,12965085,Regulation of embryonic implantation.,"['Krussel JS', 'Bielfeld P', 'Polan ML', 'Simon C']","['Animals', 'Blastocyst/chemistry/physiology', 'Embryo Implantation/*physiology', 'Embryonic and Fetal Development', 'Endometrium/physiology', 'Female', 'Gene Expression', 'Humans', 'Interleukin-1/genetics/physiology', 'Mice', 'Mice, Knockout', 'Neovascularization, Physiologic', 'Pregnancy', 'Receptors, Interleukin-1/physiology', 'Vascular Endothelial Growth Factor A/genetics/physiology']",https://pubmed.ncbi.nlm.nih.gov/12965085/
635,KDR,14691147,VEGF and KDR gene expression during human embryonic and fetal eye development.,"['Gogat K', 'Le Gat L', 'Van Den Berghe L', 'Marchant D', 'Kobetz A', 'Gadin S', 'Gasser B', 'Quere I', 'Abitbol M', 'Menasche M']","['Antibodies, Monoclonal', 'DNA Primers/chemistry', 'DNA Probes', 'Embryonic and Fetal Development/*physiology', 'Eye/blood supply/*embryology/metabolism', 'Gene Expression Regulation, Developmental/*physiology', 'Humans', 'Immunoenzyme Techniques', 'In Situ Hybridization', 'Neovascularization, Physiologic/physiology', 'Platelet Endothelial Cell Adhesion Molecule-1/metabolism', 'RNA, Messenger/metabolism', 'Vascular Endothelial Growth Factor A/*genetics', 'Vascular Endothelial Growth Factor Receptor-2/*genetics']",https://pubmed.ncbi.nlm.nih.gov/14691147/
636,ABL1,28972016,Philadelphia chromosome-like acute lymphoblastic leukemia.,"['Tasian SK', 'Loh ML', 'Hunger SP']","['Animals', '*Fusion Proteins, bcr-abl/genetics/metabolism', 'Humans', '*Philadelphia Chromosome', 'Precursor Cell Lymphoblastic Leukemia-Lymphoma/*genetics/metabolism', 'Signal Transduction/*genetics', '*Translocation, Genetic']",https://pubmed.ncbi.nlm.nih.gov/28972016/
637,ABL1,30370478,Chronic Myeloid Leukemia: Beyond BCR-ABL1.,"['Zhou T', 'Medeiros LJ', 'Hu S']","['Fusion Proteins, bcr-abl/*genetics', 'Humans', 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*diagnosis/genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/30370478/
638,ABL1,25207766,Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.,"['Roberts KG', 'Li Y', 'Payne-Turner D', 'Harvey RC', 'Yang YL', 'Pei D', 'McCastlain K', 'Ding L', 'Lu C', 'Song G', 'Ma J', 'Becksfort J', 'Rusch M', 'Chen SC', 'Easton J', 'Cheng J', 'Boggs K', 'Santiago-Morales N', 'Iacobucci I', 'Fulton RS', 'Wen J', 'Valentine M', 'Cheng C', 'Paugh SW', 'Devidas M', 'Chen IM', 'Reshmi S', 'Smith A', 'Hedlund E', 'Gupta P', 'Nagahawatte P', 'Wu G', 'Chen X', 'Yergeau D', 'Vadodaria B', 'Mulder H', 'Winick NJ', 'Larsen EC', 'Carroll WL', 'Heerema NA', 'Carroll AJ', 'Grayson G', 'Tasian SK', 'Moore AS', 'Keller F', 'Frei-Jones M', 'Whitlock JA', 'Raetz EA', 'White DL', 'Hughes TP', 'Guidry Auvil JM', 'Smith MA', 'Marcucci G', 'Bloomfield CD', 'Mrozek K', 'Kohlschmidt J', 'Stock W', 'Kornblau SM', 'Konopleva M', 'Paietta E', 'Pui CH', 'Jeha S', 'Relling MV', 'Evans WE', 'Gerhard DS', 'Gastier-Foster JM', 'Mardis E', 'Wilson RK', 'Loh ML', 'Downing JR', 'Hunger SP', 'Willman CL', 'Zhang J', 'Mullighan CG']","['Adolescent', 'Adult', 'Animals', 'Child', 'Child, Preschool', 'DNA, Neoplasm/analysis', 'Female', 'Genome, Human', 'Heterografts', 'Humans', 'Infant', 'Male', 'Mice', 'Oligonucleotide Array Sequence Analysis', 'Philadelphia Chromosome', 'Polymorphism, Single Nucleotide', 'Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy/*genetics/metabolism/mortality', 'Protein Kinase Inhibitors/*therapeutic use', 'Protein-Tyrosine Kinases/antagonists & inhibitors', 'Receptors, Cytokine/genetics/metabolism', 'Signal Transduction/genetics', 'Survival Analysis', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/25207766/
639,ABL1,37120350,Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.,"['Davis K', 'Sheikh T', 'Aggarwal N']","['Humans', 'Core Binding Factor Alpha 2 Subunit/genetics', '*Precursor T-Cell Lymphoblastic Leukemia-Lymphoma', 'Oncogene Proteins, Fusion/genetics/metabolism', '*Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics/diagnosis', '*Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/genetics/metabolism/pathology', 'Repressor Proteins', 'Tumor Suppressor Proteins', 'Transcription Factors']",https://pubmed.ncbi.nlm.nih.gov/37120350/
640,ABL1,18827185,Molecular biology of bcr-abl1-positive chronic myeloid leukemia.,"['Quintas-Cardama A', 'Cortes J']","['Animals', 'Fusion Proteins, bcr-abl/*genetics/*metabolism', 'Gene Expression Regulation, Leukemic/*physiology', 'Humans', 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*genetics/*physiopathology', 'Molecular Biology', 'Signal Transduction/physiology']",https://pubmed.ncbi.nlm.nih.gov/18827185/
641,ABL1,35021069,"Development of asciminib, a novel allosteric inhibitor of BCR-ABL1.","['Rea D', 'Hughes TP']","['*Drug Resistance, Neoplasm/genetics', 'Fusion Proteins, bcr-abl/genetics/metabolism', 'Humans', 'Niacinamide/analogs & derivatives/pharmacology/therapeutic use', '*Protein Kinase Inhibitors/pharmacology/therapeutic use', 'Pyrazoles/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/35021069/
642,ABL1,28408464,Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.,"['Reshmi SC', 'Harvey RC', 'Roberts KG', 'Stonerock E', 'Smith A', 'Jenkins H', 'Chen IM', 'Valentine M', 'Liu Y', 'Li Y', 'Shao Y', 'Easton J', 'Payne-Turner D', 'Gu Z', 'Tran TH', 'Nguyen JV', 'Devidas M', 'Dai Y', 'Heerema NA', 'Carroll AJ 3rd', 'Raetz EA', 'Borowitz MJ', 'Wood BL', 'Angiolillo AL', 'Burke MJ', 'Salzer WL', 'Zweidler-McKay PA', 'Rabin KR', 'Carroll WL', 'Zhang J', 'Loh ML', 'Mullighan CG', 'Willman CL', 'Gastier-Foster JM', 'Hunger SP']","['Child', 'Female', 'Fusion Proteins, bcr-abl/genetics', 'Gene Expression Regulation, Leukemic', '*Gene Fusion', 'Humans', 'Interleukin-7 Receptor alpha Subunit/genetics', 'Janus Kinase 2/genetics', 'Male', 'Mutation', 'Philadelphia Chromosome', 'Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/*genetics', 'Protein Kinases/*genetics', 'Receptors, Cytokine/genetics', 'Retrospective Studies', 'Transcriptome']",https://pubmed.ncbi.nlm.nih.gov/28408464/
643,ABL1,28329763,The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1.,"['Wylie AA', 'Schoepfer J', 'Jahnke W', 'Cowan-Jacob SW', 'Loo A', 'Furet P', 'Marzinzik AL', 'Pelle X', 'Donovan J', 'Zhu W', 'Buonamici S', 'Hassan AQ', 'Lombardo F', 'Iyer V', 'Palmer M', 'Berellini G', 'Dodd S', 'Thohan S', 'Bitter H', 'Branford S', 'Ross DM', 'Hughes TP', 'Petruzzelli L', 'Vanasse KG', 'Warmuth M', 'Hofmann F', 'Keen NJ', 'Sellers WR']","['Allosteric Regulation/drug effects', 'Allosteric Site/*drug effects', 'Animals', 'Catalytic Domain/drug effects', 'Cell Proliferation/drug effects', 'Dasatinib/therapeutic use', 'Drug Resistance, Neoplasm/drug effects/genetics', 'Drug Therapy, Combination', 'Fusion Proteins, bcr-abl/*antagonists & inhibitors/chemistry/genetics', 'Humans', 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy/enzymology/genetics/pathology', 'Mice', 'Mutation', 'Niacinamide/*analogs & derivatives/pharmacology/therapeutic use', 'Pyrazoles/*pharmacology/therapeutic use', 'Pyrimidines/pharmacology/therapeutic use', 'Xenograft Model Antitumor Assays']",https://pubmed.ncbi.nlm.nih.gov/28329763/
644,ABL1,37183966,Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT-PCR for BCR::ABL1.,"['Short NJ', 'Jabbour E', 'Macaron W', 'Ravandi F', 'Jain N', 'Kanagal-Shamanna R', 'Patel KP', 'Loghavi S', 'Haddad FG', 'Yilmaz M', 'Issa GC', 'Kebriaei P', 'Kornblau SM', 'Pelletier S', 'Flores W', 'Matthews J', 'Garris R', 'Kantarjian H']","['Humans', '*Fusion Proteins, bcr-abl/genetics', 'Prognosis', 'Reverse Transcriptase Polymerase Chain Reaction', '*Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis/genetics/drug therapy', 'Neoplasm, Residual/diagnosis/genetics', 'High-Throughput Nucleotide Sequencing', 'Recurrence']",https://pubmed.ncbi.nlm.nih.gov/37183966/
645,ABL1,33096322,"The specificity of asciminib, a potential treatment for chronic myeloid leukemia, as a myristate-pocket binding ABL inhibitor and analysis of its interactions with mutant forms of BCR-ABL1 kinase.","['Manley PW', 'Barys L', 'Cowan-Jacob SW']","['Binding Sites', 'Cell Proliferation/*drug effects', 'Drug Resistance, Neoplasm/*drug effects/genetics', '*Fusion Proteins, bcr-abl/antagonists & inhibitors/genetics/metabolism', 'Humans', '*Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy/enzymology/genetics/pathology', '*Mutation', 'Niacinamide/*analogs & derivatives/pharmacokinetics/therapeutic use', '*Pyrazoles/pharmacokinetics/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/33096322/
646,ABL1,37337105,Transcriptomic classes of BCR-ABL1 lymphoblastic leukemia.,"['Kim JC', 'Chan-Seng-Yue M', 'Ge S', 'Zeng AGX', 'Ng K', 'Gan OI', 'Garcia-Prat L', 'Flores-Figueroa E', 'Woo T', 'Zhang AXW', 'Arruda A', 'Chithambaram S', 'Dobson SM', 'Khoo A', 'Khan S', 'Ibrahimova N', 'George A', 'Tierens A', 'Hitzler J', 'Kislinger T', 'Dick JE', 'McPherson JD', 'Minden MD', 'Notta F']","['Humans', '*Fusion Proteins, bcr-abl/genetics/metabolism', 'Transcriptome/genetics', '*Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics', 'Gene Expression Profiling', 'Cell Differentiation/genetics', 'Protein Kinase Inhibitors/pharmacology/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/37337105/
647,ABL1,39028928,Significance of Measurable Residual Disease in Adult Philadelphia Chromosome-Positive ALL: A GRAAPH-2014 Study.,"['Kim R', 'Chalandon Y', 'Rousselot P', 'Cayuela JM', 'Huguet F', 'Balsat M', 'Passet M', 'Chevallier P', 'Hicheri Y', 'Raffoux E', 'Leguay T', 'Chantepie S', 'Maury S', 'Hayette S', 'Solly F', 'Braun T', 'De Prijck B', 'Cacheux V', 'Salanoubat C', 'Farnault L', 'Guibaud I', 'Lamarque M', 'Gastaud L', 'Lemasle E', 'Brissot E', 'Tavernier E', 'Bilger K', 'Villate A', 'Soulier J', 'Graux C', 'Lheritier V', 'Dombret H', 'Boissel N', 'Clappier E']","['Humans', '*Neoplasm, Residual', 'Adult', 'Male', 'Female', 'Middle Aged', '*Hematopoietic Stem Cell Transplantation', '*Philadelphia Chromosome', '*Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics/therapy/mortality/pathology', 'Pyrimidines/therapeutic use', 'Young Adult', 'Fusion Proteins, bcr-abl/genetics', 'Aged', 'Prognosis', 'Antineoplastic Combined Chemotherapy Protocols/therapeutic use', 'Adolescent', 'Proto-Oncogene Proteins c-abl/genetics']",https://pubmed.ncbi.nlm.nih.gov/39028928/
648,ABL1,38153913,Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL.,"['Bastian L', 'Beder T', 'Barz MJ', 'Bendig S', 'Bartsch L', 'Walter W', 'Wolgast N', 'Brandl B', 'Rohrandt C', 'Hansen BT', 'Hartmann AM', 'Iben K', 'Das Gupta D', 'Denker M', 'Zimmermann J', 'Wittig M', 'Chitadze G', 'Neumann M', 'Schneller F', 'Fiedler W', 'Steffen B', 'Stelljes M', 'Faul C', 'Schwartz S', 'Muller FJ', 'Cario G', 'Harder L', 'Haferlach C', 'Pfeifer H', 'Gokbuget N', 'Bruggemann M', 'Baldus CD']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Child', 'Child, Preschool', 'Humans', 'Middle Aged', 'Young Adult', 'Acute Disease', 'Chromosome Deletion', '*Fusion Proteins, bcr-abl/genetics', 'Genomics', 'In Situ Hybridization, Fluorescence', '*Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics']",https://pubmed.ncbi.nlm.nih.gov/38153913/
649,ABL1,38643492,BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib.,"['Leyte-Vidal A', 'Garrido Ruiz D', 'DeFilippis R', 'Leske IB', 'Rea D', 'Phan S', 'Miller KB', 'Hu F', 'Mase A', 'Shan Y', 'Hantschel O', 'Jacobson MP', 'Shah NP']","['Humans', '*Drug Resistance, Neoplasm/genetics', '*Protein Kinase Inhibitors/pharmacology/therapeutic use', '*Fusion Proteins, bcr-abl/genetics/chemistry', '*Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy/genetics', 'Mutation', 'Adenosine Triphosphate/metabolism', 'Proto-Oncogene Proteins c-abl/genetics/metabolism/chemistry', 'Niacinamide/analogs & derivatives', 'Pyrazoles']",https://pubmed.ncbi.nlm.nih.gov/38643492/
650,ABL1,31543464,Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants.,"['Eide CA', 'Zabriskie MS', 'Savage Stevens SL', 'Antelope O', 'Vellore NA', 'Than H', 'Schultz AR', 'Clair P', 'Bowler AD', 'Pomicter AD', 'Yan D', 'Senina AV', 'Qiang W', 'Kelley TW', 'Szankasi P', 'Heinrich MC', 'Tyner JW', 'Rea D', 'Cayuela JM', 'Kim DW', 'Tognon CE', ""O'Hare T"", 'Druker BJ', 'Deininger MW']","['Allosteric Regulation/drug effects', 'Animals', 'Antineoplastic Combined Chemotherapy Protocols/*pharmacology/therapeutic use', 'Binding Sites/drug effects/genetics', 'Cell Line, Tumor/transplantation', 'Disease Models, Animal', 'Drug Resistance, Neoplasm/*drug effects/genetics', 'Female', 'Fusion Proteins, bcr-abl/*antagonists & inhibitors/genetics/metabolism', 'Humans', 'Imidazoles/*pharmacology/therapeutic use', 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy/genetics/pathology', 'Mice', 'Molecular Docking Simulation', 'Molecular Dynamics Simulation', 'Molecular Targeted Therapy/methods', 'Mutation', 'Niacinamide/*analogs & derivatives/pharmacology/therapeutic use', 'Primary Cell Culture', 'Pyrazoles/*pharmacology/therapeutic use', 'Pyridazines/*pharmacology/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/31543464/
651,ABL1,30466746,Why and how to treat Ph-like ALL?,['Roberts KG'],"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Female', '*Fusion Proteins, bcr-abl/antagonists & inhibitors/genetics/metabolism', 'Humans', 'Infant', 'Male', '*Mutation', '*Philadelphia Chromosome', '*Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy/genetics/metabolism/pathology', 'Protein Kinase Inhibitors/*therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/30466746/
652,ABL1,33038988,CML - Not only BCR-ABL1 matters.,"['Rinke J', 'Hochhaus A', 'Ernst T']","['*DNA (Cytosine-5-)-Methyltransferases/biosynthesis/genetics', 'DNA Methyltransferase 3A', '*DNA-Binding Proteins/biosynthesis/genetics', 'Dioxygenases', '*Epigenesis, Genetic', '*Fusion Proteins, bcr-abl/biosynthesis/genetics', '*Gene Expression Regulation, Leukemic', 'Humans', '*Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics/metabolism/pathology', '*Proto-Oncogene Proteins/biosynthesis/genetics', '*Repressor Proteins/biosynthesis/genetics']",https://pubmed.ncbi.nlm.nih.gov/33038988/
653,ABL1,27233483,The Philadelphia chromosome in leukemogenesis.,"['Kang ZJ', 'Liu YF', 'Xu LZ', 'Long ZJ', 'Huang D', 'Yang Y', 'Liu B', 'Feng JX', 'Pan YJ', 'Yan JS', 'Liu Q']","['Carcinogenesis', 'Cell Proliferation', 'Fusion Proteins, bcr-abl/*genetics', 'Genomic Instability', 'Humans', 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*genetics/pathology', 'Leukemia, Myeloid, Acute/*genetics/pathology', 'Philadelphia Chromosome', 'Precursor Cell Lymphoblastic Leukemia-Lymphoma/*genetics/pathology', 'Prognosis', 'Proto-Oncogene Mas']",https://pubmed.ncbi.nlm.nih.gov/27233483/
654,ABL1,38653245,Integrated drug profiling and CRISPR screening identify BCR::ABL1-independent vulnerabilities in chronic myeloid leukemia.,"['Adnan Awad S', 'Dufva O', 'Klievink J', 'Karjalainen E', 'Ianevski A', 'Pietarinen P', 'Kim D', 'Potdar S', 'Wolf M', 'Lotfi K', 'Aittokallio T', 'Wennerberg K', 'Porkka K', 'Mustjoki S']","['Humans', '*Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics/drug therapy/pathology/metabolism', '*Fusion Proteins, bcr-abl/genetics/metabolism/antagonists & inhibitors', '*Protein Kinase Inhibitors/pharmacology', 'CRISPR-Cas Systems/genetics', 'Drug Resistance, Neoplasm/genetics/drug effects', 'Proto-Oncogene Proteins c-abl/metabolism/genetics/antagonists & inhibitors', 'Cell Line, Tumor']",https://pubmed.ncbi.nlm.nih.gov/38653245/
655,ABL1,25814077,Natural course and biology of CML.,"['Chereda B', 'Melo JV']","['Animals', '*Disease Progression', 'Humans', 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive/diagnosis/genetics/metabolism/*physiopathology', 'Mutation', 'Neoplasm Proteins/chemistry/genetics/metabolism', 'Prognosis']",https://pubmed.ncbi.nlm.nih.gov/25814077/
656,PDGFRB,36068374,Updates on eosinophilic disorders.,"['Tzankov A', 'Reichard KK', 'Hasserjian RP', 'Arber DA', 'Orazi A', 'Wang SA']","['Humans', '*Hypereosinophilic Syndrome/diagnosis/genetics', '*Leukemia/pathology', '*Myeloproliferative Disorders/diagnosis/genetics/pathology', 'Receptor, Platelet-Derived Growth Factor beta/genetics', 'Bone Marrow/pathology', 'Oncogene Proteins, Fusion/genetics']",https://pubmed.ncbi.nlm.nih.gov/36068374/
657,PDGFRB,29434033,PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia.,"['Zhang Y', 'Gao Y', 'Zhang H', 'Zhang J', 'He F', 'Hnizda A', 'Qian M', 'Liu X', 'Gocho Y', 'Pui CH', 'Cheng T', 'Wang Q', 'Yang JJ', 'Zhu X', 'Liu X']","['Angiogenic Proteins/genetics', 'Antineoplastic Agents/*pharmacology/therapeutic use', 'Cell Line, Tumor', 'Child, Preschool', 'Drug Resistance, Neoplasm/*genetics', 'Humans', 'Male', '*Mutation', 'Oncogene Proteins, Fusion', 'Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy/*genetics/metabolism/pathology', 'Protein Kinase Inhibitors/*pharmacology/therapeutic use', 'Receptor, Platelet-Derived Growth Factor beta/*genetics', 'Recurrence', 'Treatment Outcome', 'Whole Genome Sequencing']",https://pubmed.ncbi.nlm.nih.gov/29434033/
658,PDGFRB,31738635,Myofibromatosis.,"['Rastogi K', 'Singh L']","['Child', 'Diagnosis, Differential', 'Humans', 'Male', 'Mutation', '*Myofibroma/diagnosis/genetics', '*Myofibromatosis/diagnosis/genetics', 'Receptor, Platelet-Derived Growth Factor beta/genetics']",https://pubmed.ncbi.nlm.nih.gov/31738635/
659,PDGFRB,34686668,A human multi-lineage hepatic organoid model for liver fibrosis.,"['Guan Y', 'Enejder A', 'Wang M', 'Fang Z', 'Cui L', 'Chen SY', 'Wang J', 'Tan Y', 'Wu M', 'Chen X', 'Johansson PK', 'Osman I', 'Kunimoto K', 'Russo P', 'Heilshorn SC', 'Peltz G']","['Bile Duct Diseases/genetics/metabolism/pathology', 'Collagen/metabolism', 'Epithelial Cells/pathology', 'Humans', 'Induced Pluripotent Stem Cells/cytology', 'Liver/drug effects/metabolism/pathology', 'Liver Cirrhosis/drug therapy/genetics/metabolism/*pathology', '*Models, Biological', 'Mutation', 'Myofibroblasts/metabolism/pathology', 'Organoids/drug effects/metabolism/*pathology', 'Polycystic Kidney, Autosomal Recessive/drug therapy/genetics/metabolism/pathology', 'Receptor, Platelet-Derived Growth Factor beta/antagonists & inhibitors/metabolism', 'STAT3 Transcription Factor/metabolism', 'Signal Transduction', 'Transforming Growth Factor beta/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34686668/
660,PDGFRB,27796903,Hepatic Telocytes.,"['Zhao Y', 'Chen X', 'Wang F', 'Yang C']","['Animals', 'Antigens, CD34/genetics/metabolism', 'Biomarkers/metabolism', 'Gene Expression', 'Homeostasis/physiology', 'Humans', 'Immunohistochemistry', 'Liver/metabolism/*ultrastructure', 'Liver Cirrhosis/genetics/metabolism/*pathology', 'Liver Regeneration/*physiology', 'Mice', 'Microscopy, Electron, Transmission', 'Proto-Oncogene Proteins c-kit/genetics/metabolism', 'Receptor, Platelet-Derived Growth Factor beta/genetics/metabolism', 'Telocytes/metabolism/*ultrastructure']",https://pubmed.ncbi.nlm.nih.gov/27796903/
661,PDGFRB,31287804,Stromal integrin alpha11 regulates PDGFR-beta signaling and promotes breast cancer progression.,"['Primac I', 'Maquoi E', 'Blacher S', 'Heljasvaara R', 'Van Deun J', 'Smeland HY', 'Canale A', 'Louis T', 'Stuhr L', 'Sounni NE', 'Cataldo D', 'Pihlajaniemi T', 'Pequeux C', 'De Wever O', 'Gullberg D', 'Noel A']","['Animals', 'Breast Neoplasms/genetics/*metabolism/pathology', 'Cancer-Associated Fibroblasts/metabolism/pathology', 'Female', '*Gene Expression Regulation, Neoplastic', 'Humans', 'Integrin alpha Chains/genetics/*metabolism', 'Mammary Neoplasms, Experimental/genetics/*metabolism/pathology', 'Mice', 'Mice, Knockout', 'Neoplasm Invasiveness', 'Neoplasm Proteins/genetics/*metabolism', 'Receptor, Platelet-Derived Growth Factor beta/*biosynthesis/genetics']",https://pubmed.ncbi.nlm.nih.gov/31287804/
662,PDGFRB,22449622,Eosinophilic myeloid disorders.,['Noel P'],"['Animals', 'Eosinophilia/classification/*metabolism/pathology', 'Eosinophils/*metabolism/pathology', 'Humans', 'Hypereosinophilic Syndrome/classification/*metabolism/pathology', 'Myeloproliferative Disorders/classification/*metabolism/pathology', 'Receptor, Fibroblast Growth Factor, Type 1/metabolism', 'Receptor, Platelet-Derived Growth Factor alpha/metabolism', 'Receptor, Platelet-Derived Growth Factor beta/metabolism', 'World Health Organization']",https://pubmed.ncbi.nlm.nih.gov/22449622/
663,PDGFRB,28028030,Myeloid neoplasms with eosinophilia.,"['Reiter A', 'Gotlib J']","['Antineoplastic Agents/*therapeutic use', 'Eosinophilia/diagnosis/genetics/pathology/*therapy', '*Gene Expression Regulation, Neoplastic', '*Hematopoietic Stem Cell Transplantation', 'Humans', 'Hypereosinophilic Syndrome/diagnosis/genetics/pathology/*therapy', 'Janus Kinase 2/antagonists & inhibitors/genetics/metabolism', 'Leukemia/diagnosis/genetics/pathology/*therapy', 'Myeloproliferative Disorders/diagnosis/genetics/pathology/*therapy', 'Oncogene Proteins, Fusion/antagonists & inhibitors/genetics/metabolism', 'Protein Kinase Inhibitors/*therapeutic use', 'Proto-Oncogene Proteins c-abl/antagonists & inhibitors/genetics/metabolism', 'Receptor, Fibroblast Growth Factor, Type 1/antagonists & inhibitors/genetics/metabolism', 'Receptor, Platelet-Derived Growth Factor alpha/antagonists & inhibitors/genetics/metabolism', 'Receptor, Platelet-Derived Growth Factor beta/antagonists & inhibitors/genetics/metabolism', 'Transplantation, Homologous', 'fms-Like Tyrosine Kinase 3']",https://pubmed.ncbi.nlm.nih.gov/28028030/
664,PDGFRB,33619382,Multiple cell types contribute to the atherosclerotic lesion fibrous cap by PDGFRbeta and bioenergetic mechanisms.,"['Newman AAC', 'Serbulea V', 'Baylis RA', 'Shankman LS', 'Bradley X', 'Alencar GF', 'Owsiany K', 'Deaton RA', 'Karnewar S', 'Shamsuzzaman S', 'Salamon A', 'Reddy MS', 'Guo L', 'Finn A', 'Virmani R', 'Cherepanova OA', 'Owens GK']","['Actins/metabolism', 'Animals', 'Apolipoproteins E/genetics', 'Brachial Artery/pathology', 'Diet, Western', 'Endothelial Cells/metabolism/pathology', 'Energy Metabolism/*genetics', 'Epithelial-Mesenchymal Transition', 'Female', 'Fibroblasts/metabolism/pathology', 'Humans', 'Macrophages/metabolism', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Mice, Knockout', 'Myocytes, Smooth Muscle/pathology', 'Plaque, Atherosclerotic/metabolism/*pathology', 'Receptor, Platelet-Derived Growth Factor beta/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/33619382/
665,PDGFRB,36997513,Characterization of mesenchymal stem cells in human fetal bone marrow by single-cell transcriptomic and functional analysis.,"['Zhang P', 'Dong J', 'Fan X', 'Yong J', 'Yang M', 'Liu Y', 'Zhang X', 'Lv L', 'Wen L', 'Qiao J', 'Tang F', 'Zhou Y']","['Humans', '*Bone Marrow', 'Transcriptome/genetics', 'Receptor, Platelet-Derived Growth Factor beta/metabolism', 'Bone Marrow Cells/metabolism', '*Mesenchymal Stem Cells/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36997513/
666,PDGFRB,38652223,Exploring the impact of PDGFD in osteosarcoma metastasis through single-cell sequencing analysis.,"['Huang Y', 'Cao D', 'Zhang M', 'Yang Y', 'Niu G', 'Tang L', 'Shen Z', 'Zhang Z', 'Bai Y', 'Min D', 'He A']","['*Osteosarcoma/genetics/pathology/metabolism', 'Humans', '*Single-Cell Analysis', '*Bone Neoplasms/genetics/metabolism/pathology', '*Gene Expression Regulation, Neoplastic', 'Neoplasm Metastasis', 'Platelet-Derived Growth Factor/metabolism/genetics', 'Tumor Microenvironment/genetics', 'DNA Copy Number Variations/genetics', 'Cell Line, Tumor', 'Receptor, Platelet-Derived Growth Factor beta/metabolism/genetics', 'Signal Transduction/genetics', 'Male', 'Lymphokines/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38652223/
667,PDGFRB,26748307,Origins of cardiac fibroblasts.,"['Moore-Morris T', 'Cattaneo P', 'Puceat M', 'Evans SM']","['Animals', 'Basic Helix-Loop-Helix Transcription Factors/genetics/metabolism', 'Biomarkers/metabolism', 'Cell Lineage/*physiology', 'Collagen Type I/genetics/metabolism', 'Discoidin Domain Receptors', 'Extracellular Matrix/metabolism', 'Fibroblasts/metabolism/*pathology', 'Fibrosis', 'Gene Expression', 'Heart Failure/genetics/metabolism/*pathology', 'Humans', 'Myocardium/metabolism/*pathology', 'Receptor Protein-Tyrosine Kinases/genetics/metabolism', 'Receptor, Platelet-Derived Growth Factor beta/genetics/metabolism', 'Receptors, Mitogen/genetics/metabolism', 'T-Box Domain Proteins/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/26748307/
668,PDGFRB,37102682,Stretch regulates alveologenesis and homeostasis via mesenchymal Galphaq/11-mediated TGFbeta2 activation.,"['Goodwin AT', 'John AE', 'Joseph C', 'Habgood A', 'Tatler AL', 'Susztak K', 'Palmer M', 'Offermanns S', 'Henderson NC', 'Jenkins RG']","['Mice', 'Animals', '*Receptor, Platelet-Derived Growth Factor beta/metabolism', '*Transforming Growth Factor beta/metabolism', 'Signal Transduction', 'GTP-Binding Protein alpha Subunits/metabolism', 'Homeostasis']",https://pubmed.ncbi.nlm.nih.gov/37102682/
669,PDGFRB,25212438,The genetics of primary familial brain calcifications.,"['Westenberger A', 'Klein C']","['Blood-Brain Barrier/pathology', 'Brain Diseases/*genetics/pathology', 'Calcinosis/*genetics/pathology', 'Genetic Predisposition to Disease/genetics', 'Humans', 'Mutation/*genetics', 'Proto-Oncogene Proteins c-sis/*genetics', 'Receptor, Platelet-Derived Growth Factor beta/*genetics', 'Sodium-Phosphate Cotransporter Proteins, Type III/*genetics']",https://pubmed.ncbi.nlm.nih.gov/25212438/
670,PDGFRB,29032187,Agonistic antibodies in systemic sclerosis.,"['Moroncini G', 'Svegliati Baroni S', 'Gabrielli A']","['Animals', 'Autoantibodies/*metabolism', 'Blood Vessels/*pathology', 'Fibrosis', 'Humans', 'Lung/*pathology', 'Receptor, Angiotensin, Type 1/immunology', 'Receptor, Endothelin A/immunology', 'Receptor, Muscarinic M3/*immunology', 'Receptor, Platelet-Derived Growth Factor beta/immunology', 'Scleroderma, Systemic/*immunology', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/29032187/
671,PDGFRB,37812061,A high-throughput single-cell RNA expression profiling method identifies human pericyte markers.,"['Sziraki A', 'Zhong Y', 'Neltner AM', 'Niedowicz DM', 'Rogers CB', 'Wilcock DM', 'Nehra G', 'Neltner JH', 'Smith RR', 'Hartz AM', 'Cao J', 'Nelson PT']","['Humans', 'Mice', 'Animals', '*Pericytes/metabolism', '*RNA/metabolism', 'Brain/metabolism', 'Receptor, Platelet-Derived Growth Factor beta/metabolism', 'Immunohistochemistry']",https://pubmed.ncbi.nlm.nih.gov/37812061/
672,PDGFRB,38741091,Somatic PDGFRB activating variants promote smooth muscle cell phenotype modulation in intracranial fusiform aneurysm.,"['Hao L', 'Ya X', 'Wu J', 'Tao C', 'Ma R', 'Zheng Z', 'Mou S', 'Ling Y', 'Yang Y', 'Wang J', 'Zhang Y', 'Lin Q', 'Zhao J']","['Animals', 'Female', 'Humans', 'Male', '*Intracranial Aneurysm/genetics/metabolism', 'Mutation', '*Myocytes, Smooth Muscle/metabolism', 'Phenotype', '*Receptor, Platelet-Derived Growth Factor beta/genetics/metabolism', 'Zebrafish/genetics']",https://pubmed.ncbi.nlm.nih.gov/38741091/
673,PDGFRB,38323741,The novel TERF2::PDGFRB fusion gene enhances tumorigenesis via PDGFRB/STAT5 signalling pathways and sensitivity to TKI in ph-like ALL.,"['Xu GF', 'Zeng Z', 'Zhang ZB', 'Zhang XM', 'Wang M', 'Xiao Q', 'Li J', 'Xie XQ', 'He S', 'Fu HH', 'Liu Y', 'Yang ZL', 'Chen Y', 'Shi J', 'Wang B', 'Qiu HY', 'Zhou Q', 'Liu Y', 'Chen SN']","['Animals', 'Humans', 'Mice', 'Carcinogenesis', 'Cell Transformation, Neoplastic', 'Imatinib Mesylate', 'Protein Kinase Inhibitors/pharmacology', '*Receptor, Platelet-Derived Growth Factor beta/genetics', 'Signal Transduction', 'STAT5 Transcription Factor/genetics', '*Telomeric Repeat Binding Protein 2/genetics', '*Oncogene Proteins, Fusion/genetics', '*Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics']",https://pubmed.ncbi.nlm.nih.gov/38323741/
674,PDGFRB,31147881,Pericytes in Primary Familial Brain Calcification.,"['Zarb Y', 'Franzoso FD', 'Keller A']","['Adult', 'Animals', 'Brain', '*Brain Diseases', '*Calcinosis', 'Humans', 'Mice', '*Pericytes', 'Proto-Oncogene Proteins c-sis', 'Receptor, Platelet-Derived Growth Factor beta', 'Xenotropic and Polytropic Retrovirus Receptor']",https://pubmed.ncbi.nlm.nih.gov/31147881/
675,PDGFRB,39191789,PTPN14 aggravates neointimal hyperplasia via boosting PDGFRbeta signaling in smooth muscle cells.,"['Ma Q', 'He X', 'Wang X', 'Zhao G', 'Zhang Y', 'Su C', 'Wei M', 'Zhang K', 'Liu M', 'Zhu Y', 'He J']","['Animals', 'Humans', 'Male', 'Mice', 'Coronary Vessels/pathology/metabolism', '*Hyperplasia/metabolism', 'Mice, Inbred C57BL', 'Mice, Knockout', 'Muscle, Smooth, Vascular/metabolism/pathology', '*Myocytes, Smooth Muscle/metabolism/pathology', '*Neointima/metabolism/pathology', 'Phosphorylation', 'Protein Tyrosine Phosphatases, Non-Receptor/metabolism/genetics', '*Receptor, Platelet-Derived Growth Factor beta/metabolism/genetics', '*Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/39191789/
676,PDGFRA,28972016,Philadelphia chromosome-like acute lymphoblastic leukemia.,"['Tasian SK', 'Loh ML', 'Hunger SP']","['Animals', '*Fusion Proteins, bcr-abl/genetics/metabolism', 'Humans', '*Philadelphia Chromosome', 'Precursor Cell Lymphoblastic Leukemia-Lymphoma/*genetics/metabolism', 'Signal Transduction/*genetics', '*Translocation, Genetic']",https://pubmed.ncbi.nlm.nih.gov/28972016/
677,PDGFRA,33846639,Defining the lineage of thermogenic perivascular adipose tissue.,"['Angueira AR', 'Sakers AP', 'Holman CD', 'Cheng L', 'Arbocco MN', 'Shamsi F', 'Lynes MD', 'Shrestha R', 'Okada C', 'Batmanov K', 'Susztak K', 'Tseng YH', 'Liaw L', 'Seale P']","['Adipocytes, Brown/*physiology', 'Adipocytes, White/physiology', 'Adipogenesis/physiology', 'Adipose Tissue, Brown/growth & development/*physiology', 'Animals', 'Animals, Newborn', 'Aorta/cytology/physiology', 'Blood Vessels/physiology', 'Cell Lineage/genetics/*physiology', 'Fibroblasts/physiology', 'Gene Expression Regulation/physiology', 'Humans', 'Infant, Newborn', 'Mice', 'Mice, Inbred C57BL', 'Myocytes, Smooth Muscle/physiology', 'Stem Cells/physiology', 'Thermogenesis/genetics/*physiology']",https://pubmed.ncbi.nlm.nih.gov/33846639/
678,PDGFRA,26700815,Insulator dysfunction and oncogene activation in IDH mutant gliomas.,"['Flavahan WA', 'Drier Y', 'Liau BB', 'Gillespie SM', 'Venteicher AS', 'Stemmer-Rachamimov AO', 'Suva ML', 'Bernstein BE']","['Base Sequence', 'Binding Sites', 'CCCTC-Binding Factor', 'CRISPR-Cas Systems/genetics', 'Cell Cycle Proteins/metabolism', 'Cell Proliferation/drug effects', 'Cell Transformation, Neoplastic/drug effects', 'Cells, Cultured', 'Chromatin/drug effects/genetics/metabolism', 'Chromosomal Proteins, Non-Histone/metabolism', 'CpG Islands/genetics', 'DNA Methylation/drug effects/genetics', 'Down-Regulation/drug effects', 'Enhancer Elements, Genetic/genetics', 'Epigenesis, Genetic/drug effects', '*Gene Expression Regulation, Neoplastic/drug effects', 'Glioma/drug therapy/*enzymology/*genetics/pathology', 'Glutarates/metabolism', 'Humans', 'Insulator Elements/drug effects/*genetics', 'Isocitrate Dehydrogenase/chemistry/*genetics/metabolism', 'Mutation/*genetics', 'Oncogenes/*genetics', 'Phenotype', 'Protein Binding', 'Receptor, Platelet-Derived Growth Factor alpha/genetics', 'Repressor Proteins/metabolism', 'Up-Regulation', 'Cohesins']",https://pubmed.ncbi.nlm.nih.gov/26700815/
679,PDGFRA,32100250,Avapritinib: First Approval.,['Dhillon S'],"['*Drug Approval', 'Gastrointestinal Stromal Tumors/*drug therapy/metabolism', 'Humans', 'Mutation', 'Protein Kinase Inhibitors/chemistry/*pharmacology', 'Pyrazoles/chemistry/*pharmacology', 'Pyrroles/chemistry/*pharmacology', 'Receptor, Platelet-Derived Growth Factor alpha/*antagonists & inhibitors/genetics/metabolism', 'Triazines/chemistry/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/32100250/
680,PDGFRA,35105853,EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma.,"['Gai QJ', 'Fu Z', 'He J', 'Mao M', 'Yao XX', 'Qin Y', 'Lan X', 'Zhang L', 'Miao JY', 'Wang YX', 'Zhu J', 'Yang FC', 'Lu HM', 'Yan ZX', 'Chen FL', 'Shi Y', 'Ping YF', 'Cui YH', 'Zhang X', 'Liu X', 'Yao XH', 'Lv SQ', 'Bian XW', 'Wang Y']","['Biomarkers, Tumor/genetics/*metabolism', 'Cell Line, Tumor', 'Glioblastoma/diagnosis/genetics/*metabolism', 'Humans', 'Neoplasm Proteins/genetics/*metabolism', 'Platelet-Derived Growth Factor/genetics/*metabolism', 'Prognosis', 'Receptor, EphA2/genetics/*metabolism', 'Receptor, Platelet-Derived Growth Factor alpha/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/35105853/
681,PDGFRA,39666855,An injury-induced mesenchymal-epithelial cell niche coordinates regenerative responses in the lung.,"['Jones DL', 'Morley MP', 'Li X', 'Ying Y', 'Zhao G', 'Schaefer SE', 'Rodriguez LR', 'Cardenas-Diaz FL', 'Li S', 'Zhou S', 'Chembazhi UV', 'Kim M', 'Shen C', 'Nottingham A', 'Lin SM', 'Cantu E', 'Diamond JM', 'Basil MC', 'Vaughan AE', 'Morrisey EE']","['Animals', 'Humans', 'Mice', 'Alveolar Epithelial Cells/metabolism', 'Cell Proliferation', 'Epithelial Cells', 'Keratin-5/metabolism/genetics', '*Lung/physiology', '*Lung Injury/etiology', '*Mesenchymal Stem Cells/physiology', 'Pulmonary Alveoli/cytology', 'Receptor, Platelet-Derived Growth Factor alpha/metabolism/genetics', '*Receptors, Notch/metabolism', '*Regeneration', 'Signal Transduction', 'Single-Cell Analysis', '*Stem Cell Niche/physiology', 'Wnt Signaling Pathway']",https://pubmed.ncbi.nlm.nih.gov/39666855/
682,PDGFRA,36718802,Human and murine fibroblast single-cell transcriptomics reveals fibroblast clusters are differentially affected by ageing and serum cholesterol.,"['van Kuijk K', 'McCracken IR', 'Tillie RJHA', 'Asselberghs SEJ', 'Kheder DA', 'Muitjens S', 'Jin H', 'Taylor RS', 'Wichers Schreur R', 'Kuppe C', 'Dobie R', 'Ramachandran P', 'Gijbels MJ', 'Temmerman L', 'Kirkwoord PM', 'Luyten J', 'Li Y', 'Noels H', 'Goossens P', 'Wilson-Kanamori JR', 'Schurgers LJ', 'Shen YH', 'Mees BME', 'Biessen EAL', 'Henderson NC', 'Kramann R', 'Baker AH', 'Sluimer JC']","['Humans', 'Mice', 'Animals', 'Aged', '*Plaque, Atherosclerotic/metabolism', '*Hypercholesterolemia/metabolism', 'Transcriptome', 'Mice, Inbred C57BL', '*Atherosclerosis/metabolism', 'Collagen/metabolism', 'Receptor Protein-Tyrosine Kinases/metabolism', 'Aging/genetics', 'Fibroblasts/metabolism', 'Cholesterol/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36718802/
683,PDGFRA,38409190,Intestinal stroma guides monocyte differentiation to macrophages through GM-CSF.,"['Kvedaraite E', 'Lourda M', 'Mouratidou N', 'Duking T', 'Padhi A', 'Moll K', 'Czarnewski P', 'Sinha I', 'Xagoraris I', 'Kokkinou E', 'Damdimopoulos A', 'Weigel W', 'Hartwig O', 'Santos TE', 'Soini T', 'Van Acker A', 'Rahkonen N', 'Flodstrom Tullberg M', 'Ringqvist E', 'Buggert M', 'Jorns C', 'Lindforss U', 'Nordenvall C', 'Stamper CT', 'Unnersjo-Jess D', 'Akber M', 'Nadisauskaite R', 'Jansson J', 'Vandamme N', 'Sorini C', 'Grundeken ME', 'Rolandsdotter H', 'Rassidakis G', 'Villablanca EJ', 'Idestrom M', 'Eulitz S', 'Arnell H', 'Mjosberg J', 'Henter JI', 'Svensson M']","['Humans', 'Animals', 'Mice', 'Child', '*Monocytes/metabolism', 'Granulocyte-Macrophage Colony-Stimulating Factor/metabolism', 'Macrophages/metabolism', 'Inflammation/metabolism', '*Inflammatory Bowel Diseases/genetics/metabolism', 'Cell Differentiation']",https://pubmed.ncbi.nlm.nih.gov/38409190/
684,PDGFRA,31760651,Brain Tumors of Glial Origin.,"['Waker CA', 'Lober RM']","['Brain Neoplasms/*pathology', 'Cellular Reprogramming', 'Glioblastoma/*pathology', 'Glioma/*pathology', 'Humans', 'Isocitrate Dehydrogenase/genetics', 'Mutation', 'PTEN Phosphohydrolase/genetics', 'Receptor, Platelet-Derived Growth Factor alpha/genetics', 'Telomerase/genetics', 'Tumor Microenvironment', 'X-linked Nuclear Protein/genetics']",https://pubmed.ncbi.nlm.nih.gov/31760651/
685,PDGFRA,38342299,The Fibroblast Landscape in Stomach Carcinogenesis.,"['Contreras-Panta EW', 'Choi E', 'Goldenring JR']","['Humans', '*Gastric Mucosa/metabolism', '*Stomach Neoplasms/genetics/metabolism', 'Carcinogenesis/metabolism', 'Metaplasia/metabolism', 'Fibroblasts/metabolism', 'Tumor Microenvironment']",https://pubmed.ncbi.nlm.nih.gov/38342299/
686,PDGFRA,29303368,Imatinib for the treatment of hypereosinophilic syndromes.,['Helbig G'],"['Animals', 'Antineoplastic Agents/*therapeutic use', 'Eosinophils/*immunology', 'Hematologic Neoplasms/*drug therapy/genetics', 'Humans', 'Hypereosinophilic Syndrome/*drug therapy/genetics', 'Imatinib Mesylate/*therapeutic use', 'Mutation/genetics', 'Oncogene Proteins, Fusion/genetics', 'Protein Kinase Inhibitors/*therapeutic use', 'Receptor, Platelet-Derived Growth Factor alpha/genetics', 'Remission Induction', 'mRNA Cleavage and Polyadenylation Factors/genetics']",https://pubmed.ncbi.nlm.nih.gov/29303368/
687,PDGFRA,38344849,KIT/PDGFRA inhibitors for the treatment of gastrointestinal stromal tumors: getting to the gist of the problem.,"['Cicala CM', 'Olivares-Rivas I', 'Aguirre-Carrillo JA', 'Serrano C']","['Humans', 'Imatinib Mesylate/pharmacology/therapeutic use', '*Gastrointestinal Stromal Tumors/drug therapy/genetics', 'Proto-Oncogene Proteins c-kit/genetics/metabolism', 'Enzyme Inhibitors/pharmacology', 'Mutation', 'Tyrosine/genetics/therapeutic use', '*Antineoplastic Agents/pharmacology/therapeutic use', 'Protein Kinase Inhibitors/pharmacology/therapeutic use', 'Drug Resistance, Neoplasm/genetics']",https://pubmed.ncbi.nlm.nih.gov/38344849/
688,PDGFRA,39466697,Gastrointestinal Stromal Tumors: Variants and Some Pitfalls That They Create.,"['Ibrahim A', 'Montgomery EA']","['*Gastrointestinal Stromal Tumors/pathology/genetics/diagnosis', 'Humans', '*Gastrointestinal Neoplasms/pathology/genetics', 'Biomarkers, Tumor/genetics/analysis/metabolism', 'Proto-Oncogene Proteins c-kit/genetics', 'Immunohistochemistry', 'Anoctamin-1/metabolism/genetics', 'Neoplasm Proteins']",https://pubmed.ncbi.nlm.nih.gov/39466697/
689,PDGFRA,33867479,New treatments in advanced gastrointestinal stromal tumor.,['Serrano C'],"['Antineoplastic Agents/therapeutic use', 'Gastrointestinal Neoplasms/*drug therapy/genetics/metabolism', 'Gastrointestinal Stromal Tumors/*drug therapy/genetics/metabolism', 'Humans', 'Naphthyridines/*therapeutic use', 'Protein Kinase Inhibitors/therapeutic use', 'Proto-Oncogene Proteins c-kit/genetics/metabolism', 'Pyrazoles/*therapeutic use', 'Pyrroles/*therapeutic use', 'Receptor, Platelet-Derived Growth Factor alpha/genetics/metabolism', 'Triazines/*therapeutic use', 'Urea/*analogs & derivatives/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/33867479/
690,PDGFRA,34545084,Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma.,"['DeSisto J', 'Lucas JT Jr', 'Xu K', 'Donson A', 'Lin T', 'Sanford B', 'Wu G', 'Tran QT', 'Hedges D', 'Hsu CY', 'Armstrong GT', 'Arnold M', 'Bhatia S', 'Flannery P', 'Lemma R', 'Hardie L', 'Schuller U', 'Venkataraman S', 'Hoffman LM', 'Dorris K', 'Mulcahy Levy JM', 'Hankinson TC', 'Handler M', 'Liu AK', 'Foreman N', 'Vibhakar R', 'Jones K', 'Allen S', 'Zhang J', 'Baker SJ', 'Merchant TE', 'Orr BA', 'Green AL']","['Adolescent', 'Child', 'Cohort Studies', 'Computer Simulation', 'DNA Copy Number Variations/genetics', 'DNA Methylation/genetics', 'Drug Screening Assays, Antitumor', 'Gene Expression Regulation, Neoplastic', 'Gene Ontology', 'Glioma/*genetics/*pathology', 'Humans', 'Neoplasm Grading', '*Radiation', 'Transcriptome/genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/34545084/
691,PDGFRA,37610648,"PDGFRA, KIT, and KDR Gene Amplification in Glioblastoma: Heterogeneity and Clinical Significance.","['Carlotto BS', 'Trevisan P', 'Provenzi VO', 'Soares FP', 'Rosa RFM', 'Varella-Garcia M', 'Zen PRG']","['Humans', 'Middle Aged', 'Central Nervous System', 'Chromosome Aberrations', 'Clinical Relevance', 'Gene Amplification', '*Glioblastoma/genetics', 'Receptor Protein-Tyrosine Kinases', 'Vascular Endothelial Growth Factor Receptor-2/genetics', 'Receptor, Platelet-Derived Growth Factor alpha/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37610648/
692,PDGFRA,27163723,Molecular subtypes of gastrointestinal stromal tumor requiring specific treatments.,"['Pogorzelski M', 'Falkenhorst J', 'Bauer S']","['Animals', 'Chemotherapy, Adjuvant', 'Gastrointestinal Neoplasms/*drug therapy/*genetics/metabolism', 'Gastrointestinal Stromal Tumors/*drug therapy/*genetics/metabolism', 'Genotype', 'Humans', 'Molecular Targeted Therapy']",https://pubmed.ncbi.nlm.nih.gov/27163723/
693,PDGFRA,37115371,Surgical Management of Germline Gastrointestinal Stromal Tumor.,"['Kwak HV', 'Tardy KJ', 'Allbee A', 'Stashek K', 'DeMatteo RP']","['Humans', 'Adult', '*Gastrointestinal Stromal Tumors/genetics/surgery', 'Proto-Oncogene Proteins c-kit/genetics/metabolism', 'Receptor, Platelet-Derived Growth Factor alpha/genetics', 'Mutation', 'Germ-Line Mutation', '*Stomach Neoplasms/genetics']",https://pubmed.ncbi.nlm.nih.gov/37115371/
694,PDGFRA,36083003,"Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features.","['Pellinen T', 'Paavolainen L', 'Martin-Bernabe A', 'Papatella Araujo R', 'Strell C', 'Mezheyeuski A', 'Backman M', 'La Fleur L', 'Bruck O', 'Sjolund J', 'Holmberg E', 'Valimaki K', 'Brunnstrom H', 'Botling J', 'Moreno-Ruiz P', 'Kallioniemi O', 'Micke P', 'Ostman A']","['Humans', '*Carcinoma, Non-Small-Cell Lung/pathology', '*Lung Neoplasms/pathology', 'Receptor, Platelet-Derived Growth Factor beta/analysis/genetics/metabolism', 'Biomarkers, Tumor/metabolism', 'Fibroblasts/metabolism/pathology', '*Cancer-Associated Fibroblasts/metabolism', 'Mutation', 'Tumor Microenvironment']",https://pubmed.ncbi.nlm.nih.gov/36083003/
695,PDGFRA,25766843,Genotyping and immunohistochemistry of gastrointestinal stromal tumors: An update.,"['Rubin BP', 'Heinrich MC']","['Biomarkers, Tumor/*genetics', 'Gastrointestinal Neoplasms/chemistry/*genetics/pathology', 'Gastrointestinal Stromal Tumors/chemistry/*genetics/pathology', 'Genetic Predisposition to Disease', 'Humans', '*Immunohistochemistry', 'Molecular Diagnostic Techniques', 'Mutation', 'Neoplasm Proteins/*genetics', 'Phenotype', 'Predictive Value of Tests', 'Prognosis']",https://pubmed.ncbi.nlm.nih.gov/25766843/
696,KIT,9438854,Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.,"['Hirota S', 'Isozaki K', 'Moriyama Y', 'Hashimoto K', 'Nishida T', 'Ishiguro S', 'Kawano K', 'Hanada M', 'Kurata A', 'Takeda M', 'Muhammad Tunio G', 'Matsuzawa Y', 'Kanakura Y', 'Shinomura Y', 'Kitamura Y']","['Amino Acid Sequence', 'Animals', 'Antigens, CD34/analysis', 'Cell Line', 'Cell Transformation, Neoplastic', 'DNA, Complementary', 'Digestive System/cytology', 'Esophageal Neoplasms/genetics/metabolism/pathology', 'Gastrointestinal Neoplasms/chemistry/*genetics/pathology', 'Humans', 'Intestinal Neoplasms/chemistry/genetics/pathology', 'Ligands', 'Mice', 'Mice, Nude', 'Molecular Sequence Data', '*Mutation', 'Phosphorylation', 'Phosphotyrosine/metabolism', 'Proto-Oncogene Proteins c-kit/analysis/chemistry/*genetics/metabolism', 'Recombinant Proteins/pharmacology', 'Sequence Deletion', 'Stem Cell Factor/pharmacology', 'Stomach Neoplasms/genetics/metabolism/pathology', 'Transfection']",https://pubmed.ncbi.nlm.nih.gov/9438854/
697,KIT,21826607,Beyond BRAF in melanoma.,"['Daud A', 'Bastian BC']","['Animals', 'Antineoplastic Agents/pharmacology', 'Clinical Trials as Topic', 'Enzyme Activation', 'ErbB Receptors/antagonists & inhibitors/chemistry/genetics', 'G1 Phase Cell Cycle Checkpoints', '*Gene Expression Regulation, Neoplastic', 'Humans', '*MAP Kinase Signaling System', 'Melanoma/*drug therapy/enzymology/genetics/pathology', 'Mutation', 'Protein Kinase Inhibitors/pharmacology', 'Proto-Oncogene Proteins B-raf/*genetics/metabolism', 'Proto-Oncogene Proteins c-kit/genetics/metabolism', 'Receptor, Fibroblast Growth Factor, Type 1/antagonists & inhibitors/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/21826607/
698,KIT,30007468,Tyrosine Kinase Inhibition in Mastocytosis: KIT and Beyond KIT.,"['Bibi S', 'Arock M']","['Adult', 'Animals', 'Cytoreduction Surgical Procedures', 'Humans', 'Mast Cells/*physiology', 'Mastocytosis/*drug therapy/metabolism', 'Molecular Targeted Therapy', 'Mutation/genetics', 'Protein Kinase Inhibitors/*therapeutic use', 'Proto-Oncogene Proteins c-kit/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/30007468/
699,KIT,30007457,Pediatric Expression of Mast Cell Activation Disorders.,"['Broesby-Olsen S', 'Carter M', 'Kjaer HF', 'Mortz CG', 'Moller MB', 'Kristensen TK', 'Bindslev-Jensen C', 'Agertoft L']","['Adult', 'Anaphylaxis/genetics/*immunology', '*Cell Degranulation', 'Child', 'Humans', 'Mast Cells/*physiology', 'Mastocytosis/genetics/*immunology', 'Proto-Oncogene Proteins c-kit/*genetics', 'Tryptases/metabolism', 'Urticaria/genetics/*immunology']",https://pubmed.ncbi.nlm.nih.gov/30007457/
700,KIT,27796898,Immunohistochemistry of Telocytes in the Uterus and Fallopian Tubes.,['Cretoiu SM'],"['Animals', 'Antigens, CD34/genetics/metabolism', 'Biomarkers/metabolism', 'Cell Lineage/physiology', 'Extracellular Vesicles/*metabolism/ultrastructure', 'Fallopian Tubes/*metabolism/ultrastructure', 'Female', 'Gene Expression', 'Humans', 'Immunohistochemistry', 'Microscopy, Electron, Transmission', 'Proto-Oncogene Proteins c-kit/genetics/metabolism', 'Rats', 'Receptors, Progesterone/genetics/metabolism', 'Signal Transduction', 'Telocytes/classification/*metabolism/ultrastructure', 'Uterus/*metabolism/ultrastructure']",https://pubmed.ncbi.nlm.nih.gov/27796898/
701,KIT,39010730,CISD2 regulates oxidative stress and mitophagy to maintain the balance of the follicular microenvironment in PCOS.,"['Wu HH', 'Zhu Q', 'Liang N', 'Xiang Y', 'Xu TY', 'Huang ZC', 'Cai JY', 'Weng LL', 'Ge HS']","['Adult', 'Female', 'Humans', 'Cellular Microenvironment/physiology', 'Mitochondria/metabolism/drug effects', '*Mitophagy/drug effects/physiology', '*Oxidative Stress', '*Polycystic Ovary Syndrome/metabolism/pathology']",https://pubmed.ncbi.nlm.nih.gov/39010730/
702,KIT,24857885,Kit and Scl regulation of hematopoietic stem cells.,"['Rojas-Sutterlin S', 'Lecuyer E', 'Hoang T']","['Animals', 'Basic Helix-Loop-Helix Transcription Factors/*genetics/*metabolism', 'Cell Cycle/genetics', 'Cell Differentiation', 'Cell Survival/genetics', 'Epistasis, Genetic', 'Hematopoiesis', 'Hematopoietic Stem Cells/cytology/*physiology', 'Humans', 'Promoter Regions, Genetic', 'Protein Tyrosine Phosphatase, Non-Receptor Type 11/genetics', 'Proto-Oncogene Proteins/*genetics/*metabolism', 'Proto-Oncogene Proteins c-kit/*genetics/*metabolism', 'Stem Cell Factor/genetics/metabolism', 'T-Cell Acute Lymphocytic Leukemia Protein 1', 'Transcriptional Activation']",https://pubmed.ncbi.nlm.nih.gov/24857885/
703,KIT,10670573,c-Kit and c-kit mutations in mastocytosis and other hematological diseases.,"['Boissan M', 'Feger F', 'Guillosson JJ', 'Arock M']","['Amino Acid Substitution', 'Animals', 'Cell Differentiation', 'Cell Division', 'Cell Transformation, Neoplastic', 'Dimerization', 'Hematologic Diseases/genetics/*metabolism', 'Hematologic Neoplasms/genetics/metabolism', 'Humans', 'Leukemia/genetics/metabolism', 'Mastocytosis/genetics/*metabolism', 'Mice', 'Neoplasm Proteins/genetics/physiology', 'Phosphorylation', 'Point Mutation', 'Protein Processing, Post-Translational', 'Protein Structure, Tertiary', 'Proto-Oncogene Proteins c-kit/chemistry/genetics/*physiology', 'Proto-Oncogenes', 'Rats', 'Sequence Deletion', 'Signal Transduction', 'Stem Cell Factor/physiology', 'Tumor Cells, Cultured']",https://pubmed.ncbi.nlm.nih.gov/10670573/
704,KIT,16481408,Kit ligand and c-Kit have diverse roles during mammalian oogenesis and folliculogenesis.,"['Hutt KJ', 'McLaughlin EA', 'Holland MK']","['Animals', 'Female', 'Humans', 'Oogenesis/*physiology', 'Ovarian Follicle/growth & development/*metabolism/physiology', 'Proto-Oncogene Proteins c-kit/chemistry/*physiology', 'Stem Cell Factor/chemistry/*physiology']",https://pubmed.ncbi.nlm.nih.gov/16481408/
705,KIT,33313902,G-Quadruplex loops regulate PARP-1 enzymatic activation.,"['Edwards AD', 'Marecki JC', 'Byrd AK', 'Gao J', 'Raney KD']","['Catalysis', 'DNA Damage', 'Enzyme Activation', '*G-Quadruplexes', 'Guanine/analogs & derivatives/chemistry', 'Humans', 'Oxidation-Reduction', 'Poly (ADP-Ribose) Polymerase-1/*metabolism', 'Promoter Regions, Genetic', 'Proto-Oncogene Mas', 'Proto-Oncogene Proteins c-kit/genetics', 'Recombinant Proteins/metabolism', 'Structure-Activity Relationship', 'Substrate Specificity']",https://pubmed.ncbi.nlm.nih.gov/33313902/
706,KIT,33872193,"SPRED proteins and their roles in signal transduction, development, and malignancy.","['Lorenzo C', 'McCormick F']","['Adaptor Proteins, Signal Transducing/*metabolism', 'Animals', 'Cell Differentiation/genetics', 'Gene Expression Regulation, Developmental', 'Growth and Development/genetics/*physiology', 'Humans', 'Neoplasms/genetics/*metabolism', 'Protein Domains', 'Signal Transduction/genetics/*physiology']",https://pubmed.ncbi.nlm.nih.gov/33872193/
707,KIT,10909038,Kit signal transduction.,"['Taylor ML', 'Metcalfe DD']","['*Adaptor Proteins, Signal Transducing', 'Amino Acid Substitution', 'Animals', '*Cell Cycle Proteins', 'Dimerization', 'Feedback', 'GRB2 Adaptor Protein', 'Humans', 'Isoenzymes/physiology', 'MAP Kinase Signaling System/genetics/*physiology', 'Mice', 'Mice, Mutant Strains', 'Models, Biological', 'Phosphatidylinositol 3-Kinases/physiology', 'Phosphorylation', 'Point Mutation', 'Protein Kinase C/physiology', 'Protein Processing, Post-Translational', 'Protein Tyrosine Phosphatases/physiology', 'Proteins/physiology', 'Proto-Oncogene Proteins/physiology', 'Proto-Oncogene Proteins c-kit/chemistry/*physiology', 'Proto-Oncogene Proteins c-vav', 'Proto-Oncogenes', 'Stem Cell Factor/*physiology', 'ras Proteins/physiology', 'src Homology Domains', 'src-Family Kinases/physiology']",https://pubmed.ncbi.nlm.nih.gov/10909038/
708,KIT,37537976,Comprehensive analysis of m(6)A methylomes in idiopathic pulmonary arterial hypertension.,"['Huang T', 'Zeng Y', 'Yang Y', 'Fan H', 'Deng Y', 'Chen W', 'Liu J', 'Yang F', 'Li W', 'Xiao Y']","['Humans', 'Rats', 'Animals', 'Familial Primary Pulmonary Hypertension/genetics/metabolism', '*Hypertension, Pulmonary/genetics/metabolism', 'Becaplermin/genetics/metabolism', 'Pulmonary Artery/metabolism', 'Epigenome', 'Cell Proliferation', 'Myocytes, Smooth Muscle/metabolism', 'DNA Methylation', 'RNA, Messenger/metabolism', 'Methyltransferases/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37537976/
709,KIT,25359157,The SCF/c-KIT system in the male: Survival strategies in fertility and cancer.,"['Cardoso HJ', 'Figueira MI', 'Correia S', 'Vaz CV', 'Socorro S']","['Cell Cycle/physiology', 'Cell Differentiation/physiology', 'Fertility/*physiology', 'Genitalia/metabolism/*physiology', 'Humans', 'Male', '*Models, Biological', 'Neoplasms/*physiopathology', 'Protein Isoforms/genetics/metabolism', 'Proto-Oncogene Proteins c-kit/genetics/*metabolism', 'Signal Transduction/*physiology', 'Stem Cell Factor/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/25359157/
710,KIT,34467641,Phenotypic plasticity of melanocytes derived from human adult skin.,"['Vidacs DL', 'Vereb Z', 'Bozo R', 'Flink LB', 'Polyanka H', 'Nemeth IB', 'Poliska S', 'Papp BT', 'Manczinger M', 'Gaspar R', 'Mirdamadi S', 'Kemeny L', 'Bata-Csorgo Z']","['Adult', '*Cell Dedifferentiation', '*Cell Plasticity', 'Cell Proliferation', 'Cells, Cultured', 'ErbB Receptors/genetics/metabolism', 'Gene Expression Profiling', 'Gene Regulatory Networks', 'Humans', 'Melanins/metabolism', 'Melanocytes/metabolism/*physiology', 'Membrane Glycoproteins/genetics/metabolism', 'Middle Aged', 'Nestin/genetics/metabolism', 'Oxidoreductases/genetics/metabolism', 'Phenotype', 'Proto-Oncogene Proteins c-kit/genetics/metabolism', 'RNA-Seq', 'Signal Transduction', 'Skin/*cytology', 'Transcriptome', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/34467641/
711,KIT,25271723,"Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9.","['Gupta RM', 'Musunuru K']","['Animals', 'Bacterial Proteins/*metabolism', 'Base Sequence', '*CRISPR-Cas Systems', 'DNA/*chemistry', 'DNA Helicases/*metabolism', 'DNA Repair', 'DNA-Binding Proteins/*metabolism', 'Deoxyribonucleases/metabolism', 'Endonucleases/genetics', 'Genetic Engineering/*methods', '*Genome', 'Humans', 'Molecular Sequence Data', 'Protein Binding', 'Protein Multimerization', 'Protein Structure, Tertiary', 'Sequence Homology, Nucleic Acid', 'Transcription, Genetic', 'Zinc Fingers']",https://pubmed.ncbi.nlm.nih.gov/25271723/
712,KIT,34606974,"A holistic view on c-Kit in cancer: Structure, signaling, pathophysiology and its inhibitors.","['Pathania S', 'Pentikainen OT', 'Singh PK']","['Humans', 'Neoplasms/*genetics/physiopathology', 'Proto-Oncogene Proteins c-kit/*metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/34606974/
713,KIT,20739007,Unlocking the eukaryotic membrane protein structural proteome.,"['Lee JK', 'Stroud RM']","['Animals', 'Crystallization', '*Eukaryota/genetics', 'Green Fluorescent Proteins/genetics', 'HEK293 Cells', 'Humans', 'Membrane Proteins/*chemistry/metabolism', 'Proteome/*chemistry/metabolism']",https://pubmed.ncbi.nlm.nih.gov/20739007/
714,KIT,36262101,Coffee-Derived Exosome-Like Nanoparticles: Are They the Secret Heroes?,"['Kantarcioglu M', 'Yildirim G', 'Akpinar Oktar P', 'Yanbakan S', 'Ozer ZB', 'Yurtsever Sarica D', 'Tasdelen S', 'Bayrak E', 'Akin Bali DF', 'Ozturk S', 'Akcali KC', 'Ezer U', 'Kurekci AE']","['Humans', 'Coffee/metabolism', '*Exosomes/chemistry/genetics/metabolism', '*Carcinoma, Hepatocellular', '*MicroRNAs/metabolism', '*Nanoparticles', '*Liver Neoplasms']",https://pubmed.ncbi.nlm.nih.gov/36262101/
715,KIT,29704617,The role of small molecule Kit protein-tyrosine kinase inhibitors in the treatment of neoplastic disorders.,['Roskoski R Jr'],"['Animals', 'Antineoplastic Agents/*therapeutic use', 'Humans', 'Mutation', 'Neoplasms/*drug therapy', 'Protein Kinase Inhibitors/*therapeutic use', 'Proto-Oncogene Mas', 'Proto-Oncogene Proteins c-kit/*antagonists & inhibitors/chemistry/genetics/metabolism', 'Stem Cell Factor/metabolism']",https://pubmed.ncbi.nlm.nih.gov/29704617/
716,GSK3B,30442814,Posttranslational Modifications of PD-L1 and Their Applications in Cancer Therapy.,"['Hsu JM', 'Li CW', 'Lai YJ', 'Hung MC']","['Acetylation', 'Animals', 'Antineoplastic Agents/pharmacology', 'B7-H1 Antigen/*genetics/*metabolism', 'Cell Line, Tumor', 'Cytokines/metabolism', 'Dendrites/metabolism', 'Endoplasmic Reticulum/metabolism', 'Glycogen Synthase Kinase 3 beta/metabolism', 'Glycosylation', 'Humans', 'Immunotherapy', 'Inflammation', 'Ligands', 'Macrophages/metabolism', 'Mice', 'Mice, Inbred BALB C', 'Neoplasms/*metabolism/*therapy', 'Phosphorylation', 'Proteasome Endopeptidase Complex/metabolism', '*Protein Processing, Post-Translational', 'Protein Stability', 'Signal Transduction', 'Ubiquitination']",https://pubmed.ncbi.nlm.nih.gov/30442814/
717,GSK3B,35166234,Age-related GSK3beta overexpression drives podocyte senescence and glomerular aging.,"['Fang Y', 'Chen B', 'Liu Z', 'Gong AY', 'Gunning WT', 'Ge Y', 'Malhotra D', 'Gohara AF', 'Dworkin LD', 'Gong R']","['Adult', 'Aging/genetics/*metabolism', 'Animals', '*Cellular Senescence', 'Female', 'Gene Expression Regulation, Enzymologic', 'Glycogen Synthase Kinase 3 beta/*biosynthesis/genetics', 'Humans', 'Male', 'Mice', 'Mice, Knockout', 'Middle Aged', 'Podocytes/*enzymology']",https://pubmed.ncbi.nlm.nih.gov/35166234/
718,GSK3B,39358050,Bridging brain insulin resistance to Alzheimer's pathogenesis.,"['Chen W', 'Johansen VBI', 'Legido-Quigley C']","['*Alzheimer Disease/metabolism/pathology', '*Insulin Resistance', 'Humans', '*Brain/metabolism/pathology', '*Diabetes Mellitus, Type 2/metabolism/pathology', 'Oxidoreductases Acting on CH-CH Group Donors/metabolism', 'Glycogen Synthase Kinase 3 beta/metabolism', 'Animals', 'Mitochondria/metabolism', 'Phosphorylation', 'Glycogen Synthase Kinase 3/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39358050/
719,GSK3B,35821283,Circ-GSK3B up-regulates GSK3B to suppress the progression of lung adenocarcinoma.,"['Zhu MC', 'Zhang YH', 'Xiong P', 'Fan XW', 'Li GL', 'Zhu M']","['Humans', 'RNA, Circular/genetics', 'beta Catenin/genetics', 'Glycogen Synthase Kinase 3 beta/genetics/metabolism', '*MicroRNAs/genetics/metabolism', 'Gene Expression Regulation, Neoplastic', 'Cell Proliferation/genetics', 'Cell Line, Tumor', '*Adenocarcinoma of Lung/genetics/metabolism/pathology', '*Lung Neoplasms/pathology']",https://pubmed.ncbi.nlm.nih.gov/35821283/
720,GSK3B,24254703,GSK3 in Alzheimer's disease: mind the isoforms.,['Ma T'],"['Alzheimer Disease/diagnosis/*enzymology', 'Animals', 'Glycogen Synthase Kinase 3/*chemistry/*metabolism', 'Glycogen Synthase Kinase 3 beta', 'Humans', 'Isoenzymes/chemistry/metabolism', 'Signal Transduction/physiology']",https://pubmed.ncbi.nlm.nih.gov/24254703/
721,GSK3B,38814517,beta-Sitosterol alleviates the malignant phenotype of hepatocellular carcinoma cells via inhibiting GSK3B expression.,"['Wang R', 'Tang D', 'Ou L', 'Jiang J', 'Wu YN', 'Tian X']","['Humans', '*Sitosterols/pharmacology', '*Glycogen Synthase Kinase 3 beta/metabolism/genetics', '*Carcinoma, Hepatocellular/pathology/genetics/drug therapy/metabolism', '*Liver Neoplasms/pathology/genetics/drug therapy/metabolism', '*Cell Proliferation/drug effects/genetics', '*Apoptosis/drug effects/genetics', 'Cell Line, Tumor', '*Epithelial-Mesenchymal Transition/drug effects/genetics', 'Cell Movement/drug effects/genetics', 'Gene Expression/genetics/drug effects', 'Phenotype', 'Neoplasm Invasiveness/genetics', 'Cell Survival/drug effects/genetics', 'Network Pharmacology', 'Gene Expression Regulation, Neoplastic/drug effects']",https://pubmed.ncbi.nlm.nih.gov/38814517/
722,GSK3B,35524996,Convergent lines of evidence supporting involvement of NFKB1 in schizophrenia.,"['Long J', 'Tian L', 'Baranova A', 'Cao H', 'Yao Y', 'Rao S', 'Zhang F']","['Gene Regulatory Networks', 'Humans', '*MicroRNAs/genetics/metabolism', '*NF-kappa B p50 Subunit/genetics', 'RNA, Messenger/metabolism', '*Schizophrenia/drug therapy/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35524996/
723,GSK3B,33450305,Complex formation and reciprocal regulation between GSK3beta and C3G.,"['Sriram D', 'Dayma K', 'Devi AS', 'Raghawan AK', 'Rawat S', 'Radha V']","['Animals', 'COS Cells', 'Cell Differentiation', 'Cell Line', 'Chlorocebus aethiops', 'Cytoplasm/metabolism', 'Gene Expression Regulation', 'Glycogen Synthase Kinase 3 beta/*metabolism', 'Guanine Nucleotide-Releasing Factor 2/*chemistry/genetics/*metabolism', 'HEK293 Cells', 'Humans', 'Mice', 'Muscle Development', '*Mutation', 'Myoblasts/*cytology/metabolism', 'Phosphorylation']",https://pubmed.ncbi.nlm.nih.gov/33450305/
724,GSK3B,23768967,Glycogen synthase kinase-3beta (GSK-3beta) and its dysregulation in glioblastoma multiforme.,"['Atkins RJ', 'Stylli SS', 'Luwor RB', 'Kaye AH', 'Hovens CM']","['Animals', 'Brain Neoplasms/*enzymology/pathology', 'Carcinogenesis/metabolism/pathology', 'Glioblastoma/*enzymology/pathology', 'Glycogen Synthase Kinase 3/chemistry/*physiology', 'Glycogen Synthase Kinase 3 beta', 'Humans', 'Protein Binding/physiology', 'Protein Structure, Secondary', 'Signal Transduction/physiology']",https://pubmed.ncbi.nlm.nih.gov/23768967/
725,GSK3B,35747513,GSK3B Overexpression Alleviates Posttraumatic Osteoarthritis in Mice by Promoting DNMT1-Mediated Hypermethylation of NR4A3 Promoter.,"['Lv Z', 'Sun D', 'Li X', 'Wu G']","['Animals', 'Cells, Cultured', 'Chondrocytes/metabolism', 'Collagen Type II/genetics/metabolism/pharmacology', 'DNA-Binding Proteins/genetics', 'Glycogen Synthase Kinase 3 beta/genetics/metabolism', 'Humans', 'Interleukin-1beta/genetics', 'Mice', 'Nerve Tissue Proteins/genetics', '*Osteoarthritis/genetics/metabolism', 'Promoter Regions, Genetic', '*Receptors, Steroid/genetics/metabolism', 'Receptors, Thyroid Hormone/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35747513/
726,GSK3B,39337715,Synergistic Effect between the APOE epsilon4 Allele with Genetic Variants of GSK3B and MAPT: Differential Profile between Refractory Epilepsy and Alzheimer Disease.,"['Toral-Rios D', 'Pichardo-Rojas P', 'Ruiz-Sanchez E', 'Rosas-Carrasco O', 'Carvajal-Garcia R', 'Galvez-Coutino DC', 'Martinez-Rodriguez NL', 'Rubio-Chavez AD', 'Alcantara-Flores M', 'Lopez-Ramirez A', 'Martinez-Rosas AR', 'Ruiz-Chow AA', 'Alonso-Vanegas M', 'Campos-Pena V']","['Humans', '*tau Proteins/genetics/metabolism', '*Alzheimer Disease/genetics', '*Glycogen Synthase Kinase 3 beta/genetics/metabolism', 'Male', 'Female', 'Middle Aged', '*Alleles', '*Apolipoprotein E4/genetics', 'Adult', 'Genetic Predisposition to Disease', 'Aged', 'Drug Resistant Epilepsy/genetics/drug therapy', 'Epilepsy, Temporal Lobe/genetics/drug therapy', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/39337715/
727,GSK3B,34162557,Downregulation of GSK3B by miR-132-3p Enhances Etoposide-Induced Breast Cancer Cell Apoptosis.,"['Xu C', 'Du Z', 'Ren S', 'Pian Y']","['Antineoplastic Agents, Phytogenic/pharmacology', 'Apoptosis', 'Biomarkers, Tumor/genetics/*metabolism', 'Breast Neoplasms/drug therapy/genetics/metabolism/*pathology', 'Cell Proliferation', 'Etoposide/*pharmacology', 'Female', 'Gene Expression Regulation, Neoplastic/*drug effects', 'Glycogen Synthase Kinase 3 beta/genetics/*metabolism', 'Humans', 'MicroRNAs/*genetics', 'Neoplasms/genetics/metabolism/*pathology', 'Prognosis', 'Survival Rate', 'Tumor Cells, Cultured']",https://pubmed.ncbi.nlm.nih.gov/34162557/
728,GSK3B,37146915,Inhibition of GSK3B phosphorylation improves glucose and lipid metabolism disorder.,"['Yan Z', 'Cao X', 'Sun S', 'Sun B', 'Gao J']","['Animals', 'Humans', 'Phosphorylation', '*Glucose/metabolism', 'Lipid Metabolism', 'Zebrafish/metabolism', 'Proteomics', 'Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism', 'Glycogen/metabolism', '*Lipid Metabolism Disorders', 'Lipids', 'Glycogen Synthase Kinase 3 beta/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37146915/
729,GSK3B,38762650,miR-709 exerts an angiogenic effect through a FGF2 upregulation induced by a GSK3B downregulation.,"['Ueno K', 'Kurazumi H', 'Suzuki R', 'Yanagihara M', 'Mizoguchi T', 'Harada T', 'Morikage N', 'Hamano K']","['Animals', 'Humans', 'Male', 'Mice', ""3' Untranslated Regions"", 'Cell Proliferation', 'Disease Models, Animal', 'Down-Regulation', 'Endothelial Cells/metabolism', 'Extracellular Vesicles/metabolism', '*Fibroblast Growth Factor 2/metabolism/genetics', '*Glycogen Synthase Kinase 3 beta/metabolism/genetics', '*Hindlimb/blood supply', '*Ischemia/metabolism/genetics', '*Mice, Inbred BALB C', 'Mice, Inbred C57BL', '*MicroRNAs/genetics/metabolism', '*Neovascularization, Physiologic/genetics', 'Up-Regulation']",https://pubmed.ncbi.nlm.nih.gov/38762650/
730,GSK3B,35005835,MicroRNA-214-3p facilitates M2 macrophage polarization by targeting GSK3B.,"['Peng LY', 'Li BB', 'Deng KB', 'Wang WG']","['Down-Regulation', 'Glycogen Synthase Kinase 3 beta/genetics/metabolism', 'Humans', 'Macrophage Activation/genetics', 'Macrophages/metabolism', '*MicroRNAs/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35005835/
731,GSK3B,23951236,GSK3B and MAPT polymorphisms are associated with grey matter and intracranial volume in healthy individuals.,"['Dobson-Stone C', 'Polly P', 'Korgaonkar MS', 'Williams LM', 'Gordon E', 'Schofield PR', 'Mather K', 'Armstrong NJ', 'Wen W', 'Sachdev PS', 'Kwok JB']","['Adult', 'Aged', 'Aged, 80 and over', 'Alleles', 'Brain/*anatomy & histology/*metabolism', 'Cohort Studies', 'Female', '*Genetic Association Studies', 'Genotype', 'Glycogen Synthase Kinase 3/*genetics', 'Glycogen Synthase Kinase 3 beta', 'Humans', 'Male', 'Middle Aged', 'Organ Size', '*Polymorphism, Genetic', 'Polymorphism, Single Nucleotide', 'Promoter Regions, Genetic', 'Transcription, Genetic', 'Young Adult', 'tau Proteins/*genetics']",https://pubmed.ncbi.nlm.nih.gov/23951236/
732,GSK3B,37392853,REDD1-dependent GSK3beta dephosphorylation promotes NF-kappaB activation and macrophage infiltration in the retina of diabetic mice.,"['Sunilkumar S', 'VanCleave AM', 'McCurry CM', 'Toro AL', 'Stevens SA', 'Kimball SR', 'Dennis MD']","['Animals', 'Humans', 'Male', 'Mice', 'Cytokines/metabolism', '*Diabetes Mellitus, Experimental/genetics/metabolism', 'Glycogen Synthase Kinase 3/genetics/metabolism', 'Glycogen Synthase Kinase 3 beta/genetics/metabolism', '*Hyperglycemia/metabolism', 'Inflammation/genetics/metabolism', 'NF-kappa B/metabolism', 'Retina/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37392853/
733,GSK3B,30216111,beta-Arrestin1 enhances liver fibrosis through autophagy-mediated Snail signaling.,"['Tan S', 'Lu Y', 'Xu M', 'Huang X', 'Liu H', 'Jiang J', 'Wu B']","['Adenine/analogs & derivatives/pharmacology', 'Animals', '*Autophagy', 'Cell Line', 'Female', 'Glycogen Synthase Kinase 3 beta/genetics/metabolism', 'Hepatic Stellate Cells/*metabolism/pathology', 'Hepatocytes/*metabolism/pathology', 'Humans', 'Liver Cirrhosis/genetics/*metabolism/pathology', 'Male', 'Mice', 'Mice, Knockout', '*Signal Transduction', 'Snail Family Transcription Factors/genetics/*metabolism', 'beta-Arrestin 1/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/30216111/
734,GSK3B,38788553,"Sex-specific associations between circadian-related genes and depression in UK Biobank participants highlight links to glucose metabolism, inflammation and neuroplasticity pathways.","['Minbay M', 'Khan A', 'Ghasemi AR', 'Ingram KK', 'Ay AA']","['Humans', 'Female', 'Male', 'Middle Aged', '*Inflammation/genetics', '*Polymorphism, Single Nucleotide', 'United Kingdom/epidemiology', '*Neuronal Plasticity/genetics/physiology', 'Glucose/metabolism', 'Aged', 'Circadian Rhythm/physiology/genetics', 'Biological Specimen Banks', 'Adult', 'Circadian Clocks/genetics/physiology', 'Depression/genetics/epidemiology', 'Sex Factors', 'Depressive Disorder/genetics/epidemiology', 'UK Biobank']",https://pubmed.ncbi.nlm.nih.gov/38788553/
735,GSK3B,25807946,The Translocator Protein 18 kDa (TSPO) and Its Role in Mitochondrial Biology and Psychiatric Disorders.,"['Milenkovic VM', 'Rupprecht R', 'Wetzel CH']","['Antipsychotic Agents/therapeutic use', 'Glycogen Synthase Kinase 3/metabolism', 'Glycogen Synthase Kinase 3 beta', 'Humans', 'Isoquinolines/therapeutic use', 'Ligands', 'Mental Disorders/drug therapy/metabolism/*pathology', 'Mitochondria/*metabolism', 'Neurodegenerative Diseases/metabolism/pathology', 'Receptors, GABA/chemistry/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/25807946/
736,RET,31715421,RET fusions in solid tumors.,"['Li AY', 'McCusker MG', 'Russo A', 'Scilla KA', 'Gittens A', 'Arensmeyer K', 'Mehra R', 'Adamo V', 'Rolfo C']","['Antineoplastic Agents/pharmacology/*therapeutic use', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Lung Neoplasms/genetics', 'Molecular Targeted Therapy', 'Oncogene Proteins, Fusion/*genetics/metabolism', 'Protein Kinase Inhibitors/pharmacology/*therapeutic use', 'Proto-Oncogene Mas', 'Proto-Oncogene Proteins c-ret/*antagonists & inhibitors/*genetics/metabolism', 'Thyroid Neoplasms/genetics']",https://pubmed.ncbi.nlm.nih.gov/31715421/
737,RET,30484597,[Not Available].,"['Tronko ND', 'Pushkarev VM']","['Carcinogenesis/genetics/metabolism/pathology', '*Chernobyl Nuclear Accident', 'Gamma Rays/adverse effects', '*Gene Expression Regulation, Neoplastic', 'Humans', 'Inflammation', 'Molecular Epidemiology', 'NF-kappa B/*genetics/metabolism', 'Neoplasms, Radiation-Induced/diagnosis/epidemiology/*genetics/pathology', 'Proto-Oncogene Proteins c-ret/*genetics/metabolism', 'Radiation Dosage', 'Thyroid Cancer, Papillary/diagnosis/epidemiology/*genetics/pathology', 'Thyroid Neoplasms/diagnosis/epidemiology/*genetics/pathology', 'Tumor Microenvironment', 'Ukraine/epidemiology']",https://pubmed.ncbi.nlm.nih.gov/30484597/
738,RET,39413211,Mechanisms of RET-mediated signal transduction.,"['Carlomagno F', 'Moccia M', 'Federico G', 'Santoro M']","['Humans', '*Proto-Oncogene Proteins c-ret/metabolism/genetics', '*Signal Transduction', 'Animals', 'Neoplasms/metabolism/genetics']",https://pubmed.ncbi.nlm.nih.gov/39413211/
739,RET,39244004,MIG6 loss increased RET inhibitor tolerant persister cells in RET-rearranged non-small cell lung cancer.,"['Wei X', 'Uchibori K', 'Kondo N', 'Utsumi T', 'Takemoto A', 'Koike S', 'Takagi S', 'Yanagitani N', 'Nishio M', 'Katayama R']","['Humans', '*Proto-Oncogene Proteins c-ret/genetics/antagonists & inhibitors/metabolism', '*Carcinoma, Non-Small-Cell Lung/drug therapy/genetics/pathology', '*Lung Neoplasms/genetics/drug therapy/pathology', '*Drug Resistance, Neoplasm/genetics', '*Protein Kinase Inhibitors/pharmacology', 'Adaptor Proteins, Signal Transducing/genetics/metabolism', 'Tumor Suppressor Proteins/genetics/metabolism', 'ErbB Receptors/genetics/antagonists & inhibitors', 'Cell Line, Tumor', 'Gene Rearrangement', 'CRISPR-Cas Systems', 'Oncogene Proteins, Fusion']",https://pubmed.ncbi.nlm.nih.gov/39244004/
740,RET,25260367,Novel approaches in anaplastic thyroid cancer therapy.,"['Hsu KT', 'Yu XM', 'Audhya AW', 'Jaume JC', 'Lloyd RV', 'Miyamoto S', 'Prolla TA', 'Chen H']","['Biomarkers, Tumor/genetics/metabolism', 'Genetic Therapy', 'Histone Deacetylase Inhibitors/pharmacology', 'Histone Deacetylases/metabolism', 'Humans', 'Molecular Targeted Therapy', 'NF-kappa B/metabolism', 'Protein Kinase Inhibitors/pharmacology', 'Proto-Oncogene Proteins c-ret/genetics/metabolism', 'Receptor, Notch1/metabolism', 'Signal Transduction', 'Thyroid Carcinoma, Anaplastic/*metabolism/pathology/*therapy', 'raf Kinases/genetics/metabolism', 'ras Proteins/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/25260367/
741,RET,32080788,Ret Receptor Has Distinct Alterations and Functions in Breast Cancer.,"['Gattelli A', 'Hynes NE', 'Schor IE', 'Vallone SA']","['Animals', 'Biomarkers, Tumor/genetics/*metabolism', 'Breast Neoplasms/genetics/metabolism/*pathology', 'Female', '*Gene Expression Regulation, Neoplastic', 'Humans', '*Mutation', 'Proto-Oncogene Mas', 'Proto-Oncogene Proteins c-ret/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/32080788/
742,RET,33933276,Advances in the treatment of RET-fusion-positive lung cancer.,"['Pall G', 'Gautschi O']","['Humans', '*Lung Neoplasms/drug therapy', 'Proto-Oncogene Proteins c-ret/genetics', 'Pyrazoles', 'Pyridines', 'Pyrimidines']",https://pubmed.ncbi.nlm.nih.gov/33933276/
743,RET,29175871,Structure and function of RET in multiple endocrine neoplasia type 2.,['Plaza-Menacho I'],"['Humans', 'Multiple Endocrine Neoplasia Type 2a/genetics/*metabolism', 'Mutation', 'Protein Conformation', '*Proto-Oncogene Proteins c-ret/chemistry/genetics/metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/29175871/
744,RET,17036197,RET and neuroendocrine tumors.,"['Murakumo Y', 'Jijiwa M', 'Asai N', 'Ichihara M', 'Takahashi M']","['Adrenal Gland Neoplasms/enzymology', 'Animals', 'Biomarkers, Tumor/chemistry/genetics/*metabolism', 'Carcinoma, Medullary/enzymology', 'Carcinoma, Papillary/enzymology', 'Gene Expression Regulation, Enzymologic', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Multiple Endocrine Neoplasia Type 2a/enzymology', 'Multiple Endocrine Neoplasia Type 2b/enzymology', 'Mutation', 'Neuroendocrine Tumors/*enzymology/genetics/pathology/therapy', 'Pheochromocytoma/enzymology', 'Prognosis', 'Protein Conformation', 'Proto-Oncogene Mas', 'Proto-Oncogene Proteins c-ret/chemistry/genetics/*metabolism', '*Signal Transduction/genetics', 'Thyroid Neoplasms/enzymology']",https://pubmed.ncbi.nlm.nih.gov/17036197/
745,RET,24022366,To bud or not to bud: the RET perspective in CAKUT.,"['Davis TK', 'Hoshi M', 'Jain S']","['Animals', 'Humans', 'Organogenesis/physiology', 'Proto-Oncogene Proteins c-ret/*physiology', 'Urinary Tract/*abnormalities', 'Urogenital Abnormalities/genetics/*metabolism', 'Urologic Diseases/*congenital']",https://pubmed.ncbi.nlm.nih.gov/24022366/
746,RET,15013219,RET and neuroendocrine tumors.,"['Ichihara M', 'Murakumo Y', 'Takahashi M']","['Animals', 'Drosophila Proteins/*physiology', 'Gene Expression Regulation', 'Glial Cell Line-Derived Neurotrophic Factor', 'Humans', 'Mutation', 'Nerve Growth Factors/physiology', 'Neuroendocrine Tumors/*genetics/*metabolism', 'Proto-Oncogene Proteins c-ret', 'Receptor Protein-Tyrosine Kinases/*physiology', 'Signal Transduction/*physiology']",https://pubmed.ncbi.nlm.nih.gov/15013219/
747,RET,38805286,CCDC6-RET fusion protein regulates Ras/MAPK signaling through the fusion- GRB2-SHC1 signal niche.,"['Qiu T', 'Kong Y', 'Wei G', 'Sun K', 'Wang R', 'Wang Y', 'Chen Y', 'Wang W', 'Zhang Y', 'Jiang C', 'Yang P', 'Xie T', 'Chen X']","['Humans', '*GRB2 Adaptor Protein/metabolism/genetics', 'HEK293 Cells', '*MAP Kinase Signaling System', '*Oncogene Proteins, Fusion/metabolism/genetics', 'Phosphorylation', '*Proto-Oncogene Proteins c-ret/metabolism/genetics', '*ras Proteins/metabolism/genetics', 'Signal Transduction', '*Src Homology 2 Domain-Containing, Transforming Protein 1/metabolism/genetics']",https://pubmed.ncbi.nlm.nih.gov/38805286/
748,RET,22174542,Genetic interactions and modifier genes in Hirschsprung's disease.,"['Wallace AS', 'Anderson RB']","['Animals', 'Endothelins/metabolism', 'Enteric Nervous System/pathology/*physiology/*physiopathology', '*Genes, Modifier', 'Hirschsprung Disease/*genetics/*physiopathology', 'Humans', 'Mutation', 'Phenotype', 'Proto-Oncogene Proteins c-ret/genetics', 'Signal Transduction/physiology', 'Transcription Factors/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/22174542/
749,RET,31896937,A primer on the genetics of medullary thyroid cancer.,"['Larouche V', 'Akirov A', 'Thomas CM', 'Krzyzanowska MK', 'Ezzat S']","['Carcinoma, Neuroendocrine/*genetics', 'Genetic Association Studies', 'Genetic Testing', 'Humans', 'Mutation', 'Proto-Oncogene Mas', 'Proto-Oncogene Proteins c-ret/*genetics', 'Thyroid Neoplasms/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31896937/
750,RET,28639308,Discovery of (wt) RET and (V804M) RET Inhibitors: From Hit to Lead.,"['Mologni L', 'Dalla Via M', 'Chilin A', 'Palumbo M', 'Marzaro G']","['Aminopyridines/chemical synthesis/*chemistry/toxicity', 'Binding Sites', 'Cell Line, Tumor', 'Drug Evaluation, Preclinical', 'Heterocyclic Compounds/chemical synthesis/chemistry/pharmacology', 'Humans', 'Hydrogen Bonding', 'Inhibitory Concentration 50', 'Molecular Docking Simulation', 'Mutation', 'Phenylurea Compounds/chemical synthesis/*chemistry/toxicity', 'Phosphorylation/drug effects', 'Protein Kinase Inhibitors/chemical synthesis/*chemistry/pharmacology', 'Protein Structure, Tertiary', 'Proto-Oncogene Proteins c-ret/antagonists & inhibitors/genetics/*metabolism', 'Urea/analogs & derivatives/chemical synthesis/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/28639308/
751,RET,32737575,RET-independent signaling by GDNF ligands and GFRalpha receptors.,"['Ibanez CF', 'Paratcha G', 'Ledda F']","['Cell Movement', 'Glial Cell Line-Derived Neurotrophic Factor/*metabolism', 'Glial Cell Line-Derived Neurotrophic Factor Receptors/*metabolism', 'Humans', 'Ligands', 'Proto-Oncogene Proteins c-ret/*genetics', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/32737575/
752,RET,20930041,Targeting RET receptor tyrosine kinase activation in cancer.,"['Phay JE', 'Shah MH']","['Animals', 'Antineoplastic Agents/pharmacology/therapeutic use', 'Carcinoma, Medullary/diagnosis/drug therapy/genetics/metabolism', 'Enzyme Activation/drug effects/physiology', 'Genetic Association Studies', 'Humans', 'Models, Biological', 'Molecular Targeted Therapy/*methods', 'Neoplasms/*drug therapy', 'Protein Kinase Inhibitors/pharmacology/*therapeutic use', 'Proto-Oncogene Proteins c-ret/*antagonists & inhibitors/genetics', 'Receptor Protein-Tyrosine Kinases/*antagonists & inhibitors/metabolism', 'Thyroid Neoplasms/diagnosis/drug therapy/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/20930041/
753,RET,20015687,Oligomerization of G-protein-coupled receptors: a reality.,"['Ferre S', 'Franco R']","['Animals', 'Cell Membrane/physiology', 'Humans', 'Ligands', 'Protein Binding', 'Protein Multimerization', 'Receptors, G-Protein-Coupled/chemistry/*metabolism', '*Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/20015687/
754,RET,24296167,Central role of RET in thyroid cancer.,"['Santoro M', 'Carlomagno F']","['Carcinoma/drug therapy/*enzymology/genetics', 'Carcinoma, Neuroendocrine', 'Carcinoma, Papillary', 'Humans', 'Mutation', 'Protein Kinase Inhibitors/therapeutic use', 'Proto-Oncogene Proteins c-ret/antagonists & inhibitors/genetics/*metabolism', 'Thyroid Cancer, Papillary', 'Thyroid Neoplasms/drug therapy/*enzymology/genetics']",https://pubmed.ncbi.nlm.nih.gov/24296167/
755,RET,16765607,RGS17/RGSZ2 and the RZ/A family of regulators of G-protein signaling.,"['Nunn C', 'Mao H', 'Chidiac P', 'Albert PR']","['Animals', 'Calcium/metabolism', 'Cysteine/chemistry', 'GTP-Binding Proteins/*metabolism', 'GTPase-Activating Proteins/physiology', 'Humans', 'Models, Biological', 'Palmitic Acid/metabolism', 'Protein Binding', 'Protein Structure, Tertiary', '*RGS Proteins/chemistry/classification/genetics/metabolism/physiology', 'Signal Transduction/*physiology', 'Subcellular Fractions/metabolism', 'Tissue Distribution', 'Ubiquitin/metabolism']",https://pubmed.ncbi.nlm.nih.gov/16765607/
756,OPRM1,28699646,Review of Opioid Pharmacogenetics and Considerations for Pain Management.,"['Owusu Obeng A', 'Hamadeh I', 'Smith M']","['Analgesics, Opioid/*therapeutic use', 'Genetic Testing/trends', 'Humans', 'Pain/*drug therapy/*genetics', 'Pain Management/*methods/trends', 'Pharmacogenetics/*methods/trends', 'Receptors, Opioid, mu/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28699646/
757,OPRM1,24201053,Pharmacogenetics of OPRM1.,"['Crist RC', 'Berrettini WH']","['Alcoholism/drug therapy/genetics', 'Analgesia', 'Humans', 'Opioid-Related Disorders/genetics', 'Pain/drug therapy/genetics', '*Pharmacogenetics', 'Receptors, Opioid, mu/*genetics', 'Tobacco Use Disorder/genetics']",https://pubmed.ncbi.nlm.nih.gov/24201053/
758,OPRM1,31227296,Pharmacogenetics of Postoperative Nausea and Vomiting.,"['Aroke EN', 'Hicks TL']","['Antiemetics/*therapeutic use', 'Cytochrome P-450 CYP2D6/genetics', 'Humans', 'Ondansetron/*therapeutic use', '*Pharmacogenetics', 'Polymorphism, Genetic', 'Postoperative Nausea and Vomiting/drug therapy/*genetics/nursing', 'Receptors, Opioid, mu/genetics']",https://pubmed.ncbi.nlm.nih.gov/31227296/
759,OPRM1,25102313,OPRM1 A118G gene variant and postoperative opioid requirement: a systematic review and meta-analysis.,"['Hwang IC', 'Park JY', 'Myung SK', 'Ahn HY', 'Fukuda K', 'Liao Q']","['Analgesics, Opioid/*administration & dosage', 'Animals', 'Genetic Variation/*genetics', 'Humans', 'Pain, Postoperative/drug therapy/*genetics', 'Postoperative Care/methods', 'Receptors, Opioid, mu/*genetics']",https://pubmed.ncbi.nlm.nih.gov/25102313/
760,OPRM1,39403933,An emerging multi-omic understanding of the genetics of opioid addiction.,"['Johnson EO', 'Fisher HS', 'Sullivan KA', 'Corradin O', 'Sanchez-Roige S', 'Gaddis NC', 'Sami YN', 'Townsend A', 'Teixeira Prates E', 'Pavicic M', 'Kruse P', 'Chesler EJ', 'Palmer AA', 'Troiani V', 'Bubier JA', 'Jacobson DA', 'Maher BS']","['Humans', '*Opioid-Related Disorders/genetics/metabolism/pathology', 'Genome-Wide Association Study', 'Animals', 'Receptors, Opioid, mu/genetics/metabolism', 'Brain/metabolism/pathology', 'Multiomics']",https://pubmed.ncbi.nlm.nih.gov/39403933/
761,OPRM1,38467611,Intercellular communication atlas reveals Oprm1 as a neuroprotective factor for retinal ganglion cells.,"['Qian C', 'Xin Y', 'Qi C', 'Wang H', 'Dong BC', 'Zack DJ', 'Blackshaw S', 'Hattar S', 'Zhou FQ', 'Qian J']","['Animals', 'Mice', 'Cell Communication', 'Cell Death', 'Cell Survival', '*Neuroprotective Agents/pharmacology/metabolism', 'Optic Nerve/metabolism', '*Optic Nerve Injuries/metabolism', 'Retinal Ganglion Cells/physiology']",https://pubmed.ncbi.nlm.nih.gov/38467611/
762,OPRM1,30118972,A review of opioid addiction genetics.,"['Crist RC', 'Reiner BC', 'Berrettini WH']","['*Genome-Wide Association Study', 'Humans', 'Multifactorial Inheritance/genetics', 'Opioid-Related Disorders/*genetics', 'Receptors, Opioid, delta/genetics', 'Receptors, Opioid, mu/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30118972/
763,OPRM1,17979515,Polymorphisms in the mu-opioid receptor gene (OPRM1) and the implications for alcohol dependence in humans.,"['van der Zwaluw CS', 'van den Wildenberg E', 'Wiers RW', 'Franke B', 'Buitelaar J', 'Scholte RH', 'Engels RC']","['Alcoholism/*genetics', 'Case-Control Studies', 'Clinical Trials as Topic', 'Genetic Variation', 'Humans', 'Phenotype', '*Polymorphism, Genetic', 'Racial Groups/genetics', 'Receptors, Opioid, mu/*genetics', 'Reference Values']",https://pubmed.ncbi.nlm.nih.gov/17979515/
764,OPRM1,24993436,Genetics and implications in perioperative analgesia.,['Trescot AM'],"['Analgesia/*methods', 'Analgesics/pharmacokinetics/pharmacology/*therapeutic use', 'Analgesics, Opioid/metabolism', 'Anesthesia/adverse effects', '*Genetics', 'Humans', 'Pain/genetics']",https://pubmed.ncbi.nlm.nih.gov/24993436/
765,OPRM1,29302220,A brief review of the genetics and pharmacogenetics of opioid use disorders.,['Berrettini W'],"['Buprenorphine/therapeutic use', 'Cytochrome P-450 CYP2B6/genetics/metabolism', 'Genome-Wide Association Study', 'Humans', 'Narcotic Antagonists/therapeutic use', 'Opioid-Related Disorders/*drug therapy/*genetics', 'Pharmacogenetics/*methods', 'Polymorphism, Single Nucleotide/genetics', 'Potassium Channels/genetics', 'Receptors, Opioid, mu/genetics']",https://pubmed.ncbi.nlm.nih.gov/29302220/
766,OPRM1,34523422,Reviewing pharmacogenetics to advance precision medicine for opioids.,"['Magarbeh L', 'Gorbovskaya I', 'Le Foll B', 'Jhirad R', 'Muller DJ']","['Analgesics, Opioid/*administration & dosage/pharmacokinetics/pharmacology', 'Animals', 'Cytochrome P-450 CYP2D6/genetics', 'Dose-Response Relationship, Drug', 'Humans', 'Pain/drug therapy', '*Pharmacogenetics', 'Precision Medicine/*methods', 'Randomized Controlled Trials as Topic', 'Receptors, Opioid, mu/genetics']",https://pubmed.ncbi.nlm.nih.gov/34523422/
767,OPRM1,28294082,Genetics of fat intake in the determination of body mass.,"['Chmurzynska A', 'Mlodzik MA']","['Abdominal Fat', 'Adiposity', 'Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics', 'Body Composition/*genetics', 'Body Mass Index', 'CD36 Antigens/genetics', 'Dietary Fats/*administration & dosage', 'Energy Metabolism/genetics', 'Fatty Acids/administration & dosage', 'Food Preferences', 'Gene-Environment Interaction', 'Genetic Linkage', 'Humans', 'Obesity/genetics', 'Polymorphism, Genetic/genetics', 'Taste/genetics', 'Weight Loss/genetics']",https://pubmed.ncbi.nlm.nih.gov/28294082/
768,OPRM1,37774411,Association of Genetic Variants with Postsurgical Pain: A Systematic Review and Meta-analyses.,"['Frangakis SG', 'MacEachern M', 'Akbar TA', 'Bolton C', 'Lin V', 'Smith AV', 'Brummett CM', 'Bicket MC']","['Adult', 'Humans', '*Analgesics, Opioid', '*Polymorphism, Single Nucleotide', 'Pain, Postoperative/genetics', 'Analgesics']",https://pubmed.ncbi.nlm.nih.gov/37774411/
769,OPRM1,30068261,Molecular Genetics and New Medication Strategies for Opioid Addiction.,"['Hurd YL', ""O'Brien CP""]","['Alternative Splicing', 'Epigenesis, Genetic', 'Genetic Predisposition to Disease', 'Humans', 'Medical Marijuana/therapeutic use', 'Opiate Substitution Treatment', 'Opioid-Related Disorders/drug therapy/*genetics/*therapy', 'Pharmacogenomic Variants', 'Receptors, Opioid, mu/genetics', 'Vaccines/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/30068261/
770,OPRM1,22193538,"Morphine metabolism, transport and brain disposition.","['De Gregori S', 'De Gregori M', 'Ranzani GN', 'Allegri M', 'Minella C', 'Regazzi M']","['ATP Binding Cassette Transporter, Subfamily B', 'ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics/metabolism', 'Analgesics, Opioid/chemistry/pharmacokinetics', 'Animals', 'Biological Transport', 'Blood-Brain Barrier/*metabolism', 'Brain/metabolism', 'Glucuronosyltransferase/genetics/metabolism', 'Humans', 'Liver/metabolism', 'Mice', 'Morphine/chemistry/*pharmacokinetics', 'Morphine Derivatives/chemistry/*pharmacokinetics', 'Neoplasms/drug therapy', 'Pain/drug therapy/genetics/metabolism', 'Rats', 'Receptors, Opioid, mu/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/22193538/
771,OPRM1,38118075,Chronic intermittent ethanol exposure-induced m6A modifications around mRNA stop codons of opioid receptor genes.,"['Liu Y', 'Koo JS', 'Zhang H']","['Humans', '*Receptors, Opioid/genetics', 'Codon, Terminator', 'Ethanol/pharmacology', 'RNA, Messenger/genetics', 'DNA Methylation', '*Neuroblastoma/genetics']",https://pubmed.ncbi.nlm.nih.gov/38118075/
772,OPRM1,35727214,ABCB1 and OPRM1 single-nucleotide polymorphisms collectively modulate chronic shoulder pain and dysfunction in South African breast cancer survivors.,"['Firfirey F', 'September AV', 'Shamley D']","['*ATP Binding Cassette Transporter, Subfamily B/genetics', 'Analgesics, Opioid/therapeutic use', '*Breast Neoplasms/complications/genetics', '*Cancer Survivors', 'Female', 'Genotype', 'Humans', 'Polymorphism, Single Nucleotide', '*Receptors, Opioid, mu/genetics', '*Shoulder Pain/etiology/genetics', 'South Africa']",https://pubmed.ncbi.nlm.nih.gov/35727214/
773,OPRM1,32442101,Pharmacogenetics of Postoperative Pain Management: A Review.,"['Aroke EN', 'Kittelsrud JM']","['Analgesics, Opioid/pharmacokinetics/*therapeutic use', 'Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics/*therapeutic use', 'Humans', 'Pain, Postoperative/*drug therapy', 'Pharmacogenetics', 'Receptors, Opioid, mu/genetics']",https://pubmed.ncbi.nlm.nih.gov/32442101/
774,OPRM1,24368617,Neurogenetics of aggressive behavior: studies in primates.,"['Barr CS', 'Driscoll C']","['Aggression/*physiology', 'Animals', 'Behavior, Animal', '*Gene-Environment Interaction', 'Genetic Variation', '*Genetics', 'Humans', 'Impulsive Behavior/genetics', 'Primates', 'Reward']",https://pubmed.ncbi.nlm.nih.gov/24368617/
775,OPRM1,29413524,Mu Opioid Pharmacology: 40 Years to the Promised Land.,['Pasternak GW'],"['Alternative Splicing/genetics', 'Analgesics, Opioid/metabolism', 'Animals', 'Humans', 'Morphine/pharmacology', 'Receptors, Opioid, mu/genetics/*metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/29413524/
776,HTR3A,34285037,Overproduction of Gastrointestinal 5-HT Promotes Colitis-Associated Colorectal Cancer Progression via Enhancing NLRP3 Inflammasome Activation.,"['Li T', 'Fu B', 'Zhang X', 'Zhou Y', 'Yang M', 'Cao M', 'Chen Y', 'Tan Y', 'Hu R']","['Animals', 'Azoxymethane/administration & dosage', 'Cell Line, Tumor', 'Colitis-Associated Neoplasms/chemically induced/*immunology/pathology', 'Dextran Sulfate/administration & dosage', 'Gastrointestinal Tract/metabolism/pathology', 'Humans', 'Inflammasomes/*metabolism', 'Inflammation/metabolism', 'Interleukin-1beta/metabolism', 'Macrophages/metabolism', 'Male', 'Mice', 'Mice, Inbred BALB C', 'Mice, Inbred C57BL', 'NLR Family, Pyrin Domain-Containing 3 Protein/genetics/*metabolism', 'Serotonin/*metabolism', 'Signal Transduction/*drug effects', 'Tryptophan Hydroxylase/deficiency/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34285037/
777,HTR3A,27615133,beta-Cell adaptation in pregnancy.,"['Baeyens L', 'Hindi S', 'Sorenson RL', 'German MS']","['*Adaptation, Physiological', 'Animals', '*Cell Proliferation', 'Diabetes, Gestational/metabolism', 'Female', 'Glucose/*metabolism', 'Humans', 'Insulin/*metabolism', 'Insulin Resistance', 'Insulin Secretion', 'Insulin-Secreting Cells/cytology/*metabolism', 'Mice', 'Placental Lactogen/metabolism', 'Postpartum Period', 'Pregnancy/*metabolism', 'Rats', 'Serotonin/metabolism']",https://pubmed.ncbi.nlm.nih.gov/27615133/
778,HTR3A,35614045,Serotonin limits generation of chromaffin cells during adrenal organ development.,"['Kameneva P', 'Melnikova VI', 'Kastriti ME', 'Kurtova A', 'Kryukov E', 'Murtazina A', 'Faure L', 'Poverennaya I', 'Artemov AV', 'Kalinina TS', 'Kudryashov NV', 'Bader M', 'Skoda J', 'Chlapek P', 'Curylova L', 'Sourada L', 'Neradil J', 'Tesarova M', 'Pasqualetti M', 'Gaspar P', 'Yakushov VD', 'Sheftel BI', 'Zikmund T', 'Kaiser J', 'Fried K', 'Alenina N', 'Voronezhskaya EE', 'Adameyko I']","['Adrenal Glands/metabolism', 'Animals', 'Catecholamines/metabolism', '*Chromaffin Cells/metabolism', 'Female', 'Mice', '*Neuroblastoma/metabolism', 'Pregnancy', 'Serotonin/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35614045/
779,HTR3A,38326723,Risk Factors of Depression Screened by Two-Sample Mendelian Randomization Analysis: A Systematic Review.,"['Wang HL', 'Xue YF', 'Cui BQ', 'Liu H', 'Shen XX']","['Humans', '*Depressive Disorder, Major/genetics', 'Depression', 'Genome-Wide Association Study', 'Mendelian Randomization Analysis', 'Risk Factors', 'Serotonin Plasma Membrane Transport Proteins']",https://pubmed.ncbi.nlm.nih.gov/38326723/
780,HTR3A,34730627,Fibromyalgia: A Review of Related Polymorphisms and Clinical Relevance.,"['Janssen LP', 'Medeiros LF', 'Souza A', 'Silva JD']","['*Fibromyalgia/genetics', '*Homocystinuria', 'Humans', 'Methylenetetrahydrofolate Reductase (NADPH2)', 'NAV1.7 Voltage-Gated Sodium Channel', 'Pain', 'Polymorphism, Genetic/genetics', 'Pyrin', 'Receptors, Adrenergic, beta-3', 'Receptors, GABA', 'Serotonin Plasma Membrane Transport Proteins']",https://pubmed.ncbi.nlm.nih.gov/34730627/
781,HTR3A,27759945,Review: DNA methylation and alcohol use disorders: Progress and challenges.,"['Zhang H', 'Gelernter J']","['Alcoholism/*genetics', 'DNA Methylation/*genetics', 'Humans', 'Promoter Regions, Genetic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27759945/
782,HTR3A,35855515,Genetic determinants associated with response to clozapine in schizophrenia: an umbrella review.,"['van der Horst MZ', 'Papadimitriou G', 'Luykx JJ']","['*Clozapine/therapeutic use', 'Databases, Factual', 'Humans', '*Schizophrenia/drug therapy/genetics', 'Systematic Reviews as Topic']",https://pubmed.ncbi.nlm.nih.gov/35855515/
783,HTR3A,27706728,"Associations of serotonin receptor gene HTR3A, HTR3B, and HTR3A haplotypes with bipolar disorder in Chinese patients.","['Jian J', 'Li C', 'Xu J', 'Qiao D', 'Mi G', 'Chen X', 'Tang M']","['Alleles', 'Bipolar Disorder/*genetics/pathology', 'China', 'Female', 'Genetic Association Studies', '*Genetic Predisposition to Disease', 'Genotype', 'Haplotypes', 'Humans', 'Male', 'Phenotype', 'Polymorphism, Single Nucleotide', 'Receptors, Serotonin, 5-HT3/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27706728/
784,HTR3A,29279099,A review of the literature on the relationships between genetic polymorphisms and chemotherapy-induced nausea and vomiting.,"['Singh KP', 'Dhruva AA', 'Flowers E', 'Kober KM', 'Miaskowski C']","['ATP Binding Cassette Transporter, Subfamily B/genetics', 'Antineoplastic Agents/*adverse effects/therapeutic use', 'Cytochrome P-450 CYP2D6/genetics', 'Humans', 'Nausea/*chemically induced/*genetics', 'Neoplasms/*drug therapy/*genetics', 'Polymorphism, Single Nucleotide', 'Receptors, Serotonin, 5-HT3/genetics', 'Vomiting/*chemically induced/*genetics']",https://pubmed.ncbi.nlm.nih.gov/29279099/
785,HTR3A,21345729,5-HT(3) receptors: potential of individual isoforms for personalised therapy.,['Niesler B'],"['Humans', 'Irritable Bowel Syndrome/drug therapy/metabolism', 'Mental Disorders/drug therapy/metabolism', 'MicroRNAs/metabolism', 'Molecular Chaperones/metabolism', 'Precision Medicine/*methods', 'Protein Isoforms', 'Receptors, Serotonin, 5-HT3/chemistry/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/21345729/
786,HTR3A,23489111,Discriminating between 5-HT(3)A and 5-HT(3)AB receptors.,"['Thompson AJ', 'Lummis SC']","['Allosteric Regulation/drug effects', 'Animals', 'Antiemetics/chemistry/metabolism/pharmacology/therapeutic use', 'Binding Sites/drug effects', 'Binding, Competitive/drug effects', 'Drug Partial Agonism', 'Humans', 'Ligands', '*Models, Molecular', 'Molecular Conformation', 'Protein Multimerization', 'Protein Subunits/antagonists & inhibitors/chemistry/genetics/metabolism', 'Receptors, Serotonin, 5-HT3/chemistry/genetics/*metabolism', 'Recombinant Proteins/chemistry/metabolism', 'Serotonin 5-HT3 Receptor Agonists/chemistry/metabolism/pharmacology/therapeutic use', 'Serotonin 5-HT3 Receptor Antagonists/chemistry/metabolism/pharmacology/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/23489111/
787,HTR3A,38674857,Mendelian Randomization Analysis Identifies Inverse Causal Relationship between External Eating and Metabolic Phenotypes.,"['Timasheva Y', 'Balkhiyarova Z', 'Avzaletdinova D', 'Morugova T', 'Korytina GF', 'Nouwen A', 'Prokopenko I', 'Kochetova O']","['Humans', '*Mendelian Randomization Analysis', '*Phenotype', '*Diabetes Mellitus, Type 2/genetics/etiology', '*Feeding Behavior', 'Female', 'Male', 'Metabolic Syndrome/genetics/etiology', 'tRNA Methyltransferases/genetics', 'Glycated Hemoglobin/metabolism/analysis', 'Middle Aged', 'Body Mass Index', 'Adenylyl Cyclases/genetics', 'Genome-Wide Association Study', 'Polymorphism, Single Nucleotide', 'Adult', 'Waist Circumference', 'Genetic Variation', '*Ghrelin']",https://pubmed.ncbi.nlm.nih.gov/38674857/
788,HTR3A,18466097,"Serotonin type 3 receptor genes: HTR3A, B, C, D, E.","['Niesler B', 'Kapeller J', 'Hammer C', 'Rappold G']","['Animals', 'Databases, Genetic', 'Genetic Variation/genetics', 'Humans', 'Receptors, Serotonin/*genetics', 'Receptors, Serotonin, 5-HT3/genetics']",https://pubmed.ncbi.nlm.nih.gov/18466097/
789,HTR3A,32736413,HTR3A is correlated with unfavorable histology and promotes proliferation through ERK phosphorylation in lung adenocarcinoma.,"['Tone M', 'Tahara S', 'Nojima S', 'Motooka D', 'Okuzaki D', 'Morii E']","['Adenocarcinoma of Lung/*drug therapy/*genetics/pathology', 'Aged', 'Cell Proliferation/drug effects', 'ErbB Receptors/genetics', 'Female', 'Gene Expression Regulation, Neoplastic/genetics', 'Gene Knockdown Techniques', 'Humans', 'Ki-67 Antigen/genetics', 'Male', 'Middle Aged', 'Mitogen-Activated Protein Kinase 3/genetics', 'Phosphorylation/drug effects', 'Prognosis', 'Receptors, Serotonin, 5-HT3/*genetics', 'Serotonin 5-HT3 Receptor Antagonists/pharmacology', 'Tropisetron/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/32736413/
790,HTR3A,28002447,Influence of Polymorphisms in the HTR3A and HTR3B Genes on Experimental Pain and the Effect of the 5-HT3 Antagonist Granisetron.,"['Louca Jounger S', 'Christidis N', 'Hedenberg-Magnusson B', 'List T', 'Svensson P', 'Schalling M', 'Ernberg M']","['Adult', 'Alleles', 'Double-Blind Method', 'Female', 'Genotype', 'Granisetron/*therapeutic use', 'Healthy Volunteers', 'Humans', 'Male', 'Myalgia/chemically induced/*drug therapy/*genetics/prevention & control', 'Pain Threshold/physiology', 'Placebo Effect', 'Polymorphism, Single Nucleotide', 'Receptors, Serotonin, 5-HT3/*genetics', 'Serotonin 5-HT3 Receptor Antagonists/*therapeutic use', 'Sex Factors', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/28002447/
791,HTR3A,23886513,Gene environment interaction studies in depression and suicidal behavior: An update.,"['Mandelli L', 'Serretti A']","['Depressive Disorder, Major/*genetics', '*Gene-Environment Interaction', 'Genetic Predisposition to Disease/genetics', 'Humans', 'Life Change Events', 'Suicide/*psychology']",https://pubmed.ncbi.nlm.nih.gov/23886513/
792,HTR3A,33108388,Discrimination of alcohol dependence based on the convolutional neural network.,"['Chen F', 'Xiao M', 'Chen C', 'Chen C', 'Yan Z', 'Han H', 'Zhang S', 'Yue F', 'Gao R', 'Lv X']","['Adult', 'Age Factors', 'Alcoholism/*diagnosis/genetics', 'Educational Status', 'Female', 'Genotype', 'Humans', 'Linear Models', 'Male', 'Marital Status', 'Middle Aged', '*Neural Networks, Computer', 'Support Vector Machine', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/33108388/
793,HTR3A,35757399,Construction of a Tumor Immune Microenvironment-Related Prognostic Model in BRAF-Mutated Papillary Thyroid Cancer.,"['Xia Y', 'Jiang X', 'Huang Y', 'Liu Q', 'Huang Y', 'Zhang B', 'Mei Z', 'Xu D', 'Shi Y', 'Tu W']","['*Carcinoma/pathology', '*Carcinoma, Papillary/genetics/pathology', 'Humans', 'Prognosis', 'Proto-Oncogene Proteins B-raf/genetics', 'Thyroid Cancer, Papillary/genetics', '*Thyroid Neoplasms/pathology', 'Tumor Microenvironment/genetics']",https://pubmed.ncbi.nlm.nih.gov/35757399/
794,HTR3A,24229632,New insights into rosacea pathophysiology: a review of recent findings.,"['Steinhoff M', 'Schauber J', 'Leyden JJ']","['Adaptive Immunity', 'Antimicrobial Cationic Peptides/drug effects', 'Disease Progression', 'Gene Expression Profiling', 'Humans', 'Immunity, Innate', 'Lipopolysaccharides', 'Mast Cells/physiology', 'Rosacea/immunology/*physiopathology', 'Skin/immunology', 'Th1 Cells/physiology', 'Toll-Like Receptors/physiology', 'Cathelicidins']",https://pubmed.ncbi.nlm.nih.gov/24229632/
795,HTR3A,35105872,"DNA-methylation dynamics across short-term, exposure-containing CBT in patients with panic disorder.","['Moser S', 'Martins J', 'Czamara D', 'Lange J', 'Muller-Myhsok B', 'Erhardt A']","['*Cognitive Behavioral Therapy/methods', 'CpG Islands', 'DNA', 'DNA Methylation', 'Humans', '*Panic Disorder/genetics/psychology/therapy']",https://pubmed.ncbi.nlm.nih.gov/35105872/
796,HTR7,33461384,"Autophagy activation, lipotoxicity and lysosomal membrane permeabilization synergize to promote pimozide- and loperamide-induced glioma cell death.","['Meyer N', 'Henkel L', 'Linder B', 'Zielke S', 'Tascher G', 'Trautmann S', 'Geisslinger G', 'Munch C', 'Fulda S', 'Tegeder I', 'Kogel D']","['Autophagy/*drug effects/*physiology', 'Autophagy-Related Protein 5/antagonists & inhibitors/genetics/metabolism', 'Autophagy-Related Protein 7/antagonists & inhibitors/genetics/metabolism', 'Brain Neoplasms/*drug therapy/metabolism/*pathology', 'Cathepsins/metabolism', 'Cell Death/drug effects/physiology', 'Cell Line, Tumor', 'Ceramides/metabolism', 'Gene Knockout Techniques', 'Glioblastoma/*drug therapy/metabolism/*pathology', 'Humans', 'Lipid Metabolism/drug effects', 'Loperamide/*pharmacology', 'Lysosomes/drug effects/metabolism', 'Permeability/drug effects', 'Pimozide/*pharmacology', 'Proteome/metabolism', 'Sphingomyelin Phosphodiesterase/antagonists & inhibitors/metabolism']",https://pubmed.ncbi.nlm.nih.gov/33461384/
797,HTR7,39455564,Mouse enteric neurons control intestinal plasmacytoid dendritic cell function via serotonin-HTR7 signaling.,"['Zhang H', 'Hasegawa Y', 'Suzuki M', 'Zhang T', 'Leitner DR', 'Jackson RP', 'Waldor MK']","['Animals', '*Dendritic Cells/immunology/metabolism', '*Serotonin/metabolism', 'Mice', '*Signal Transduction', '*Receptors, Serotonin/metabolism/genetics', '*Serotonergic Neurons/metabolism', 'Intestinal Mucosa/metabolism/immunology', 'Mice, Inbred C57BL', 'Immunoglobulin A/metabolism/immunology', 'B-Lymphocytes/immunology/metabolism', 'Enteric Nervous System/metabolism/immunology', 'Salmonella typhimurium/immunology/physiology', 'Intestines/immunology', 'Mice, Knockout', 'Salmonella Infections/immunology/microbiology/metabolism', 'Male', 'Cell Differentiation/immunology']",https://pubmed.ncbi.nlm.nih.gov/39455564/
798,HTR7,34555475,5-HT(7) receptors in Alzheimer's disease.,"['Solas M', 'Van Dam D', 'Janssens J', 'Ocariz U', 'Vermeiren Y', 'De Deyn PP', 'Ramirez MJ']","['Aged', 'Aged, 80 and over', 'Alzheimer Disease/genetics/*metabolism/pathology', 'Animals', 'Brain/*metabolism/pathology', 'Brain Chemistry/physiology', 'Female', 'Humans', 'Male', 'Middle Aged', 'Receptors, Serotonin/analysis/*biosynthesis/genetics', 'Reverse Transcriptase Polymerase Chain Reaction/methods', 'Serotonin/analysis/*biosynthesis/genetics']",https://pubmed.ncbi.nlm.nih.gov/34555475/
799,HTR7,36344870,Habenula as a Possible Target for Treatment-Resistant Depression Phenotype in Wistar Kyoto Rats.,"['Korlatowicz A', 'Pabian P', 'Solich J', 'Kolasa M', 'Latocha K', 'Dziedzicka-Wasylewska M', 'Faron-Gorecka A']","['Animals', 'Rats', 'Depression', 'G Protein-Coupled Inwardly-Rectifying Potassium Channels/metabolism', '*Habenula/metabolism', '*MicroRNAs/genetics/metabolism', 'Phenotype', 'Rats, Inbred WKY']",https://pubmed.ncbi.nlm.nih.gov/36344870/
800,HTR7,30893423,Tissue regulatory T cells and neural repair.,"['Ito M', 'Komai K', 'Nakamura T', 'Srirat T', 'Yoshimura A']","['Animals', 'Astrocytes/*immunology', 'Brain/*immunology', 'Cytokines/metabolism', 'Disease Models, Animal', 'Humans', 'Inflammation/*immunology', 'Mice', 'Receptors, Serotonin/metabolism', 'Reperfusion Injury/*immunology', 'T-Lymphocytes, Regulatory/*immunology', 'Wound Healing']",https://pubmed.ncbi.nlm.nih.gov/30893423/
801,HTR7,31353330,Regulatory T Cells: Pathophysiological Roles and Clinical Applications.,"['Sakai R', 'Komai K', 'Iizuka-Koga M', 'Yoshimura A', 'Ito M']","['Animals', 'Brain/immunology', 'Brain Ischemia/immunology', 'Central Nervous System Diseases/immunology', 'DNA Methylation', 'Forkhead Transcription Factors/genetics', 'Graft vs Host Disease/prevention & control', 'Humans', 'Mice', 'T-Lymphocytes, Regulatory/immunology/*physiology']",https://pubmed.ncbi.nlm.nih.gov/31353330/
802,HTR7,26074006,HTR7 Mediates Serotonergic Acute and Chronic Itch.,"['Morita T', 'McClain SP', 'Batia LM', 'Pellegrino M', 'Wilson SR', 'Kienzler MA', 'Lyman K', 'Olsen AS', 'Wong JF', 'Stucky CL', 'Brem RB', 'Bautista DM']","['Acute Disease', 'Animals', 'Chronic Disease', 'Dermatitis, Atopic/*genetics/metabolism', 'Disease Models, Animal', 'Ganglia, Spinal/metabolism', 'Gene Expression Profiling', 'Humans', 'Mice', 'Mice, Inbred C57BL/*genetics/metabolism', 'Mice, Inbred DBA/*genetics/metabolism', 'Pruritus/chemically induced/*genetics/metabolism', 'RNA, Messenger/*metabolism', 'Receptors, Serotonin/drug effects/*genetics/metabolism', 'Reverse Transcriptase Polymerase Chain Reaction', 'Serotonin/pharmacology', 'Serotonin Receptor Agonists/pharmacology', 'Selective Serotonin Reuptake Inhibitors/adverse effects/pharmacology', 'TRPA1 Cation Channel', 'Transient Receptor Potential Channels/drug effects/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/26074006/
803,HTR7,25278008,Genome-wide association discoveries of alcohol dependence.,"['Zuo L', 'Lu L', 'Tan Y', 'Pan X', 'Cai Y', 'Wang X', 'Hong J', 'Zhong C', 'Wang F', 'Zhang XY', 'Vanderlinden LA', 'Tabakoff B', 'Luo X']","['Alcoholism/*genetics/metabolism', 'Animals', 'Brain/*metabolism', '*Genome-Wide Association Study', 'Humans', 'Mice', 'RNA, Messenger/*metabolism', 'Rats']",https://pubmed.ncbi.nlm.nih.gov/25278008/
804,HTR7,36964762,5-Hydroxytryptophan inhibits beta-casein biosynthesis and promotes goat mammary epithelial cell apoptosis through the JAK2/STAT5a axis and the HTR7.,"['Du W', 'Zhang ZF', 'Xiao JY', 'Wang Y', 'Liu WY', 'Zheng HL']","['Animals', 'Female', 'Pregnancy', '*5-Hydroxytryptophan/pharmacology/metabolism', 'Apoptosis', '*Caseins/metabolism', 'Epithelial Cells/metabolism', 'Goats/genetics', 'Lactation', 'Mammary Glands, Animal/metabolism', 'Serotonin/pharmacology/metabolism', 'STAT5 Transcription Factor/genetics/metabolism/pharmacology', 'Receptors, Serotonin/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36964762/
805,HTR7,25038996,Serotonin modulation of macrophage polarization: inflammation and beyond.,"['de Las Casas-Engel M', 'Corbi AL']","['Animals', 'Gene Expression Regulation/*immunology', 'Homeostasis/*immunology', 'Humans', 'Inflammation/immunology/metabolism/pathology', 'Macrophages/*immunology/metabolism/pathology', 'Receptors, Serotonin/*immunology', 'Serotonin/*immunology/metabolism']",https://pubmed.ncbi.nlm.nih.gov/25038996/
806,HTR7,36335540,Targeting the brain 5-HT7 receptor to prevent hypomyelination in a rodent model of perinatal white matter injuries.,"['Bokobza C', 'Jacquens A', 'Guenoun D', 'Bianco B', 'Galland A', 'Pispisa M', 'Cruz A', 'Zinni M', 'Faivre V', 'Roumier A', 'Lebon S', 'Vitalis T', 'Csaba Z', 'Le Charpentier T', 'Schwendimann L', 'Young-Ten P', 'Degos V', 'Monteiro P', 'Dournaud P', 'Gressens P', 'Van Steenwinckel J']","['Animals', 'Mice', 'Pregnancy', 'Female', 'Child', 'Infant, Newborn', 'Humans', '*White Matter/pathology', 'Rodentia', 'Neuroinflammatory Diseases', 'Serotonin/metabolism', '*Premature Birth/metabolism/pathology', 'Brain/metabolism', '*Brain Injuries/etiology/prevention & control', 'Inflammation/pathology', 'Microglia/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36335540/
807,HTR7,30827505,MiRNA-29a modulates visceral hyperalgesia in irritable bowel syndrome by targeting HTR7.,"['Zhu H', 'Xiao X', 'Chai Y', 'Li D', 'Yan X', 'Tang H']","['Animals', 'Cell Line', 'Down-Regulation', 'Humans', 'Hyperalgesia/complications/*genetics/pathology', 'Irritable Bowel Syndrome/complications/*genetics/pathology', 'Mice, Inbred C57BL', 'MicroRNAs/analysis/*genetics', 'Receptors, Serotonin/analysis/*genetics', 'Up-Regulation', 'Visceral Pain/complications/genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/30827505/
808,HTR7,23355731,Serotonin skews human macrophage polarization through HTR2B and HTR7.,"['de las Casas-Engel M', 'Dominguez-Soto A', 'Sierra-Filardi E', 'Bragado R', 'Nieto C', 'Puig-Kroger A', 'Samaniego R', 'Loza M', 'Corcuera MT', 'Gomez-Aguado F', 'Bustos M', 'Sanchez-Mateos P', 'Corbi AL']","['Animals', 'Biomarkers/*metabolism', 'Cell Differentiation/*drug effects', 'Cell Lineage', 'Cells, Cultured', 'Gene Expression Regulation/drug effects/immunology', 'Genes, Reporter', 'Humans', 'Inflammation/chemically induced/immunology/metabolism', 'Interleukin-10/biosynthesis/immunology', 'Kupffer Cells/cytology/drug effects/immunology', 'Lipopolysaccharides', 'Luciferases', 'Macrophages/cytology/*drug effects/immunology', 'Mice', 'Mice, Inbred C57BL', 'Receptor, Serotonin, 5-HT2B/genetics/*immunology', 'Receptors, Serotonin/genetics/*immunology', 'Serotonin/immunology/*pharmacology', 'Signal Transduction/drug effects']",https://pubmed.ncbi.nlm.nih.gov/23355731/
809,HTR7,21376076,Neurobehavioral adaptations to methylphenidate: the issue of early adolescent exposure.,"['Marco EM', 'Adriani W', 'Ruocco LA', 'Canese R', 'Sadile AG', 'Laviola G']","['Adaptation, Physiological/*drug effects', 'Adolescent', 'Adolescent Development/*drug effects', 'Adult', 'Animals', 'Brain/*drug effects/growth & development', 'Central Nervous System Stimulants/*pharmacology', '*Critical Period, Psychological', 'Disease Models, Animal', 'Humans', 'Methylphenidate/*pharmacology', 'Mice', 'Rats']",https://pubmed.ncbi.nlm.nih.gov/21376076/
810,HTR7,29143228,Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients.,"['Wang M', 'Ji S', 'Shao G', 'Zhang J', 'Zhao K', 'Wang Z', 'Wu A']","['Biomarkers, Tumor/blood/*genetics', 'Breast Neoplasms/blood/diagnosis/*genetics/therapy', 'Case-Control Studies', 'Combined Modality Therapy', 'Exosomes/*genetics', 'Female', 'Humans', 'Neoplasm Metastasis', 'Neoplasm Recurrence, Local/blood/diagnosis/*genetics/therapy', 'Prognosis', 'Survival Rate']",https://pubmed.ncbi.nlm.nih.gov/29143228/
811,HTR7,10490701,"Physical mapping of the serotonin 5-HT(7) receptor gene (HTR7) to chromosome 10 and pseudogene (HTR7P) to chromosome 12, and testing of linkage disequilibrium between HTR7 and autistic disorder.","['Lassig JP', 'Vachirasomtoon K', 'Hartzell K', 'Leventhal M', 'Courchesne E', 'Courchesne R', 'Lord C', 'Leventhal BL', 'Cook EH Jr']","['Autistic Disorder/ethnology/*genetics', '*Chromosomes, Human, Pair 10', '*Chromosomes, Human, Pair 12', 'Female', 'Genetic Markers', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Linkage Disequilibrium/*genetics', 'Male', 'Parents', '*Physical Chromosome Mapping', 'Polymorphism, Restriction Fragment Length', 'Pseudogenes/*genetics', 'Receptors, Serotonin/*genetics']",https://pubmed.ncbi.nlm.nih.gov/10490701/
812,HTR7,31715674,[Analysis of genes related to hypothyroidism during pregnancy].,"['Liang L', 'Mao Y', 'Zhang JR', 'Zhang SC', 'Yang HX']","['Female', 'Humans', '*Hypothyroidism', 'Pregnancy', '*Pregnancy Complications', 'Thyroid Function Tests', 'Thyrotropin', 'Thyroxine']",https://pubmed.ncbi.nlm.nih.gov/31715674/
813,HTR7,37797929,The impact of Akkermansia muciniphila and its extracellular vesicles in the regulation of serotonergic gene expression in a small intestine of mice.,"['Yaghoubfar R', 'Zare BanadKoki E', 'Ashrafian F', 'Shahryari A', 'Kariman A', 'Davari M', 'Fateh A', 'Khatami S', 'Siadat SD']","['Intestine, Small', '*Extracellular Vesicles', 'Humans', 'Animals', 'Male', 'Gene Expression', 'Mice, Inbred C57BL', 'Akkermansia', '*Serotonin/metabolism', 'Monoamine Oxidase/genetics/metabolism', 'Verrucomicrobia/physiology', 'Mice']",https://pubmed.ncbi.nlm.nih.gov/37797929/
814,HTR7,19233240,Association analysis of serotonin receptor 7 gene (HTR7) and risperidone response in Chinese schizophrenia patients.,"['Wei Z', 'Wang L', 'Xuan J', 'Che R', 'Du J', 'Qin S', 'Xing Y', 'Gu B', 'Yang L', 'Li H', 'Li J', 'Feng G', 'He L', 'Xing Q']","['Adult', 'Antipsychotic Agents/*therapeutic use', 'China/ethnology', 'Female', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study/methods', 'Humans', 'Male', 'Middle Aged', '*Pharmacogenetics', 'Psychiatric Status Rating Scales', 'Receptors, Serotonin/*genetics', 'Risperidone/*therapeutic use', 'Schizophrenia/*drug therapy/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/19233240/
815,HTR7,36913918,Studying the Brain Monoaminergic Systems and Neurotrophic Factors in Minipigs with High and Low Tolerance to the Presence of Human.,"['Bazovkina D', 'Illarionova NB', 'Kulikova EA', 'Bazhenova EY', 'Sinyakova NA', 'Khotskin NV', 'Nikitin S', 'Lankin VS', 'Terenina EE', 'Trapezov OV', 'Kulikov AV']","['Humans', 'Animals', 'Swine', '*Dopamine/metabolism', 'Swine, Miniature/metabolism', '*Serotonin/metabolism', 'Brain/metabolism', 'Norepinephrine']",https://pubmed.ncbi.nlm.nih.gov/36913918/
816,HRH3,19450133,Histamine pharmacogenomics.,"['Garcia-Martin E', 'Ayuso P', 'Martinez C', 'Blanca M', 'Agundez JA']","['Amine Oxidase (Copper-Containing)/*genetics', 'Amino Acid Substitution', 'Genetic Variation', 'Histamine/*genetics', 'Histamine N-Methyltransferase/*genetics', 'Histidine Decarboxylase/*genetics', 'Humans', 'Pharmacogenetics/methods', '*Polymorphism, Genetic', 'Promoter Regions, Genetic/genetics', 'Receptors, Histamine/*genetics']",https://pubmed.ncbi.nlm.nih.gov/19450133/
817,HRH3,31002350,Upregulated histamine receptor H3 promotes tumor growth and metastasis in hepatocellular carcinoma.,"['Yu D', 'Zhao J', 'Wang Y', 'Hu J', 'Zhao Q', 'Li J', 'Zhu J']","['Animals', 'Biomarkers, Tumor/*genetics', 'Carcinoma, Hepatocellular/*genetics/pathology', 'Cell Line, Tumor', 'Cell Movement/genetics', 'Cell Proliferation/genetics', 'Gene Expression Regulation, Neoplastic/genetics', 'Humans', 'Liver Neoplasms/*genetics/pathology', 'Mice', 'Neoplasm Metastasis', 'Receptors, Histamine H3/*genetics', 'Xenograft Model Antitumor Assays']",https://pubmed.ncbi.nlm.nih.gov/31002350/
818,HRH3,32743878,"The zebrafish histamine H3 receptor modulates aggression, neural activity and forebrain functional connectivity.","['Reichmann F', 'Rimmer N', 'Tilley CA', 'Dalla Vecchia E', 'Pinion J', 'Al Oustah A', 'Carreno Gutierrez H', 'Young AMJ', 'McDearmid JR', 'Winter MJ', 'Norton WHJ']","['Aggression', 'Animals', 'Brain/metabolism', 'Histamine', 'Humans', 'Prosencephalon/metabolism', '*Receptors, Histamine H3/metabolism', 'Serotonin', 'Zebrafish/metabolism']",https://pubmed.ncbi.nlm.nih.gov/32743878/
819,HRH3,39462031,Histamine stimulates human microglia to alter cellular prion protein expression via the HRH2 histamine receptor.,"['Pehar M', 'Hewitt M', 'Wagner A', 'Sandhu JK', 'Khalili A', 'Wang X', 'Cho JY', 'Sim VL', 'Kulka M']","['Humans', '*Microglia/metabolism/drug effects', '*Histamine/pharmacology/metabolism', 'Cell Line', '*Receptors, Histamine H2/metabolism/genetics', '*Calcium/metabolism', 'PrPC Proteins/metabolism/genetics', 'Cytokines/metabolism', 'Gene Expression Regulation/drug effects', 'Receptors, Histamine/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39462031/
820,HRH3,36902343,Histaminergic System and Inflammation-Related Genes in Normal Large Intestine and Adenocarcinoma Tissues: Transcriptional Profiles and Relations.,"['Janikowska G', 'Janikowski T', 'Plato M', 'Mazurek U', 'Orchel J', 'Opilka M', 'Lorenc Z']","['Male', 'Humans', 'Female', 'Intestine, Large/metabolism', '*Colorectal Neoplasms/pathology', 'Inflammation', '*Adenocarcinoma/pathology', 'Gene Expression Profiling', 'Carboxypeptidases', 'Repressor Proteins/genetics']",https://pubmed.ncbi.nlm.nih.gov/36902343/
821,HRH3,27855565,Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain.,"['Tiwari AK', 'Zhang D', 'Pouget JG', 'Zai CC', 'Chowdhury NI', 'Brandl EJ', 'Qin L', 'Freeman N', 'Lieberman JA', 'Meltzer HY', 'Kennedy JL', 'Muller DJ']","['Adult', 'Antipsychotic Agents/*adverse effects', 'Clozapine/adverse effects', 'Female', 'Humans', 'Male', 'Olanzapine/adverse effects', 'Polymorphism, Single Nucleotide', 'Psychotic Disorders/*drug therapy', 'Receptors, Histamine H1/*genetics', 'Receptors, Histamine H3/*genetics', 'Schizophrenia/*drug therapy', 'Weight Gain/*drug effects/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27855565/
822,HRH3,33159174,Inhibition of histamine receptor H3 suppresses the growth and metastasis of human non-small cell lung cancer cells via inhibiting PI3K/Akt/mTOR and MEK/ERK signaling pathways and blocking EMT.,"['Zhao YY', 'Jia J', 'Zhang JJ', 'Xun YP', 'Xie SJ', 'Liang JF', 'Guo HG', 'Zhu JZ', 'Ma SL', 'Zhang SR']","['Antineoplastic Agents/*pharmacology/therapeutic use', 'Apoptosis/drug effects', 'Carcinoma, Non-Small-Cell Lung/drug therapy', 'Cell Line, Tumor', 'Cell Proliferation/drug effects', 'Epithelial-Mesenchymal Transition/*drug effects', 'Histamine Antagonists/*pharmacology/therapeutic use', 'Humans', 'Imidazoles/*pharmacology/therapeutic use', 'Lung Neoplasms/drug therapy', 'MAP Kinase Signaling System/*drug effects', 'Phosphatidylinositol 3-Kinases/metabolism', 'Proto-Oncogene Proteins c-akt/metabolism', 'Receptors, Histamine H3/*metabolism', 'TOR Serine-Threonine Kinases/metabolism', 'Xenograft Model Antitumor Assays']",https://pubmed.ncbi.nlm.nih.gov/33159174/
823,HRH3,26989676,"Associations of Polymorphisms in HRH2, HRH3, DAO, and HNMT Genes with Risk of Chronic Heart Failure.","['He GH', 'Cai WK', 'Zhang JB', 'Ma CY', 'Yan F', 'Lu J', 'Xu GL']","['Adult', 'Aged', 'Chronic Disease', 'D-Amino-Acid Oxidase/*genetics', 'Female', 'Genetic Association Studies', 'Genotype', 'Haplotypes', 'Heart Failure/*genetics/pathology', 'Histamine/genetics', 'Histamine N-Methyltransferase/*genetics', 'Humans', 'Male', 'Middle Aged', 'Receptors, G-Protein-Coupled/*genetics', 'Receptors, Histamine/*genetics', 'Receptors, Histamine H3/*genetics', 'Receptors, Histamine H4']",https://pubmed.ncbi.nlm.nih.gov/26989676/
824,HRH3,31740666,A regulatory variant of CHRM3 is associated with cannabis-induced hallucinations in European Americans.,"['Cheng Z', 'Phokaew C', 'Chou YL', 'Lai D', 'Meyers JL', 'Agrawal A', 'Farrer LA', 'Kranzler HR', 'Gelernter J']","['Black or African American', 'Alleles', 'Animals', 'Cannabis', 'Female', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Hallucinations/*chemically induced', 'Humans', 'Male', 'Marijuana Abuse/complications/*genetics', 'Mice', 'Polymorphism, Single Nucleotide', 'Receptor, Muscarinic M3/*genetics', 'White People/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31740666/
825,HRH3,28969474,Affection of Comt1 genetype on anxiety and nociceptive sensitivity: an Ego-network analysis approach.,"['Li W', 'Zhao S', 'Zhang Z']","['Anxiety/*genetics', 'Biomarkers/analysis', 'Databases, Genetic', '*Gene Expression Profiling', 'Gene Regulatory Networks/*genetics', 'Genotype', 'Humans', 'Protein Interaction Maps/*genetics', 'Transcriptome/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28969474/
826,HRH3,20981000,Acute alertness-promoting effects of a novel histamine subtype-3 receptor inverse agonist in healthy sleep-deprived male volunteers.,"['Iannone R', 'Palcza J', 'Renger JJ', 'Calder N', 'Cerchio K', 'Gottesdiener K', 'Hargreaves R', 'Dijk DJ', 'Boyle J', 'Murphy MG']","['Adolescent', 'Adult', 'Cross-Over Studies', 'Double-Blind Method', '*Drug Inverse Agonism', 'Histamine Agonists/*pharmacology/*therapeutic use', 'Humans', 'Male', 'Middle Aged', 'Receptors, Histamine H3/*physiology', 'Sleep Deprivation/*drug therapy/physiopathology', 'Sleep Stages/drug effects/physiology', 'Time Factors', 'Wakefulness/*drug effects/physiology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/20981000/
827,HRH3,21652606,A pharmacogenetic study of risperidone on histamine H3 receptor gene (HRH3) in Chinese Han schizophrenia patients.,"['Wei Z', 'Wang L', 'Zhang M', 'Xuan J', 'Wang Y', 'Liu B', 'Shao L', 'Li J', 'Zeng Z', 'Li T', 'Liu J', 'Wang T', 'Zhang M', 'Qin S', 'Xu Y', 'Feng G', 'He L', 'Xing Q']","['Adult', 'Antipsychotic Agents/*therapeutic use', 'Asian People/genetics', 'Brief Psychiatric Rating Scale', 'Female', 'Genotype', 'Humans', 'Male', 'Pharmacogenetics/methods', 'Polymorphism, Single Nucleotide', 'Receptors, Histamine H3/*genetics', 'Risperidone/*therapeutic use', 'Schizophrenia/*drug therapy/*genetics']",https://pubmed.ncbi.nlm.nih.gov/21652606/
828,HRH3,39586217,Histamine receptor agonism differentially induces immune and reparative healing responses in biomaterial-facilitated tissue repair.,"['Yaron JR', 'Pallod S', 'Grigaitis-Esman N', 'Singh V', 'Rhodes S', 'Patel DM', 'Ghosh D', 'Rege K']","['Animals', '*Wound Healing/drug effects', '*Receptors, Histamine/metabolism', '*Mice, Inbred C57BL', '*Biocompatible Materials/pharmacology/chemistry', 'Mice', 'Skin/drug effects', 'Histamine Agonists/pharmacology', 'Humans', 'Male', 'Macrophages/drug effects/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39586217/
829,HRH3,39918973,Expression and clinical significance of histamine receptors in pediatric AML.,"['Zhou B', 'Wang W', 'Yu P', 'Yang Y', 'Mi D', 'Tian Y', 'Li Y', 'Zhu F']","['Humans', '*Leukemia, Myeloid, Acute/genetics/mortality/metabolism/diagnosis', 'Child', 'Male', 'Female', 'Child, Preschool', 'Infant', 'Adolescent', '*Receptors, Histamine/genetics/metabolism/biosynthesis', 'Prognosis', 'Clinical Relevance']",https://pubmed.ncbi.nlm.nih.gov/39918973/
830,HRH3,28485729,Altered expression of histamine signaling genes in autism spectrum disorder.,"['Wright C', 'Shin JH', 'Rajpurohit A', 'Deep-Soboslay A', 'Collado-Torres L', 'Brandon NJ', 'Hyde TM', 'Kleinman JE', 'Jaffe AE', 'Cross AJ', 'Weinberger DR']","['Adolescent', 'Adult', 'Aged', 'Autism Spectrum Disorder/*genetics/metabolism/physiopathology', 'Child', 'Child, Preschool', 'Cognition/physiology', 'Diagnosis', 'Female', 'Genome-Wide Association Study/methods', 'Histamine/*genetics/metabolism', 'Humans', 'Male', 'Middle Aged', 'Neurogenic Inflammation/genetics', 'Prefrontal Cortex/metabolism/pathology', 'Receptors, Histamine/*drug effects', 'Sequence Analysis, RNA/*methods', 'Sleep/physiology', 'Tourette Syndrome/*genetics/metabolism/physiopathology', 'Transcriptome/genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/28485729/
831,HRH3,35899934,Effects of Cyclosporine A and Adalimumab on the expression profiles histaminergic system-associated genes and microRNAs regulating these genes in HaCaT cells.,"['Kasela T', 'Dabala M', 'Mistarz M', 'Wieczorek W', 'Wierzbik-Stronska M', 'Boron K', 'Zawidlak-Wegrzynska B', 'Oskar Grabarek B']","['Adult', 'Humans', '*MicroRNAs/genetics/metabolism', 'Adalimumab', 'Matrix Metalloproteinase 2', 'Cyclosporine/pharmacology', 'HaCaT Cells', 'Phosphatidylinositol 3-Kinases/metabolism', 'Lipopolysaccharides', 'Histamine N-Methyltransferase', 'Tumor Necrosis Factor-alpha', 'Transforming Growth Factor beta', '*Psoriasis/genetics', 'gamma-Aminobutyric Acid', 'Polycomb Repressive Complex 1']",https://pubmed.ncbi.nlm.nih.gov/35899934/
832,HRH3,23894272,Histamine H(3) receptor integrates peripheral inflammatory signals in the neurogenic control of immune responses and autoimmune disease susceptibility.,"['Krementsov DN', 'Wall EH', 'Martin RA', 'Subramanian M', 'Noubade R', 'Del Rio R', 'Mawe GM', 'Bond JP', 'Poynter ME', 'Blankenhorn EP', 'Teuscher C']","['Amino Acid Sequence', 'Animals', 'Central Nervous System/immunology/metabolism/*pathology', 'Encephalomyelitis, Autoimmune, Experimental/*genetics/*immunology/pathology', 'Female', 'Gene Expression Regulation', 'Genetic Predisposition to Disease/*genetics', 'Hematopoiesis/genetics/immunology', 'Humans', 'Inflammation/genetics/immunology/pathology', 'Intracellular Space/metabolism', 'Lymph Nodes/immunology', 'Male', 'Mice', 'Molecular Sequence Data', 'Polymorphism, Single Nucleotide', 'Protein Isoforms/chemistry/genetics', 'Protein Structure, Tertiary', 'Receptors, Histamine H3/chemistry/*genetics', 'Signal Transduction/*genetics/*immunology']",https://pubmed.ncbi.nlm.nih.gov/23894272/
833,HRH3,19824886,Association and interaction analyses of eight genes under asthma linkage peaks.,"['Ferreira MA', 'Zhao ZZ', 'Thomsen SF', 'James M', 'Evans DM', 'Postmus PE', 'Kyvik KO', 'Backer V', 'Boomsma DI', 'Martin NG', 'Montgomery GW', 'Duffy DL']","['Asthma/*genetics', 'Chromosome Mapping', 'Chromosomes, Human, Pair 11/genetics', '*Epistasis, Genetic', '*Genes', '*Genetic Linkage', '*Genetic Predisposition to Disease', 'Genome, Human', 'Humans', 'Hypersensitivity, Immediate/*genetics', 'Immunoglobulin E/blood', 'Polymorphism, Genetic', 'Receptors, IgE/genetics']",https://pubmed.ncbi.nlm.nih.gov/19824886/
834,HRH3,29253893,Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination.,"['Chen Y', 'Zhen W', 'Guo T', 'Zhao Y', 'Liu A', 'Rubio JP', 'Krull D', 'Richardson JC', 'Lu H', 'Wang R']","['Animals', 'Animals, Newborn', 'Brain/pathology', 'Cell Differentiation', 'Cell Proliferation', 'Glutathione Transferase/metabolism', 'Humans', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Multiple Sclerosis/drug therapy/*genetics/metabolism', 'Myelin Sheath/*metabolism', 'Oligodendroglia/*cytology/metabolism', 'Phenotype', 'Polymorphism, Single Nucleotide', 'Prosencephalon/pathology', 'Rats', 'Receptors, Histamine H3/genetics/*metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/29253893/
835,HRH3,37415734,Targeting LncRNA LLNLR-299G3.1 with antisense oligonucleotide inhibits malignancy of esophageal squamous cell carcinoma cells in vitro and in vivo.,"['Tian LI', 'Huang Y', 'Zhang B', 'Song YI', 'Yang L', 'Chen Q', 'Wang Z', 'Wang Y', 'He Q', 'Yang W', 'Yu S', 'Lu T', 'Liu Z', 'Gao K', 'Fan X', 'Song J', 'Zhai R']","['Pregnancy', 'Animals', 'Humans', 'Female', '*Esophageal Squamous Cell Carcinoma/genetics/pathology', '*RNA, Long Noncoding/genetics/metabolism', '*Esophageal Neoplasms/drug therapy/genetics/metabolism', 'Oligonucleotides, Antisense/genetics/pharmacology', 'Cell Proliferation/genetics', 'Placenta/metabolism/pathology', 'Chromatin', 'Gene Expression Regulation, Neoplastic', 'Cell Line, Tumor', 'Cell Movement/genetics']",https://pubmed.ncbi.nlm.nih.gov/37415734/
836,ADRA1A,27638020,Genetics of Takotsubo Syndrome.,"['Limongelli G', 'Masarone D', 'Maddaloni V', 'Rubino M', 'Fratta F', 'Cirillo A', 'Ludovica SB', 'Pacileo R', 'Fusco A', 'Coppola GR', 'Pisacane F', 'Bossone E', 'Calabro P', 'Calabro R', 'Russo MG', 'Pacileo G']","['G-Protein-Coupled Receptor Kinase 5/genetics', 'Genetic Predisposition to Disease', 'Humans', 'Polymorphism, Genetic', 'Receptors, Adrenergic, alpha-1/genetics', 'Receptors, Adrenergic, beta-1/genetics', 'Receptors, Adrenergic, beta-2/genetics', 'Takotsubo Cardiomyopathy/*genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/27638020/
837,ADRA1A,36736425,Increased angiotensin II coupled with decreased Adra1a expression enhances cardiac hypertrophy in pregnancy-associated hypertensive mice.,"['Kim JD', 'Kwon C', 'Nakamura K', 'Muromachi N', 'Mori H', 'Muroi SI', 'Yamada Y', 'Saito H', 'Nakagawa Y', 'Fukamizu A']","['Animals', 'Female', 'Humans', 'Mice', 'Pregnancy', '*Angiotensin II/metabolism', 'Cardiomegaly/metabolism', 'Myocardium/metabolism', '*Receptors, Adrenergic, alpha-1/genetics/metabolism', 'Renin-Angiotensin System', '*Hypertension, Pregnancy-Induced/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36736425/
838,ADRA1A,34730627,Fibromyalgia: A Review of Related Polymorphisms and Clinical Relevance.,"['Janssen LP', 'Medeiros LF', 'Souza A', 'Silva JD']","['*Fibromyalgia/genetics', '*Homocystinuria', 'Humans', 'Methylenetetrahydrofolate Reductase (NADPH2)', 'NAV1.7 Voltage-Gated Sodium Channel', 'Pain', 'Polymorphism, Genetic/genetics', 'Pyrin', 'Receptors, Adrenergic, beta-3', 'Receptors, GABA', 'Serotonin Plasma Membrane Transport Proteins']",https://pubmed.ncbi.nlm.nih.gov/34730627/
839,ADRA1A,33275531,Cardiac alpha1A-adrenergic receptors: emerging protective roles in cardiovascular diseases.,"['Zhang J', 'Simpson PC', 'Jensen BC']","['Adrenergic alpha-1 Receptor Agonists/therapeutic use', 'Adrenergic alpha-1 Receptor Antagonists/adverse effects', 'Animals', 'Cardiovascular Diseases/drug therapy/*metabolism/physiopathology', 'Heart/*innervation', 'Humans', 'Myocardium/*metabolism', 'Receptors, Adrenergic, alpha-1/drug effects/*metabolism', 'Signal Transduction', 'Sympathetic Nervous System/*metabolism/physiopathology']",https://pubmed.ncbi.nlm.nih.gov/33275531/
840,ADRA1A,34706275,MiR-3682 promotes the progression of hepatocellular carcinoma (HCC) via inactivating AMPK signaling by targeting ADRA1A.,"['Zhao W', 'Liu X']","['AMP-Activated Protein Kinases/genetics/metabolism', '*Carcinoma, Hepatocellular/pathology', 'Cell Line, Tumor', 'Cell Movement/genetics', 'Cell Proliferation/genetics', 'Gene Expression Regulation, Neoplastic', 'Humans', '*Liver Neoplasms/pathology', '*MicroRNAs/genetics/metabolism', 'Receptors, Adrenergic, alpha-1/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34706275/
841,ADRA1A,31933413,Promoter aberrant methylation status of ADRA1A is associated with hepatocellular carcinoma.,"['Chen G', 'Fan X', 'Li Y', 'He L', 'Wang S', 'Dai Y', 'Bin C', 'Zhou D', 'Lin H']","['Biomarkers, Tumor/*genetics/metabolism', 'Carcinoma, Hepatocellular/*genetics/pathology', '*DNA Methylation', 'Epigenesis, Genetic', 'Female', 'Gene Expression Regulation, Neoplastic', 'HEK293 Cells', 'Hep G2 Cells', 'Humans', 'Liver Neoplasms/*genetics/pathology', 'Male', 'Middle Aged', 'Promoter Regions, Genetic', 'Receptors, Adrenergic, alpha-1/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31933413/
842,ADRA1A,28531963,MiR-19b and miR-16 cooperatively signaling target the regulator ADRA1A in Hypertensive heart disease.,"['He L', 'Huang C']","['Animals', 'Apoptosis/genetics', 'Blood Pressure/genetics', 'Caspase 3/genetics', 'Caspase 7/genetics', 'Cells, Cultured', 'Disease Models, Animal', 'Gene Expression Profiling/methods', 'Heart Diseases/*genetics', 'Heart Rate/genetics', 'Hypertension/*genetics', 'Mice', 'MicroRNAs/*genetics', 'Rats', 'Receptors, Adrenergic, alpha-1/*genetics', 'Signal Transduction/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28531963/
843,ADRA1A,35964682,Hypermethylation in the promoter region of the ADRA1A gene is associated with opioid use disorder in Han Chinese.,"['Zhang J', 'Fu X', 'Lu Y', 'Cheng C', 'Wang K', 'Zhu Y', 'Xie Q']","['China', 'CpG Islands/genetics', 'DNA Methylation', '*Heroin', 'Humans', 'Methadone/therapeutic use', '*Opioid-Related Disorders/genetics', 'Promoter Regions, Genetic/genetics', 'Receptors, Adrenergic, alpha-1']",https://pubmed.ncbi.nlm.nih.gov/35964682/
844,ADRA1A,21894153,Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.,"['Lett TA', 'Wallace TJ', 'Chowdhury NI', 'Tiwari AK', 'Kennedy JL', 'Muller DJ']","['Antipsychotic Agents/*adverse effects/classification/pharmacokinetics', 'Appetite/genetics', 'Biogenic Monoamines/metabolism', 'Biological Transport/genetics', 'Biotransformation/genetics', 'Cardiovascular Diseases/etiology', 'Epigenesis, Genetic', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Humans', 'Lipid Metabolism/genetics', 'Meta-Analysis as Topic', 'Metabolic Syndrome/etiology', 'Neurotransmitter Agents/metabolism', 'Obesity/chemically induced/complications/genetics', 'Patient Compliance', 'Precision Medicine', 'Receptors, Neurotransmitter/genetics/metabolism', 'Weight Gain/*drug effects/genetics']",https://pubmed.ncbi.nlm.nih.gov/21894153/
845,ADRA1A,34875034,Interplay between genetics and lifestyle on pain susceptibility in women with fibromyalgia: the al-Andalus project.,"['Estevez-Lopez F', 'Guerrero-Gonzalez JM', 'Salazar-Tortosa D', 'Camiletti-Moiron D', 'Gavilan-Carrera B', 'Aparicio VA', 'Acosta-Manzano P', 'Alvarez-Gallardo IC', 'Segura-Jimenez V', 'Soriano-Maldonado A', 'Geenen R', 'Delgado-Fernandez M', 'Martinez-Gonzalez LJ', 'Ruiz JR', 'Alvarez-Cubero MJ']","['*Catechol O-Methyltransferase/genetics', 'Female', '*Fibromyalgia/genetics', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Life Style', 'Middle Aged', 'NAV1.7 Voltage-Gated Sodium Channel/genetics', 'Pain', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/34875034/
846,ADRA1A,36012699,Vascular Reactions of the Diving Reflex in Men and Women Carrying Different ADRA1A Genotypes.,"['Baranova T', 'Podyacheva E', 'Zemlyanukhina T', 'Berlov D', 'Danilova M', 'Glotov O', 'Glotov A']","['Adolescent', 'Adult', 'Apnea/genetics', 'Bradycardia', '*Diving Reflex', 'Female', 'Genotype', 'Heart Rate/physiology', 'Humans', 'Hypoxia/genetics', 'Male', 'Oxygen', '*Receptors, Adrenergic, alpha-1/genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/36012699/
847,ADRA1A,37820700,Hsa_circ_0080608 Attenuates Lung Cancer Progression by Functioning as a Competitive Endogenous RNA to Regulate the miR-661/ADRA1A Pathway.,"['Ren C', 'Cui L', 'Li R', 'Song X', 'Li J', 'Xi Q', 'Zhang Z', 'Zhao L']","['Animals', 'Humans', ""3' Untranslated Regions"", 'Biological Assay', 'Cell Line, Tumor', 'Cell Proliferation/genetics', '*Lung Neoplasms/genetics', '*MicroRNAs/genetics', '*Receptors, Adrenergic, alpha-1/metabolism', '*RNA, Circular/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37820700/
848,ADRA1A,27702852,Antiadrenergic autoimmunity in postural tachycardia syndrome.,"['Fedorowski A', 'Li H', 'Yu X', 'Koelsch KA', 'Harris VM', 'Liles C', 'Murphy TA', 'Quadri SMS', 'Scofield RH', 'Sutton R', 'Melander O', 'Kem DC']","['Abdominal Muscles/*blood supply', 'Adolescent', 'Adrenergic alpha-1 Receptor Agonists/pharmacology', 'Adrenergic beta-1 Receptor Agonists/pharmacology', 'Adrenergic beta-2 Receptor Agonists/pharmacology', 'Adult', 'Animals', 'Arterioles/drug effects/metabolism', 'Autoantibodies/*blood', '*Autoimmunity', 'CHO Cells', 'Case-Control Studies', 'Cricetulus', 'Dose-Response Relationship, Drug', 'Female', 'Humans', 'Immunoglobulin G/*blood', 'In Vitro Techniques', 'Male', 'Postural Orthostatic Tachycardia Syndrome/blood/diagnosis/*immunology', 'Rats', 'Receptors, Adrenergic, alpha-1/drug effects/genetics/*immunology/metabolism', 'Receptors, Adrenergic, beta-1/drug effects/genetics/*immunology/metabolism', 'Receptors, Adrenergic, beta-2/drug effects/genetics/*immunology/metabolism', 'Transfection', 'Vasoconstriction/drug effects', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/27702852/
849,ADRA1A,33166306,Identifying genetic variants associated with ritodrine-induced pulmonary edema.,"['Lee SM', 'Park Y', 'Kim YJ', 'Hwang HS', 'Seo H', 'Min BJ', 'Lee KH', 'Kim SY', 'Jung YM', 'Lee S', 'Park CW', 'Kim JH', 'Park JS']","['Adult', 'Case-Control Studies', 'Female', 'Genetic Variation/*genetics', 'Humans', 'Myometrium/drug effects', 'Obstetric Labor, Premature/drug therapy/genetics', 'Pregnancy', 'Pulmonary Edema/*chemically induced/*genetics', 'Ritodrine/*adverse effects', 'Tocolytic Agents/adverse effects']",https://pubmed.ncbi.nlm.nih.gov/33166306/
850,ADRA1A,37622313,Prognostic Prediction Value and Biological Functions of Non-Apoptotic Regulated Cell Death Genes in Lung Adenocarcinoma.,"['Li HL', 'Wang JX', 'Dai HW', 'Liu JJ', 'Liu ZY', 'Zou MY', 'Zhang L', 'Wang WR']","['Humans', 'Prognosis', 'Apoptosis', '*Regulated Cell Death', '*Adenocarcinoma of Lung/genetics', '*Lung Neoplasms/genetics', 'Tumor Microenvironment']",https://pubmed.ncbi.nlm.nih.gov/37622313/
851,ADRA1A,29048744,Comorbidity of Alcohol Use Disorder and Chronic Pain: Genetic Influences on Brain Reward and Stress Systems.,"['Yeung EW', 'Craggs JG', 'Gizer IR']","['Alcoholism/epidemiology/*genetics/psychology', 'Animals', 'Brain/*physiology', 'Chronic Pain/epidemiology/*genetics/psychology', 'Comorbidity', 'Genetic Predisposition to Disease/epidemiology/*genetics', 'Humans', 'Neural Pathways/physiology', '*Reward', 'Stress, Psychological/epidemiology/*genetics/psychology']",https://pubmed.ncbi.nlm.nih.gov/29048744/
852,ADRA1A,34523347,Effect of ingesting a meal and orthostasis on the regulation of splanchnic and systemic hemodynamics and the responsiveness of cardiovascular alpha(1)-adrenoceptors.,"['Zreik F', 'Meshulam R', 'Shichel I', 'Webb M', 'Shibolet O', 'Jacob G']","['Adrenergic alpha-1 Receptor Agonists/administration & dosage', 'Adult', 'Autonomic Nervous System/drug effects/metabolism/*physiopathology', 'Blood Flow Velocity', 'Cardiovascular System/innervation/*physiopathology', 'Dizziness/diagnostic imaging/metabolism/*physiopathology', 'Female', 'Healthy Volunteers', '*Hemodynamics/drug effects', 'Hepatic Artery/diagnostic imaging/physiopathology', 'Humans', 'Infusions, Intravenous', 'Male', 'Mesenteric Artery, Superior/diagnostic imaging/physiopathology', 'Middle Aged', 'Phenylephrine/administration & dosage', 'Portal Vein/diagnostic imaging/physiopathology', '*Postprandial Period', 'Receptors, Adrenergic, alpha-1/drug effects/*metabolism', 'Signal Transduction', '*Splanchnic Circulation', 'Time Factors', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/34523347/
853,ADRA1A,36030699,Identification of novel proteins associated with movement-related adverse antipsychotic effects by integrating GWAS data and human brain proteomes.,"['Li J', 'Pang J', 'Si S', 'Zhang K', 'Tang F', 'Xue F']","['Humans', '*Antipsychotic Agents/adverse effects/pharmacology/therapeutic use', 'Brain/drug effects/metabolism', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', '*Parkinson Disease/etiology/genetics/metabolism', 'Polymorphism, Single Nucleotide/genetics', '*Proteome/genetics/metabolism', 'Mendelian Randomization Analysis', '*Dyskinesia, Drug-Induced/etiology/genetics/metabolism', 'Quantitative Trait Loci']",https://pubmed.ncbi.nlm.nih.gov/36030699/
854,ADRA1A,20109995,Silodosin: a selective alpha1A-adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia.,"['Schilit S', 'Benzeroual KE']","['*Adrenergic alpha-1 Receptor Agonists', 'Adrenergic alpha-Agonists/administration & dosage/adverse effects/*economics/pharmacokinetics/pharmacology/*therapeutic use', 'Adult', 'Aged', 'Animals', 'Clinical Trials, Phase III as Topic', 'Dogs', 'Drug Interactions', 'Humans', 'Indoles/administration & dosage/adverse effects/*economics/pharmacokinetics/pharmacology/*therapeutic use', 'Male', 'Middle Aged', 'Prostatic Hyperplasia/complications/*drug therapy/economics', 'Randomized Controlled Trials as Topic', 'Rats', 'Receptors, Adrenergic, alpha-1']",https://pubmed.ncbi.nlm.nih.gov/20109995/
855,ADRA1A,17408692,No association found between the promoter variants of ADRA1A and schizophrenia in the Chinese population.,"['Huang K', 'Shi Y', 'Tang W', 'Tang R', 'Guo S', 'Xu Y', 'Meng J', 'Li X', 'Feng G', 'He L']","['Adult', 'Asian People/*genetics', 'China/epidemiology', 'Control Groups', 'DNA Mutational Analysis', 'Female', 'Gene Frequency', 'Genetic Predisposition to Disease/genetics', 'Genetic Variation/*genetics', 'Genotype', 'Haplotypes/genetics', 'Humans', 'Linkage Disequilibrium', 'Male', 'Polymorphism, Genetic/*genetics', 'Polymorphism, Single Nucleotide/genetics', 'Promoter Regions, Genetic/*genetics', 'Receptors, Adrenergic, alpha-1/*genetics', 'Schizophrenia/diagnosis/epidemiology/*genetics']",https://pubmed.ncbi.nlm.nih.gov/17408692/
856,CHRM4,37142586,CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.,"['Wen YC', 'Tram VTN', 'Chen WH', 'Li CH', 'Yeh HL', 'Thuy Dung PV', 'Jiang KC', 'Li HR', 'Huang J', 'Hsiao M', 'Chen WY', 'Liu YN']","['Male', 'Humans', '*Prostatic Neoplasms/drug therapy/genetics/metabolism', 'N-Myc Proto-Oncogene Protein/metabolism', 'Proto-Oncogene Proteins c-akt', 'Androgen Antagonists/therapeutic use', 'Interferon-alpha/therapeutic use', 'Tumor Microenvironment', 'Cell Line, Tumor', 'Cell Differentiation', 'Receptors, Androgen/metabolism', 'Receptor, Muscarinic M4/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/37142586/
857,CHRM4,38674857,Mendelian Randomization Analysis Identifies Inverse Causal Relationship between External Eating and Metabolic Phenotypes.,"['Timasheva Y', 'Balkhiyarova Z', 'Avzaletdinova D', 'Morugova T', 'Korytina GF', 'Nouwen A', 'Prokopenko I', 'Kochetova O']","['Humans', '*Mendelian Randomization Analysis', '*Phenotype', '*Diabetes Mellitus, Type 2/genetics/etiology', '*Feeding Behavior', 'Female', 'Male', 'Metabolic Syndrome/genetics/etiology', 'tRNA Methyltransferases/genetics', 'Glycated Hemoglobin/metabolism/analysis', 'Middle Aged', 'Body Mass Index', 'Adenylyl Cyclases/genetics', 'Genome-Wide Association Study', 'Polymorphism, Single Nucleotide', 'Adult', 'Waist Circumference', 'Genetic Variation', '*Ghrelin']",https://pubmed.ncbi.nlm.nih.gov/38674857/
858,CHRM4,33398073,Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance.,"['Chen WY', 'Wen YC', 'Lin SR', 'Yeh HL', 'Jiang KC', 'Chen WH', 'Lin YS', 'Zhang Q', 'Liew PL', 'Hsiao M', 'Huang J', 'Liu YN']","['Adenocarcinoma/drug therapy/*metabolism', 'Androgen Antagonists/adverse effects', 'Carcinoma, Neuroendocrine/*etiology/metabolism/pathology', 'Case-Control Studies', 'Drug Resistance, Neoplasm', 'Humans', 'Male', 'Nerve Growth Factor/*metabolism', 'PC-3 Cells', 'Prostate/pathology', 'Prostatic Neoplasms/drug therapy/*metabolism/pathology', 'Receptor, Muscarinic M4/metabolism', 'Transcription Factors/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/33398073/
859,CHRM4,34806612,Muscarinic Receptors Expression in the Peripheral Blood Cells Differentiate Dementia with Lewy Bodies from Alzheimer's Disease.,"['Reale M', 'Carrarini C', 'Russo M', 'Dono F', 'Ferri L', 'Di Pietro M', 'Costantini E', 'Porreca A', 'Di Nicola M', 'Onofrj M', 'Bonanni L']","['Aged', 'Aged, 80 and over', 'Alzheimer Disease/genetics/*metabolism', 'Case-Control Studies', 'Diagnosis, Differential', 'Female', 'Humans', 'Lewy Body Disease/genetics/*metabolism', 'Logistic Models', 'Male', 'ROC Curve', 'Receptor, Muscarinic M1/genetics/*metabolism', 'Receptor, Muscarinic M4/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/34806612/
860,CHRM4,26818859,The Cholinergic System: An Emerging Drug Target for Schizophrenia.,"['Gibbons A', 'Dean B']","['Animals', 'Cholinergic Agents/chemistry/*pharmacology', 'Humans', 'Schizophrenia/*drug therapy/metabolism', 'alpha7 Nicotinic Acetylcholine Receptor/*agonists/metabolism']",https://pubmed.ncbi.nlm.nih.gov/26818859/
861,CHRM4,39837323,Postprandial parasympathetic signals promote lung type 2 immunity.,"['Chen H', 'Zhou X', 'Liu T', 'Liu J', 'Wu D', 'Xu X', 'Ma S', 'Qiang G', 'Chen J', 'Cao Y', 'Fu W', 'Yang J']","['Animals', 'Mice', '*Lung/immunology', '*Parasympathetic Nervous System', '*Postprandial Period/physiology', 'Lymphocytes/immunology/metabolism', 'Humans', 'Immunity, Innate', 'Mice, Inbred C57BL', 'Male']",https://pubmed.ncbi.nlm.nih.gov/39837323/
862,CHRM4,31554738,Muscarinic acetylcholine receptor regulates self-renewal of early erythroid progenitors.,"['Trivedi G', 'Inoue D', 'Chen C', 'Bitner L', 'Chung YR', 'Taylor J', 'Gonen M', 'Wess J', 'Abdel-Wahab O', 'Zhang L']","['Anemia/drug therapy', 'Animals', '*Cell Self Renewal/drug effects/genetics', 'Erythrocytes/drug effects/metabolism', 'Erythroid Cells/*cytology/drug effects/*metabolism', 'Erythroid Precursor Cells', 'Erythropoiesis/drug effects', 'Gene Expression Regulation/drug effects', 'Humans', 'Mice', 'Mice, Inbred C57BL', 'Muscarinic Antagonists/pharmacology/therapeutic use', 'Receptors, Muscarinic/*metabolism', 'Stem Cells/*cytology/drug effects/metabolism']",https://pubmed.ncbi.nlm.nih.gov/31554738/
863,CHRM4,25788142,Ocular biomarkers of Alzheimer's disease.,"['Heaton GR', 'Davis BM', 'Turner LA', 'Cordeiro MF']","['Alzheimer Disease/*diagnosis/epidemiology/pathology', 'Amyloid beta-Peptides/analysis', 'Animals', 'Choroid/pathology', 'Disease Models, Animal', 'Disease Progression', 'Early Diagnosis', 'Humans', 'Lens, Crystalline/chemistry', 'Mice', 'Mice, Transgenic', 'Muscarinic Antagonists/pharmacology', 'Mydriatics/pharmacology', 'Neurofibrillary Tangles', 'Receptor, Muscarinic M4', 'Receptors, Muscarinic/drug effects', 'Reflex, Abnormal', 'Reflex, Pupillary/drug effects', 'Retina/*pathology', 'Retinal Vessels/pathology', 'Tomography, Optical Coherence', 'Tropicamide/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/25788142/
864,CHRM4,38945201,Binding of interleukin-1 receptor antagonist to cholinergic receptor muscarinic 4 promotes immunosuppression and neuroendocrine differentiation in prostate cancer.,"['Liu YN', 'Liu MK', 'Wen YC', 'Li CH', 'Yeh HL', 'Dung PVT', 'Jiang KC', 'Chen WH', 'Li HR', 'Huang J', 'Chen WY']","['Male', 'Humans', '*Tumor Microenvironment', '*Interleukin 1 Receptor Antagonist Protein/pharmacology/metabolism', '*Prostatic Neoplasms/pathology/drug therapy/immunology/metabolism', '*Cell Differentiation/drug effects', 'Cell Line, Tumor', 'Signal Transduction/drug effects', 'Animals', 'Androgen Antagonists/pharmacology/therapeutic use', 'Macrophages/metabolism/immunology', 'E2F1 Transcription Factor/metabolism/genetics']",https://pubmed.ncbi.nlm.nih.gov/38945201/
865,CHRM4,37595966,"Development of a Selective and High Affinity Radioligand, [(3)H]VU6013720, for the M(4) Muscarinic Receptor.","['Qi A', 'Kling HE', 'Billard N', 'Rodriguez AL', 'Peng L', 'Dickerson JW', 'Engers JL', 'Bender AM', 'Moehle MS', 'Lindsley CW', 'Rook JM', 'Niswender CM']","['Rats', 'Humans', 'Mice', 'Animals', '*Acetylcholine/metabolism', '*Receptors, Muscarinic/metabolism', 'Receptor, Muscarinic M4/metabolism', 'Atropine', 'Ligands', 'Cholinergic Agents', 'Muscarinic Antagonists/pharmacology/metabolism', 'Receptor, Muscarinic M2/metabolism', 'Radioligand Assay', 'Receptor, Muscarinic M1/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37595966/
866,CHRM4,33401985,Identification of vascular dementia and Alzheimer's disease hub genes expressed in the frontal lobe and temporal cortex by weighted co-expression network analysis and construction of a protein-protein interaction.,"['Tian X', 'Qin Y', 'Tian Y', 'Ge X', 'Cui J', 'Han H', 'Liu L', 'Yu H']","['*Alzheimer Disease/diagnosis/genetics/psychology', 'Biomarkers', '*Dementia, Vascular/diagnosis', 'Frontal Lobe', 'Humans', '*Protein Interaction Mapping', 'Temporal Lobe']",https://pubmed.ncbi.nlm.nih.gov/33401985/
867,CHRM4,38508027,Autoantibodies against acetylcholine receptors are increased in archived serum samples from patients with schizophrenia.,"['McLean RT', 'Buist E', 'St Clair D', 'Wei J']","['Humans', '*Schizophrenia/blood/immunology', '*Autoantibodies/blood', 'Female', 'Male', 'Adult', 'Middle Aged', '*Immunoglobulin G/blood', '*Receptors, Cholinergic/immunology', 'Enzyme-Linked Immunosorbent Assay']",https://pubmed.ncbi.nlm.nih.gov/38508027/
868,CHRM4,27269905,African-specific variability in the acetylcholine muscarinic receptor M4: association with cocaine and heroin addiction.,"['Levran O', 'Randesi M', 'Peles E', 'Correa da Rosa J', 'Ott J', 'Rotrosen J', 'Adelson M', 'Kreek MJ']","['Adaptor Proteins, Signal Transducing/genetics', 'Black People/*genetics', 'Chromosomes, Human, Pair 11/genetics', 'Cocaine-Related Disorders/*genetics', 'Diacylglycerol Kinase/genetics', '*Genetic Variation', 'Heroin Dependence/*genetics', 'Humans', 'Linkage Disequilibrium', 'Polymorphism, Genetic/genetics', 'Polymorphism, Single Nucleotide', 'Receptor, Muscarinic M4', 'Receptors, Muscarinic/*genetics', 'Schizophrenia/genetics', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/27269905/
869,CHRM4,30564629,Evolution of the Muscarinic Acetylcholine Receptors in Vertebrates.,"['Pedersen JE', 'Bergqvist CA', 'Larhammar D']","['Animals', 'Humans', 'Phylogeny', 'Receptor, Muscarinic M1/*metabolism', 'Receptor, Muscarinic M3/*metabolism', 'Receptor, Muscarinic M4/metabolism', 'Receptors, Cholinergic/*metabolism', 'Receptors, Muscarinic/*metabolism', 'Vertebrates/metabolism']",https://pubmed.ncbi.nlm.nih.gov/30564629/
870,CHRM4,33546161,A Multi-Objective Approach for Drug Repurposing in Preeclampsia.,"['Tejera E', 'Perez-Castillo Y', 'Chamorro A', 'Cabrera-Andrade A', 'Sanchez ME']","['Antihypertensive Agents/chemistry/*therapeutic use', '*Databases, Pharmaceutical', '*Drug Repositioning', 'Female', 'Humans', '*Models, Cardiovascular', 'Pre-Eclampsia/*drug therapy', 'Pregnancy']",https://pubmed.ncbi.nlm.nih.gov/33546161/
871,CHRM4,25817858,Possible involvement of muscarinic receptors in psychiatric disorders: a focus on schizophrenia and mood disorders.,"['Dean B', 'Scarr E']","['Animals', 'Brain/metabolism', 'Depression/*metabolism/pathology', 'Humans', 'Mood Disorders/*metabolism/pathology', 'Receptors, Muscarinic/*physiology', 'Schizophrenia/*metabolism/pathology', 'Synaptic Transmission']",https://pubmed.ncbi.nlm.nih.gov/25817858/
872,CHRM4,23490763,Cholinergic muscarinic M4 receptor gene polymorphisms: a potential risk factor and pharmacogenomic marker for schizophrenia.,"['Scarr E', 'Um JY', 'Cowie TF', 'Dean B']","['Adult', 'Antipsychotic Agents/therapeutic use', 'Female', 'Gene Frequency', 'Genetic Association Studies', 'Genetic Predisposition to Disease/*genetics', 'Genotype', 'Humans', 'Male', 'Middle Aged', '*Pharmacogenetics', 'Polymorphism, Single Nucleotide/*genetics', 'Receptor, Muscarinic M4/*genetics', 'Risk Factors', 'Schizophrenia/drug therapy/*genetics', 'Statistics, Nonparametric']",https://pubmed.ncbi.nlm.nih.gov/23490763/
873,CHRM4,28895408,Sympathetic and parasympathetic innervation in hepatocellular carcinoma.,"['Zhang L', 'Wu LL', 'Huan HB', 'Chen XJ', 'Wen XD', 'Yang DP', 'Xia F']","['*Autonomic Nervous System', 'Carcinoma, Hepatocellular/*pathology', 'Humans', 'Liver Neoplasms/*pathology', '*Parasympathetic Nervous System', 'Receptor, Muscarinic M3/metabolism', 'Receptor, Muscarinic M4/metabolism', 'Receptors, Adrenergic, beta-2/metabolism', 'alpha7 Nicotinic Acetylcholine Receptor/metabolism']",https://pubmed.ncbi.nlm.nih.gov/28895408/
874,CHRM4,39566671,IUPHAR Review on muscarinic M1 and M4 receptors as drug treatment targets relevant to the molecular pathology of schizophrenia.,['Dean B'],"['Humans', 'Animals', '*Schizophrenia/drug therapy/metabolism', '*Receptor, Muscarinic M1/metabolism/genetics', '*Receptor, Muscarinic M4/metabolism/genetics', 'Antipsychotic Agents/therapeutic use/pharmacology', 'Pyridines/pharmacology/therapeutic use', 'Muscarinic Agonists/therapeutic use/pharmacology', 'Thiadiazoles/pharmacology/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/39566671/
875,CHRM4,31704718,Evaluation of Operational Models of Agonism and Allosterism at Receptors with Multiple Orthosteric Binding Sites.,"['Gregory KJ', 'Giraldo J', 'Diao J', 'Christopoulos A', 'Leach K']","['Allosteric Regulation/drug effects', 'Binding Sites/*drug effects', 'Calcium/metabolism', 'Calcium Ionophores/*pharmacology', 'Computer Simulation', 'Dose-Response Relationship, Drug', '*Drug Agonism', 'Drug Synergism', 'HEK293 Cells', 'Humans', 'Ligands', '*Models, Biological', 'Receptor, Metabotropic Glutamate 5/agonists/chemistry/metabolism', 'Receptor, Muscarinic M4/agonists/chemistry/metabolism', 'Receptors, Calcium-Sensing/*agonists/chemistry/metabolism']",https://pubmed.ncbi.nlm.nih.gov/31704718/
876,DRD2,33859743,Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-kappaB signaling to trigger pyroptosis in breast cancer.,"['Tan Y', 'Sun R', 'Liu L', 'Yang D', 'Xiang Q', 'Li L', 'Tang J', 'Qiu Z', 'Peng W', 'Wang Y', 'Ye L', 'Ren G', 'Xiang T']","['Animals', 'Breast Neoplasms/*metabolism/*pathology', 'Cell Line', 'Cell Line, Tumor', 'Female', 'HEK293 Cells', 'Humans', 'Macrophages/*metabolism/pathology', 'Mice', 'Mice, Inbred BALB C', 'Middle Aged', 'NF-kappa B/*metabolism', 'Pyroptosis/*physiology', 'Receptors, Dopamine D2/*metabolism', 'Signal Transduction/*physiology', 'THP-1 Cells/metabolism/pathology', 'Tumor Microenvironment/physiology']",https://pubmed.ncbi.nlm.nih.gov/33859743/
877,DRD2,26850211,The neurobiological basis of binge-eating disorder.,"['Kessler RM', 'Hutson PH', 'Herman BK', 'Potenza MN']","['Animals', 'Attention', 'Binge-Eating Disorder/genetics/*physiopathology/*psychology', 'Brain/*physiopathology', 'Cognition/*physiology', 'Decision Making/physiology', 'Dopamine/metabolism/physiology', 'Female', 'Humans', 'Impulsive Behavior/physiology', 'Male', 'Motivation', 'Receptors, Dopamine D2/genetics/physiology', '*Reward']",https://pubmed.ncbi.nlm.nih.gov/26850211/
878,DRD2,28372879,DRD2: Bridging the Genome and Ingestive Behavior.,"['Sun X', 'Luquet S', 'Small DM']","['Alpha-Ketoglutarate-Dependent Dioxygenase FTO/*genetics', 'Dopamine', '*Gene-Environment Interaction', 'Genetic Predisposition to Disease', 'Humans', 'Obesity/*genetics', 'Protein Serine-Threonine Kinases/*genetics', 'Receptors, Dopamine D2/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28372879/
879,DRD2,28104410,The DRD2 rs1076560 polymorphism and schizophrenia-related intermediate phenotypes: A systematic review and meta-analysis.,"['Luykx JJ', 'Broersen JL', 'de Leeuw M']","['Genotype', 'Humans', 'Phenotype', '*Polymorphism, Single Nucleotide', 'Receptors, Dopamine D2/*genetics', '*Schizophrenia']",https://pubmed.ncbi.nlm.nih.gov/28104410/
880,DRD2,20631684,"Neurogenetics and pharmacology of learning, motivation, and cognition.","['Frank MJ', 'Fossella JA']","['Animals', 'Cognition/physiology', 'Corpus Striatum/chemistry/*physiology', 'Dopamine/deficiency/genetics/*metabolism', 'Dopamine Plasma Membrane Transport Proteins/genetics', 'Dopamine and cAMP-Regulated Phosphoprotein 32/genetics', 'Genetic Variation/genetics', 'Humans', 'Learning/physiology', 'Motivation/genetics', 'Polymorphism, Genetic', 'Prefrontal Cortex/chemistry/*physiology', 'Receptors, Dopamine D2/genetics', 'Receptors, Dopamine D4/genetics']",https://pubmed.ncbi.nlm.nih.gov/20631684/
881,DRD2,25504812,Association between DRD2 (rs1799732 and rs1801028) and ANKK1 (rs1800497) polymorphisms and schizophrenia: a meta-analysis.,"['Yao J', 'Pan YQ', 'Ding M', 'Pang H', 'Wang BJ']","['Gene Frequency', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Humans', 'Polymorphism, Single Nucleotide', 'Protein Serine-Threonine Kinases/*genetics', 'Receptors, Dopamine D2/*genetics', 'Schizophrenia/*genetics']",https://pubmed.ncbi.nlm.nih.gov/25504812/
882,DRD2,27333159,Variants in the DRD2 locus and antipsychotic-related prolactin levels: A meta-analysis.,"['Miura I', 'Zhang JP', 'Hagi K', 'Lencz T', 'Kane JM', 'Yabe H', 'Malhotra AK', 'Correll CU']","['Antipsychotic Agents/*pharmacology', 'Humans', 'Prolactin/*drug effects', '*Psychotic Disorders/drug therapy/genetics/metabolism', 'Receptors, Dopamine D2/*genetics', '*Schizophrenia/drug therapy/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/27333159/
883,DRD2,34376746,Blending oxytocin and dopamine with everyday creativity.,"['Chong A', 'Tolomeo S', 'Xiong Y', 'Angeles D', 'Cheung M', 'Becker B', 'Lai PS', 'Lei Z', 'Malavasi F', 'Tang Q', 'Chew SH', 'Ebstein RP']","['ADP-ribosyl Cyclase/genetics/metabolism', 'ADP-ribosyl Cyclase 1/genetics/metabolism', 'Adult', 'Antigens, CD/genetics/metabolism', 'Catechol O-Methyltransferase/genetics/metabolism', 'Cognition/*drug effects', '*Creativity', 'Dopamine/*pharmacology', 'Dopamine Agents/pharmacology', 'Female', 'GPI-Linked Proteins/genetics/metabolism', 'Gene Expression Regulation/*drug effects', 'Gene-Environment Interaction', 'Humans', 'Male', 'Membrane Glycoproteins/genetics/metabolism', 'Oxytocics/pharmacology', 'Oxytocin/*pharmacology', 'Polymorphism, Single Nucleotide', 'Receptors, Dopamine D2/genetics/metabolism', 'Saliva/drug effects/*metabolism', 'Sex Factors', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/34376746/
884,DRD2,11256581,The DRD2 gene in psychiatric and neurological disorders and its phenotypes.,['Noble EP'],"['Animals', 'Humans', 'Mental Disorders/*genetics/metabolism', 'Nervous System Diseases/*genetics/metabolism', 'Phenotype', 'Receptors, Dopamine D2/drug effects/*genetics']",https://pubmed.ncbi.nlm.nih.gov/11256581/
885,DRD2,37249604,The DRD2 Antagonist Haloperidol Mediates Autophagy-Induced Ferroptosis to Increase Temozolomide Sensitivity by Promoting Endoplasmic Reticulum Stress in Glioblastoma.,"['Shi L', 'Chen H', 'Chen K', 'Zhong C', 'Song C', 'Huang Y', 'Wang T', 'Chen L', 'Li C', 'Huang A', 'Qi S', 'Li H', 'Lu Y']","['Humans', 'Temozolomide/pharmacology/therapeutic use', '*Glioblastoma/drug therapy/genetics/metabolism', 'Haloperidol/pharmacology/therapeutic use', '*Ferroptosis', 'Dopamine D2 Receptor Antagonists/pharmacology', 'Cell Line, Tumor', 'Autophagy', 'Endoplasmic Reticulum Stress', '*Brain Neoplasms/drug therapy/genetics/metabolism', 'Drug Resistance, Neoplasm/genetics', 'Receptors, Dopamine D2/genetics']",https://pubmed.ncbi.nlm.nih.gov/37249604/
886,DRD2,23743496,"Functional proteomics, human genetics and cancer biology of GIPC family members.",['Katoh M'],"['Adaptor Proteins, Signal Transducing/chemistry/genetics/*metabolism', 'Amino Acid Sequence', 'Evolution, Molecular', 'Humans', 'Molecular Sequence Data', '*Multigene Family', 'Neoplasms/*genetics', 'Protein Binding', '*Proteomics']",https://pubmed.ncbi.nlm.nih.gov/23743496/
887,DRD2,35263227,Olfactory regulation by dopamine and DRD2 receptor in the nose.,"['Zhou HQ', 'Zhuang LJ', 'Bao HQ', 'Li SJ', 'Dai FY', 'Wang P', 'Li Q', 'Yin DM']","['Animals', '*Dopamine/metabolism', 'Dopamine D2 Receptor Antagonists/pharmacology', 'Humans', 'Mice', '*Olfactory Receptor Neurons/metabolism', '*Receptors, Dopamine D2/genetics/metabolism', 'Signal Transduction', 'Smell']",https://pubmed.ncbi.nlm.nih.gov/35263227/
888,DRD2,38530646,Lesion network of oculogyric crises maps to brain dopaminergic transcriptomic signature.,"['Al-Fatly B', 'Neudorfer C', 'Kaski D', 'Lang AE', 'Kuhn AA', 'Fox MD', 'Horn A', 'Ganos C']","['Humans', '*Transcriptome', '*Receptors, Dopamine D2/genetics/metabolism', '*Ocular Motility Disorders/genetics', '*Brain/metabolism', 'Male', 'Female', 'Middle Aged', 'Adult', 'Nerve Net/metabolism', 'Aged', 'Dopamine/metabolism', 'Receptors, Dopamine D3/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38530646/
889,DRD2,32260442,"Ankyrin Repeat and Kinase Domain Containing 1 Gene, and Addiction Vulnerability.","['Koeneke A', 'Ponce G', 'Troya-Balseca J', 'Palomo T', 'Hoenicka J']","['Behavior, Addictive/*genetics/metabolism', 'Central Nervous System/metabolism', 'Epistasis, Genetic', 'Humans', 'Polymorphism, Single Nucleotide', 'Protein Serine-Threonine Kinases/*genetics/*metabolism', 'Receptors, Dopamine D2/metabolism', 'Substance-Related Disorders/*genetics/metabolism', 'Tissue Distribution']",https://pubmed.ncbi.nlm.nih.gov/32260442/
890,DRD2,22610946,Role of dopamine receptors in ADHD: a systematic meta-analysis.,"['Wu J', 'Xiao H', 'Sun H', 'Zou L', 'Zhu LQ']","['Attention Deficit Disorder with Hyperactivity/*genetics/*metabolism', 'Genetic Predisposition to Disease', 'Humans', 'Polymorphism, Genetic', 'Receptors, Dopamine/chemistry/*genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/22610946/
891,DRD2,30836122,The effect of ANKK1 Taq1A and DRD2 C957T polymorphisms on executive function: A systematic review and meta-analysis.,"['Klaus K', 'Butler K', 'Curtis F', 'Bridle C', 'Pennington K']","['Executive Function/*physiology', 'Genotype', 'Humans', 'Inhibition, Psychological', 'Memory, Short-Term/physiology', 'Polymorphism, Single Nucleotide', 'Protein Serine-Threonine Kinases/*genetics', 'Receptors, Dopamine D2/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30836122/
892,DRD2,32894113,Inhibiting MAPK14 showed anti-prolactinoma effect.,"['Ding QY', 'Zhang Y', 'Ma L', 'Chen YG', 'Wu JH', 'Zhang HF', 'Wang X']","['Animals', 'Cell Proliferation/drug effects/genetics', 'Cells, Cultured', 'Female', 'Gene Deletion', 'Gene Expression Regulation, Neoplastic/drug effects', 'Humans', 'Mice', 'Mice, Inbred C57BL', 'Mice, Knockout', 'Mitogen-Activated Protein Kinase 14/*antagonists & inhibitors/genetics', 'Pituitary Neoplasms/genetics/metabolism/*pathology', 'Prolactin/genetics/metabolism', 'Prolactinoma/genetics/metabolism/*pathology', 'RNA, Small Interfering/*pharmacology', 'Rats', 'Receptors, Dopamine D2/genetics/metabolism', 'Signal Transduction/drug effects/genetics', 'Somatotrophs/metabolism/pathology']",https://pubmed.ncbi.nlm.nih.gov/32894113/
893,DRD2,39127265,DNA methylation at cannabinoid type 1 and dopamine D2 receptor genes in saliva samples of psychotic subjects: Is there an effect of Cannabis use?,"['Di Bartolomeo M', 'Cernanova A', 'Petrusova V', 'Di Martino S', 'Hodosy J', 'Drago F', 'Micale V', ""D'Addario C""]","['Humans', '*DNA Methylation', '*Saliva/metabolism/chemistry', '*Receptors, Dopamine D2/genetics/metabolism', 'Male', 'Adult', 'Female', '*Receptor, Cannabinoid, CB1/genetics/metabolism', '*Psychotic Disorders/genetics/metabolism', 'Young Adult', 'Dronabinol/pharmacology', 'Middle Aged', 'Epigenesis, Genetic', 'Marijuana Use/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39127265/
894,DRD2,37729778,Hypomethylation of DRD2 promotes breast cancer through the FLNA-ERK pathway.,"['Zhang S', 'Zhong M', 'Zhu H', 'You Q', 'Yuan H', 'Li Y']","['Animals', 'Humans', 'Filamins/genetics/metabolism', '*Extracellular Signal-Regulated MAP Kinases/metabolism', 'MAP Kinase Signaling System/genetics', 'DNA Methylation/genetics', '*Triple Negative Breast Neoplasms', 'Hormones', 'Receptors, Dopamine D2/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37729778/
895,DRD2,24139694,Developmental imaging genetics: linking dopamine function to adolescent behavior.,"['Padmanabhan A', 'Luna B']","['Adolescent', 'Adolescent Behavior/*physiology', 'Adolescent Development', 'Animals', 'Brain/*growth & development/*physiology', 'Brain Mapping', 'Dopamine/*genetics', 'Genetic Association Studies', 'Genotype', 'Humans', 'Magnetic Resonance Imaging', 'Polymorphism, Genetic', 'Receptors, Dopamine/*genetics']",https://pubmed.ncbi.nlm.nih.gov/24139694/
896,ALDH2,38666340,Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition.,"['Yang K', 'Gao R', 'Chen H', 'Hu J', 'Zhang P', 'Wei X', 'Shi J', 'Chen Y', 'Zhang L', 'Chen J', 'Lyu Y', 'Dong Z', 'Wei W', 'Hu K', 'Guo Y', 'Ge J', 'Sun A']","['Animals', 'Female', 'Humans', 'Male', 'Mice', 'Middle Aged', '*Aldehyde Dehydrogenase, Mitochondrial/genetics/metabolism', 'Benzamides', 'Benzodioxoles', 'Disease Models, Animal', '*Extracellular Traps/metabolism', 'Leukotriene Antagonists/pharmacology/therapeutic use', '*Leukotriene C4/antagonists & inhibitors/metabolism', 'Mice, Knockout', '*Myocardial Reperfusion Injury/prevention & control/genetics/metabolism', 'Neutrophils/metabolism', 'Protein-Arginine Deiminase Type 4/metabolism', 'ST Elevation Myocardial Infarction/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38666340/
897,ALDH2,24382882,Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.,"['Chen CH', 'Ferreira JC', 'Gross ER', 'Mochly-Rosen D']","['Aging', 'Aldehyde Dehydrogenase/genetics/*metabolism', 'Aldehyde Dehydrogenase, Mitochondrial', 'Animals', 'Humans', 'Liver/enzymology', 'Mutation/genetics', 'Neoplasms/metabolism']",https://pubmed.ncbi.nlm.nih.gov/24382882/
898,ALDH2,38299365,LncRNA CHKB-DT Downregulation Enhances Dilated Cardiomyopathy Through ALDH2.,"['Nie X', 'Fan J', 'Dai B', 'Wen Z', 'Li H', 'Chen C', 'Wang DW']","['Animals', 'Humans', 'Mice', 'Adenosine Triphosphate/metabolism', '*Aldehyde Dehydrogenase, Mitochondrial/genetics/metabolism', '*Cardiomyopathy, Dilated/genetics/metabolism', 'Down-Regulation', 'In Situ Hybridization, Fluorescence', 'Mice, Knockout', 'Mitochondria, Heart/metabolism', 'Myocytes, Cardiac/metabolism', '*RNA, Long Noncoding/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38299365/
899,ALDH2,17718394,The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants.,['Edenberg HJ'],"['Alcohol Dehydrogenase/genetics/*metabolism', 'Alcoholism/*enzymology/*genetics', 'Aldehyde Dehydrogenase/*genetics/metabolism', 'Aldehyde Dehydrogenase 1 Family', 'Alleles', 'Ethanol/*metabolism', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Genetic Variation', 'Genotype', 'Humans', 'Linkage Disequilibrium', 'Neurophysins/genetics', 'Protein Precursors/genetics', 'Retinal Dehydrogenase', 'Vasopressins/genetics']",https://pubmed.ncbi.nlm.nih.gov/17718394/
900,ALDH2,34228649,Aldehyde dehydrogenase 2 protects against acute kidney injury by regulating autophagy via the Beclin-1 pathway.,"['Xu T', 'Guo J', 'Wei M', 'Wang J', 'Yang K', 'Pan C', 'Pang J', 'Xue L', 'Yuan Q', 'Xue M', 'Zhang J', 'Sang W', 'Jiang T', 'Chen Y', 'Xu F']","['Acute Kidney Injury/*metabolism', 'Aldehyde Dehydrogenase, Mitochondrial/*metabolism', 'Animals', 'Apoptosis/physiology', 'Autophagy/physiology', 'Beclin-1/*metabolism', 'Cell Survival', 'Cells, Cultured', 'Gene Expression Regulation', 'Humans', '*Kidney Tubules/metabolism/pathology', 'Mice', '*Mitochondria/enzymology/metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/34228649/
901,ALDH2,30852706,Genetics of Alcoholism.,"['Edenberg HJ', 'Gelernter J', 'Agrawal A']","['Alcohol Dehydrogenase/genetics', 'Alcohol Drinking/genetics', 'Alcoholism/enzymology/*genetics', 'Aldehyde Dehydrogenase, Mitochondrial/genetics', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/30852706/
902,ALDH2,37749090,A common East-Asian ALDH2 mutation causes metabolic disorders and the therapeutic effect of ALDH2 activators.,"['Chang YC', 'Lee HL', 'Yang W', 'Hsieh ML', 'Liu CC', 'Lee TY', 'Huang JY', 'Nong JY', 'Li FA', 'Chuang HL', 'Ding ZZ', 'Su WL', 'Chueh LY', 'Tsai YT', 'Chen CH', 'Mochly-Rosen D', 'Chuang LM']","['Humans', 'Male', 'Mice', 'Animals', '*Diabetes Mellitus, Type 2/genetics', 'Proteomics', 'Aldehyde Dehydrogenase, Mitochondrial/genetics/metabolism', 'Mutation', '*Fatty Liver', 'Obesity/genetics', 'Fatty Acids', 'Aldehyde Dehydrogenase/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37749090/
903,ALDH2,36670098,Aldehyde dehydrogenase 2 alleviates mitochondrial dysfunction by promoting PGC-1alpha-mediated biogenesis in acute kidney injury.,"['Li J', 'Shi X', 'Chen Z', 'Xu J', 'Zhao R', 'Liu Y', 'Wen Y', 'Chen L']","['Animals', 'Humans', 'Mice', '*Acute Kidney Injury/chemically induced/genetics/metabolism', 'Aldehyde Dehydrogenase/metabolism', 'Aldehyde Dehydrogenase, Mitochondrial/genetics/metabolism', '*Cisplatin/adverse effects', 'Kidney/metabolism', 'Mice, Knockout', 'Mitochondria/metabolism', 'Organelle Biogenesis', 'Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36670098/
904,ALDH2,35354308,Macrophage ALDH2 (Aldehyde Dehydrogenase 2) Stabilizing Rac2 Is Required for Efferocytosis Internalization and Reduction of Atherosclerosis Development.,"['Zhang J', 'Zhao X', 'Guo Y', 'Liu Z', 'Wei S', 'Yuan Q', 'Shang H', 'Sang W', 'Cui S', 'Xu T', 'Yang K', 'Guo J', 'Pan C', 'Wang J', 'Pang J', 'Han T', 'Chen Y', 'Xu F']","['Aldehyde Dehydrogenase, Mitochondrial/genetics/metabolism', 'Animals', 'Apolipoproteins E/genetics', 'Apoptosis/physiology', '*Atherosclerosis/genetics/metabolism/prevention & control', '*Cardiovascular Diseases/metabolism', 'Macrophages/metabolism', 'Mice', 'Mice, Inbred C57BL', 'Mice, Knockout', '*Plaque, Atherosclerotic/pathology', 'rac GTP-Binding Proteins/*metabolism', 'RAC2 GTP-Binding Protein']",https://pubmed.ncbi.nlm.nih.gov/35354308/
905,ALDH2,37822152,Early Progression of Abdominal Aortic Aneurysm is Decelerated by Improved Endothelial Barrier Function via ALDH2-LIN28B-ELK3 Signaling.,"['Yang K', 'Cui S', 'Wang J', 'Xu T', 'Du H', 'Yue H', 'Ye H', 'Guo J', 'Zhang J', 'Li P', 'Guo Y', 'Pan C', 'Pang J', 'Wang J', 'Yu X', 'Zhang C', 'Liu Z', 'Chen Y', 'Xu F']","['Humans', '*Endothelial Cells/metabolism', '*Aortic Aneurysm, Abdominal/genetics', 'Signal Transduction', 'RNA, Messenger/metabolism', 'Aldehyde Dehydrogenase, Mitochondrial/genetics/metabolism', 'RNA-Binding Proteins/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37822152/
906,ALDH2,36696485,SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common ALDH2 alcohol flushing variant.,"['Guo H', 'Yu X', 'Liu Y', 'Paik DT', 'Justesen JM', 'Chandy M', 'Jahng JWS', 'Zhang T', 'Wu W', 'Rwere F', 'Zhao SR', 'Pokhrel S', 'Shivnaraine RV', 'Mukherjee S', 'Simon DJ', 'Manhas A', 'Zhang A', 'Chen CH', 'Rivas MA', 'Gross ER', 'Mochly-Rosen D', 'Wu JC']","['Humans', 'Mice', 'Animals', 'Aldehyde Dehydrogenase, Mitochondrial/genetics', '*Sodium-Glucose Transporter 2 Inhibitors', 'Genome-Wide Association Study', '*Induced Pluripotent Stem Cells/metabolism', '*Coronary Artery Disease', 'Aldehyde Dehydrogenase']",https://pubmed.ncbi.nlm.nih.gov/36696485/
907,ALDH2,15099407,Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology.,"['Crabb DW', 'Matsumoto M', 'Chang D', 'You M']","['Alcohol Dehydrogenase/genetics/*metabolism', 'Alcoholism/complications/*enzymology/genetics', 'Aldehyde Dehydrogenase/genetics/*metabolism', 'Aldehyde Dehydrogenase, Mitochondrial', 'Ethanol/metabolism', 'Genetic Predisposition to Disease', '*Genetic Variation', 'Humans', 'Intestinal Absorption']",https://pubmed.ncbi.nlm.nih.gov/15099407/
908,ALDH2,36528936,"ALDH2 deficiency increases susceptibility to binge alcohol-induced gut leakiness, endotoxemia, and acute liver injury in mice through the gut-liver axis.","['Rungratanawanich W', 'Lin Y', 'Wang X', 'Kawamoto T', 'Chidambaram SB', 'Song BJ']","['Animals', 'Humans', 'Mice', 'Aldehyde Dehydrogenase, Mitochondrial/genetics', '*Endotoxemia/genetics', 'Ethanol/toxicity', '*Liver Diseases, Alcoholic/metabolism', 'Mice, Knockout', 'Intestinal Diseases/chemically induced']",https://pubmed.ncbi.nlm.nih.gov/36528936/
909,ALDH2,31368107,ALDH2 and Cancer Therapy.,"['Wang LS', 'Wu ZX']","['*Alcohol Drinking', 'Alcoholism/genetics', 'Aldehyde Dehydrogenase, Mitochondrial/*genetics', 'Anthracyclines/*therapeutic use', 'Humans', 'Neoplasms/*drug therapy/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31368107/
910,ALDH2,31368097,ALDH2 and Cardiovascular Disease.,"['Chen CH', 'Ferreira JCB', 'Mochly-Rosen D']","['Acetaldehyde/*adverse effects', '*Alcohol Drinking', 'Aldehyde Dehydrogenase, Mitochondrial/*genetics', 'Asian People', 'Cardiovascular Diseases/*genetics', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/31368097/
911,ALDH2,23712313,Genetics and alcoholism.,"['Edenberg HJ', 'Foroud T']","['Alcohol Dehydrogenase/genetics', 'Alcoholism/*epidemiology/*genetics/physiopathology', 'Aldehyde Dehydrogenase/genetics', 'Aldehyde Dehydrogenase, Mitochondrial', 'Cytoskeletal Proteins', 'G Protein-Coupled Inwardly-Rectifying Potassium Channels/genetics', 'Humans', 'Liver/*physiology', 'Proteins/genetics', 'Receptor, Muscarinic M2/genetics', 'Receptors, GABA-A/genetics', 'Risk Factors', 'Transcription Factors']",https://pubmed.ncbi.nlm.nih.gov/23712313/
912,ALDH2,35568135,Aldehyde dehydrogenase 2 and arrhythmogenesis.,"['Jin J', 'Chen J', 'Wang Y']","['Aldehyde Dehydrogenase, Mitochondrial/genetics', 'Aldehydes', 'Arrhythmias, Cardiac/genetics', 'Humans', '*Oxidative Stress', '*Polymorphism, Genetic']",https://pubmed.ncbi.nlm.nih.gov/35568135/
913,ALDH2,35056791,Novel Disulfiram Derivatives as ALDH1a1-Selective Inhibitors.,['Omran Z'],"['Acetaldehyde Dehydrogenase Inhibitors/chemical synthesis/*chemistry/metabolism/*pharmacology', 'Aldehyde Dehydrogenase 1 Family/*antagonists & inhibitors/chemistry/metabolism', 'Aldehyde Dehydrogenase, Mitochondrial/antagonists & inhibitors/chemistry/metabolism', 'Disulfiram/analogs & derivatives/chemical synthesis/*chemistry/*pharmacology', 'Humans', 'Molecular Docking Simulation', 'Recombinant Proteins/metabolism', 'Retinal Dehydrogenase/*antagonists & inhibitors/chemistry/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35056791/
914,ALDH2,39217614,Aldehydes alter TGF-beta signaling and induce obesity and cancer.,"['Yang X', 'Bhowmick K', 'Rao S', 'Xiang X', 'Ohshiro K', 'Amdur RL', 'Hassan MI', 'Mohammad T', 'Crandall K', 'Cifani P', 'Shetty K', 'Lyons SK', 'Merrill JR', 'Vegesna AK', 'John S', 'Latham PS', 'Crawford JM', 'Mishra B', 'Dasarathy S', 'Wang XW', 'Yu H', 'Wang Z', 'Huang H', 'Krainer AR', 'Mishra L']","['Animals', 'Humans', '*Transforming Growth Factor beta/metabolism', '*Aldehydes/metabolism', '*Signal Transduction', '*Obesity/metabolism/pathology', 'Mice', '*Aldehyde Dehydrogenase, Mitochondrial/metabolism/genetics', '*Smad3 Protein/metabolism', '*Neoplasms/metabolism/pathology/genetics', 'Spectrin/metabolism/genetics', 'Mice, Inbred C57BL', 'Male', 'Mice, Knockout', 'Metabolic Syndrome/metabolism/pathology/genetics']",https://pubmed.ncbi.nlm.nih.gov/39217614/
915,ALDH2,35749303,ALDH2 variance in disease and populations.,"['Chen CH', 'Kraemer BR', 'Mochly-Rosen D']","['*Alcohol Drinking/genetics', 'Aldehyde Dehydrogenase, Mitochondrial/genetics', 'Asian People', 'Ethanol', 'Humans', '*Polymorphism, Genetic']",https://pubmed.ncbi.nlm.nih.gov/35749303/
916,PTGS1,29221664,Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs.,"['Bjarnason I', 'Scarpignato C', 'Holmgren E', 'Olszewski M', 'Rainsford KD', 'Lanas A']","['Animals', 'Cyclooxygenase 1/metabolism', 'Cyclooxygenase 2/metabolism', 'Cyclooxygenase 2 Inhibitors/adverse effects', 'Cyclooxygenase Inhibitors/*adverse effects', 'Gastrointestinal Diseases/*chemically induced/diagnosis/metabolism/microbiology', 'Gastrointestinal Microbiome', 'Gastrointestinal Tract/*drug effects/metabolism/microbiology/pathology', 'Helicobacter pylori/pathogenicity', 'Humans', 'Mitochondria/drug effects/metabolism', 'Oxidative Phosphorylation/drug effects', 'Phospholipids/metabolism', 'Prostaglandins/metabolism']",https://pubmed.ncbi.nlm.nih.gov/29221664/
917,PTGS1,14965321,Cyclooxygenase enzymes: regulation and function.,['Fitzpatrick FA'],"['Cyclooxygenase 1', 'Cyclooxygenase 2', 'Cyclooxygenase 2 Inhibitors', 'Cyclooxygenase Inhibitors/chemistry/pharmacology', 'Humans', 'Isoenzymes/chemistry/*metabolism/physiology', 'Membrane Proteins', 'Peroxidase/metabolism', 'Prostaglandin-Endoperoxide Synthases/chemistry/*metabolism/physiology', 'Prostaglandins/biosynthesis', 'Protein Conformation', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/14965321/
918,PTGS1,25916522,Pharmacogenomics of cyclooxygenases.,"['Agundez JA', 'Blanca M', 'Cornejo-Garcia JA', 'Garcia-Martin E']","['Cyclooxygenase 1/genetics', 'Cyclooxygenase 2/genetics', 'Cyclooxygenase Inhibitors/*pharmacology', 'Genetic Variation', 'Humans', '*Pharmacogenetics', 'Polymorphism, Single Nucleotide', 'Prostaglandin-Endoperoxide Synthases/*drug effects/*genetics']",https://pubmed.ncbi.nlm.nih.gov/25916522/
919,PTGS1,11566041,Regulation of cyclo-oxygenase-2.,"['Stack E', 'DuBois RN']","['Arachidonic Acid/metabolism', 'Cyclooxygenase 1', 'Cyclooxygenase 2', 'Cyclooxygenase 2 Inhibitors', 'Cyclooxygenase Inhibitors/therapeutic use', 'Humans', 'Isoenzymes/*metabolism', 'Membrane Proteins', 'Peroxidases/metabolism', 'Prostaglandin-Endoperoxide Synthases/*metabolism', 'Prostaglandins/biosynthesis/*physiology']",https://pubmed.ncbi.nlm.nih.gov/11566041/
920,PTGS1,38507887,"Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways.","['Ni L', 'Zhu X', 'Zhao Q', 'Shen Y', 'Tao L', 'Zhang J', 'Lin H', 'Zhuge W', 'Cho YC', 'Cui R', 'Zhu W']","['Humans', 'Apoptosis', '*Artemisinins/pharmacology/therapeutic use', '*Carcinoma, Non-Small-Cell Lung/drug therapy/genetics/metabolism', 'Cell Death', 'Cell Line, Tumor', 'Cisplatin/pharmacology', 'Cyclooxygenase 1/metabolism', '*Lung Neoplasms/pathology', 'p38 Mitogen-Activated Protein Kinases/metabolism', '*Reactive Oxygen Species/metabolism', 'Signal Transduction', 'Cyclooxygenase Inhibitors/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/38507887/
921,PTGS1,39389415,Eicosanoid biosynthesizing enzymes in Prototheria.,"['Kakularam KR', 'Gundem E', 'Stehling S', 'Rothe M', 'Heydeck D', 'Kuhn H']","['Animals', '*Eicosanoids/metabolism', 'Humans', 'Prostaglandin-Endoperoxide Synthases/genetics/metabolism', 'Lipoxygenase/genetics/metabolism', 'Arachidonate 15-Lipoxygenase/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39389415/
922,PTGS1,30312731,Androgen deprivation-induced ZBTB46-PTGS1 signaling promotes neuroendocrine differentiation of prostate cancer.,"['Chen WY', 'Zeng T', 'Wen YC', 'Yeh HL', 'Jiang KC', 'Chen WH', 'Zhang Q', 'Huang J', 'Liu YN']","['Androgen Receptor Antagonists/*pharmacology', 'Animals', 'Cell Differentiation', 'Cell Line, Tumor', 'Cyclooxygenase 1/*metabolism', 'Humans', 'Male', 'Mice', 'Mice, Nude', 'Neuroendocrine Tumors/drug therapy/genetics/*metabolism/pathology', 'Prostatic Neoplasms/drug therapy/genetics/*metabolism/pathology', 'Proto-Oncogene Proteins c-ets/antagonists & inhibitors/genetics/metabolism', 'Receptors, Androgen/metabolism', 'Signal Transduction', 'Transcription Factors/biosynthesis/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/30312731/
923,PTGS1,27111555,COX-1 Inhibitors: Beyond Structure Toward Therapy.,"['Vitale P', 'Panella A', 'Scilimati A', 'Perrone MG']","['Animals', 'Cyclooxygenase 1/chemistry/*metabolism', 'Cyclooxygenase Inhibitors/chemistry/*pharmacology', 'Humans', 'Inhibitory Concentration 50', 'Models, Molecular', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/27111555/
924,PTGS1,11764532,Prostaglandin biology.,['Crofford LJ'],"['Cyclooxygenase 1', 'Cyclooxygenase 2', 'Gene Expression', 'Humans', 'Isoenzymes/genetics/metabolism', 'Membrane Proteins', 'Phospholipases/classification/*metabolism', 'Prostaglandin H2', 'Prostaglandin-Endoperoxide Synthases/genetics/*metabolism', 'Prostaglandins/biosynthesis/classification/*metabolism', 'Prostaglandins H/*metabolism', 'RNA, Messenger', 'Receptors, Cytoplasmic and Nuclear/genetics/metabolism', 'Receptors, Prostaglandin/genetics/*metabolism', 'Transcription Factors/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/11764532/
925,PTGS1,23967159,A meta-analysis of PTGS1 and PTGS2 polymorphisms and NSAID intake on the risk of developing cancer.,"['Nagao M', 'Sato Y', 'Yamauchi A']","['Anti-Inflammatory Agents, Non-Steroidal/administration & dosage/*adverse effects', 'Cyclooxygenase 1/*genetics', 'Cyclooxygenase 2/*genetics', 'Female', 'Humans', 'Male', 'Neoplasms/epidemiology/*etiology', 'Odds Ratio', '*Polymorphism, Single Nucleotide', 'Publication Bias', 'Risk']",https://pubmed.ncbi.nlm.nih.gov/23967159/
926,PTGS1,33800915,MYLK and PTGS1 Genetic Variations Associated with Osteoporosis and Benign Breast Tumors in Korean Women.,"['Cho HW', 'Jin HS', 'Eom YB']","['Breast Neoplasms/*genetics', 'Calcium-Binding Proteins/*genetics', 'Case-Control Studies', 'Cyclooxygenase 1/*genetics', 'Female', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Humans', 'Middle Aged', 'Myosin-Light-Chain Kinase/*genetics', 'Osteoporosis/*genetics', 'Ovariectomy/adverse effects', 'Phenotype', '*Polymorphism, Single Nucleotide', 'Republic of Korea']",https://pubmed.ncbi.nlm.nih.gov/33800915/
927,PTGS1,10399316,Cyclooxygenase-1 and -2 isoenzymes.,"['Hla T', 'Bishop-Bailey D', 'Liu CH', 'Schaefers HJ', 'Trifan OC']","['Animals', 'Cyclooxygenase 1', 'Cyclooxygenase 2', 'Gene Expression', 'Humans', '*Isoenzymes/*chemistry/*physiology', 'Membrane Proteins', 'Models, Biological', 'Peroxidases/physiology', 'Prostaglandin-Endoperoxide Synthases/*chemistry/*physiology']",https://pubmed.ncbi.nlm.nih.gov/10399316/
928,PTGS1,9597150,Cyclooxygenases 1 and 2.,"['Vane JR', 'Bakhle YS', 'Botting RM']","['Animals', 'Cyclooxygenase 1', 'Cyclooxygenase 2', 'Enzyme Induction/drug effects', 'Humans', 'Isoenzymes/biosynthesis/genetics/*metabolism', 'Membrane Proteins', 'Prostaglandin-Endoperoxide Synthases/biosynthesis/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/9597150/
929,PTGS1,11818462,Cyclooxygenase-2: a therapeutic target.,"['Turini ME', 'DuBois RN']","['Anti-Inflammatory Agents, Non-Steroidal/adverse effects/*therapeutic use', 'Clinical Trials as Topic', 'Cyclooxygenase 1', 'Cyclooxygenase 2', 'Cyclooxygenase 2 Inhibitors', 'Cyclooxygenase Inhibitors/adverse effects/*therapeutic use', 'Humans', 'Inflammation/*drug therapy/enzymology', 'Isoenzymes/*antagonists & inhibitors', 'Membrane Proteins', 'Neoplasms/*drug therapy/enzymology', 'Prostaglandin-Endoperoxide Synthases']",https://pubmed.ncbi.nlm.nih.gov/11818462/
930,PTGS1,11338376,[Reproduction physiology and prostanoids].,"['Tsuboi K', 'Ichikawa A']","['Animals', 'Cloning, Molecular', 'Cyclooxygenase 1', 'Cyclooxygenase 2', 'Dinoprost/*physiology', 'Drug Design', 'Female', 'Fertilization', 'Humans', 'Isoenzymes/genetics/physiology', 'Labor, Obstetric', 'Luteolysis', 'Membrane Proteins', 'Ovulation', 'Pregnancy', 'Prostaglandin-Endoperoxide Synthases/genetics/physiology', 'Receptors, Prostaglandin E/genetics/physiology', 'Receptors, Prostaglandin E, EP2 Subtype', 'Reproduction/*physiology']",https://pubmed.ncbi.nlm.nih.gov/11338376/
931,PTGS1,31237067,Peritubular cells of the human testis: prostaglandin E(2) and more.,['Mayerhofer A'],"['Animals', 'Dinoprostone/*metabolism', 'Extracellular Matrix/metabolism', 'Humans', 'Male', 'Mice', 'Spermatogenesis/*physiology', 'Spermatogonia/cytology', 'Testis/*cytology/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/31237067/
932,PTGS1,14592545,Variants of cyclooxygenase-1 and their roles in medicine.,['Simmons DL'],"['Acetaminophen/*administration & dosage', 'Analgesics/administration & dosage', 'Analgesics, Non-Narcotic/administration & dosage', 'Animals', 'Anti-Inflammatory Agents, Non-Steroidal/*administration & dosage', 'Brain/metabolism', 'Cyclooxygenase 1', 'Cyclooxygenase Inhibitors/*administration & dosage/chemistry', 'Humans', 'Isoenzymes/*antagonists & inhibitors/chemistry/*metabolism', 'Membrane Proteins', 'Prostaglandin-Endoperoxide Synthases/chemistry/*drug effects/*metabolism', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/14592545/
933,PTGS1,32299908,Identification of a homozygous recessive variant in PTGS1 resulting in a congenital aspirin-like defect in platelet function.,"['Chan MV', 'Hayman MA', 'Sivapalaratnam S', 'Crescente M', 'Allan HE', 'Edin ML', 'Zeldin DC', 'Milne GL', 'Stephens J', 'Greene D', 'Hanif M', ""O'Donnell VB"", 'Dong L', 'Malkowski MG', 'Lentaigne C', 'Wedderburn K', 'Stubbs M', 'Downes K', 'Ouwehand WH', 'Turro E', 'BioResource N', 'Hart DP', 'Freson K', 'Laffan MA', 'Warner TD']","['*Aspirin', 'Blood Platelets', 'Cyclooxygenase 1/genetics', 'Female', 'Humans', 'Platelet Aggregation/genetics', '*Platelet Function Tests', 'Thromboxane A2']",https://pubmed.ncbi.nlm.nih.gov/32299908/
934,PTGS1,34920330,PTGES3 is a Putative Prognostic Marker in Breast Cancer.,"['Adekeye A', 'Agarwal D', 'Nayak A', 'Tchou J']","['Biomarkers, Tumor/metabolism', '*Breast Neoplasms/enzymology/pathology', 'Cyclooxygenase 2/genetics/metabolism', 'Dinoprostone/metabolism', 'Female', 'Humans', 'Prognosis', '*Prostaglandin-E Synthases/metabolism', 'Proteomics', 'Tumor Microenvironment']",https://pubmed.ncbi.nlm.nih.gov/34920330/
935,PTGS1,10630643,"The role of cyclooxygenases in inflammation, cancer, and development.","['Williams CS', 'Mann M', 'DuBois RN']","['Animals', 'Anticarcinogenic Agents/therapeutic use', 'Colonic Neoplasms/enzymology/genetics/prevention & control', 'Colorectal Neoplasms/enzymology/genetics', 'Cyclooxygenase 1', 'Cyclooxygenase 2', 'Cyclooxygenase 2 Inhibitors', 'Cyclooxygenase Inhibitors/therapeutic use', '*Embryonic and Fetal Development', 'Humans', 'Isoenzymes/deficiency/genetics/*metabolism', 'Membrane Proteins', 'Mice', 'Mice, Knockout', 'Prostaglandin-Endoperoxide Synthases/deficiency/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/10630643/
936,HTR1E,34093864,Serotonin/HTR1E signaling blocks chronic stress-promoted progression of ovarian cancer.,"['Qin X', 'Li J', 'Wang S', 'Lv J', 'Luan F', 'Liu Y', 'Chen Y', 'Chen X', 'Zhao Y', 'Zhu J', 'Piao Y', 'Zhang W', 'Shi Y', 'Xiang R', 'Qu P', 'Wang L']","['Adenocarcinoma/genetics/*metabolism/pathology', 'Animals', 'Behavior Rating Scale', 'Cell Line, Tumor', 'Cell Movement/drug effects/ethics', 'Cell Proliferation/drug effects/genetics', 'Disease Progression', 'Epithelial-Mesenchymal Transition/drug effects/genetics', 'Female', 'Gene Expression Regulation, Neoplastic/genetics', 'Genetic Testing', 'Humans', 'Immunohistochemistry', 'Mice', 'Mice, Inbred NOD', 'Mice, SCID', 'Middle Aged', 'Neoplasm Invasiveness/genetics', 'Ovarian Neoplasms/genetics/*metabolism/pathology', 'RNA-Seq', 'Real-Time Polymerase Chain Reaction', 'Receptors, Serotonin/genetics/*metabolism', 'Receptors, Serotonin, 5-HT1/*metabolism', 'Serotonin/*pharmacology', 'Signal Transduction/drug effects/genetics', '*Stress, Physiological/drug effects/genetics', 'Xenograft Model Antitumor Assays']",https://pubmed.ncbi.nlm.nih.gov/34093864/
937,HTR1E,37078547,Characterization of serotonin-5-HTR1E signaling pathways and its role in cell survival.,"['Sharma VK', 'Campbell K', 'Yang X', 'Dale R', 'Loh YP']","['Humans', '*Serotonin/pharmacology/metabolism', 'Cell Survival', 'HEK293 Cells', '*Neuroblastoma', 'Signal Transduction', 'Extracellular Signal-Regulated MAP Kinases/metabolism', 'Phosphorylation', 'MAP Kinase Signaling System']",https://pubmed.ncbi.nlm.nih.gov/37078547/
938,HTR1E,34207786,"Molecular Cloning and Functional Characterization of Three 5-HT Receptor Genes (HTR1B, HTR1E, and HTR1F) in Chickens.","['Sun C', 'Qiu Y', 'Ren Q', 'Zhang X', 'Cao B', 'Zou Y', 'Li J', 'Zhang J', 'Wang Y']","['Animals', 'Avian Proteins/*genetics/metabolism', 'Brain/metabolism', 'Cells, Cultured', 'Chickens/*genetics/metabolism', 'Cloning, Molecular', 'Colforsin/pharmacology', 'HEK293 Cells', 'Humans', 'MAP Kinase Signaling System', 'Pituitary Gland/drug effects/metabolism', 'Receptors, Serotonin, 5-HT1/*genetics/metabolism', 'Serotonin Receptor Agonists/pharmacology', 'Vasoactive Intestinal Peptide/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/34207786/
939,HTR1E,24721318,Transitions in the transcriptome of the serotonergic and dopaminergic systems in the human brain during adolescence.,"['Shoval G', 'Bar-Shira O', 'Zalsman G', 'John Mann J', 'Chechik G']","['Adolescent', 'Adult', 'Animals', 'Brain/growth & development/*metabolism', 'Child', 'Child, Preschool', 'Dopamine/metabolism', 'Dopamine Plasma Membrane Transport Proteins/*genetics/metabolism', 'Humans', 'Infant', 'Macaca mulatta', 'Receptors, Dopamine/*genetics/metabolism', 'Receptors, Serotonin/*genetics/metabolism', 'Serotonin/metabolism', 'Serotonin Plasma Membrane Transport Proteins/*genetics/metabolism', '*Transcriptome', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/24721318/
940,HTR1E,34966948,"Novel interaction between neurotrophic factor-alpha1/carboxypeptidase E and serotonin receptor, 5-HTR1E, protects human neurons against oxidative/neuroexcitotoxic stress via beta-arrestin/ERK signaling.","['Sharma VK', 'Yang X', 'Kim SK', 'Mafi A', 'Saiz-Sanchez D', 'Villanueva-Anguita P', 'Xiao L', 'Inoue A', 'Goddard WA 3rd', 'Loh YP']","['Animals', 'Carboxypeptidase H/chemistry/*metabolism', 'Cell Survival/drug effects', 'Cyclic AMP/metabolism', 'Cyclic AMP Response Element-Binding Protein/metabolism', 'Down-Regulation/drug effects', 'HEK293 Cells', 'Hippocampus/metabolism', 'Humans', '*MAP Kinase Signaling System/drug effects', 'Mice', 'Molecular Docking Simulation', 'Molecular Dynamics Simulation', 'Nerve Growth Factors/*metabolism', 'Neurons/drug effects/*metabolism/pathology', 'Neuroprotective Agents/metabolism', 'Neurotoxins/*toxicity', '*Oxidative Stress', 'Phosphorylation/drug effects', 'Protein Binding/drug effects', 'Protein Domains', 'Receptors, Serotonin/chemistry/*metabolism', 'beta-Arrestins/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/34966948/
941,HTR1E,30074224,Association of Serotonin Receptors with Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-analysis.,"['Hou YW', 'Xiong P', 'Gu X', 'Huang X', 'Wang M', 'Wu J']","['Attention Deficit Disorder with Hyperactivity/*genetics', '*Genetic Association Studies', '*Genetic Predisposition to Disease', 'Humans', 'Odds Ratio', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, Serotonin/*genetics', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/30074224/
942,HTR1E,22072498,Genome-wide association of an integrated osteoporosis-related phenotype: is there evidence for pleiotropic genes?,"['Karasik D', 'Cheung CL', 'Zhou Y', 'Cupples LA', 'Kiel DP', 'Demissie S']","['Aged', 'Cohort Studies', 'Computational Biology', 'Female', 'Gene Regulatory Networks/genetics', 'Genetic Pleiotropy/*genetics', '*Genome-Wide Association Study', 'Humans', 'Male', 'Middle Aged', 'Osteoporosis/*genetics', 'Osteoporotic Fractures/genetics', 'Phenotype', 'Polymorphism, Single Nucleotide/genetics', 'Principal Component Analysis']",https://pubmed.ncbi.nlm.nih.gov/22072498/
943,HTR1E,22199298,Genome-wide identification of chemosensitive single nucleotide polymorphism markers in gastric cancer.,"['Ha YJ', 'Yoon SN', 'Jeon YJ', 'Cho DH', 'Roh SA', 'Kim BS', 'Kim HJ', 'Kim SY', 'Kim YS', 'Kim JC']","['Adult', 'Aged', 'Alleles', 'Cell Survival', 'Docetaxel', 'Drug Screening Assays, Antitumor', 'Female', '*Genome-Wide Association Study', 'Genotype', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Male', 'Middle Aged', 'Oligonucleotide Array Sequence Analysis', '*Polymorphism, Single Nucleotide', 'Receptors, Serotonin/genetics', 'Stomach Neoplasms/*genetics', 'Taxoids/pharmacology', 'Transfection']",https://pubmed.ncbi.nlm.nih.gov/22199298/
944,HTR1E,29904178,The phenotypic spectrum of proximal 6q deletions based on a large cohort derived from social media and literature reports.,"['Engwerda A', 'Frentz B', 'den Ouden AL', 'Flapper BCT', 'Swertz MA', 'Gerkes EH', 'Plantinga M', 'Dijkhuizen T', 'van Ravenswaaij-Arts CMA']","['Abnormalities, Multiple/*genetics/physiopathology', 'Child', 'Chromosome Deletion', 'Chromosomes, Human, Pair 6/*genetics', 'Developmental Disabilities/*genetics/physiopathology', 'Female', 'Genetic Counseling/trends', 'Humans', 'Male', 'Phenotype', '*Social Media']",https://pubmed.ncbi.nlm.nih.gov/29904178/
945,HTR1E,19455598,Nucleotide variation in central nervous system genes among male suicide attempters.,"['Baca-Garcia E', 'Vaquero-Lorenzo C', 'Perez-Rodriguez MM', 'Gratacos M', 'Bayes M', 'Santiago-Mozos R', 'Leiva-Murillo JM', 'de Prado-Cumplido M', 'Artes-Rodriguez A', 'Ceverino A', 'Diaz-Sastre C', 'Fernandez-Navarro P', 'Costas J', 'Fernandez-Piqueras J', 'Diaz-Hernandez M', 'de Leon J', 'Baca-Baldomero E', 'Saiz-Ruiz J', 'Mann JJ', 'Parsey RV', 'Carracedo A', 'Estivill X', 'Oquendo MA']","['Adult', 'Central Nervous System/*metabolism', 'Humans', 'Male', 'Polymorphism, Single Nucleotide', 'Sensitivity and Specificity', '*Suicide, Attempted']",https://pubmed.ncbi.nlm.nih.gov/19455598/
946,HTR1E,22509378,A genome-wide association study of female sexual dysfunction.,"['Burri A', 'Hysi P', 'Clop A', 'Rahman Q', 'Spector TD']","['Adult', 'Aged', 'Aged, 80 and over', 'Alleles', 'Chromosomes, Human, Pair 6/genetics', 'Female', '*Genetic Predisposition to Disease', '*Genome-Wide Association Study', 'Humans', 'Middle Aged', 'Polymorphism, Single Nucleotide', 'Receptors, Serotonin/*genetics', 'Serotonin/genetics', 'Sexual Dysfunction, Physiological/*genetics', 'gamma-Aminobutyric Acid/genetics']",https://pubmed.ncbi.nlm.nih.gov/22509378/
947,HTR1E,16873768,Serotoninergic receptors on human airway epithelial cells.,"['Bayer H', 'Muller T', 'Myrtek D', 'Sorichter S', 'Ziegenhagen M', 'Norgauer J', 'Zissel G', 'Idzko M']","['Biological Transport, Active', 'Calcium/metabolism', 'Cells, Cultured', 'Dinoprostone/biosynthesis', 'Epithelial Cells/*metabolism', 'Humans', 'Interleukin-6/metabolism', 'Interleukin-8/metabolism', 'Receptors, Serotonin/*biosynthesis', 'Respiratory Mucosa/cytology/metabolism']",https://pubmed.ncbi.nlm.nih.gov/16873768/
948,HTR1E,18079067,Genetic evaluation of the serotonergic system in chronic fatigue syndrome.,"['Smith AK', 'Dimulescu I', 'Falkenberg VR', 'Narasimhan S', 'Heim C', 'Vernon SD', 'Rajeevan MS']","['Adult', 'Case-Control Studies', 'Chi-Square Distribution', 'Chromosomes, Human, X/*genetics', 'Disability Evaluation', 'Fatigue/diagnosis/*genetics', 'Fatigue Syndrome, Chronic/diagnosis/*genetics', 'Female', 'Genetic Markers', 'Humans', 'Linkage Disequilibrium', 'Male', 'Middle Aged', 'Receptor, Serotonin, 5-HT2A/*genetics', 'Receptors, Serotonin/classification/genetics', 'Reference Values', 'Serotonin Plasma Membrane Transport Proteins/genetics']",https://pubmed.ncbi.nlm.nih.gov/18079067/
949,HTR1E,33123575,The Important Role of Perituberal Tissue in Epileptic Patients with Tuberous Sclerosis Complex by the Transcriptome Analysis.,"['Li S', 'Shao H', 'Chang L']","['Computational Biology/methods', 'Databases, Genetic', 'Down-Regulation/genetics', 'Epilepsy/*genetics', 'Gene Expression Profiling/methods', 'Gene Ontology', 'Gene Regulatory Networks/genetics', 'Humans', 'Protein Interaction Maps/genetics', 'Signal Transduction/genetics', 'Transcriptome/*genetics', 'Tuberous Sclerosis/*genetics', 'Up-Regulation/genetics']",https://pubmed.ncbi.nlm.nih.gov/33123575/
950,HTR1E,31176514,Disrupted placental serotonin synthetic pathway and increased placental serotonin: Potential implications in the pathogenesis of human fetal growth restriction.,"['Ranzil S', 'Ellery S', 'Walker DW', 'Vaillancourt C', 'Alfaidy N', 'Bonnin A', 'Borg A', 'Wallace EM', 'Ebeling PR', 'Erwich JJ', 'Murthi P']","['Adult', 'Case-Control Studies', 'Female', 'Fetal Growth Retardation/genetics/*metabolism/pathology', 'Humans', 'Metabolic Networks and Pathways/physiology', 'Placenta/*metabolism/pathology', 'Placental Insufficiency/genetics/metabolism/pathology', 'Pregnancy', 'Pregnancy Trimester, Third/metabolism', 'Serotonin/*metabolism', 'Serotonin Plasma Membrane Transport Proteins/genetics/metabolism', 'Tryptophan Hydroxylase/genetics/metabolism', 'Up-Regulation/genetics']",https://pubmed.ncbi.nlm.nih.gov/31176514/
951,HTR1E,23235336,Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia.,"['Nishioka M', 'Bundo M', 'Koike S', 'Takizawa R', 'Kakiuchi C', 'Araki T', 'Kasai K', 'Iwamoto K']","['Adolescent', 'Adult', 'Case-Control Studies', 'Cluster Analysis', 'CpG Islands', '*DNA Methylation', 'Female', 'Humans', 'Male', 'Principal Component Analysis', 'Schizophrenia/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/23235336/
952,HTR1E,30639027,"Short communication: Differences in distribution of serotonin receptor subtypes in the mammary gland of sheep, goats, and cows during lactation and involution.","['Suarez-Trujillo A', 'Arguello A', 'Rivero MA', 'Capote J', 'Castro N']","['Animals', 'Cattle/genetics/*metabolism', 'Cell Count', 'Epithelial Cells/metabolism', 'Female', 'Gene Expression', 'Goats/genetics/*metabolism', 'Lactation', 'Mammary Glands, Animal/*metabolism', 'Mice', 'Milk/metabolism', 'Receptors, Serotonin/*biosynthesis/genetics', 'Serotonin/metabolism', 'Sheep/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/30639027/
953,HTR1E,30519864,Altered Global mRNA Expressions of Pain and Aggression Related Genes in the Blood of Children with Autism Spectrum Disorders.,"['Sener EF', 'Taheri S', 'Sahin MC', 'Bayramov KK', 'Marasli MK', 'Zararsiz G', 'Mehmetbeyoglu E', 'Oztop DB', 'Canpolat M', 'Canatan H', 'Ozkul Y']","['Aggression', 'Autism Spectrum Disorder/blood/*genetics/physiopathology', 'Biomarkers/blood', 'Child, Preschool', 'Cyclic GMP-Dependent Protein Kinase Type I/genetics/metabolism', 'Female', 'Humans', 'Male', 'NAV1.7 Voltage-Gated Sodium Channel/*genetics/metabolism', 'Pain Perception', 'RNA, Messenger/*blood/genetics/metabolism', 'Receptor, Serotonin, 5-HT1A/*genetics/metabolism', 'Receptors, Dopamine D4/*genetics/metabolism', 'Receptors, Opioid/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/30519864/
954,HTR1E,31045513,Correlation of BRCA2 gene mutation and prognosis as well as variant genes in invasive urothelial carcinoma of the bladder.,"['Kuang S', 'Li H', 'Feng J', 'Xu S', 'Le Y']","['*Biomarkers, Tumor', 'Carcinoma, Transitional Cell/*genetics/*mortality/pathology', 'Gene Expression Regulation, Neoplastic', '*Genes, BRCA2', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Humans', '*Mutation', 'Neoplasm Invasiveness', 'Neoplasm Staging', 'Prognosis', 'Survival Analysis', 'Transcriptome', 'Urinary Bladder Neoplasms/*genetics/*mortality/pathology']",https://pubmed.ncbi.nlm.nih.gov/31045513/
955,ADRA1B,37289021,Alpha-1 Adrenergic Antagonists Sensitize Neuroblastoma to Therapeutic Differentiation.,"['Broso F', 'Gatto P', 'Sidarovich V', 'Ambrosini C', 'De Sanctis V', 'Bertorelli R', 'Zaccheroni E', 'Ricci B', 'Destefanis E', 'Longhi S', 'Sebastiani E', 'Tebaldi T', 'Adami V', 'Quattrone A']","['Humans', 'Mice', 'Child', 'Animals', '*Isotretinoin/pharmacology/therapeutic use', 'Adrenergic alpha-1 Receptor Antagonists/therapeutic use', 'Cell Line, Tumor', 'Neoplasm Recurrence, Local', '*Neuroblastoma/drug therapy/genetics/metabolism', 'Cell Differentiation', 'Receptors, Adrenergic/therapeutic use', 'Recurrence', 'N-Myc Proto-Oncogene Protein']",https://pubmed.ncbi.nlm.nih.gov/37289021/
956,ADRA1B,21053136,"Pharmacology, biodistribution, and efficacy of GPCR-based pepducins in disease models.","['Tressel SL', 'Koukos G', 'Tchernychev B', 'Jacques SL', 'Covic L', 'Kuliopulos A']","['Amino Acid Sequence', 'Animals', '*Disease', 'Humans', 'Lipopeptides/chemistry/metabolism/*pharmacokinetics/*pharmacology', 'Molecular Sequence Data', 'Protein Transport', 'Receptors, G-Protein-Coupled/chemistry/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/21053136/
957,ADRA1B,30785334,Fine mapping and subphenotyping implicates ADRA1B gene variants in psoriasis susceptibility in a Chinese population.,"['Fan X', 'Wang H', 'Sun L', 'Zheng X', 'Yin X', 'Zuo X', 'Peng Q', 'Standish KA', 'Cheng H', 'Zhang Y', 'Wang Z', 'Xiao F', 'Yang S', 'Zhang X', 'Schork NJ']","['Adult', 'Age of Onset', 'Alleles', 'Asian People/genetics', 'Case-Control Studies', 'China', '*Chromosome Mapping', 'Female', 'Genetic Association Studies', 'Genetic Predisposition to Disease', '*Genetic Variation', 'Humans', 'Inheritance Patterns', 'Linkage Disequilibrium', 'Male', 'Middle Aged', '*Phenotype', 'Polymorphism, Single Nucleotide', 'Psoriasis/*diagnosis/*genetics', 'Quantitative Trait Loci', 'ROC Curve', 'Receptors, Adrenergic, alpha-1/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30785334/
958,ADRA1B,37394637,L-DOPA Receptor GPR143 Functionally Couples with Adrenergic alpha(1B) Receptor at the Second Transmembrane Interface.,"['Masukawa D', 'Takahagi R', 'Nakao Y', 'Goshima Y']","['Humans', '*Adrenergic Agents', '*Dihydroxyphenylalanine', 'Extracellular Signal-Regulated MAP Kinases', 'Eye Proteins', 'HEK293 Cells', '*Membrane Glycoproteins/metabolism', 'Phenylephrine/pharmacology', '*Receptors, Adrenergic, alpha-1/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37394637/
959,ADRA1B,38066059,A novel feature selection algorithm for identifying hub genes in lung cancer.,"['Mohamed TIA', 'Ezugwu AE', 'Fonou-Dombeu JV', 'Mohammed M', 'Greeff J', 'Elbashir MK']","['Humans', '*Lung Neoplasms/diagnosis/genetics', '*Hemorrhagic Fever, Ebola', 'Algorithms', 'Software', 'Calcium Signaling', 'Gene Regulatory Networks']",https://pubmed.ncbi.nlm.nih.gov/38066059/
960,ADRA1B,37579693,Chemical profiling and investigation of molecular mechanisms underlying anti-hepatocellular carcinoma activity of extracts from Polygonum perfoliatum L.,"['Tang X', 'Liu L', 'Li Y', 'Hao S', 'Zhao Y', 'Wu X', 'Li M', 'Chen Y', 'Deng S', 'Gou S', 'Cai D', 'Chen M', 'Li X', 'Sun Y', 'Gu L', 'Li W', 'Wang F', 'Zhang Z', 'Yao L', 'Shen J', 'Xiao Z', 'Du F']","['Humans', '*Polygonum/chemistry', '*Plants, Medicinal', '*Carcinoma, Hepatocellular/drug therapy', 'Anti-Inflammatory Agents/chemistry', '*Liver Neoplasms/drug therapy', 'Plant Extracts/pharmacology/therapeutic use/chemistry']",https://pubmed.ncbi.nlm.nih.gov/37579693/
961,ADRA1B,17005232,Oligomeric structure of the alpha1b-adrenoceptor: comparisons with rhodopsin.,"['Milligan G', 'Pediani JD', 'Canals M', 'Lopez-Gimenez JF']","['Animals', 'Cell Membrane/metabolism', 'Dimerization', 'Humans', 'Mutation', 'Protein Structure, Quaternary', 'Receptors, Adrenergic, alpha-1/*chemistry/genetics', 'Rhodopsin/*chemistry', 'Rod Cell Outer Segment/metabolism', 'Vision, Ocular/physiology']",https://pubmed.ncbi.nlm.nih.gov/17005232/
962,ADRA1B,17242706,Frequent reduced expression of alpha-1B-adrenergic receptor caused by aberrant promoter methylation in gastric cancers.,"['Noda H', 'Miyaji Y', 'Nakanishi A', 'Konishi F', 'Miki Y']","['Base Sequence', 'Chromosomes, Human, Pair 5', 'Colorectal Neoplasms/genetics', '*DNA Methylation', 'DNA Primers', 'Humans', 'Loss of Heterozygosity', '*Promoter Regions, Genetic', 'Receptors, Adrenergic, alpha-1/*genetics', 'Reverse Transcriptase Polymerase Chain Reaction', 'Stomach Neoplasms/*genetics']",https://pubmed.ncbi.nlm.nih.gov/17242706/
963,ADRA1B,27089938,Genetic variation in the alpha(1B)-adrenergic receptor and vascular response.,"['Adefurin A', 'Ghimire LV', 'Kohli U', 'Muszkat M', 'Sofowora GG', 'Li C', 'Levinson RT', 'Paranjape SY', 'Stein CM', 'Kurnik D']","['Adult', 'Black People/genetics', 'Catecholamines/pharmacology', 'Female', 'Genetic Variation/*genetics', 'Genotype', 'Humans', 'Male', 'Phenylephrine/pharmacology', 'Receptors, Adrenergic, alpha-1/*genetics', 'Vasoconstriction/*genetics', 'Veins/drug effects', 'White People/genetics', 'Black or African American']",https://pubmed.ncbi.nlm.nih.gov/27089938/
964,ADRA1B,37540140,Idiopathic Pulmonary Fibrosis Molecular Substrates Revealed by Competing Endogenous RNA Regulatory Networks.,"['Kircali MF', 'Turanli B']","['Humans', 'RNA, Circular/genetics/metabolism', '*MicroRNAs/genetics/metabolism', 'RNA, Messenger/genetics', 'Protein Interaction Maps/genetics', '*Idiopathic Pulmonary Fibrosis/genetics', 'Gene Regulatory Networks']",https://pubmed.ncbi.nlm.nih.gov/37540140/
965,ADRA1B,22615923,Adrenergic alpha-1 pathway is associated with hypertension among Nigerians in a pathway-focused analysis.,"['Reder NP', 'Tayo BO', 'Salako B', 'Ogunniyi A', 'Adeyemo A', 'Rotimi C', 'Cooper RS']","['Blood Pressure/genetics', 'Female', 'Genome-Wide Association Study/methods', 'Genotype', 'Humans', 'Hypertension/*genetics/*metabolism', 'Male', 'Middle Aged', 'Nigeria', 'Phenotype', 'Polymorphism, Single Nucleotide', 'Receptors, Adrenergic, alpha-1/*genetics/*metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/22615923/
966,ADRA1B,38830989,Smoking-informed methylation and expression QTLs in human brain and colocalization with smoking-associated genetic loci.,"['Carnes MU', 'Quach BC', 'Zhou L', 'Han S', 'Tao R', 'Mandal M', 'Deep-Soboslay A', 'Marks JA', 'Page GP', 'Maher BS', 'Jaffe AE', 'Won H', 'Bierut LJ', 'Hyde TM', 'Kleinman JE', 'Johnson EO', 'Hancock DB']","['Humans', '*Quantitative Trait Loci', 'Male', '*DNA Methylation', 'Female', '*Genome-Wide Association Study', 'Middle Aged', 'Adult', '*Smoking/genetics/metabolism', 'Nucleus Accumbens/metabolism', 'Brain/metabolism', 'Aged']",https://pubmed.ncbi.nlm.nih.gov/38830989/
967,ADRA1B,33402011,Development of a Novel SNAP-Epitope Tag/Near-Infrared Imaging Assay to Quantify G Protein-Coupled Receptor Degradation in Human Cells.,"['Lee KS', 'Navaluna E', 'Marsh NM', 'Janezic EM', 'Hague C']","['Bortezomib/pharmacology', 'Cell Line, Tumor', 'Cycloheximide/pharmacology', 'Epithelial Cells/cytology/drug effects/metabolism', 'Gene Expression', 'HEK293 Cells', 'Half-Life', '*High-Throughput Screening Assays', 'Humans', 'Molecular Imaging/methods', 'Norepinephrine/pharmacology', 'Proteasome Endopeptidase Complex/drug effects/metabolism', 'Proteasome Inhibitors/pharmacology', 'Protein Isoforms/genetics/metabolism', 'Protein Synthesis Inhibitors/pharmacology', 'Proteolysis/drug effects', 'Receptor, Serotonin, 5-HT2A/genetics/*metabolism', 'Receptors, Adrenergic, alpha-1/genetics/*metabolism', 'Receptors, Interleukin-8A/genetics/*metabolism', 'Receptors, Somatostatin/genetics/*metabolism', 'Recombinant Fusion Proteins/*chemistry/genetics/metabolism', 'Spectroscopy, Near-Infrared/methods']",https://pubmed.ncbi.nlm.nih.gov/33402011/
968,ADRA1B,33434145,Norepinephrine exposure restrains endometrial decidualization during early pregnancy.,"['Wang J', 'Tang Y', 'Wang S', 'Cui L', 'Li D', 'Du M']","['Adult', 'Animals', 'Endometrium/*physiology', 'Female', 'Fetal Development', 'Humans', 'Mice', 'Norepinephrine/*physiology', 'Pregnancy', 'Pregnancy Complications/*etiology', 'Primary Cell Culture', 'Protein Kinase C/metabolism', 'Receptors, Adrenergic, alpha-1/metabolism', 'Signal Transduction', 'Stress, Psychological/*complications']",https://pubmed.ncbi.nlm.nih.gov/33434145/
969,ADRA1B,37769871,Human Dental Pulp Stem Cells Are Subjected to Metabolic Reprogramming and Repressed Proliferation and Migration by the Sympathetic Nervous System via alpha1B-Adrenergic Receptor.,"['Yang C', 'Gao Q', 'Xu N', 'Yang K', 'Bian Z']","['Humans', '*Dental Pulp', 'Cell Proliferation', '*Protein Serine-Threonine Kinases/metabolism/pharmacology', 'Cell Differentiation/physiology', 'Stem Cells/physiology', 'Sympathetic Nervous System', 'p38 Mitogen-Activated Protein Kinases/metabolism/pharmacology', 'Norepinephrine/pharmacology/metabolism', 'Receptors, Neurotransmitter/metabolism', 'Receptors, Adrenergic/metabolism', 'Cells, Cultured']",https://pubmed.ncbi.nlm.nih.gov/37769871/
970,ADRA1B,14607266,"Regulation of alpha-1B adrenergic receptor localization, trafficking, function, and stability.","['Toews ML', 'Prinster SC', 'Schulte NA']","['Animals', 'Caveolae/metabolism', 'Down-Regulation/genetics/physiology', 'Humans', 'Membrane Microdomains/metabolism', 'Mitogen-Activated Protein Kinases/physiology', 'Protein Kinase C/metabolism/physiology', 'Receptors, Adrenergic, alpha-1/drug effects/genetics/*metabolism/physiology']",https://pubmed.ncbi.nlm.nih.gov/14607266/
971,ADRA1B,35353796,Synthesis of genetic association studies on autism spectrum disorders using a genetic model-free approach.,"['Mpoulimari I', 'Zintzaras E']","['Alleles', '*Autism Spectrum Disorder/genetics', 'Case-Control Studies', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/35353796/
972,ADRA1B,36251941,The Mechanism of Crocetin Targeting Cardiovascular Disease Based on Network Pharmacology Constrained by Spectral Experiments.,"['Geng Z', 'Guo M', 'Zhou Q', 'Pan L']","['Humans', 'Molecular Docking Simulation', '*Cardiovascular Diseases/drug therapy', 'Network Pharmacology', 'Carotenoids/pharmacology/chemistry', '*Drugs, Chinese Herbal/pharmacology', 'Medicine, Chinese Traditional', 'Receptor, Muscarinic M1', 'Receptors, Adrenergic, alpha-1']",https://pubmed.ncbi.nlm.nih.gov/36251941/
973,ADRA1B,32930525,In Silico and in Vitro Study of Trace Amines (TA) and Dopamine (DOP) Interaction with Human Alpha 1-Adrenergic Receptor and the Bacterial Adrenergic Receptor QseC.,"['Luqman A', 'Kharisma VD', 'Ruiz RA', 'Gotz F']","['Amines/*metabolism', 'Animals', 'Computer Simulation', 'Dopamine/*metabolism', 'Escherichia coli Proteins/drug effects/*metabolism/physiology', 'Humans', 'Molecular Docking Simulation', 'Phosphorylation', 'Receptors, Adrenergic, alpha-1/drug effects/genetics/*metabolism/physiology', 'Signal Transduction/drug effects', 'Trace Elements/analysis']",https://pubmed.ncbi.nlm.nih.gov/32930525/
974,DRD3,25224105,"Autism, DRD3 and repetitive and stereotyped behavior, an overview of the current knowledge.",['Staal WG'],"['Autism Spectrum Disorder/drug therapy/genetics/*physiopathology', 'Basal Ganglia/physiopathology', 'Humans', 'Polymorphism, Genetic', 'Receptors, Dopamine D3/genetics/*metabolism', 'Stereotyped Behavior/drug effects/*physiology']",https://pubmed.ncbi.nlm.nih.gov/25224105/
975,DRD3,25185985,Pharmacogenomics in psychiatry: implications for practice.,"['Moore TR', 'Hill AM', 'Panguluri SK']","['Antipsychotic Agents/metabolism/therapeutic use', 'Cytochrome P-450 CYP2C19/genetics/metabolism', 'Cytochrome P-450 CYP2D6/genetics/metabolism', 'Humans', 'Mental Disorders/drug therapy/*genetics/pathology', 'Patents as Topic', '*Pharmacogenetics', 'Receptors, Dopamine D2/genetics/metabolism', 'Receptors, Serotonin, 5-HT2/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/25185985/
976,DRD3,37009199,Dopamine Receptor D(1)R and D(3)R and GRK4 Interaction in Hypertension.,"['Zeng C', 'Armando I', 'Yang J', 'Jose PA']","['Humans', 'Mice', 'Animals', '*Hypertension/genetics', 'Kidney/metabolism', 'Blood Pressure', 'Dopamine/metabolism', 'Essential Hypertension/genetics/complications/metabolism', 'Sodium/metabolism', 'G-Protein-Coupled Receptor Kinase 4/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37009199/
977,DRD3,20135898,Pharmacogenetics of antipsychotic-induced side effects.,"['Lencz T', 'Malhotra AK']","['*Akathisia, Drug-Induced/etiology/genetics', 'Animals', 'Antipsychotic Agents/adverse effects/*therapeutic use', '*Basal Ganglia Diseases/chemically induced/genetics', 'Humans', 'Mental Disorders/drug therapy', 'Meta-Analysis as Topic', '*Pharmacogenetics', 'Polymorphism, Single Nucleotide', 'Prolactin/metabolism', 'Receptor, Serotonin, 5-HT2C/drug effects', 'Receptors, Dopamine D2/genetics', 'Receptors, Dopamine D3/genetics', 'Weight Gain/drug effects/genetics']",https://pubmed.ncbi.nlm.nih.gov/20135898/
978,DRD3,38363619,DRD3 Predicts Cognitive Impairment and Anxiety in Parkinson's Disease: Susceptibility and Protective Effects.,"['Goncalves A', 'Mendes A', 'Damasio J', 'Vila-Cha N', 'Boleixa D', 'Leal B', 'Cavaco S']","['Humans', 'Receptors, Dopamine D3/genetics', '*Parkinson Disease/complications/genetics/drug therapy', '*Cognitive Dysfunction/genetics/complications', 'Polymorphism, Genetic', 'Anxiety/genetics']",https://pubmed.ncbi.nlm.nih.gov/38363619/
979,DRD3,32755611,Genetic differences between bipolar disorder subtypes: A systematic review focused in bipolar disorder type II.,"['Almeida HS', 'Mitjans M', 'Arias B', 'Vieta E', 'Rios J', 'Benabarre A']","['Alcohol Dehydrogenase', '*Bipolar Disorder/genetics', '*Depressive Disorder, Major', 'Humans', 'Polymorphism, Single Nucleotide', 'Serotonin Plasma Membrane Transport Proteins']",https://pubmed.ncbi.nlm.nih.gov/32755611/
980,DRD3,35285297,HUMAN STUDY COMT and DRD3 haplotype-associated pain intensity and acute care utilization in adult sickle cell disease.,"['Powell-Roach KL', 'Yao Y', 'Wallace MR', 'Chamala S', 'Cruz-Almeida Y', 'Jhun E', 'Molokie RE', 'Wang ZJ', 'Wilkie DJ']","['Adult', 'Humans', '*Anemia, Sickle Cell/complications/genetics/therapy', '*Catechol O-Methyltransferase/genetics', 'Genotype', 'Haplotypes/genetics', 'Pain/genetics', 'Pain Measurement', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, Dopamine D3/genetics']",https://pubmed.ncbi.nlm.nih.gov/35285297/
981,DRD3,34920747,Dopaminergic stimulation leads B-cell infiltration into the central nervous system upon autoimmunity.,"['Prado C', 'Osorio-Barrios F', 'Falcon P', 'Espinoza A', 'Saez JJ', 'Yuseff MI', 'Pacheco R']","['Amino Acid Sequence', 'Animals', 'Autoimmunity/*physiology', 'B-Lymphocytes/immunology/*metabolism', 'Cells, Cultured', 'Central Nervous System/immunology/metabolism', 'Dopamine/immunology/*metabolism', 'Encephalomyelitis, Autoimmune, Experimental/genetics/immunology/*metabolism', 'Female', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Mice, Knockout', 'Mice, Transgenic', 'Receptors, Dopamine D3/genetics/immunology/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/34920747/
982,DRD3,11008065,Oligomerization of dopamine and serotonin receptors.,"['Lee SP', 'Xie Z', 'Varghese G', 'Nguyen T', ""O'Dowd BF"", 'George SR']","['Animals', 'Dimerization', 'Dopamine Agonists/pharmacology', 'GTP-Binding Proteins/*metabolism', 'Humans', 'Receptor, Serotonin, 5-HT1B', 'Receptor, Serotonin, 5-HT1D', 'Receptors, Dopamine/chemistry/drug effects/*metabolism', 'Receptors, Dopamine D2/chemistry/genetics/metabolism', 'Receptors, Dopamine D3', 'Receptors, Serotonin/chemistry/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/11008065/
983,DRD3,39245478,Antibody conjugated targeted nanotherapy epigenetically inhibits calpain-mediated mitochondrial dysfunction to attenuate Parkinson's disease.,"['Biswal L', 'Sahu VK', 'Sardoiwala MN', 'Karmakar S', 'Choudhury SR']","['*Mitochondria/drug effects/metabolism', '*Calpain/metabolism/genetics', 'Animals', '*Parkinson Disease/drug therapy', '*Nanoparticles/chemistry', '*Chitosan/chemistry', 'Humans', 'Mice', 'Epigenesis, Genetic/drug effects', 'Membrane Potential, Mitochondrial/drug effects', 'Polycomb Repressive Complex 1/genetics/metabolism', 'Cell Survival/drug effects', 'Male', 'Mice, Inbred C57BL']",https://pubmed.ncbi.nlm.nih.gov/39245478/
984,DRD3,36744646,Genetic Variants Associated With Opioid Use Disorder.,"['Freiermuth CE', 'Kisor DF', 'Lambert J', 'Braun R', 'Frey JA', 'Bachmann DJ', 'Bischof JJ', 'Lyons MS', 'Pantalon MV', 'Punches BE', 'Ancona R', 'Sprague JE']","['Humans', '*Cytochrome P-450 CYP3A/genetics', 'Cytochrome P-450 CYP1A2', 'Dopamine', 'Cross-Sectional Studies', '*Opioid-Related Disorders/diagnosis/genetics', 'Analgesics, Opioid']",https://pubmed.ncbi.nlm.nih.gov/36744646/
985,DRD3,23327578,Pharmacogenetics of clinical response to risperidone.,"['Llerena A', 'Berecz R', 'Penas-Lledo E', 'Suveges A', 'Farinas H']","['ATP Binding Cassette Transporter, Subfamily B', 'ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics', 'Antipsychotic Agents/administration & dosage/*adverse effects/pharmacokinetics/therapeutic use', 'Biomarkers/*analysis', 'Biotransformation/genetics', 'Cytochrome P-450 CYP2D6/genetics', 'Cytochrome P-450 CYP3A/genetics', 'Dose-Response Relationship, Drug', 'Drug Interactions', 'Genetic Association Studies', 'Humans', '*Pharmacogenetics', '*Polymorphism, Genetic', 'Risperidone/administration & dosage/*adverse effects/pharmacokinetics/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/23327578/
986,DRD3,9335067,Molecular characteristics of mammalian dopamine receptors.,"['Lachowicz JE', 'Sibley DR']","['Adenylyl Cyclases/metabolism', 'Amino Acid Sequence', 'Animals', 'Cloning, Molecular', 'Dopamine Agonists/*pharmacology', 'Dopamine Antagonists/*pharmacology', 'Gene Expression Regulation/*genetics', 'Humans', 'Ion Channels/metabolism', 'Molecular Sequence Data', 'Phospholipases/metabolism', 'Receptors, Dopamine/biosynthesis/drug effects/*genetics', 'Receptors, Dopamine D1/drug effects/genetics/metabolism', 'Receptors, Dopamine D2/drug effects/genetics/metabolism', 'Receptors, Dopamine D3', 'Receptors, Dopamine D4', 'Receptors, Dopamine D5', 'Signal Transduction/genetics']",https://pubmed.ncbi.nlm.nih.gov/9335067/
987,DRD3,11843779,Association studies of bipolar disorder.,"['Craddock N', 'Dave S', 'Greening J']","['Bipolar Disorder/enzymology/*genetics', 'Carrier Proteins/genetics', 'Humans', 'Linkage Disequilibrium/genetics', 'Membrane Glycoproteins/genetics', '*Membrane Transport Proteins', 'Minisatellite Repeats', 'Monoamine Oxidase/metabolism', '*Nerve Tissue Proteins', 'Phenotype', 'Point Mutation/genetics', 'Polymorphism, Genetic/genetics', 'Polymorphism, Restriction Fragment Length', 'Receptors, Dopamine D2/genetics', 'Receptors, Dopamine D3', 'Serotonin Plasma Membrane Transport Proteins', 'Tyrosine 3-Monooxygenase/metabolism']",https://pubmed.ncbi.nlm.nih.gov/11843779/
988,DRD3,11405546,Candidate gene studies of bipolar disorder.,"['Jones I', 'Craddock N']","['Bipolar Disorder/*genetics', 'Carrier Proteins/genetics', 'Case-Control Studies', 'Catechol O-Methyltransferase/genetics', 'Genetic Predisposition to Disease', 'Genetic Techniques', 'Genetics, Population', 'Humans', 'Membrane Glycoproteins/genetics', '*Membrane Transport Proteins', 'Monoamine Oxidase/physiology', '*Nerve Tissue Proteins', 'Receptors, Dopamine D2/genetics', 'Receptors, Dopamine D3', 'Receptors, Serotonin/genetics', 'Serotonin Plasma Membrane Transport Proteins', 'Tyrosine 3-Monooxygenase/genetics']",https://pubmed.ncbi.nlm.nih.gov/11405546/
989,DRD3,32086104,Association of Genetic Variants of Dopamine and Serotonin In Schizophrenia.,"['Zakharyan R', 'Ghazaryan H', 'Kocourkova L', 'Chavushyan A', 'Mkrtchyan A', 'Zizkova V', 'Arakelyan A', 'Petrek M']","['Adult', 'Aged', 'Antipsychotic Agents/therapeutic use', 'Case-Control Studies', 'Catechol O-Methyltransferase/*genetics', 'Cytochrome P-450 CYP2D6/*genetics', 'Dopamine/genetics/metabolism', 'Female', 'Gene Frequency', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Male', 'Metabolic Networks and Pathways/genetics', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Receptors, Dopamine/*genetics', 'Receptors, Serotonin/*genetics', 'Schizophrenia/drug therapy/*genetics', 'Serotonin/genetics/metabolism', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/32086104/
990,DRD3,18790725,Dopaminergic mechanism of reward-related incentive learning: focus on the dopamine D(3) receptor.,"['Beninger RJ', 'Banasikowski TJ']","['Animals', 'Dopamine/*metabolism', 'Humans', 'Learning/*physiology', '*Motivation', 'Receptors, Dopamine D3/*physiology', '*Reward']",https://pubmed.ncbi.nlm.nih.gov/18790725/
991,DRD3,22507762,Psychotropic drug effects on gene transcriptomics relevant to Parkinson's disease.,['Lauterbach EC'],"['Humans', 'Parkinson Disease/drug therapy/*genetics', 'Psychotropic Drugs/*pharmacology', 'Transcriptome/*drug effects', 'Ubiquitin Thiolesterase/genetics', 'Ubiquitin-Protein Ligases/genetics']",https://pubmed.ncbi.nlm.nih.gov/22507762/
992,DRD3,33318558,Fluorescent ligands for dopamine D(2)/D(3) receptors.,"['Allikalt A', 'Purkayastha N', 'Flad K', 'Schmidt MF', 'Tabor A', 'Gmeiner P', 'Hubner H', 'Weikert D']","['Animals', 'CHO Cells', 'Carbocyanines/*chemistry', 'Cricetulus', 'Fluorescent Dyes/*chemistry', 'HEK293 Cells', 'Humans', '*Receptors, Dopamine D2/chemistry/genetics/metabolism', '*Receptors, Dopamine D3/chemistry/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/33318558/
993,DRD3,17851196,Genetics of Alzheimer's disease. A rapidly evolving field.,"['Serretti A', 'Olgiati P', 'De Ronchi D']","['Age of Onset', 'Aged', 'Aged, 80 and over', 'Alzheimer Disease/drug therapy/epidemiology/*genetics', 'Amyloid Precursor Protein Secretases/antagonists & inhibitors', 'Amyloid beta-Peptides/genetics', 'Apolipoprotein E4/genetics', 'Cystatin C', 'Cystatins/genetics', 'Gene Expression/*genetics', 'Genetic Predisposition to Disease', 'Humans', 'Interleukin-1/genetics', 'Interleukin-6/genetics', 'Oxidative Stress/physiology', 'Tumor Necrosis Factor-alpha/genetics']",https://pubmed.ncbi.nlm.nih.gov/17851196/
994,SLC47A1,37055935,Copper metabolism in cell death and autophagy.,"['Xue Q', 'Kang R', 'Klionsky DJ', 'Tang D', 'Liu J', 'Chen X']","['Humans', '*Autophagy/physiology', 'Tumor Suppressor Protein p53', 'Apoptosis Inducing Factor', 'Copper', 'Ubiquinone', 'Electron Transport Complex IV', 'Autophagy-Related Protein-1 Homolog', 'Proto-Oncogene Proteins p21(ras)', 'Apoptosis/physiology', 'Caspases', 'Hypoxia-Inducible Factor 1', 'Superoxide Dismutase', '*Neoplasms', 'Ions', 'Proto-Oncogene Proteins c-bcl-2']",https://pubmed.ncbi.nlm.nih.gov/37055935/
995,SLC47A1,36575162,The lipid flippase SLC47A1 blocks metabolic vulnerability to ferroptosis.,"['Lin Z', 'Liu J', 'Long F', 'Kang R', 'Kroemer G', 'Tang D', 'Yang M']","['Animals', 'Humans', 'Mice', 'Apoptosis/genetics', 'Cell Line', '*Ferroptosis', 'Lipid Peroxidation/physiology', 'Lipids', 'Necrosis']",https://pubmed.ncbi.nlm.nih.gov/36575162/
996,SLC47A1,35710981,"Epigenomic and transcriptomic analyses define core cell types, genes and targetable mechanisms for kidney disease.","['Liu H', 'Doke T', 'Guo D', 'Sheng X', 'Ma Z', 'Park J', 'Vy HMT', 'Nadkarni GN', 'Abedini A', 'Miao Z', 'Palmer M', 'Voight BF', 'Li H', 'Brown CD', 'Ritchie MD', 'Shu Y', 'Susztak K']","['Animals', '*Epigenomics', 'Genome-Wide Association Study', 'Humans', '*Kidney Diseases/genetics', 'Mice', 'Polymorphism, Single Nucleotide/genetics', 'Transcriptome/genetics']",https://pubmed.ncbi.nlm.nih.gov/35710981/
997,SLC47A1,21787191,Transporter-mediated drug-drug interactions.,"['Muller F', 'Fromm MF']","['ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism', 'ATP Binding Cassette Transporter, Subfamily G, Member 2', 'ATP-Binding Cassette Transporters/metabolism', '*Drug Interactions', 'Humans', 'Intestine, Small/*metabolism', 'Kidney/*metabolism', 'Liver/*metabolism', 'Neoplasm Proteins/metabolism', 'Organic Anion Transporters/genetics/*metabolism', 'Organic Cation Transport Proteins/genetics/*metabolism', 'Xenobiotics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/21787191/
998,SLC47A1,35639991,Association of the SLC47A1 Gene Variant With Responses to Metformin Monotherapy in Drug-naive Patients With Type 2 Diabetes.,"['Kim H', 'Bae S', 'Yoon HY', 'Yee J', 'Gwak HS']","['Blood Glucose', '*Diabetes Mellitus, Type 2/drug therapy/genetics', 'Glycated Hemoglobin/analysis', 'Humans', 'Hypoglycemic Agents/adverse effects', '*Metformin', 'Organic Cation Transport Proteins/genetics']",https://pubmed.ncbi.nlm.nih.gov/35639991/
999,SLC47A1,23851697,Polyamines and membrane transporters.,"['Abdulhussein AA', 'Wallace HM']","['Animals', 'Humans', 'Membrane Transport Proteins/*metabolism', 'Polyamines/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/23851697/
1000,SLC47A1,35955741,MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia.,"['Uddin ME', 'Eisenmann ED', 'Li Y', 'Huang KM', 'Garrison DA', 'Talebi Z', 'Gibson AA', 'Jin Y', 'Nepal M', 'Bonilla IM', 'Fu Q', 'Sun X', 'Millar A', 'Tarasov M', 'Jay CE', 'Cui X', 'Einolf HJ', 'Pelis RM', 'Smith SA', 'Radwanski PB', 'Sweet DH', 'Konig J', 'Fromm MF', 'Carnes CA', 'Hu S', 'Sparreboom A']","['Animals', '*Anti-Arrhythmia Agents/pharmacology', '*Atrial Fibrillation', 'Humans', 'Mice', 'Phenethylamines/pharmacology', 'Sulfonamides/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/35955741/
1001,SLC47A1,22986709,Polymorphic transporters and platinum pharmacodynamics.,"['Sprowl JA', 'Ness RA', 'Sparreboom A']","['Animals', 'Antineoplastic Agents/*pharmacology', 'Cation Transport Proteins/genetics', 'Copper Transporter 1', 'Humans', 'Membrane Transport Proteins/*genetics', 'Multidrug Resistance-Associated Proteins/genetics', 'Organic Cation Transport Proteins/genetics', 'Platinum Compounds/*pharmacokinetics/*pharmacology', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/22986709/
1002,SLC47A1,37070463,Genetic variation in organic cation transporters and considerations in drug development.,['Varma MVS'],"['Humans', '*Organic Cation Transport Proteins/genetics/metabolism', 'Cisplatin', '*Metformin/pharmacokinetics', 'Drug Development', 'Genetic Variation', 'Organic Cation Transporter 2/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37070463/
1003,SLC47A1,32321403,Genetic Editing and Pharmacogenetics in Current And Future Therapy Of Neurocognitive Disorders.,"['Prendecki M', 'Kowalska M', 'Toton E', 'Kozubski W']","['Constitutive Androstane Receptor', 'Gene Editing/*methods/*trends', 'Humans', 'Neurocognitive Disorders/genetics/*therapy', 'Pharmacogenetics/*methods/*trends']",https://pubmed.ncbi.nlm.nih.gov/32321403/
1004,SLC47A1,35905099,The influence of metformin transporter gene SLC22A1 and SLC47A1 variants on steady-state pharmacokinetics and glycemic response.,"['Ningrum VDA', 'Sadewa AH', 'Ikawati Z', 'Yuliwulandari R', 'Ikhsan MR', 'Fajriyah R']","['Blood Glucose', 'Catecholamine Plasma Membrane Transport Proteins/*metabolism', 'Cohort Studies', '*Diabetes Mellitus, Type 2/drug therapy/genetics', 'Genotype', 'Humans', 'Hypoglycemic Agents/pharmacology/therapeutic use', '*Metformin/pharmacology', 'Organic Cation Transport Proteins/genetics', 'Prospective Studies']",https://pubmed.ncbi.nlm.nih.gov/35905099/
1005,SLC47A1,37175943,Novel Susceptibility Genes Drive Familial Non-Medullary Thyroid Cancer in a Large Consanguineous Kindred.,"['Majdalani P', 'Yoel U', 'Nasasra T', 'Fraenkel M', 'Haim A', 'Loewenthal N', 'Zarivach R', 'Hershkovitz E', 'Parvari R']","['Humans', 'Thyroid Cancer, Papillary/genetics', 'Consanguinity', 'Genetic Predisposition to Disease', '*Thyroid Neoplasms/genetics/pathology', '*Neoplastic Syndromes, Hereditary', 'X-ray Repair Cross Complementing Protein 1/genetics']",https://pubmed.ncbi.nlm.nih.gov/37175943/
1006,SLC47A1,35598119,Challenges and Opportunities for Improved Drug-Drug Interaction Predictions for Renal OCT2 and MATE1/2-K Transporters.,"['Krishnan S', 'Ramsden D', 'Ferguson D', 'Stahl SH', 'Wang J', 'McGinnity DF', 'Hariparsad N']","['Drug Interactions', 'HEK293 Cells', 'Humans', '*Kidney/metabolism', '*Organic Cation Transport Proteins/metabolism', 'Organic Cation Transporter 2/metabolism', 'Renal Elimination']",https://pubmed.ncbi.nlm.nih.gov/35598119/
1007,SLC47A1,30449032,Abemaciclib Inhibits Renal Tubular Secretion Without Changing Glomerular Filtration Rate.,"['Chappell JC', 'Turner PK', 'Pak YA', 'Bacon J', 'Chiang AY', 'Royalty J', 'Hall SD', 'Kulanthaivel P', 'Bonventre JV']","['Aminopyridines/*pharmacology', 'Antineoplastic Agents, Immunological/pharmacology', 'Benzimidazoles/*pharmacology', 'Biological Transport/drug effects', 'Breast Neoplasms/drug therapy', 'Cyclin-Dependent Kinase 4/*antagonists & inhibitors', 'Cyclin-Dependent Kinase 6/*antagonists & inhibitors', 'Glomerular Filtration Rate/*drug effects', 'Humans', 'Hypoglycemic Agents/pharmacology', '*Kidney Tubules/drug effects/metabolism', 'Metabolic Clearance Rate/drug effects', 'Metformin/*pharmacology', 'Organic Cation Transport Proteins/metabolism', 'Organic Cation Transporter 2/metabolism']",https://pubmed.ncbi.nlm.nih.gov/30449032/
1008,SLC47A1,23894862,Pharmacogenetics and personalized treatment of type 2 diabetes.,"['Semiz S', 'Dujic T', 'Causevic A']","['Diabetes Mellitus, Type 2/*drug therapy', 'Humans', 'Hypoglycemic Agents/classification/*therapeutic use', '*Pharmacogenetics', '*Precision Medicine']",https://pubmed.ncbi.nlm.nih.gov/23894862/
1009,SLC47A1,38951433,"The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study.","['Guchelaar NAD', 'Buck SAJ', 'van Doorn L', 'Hussaarts KGAM', 'Sandberg Y', 'van der Padt-Pruijsten A', 'van Alphen RJ', 'Poppe-Manenschijn L', 'Vleut I', 'de Bruijn P', 'van Leeuwen RWF', 'Mostert B', 'Eskens FALM', 'Oomen-de Hoop E', 'Koolen SLW', 'Mathijssen RHJ']","['Adult', 'Aged', 'Female', 'Humans', 'Male', 'Middle Aged', '*Cimetidine/pharmacokinetics/pharmacology/administration & dosage', 'Colorectal Neoplasms/drug therapy/metabolism', '*Cross-Over Studies', 'Drug Combinations', '*Drug Interactions', '*Metformin/pharmacokinetics/administration & dosage/pharmacology', '*Organic Cation Transport Proteins/metabolism/antagonists & inhibitors', 'Organic Cation Transporter 2/metabolism', 'Prospective Studies', 'Pyrrolidines/pharmacokinetics/administration & dosage', 'Stomach Neoplasms/drug therapy/metabolism', 'Thymine', '*Trifluridine/pharmacokinetics/administration & dosage']",https://pubmed.ncbi.nlm.nih.gov/38951433/
1010,SLC47A1,24889085,Emerging roles of metal solute carriers in cancer mechanisms and treatment.,"['Jong NN', 'McKeage MJ']","['Animals', 'Anion Transport Proteins/*metabolism', 'Antineoplastic Agents/*metabolism/pharmacokinetics/therapeutic use', 'Biological Transport', 'Cation Transport Proteins/*metabolism', 'Glucose Transport Proteins, Facilitative/metabolism', 'Humans', 'Metals/*metabolism', 'Mitochondrial ADP, ATP Translocases/metabolism', '*Models, Biological', 'Neoplasm Proteins/*metabolism', 'Neoplasms/drug therapy/*metabolism', 'Tissue Distribution']",https://pubmed.ncbi.nlm.nih.gov/24889085/
1011,SLC47A1,27165417,Structure and function of multidrug and toxin extrusion proteins (MATEs) and their relevance to drug therapy and personalized medicine.,"['Nies AT', 'Damme K', 'Kruck S', 'Schaeffeler E', 'Schwab M']","['Amino Acid Sequence', 'Animals', 'Computational Biology', '*Drug Therapy', 'Humans', 'Models, Biological', 'Models, Molecular', 'Organ Specificity', 'Organic Cation Transport Proteins/antagonists & inhibitors/chemistry/genetics/*metabolism', 'Pharmaceutical Preparations/chemistry', 'Phosphorylation', '*Precision Medicine', '*Protein Processing, Post-Translational', 'Sequence Alignment', 'Species Specificity', 'Substrate Specificity']",https://pubmed.ncbi.nlm.nih.gov/27165417/
1012,HRH2,31462402,Single-Cell Transcriptomic Map of the Human and Mouse Bladders.,"['Yu Z', 'Liao J', 'Chen Y', 'Zou C', 'Zhang H', 'Cheng J', 'Liu D', 'Li T', 'Zhang Q', 'Li J', 'Yang X', 'Ye Y', 'Huang Z', 'Long X', 'Yang R', 'Mo Z']","['Animals', 'Female', 'Humans', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Rats', 'Rats, Sprague-Dawley', 'Receptors, Adrenergic, alpha-2/analysis', 'Receptors, Histamine H2/analysis', 'Sequence Analysis, RNA', '*Single-Cell Analysis', '*Transcriptome', 'Troponin T/analysis', 'Urinary Bladder/*cytology/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/31462402/
1013,HRH2,38458750,Function of mast cell and bile-cholangiocarcinoma interplay in cholangiocarcinoma microenvironment.,"['Shi A', 'Liu Z', 'Fan Z', 'Li K', 'Liu X', 'Tang Y', 'Hu J', 'Li X', 'Shu L', 'Zhao L', 'Huang L', 'Zhang Z', 'Lv G', 'Zhang Z', 'Xu Y']","['*Cholangiocarcinoma/metabolism/pathology/genetics', '*Mast Cells/metabolism', '*Bile Duct Neoplasms/metabolism/pathology/genetics', 'Animals', 'Humans', '*Tumor Microenvironment', 'Mice', 'Bile/metabolism', 'Receptors, G-Protein-Coupled/metabolism/genetics', 'Receptors, Histamine/metabolism', 'Histamine/metabolism', 'Cell Proliferation', 'Cancer-Associated Fibroblasts/metabolism/pathology', 'Cell Degranulation']",https://pubmed.ncbi.nlm.nih.gov/38458750/
1014,HRH2,19450133,Histamine pharmacogenomics.,"['Garcia-Martin E', 'Ayuso P', 'Martinez C', 'Blanca M', 'Agundez JA']","['Amine Oxidase (Copper-Containing)/*genetics', 'Amino Acid Substitution', 'Genetic Variation', 'Histamine/*genetics', 'Histamine N-Methyltransferase/*genetics', 'Histidine Decarboxylase/*genetics', 'Humans', 'Pharmacogenetics/methods', '*Polymorphism, Genetic', 'Promoter Regions, Genetic/genetics', 'Receptors, Histamine/*genetics']",https://pubmed.ncbi.nlm.nih.gov/19450133/
1015,HRH2,34535664,A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery.,"['Crouchet E', 'Bandiera S', 'Fujiwara N', 'Li S', 'El Saghire H', 'Fernandez-Vaquero M', 'Riedl T', 'Sun X', 'Hirschfield H', 'Juhling F', 'Zhu S', 'Roehlen N', 'Ponsolles C', 'Heydmann L', 'Saviano A', 'Qian T', 'Venkatesh A', 'Lupberger J', 'Verrier ER', 'Sojoodi M', 'Oudot MA', 'Duong FHT', 'Masia R', 'Wei L', 'Thumann C', 'Durand SC', 'Gonzalez-Motos V', 'Heide D', 'Hetzer J', 'Nakagawa S', 'Ono A', 'Song WM', 'Higashi T', 'Sanchez R', 'Kim RS', 'Bian CB', 'Kiani K', 'Croonenborghs T', 'Subramanian A', 'Chung RT', 'Straub BK', 'Schuppan D', 'Ankavay M', 'Cocquerel L', 'Schaeffer E', 'Goossens N', 'Koh AP', 'Mahajan M', 'Nair VD', 'Gunasekaran G', 'Schwartz ME', 'Bardeesy N', 'Shalek AK', 'Rozenblatt-Rosen O', 'Regev A', 'Felli E', 'Pessaux P', 'Tanabe KK', 'Heikenwalder M', 'Schuster C', 'Pochet N', 'Zeisel MB', 'Fuchs BC', 'Hoshida Y', 'Baumert TF']","['Animals', 'Carcinogenesis/pathology', 'Carcinoma, Hepatocellular/pathology', 'Cell Line, Tumor', 'Chemoprevention', 'Cohort Studies', 'Cyclic AMP/metabolism', 'Cyclic AMP Response Element-Binding Protein/metabolism', 'Disease Models, Animal', '*Drug Discovery', 'Gene Expression Regulation, Neoplastic/drug effects', 'HEK293 Cells', 'Hepacivirus/physiology', 'Hepatitis C/genetics', 'Hepatocytes/drug effects/metabolism/pathology', 'Humans', 'Immunologic Surveillance/drug effects', 'Inflammation/pathology', 'Liver/drug effects/metabolism/*pathology', 'Liver Cirrhosis/pathology', 'Liver Neoplasms/pathology', 'Macrophages/drug effects/metabolism/pathology', 'Male', 'Mice, Knockout', '*Models, Biological', 'Nizatidine/pharmacology', 'Prognosis', 'Signal Transduction/drug effects', 'Transcriptome/genetics', 'Mice']",https://pubmed.ncbi.nlm.nih.gov/34535664/
1016,HRH2,36674940,Molecular Landscape of Tourette's Disorder.,"['Widomska J', 'De Witte W', 'Buitelaar JK', 'Glennon JC', 'Poelmans G']","['Humans', 'Child', '*Tourette Syndrome/genetics', '*Obsessive-Compulsive Disorder/genetics', 'Brain', 'Behavior Rating Scale']",https://pubmed.ncbi.nlm.nih.gov/36674940/
1017,HRH2,37781030,Protein Arginine Methyltransferases Refine the Classification of Clear Cell Renal Cell Carcinoma with Distinct Prognosis and Tumor Microenvironment Characteristics.,"['Ye S', 'Tian X', 'Anwaier A', 'Wei S', 'Liu W', 'Su J', 'Zhu S', 'Dai B', 'Gu J', 'Qu Y', 'Xu W', 'Zhang H', 'Ye D']","['Humans', 'Arginine', '*Carcinoma/genetics', '*Carcinoma, Renal Cell/genetics', 'China', '*Kidney Neoplasms/genetics', 'Protein-Arginine N-Methyltransferases/genetics/metabolism', 'Proteomics', 'Reproducibility of Results', '*Tumor Microenvironment/genetics']",https://pubmed.ncbi.nlm.nih.gov/37781030/
1018,HRH2,29523718,Potential negative effects of anti-histamines on male reproductive function.,"['Mondillo C', 'Varela ML', 'Abiuso AMB', 'Vazquez R']","['Animals', 'Fertility/drug effects/physiology', 'Histamine Antagonists/*pharmacology', 'Humans', 'Leydig Cells/drug effects/metabolism', 'Male', 'Reproduction/*drug effects/physiology', 'Spermatozoa/*drug effects', 'Testis/*drug effects/metabolism', 'Testosterone/metabolism']",https://pubmed.ncbi.nlm.nih.gov/29523718/
1019,HRH2,39462031,Histamine stimulates human microglia to alter cellular prion protein expression via the HRH2 histamine receptor.,"['Pehar M', 'Hewitt M', 'Wagner A', 'Sandhu JK', 'Khalili A', 'Wang X', 'Cho JY', 'Sim VL', 'Kulka M']","['Humans', '*Microglia/metabolism/drug effects', '*Histamine/pharmacology/metabolism', 'Cell Line', '*Receptors, Histamine H2/metabolism/genetics', '*Calcium/metabolism', 'PrPC Proteins/metabolism/genetics', 'Cytokines/metabolism', 'Gene Expression Regulation/drug effects', 'Receptors, Histamine/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39462031/
1020,HRH2,16825866,Genetic mechanism of aspirin-induced urticaria/angioedema.,"['Kim SH', 'Ye YM', 'Lee SK', 'Park HS']","['Angioedema/blood/*chemically induced/*genetics/immunology', 'Aspirin/*adverse effects', 'Drug Hypersensitivity/etiology/*genetics/immunology', 'HLA-DQ Antigens/genetics/immunology', 'HLA-DQ beta-Chains', 'HLA-DR Antigens/genetics/immunology', 'HLA-DRB1 Chains', 'Histamine/genetics/immunology', 'Humans', 'Urticaria/*chemically induced/*genetics/immunology/microbiology']",https://pubmed.ncbi.nlm.nih.gov/16825866/
1021,HRH2,38970690,Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma.,"['Wu G', 'Li T', 'Chen Y', 'Ye S', 'Zhou S', 'Tian X', 'Anwaier A', 'Zhu S', 'Xu W', 'Hao X', 'Ye D', 'Zhang H']","['Humans', '*Carcinoma, Renal Cell/pathology/metabolism/genetics', '*Tumor Microenvironment', '*Glutamine/metabolism', '*Kidney Neoplasms/pathology/metabolism/genetics', 'Prognosis', 'Cell Line, Tumor', 'Male', 'Female', 'Gene Expression Regulation, Neoplastic', 'Cell Proliferation', 'Biomarkers, Tumor/metabolism/genetics', 'Nomograms', 'Middle Aged', 'Apoptosis', 'Gene Expression Profiling']",https://pubmed.ncbi.nlm.nih.gov/38970690/
1022,HRH2,36902343,Histaminergic System and Inflammation-Related Genes in Normal Large Intestine and Adenocarcinoma Tissues: Transcriptional Profiles and Relations.,"['Janikowska G', 'Janikowski T', 'Plato M', 'Mazurek U', 'Orchel J', 'Opilka M', 'Lorenc Z']","['Male', 'Humans', 'Female', 'Intestine, Large/metabolism', '*Colorectal Neoplasms/pathology', 'Inflammation', '*Adenocarcinoma/pathology', 'Gene Expression Profiling', 'Carboxypeptidases', 'Repressor Proteins/genetics']",https://pubmed.ncbi.nlm.nih.gov/36902343/
1023,HRH2,24236486,"Variability in histamine receptor genes HRH1, HRH2 and HRH4 in patients with hypersensitivity to NSAIDs.","['Ayuso P', 'Blanca M', 'Cornejo-Garcia JA', 'Torres MJ', 'Dona I', 'Salas M', 'Blanca-Lopez N', 'Canto G', 'Rondon C', 'Campo P', 'Laguna JJ', 'Fernandez J', 'Martinez C', 'Agundez JA', 'Garcia-Martin E']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Anti-Inflammatory Agents, Non-Steroidal/*adverse effects', 'Case-Control Studies', 'Child', 'Child, Preschool', 'DNA Copy Number Variations/*genetics', 'Drug Hypersensitivity/*genetics', 'Female', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide/*genetics', 'Receptors, G-Protein-Coupled/*genetics', 'Receptors, Histamine/*genetics', 'Receptors, Histamine H1/*genetics', 'Receptors, Histamine H2/*genetics', 'Receptors, Histamine H4', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/24236486/
1024,HRH2,26989676,"Associations of Polymorphisms in HRH2, HRH3, DAO, and HNMT Genes with Risk of Chronic Heart Failure.","['He GH', 'Cai WK', 'Zhang JB', 'Ma CY', 'Yan F', 'Lu J', 'Xu GL']","['Adult', 'Aged', 'Chronic Disease', 'D-Amino-Acid Oxidase/*genetics', 'Female', 'Genetic Association Studies', 'Genotype', 'Haplotypes', 'Heart Failure/*genetics/pathology', 'Histamine/genetics', 'Histamine N-Methyltransferase/*genetics', 'Humans', 'Male', 'Middle Aged', 'Receptors, G-Protein-Coupled/*genetics', 'Receptors, Histamine/*genetics', 'Receptors, Histamine H3/*genetics', 'Receptors, Histamine H4']",https://pubmed.ncbi.nlm.nih.gov/26989676/
1025,HRH2,22720301,Effects of -1018G>A polymorphism of HRH2 (rs2607474) on the severity of gastric mucosal atrophy.,"['Yamada H', 'Tahara T', 'Shiroeda H', 'Hayashi R', 'Saito T', 'Nakamura M', 'Tsuchishima M', 'Tsutsumi M', 'Shibata T', 'Arisawa T']","['Adult', 'Age Factors', 'Aged', 'Female', 'Gastric Mucosa/pathology', 'Gastritis, Atrophic/enzymology/*genetics/microbiology', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Helicobacter Infections/complications/enzymology', 'Helicobacter pylori', 'Heterozygote', 'Homozygote', 'Humans', 'Male', 'Middle Aged', 'Pepsinogen A/blood', '*Polymorphism, Genetic', 'Polymorphism, Single-Stranded Conformational', 'Receptors, Histamine H2/*genetics', 'Severity of Illness Index']",https://pubmed.ncbi.nlm.nih.gov/22720301/
1026,HRH2,29191567,"Histamine H(2) Receptor Polymorphisms, Myocardial Transcripts, and Heart Failure (from the Multi-Ethnic Study of Atherosclerosis and Beta-Blocker Effect on Remodeling and Gene Expression Trial).","['Leary PJ', 'Kronmal RA', 'Bluemke DA', 'Buttrick PM', 'Jones KL', 'Kao DP', 'Kawut SM', 'Krieger EV', 'Lima JA', 'Minobe W', 'Ralph DD', 'Tedford RJ', 'Weiss NS', 'Bristow MR']","['Adrenergic beta-Antagonists/therapeutic use', 'Black or African American/genetics', 'Aged', 'Aged, 80 and over', 'Asian/genetics', 'Cardiomyopathy, Dilated/drug therapy', 'Female', 'Gene Expression', 'Genetic Predisposition to Disease', 'Heart Failure/drug therapy/*genetics/metabolism', 'Hispanic or Latino/genetics', 'Humans', 'Male', 'Middle Aged', 'Myocardium/*metabolism', 'Pharmacogenomic Variants', 'Polymorphism, Single Nucleotide', 'Proportional Hazards Models', 'RNA, Messenger/*metabolism', 'Receptors, Histamine H2/*genetics', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/29191567/
1027,HRH2,35930594,Discovery of 8-Hydroxyquinoline as a Histamine Receptor 2 Blocker Scaffold.,"['Marquez-Gomez PL', 'Kruyer NS', 'Eisen SL', 'Torp LR', 'Howie RL', 'Jones EV', 'France S', 'Peralta-Yahya P']","['Animals', 'Humans', 'Mammals', 'Molecular Docking Simulation', 'Oxyquinoline', '*Phagocytosis', '*Receptors, Histamine']",https://pubmed.ncbi.nlm.nih.gov/35930594/
1028,HRH2,24661982,Modulation of behavior by the histaminergic system: lessons from H(1)R-and H(2)R-deficient mice.,"['Schneider EH', 'Neumann D', 'Seifert R']","['Animals', 'Behavior/*physiology', 'Brain/physiology', 'Humans', 'Mice, Knockout', 'Receptors, Histamine H1/*deficiency/genetics/metabolism', 'Receptors, Histamine H2/*deficiency/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/24661982/
1029,HRH2,22615049,Association between common genetic variant of HRH2 and gastric cancer risk.,"['Arisawa T', 'Tahara T', 'Ozaki K', 'Matsue Y', 'Minato T', 'Yamada H', 'Nomura T', 'Hayashi R', 'Matsunaga K', 'Fukumura A', 'Nakamura M', 'Toshikuni N', 'Shiroeda H', 'Shibata T']","['Aged', 'Female', 'Gastritis/genetics', 'Gene Frequency', 'Genetic Association Studies', 'Genotype', 'Helicobacter Infections/complications', 'Humans', 'Logistic Models', 'Male', 'Middle Aged', 'Pepsinogen A/blood', '*Polymorphism, Single Nucleotide', 'Receptors, Histamine H2/*genetics', 'Risk Factors', 'Stomach Neoplasms/blood/*genetics/microbiology']",https://pubmed.ncbi.nlm.nih.gov/22615049/
1030,HRH2,25922853,Lack of Association between rs2067474 Polymorphism in Histamine Receptor H2 Gene and Breast Cancer in Chinese Han Population.,"['Cai WK', 'Zhang JB', 'Wang NM', 'Wang YL', 'Zhao CH', 'Lu J', 'He GH']","['Adult', 'Alleles', 'Asian People/*genetics', 'Biomarkers, Tumor', 'Breast Neoplasms/*genetics/pathology', 'Case-Control Studies', 'China', 'Female', 'Gene Frequency', '*Genetic Association Studies', '*Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Lymphatic Metastasis', 'Middle Aged', 'Neoplasm Staging', '*Polymorphism, Single Nucleotide', 'Receptors, Histamine H2/*genetics', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/25922853/
1031,HRH2,31278444,A Novel Genes Signature Associated with the Progression of Polycystic Ovary Syndrome.,"['He D', 'Liu L', 'Wang Y', 'Sheng M']","['Disease Progression', 'Female', 'Humans', 'Polycystic Ovary Syndrome/*genetics/*pathology', '*Transcriptome']",https://pubmed.ncbi.nlm.nih.gov/31278444/
1032,HTR6,34002096,"Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology.","['Mullins N', 'Forstner AJ', ""O'Connell KS"", 'Coombes B', 'Coleman JRI', 'Qiao Z', 'Als TD', 'Bigdeli TB', 'Borte S', 'Bryois J', 'Charney AW', 'Drange OK', 'Gandal MJ', 'Hagenaars SP', 'Ikeda M', 'Kamitaki N', 'Kim M', 'Krebs K', 'Panagiotaropoulou G', 'Schilder BM', 'Sloofman LG', 'Steinberg S', 'Trubetskoy V', 'Winsvold BS', 'Won HH', 'Abramova L', 'Adorjan K', 'Agerbo E', 'Al Eissa M', 'Albani D', 'Alliey-Rodriguez N', 'Anjorin A', 'Antilla V', 'Antoniou A', 'Awasthi S', 'Baek JH', 'Baekvad-Hansen M', 'Bass N', 'Bauer M', 'Beins EC', 'Bergen SE', 'Birner A', 'Bocker Pedersen C', 'Boen E', 'Boks MP', 'Bosch R', 'Brum M', 'Brumpton BM', 'Brunkhorst-Kanaan N', 'Budde M', 'Bybjerg-Grauholm J', 'Byerley W', 'Cairns M', 'Casas M', 'Cervantes P', 'Clarke TK', 'Cruceanu C', 'Cuellar-Barboza A', 'Cunningham J', 'Curtis D', 'Czerski PM', 'Dale AM', 'Dalkner N', 'David FS', 'Degenhardt F', 'Djurovic S', 'Dobbyn AL', 'Douzenis A', 'Elvsashagen T', 'Escott-Price V', 'Ferrier IN', 'Fiorentino A', 'Foroud TM', 'Forty L', 'Frank J', 'Frei O', 'Freimer NB', 'Frisen L', 'Gade K', 'Garnham J', 'Gelernter J', 'Giortz Pedersen M', 'Gizer IR', 'Gordon SD', 'Gordon-Smith K', 'Greenwood TA', 'Grove J', 'Guzman-Parra J', 'Ha K', 'Haraldsson M', 'Hautzinger M', 'Heilbronner U', 'Hellgren D', 'Herms S', 'Hoffmann P', 'Holmans PA', 'Huckins L', 'Jamain S', 'Johnson JS', 'Kalman JL', 'Kamatani Y', 'Kennedy JL', 'Kittel-Schneider S', 'Knowles JA', 'Kogevinas M', 'Koromina M', 'Kranz TM', 'Kranzler HR', 'Kubo M', 'Kupka R', 'Kushner SA', 'Lavebratt C', 'Lawrence J', 'Leber M', 'Lee HJ', 'Lee PH', 'Levy SE', 'Lewis C', 'Liao C', 'Lucae S', 'Lundberg M', 'MacIntyre DJ', 'Magnusson SH', 'Maier W', 'Maihofer A', 'Malaspina D', 'Maratou E', 'Martinsson L', 'Mattheisen M', 'McCarroll SA', 'McGregor NW', 'McGuffin P', 'McKay JD', 'Medeiros H', 'Medland SE', 'Millischer V', 'Montgomery GW', 'Moran JL', 'Morris DW', 'Muhleisen TW', ""O'Brien N"", ""O'Donovan C"", 'Olde Loohuis LM', 'Oruc L', 'Papiol S', 'Pardinas AF', 'Perry A', 'Pfennig A', 'Porichi E', 'Potash JB', 'Quested D', 'Raj T', 'Rapaport MH', 'DePaulo JR', 'Regeer EJ', 'Rice JP', 'Rivas F', 'Rivera M', 'Roth J', 'Roussos P', 'Ruderfer DM', 'Sanchez-Mora C', 'Schulte EC', 'Senner F', 'Sharp S', 'Shilling PD', 'Sigurdsson E', 'Sirignano L', 'Slaney C', 'Smeland OB', 'Smith DJ', 'Sobell JL', 'Soholm Hansen C', 'Soler Artigas M', 'Spijker AT', 'Stein DJ', 'Strauss JS', 'Swiatkowska B', 'Terao C', 'Thorgeirsson TE', 'Toma C', 'Tooney P', 'Tsermpini EE', 'Vawter MP', 'Vedder H', 'Walters JTR', 'Witt SH', 'Xi S', 'Xu W', 'Yang JMK', 'Young AH', 'Young H', 'Zandi PP', 'Zhou H', 'Zillich L', 'Adolfsson R', 'Agartz I', 'Alda M', 'Alfredsson L', 'Babadjanova G', 'Backlund L', 'Baune BT', 'Bellivier F', 'Bengesser S', 'Berrettini WH', 'Blackwood DHR', 'Boehnke M', 'Borglum AD', 'Breen G', 'Carr VJ', 'Catts S', 'Corvin A', 'Craddock N', 'Dannlowski U', 'Dikeos D', 'Esko T', 'Etain B', 'Ferentinos P', 'Frye M', 'Fullerton JM', 'Gawlik M', 'Gershon ES', 'Goes FS', 'Green MJ', 'Grigoroiu-Serbanescu M', 'Hauser J', 'Henskens F', 'Hillert J', 'Hong KS', 'Hougaard DM', 'Hultman CM', 'Hveem K', 'Iwata N', 'Jablensky AV', 'Jones I', 'Jones LA', 'Kahn RS', 'Kelsoe JR', 'Kirov G', 'Landen M', 'Leboyer M', 'Lewis CM', 'Li QS', 'Lissowska J', 'Lochner C', 'Loughland C', 'Martin NG', 'Mathews CA', 'Mayoral F', 'McElroy SL', 'McIntosh AM', 'McMahon FJ', 'Melle I', 'Michie P', 'Milani L', 'Mitchell PB', 'Morken G', 'Mors O', 'Mortensen PB', 'Mowry B', 'Muller-Myhsok B', 'Myers RM', 'Neale BM', 'Nievergelt CM', 'Nordentoft M', 'Nothen MM', ""O'Donovan MC"", 'Oedegaard KJ', 'Olsson T', 'Owen MJ', 'Paciga SA', 'Pantelis C', 'Pato C', 'Pato MT', 'Patrinos GP', 'Perlis RH', 'Posthuma D', 'Ramos-Quiroga JA', 'Reif A', 'Reininghaus EZ', 'Ribases M', 'Rietschel M', 'Ripke S', 'Rouleau GA', 'Saito T', 'Schall U', 'Schalling M', 'Schofield PR', 'Schulze TG', 'Scott LJ', 'Scott RJ', 'Serretti A', 'Shannon Weickert C', 'Smoller JW', 'Stefansson H', 'Stefansson K', 'Stordal E', 'Streit F', 'Sullivan PF', 'Turecki G', 'Vaaler AE', 'Vieta E', 'Vincent JB', 'Waldman ID', 'Weickert TW', 'Werge T', 'Wray NR', 'Zwart JA', 'Biernacka JM', 'Nurnberger JI', 'Cichon S', 'Edenberg HJ', 'Stahl EA', 'McQuillin A', 'Di Florio A', 'Ophoff RA', 'Andreassen OA']","['Bipolar Disorder/*genetics', 'Case-Control Studies', 'Chromosomes, Human/genetics', 'Genetic Predisposition to Disease', 'Genome, Human', '*Genome-Wide Association Study', 'Humans', 'Major Histocompatibility Complex/genetics', 'Multifactorial Inheritance/genetics', 'Phenotype', 'Quantitative Trait Loci/genetics', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/34002096/
1033,HTR6,33599752,HTR6 and SSTR3 targeting to primary cilia.,"['Barbeito P', 'Garcia-Gonzalo FR']","['Animals', 'Cilia/*metabolism', 'Humans', 'Protein Interaction Domains and Motifs/physiology', 'Protein Sorting Signals/genetics', 'Protein Transport/physiology', 'Receptors, Serotonin/chemistry/genetics/*metabolism', 'Receptors, Somatostatin/chemistry/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/33599752/
1034,HTR6,33372037,HTR6 and SSTR3 ciliary targeting relies on both IC3 loops and C-terminal tails.,"['Barbeito P', 'Tachibana Y', 'Martin-Morales R', 'Moreno P', 'Mykytyn K', 'Kobayashi T', 'Garcia-Gonzalo FR']","['Amino Acid Sequence', 'Animals', 'Cell Membrane/*metabolism', 'Cilia/*metabolism', 'Gene Knockdown Techniques', 'HEK293 Cells', 'Humans', 'Intracellular Signaling Peptides and Proteins/genetics/metabolism', 'Mice', 'Protein Interaction Domains and Motifs', 'Protein Transport/genetics', 'Receptors, Serotonin/*chemistry/*metabolism', 'Receptors, Somatostatin/*chemistry/*metabolism', 'Signal Transduction/*genetics', 'Transfection']",https://pubmed.ncbi.nlm.nih.gov/33372037/
1035,HTR6,32086104,Association of Genetic Variants of Dopamine and Serotonin In Schizophrenia.,"['Zakharyan R', 'Ghazaryan H', 'Kocourkova L', 'Chavushyan A', 'Mkrtchyan A', 'Zizkova V', 'Arakelyan A', 'Petrek M']","['Adult', 'Aged', 'Antipsychotic Agents/therapeutic use', 'Case-Control Studies', 'Catechol O-Methyltransferase/*genetics', 'Cytochrome P-450 CYP2D6/*genetics', 'Dopamine/genetics/metabolism', 'Female', 'Gene Frequency', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Male', 'Metabolic Networks and Pathways/genetics', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Receptors, Dopamine/*genetics', 'Receptors, Serotonin/*genetics', 'Schizophrenia/drug therapy/*genetics', 'Serotonin/genetics/metabolism', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/32086104/
1036,HTR6,25034463,5-HT6 Receptor Recruitment of mTOR Modulates Seizure Activity in Epilepsy.,"['Wang L', 'Lv Y', 'Deng W', 'Peng X', 'Xiao Z', 'Xi Z', 'Chen G', 'Wang X']","['Animals', 'Disease Models, Animal', 'Electroencephalography/methods', 'Epilepsy/drug therapy/metabolism/physiopathology', 'Humans', 'Male', 'Pilocarpine/*pharmacology', 'Rats, Sprague-Dawley', 'Receptors, Serotonin/*metabolism', 'Seizures/drug therapy/*metabolism/physiopathology', 'TOR Serine-Threonine Kinases/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/25034463/
1037,HTR6,30883547,Serotonin receptor HTR6-mediated mTORC1 signaling regulates dietary restriction-induced memory enhancement.,"['Teng LL', 'Lu GL', 'Chiou LC', 'Lin WS', 'Cheng YY', 'Hsueh TE', 'Huang YC', 'Hwang NH', 'Yeh JW', 'Liao RM', 'Fan SZ', 'Yen JH', 'Fu TF', 'Tsai TF', 'Wu MS', 'Wang PY']","['3-Hydroxybutyric Acid/blood', 'Animals', 'Blotting, Western', 'Corticosterone/blood', 'Electrophysiology', 'Glucose Tolerance Test', 'Hippocampus/cytology/metabolism', 'Long-Term Potentiation/physiology', 'Male', 'Mechanistic Target of Rapamycin Complex 1/genetics/*metabolism', 'Memory/*physiology', 'Mice', 'Mice, Inbred C57BL', 'Neurons/cytology/metabolism', 'RNA, Messenger/metabolism', 'Receptors, Serotonin/genetics/*metabolism', 'Serotonin/blood', 'Signal Transduction/genetics/physiology']",https://pubmed.ncbi.nlm.nih.gov/30883547/
1038,HTR6,38995644,Neighborhood Disadvantage and Prostate Tumor RNA Expression of Stress-Related Genes.,"['Boyle J', 'Yau J', 'Slade JL', 'Butts DA', 'Zhang Y', 'Legesse TB', 'Cellini A', 'Clark K', 'Park JY', 'Wimbush J', 'Ambulos N Jr', 'Yin J', 'Hussain A', 'Onukwugha E', 'Knott CL', 'Wheeler DC', 'Barry KH']","['Aged', 'Humans', 'Male', 'Middle Aged', '*Black or African American/statistics & numerical data/genetics', 'Cross-Sectional Studies', 'Maryland/epidemiology', 'Neighborhood Characteristics', 'Prostatectomy/statistics & numerical data', '*Prostatic Neoplasms/genetics/surgery', 'Residence Characteristics/statistics & numerical data', 'Stress, Psychological/genetics', '*White/genetics/statistics & numerical data']",https://pubmed.ncbi.nlm.nih.gov/38995644/
1039,HTR6,31587366,Correlation of 5-HTR6 gene polymorphism with vestibular migraine.,"['Wu X', 'Qiu F', 'Wang Z', 'Liu B', 'Qi X']","['Adult', 'Caloric Tests', 'Case-Control Studies', 'Female', 'Gene Frequency', 'Humans', 'Male', 'Middle Aged', 'Migraine Disorders/*genetics', '*Polymorphism, Single Nucleotide', 'Receptors, Serotonin/*genetics', 'Serotonin/blood', 'Vertigo/genetics/physiopathology', '*Vestibular Function Tests']",https://pubmed.ncbi.nlm.nih.gov/31587366/
1040,HTR6,20394784,Serotonin 6 receptor gene and mood disorders: case-control study and meta-analysis.,"['Fukuo Y', 'Kishi T', 'Yoshimura R', 'Kitajima T', 'Okochi T', 'Yamanouchi Y', 'Kinoshita Y', 'Kawashima K', 'Naitoh H', 'Umene-Nakano W', 'Inada T', 'Kunugi H', 'Kato T', 'Yoshikawa T', 'Ujike H', 'Nakamura J', 'Ozaki N', 'Iwata N']","['Adult', 'Bipolar Disorder/genetics/psychology', 'Case-Control Studies', 'Depressive Disorder, Major/genetics/psychology', 'Female', 'Genotype', 'Haplotypes', 'Humans', 'Linkage Disequilibrium/genetics', 'Male', 'Middle Aged', 'Mood Disorders/*genetics/*psychology', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, Serotonin/*genetics', 'Sample Size']",https://pubmed.ncbi.nlm.nih.gov/20394784/
1041,HTR6,15531082,Association of the HTR6 polymorphism C267T with late-onset Alzheimer's disease in Chinese.,"['Kan R', 'Wang B', 'Zhang C', 'Yang Z', 'Ji S', 'Lu Z', 'Zheng C', 'Jin F', 'Wang L']","['Aged', 'Aged, 80 and over', 'Alzheimer Disease/*genetics', 'Asian People/*genetics', 'Chi-Square Distribution', 'Female', 'Gene Frequency/genetics', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Genetic/*genetics', 'Receptors, Serotonin/*genetics']",https://pubmed.ncbi.nlm.nih.gov/15531082/
1042,HTR6,35359970,Systematic Analysis of Neurotransmitter Receptors in Human Breast Cancer Reveals a Strong Association With Outcome and Uncovers HTR6 as a Survival-Associated Gene Potentially Regulating the Immune Microenvironment.,"['Zhang W', 'Li L', 'Li J', 'Yu H', 'Zheng F', 'Yan B', 'Cai W', 'Chen Y', 'Yin L', 'Tang D', 'Xu Y', 'Dai Y']","['*Breast Neoplasms/genetics/pathology', 'Female', 'Humans', 'Neoplasm Recurrence, Local', 'Receptors, Neurotransmitter/genetics', 'Tumor Microenvironment/genetics']",https://pubmed.ncbi.nlm.nih.gov/35359970/
1043,HTR6,19590397,"5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.","['Illi A', 'Setala-Soikkeli E', 'Viikki M', 'Poutanen O', 'Huhtala H', 'Mononen N', 'Lehtimaki T', 'Leinonen E', 'Kampman O']","['Adolescent', 'Adult', 'Aged', 'Citalopram/therapeutic use', 'Depressive Disorder, Major/*drug therapy/*genetics', 'Fluoxetine/therapeutic use', 'Humans', 'Middle Aged', 'Paroxetine/therapeutic use', '*Polymorphism, Single Nucleotide', 'Psychiatric Status Rating Scales', 'Receptor, Serotonin, 5-HT1A/genetics', 'Receptor, Serotonin, 5-HT2A/genetics', 'Receptors, Serotonin/genetics', 'Selective Serotonin Reuptake Inhibitors/*therapeutic use', 'Treatment Outcome', 'Tryptophan Hydroxylase/genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/19590397/
1044,HTR6,28694424,"A tricyclic antidepressant, amoxapine, reduces amyloid-beta generation through multiple serotonin receptor 6-mediated targets.","['Li X', 'Wang Q', 'Hu T', 'Wang Y', 'Zhao J', 'Lu J', 'Pei G']","['Alzheimer Disease/drug therapy/metabolism', 'Amoxapine/*pharmacology', 'Amyloid beta-Peptides/drug effects/*metabolism', 'Antidepressive Agents, Tricyclic/*pharmacology', 'Cell Line', 'Cyclin-Dependent Kinase 5/metabolism', 'Drug Evaluation, Preclinical', 'Gene Knockdown Techniques', 'HEK293 Cells', 'Humans', 'Neurons/cytology/drug effects/*metabolism', 'Piperazines/pharmacology', 'Receptors, Serotonin/*genetics/metabolism', 'Sulfonamides/pharmacology', 'beta-Arrestin 2/metabolism']",https://pubmed.ncbi.nlm.nih.gov/28694424/
1045,HTR6,32231051,"HTR1A, HTR1B, HTR2A, HTR2C and HTR6 Gene Polymorphisms and Extrapyramidal Side Effects in Haloperidol-Treated Patients with Schizophrenia.","['Grubor M', 'Zivkovic M', 'Sagud M', 'Nikolac Perkovic M', 'Mihaljevic-Peles A', 'Pivac N', 'Muck-Seler D', 'Svob Strac D']","['Adult', 'Antipsychotic Agents/*adverse effects/therapeutic use', 'Haloperidol/*adverse effects/therapeutic use', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Genetic', 'Receptor, Serotonin, 5-HT1A/genetics', 'Receptor, Serotonin, 5-HT1B/genetics', 'Receptor, Serotonin, 5-HT2A/genetics', 'Receptor, Serotonin, 5-HT2C/genetics', 'Receptors, Serotonin/*genetics', 'Schizophrenia/*drug therapy/genetics']",https://pubmed.ncbi.nlm.nih.gov/32231051/
1046,HTR6,30578315,RABL2 positively controls localization of GPCRs in mammalian primary cilia.,"['Dateyama I', 'Sugihara Y', 'Chiba S', 'Ota R', 'Nakagawa R', 'Kobayashi T', 'Itoh H']","['Centrioles/genetics/metabolism', 'Cilia/genetics/*metabolism', 'HEK293 Cells', 'Humans', 'Intracellular Signaling Peptides and Proteins/genetics/metabolism', 'Receptors, G-Protein-Coupled/genetics/*metabolism', 'rab GTP-Binding Proteins/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/30578315/
1047,HTR6,25795301,SNX14 is a bifunctional negative regulator for neuronal 5-HT6 receptor signaling.,"['Ha CM', 'Park D', 'Kim Y', 'Na M', 'Panda S', 'Won S', 'Kim H', 'Ryu H', 'Park ZY', 'Rasenick MM', 'Chang S']","['Animals', 'Cell Membrane/metabolism', 'Cyclic AMP/metabolism', 'Cyclic AMP-Dependent Protein Kinases/metabolism', 'Cytosol/metabolism', 'Endocytosis', 'GTP-Binding Protein alpha Subunits, Gs/metabolism', 'Gene Knockdown Techniques', 'HEK293 Cells', 'Humans', 'Mice', 'Neurons/*metabolism', 'Phosphorylation', 'Phosphoserine/metabolism', 'Protein Binding', 'Protein Structure, Tertiary', 'Proteolysis', 'Rats', 'Receptors, Serotonin/*metabolism', '*Signal Transduction', 'Sorting Nexins/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/25795301/
1048,HTR6,29847509,Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events.,"['Haas DW', 'Bradford Y', 'Verma A', 'Verma SS', 'Eron JJ', 'Gulick RM', 'Riddler SA', 'Sax PE', 'Daar ES', 'Morse GD', 'Acosta EP', 'Ritchie MD']","['Adult', 'Alkynes', 'Benzoxazines/*adverse effects', 'Central Nervous System Diseases/*chemically induced/*genetics', 'Cyclopropanes', 'Female', 'Genomics', 'Genotype', 'HIV/drug effects', 'HIV Infections/*drug therapy', 'Humans', 'Male', 'Middle Aged', 'Neurotransmitter Transport Proteins/*genetics', 'Pharmacogenomic Testing', '*Polymorphism, Single Nucleotide', 'Receptors, Neurotransmitter/*genetics', 'Reverse Transcriptase Inhibitors/adverse effects']",https://pubmed.ncbi.nlm.nih.gov/29847509/
1049,HTR6,18256283,Identification of ciliary localization sequences within the third intracellular loop of G protein-coupled receptors.,"['Berbari NF', 'Johnson AD', 'Lewis JS', 'Askwith CC', 'Mykytyn K']","['Amino Acid Sequence', 'Animals', 'Binding Sites/genetics', 'Cell Line', 'Cilia/*metabolism', 'Consensus Sequence', 'Green Fluorescent Proteins/genetics/metabolism', 'Humans', 'Kidney Tubules, Collecting/cytology/metabolism', 'Mice', 'Molecular Sequence Data', 'Mutagenesis, Site-Directed', 'Receptors, G-Protein-Coupled/*chemistry/genetics/*metabolism', 'Receptors, Serotonin/chemistry/genetics/metabolism', 'Receptors, Somatostatin/chemistry/genetics/metabolism', 'Recombinant Fusion Proteins/chemistry/genetics/metabolism', 'Sequence Homology, Amino Acid']",https://pubmed.ncbi.nlm.nih.gov/18256283/
1050,HTR6,23733030,Pharmacogenetics in major depression: a comprehensive meta-analysis.,"['Niitsu T', 'Fabbri C', 'Bentini F', 'Serretti A']","['Antidepressive Agents/*therapeutic use', 'Asian People/genetics', 'Brain-Derived Neurotrophic Factor/genetics', 'Clinical Trials as Topic', 'Depressive Disorder, Major/*drug therapy/*genetics', 'Genetic Association Studies', 'Humans', 'Models, Genetic', 'Pharmacogenetics', 'Polymorphism, Genetic/genetics', 'Treatment Outcome', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/23733030/
1051,HTR6,37481174,"Identification, characterization, and transcription of serotonin receptors in rainbow trout (Oncorhynchus mykiss) in response to bacterial infection and salinity changes.","['Hou ZS', 'Liu MQ', 'Wen HS', 'Gao QF', 'Li Z', 'Yang XD', 'Xiang KW', 'Yang Q', 'Hu X', 'Qian MZ', 'Li JF']","['Animals', 'Humans', '*Oncorhynchus mykiss/genetics/metabolism', 'Serotonin/metabolism', 'Drug Inverse Agonism', 'Salinity', 'Receptors, Serotonin/genetics/metabolism', '*Bacterial Infections']",https://pubmed.ncbi.nlm.nih.gov/37481174/
1052,DRD5,15950004,Molecular genetics of attention-deficit/hyperactivity disorder.,"['Faraone SV', 'Perlis RH', 'Doyle AE', 'Smoller JW', 'Goralnick JJ', 'Holmgren MA', 'Sklar P']","['Adoption/psychology', 'Animals', 'Attention Deficit Disorder with Hyperactivity/*etiology/*genetics', 'Dopamine Plasma Membrane Transport Proteins', 'Dopamine beta-Hydroxylase/genetics', 'Family', 'Humans', 'Membrane Glycoproteins/genetics', 'Membrane Proteins/genetics', 'Membrane Transport Proteins/genetics', 'Molecular Biology', 'Nerve Tissue Proteins/genetics', 'Receptor, Serotonin, 5-HT1B/genetics', 'Receptors, Dopamine D1/genetics', 'Receptors, Dopamine D2/genetics', 'Receptors, Dopamine D4', 'Receptors, Dopamine D5', 'Serotonin Plasma Membrane Transport Proteins', 'Synaptosomal-Associated Protein 25', '*Twin Studies as Topic']",https://pubmed.ncbi.nlm.nih.gov/15950004/
1053,DRD5,15950005,Attention-deficit/hyperactivity disorder endophenotypes.,"['Doyle AE', 'Willcutt EG', 'Seidman LJ', 'Biederman J', 'Chouinard VA', 'Silva J', 'Faraone SV']","['Adoption', 'Attention Deficit Disorder with Hyperactivity/*genetics/pathology/*physiopathology', 'Brain/pathology/physiopathology', 'Diagnostic Imaging', 'Evoked Potentials', 'Family', '*Genetic Predisposition to Disease', 'Humans', 'Molecular Biology', 'Neuropsychological Tests', 'Problem Solving', 'Receptors, Dopamine D1/genetics', 'Receptors, Dopamine D5', 'Receptors, Glutamate/genetics', '*Twin Studies as Topic']",https://pubmed.ncbi.nlm.nih.gov/15950005/
1054,DRD5,15950009,Attention-deficit/hyperactivity disorder pharmacogenomics.,['McGough JJ'],"['Attention Deficit Disorder with Hyperactivity/*drug therapy/*genetics', 'Dopamine Agents/therapeutic use', 'Electroencephalography/methods', 'Genetic Variation', 'Humans', 'Methylphenidate/therapeutic use', '*Pharmacogenetics']",https://pubmed.ncbi.nlm.nih.gov/15950009/
1055,DRD5,38246990,"The dopamine receptor D1 inhibitor, SKF83566, suppresses GBM stemness and invasion through the DRD1-c-Myc-UHRF1 interactions.","['Xue Z', 'Zhang Y', 'Zhao R', 'Liu X', 'Grutzmann K', 'Klink B', 'Zhang X', 'Wang S', 'Zhao W', 'Sun Y', 'Han M', 'Wang X', 'Hu Y', 'Liu X', 'Yang N', 'Qiu C', 'Li W', 'Huang B', 'Li X', 'Bjerkvig R', 'Wang J', 'Zhou W']","['Animals', 'Humans', 'Mice', 'Brain', 'CCAAT-Enhancer-Binding Proteins/drug effects/metabolism', 'Dopamine', '*Dopamine Antagonists/metabolism/pharmacology', '*Glioblastoma/drug therapy/genetics', '*Glioma', 'Mice, Nude', 'Multigene Family', '*Proto-Oncogene Proteins c-myc/drug effects/metabolism', 'Receptors, Dopamine D1/antagonists & inhibitors', 'Ubiquitin-Protein Ligases/drug effects/metabolism', '*2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/analogs & derivatives/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/38246990/
1056,DRD5,38713055,"Theobromine improves hyperactivity, inattention, and working memory via modulation of dopaminergic neural function in the frontal cortex of spontaneously hypertensive rats.","['Matsuzaki K', 'Sugimoto N', 'Hossain S', 'Islam R', 'Sumiyoshi E', 'Hashimoto M', 'Kishi H', 'Shido O']","['Animals', '*Rats, Inbred SHR', 'Male', 'Rats', '*Rats, Inbred WKY', '*Theobromine/pharmacology', '*Attention Deficit Disorder with Hyperactivity/drug therapy/metabolism', '*Memory, Short-Term/drug effects', '*Dopamine/metabolism', 'Brain-Derived Neurotrophic Factor/metabolism/genetics', 'Dopamine Plasma Membrane Transport Proteins/metabolism/genetics', 'Frontal Lobe/metabolism/drug effects', 'Prefrontal Cortex/metabolism/drug effects', 'Tyrosine 3-Monooxygenase/metabolism/genetics', 'Disease Models, Animal', 'Synaptosomal-Associated Protein 25/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38713055/
1057,DRD5,19831843,The genetics of attention-deficit/hyperactivity disorder.,"['Coghill D', 'Banaschewski T']","['Attention Deficit Disorder with Hyperactivity/etiology/*genetics', 'Dopamine Plasma Membrane Transport Proteins/genetics', 'Environment', '*Genetic Predisposition to Disease', '*Genetics', 'Genome-Wide Association Study/methods', 'Humans', 'Polymorphism, Single Nucleotide', 'Receptors, Dopamine/genetics/metabolism', 'Receptors, Serotonin, 5-HT1/genetics', 'Synaptosomal-Associated Protein 25/genetics']",https://pubmed.ncbi.nlm.nih.gov/19831843/
1058,DRD5,22825876,Biochemical and genetic analyses of childhood attention deficit/hyperactivity disorder.,['Caylak E'],"['Attention Deficit Disorder with Hyperactivity/*genetics', 'Biomarkers/metabolism', 'Central Nervous System/growth & development/pathology', 'Child', 'Genetic Association Studies', '*Genetic Predisposition to Disease', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/22825876/
1059,DRD5,17449449,From dopaminergic genes to psychiatric disorders.,"['Hoenicka J', 'Aragues M', 'Ponce G', 'Rodriguez-Jimenez R', 'Jimenez-Arriero MA', 'Palomo T']","['Animals', 'Dopamine/*genetics/*physiology', 'Humans', 'Mental Disorders/*genetics', 'Receptors, Dopamine/*genetics/*physiology', 'Receptors, Dopamine D1/genetics/physiology', 'Receptors, Dopamine D2/genetics/physiology', 'Receptors, Dopamine D3/genetics/physiology', 'Receptors, Dopamine D4/genetics/physiology', 'Receptors, Dopamine D5/genetics/physiology']",https://pubmed.ncbi.nlm.nih.gov/17449449/
1060,DRD5,36401517,Peroxiredoxin-4 and Dopamine D5 Receptor Interact to Reduce Oxidative Stress and Inflammation in the Kidney.,"['Amatya B', 'Yang S', 'Yu P', 'Vaz de Castro PAS', 'Armando I', 'Zeng C', 'Felder RA', 'Asico LD', 'Jose PA', 'Lee H']","['Mice', 'Humans', 'Animals', '*Receptors, Dopamine D5/metabolism', 'Interleukin-1beta/metabolism', '*Hydrogen Peroxide/metabolism', 'Caspase 12/metabolism', 'HEK293 Cells', 'Kidney/metabolism', 'Fenoldopam/metabolism/pharmacology', 'Oxidative Stress', 'Inflammation/metabolism', 'Peroxiredoxins/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36401517/
1061,DRD5,25600112,The molecular genetic architecture of attention deficit hyperactivity disorder.,"['Hawi Z', 'Cummins TD', 'Tong J', 'Johnson B', 'Lau R', 'Samarrai W', 'Bellgrove MA']","['Attention Deficit Disorder with Hyperactivity/*genetics', 'DNA Copy Number Variations/*genetics', 'Genetic Predisposition to Disease/*genetics', 'Genome-Wide Association Study', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/25600112/
1062,DRD5,35544697,Dopamine receptor signaling regulates fibrotic activation of retinal pigmented epithelial cells.,"['Gao AY', 'Link PA', 'Bakri SJ', 'Haak AJ']","['Cell Movement', 'Dopamine/metabolism', 'Dopamine Agonists/metabolism/pharmacology', 'Epithelial Cells/metabolism', 'Epithelial-Mesenchymal Transition', '*Fibronectins/metabolism', 'Fibrosis', 'Humans', 'Receptors, Dopamine/metabolism', 'Retinal Pigment Epithelium/metabolism', '*Vitreoretinopathy, Proliferative/metabolism/pathology']",https://pubmed.ncbi.nlm.nih.gov/35544697/
1063,DRD5,22610946,Role of dopamine receptors in ADHD: a systematic meta-analysis.,"['Wu J', 'Xiao H', 'Sun H', 'Zou L', 'Zhu LQ']","['Attention Deficit Disorder with Hyperactivity/*genetics/*metabolism', 'Genetic Predisposition to Disease', 'Humans', 'Polymorphism, Genetic', 'Receptors, Dopamine/chemistry/*genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/22610946/
1064,DRD5,35961947,Relationship of DRD5 and MAO-B VNTR polymorphisms with paranoid and antisocial personality disorders in polydrug users.,"[""O'Higgins M"", 'Benito A', 'Real-Lopez M', 'Gil-Miravet I', 'Ochoa E', 'Haro G']","['Humans', '*Antisocial Personality Disorder/genetics', '*Polymorphism, Genetic', 'Monoamine Oxidase/genetics', 'Minisatellite Repeats', 'Cross-Sectional Studies', 'Receptors, Dopamine D5/genetics']",https://pubmed.ncbi.nlm.nih.gov/35961947/
1065,DRD5,30643666,Risk Factor Genes in Patients with Dystonia: A Comprehensive Review.,"['Siokas V', 'Aloizou AM', 'Tsouris Z', 'Michalopoulou A', 'Mentis AA', 'Dardiotis E']","['Apoptosis Regulatory Proteins/genetics', 'DNA-Binding Proteins/genetics', 'Dystonia/*diagnosis/epidemiology/*genetics', 'Dystonic Disorders/diagnosis/epidemiology/genetics', 'Genetic Predisposition to Disease/epidemiology/*genetics', 'Humans', 'Molecular Chaperones/genetics', 'Nuclear Proteins/genetics', 'Polymorphism, Single Nucleotide/genetics', 'Risk Factors', 'Sodium-Potassium-Exchanging ATPase/genetics']",https://pubmed.ncbi.nlm.nih.gov/30643666/
1066,DRD5,11134669,Polymorphisms in dopamine receptors: what do they tell us?,"['Wong AH', 'Buckle CE', 'Van Tol HH']","['Animals', 'Dopamine Agents/*pharmacology', 'Humans', 'Polymorphism, Genetic/*genetics', 'Receptors, Dopamine/drug effects/*genetics', 'Receptors, Dopamine D1/drug effects/genetics', 'Receptors, Dopamine D2/drug effects/genetics', 'Receptors, Dopamine D3', 'Receptors, Dopamine D4', 'Receptors, Dopamine D5']",https://pubmed.ncbi.nlm.nih.gov/11134669/
1067,DRD5,27480019,Meta-analysis of the DRD5 VNTR in persistent ADHD.,"['Klein M', 'Berger S', 'Hoogman M', 'Dammers J', 'Makkinje R', 'Heister AJGAM', 'Galesloot TE', 'Kiemeney LALM', 'Weber H', 'Kittel-Schneider S', 'Lesch KP', 'Reif A', 'Ribase S M', 'Ramos-Quiroga JA', 'Cormand B', 'Zayats T', 'Hegvik TA', 'Jacobsen KK', 'Johansson S', 'Haavik J', 'Mota NR', 'Bau CHD', 'Grevet EH', 'Doyle A', 'Faraone SV', 'Arias-Va Squez A', 'Franke B']","['Attention Deficit Disorder with Hyperactivity/*genetics', 'Genetic Predisposition to Disease', 'Humans', '*Minisatellite Repeats', 'Receptors, Dopamine D5/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27480019/
1068,DRD5,31311029,Expression of Dopamine Receptors in Immune Regulatory Cells.,"['Arce-Sillas A', 'Sevilla-Reyes E', 'Alvarez-Luquin DD', 'Guevara-Salinas A', 'Boll MC', 'Perez-Correa CA', 'Vivas-Almazan AV', 'Rodriguez-Ortiz U', 'Castellanos Barba C', 'Hernandez M', 'Fragoso G', 'Sciutto E', 'Cardenas G', 'Adalid-Peralta LV']","['Aged', 'B-Lymphocytes, Regulatory/*metabolism', 'CD8-Positive T-Lymphocytes/*metabolism', 'Dendritic Cells/*metabolism', 'Female', 'Humans', 'Male', 'Middle Aged', 'Monocytes/*metabolism', 'Parkinson Disease/immunology/*metabolism', 'Receptors, Dopamine/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/31311029/
1069,DRD5,11462757,Clinical and molecular genetics of ADHD and Tourette syndrome. Two related polygenic disorders.,['Comings DE'],"['Attention Deficit Disorder with Hyperactivity/diagnosis/epidemiology/*genetics', 'Comorbidity', 'Dopamine/*genetics', 'Female', 'Genetic Linkage', 'Humans', 'Male', 'Mental Disorders/epidemiology', 'Molecular Biology/*methods', 'Pedigree', 'Psychiatric Status Rating Scales', 'Serotonin/genetics', 'Tourette Syndrome/diagnosis/epidemiology/*genetics', 'Twins/genetics']",https://pubmed.ncbi.nlm.nih.gov/11462757/
1070,DRD5,23886513,Gene environment interaction studies in depression and suicidal behavior: An update.,"['Mandelli L', 'Serretti A']","['Depressive Disorder, Major/*genetics', '*Gene-Environment Interaction', 'Genetic Predisposition to Disease/genetics', 'Humans', 'Life Change Events', 'Suicide/*psychology']",https://pubmed.ncbi.nlm.nih.gov/23886513/
1071,DRD5,20145962,Molecular genetics of attention-deficit/hyperactivity disorder: an overview.,"['Banaschewski T', 'Becker K', 'Scherag S', 'Franke B', 'Coghill D']","['Adolescent', 'Cell Division/genetics', 'Child', 'Genetic Markers/*genetics', 'Genetic Predisposition to Disease/*genetics', 'Genome-Wide Association Study', 'Humans', 'Malformations of Cortical Development, Group II/genetics', 'Neurotransmitter Agents/genetics', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/20145962/
1072,CHRM5,37213061,Recessive CHRM5 variant as a potential cause of neurogenic bladder.,"['Schneider S', 'Schierbaum L', 'Burger WAC', 'Seltzsam S', 'Wang C', 'Zheng B', 'Wu CW', 'Nakayama M', 'Connaughton DM', 'Mann N', 'Shalaby MA', 'Kari JA', 'ElDesoky S', 'Tasic V', 'Eid LA', 'Shril S', 'Thal DM', 'Hildebrandt F']","['Humans', 'Mice', 'Animals', '*Urinary Bladder, Neurogenic/genetics', '*Urogenital Abnormalities/genetics', '*Vesico-Ureteral Reflux/genetics', 'Kidney/abnormalities', '*Urinary Tract', 'Mice, Knockout']",https://pubmed.ncbi.nlm.nih.gov/37213061/
1073,CHRM5,15292665,Linkage of M5 muscarinic and alpha7-nicotinic receptor genes on 15q13 to schizophrenia.,"['De Luca V', 'Wang H', 'Squassina A', 'Wong GW', 'Yeomans J', 'Kennedy JL']","['Alleles', 'Canada/epidemiology', 'Chromosomes, Human, Pair 15/*genetics', 'DNA/genetics', 'Erythrocytes/chemistry', 'Gene Frequency', 'Genetic Linkage/*genetics', 'Haplotypes', 'Humans', 'Receptor, Muscarinic M5/*genetics', 'Receptors, Nicotinic/*genetics', 'Schizophrenia/epidemiology/*genetics', 'alpha7 Nicotinic Acetylcholine Receptor']",https://pubmed.ncbi.nlm.nih.gov/15292665/
1074,CHRM5,10549128,Mapping of five subtype genes for muscarinic acetylcholine receptor to mouse chromosomes.,"['Matsui M', 'Araki Y', 'Karasawa H', 'Matsubara N', 'Taketo MM', 'Seldin MF']","['Animals', 'Base Sequence', 'Chromosome Mapping', 'Crosses, Genetic', 'DNA Primers/genetics', 'Female', 'Humans', 'Male', 'Mice', 'Mice, Inbred C3H', 'Mice, Mutant Strains', 'Muridae', 'Polymorphism, Restriction Fragment Length', 'Rats', 'Receptors, Muscarinic/*classification/*genetics']",https://pubmed.ncbi.nlm.nih.gov/10549128/
1075,CHRM5,28722769,"Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments.","['Sakata K', 'Overacre AE']","['Animals', 'Antidepressive Agents/*pharmacology', 'Brain-Derived Neurotrophic Factor/*deficiency/genetics', '*Environment', 'Female', 'Frontal Lobe/drug effects/metabolism', 'Gene Expression', 'Hippocampus/drug effects/metabolism', 'Male', 'Mice', 'Mice, 129 Strain', 'Mice, Inbred C57BL', 'Promoter Regions, Genetic/drug effects/physiology', 'Receptor, Muscarinic M2/*biosynthesis/genetics', 'Receptor, Muscarinic M5/*biosynthesis/genetics', 'Receptors, Nicotinic/*biosynthesis/genetics']",https://pubmed.ncbi.nlm.nih.gov/28722769/
1076,CHRM5,30564629,Evolution of the Muscarinic Acetylcholine Receptors in Vertebrates.,"['Pedersen JE', 'Bergqvist CA', 'Larhammar D']","['Animals', 'Humans', 'Phylogeny', 'Receptor, Muscarinic M1/*metabolism', 'Receptor, Muscarinic M3/*metabolism', 'Receptor, Muscarinic M4/metabolism', 'Receptors, Cholinergic/*metabolism', 'Receptors, Muscarinic/*metabolism', 'Vertebrates/metabolism']",https://pubmed.ncbi.nlm.nih.gov/30564629/
1077,CHRM5,32650830,"Clinical features, treatment, and survival outcome of primary pulmonary NUT midline carcinoma.","['Xie XH', 'Wang LQ', 'Qin YY', 'Lin XQ', 'Xie ZH', 'Liu M', 'Zhang JX', 'Ouyang M', 'Liu J', 'Gu YY', 'Li SY', 'Zhou CZ']","['Adult', 'Aged', '*Antineoplastic Agents, Immunological/therapeutic use', '*Carcinoma, Squamous Cell', 'Female', 'Humans', 'Lung', '*Lung Neoplasms/drug therapy/genetics', 'Male', 'Middle Aged', 'Retrospective Studies', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/32650830/
1078,CHRM5,22899762,Muscarinic acetylcholine receptor 3 is dominant in myopia progression.,"['Lin HJ', 'Wan L', 'Chen WC', 'Lin JM', 'Lin CJ', 'Tsai FJ']","['Adolescent', 'Adult', 'Animals', 'Atropine/pharmacology', 'Chromosome Mapping', 'Cricetinae', 'Disease Models, Animal', 'Disease Progression', 'Female', 'Genetic Predisposition to Disease/epidemiology/genetics', 'Humans', 'Male', 'Mesocricetus', 'Muscarinic Antagonists/pharmacology', 'Myopia/drug therapy/epidemiology/*genetics', 'Receptor, Muscarinic M1', 'Receptor, Muscarinic M2/genetics', 'Receptor, Muscarinic M3/antagonists & inhibitors/*genetics', 'Receptor, Muscarinic M4/genetics', 'Receptor, Muscarinic M5/genetics', 'Receptors, Muscarinic/genetics', 'Risk Factors', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/22899762/
1079,CHRM5,21570824,Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids.,"['Laugsand EA', 'Fladvad T', 'Skorpen F', 'Maltoni M', 'Kaasa S', 'Fayers P', 'Klepstad P']","['Aged', 'Analgesics, Opioid/*adverse effects', 'Body Mass Index', 'Female', '*Gene Expression Regulation, Neoplastic', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Nausea/*etiology/*genetics', 'Neoplasms/complications/*drug therapy', 'Polymorphism, Single Nucleotide', 'Signal Transduction', 'Vomiting/*etiology/*genetics']",https://pubmed.ncbi.nlm.nih.gov/21570824/
1080,CHRM5,39938415,Repurposing of dipeptidyl peptidase FDA-approved drugs in Alzheimer's disease using network pharmacology and in-silico approaches.,"['Roney M', 'Uddin MN', 'Khan AA', 'Fatima S', 'Mohd Aluwi MFF', 'Hamim SMI', 'Ahmad A']","['*Alzheimer Disease/drug therapy/metabolism', 'Humans', '*Dipeptidyl-Peptidase IV Inhibitors/chemistry/pharmacology/therapeutic use', '*Drug Repositioning', 'Molecular Docking Simulation', 'Network Pharmacology', 'Molecular Dynamics Simulation', 'Dipeptidyl Peptidase 4/metabolism/chemistry', 'United States', 'Drug Approval', 'United States Food and Drug Administration', 'Principal Component Analysis']",https://pubmed.ncbi.nlm.nih.gov/39938415/
1081,CHRM5,17608938,Variation in the gene coding for the M5 muscarinic receptor (CHRM5) influences cigarette dose but is not associated with dependence to drugs of addiction: evidence from a prospective population based cohort study of young adults.,"['Anney RJ', 'Lotfi-Miri M', 'Olsson CA', 'Reid SC', 'Hemphill SA', 'Patton GC']","['Adolescent', 'Alcohol Drinking/*genetics', 'Chromatography, High Pressure Liquid', 'Cohort Studies', 'Gene Frequency', '*Genetic Variation', 'Humans', 'Marijuana Abuse/*genetics', 'Polymorphism, Single Nucleotide', 'Prospective Studies', 'Receptor, Muscarinic M5/*genetics', 'Tobacco Use Disorder/*genetics', 'Victoria', 'White People']",https://pubmed.ncbi.nlm.nih.gov/17608938/
1082,CHRM5,20082457,An interstitial 15q11-q14 deletion: expanded Prader-Willi syndrome phenotype.,"['Butler MG', 'Bittel DC', 'Kibiryeva N', 'Cooley LD', 'Yu S']","['Child, Preschool', 'Chromosome Aberrations', '*Chromosome Deletion', '*Chromosomes, Human, Pair 15', 'Comparative Genomic Hybridization', 'Cytogenetics', 'Female', 'Humans', 'In Situ Hybridization, Fluorescence', 'Karyotyping', 'Phenotype', 'Prader-Willi Syndrome/*diagnosis/*genetics']",https://pubmed.ncbi.nlm.nih.gov/20082457/
1083,CHRM5,17163532,"Characterization of a 5.3 Mb deletion in 15q14 by comparative genomic hybridization using a whole genome ""tiling path"" BAC array in a girl with heart defect, cleft palate, and developmental delay.","['Erdogan F', 'Ullmann R', 'Chen W', 'Schubert M', 'Adolph S', 'Hultschig C', 'Kalscheuer V', 'Ropers HH', 'Spaich C', 'Tzschach A']","['Adult', '*Chromosome Deletion', 'Chromosomes, Artificial, Bacterial', 'Chromosomes, Human, Pair 15/*genetics', 'Cleft Palate/*genetics/pathology', 'Developmental Disabilities/*genetics/pathology', 'Female', 'Heart Defects, Congenital/*genetics/pathology', 'Humans', 'In Situ Hybridization, Fluorescence', 'Infant, Newborn', 'Intellectual Disability/genetics/pathology', 'Karyotyping', 'Male', 'Nucleic Acid Hybridization/methods', 'Oligonucleotide Array Sequence Analysis/methods']",https://pubmed.ncbi.nlm.nih.gov/17163532/
1084,CHRM5,39740827,Epigenetic Modification of Muscarinic Acetylcholine Receptors in Squamous Cell Carcinoma of the Head and Neck.,"['Sugiyama N', 'Yamada S', 'Nakamura Y', 'Morita K', 'Kano K', 'Ishida K', 'Takeuchi K', 'Kita JY', 'Sahara S', 'Sugawara K', 'Nagai KI', 'Matsuda S', 'Hayashi A', 'Makoshi Y', 'Mochizuki D', 'Nakanishi H', 'Imai A', 'Takizawa Y', 'Misawa Y', 'Misawa K']","['Humans', '*Epigenesis, Genetic', '*DNA Methylation', 'Male', 'Female', '*Head and Neck Neoplasms/genetics/pathology/virology', 'Middle Aged', '*Squamous Cell Carcinoma of Head and Neck/genetics/virology/pathology', 'Aged', 'Receptors, Muscarinic/genetics/metabolism', 'Carcinoma, Squamous Cell/genetics/pathology/virology', 'Neoplasm Recurrence, Local/genetics/pathology/virology', 'Adult', 'Promoter Regions, Genetic/genetics', 'Aged, 80 and over', 'Gene Expression Regulation, Neoplastic', 'Papillomavirus Infections/genetics/virology/pathology/complications']",https://pubmed.ncbi.nlm.nih.gov/39740827/
1085,OPRD1,28035534,OPRD1 Genetic Variation and Human Disease.,"['Crist RC', 'Clarke TK']","['Alzheimer Disease/*genetics/physiopathology/therapy', 'Animals', 'Feeding and Eating Disorders/*genetics/physiopathology/therapy', 'Genetic Variation', 'Humans', 'Obesity/*genetics/physiopathology/therapy', 'Opioid-Related Disorders/*genetics/physiopathology/*therapy', 'Receptors, Opioid, delta/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28035534/
1086,OPRD1,31455857,Neurobiological roots of psychopathy.,"['Tiihonen J', 'Koskuvi M', 'Lahteenvuo M', 'Virtanen PLJ', 'Ojansuu I', 'Vaurio O', 'Gao Y', 'Hyotylainen I', 'Puttonen KA', 'Repo-Tiihonen E', 'Paunio T', 'Rautiainen MR', 'Tyni S', 'Koistinaho J', 'Lehtonen S']","['Aggression', '*Antisocial Personality Disorder/genetics', '*Criminals', 'Emotions', 'Empathy', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/31455857/
1087,OPRD1,37409929,The potent BECN2-ATG14 coiled-coil interaction is selectively critical for endolysosomal degradation of GPRASP1/GASP1-associated GPCRs.,"['Qiu X', 'Li N', 'Yang Q', 'Wu S', 'Li X', 'Pan X', 'Yamamoto S', 'Zhang X', 'Zeng J', 'Liao J', 'He C', 'Wang R', 'Zhao Y']","['Humans', '*Lysosomes/metabolism', '*Receptors, G-Protein-Coupled/metabolism', '*Endosomes/metabolism', 'Animals', '*Autophagy-Related Proteins/metabolism', 'Autophagy/physiology', 'Protein Binding', 'Mice', 'Proteolysis', 'HEK293 Cells', 'Beclin-1/metabolism', 'Vesicular Transport Proteins', 'Adaptor Proteins, Vesicular Transport']",https://pubmed.ncbi.nlm.nih.gov/37409929/
1088,OPRD1,30118972,A review of opioid addiction genetics.,"['Crist RC', 'Reiner BC', 'Berrettini WH']","['*Genome-Wide Association Study', 'Humans', 'Multifactorial Inheritance/genetics', 'Opioid-Related Disorders/*genetics', 'Receptors, Opioid, delta/genetics', 'Receptors, Opioid, mu/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30118972/
1089,OPRD1,33154520,A review of the existing literature on buprenorphine pharmacogenomics.,"['Meaden CW', 'Mozeika A', 'Asri R', 'Santos CD']","['Animals', 'Buprenorphine/*therapeutic use', 'Genotype', 'Humans', 'Pharmacogenetics/methods', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, Opioid, mu/genetics']",https://pubmed.ncbi.nlm.nih.gov/33154520/
1090,OPRD1,38118075,Chronic intermittent ethanol exposure-induced m6A modifications around mRNA stop codons of opioid receptor genes.,"['Liu Y', 'Koo JS', 'Zhang H']","['Humans', '*Receptors, Opioid/genetics', 'Codon, Terminator', 'Ethanol/pharmacology', 'RNA, Messenger/genetics', 'DNA Methylation', '*Neuroblastoma/genetics']",https://pubmed.ncbi.nlm.nih.gov/38118075/
1091,OPRD1,25247900,A review of the role of genetic testing in pain medicine.,"['Trescot AM', 'Faynboym S']","['Analgesics, Opioid/*metabolism', 'Genetic Testing/*standards', 'Humans', 'Opioid-Related Disorders/*genetics', 'Pain/*genetics', 'Pain Management/*standards']",https://pubmed.ncbi.nlm.nih.gov/25247900/
1092,OPRD1,37146669,OPRD1 rs569356 polymorphism has an effect on plasma norbuprenorphine levels and dose/kg-normalized norbuprenorphine values in individuals with opioid use disorder.,"['Kaya-Akyuzlu D', 'Ozkan-Kotiloglu S', 'Danisman M', 'Bal C', 'Ogur B', 'Ispir GZ']","['Humans', 'Chromatography, Liquid', 'Tandem Mass Spectrometry', '*Buprenorphine/therapeutic use', '*Opioid-Related Disorders/genetics/drug therapy', 'Receptors, Opioid, delta/genetics/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/37146669/
1093,OPRD1,37660978,Methylation and expression quantitative trait loci rs1799971 in the OPRM1 gene and rs4654327 in the OPRD1 gene are associated with opioid use disorder.,"['Yu J', 'Zhang Y', 'Xun Y', 'Tang H', 'Fu X', 'Zhang R', 'Zhu F', 'Zhang J']","['Humans', '*Quantitative Trait Loci', 'Methylation', 'Genotype', '*Opioid-Related Disorders/genetics', 'Polymorphism, Single Nucleotide', 'Receptors, Opioid, mu/genetics', 'Receptors, Opioid, delta/genetics']",https://pubmed.ncbi.nlm.nih.gov/37660978/
1094,OPRD1,17622222,The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk.,"['Zhang H', 'Kranzler HR', 'Yang BZ', 'Luo X', 'Gelernter J']","['Adolescent', 'Adult', 'Aged', 'Alcoholism/*genetics', 'Case-Control Studies', 'Cocaine-Related Disorders/genetics', 'Europe/ethnology', 'Exons/genetics', 'Female', 'Genetic Predisposition to Disease', 'Haplotypes/genetics', 'Heroin Dependence/genetics', 'Humans', 'Linkage Disequilibrium', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Receptors, Opioid, delta/genetics/*physiology', 'Receptors, Opioid, kappa/genetics/*physiology', 'Risk', 'Substance-Related Disorders/*genetics', 'United States/epidemiology']",https://pubmed.ncbi.nlm.nih.gov/17622222/
1095,OPRD1,38918439,Predicting type 2 diabetes via machine learning integration of multiple omics from human pancreatic islets.,"['Ronn T', 'Perfilyev A', 'Oskolkov N', 'Ling C']","['Humans', '*Diabetes Mellitus, Type 2/genetics/metabolism', '*Machine Learning', '*DNA Methylation', '*Islets of Langerhans/metabolism', '*Polymorphism, Single Nucleotide', 'Male', 'Female', 'Middle Aged', 'Biomarkers', 'Adult', 'Aged']",https://pubmed.ncbi.nlm.nih.gov/38918439/
1096,OPRD1,34031368,"OPRD1 SNPs associated with opioid addiction are cis-eQTLs for the phosphatase and actin regulator 4 gene, PHACTR4, a mediator of cytoskeletal dynamics.","['Levran O', 'Randesi M', 'Adelson M', 'Kreek MJ']","['*Actins', 'Follow-Up Studies', 'Haplotypes', 'Humans', '*Opioid-Related Disorders/genetics', 'Phosphoric Monoester Hydrolases', 'Polymorphism, Single Nucleotide', 'Receptors, Opioid, delta/genetics']",https://pubmed.ncbi.nlm.nih.gov/34031368/
1097,OPRD1,20942817,Pharmacogenetics of new analgesics.,"['Lotsch J', 'Geisslinger G']","['Amidohydrolases/genetics', 'Analgesia/*methods', 'Analgesics/*pharmacology/therapeutic use', 'Genotype', 'Humans', 'Ion Channels/genetics', 'Molecular Targeted Therapy', 'Pain/*drug therapy/metabolism', 'Pharmacogenetics', 'Receptors, G-Protein-Coupled/genetics', 'Signal Transduction/genetics']",https://pubmed.ncbi.nlm.nih.gov/20942817/
1098,OPRD1,35674691,Distribution of delta and mu opioid receptor mRNA in rodent dorsal root ganglia neurons.,"['Quirion B', 'Beaulieu C', 'Cote L', 'Parent JL', 'Gendron L']","['Animals', '*Ganglia, Spinal/metabolism', 'Mice', '*Neurons/metabolism', '*RNA, Messenger/genetics/metabolism', 'Rats', '*Receptors, Opioid, delta/genetics/metabolism', '*Receptors, Opioid, mu/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35674691/
1099,OPRD1,33953123,The OPRD1 rs678849 variant influences outcome of disulfiram treatment for cocaine dependency in methadone-maintained patients.,"['Thomas PS Jr', 'Nielsen EM', 'Spellicy CJ', 'Harding MJ', 'Ye A', 'Patriquin M', 'Hamon SC', 'Kosten TR', 'Nielsen DA']","['Adult', 'Alleles', 'Cocaine/urine', 'Cocaine-Related Disorders/*drug therapy/*genetics', 'Disulfiram/therapeutic use', 'Female', 'Genotype', 'Humans', 'Male', 'Methadone/therapeutic use', 'Middle Aged', 'Opioid-Related Disorders/*drug therapy/*genetics', 'Receptors, Opioid, delta/*genetics', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/33953123/
1100,OPRD1,22417668,Expression and localization of opioid receptors during the maturation of human oocytes.,"['Agirregoitia E', 'Peralta L', 'Mendoza R', 'Exposito A', 'Ereno ED', 'Matorras R', 'Agirregoitia N']","['Adult', 'Female', 'Humans', 'Immunohistochemistry', 'Metaphase/physiology', 'Oocytes/*metabolism', 'Oogenesis/*physiology', 'RNA, Messenger/metabolism', 'Real-Time Polymerase Chain Reaction', 'Receptors, Opioid, delta/*metabolism', 'Receptors, Opioid, kappa/*metabolism', 'Receptors, Opioid, mu/*metabolism', 'Reverse Transcriptase Polymerase Chain Reaction', 'Sperm Injections, Intracytoplasmic']",https://pubmed.ncbi.nlm.nih.gov/22417668/
1101,OPRD1,39103322,Functional genetics reveals the contribution of delta opioid receptor to type 2 diabetes and beta-cell function.,"['Meulebrouck S', 'Merrheim J', 'Queniat G', 'Bourouh C', 'Derhourhi M', 'Boissel M', 'Yi X', 'Badreddine A', 'Boutry R', 'Leloire A', 'Toussaint B', 'Amanzougarene S', 'Vaillant E', 'Durand E', 'Loiselle H', 'Huyvaert M', 'Dechaume A', 'Scherrer V', 'Marchetti P', 'Balkau B', 'Charpentier G', 'Franc S', 'Marre M', 'Roussel R', 'Scharfmann R', 'Cnop M', 'Canouil M', 'Baron M', 'Froguel P', 'Bonnefond A']","['*Receptors, Opioid, delta/metabolism/genetics', '*Diabetes Mellitus, Type 2/genetics/metabolism', 'Humans', '*Insulin-Secreting Cells/metabolism', 'Male', 'Female', 'Middle Aged', 'Insulin/metabolism', 'Insulin Secretion/drug effects/genetics', 'Adult']",https://pubmed.ncbi.nlm.nih.gov/39103322/
1102,OPRD1,24126707,Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females.,"['Clarke TK', 'Crist RC', 'Ang A', 'Ambrose-Lanci LM', 'Lohoff FW', 'Saxon AJ', 'Ling W', 'Hillhouse MP', 'Bruce RD', 'Woody G', 'Berrettini WH']","['Buprenorphine/*therapeutic use', 'Female', '*Genetic Variation', 'Humans', 'Opioid-Related Disorders/*drug therapy/genetics', 'Receptors, Opioid, delta/*genetics', 'White People']",https://pubmed.ncbi.nlm.nih.gov/24126707/
1103,OPRD1,28253273,Elevated OPRD1 promoter methylation in Alzheimer's disease patients.,"['Ji H', 'Wang Y', 'Liu G', 'Chang L', 'Chen Z', 'Zhou D', 'Xu X', 'Cui W', 'Hong Q', 'Jiang L', 'Li J', 'Zhou X', 'Li Y', 'Guo Z', 'Zha Q', 'Niu Y', 'Weng Q', 'Duan S', 'Wang Q']","['Aged', 'Aged, 80 and over', 'Alzheimer Disease/*genetics', 'Base Sequence', 'Case-Control Studies', '*DNA Methylation', 'Female', 'HEK293 Cells', 'Humans', 'Male', 'Middle Aged', 'Promoter Regions, Genetic/*genetics', 'Receptors, Opioid, delta/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28253273/
1104,OPRD1,34638633,Opioid Addiction and Opioid Receptor Dimerization: Structural Modeling of the OPRD1 and OPRM1 Heterodimer and Its Signaling Pathways.,"['Wu B', 'Hand W', 'Alexov E']","['Dimerization', 'Humans', 'Mutation/genetics', 'Opioid-Related Disorders/*genetics', 'Receptors, Opioid/*genetics', 'Receptors, Opioid, delta/*genetics', 'Receptors, Opioid, mu/*genetics', 'Signal Transduction/*genetics', 'beta-Arrestins/genetics']",https://pubmed.ncbi.nlm.nih.gov/34638633/
1105,MAOB,38335292,Stromal-derived MAOB promotes prostate cancer growth and progression.,"['Pu T', 'Wang J', 'Wei J', 'Zeng A', 'Zhang J', 'Chen J', 'Yin L', 'Li J', 'Lin TP', 'Melamed J', 'Corey E', 'Gao AC', 'Wu BJ']","['Animals', 'Humans', 'Male', 'Mice', 'Cell Line, Tumor', 'Fibroblasts/metabolism', '*Monoamine Oxidase/genetics', '*Prostatic Neoplasms/genetics/pathology', 'Signal Transduction', 'Tumor Microenvironment']",https://pubmed.ncbi.nlm.nih.gov/38335292/
1106,MAOB,21971003,The pharmacology of selegiline.,['Magyar K'],"['Animals', 'Humans', 'Monoamine Oxidase/metabolism', 'Monoamine Oxidase Inhibitors/chemistry/pharmacology', 'Neuroprotective Agents/chemistry/*pharmacology', 'Parkinson Disease/drug therapy/metabolism', 'Selegiline/chemistry/*pharmacology', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/21971003/
1107,MAOB,24218136,Selective MAO-B inhibitors: a lesson from natural products.,"['Carradori S', ""D'Ascenzio M"", 'Chimenti P', 'Secci D', 'Bolasco A']","['Animals', 'Biological Products/chemistry/*pharmacology', 'Humans', 'Monoamine Oxidase/*metabolism', 'Monoamine Oxidase Inhibitors/chemistry/*pharmacology', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/24218136/
1108,MAOB,37955252,Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer's disease.,"['Zou D', 'Liu R', 'Lv Y', 'Guo J', 'Zhang C', 'Xie Y']","['Humans', '*Monoamine Oxidase/metabolism', 'Acetylcholinesterase/metabolism', '*Alzheimer Disease/drug therapy', 'Monoamine Oxidase Inhibitors/pharmacology/chemistry', 'Molecular Docking Simulation', 'Cholinesterase Inhibitors/pharmacology/chemistry', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/37955252/
1109,MAOB,37375370,Structure-Based Design of Novel MAO-B Inhibitors: A Review.,"['Mateev E', 'Georgieva M', 'Mateeva A', 'Zlatkov A', 'Ahmad S', 'Raza K', 'Azevedo V', 'Barh D']","['Humans', '*Monoamine Oxidase Inhibitors/pharmacology/chemistry', 'Molecular Docking Simulation', '*Monoamine Oxidase/metabolism', 'Drug Discovery', 'Drug Design', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/37375370/
1110,MAOB,36307034,"The inhibition of monoamine oxidase by 2H-1,4-benzothiazin-3(4H)-ones.","['Hitge R', 'Petzer JP', 'Petzer A']","['Humans', '*Monoamine Oxidase Inhibitors/chemistry', '*Parkinson Disease/drug therapy', 'Molecular Docking Simulation', 'Structure-Activity Relationship', 'Monoamine Oxidase/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36307034/
1111,MAOB,2290855,Biochemistry and genetics of monoamine oxidase.,"['Weyler W', 'Hsu YP', 'Breakefield XO']","['Amino Acid Sequence', 'Animals', 'Humans', 'Molecular Sequence Data', 'Monoamine Oxidase/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/2290855/
1112,MAOB,15461973,[MAOB: a modifier gene in phenylketonuria?].,"['Ghozlan A', 'Munnich A']","['Genes, Recessive', 'Humans', 'Infant, Newborn', 'Monoamine Oxidase/*genetics', 'Phenethylamines/metabolism', 'Phenylalanine/metabolism', 'Phenylalanine Hydroxylase/deficiency', 'Phenylketonurias/enzymology/*genetics']",https://pubmed.ncbi.nlm.nih.gov/15461973/
1113,MAOB,39107307,Stanniocalcin 2 governs cancer cell adaptation to nutrient insufficiency through alleviation of oxidative stress.,"['Qie S', 'Xiong H', 'Liu Y', 'Yan C', 'Wang Y', 'Tian L', 'Wang C', 'Sang N']","['Humans', '*Glycoproteins/metabolism', 'Animals', '*Oxidative Stress', 'Mice', '*Intercellular Signaling Peptides and Proteins/metabolism/genetics', 'Cell Line, Tumor', 'Reactive Oxygen Species/metabolism', 'Cell Proliferation', 'Neoplasms/metabolism/genetics/pathology', 'Apoptosis/drug effects', 'Nutrients/metabolism', 'Mice, Nude', 'Adaptation, Physiological', 'Gene Expression Regulation, Neoplastic']",https://pubmed.ncbi.nlm.nih.gov/39107307/
1114,MAOB,26964906,The role of MAO in personality and drug use.,"['Harro J', 'Oreland L']","['Animals', 'Humans', 'Monoamine Oxidase/*genetics/*metabolism', 'Personality/*genetics/*physiology', 'Sex Characteristics', 'Substance-Related Disorders/*enzymology/*genetics']",https://pubmed.ncbi.nlm.nih.gov/26964906/
1115,MAOB,33047950,(Hetero-)(arylidene)arylhydrazides as Multitarget-Directed Monoamine Oxidase Inhibitors.,"['Palakkathondi A', 'Oh JM', 'Dev S', 'Rangarajan TM', 'Kaipakasseri S', 'Kavully FS', 'Gambacorta N', 'Nicolotti O', 'Kim H', 'Mathew B']","['Acetylcholinesterase/metabolism', 'AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase/metabolism', 'Drug Design', 'Humans', 'Hydrazines/chemistry', 'Molecular Docking Simulation', 'Monoamine Oxidase/*metabolism', 'Monoamine Oxidase Inhibitors/*chemistry/pharmacology', 'Neurodegenerative Diseases/*drug therapy', 'Neuroprotective Agents/*chemistry/pharmacology', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/33047950/
1116,MAOB,36705300,Immune-based prognostic biomarkers associated with metastasis of osteosarcoma.,"['Ma T', 'Peng C', 'Wu D', 'Yang S', 'Ji L', 'Cheng Z', 'Gao C']","['Humans', 'Prognosis', '*MicroRNAs/metabolism', 'Biomarkers', 'Gene Expression Profiling', '*Osteosarcoma/genetics/pathology', 'Carrier Proteins/genetics', 'Glycoproteins/genetics/metabolism', 'Extracellular Matrix Proteins/genetics/metabolism', 'Kinesins/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36705300/
1117,MAOB,23111930,MAOA and MAOB polymorphisms and anger-related traits in suicidal participants and controls.,"['Antypa N', 'Giegling I', 'Calati R', 'Schneider B', 'Hartmann AM', 'Friedl M', 'Konte B', 'Lia L', 'De Ronchi D', 'Serretti A', 'Rujescu D']","['Adult', 'Aged', 'Aggression', 'Analysis of Variance', 'Anger/*physiology', 'DNA Mutational Analysis', 'Female', 'Humans', 'Male', 'Middle Aged', 'Monoamine Oxidase/*genetics', 'Polymorphism, Single Nucleotide/*genetics', 'Sex Factors', '*Suicide', 'Surveys and Questionnaires']",https://pubmed.ncbi.nlm.nih.gov/23111930/
1118,MAOB,22890201,Monoamine oxidases in major depressive disorder and alcoholism.,"['Duncan J', 'Johnson S', 'Ou XM']","['Alcoholism/*enzymology/etiology', 'Apoptosis Regulatory Proteins', 'Cell Cycle Proteins/physiology', 'Depressive Disorder, Major/*enzymology/etiology', 'Humans', 'Monoamine Oxidase/genetics/*physiology', 'Repressor Proteins/physiology', 'Stress, Psychological/enzymology', 'Transcription, Genetic']",https://pubmed.ncbi.nlm.nih.gov/22890201/
1119,MAOB,31834986,Monoamine oxidase inhibition by selected dye compounds.,"['de Beer F', 'Petzer JP', 'Petzer A']","['Acridine Orange/pharmacology', 'Anthraquinones/pharmacology', 'Azure Stains/pharmacology', 'Coloring Agents/*chemistry/pharmacology', 'Drug Design', 'Humans', 'Methylene Blue/pharmacology', 'Monoamine Oxidase/*metabolism', 'Monoamine Oxidase Inhibitors/*chemistry/pharmacology', 'Neurodegenerative Diseases/*drug therapy', 'Neuroprotective Agents/*chemistry/pharmacology', 'Oxazines/pharmacology', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/31834986/
1120,MAOB,36179486,Isatoic anhydrides as novel inhibitors of monoamine oxidase.,"['Hitge R', 'Petzer A', 'Petzer JP']","['Acetylcholinesterase/metabolism', 'Amines', 'Amino Acids', 'Anhydrides', 'Butyrylcholinesterase/metabolism', 'Cholinesterase Inhibitors/pharmacology', 'Humans', 'Molecular Docking Simulation', 'Monoamine Oxidase/metabolism', '*Monoamine Oxidase Inhibitors/chemistry', 'Phthalimides', 'Protein Isoforms/metabolism', '*Quinolones', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/36179486/
1121,MAOB,36934384,"Monoamine oxidase inhibition properties of 2,1-benzisoxazole derivatives.","['Shetnev A', 'Kotov A', 'Kunichkina A', 'Proskurina I', 'Baykov S', 'Korsakov M', 'Petzer A', 'Petzer JP']","['*Monoamine Oxidase Inhibitors/pharmacology/chemistry', '*Isoxazoles/pharmacology/chemistry', '*Monoamine Oxidase/metabolism', 'Humans', 'Structure-Activity Relationship', 'Molecular Docking Simulation']",https://pubmed.ncbi.nlm.nih.gov/36934384/
1122,MAOB,37549764,Monoamine oxidase B inhibitors based on natural privileged scaffolds: A review of systematically structural modification.,"['Lv Y', 'Zheng Z', 'Liu R', 'Guo J', 'Zhang C', 'Xie Y']","['*Monoamine Oxidase Inhibitors/chemistry/pharmacology', '*Monoamine Oxidase/metabolism/chemistry', 'Humans', 'Structure-Activity Relationship', '*Biological Products/chemistry/pharmacology', 'Animals']",https://pubmed.ncbi.nlm.nih.gov/37549764/
1123,MAOB,21971000,Structural properties of human monoamine oxidases A and B.,"['Binda C', 'Mattevi A', 'Edmondson DE']","['Animals', 'Crystallography, X-Ray', 'Humans', 'Isoenzymes/chemistry/metabolism/physiology', 'Membrane Proteins/chemistry/metabolism/physiology', 'Monoamine Oxidase/*chemistry/metabolism/physiology', 'Protein Multimerization', 'Rats', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/21971000/
1124,MAOB,33376014,"Investigation of pyrazolo[1,5-a]quinoxalin-4-ones as novel monoamine oxidase inhibitors.","['Panova VA', 'Filimonov SI', 'Chirkova ZV', 'Kabanova MV', 'Shetnev AA', 'Korsakov MK', 'Petzer A', 'Petzer JP', 'Suponitsky KY']","['Dose-Response Relationship, Drug', 'Humans', 'Models, Molecular', 'Molecular Structure', 'Monoamine Oxidase/*metabolism', 'Monoamine Oxidase Inhibitors/chemical synthesis/chemistry/*pharmacology', 'Quinoxalines/chemical synthesis/chemistry/*pharmacology', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/33376014/
1125,CA12,39515331,CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity.,"['Liu C', 'Shen M', 'Liu Y', 'Manhas A', 'Zhao SR', 'Zhang M', 'Belbachir N', 'Ren L', 'Zhang JZ', 'Caudal A', 'Nishiga M', 'Thomas D', 'Zhang A', 'Yang H', 'Zhou Y', 'Ameen M', 'Sayed N', 'Rhee JW', 'Qi LS', 'Wu JC']","['*Induced Pluripotent Stem Cells/metabolism/drug effects', 'Humans', '*Doxorubicin/pharmacology', '*Myocytes, Cardiac/metabolism/drug effects/pathology', '*Cardiotoxicity/metabolism', '*Glycolysis/drug effects', 'Animals', 'Carbonic Anhydrases/metabolism', 'Mice']",https://pubmed.ncbi.nlm.nih.gov/39515331/
1126,CA12,39475639,A comprehensive transcriptome characterization of individual nuclear receptor pathways in the human small intestine.,"['Willemsen S', 'Yengej FAY', 'Puschhof J', 'Rookmaaker MB', 'Verhaar MC', 'van Es J', 'Beumer J', 'Clevers H']","['Humans', '*Intestine, Small/metabolism', '*Receptors, Cytoplasmic and Nuclear/metabolism/genetics', '*Transcriptome', 'Receptors, Calcitriol/metabolism/genetics', 'Liver X Receptors/metabolism/genetics/agonists', 'Organoids/metabolism', 'Signal Transduction', 'Lipid Metabolism/genetics', 'Enterocytes/metabolism', 'Pregnane X Receptor/metabolism/genetics', 'Gene Expression Regulation/drug effects']",https://pubmed.ncbi.nlm.nih.gov/39475639/
1127,CA12,35229335,Correlation between CA12 and TFF3 and their prediction value of neoadjuvant chemotherapy response in breast cancer.,"['Shen M', 'Yang L', 'Lei T', 'Zhang P', 'Xiao L', 'Cao S', 'Chen F', 'Li L', 'Ye F', 'Bu H']","['Antineoplastic Combined Chemotherapy Protocols/pharmacology/therapeutic use', '*Breast Neoplasms/drug therapy/genetics/pathology', 'Carbonic Anhydrases', 'Docetaxel/pharmacology', 'Doxorubicin/therapeutic use', 'Female', 'Humans', '*Neoadjuvant Therapy', 'RNA, Messenger', 'Receptors, Estrogen/metabolism/therapeutic use', 'Trefoil Factor-3/genetics']",https://pubmed.ncbi.nlm.nih.gov/35229335/
1128,CA12,38334254,MRI biomarkers and neuropsychological assessments of hippocampal and parahippocampal regions affected by ALS: A systematic review.,"['Mohammadi S', 'Ghaderi S', 'Fatehi F']","['Humans', '*Hippocampus/diagnostic imaging/pathology', '*Amyotrophic Lateral Sclerosis/diagnostic imaging/psychology/pathology/metabolism', '*Magnetic Resonance Imaging', '*Neuropsychological Tests', '*Biomarkers/metabolism', 'Parahippocampal Gyrus/diagnostic imaging/pathology']",https://pubmed.ncbi.nlm.nih.gov/38334254/
1129,CA12,34083809,The role of HIF proteins in maintaining the metabolic health of the intervertebral disc.,"['Silagi ES', 'Schipani E', 'Shapiro IM', 'Risbud MV']","['Animals', 'Basic Helix-Loop-Helix Transcription Factors/metabolism/physiology', 'Humans', 'Hypoxia/metabolism', 'Hypoxia-Inducible Factor 1/metabolism/*physiology', 'Intervertebral Disc/*metabolism/physiology']",https://pubmed.ncbi.nlm.nih.gov/34083809/
1130,CA12,31900648,Multifocal electroretinography in amblyopia.,"['Al-Haddad C', 'Bou Ghannam A', 'El Moussawi Z', 'Rachid E', 'Ismail K', 'Atallah M', 'Smeets L', 'Chahine H']","['Adolescent', 'Amblyopia/diagnosis/*physiopathology', 'Child', 'Electroretinography', 'Evoked Potentials, Visual/*physiology', 'Female', 'Humans', 'Male', 'Nerve Fibers/pathology', 'Prospective Studies', 'Retina/diagnostic imaging/*physiopathology', 'Tomography, Optical Coherence/*methods', '*Visual Acuity', 'Visual Fields/*physiology']",https://pubmed.ncbi.nlm.nih.gov/31900648/
1131,CA12,38515178,"Auranofin repurposing for lung and pancreatic cancer: low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition.","['Deben C', 'Boullosa LF', 'Fortes FR', 'De La Hoz EC', 'Le Compte M', 'Seghers S', 'Peeters M', 'Vanlanduit S', 'Lin A', 'Dijkstra KK', 'Van Schil P', 'Hendriks JMH', 'Prenen H', 'Roeyen G', 'Lardon F', 'Smits E']","['Humans', 'Auranofin/pharmacology/therapeutic use', '*Carcinoma, Non-Small-Cell Lung/pathology', 'Proto-Oncogene Proteins c-akt/metabolism', '*Lung Neoplasms/genetics', 'Drug Repositioning', '*Pancreatic Neoplasms/pathology', '*Carcinoma, Pancreatic Ductal/drug therapy', '*Adenocarcinoma/drug therapy', '*Antineoplastic Agents/pharmacology/therapeutic use', 'Lung/pathology', 'Biomarkers', 'Organoids/metabolism', '*Carbonic Anhydrases']",https://pubmed.ncbi.nlm.nih.gov/38515178/
1132,CA12,37535601,"TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach.","['Cheraghi-Shavi T', 'Jalal R', 'Minuchehr Z']","['Humans', 'Oxaliplatin/pharmacology/therapeutic use', '*Galectin 4/genetics/metabolism', '*Colorectal Neoplasms/drug therapy/genetics/metabolism', 'Systems Biology', 'Biomarkers, Tumor/genetics/metabolism', 'Transcription Factors/genetics', 'Gene Expression Regulation, Neoplastic', 'Drug Resistance, Neoplasm/genetics', 'Computational Biology', 'Membrane Proteins/genetics', 'Neoplasm Proteins/genetics/metabolism', 'Aldehyde Dehydrogenase, Mitochondrial/genetics']",https://pubmed.ncbi.nlm.nih.gov/37535601/
1133,CA12,33528822,Gene therapy in color vision deficiency: a review.,"['El Moussawi Z', 'Boueiri M', 'Al-Haddad C']","['Animals', '*Color Vision Defects/genetics/therapy', 'Cyclic Nucleotide-Gated Cation Channels/genetics', 'Electroretinography', 'Genetic Therapy', 'Humans', 'Mutation', 'Retinal Cone Photoreceptor Cells']",https://pubmed.ncbi.nlm.nih.gov/33528822/
1134,CA12,35362482,An acid trip activates protumoral macrophages to promote hepatocellular carcinoma malignancy.,"['Graham N', 'Pollard JW']","['Animals', '*Carcinoma, Hepatocellular/genetics', '*Liver Neoplasms/metabolism', 'Macrophages/metabolism', 'Mice', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/35362482/
1135,CA12,35362480,Carbonic anhydrase XII mediates the survival and prometastatic functions of macrophages in human hepatocellular carcinoma.,"['Ning WR', 'Jiang D', 'Liu XC', 'Huang YF', 'Peng ZP', 'Jiang ZZ', 'Kang T', 'Zhuang SM', 'Wu Y', 'Zheng L']","['Animals', '*Carbonic Anhydrases/genetics/metabolism', '*Carcinoma, Hepatocellular/metabolism', 'Humans', '*Liver Neoplasms/metabolism', 'Macrophages/metabolism', 'Mice', 'Tumor Microenvironment']",https://pubmed.ncbi.nlm.nih.gov/35362480/
1136,CA12,37198621,Revealing platelet-related subtypes and prognostic signature in pancreatic adenocarcinoma.,"['Zhao JG', 'Li YJ', 'Wu Y', 'Zhang K', 'Peng LJ', 'Chen H']","['Humans', '*Adenocarcinoma/genetics', '*Pancreatic Neoplasms/genetics', 'Prognosis', 'Blood Platelets', 'Cell Cycle Proteins']",https://pubmed.ncbi.nlm.nih.gov/37198621/
1137,CA12,19828359,Saliva as a tool for oral cancer diagnosis and prognosis.,['Nagler RM'],"['Biomarkers, Tumor/*analysis/genetics', 'Humans', 'Methylation', 'Mouth Neoplasms/*diagnosis', 'Oxidative Stress', 'Prognosis', 'Saliva/*chemistry']",https://pubmed.ncbi.nlm.nih.gov/19828359/
1138,CA12,27765277,Ovarian cancer presenting as an axillary mass: Case series and literature review.,"['Ilhan B', 'Kilic B', 'Karanlik H']","['Aged', 'Aged, 80 and over', '*Axilla', 'Biomarkers, Tumor', 'Breast Neoplasms/diagnosis', 'CA-125 Antigen/analysis', 'Carcinoma/chemistry/diagnosis/*secondary', 'Carrier Proteins/analysis', 'Diagnosis, Differential', 'Female', 'Glycoproteins/analysis', 'Humans', 'Lymphatic Metastasis/*diagnosis', 'Membrane Transport Proteins', 'Middle Aged', 'Ovarian Neoplasms/chemistry/*diagnosis/pathology', 'PAX8 Transcription Factor/analysis', 'WT1 Proteins/analysis']",https://pubmed.ncbi.nlm.nih.gov/27765277/
1139,CA12,33387040,Overexpressed CA12 has prognostic value in pancreatic cancer and promotes tumor cell apoptosis via NF-kappaB signaling.,"['Du Y', 'Xin Z', 'Liu T', 'Xu P', 'Mao F', 'Yao J']","['Adenocarcinoma/genetics/pathology', 'Apoptosis/*genetics', 'Carbonic Anhydrases/*genetics', 'Cell Line, Tumor', 'Cell Proliferation/genetics', 'Down-Regulation/genetics', 'Female', 'G1 Phase Cell Cycle Checkpoints/genetics', 'Gene Expression Regulation, Neoplastic/genetics', 'Humans', 'Male', 'Middle Aged', 'NF-kappa B/*genetics', 'Pancreatic Neoplasms/*genetics/pathology', 'Prognosis', 'Resting Phase, Cell Cycle/genetics', 'Signal Transduction/*genetics']",https://pubmed.ncbi.nlm.nih.gov/33387040/
1140,CA12,34978651,Characteristics and long-term surgical outcomes of horizontal strabismus.,"['Dakroub M', 'El Hadi D', 'El Moussawi Z', 'Ibrahim P', 'Al-Haddad C']","['*Esotropia/surgery', '*Exotropia/surgery', 'Follow-Up Studies', 'Humans', 'Oculomotor Muscles/surgery', 'Ophthalmologic Surgical Procedures/methods', 'Retrospective Studies', '*Strabismus/surgery', 'Treatment Outcome', 'Vision, Binocular/physiology']",https://pubmed.ncbi.nlm.nih.gov/34978651/
1141,CA12,33960436,Screening of tumor grade-related mRNAs and lncRNAs for Esophagus Squamous Cell Carcinoma.,"['Gao X', 'Liu Q', 'Chen X', 'Chen S', 'Yang J', 'Liu Q', 'Cheng Y']","['Biomarkers, Tumor/*genetics', 'Computational Biology/*methods', 'Esophageal Neoplasms/genetics/*pathology', 'Esophageal Squamous Cell Carcinoma/genetics/*pathology', 'Gene Expression Profiling', '*Gene Expression Regulation, Neoplastic', 'Gene Regulatory Networks', 'Humans', 'Neoplasm Grading', 'RNA, Long Noncoding/*genetics', 'RNA, Messenger/*genetics']",https://pubmed.ncbi.nlm.nih.gov/33960436/
1142,CA12,26864256,"Tumor metabolism, cancer cell transporters, and microenvironmental resistance.",['Alfarouk KO'],"['Animals', 'Antineoplastic Agents/*pharmacology/therapeutic use', 'Drug Resistance, Neoplasm/*drug effects', 'Humans', 'Hydrogen-Ion Concentration', 'Neoplasms/drug therapy/*metabolism/*pathology', 'Treatment Failure', 'Tumor Microenvironment/*drug effects']",https://pubmed.ncbi.nlm.nih.gov/26864256/
1143,CA4,31182966,Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer.,"['Bao Y', 'Wang L', 'Shi L', 'Yun F', 'Liu X', 'Chen Y', 'Chen C', 'Ren Y', 'Jia Y']","['Breast Neoplasms/*genetics', 'Down-Regulation/genetics', 'Female', '*Gene Expression Profiling', '*Gene Expression Regulation, Neoplastic', 'Humans', 'Neoplasm Proteins/genetics/metabolism', 'Receptors, Cell Surface/*metabolism', 'Reproducibility of Results', 'Sequence Analysis, RNA', 'Signal Transduction/*genetics', 'Transcriptome/genetics', 'Up-Regulation/genetics']",https://pubmed.ncbi.nlm.nih.gov/31182966/
1144,CA4,38228036,NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1.,"['Zhang Z', 'Song B', 'Wei H', 'Liu Y', 'Zhang W', 'Yang Y', 'Sun B']","['Animals', 'Humans', 'Mice', '*Carcinoma, Pancreatic Ductal/drug therapy/genetics', 'Cell Line, Tumor', 'Disease Models, Animal', 'Histocompatibility Antigens Class I/genetics', 'Immunotherapy', '*Pancreatic Neoplasms/drug therapy/genetics', 'Tumor Microenvironment']",https://pubmed.ncbi.nlm.nih.gov/38228036/
1145,CA4,27156516,Review of Cytotoxic CA4 Analogues that Do Not Target Microtubules: Implications for CA4 Development.,"['Tarade D', 'Pandey S', 'McNulty J']","['Animals', 'Antineoplastic Agents/*chemistry/*pharmacology/therapeutic use/toxicity', 'Drug Discovery', 'Humans', 'Microtubules/drug effects/metabolism/pathology', 'Molecular Targeted Therapy', 'Neoplasms/*drug therapy/metabolism/pathology', 'Stilbenes/*chemistry/*pharmacology/therapeutic use/toxicity']",https://pubmed.ncbi.nlm.nih.gov/27156516/
1146,CA4,36995894,In-depth proteomic signature of parathyroid carcinoma.,"['Kong SH', 'Lee JH', 'Bae JM', 'Hong N', 'Kim H', 'Park SY', 'Choi YJ', 'Lee S', 'Rhee Y', 'Kim SW', 'Han D', 'Kim JH', 'Shin CS']","['Humans', 'Female', 'Middle Aged', 'Male', '*Parathyroid Neoplasms/metabolism', 'Retrospective Studies', 'Proteomics', 'Republic of Korea']",https://pubmed.ncbi.nlm.nih.gov/36995894/
1147,CA4,28460355,Development of combretastatins as potent tubulin polymerization inhibitors.,"['Bukhari SNA', 'Kumar GB', 'Revankar HM', 'Qin HL']","['Animals', 'Bibenzyls/chemistry/isolation & purification/*pharmacology', 'Humans', 'Plant Extracts/chemistry/isolation & purification/*pharmacology', 'Plants, Medicinal/*chemistry', 'Polymerization/*drug effects', 'South Africa', 'Tubulin/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/28460355/
1148,CA4,26831010,Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potential.,"['Xu T', 'Fan Z', 'Li W', 'Dietel B', 'Wu Y', 'Beckmann MW', 'Wrosch JK', 'Buchfelder M', 'Eyupoglu IY', 'Cao Z', 'Savaskan NE']","['Angiogenesis Inhibitors/chemistry/*pharmacology', 'Animals', 'Antineoplastic Agents/chemistry/*pharmacology', '*Brain Neoplasms/blood supply/drug therapy/metabolism/pathology', 'Cell Line, Tumor', 'Cell Proliferation/*drug effects', '*Glioma/blood supply/drug therapy/metabolism/pathology', 'Humans', '*Neovascularization, Pathologic/drug therapy/metabolism/pathology', 'Rats', 'Scorpion Venoms/chemistry/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/26831010/
1149,CA4,33721668,Combretastatin A4-derived payloads for antibody-drug conjugates.,"['Huang R', 'Sheng Y', 'Xu Z', 'Wei D', 'Song X', 'Jiang B', 'Chen H']","['Animals', 'Cell Line, Tumor', 'Cell Survival/drug effects', 'Cetuximab/*chemistry', 'Disulfides', 'Drug Design', 'Humans', 'Immunoconjugates/*chemistry/therapeutic use', 'Male', 'Mice', 'Mice, Inbred NOD', 'Neoplasms/drug therapy/pathology', 'Stilbenes/*chemistry', 'Transplantation, Heterologous']",https://pubmed.ncbi.nlm.nih.gov/33721668/
1150,CA4,24146387,Glaucoma and the applications of carbonic anhydrase inhibitors.,"['Scozzafava A', 'Supuran CT']","['Acetazolamide/therapeutic use', 'Carbonic Anhydrase II/antagonists & inhibitors/chemistry', 'Carbonic Anhydrase IV/antagonists & inhibitors/chemistry', 'Carbonic Anhydrase Inhibitors/chemistry/*therapeutic use', 'Carbonic Anhydrases/chemistry/metabolism', 'Glaucoma/*drug therapy/pathology', 'Humans', 'Intraocular Pressure/drug effects', 'Nitric Oxide/chemistry', '*Structure-Activity Relationship', 'Sulfanilamide', 'Sulfanilamides/*therapeutic use', 'Sulfonamides/therapeutic use', 'Thiazines/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/24146387/
1151,CA4,34856892,Recent Trends in Tubulin-Binding Combretastatin A-4 Analogs for Anticancer Drug Development.,"['Paidakula S', 'Nerella S', 'Kankala S', 'Kankala RK']","['*Antineoplastic Agents/chemistry/pharmacology/therapeutic use', 'Bibenzyls', 'Cell Line, Tumor', 'Cell Proliferation', 'Drug Design', 'Humans', '*Neoplasms/drug therapy', 'Stilbenes', 'Structure-Activity Relationship', 'Tubulin/metabolism', 'Tubulin Modulators/pharmacology/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/34856892/
1152,CA4,27377321,Tau pathology in Creutzfeldt-Jakob disease revisited.,"['Kovacs GG', 'Rahimi J', 'Strobel T', 'Lutz MI', 'Regelsberger G', 'Streichenberger N', 'Perret-Liaudet A', 'Hoftberger R', 'Liberski PP', 'Budka H', 'Sikorska B']","['Aged', 'Aged, 80 and over', 'Astrocytes/metabolism/pathology', 'Biomarkers/cerebrospinal fluid', 'Brain/metabolism/*pathology', 'Creutzfeldt-Jakob Syndrome/*complications/genetics/metabolism/*pathology', 'Female', 'Humans', 'Immunohistochemistry', 'Male', 'Middle Aged', 'Neurons/metabolism/pathology', 'Phosphorylation', 'Prion Proteins/genetics', 'Tauopathies/*complications/genetics/metabolism/*pathology', 'tau Proteins/metabolism']",https://pubmed.ncbi.nlm.nih.gov/27377321/
1153,CA4,38471818,CRISPR antiphage defence mediated by the cyclic nucleotide-binding membrane protein Csx23.,"['Gruschow S', 'McQuarrie S', 'Ackermann K', 'McMahon S', 'Bode BE', 'Gloster TM', 'White MF']","['Adenine Nucleotides/metabolism', '*CRISPR-Associated Proteins/metabolism', 'CRISPR-Cas Systems/genetics', 'Membrane Proteins/genetics/metabolism', 'Nucleotides, Cyclic', 'Second Messenger Systems', '*Bacterial Proteins/metabolism', '*Vibrio cholerae/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38471818/
1154,CA4,29865938,Ammon's Horn 2 (CA2) of the Hippocampus: A Long-Known Region with a New Potential Role in Neurodegeneration.,"['Pang CC', 'Kiecker C', ""O'Brien JT"", 'Noble W', 'Chang RC']","['Animals', 'Encephalitis/complications/metabolism', 'Hippocampus/*physiology/physiopathology', 'Humans', 'Lewy Body Disease/physiopathology', 'Neurodegenerative Diseases/complications/metabolism/*physiopathology', 'Parkinson Disease/physiopathology', 'alpha-Synuclein/metabolism']",https://pubmed.ncbi.nlm.nih.gov/29865938/
1155,CA4,31580244,Tubulin Inhibitors Binding to Colchicine-Site: A Review from 2015 to 2019.,"['Xia LY', 'Zhang YL', 'Yang R', 'Wang ZC', 'Lu YD', 'Wang BZ', 'Zhu HL']","['Antineoplastic Agents/pharmacology', 'Binding Sites', 'Cell Line, Tumor', 'Colchicine', 'Drug Screening Assays, Antitumor', 'Humans', 'Structure-Activity Relationship', 'Tubulin/metabolism', 'Tubulin Modulators/*chemistry/pharmacology/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/31580244/
1156,CA4,23818224,Tubulin-interactive stilbene derivatives as anticancer agents.,"['Mikstacka R', 'Stefanski T', 'Rozanski J']","['Antineoplastic Agents, Phytogenic/chemistry/metabolism/*therapeutic use', 'Binding, Competitive', 'Cell Survival/drug effects', 'Clinical Trials as Topic', 'Humans', 'Models, Molecular', 'Molecular Structure', 'Neoplasms/*drug therapy/pathology', 'Stilbenes/chemistry/metabolism/*therapeutic use', 'Tubulin/chemistry/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/23818224/
1157,CA4,30396033,Medicinal chemistry of vicinal diaryl scaffold: A mini review.,['Ramajayam R'],"['Carbonic Anhydrase IV', 'Chemistry, Pharmaceutical/*methods', 'Cyclooxygenase 2 Inhibitors', 'Drug Discovery', 'Humans', 'Hydrocarbons, Aromatic/*chemistry', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/30396033/
1158,CA4,31955294,Multimodal mapping and analysis of the cyto- and receptorarchitecture of the human hippocampus.,"['Palomero-Gallagher N', 'Kedo O', 'Mohlberg H', 'Zilles K', 'Amunts K']","['Aged', 'Autoradiography', 'Brain Mapping/methods', 'Female', 'Hippocampus/*cytology/*metabolism', 'Humans', 'Magnetic Resonance Imaging', 'Male', 'Middle Aged', 'Multimodal Imaging/methods', 'Neurons/*cytology/*metabolism', 'Receptors, Neurotransmitter/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/31955294/
1159,CA4,33539623,Expression of reelin with age in the human hippocampal formation.,"['Despotovski V', 'Vivekanandarajah A', 'Waters KA', 'Machaalani R']","['Animals', 'Cerebral Cortex/metabolism', 'Child, Preschool', '*Hippocampus/metabolism', 'Humans', '*Nerve Tissue Proteins/metabolism', 'Neurogenesis', 'Neurons/physiology']",https://pubmed.ncbi.nlm.nih.gov/33539623/
1160,CA4,21143124,Developments of combretastatin A-4 derivatives as anticancer agents.,"['Shan Y', 'Zhang J', 'Liu Z', 'Wang M', 'Dong Y']","['Antineoplastic Agents/*chemistry/therapeutic use', 'Combretum/chemistry', 'Humans', 'Neoplasms/drug therapy', 'Stilbenes/*chemistry/therapeutic use', 'Tubulin/chemistry/metabolism', 'Tubulin Modulators/chemistry/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/21143124/
1161,CA4,26899186,Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site.,"['Wu X', 'Wang Q', 'Li W']","['Antineoplastic Agents/*chemistry/*pharmacology', 'Binding Sites', 'Chalcones/chemistry', 'Colchicine/*metabolism', 'Humans', 'Molecular Structure', 'Molecular Targeted Therapy/methods', 'Stilbenes/chemistry', 'Tubulin/chemistry/*metabolism', 'Tubulin Modulators/chemistry/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/26899186/
1162,CA4,32061961,Developments of isoCombretastatin A-4 derivatives as highly cytotoxic agents.,"['Hamze A', 'Alami M', 'Provot O']","['Animals', 'Antineoplastic Agents/chemistry/*pharmacology', 'Cell Line, Tumor', 'Humans', 'Molecular Structure', 'Stilbenes/chemistry/*pharmacology', 'Structure-Activity Relationship', 'Tubulin Modulators/chemistry/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/32061961/
1163,CA7,38557358,BEST4(+) cells in the intestinal epithelium.,"['Malonga T', 'Vialaneix N', 'Beaumont M']","['Animals', 'Humans', '*Intestinal Mucosa/metabolism', 'Bestrophins/metabolism/genetics', 'Rabbits', 'Epithelial Cells/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38557358/
1164,CA7,25885898,Prognostic value of carbonic anhydrase VII expression in colorectal carcinoma.,"['Yang GZ', 'Hu L', 'Cai J', 'Chen HY', 'Zhang Y', 'Feng D', 'Qi CY', 'Zhai YX', 'Gong H', 'Fu H', 'Cai QP', 'Gao CF']","['Aged', 'Biomarkers, Tumor/*biosynthesis/genetics', 'Carbonic Anhydrases/*biosynthesis/genetics', 'China', 'Colorectal Neoplasms/*genetics/pathology', 'Female', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Kaplan-Meier Estimate', 'Male', 'Middle Aged', 'Neoplasm Staging', '*Prognosis', 'RNA, Messenger/biosynthesis']",https://pubmed.ncbi.nlm.nih.gov/25885898/
1165,CA7,39691454,Development of the Curcumin Analog CA7 Liposome and Its Evaluation for Efficacy Against Cervical Cancer in vitro and in vivo.,"['Xiong L', 'Wei Y', 'Si H', 'Li Z', 'Wen J', 'Liu F', 'Wang X', 'Yang H', 'Chen L', 'Pi C', 'Han Y', 'Zhao L']","['*Liposomes/chemistry/pharmacokinetics', 'Animals', 'Humans', 'HeLa Cells', '*Uterine Cervical Neoplasms/drug therapy/pathology', 'Female', '*Curcumin/chemistry/pharmacology/pharmacokinetics', 'Mice', 'Particle Size', 'Antineoplastic Agents/chemistry/pharmacology/pharmacokinetics', 'Apoptosis/drug effects', 'Mice, Inbred BALB C', 'Rats, Sprague-Dawley', 'Cell Proliferation/drug effects', 'Xenograft Model Antitumor Assays', 'Drug Liberation']",https://pubmed.ncbi.nlm.nih.gov/39691454/
1166,CA7,37895185,"Unlocking the Potential of the CA2, CA7, and ITM2C Gene Signatures for the Early Detection of Colorectal Cancer: A Comprehensive Analysis of RNA-Seq Data by Utilizing Machine Learning Algorithms.","['Maurya NS', 'Kushwaha S', 'Vetukuri RR', 'Mani A']","['Humans', 'Algorithms', 'Bayes Theorem', '*Colorectal Neoplasms/diagnosis/genetics', '*Early Detection of Cancer', 'Machine Learning', 'RNA-Seq']",https://pubmed.ncbi.nlm.nih.gov/37895185/
1167,CA7,30957640,Long noncoding RNA CA7-4 promotes autophagy and apoptosis via sponging MIR877-3P and MIR5680 in high glucose-induced vascular endothelial cells.,"['Zhao X', 'Su L', 'He X', 'Zhao B', 'Miao J']","['Apoptosis/*genetics', 'Apoptosis Regulatory Proteins/metabolism', 'Autophagy/*genetics/physiology', 'Endothelial Cells/*metabolism', 'Glucose/metabolism', 'Humans', 'RNA, Long Noncoding/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30957640/
1168,CA7,29788743,Novel insights into transcriptional dysregulation in colorectal cancer.,"['Feodorova Y', 'Tashkova D', 'Koev I', 'Todorov A', 'Kostov G', 'Simitchiev K', 'Belovejdov V', 'Dimov R', 'Sarafian V']","['Colorectal Neoplasms/*genetics', '*Gene Expression Regulation, Neoplastic', 'Humans', 'Mutation', 'Prognosis', 'Proto-Oncogene Proteins p21(ras)/*genetics']",https://pubmed.ncbi.nlm.nih.gov/29788743/
1169,CA7,26208990,"Gene-expression analysis of a colorectal cancer-specific discriminatory transcript set on formalin-fixed, paraffin-embedded (FFPE) tissue samples.","['Kalmar A', 'Wichmann B', 'Galamb O', 'Spisak S', 'Toth K', 'Leiszter K', 'Nielsen BS', 'Bartak BK', 'Tulassay Z', 'Molnar B']","['Area Under Curve', 'Biomarkers, Tumor/*analysis/genetics', 'Colorectal Neoplasms/*genetics', 'Formaldehyde', 'Gene Expression Profiling/*methods', 'Humans', 'In Situ Hybridization', 'Paraffin Embedding', 'ROC Curve', 'Real-Time Polymerase Chain Reaction', 'Sensitivity and Specificity', 'Tissue Fixation']",https://pubmed.ncbi.nlm.nih.gov/26208990/
1170,CA7,28260338,[Genotyping by CRISPR and regional distribution of Yersinia pestis in Qinghai-plateau from 1954 to 2011].,"['Xu XQ', 'Xin YQ', 'Li X', 'Zhang QW', 'Yang XY', 'Jin Y', 'Zhao HH', 'Jin X', 'Qi ZZ']","['Animals', 'Base Sequence', 'Clustered Regularly Interspaced Short Palindromic Repeats/*genetics', 'Genotype', 'Humans', 'Plague/*genetics', '*Polymorphism, Genetic', 'Yersinia pestis/*genetics/isolation & purification']",https://pubmed.ncbi.nlm.nih.gov/28260338/
1171,CA7,28002487,Long-Term Transcriptomic Effects of Prebiotics and Synbiotics Delivered In Ovo in Broiler Chickens.,"['Slawinska A', 'Plowiec A', 'Siwek M', 'Jaroszewski M', 'Bednarczyk M']","['Animals', 'Chickens/*genetics/growth & development/metabolism', 'Down-Regulation', 'Female', 'Immunity, Cellular/physiology', 'Immunity, Humoral/physiology', 'Intestine, Large/metabolism', 'Male', 'Oligonucleotide Array Sequence Analysis', 'Ovum/metabolism', '*Prebiotics', 'Real-Time Polymerase Chain Reaction', 'Spleen/metabolism', '*Synbiotics', '*Transcriptome', 'Up-Regulation']",https://pubmed.ncbi.nlm.nih.gov/28002487/
1172,CA7,29668045,When does the influence of maturation on anthropometric and physical fitness characteristics increase and subside?,"['Towlson C', 'Cobley S', 'Parkin G', 'Lovell R']","['Adolescent', 'Adolescent Development', '*Anthropometry', 'Athletes', 'Athletic Performance/*physiology', 'Body Height', 'Body Weight', 'Child', 'Humans', '*Physical Fitness', 'Soccer']",https://pubmed.ncbi.nlm.nih.gov/29668045/
1173,CA7,35114976,Uncovering potential genes in colorectal cancer based on integrated and DNA methylation analysis in the gene expression omnibus database.,"['Wang G', 'Wang F', 'Meng Z', 'Wang N', 'Zhou C', 'Zhang J', 'Zhao L', 'Wang G', 'Shan B']","['Biomarkers, Tumor/*genetics', 'Carcinogenesis/*genetics', 'Colorectal Neoplasms/diagnosis/*genetics/pathology', '*DNA Methylation', 'Databases, Genetic/statistics & numerical data', 'Datasets as Topic', 'Female', 'Gene Expression Profiling', '*Gene Expression Regulation, Neoplastic', 'Humans', 'Male', 'Middle Aged', 'Prognosis', 'Signal Transduction', 'Transcriptome']",https://pubmed.ncbi.nlm.nih.gov/35114976/
1174,CA7,38056601,In-vitro and in-silico anti-HSV-1 activity of a marine steroid from the jellyfish Cassiopea andromeda venom.,"['Shamsian S', 'Nabipour I', 'Mohebbi G', 'Baghban N', 'Zare M', 'Zandi K', 'Vazirizadeh A', 'Maryamabadi A', 'Delattre C']","['Chlorocebus aethiops', 'Animals', 'Mice', '*Herpesvirus 1, Human', 'Antiviral Agents/pharmacology/chemistry', 'Vero Cells', 'Thymidine Kinase/genetics/chemistry', '*Cnidarian Venoms/pharmacology', 'Steroids/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/38056601/
1175,CA7,35141800,Mitochondrial DNA (CA)(n) dinucleotide repeat variations in Sinhalese and Vedda populations in Sri Lanka.,"['Welikala AHJ', 'Ranasinghe R', 'Tennekoon KH', 'Kotelawala JT', 'Weerasooriya PR']","['*DNA, Mitochondrial/genetics', '*Dinucleotide Repeats', 'Ethnicity', 'Humans', 'Sri Lanka']",https://pubmed.ncbi.nlm.nih.gov/35141800/
1176,CA7,34153790,Machine learning and network-based models to identify genetic risk factors to the progression and survival of colorectal cancer.,"['Hossain MJ', 'Chowdhury UN', 'Islam MB', 'Uddin S', 'Ahmed MB', 'Quinn JMW', 'Moni MA']","['Biomarkers, Tumor/genetics', '*Colorectal Neoplasms/genetics', 'Cytoskeletal Proteins', 'Databases, Genetic', 'GTPase-Activating Proteins', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Machine Learning', 'Muscle Proteins', 'Risk Factors', 'Transcriptome']",https://pubmed.ncbi.nlm.nih.gov/34153790/
1177,CA7,20405109,Age-related changes in bone structure and strength in female and male BALB/c mice.,"['Willinghamm MD', 'Brodt MD', 'Lee KL', 'Stephens AL', 'Ye J', 'Silva MJ']","['Aging/*pathology/*physiology', 'Animals', 'Bone Density', 'Bone and Bones/*anatomy & histology/diagnostic imaging/*physiology', 'Compressive Strength', 'Female', 'Male', 'Mice', 'Mice, Inbred BALB C', 'Stress, Mechanical', 'Tomography, X-Ray Computed']",https://pubmed.ncbi.nlm.nih.gov/20405109/
1178,CA7,11709519,Bile acid metabolism by fresh human colonic contents: a comparison of caecal versus faecal samples.,"['Thomas LA', 'Veysey MJ', 'French G', 'Hylemon PB', 'Murphy GM', 'Dowling RH']","['Aged', 'Amidohydrolases/analysis/*metabolism', 'Cecum', 'Cholelithiasis/*metabolism', 'Cholic Acid/analysis/*metabolism', 'Deoxycholic Acid/blood/*metabolism', 'Feces/enzymology', 'Female', 'Gastrointestinal Contents/*chemistry', 'Humans', '*Hydroxysteroid Dehydrogenases', 'Male', 'Middle Aged', '*Oxidoreductases', 'Steroid Hydroxylases/blood/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/11709519/
1179,CA7,24648190,Synthesis and characterization of new curcumin derivatives as potential chemotherapeutic and antioxidant agents.,"['Ciochina R', 'Savella C', 'Cote B', 'Chang D', 'Rao D']","['Antineoplastic Agents, Phytogenic/*chemical synthesis/pharmacology', 'Antioxidants/*chemical synthesis/chemistry/pharmacology', 'Biphenyl Compounds/chemistry', 'Cell Line, Tumor', 'Cell Survival/drug effects', 'Curcumin/*analogs & derivatives/*chemical synthesis/chemistry/pharmacology', 'Free Radicals/chemistry', 'Humans', 'Molecular Structure', 'Picrates/chemistry', 'Solubility', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/24648190/
1180,CA7,24722189,Time course of physiological and psychological responses in humans during a 20-day severe-cold-acclimation programme.,"['Brazaitis M', 'Eimantas N', 'Daniuseviciute L', 'Baranauskiene N', 'Skrodeniene E', 'Skurvydas A']","['Acclimatization/*physiology', 'Body Temperature/*physiology', '*Cold Temperature', 'Heart Rate/*physiology', 'Humans', 'Male', 'Oxygen Consumption/physiology', 'Stress, Physiological/*physiology', 'Stress, Psychological/*physiopathology', 'Time Factors', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/24722189/
1181,CA13,39394562,Genetic architectures of the human hippocampus and those involved in neuropsychiatric traits.,"['Ning C', 'Jin M', 'Cai Y', 'Fan L', 'Hu K', 'Lu Z', 'Zhang M', 'Chen C', 'Li Y', 'Hu N', 'Zhang D', 'Liu Y', 'Chen S', 'Jiang Y', 'He C', 'Wang Z', 'Cao Z', 'Li H', 'Li G', 'Ma Q', 'Geng H', 'Tian W', 'Zhang H', 'Yang X', 'Huang C', 'Wei Y', 'Li B', 'Zhu Y', 'Li X', 'Miao X', 'Tian J']","['Humans', '*Hippocampus', '*Genome-Wide Association Study', 'Female', 'Male', 'Magnetic Resonance Imaging', 'Multifactorial Inheritance/genetics', 'Mental Disorders/genetics', 'Mendelian Randomization Analysis', 'Middle Aged', 'Genetic Predisposition to Disease', 'Aged']",https://pubmed.ncbi.nlm.nih.gov/39394562/
1182,CA13,39658621,IL-23R is a senescence-linked circulating and tissue biomarker of aging.,"['Carver CM', 'Rodriguez SL', 'Atkinson EJ', 'Dosch AJ', 'Asmussen NC', 'Gomez PT', 'Leitschuh EA', 'Espindola-Netto JM', 'Jeganathan KB', 'Whaley MG', 'Kamenecka TM', 'Baker DJ', 'Haak AJ', 'LeBrasseur NK', 'Schafer MJ']","['Animals', '*Aging/metabolism', '*Cellular Senescence/drug effects', 'Mice', 'Male', '*Biomarkers/metabolism/blood', 'Humans', 'Female', '*Receptors, Interleukin/metabolism/genetics', 'Sulfonamides/pharmacology', 'Senotherapeutics/pharmacology', 'Bridged Bicyclo Compounds, Heterocyclic/pharmacology', 'Aniline Compounds/pharmacology', 'Flavonoids/pharmacology', 'Senescence-Associated Secretory Phenotype', 'Mice, Transgenic', 'Flavonols']",https://pubmed.ncbi.nlm.nih.gov/39658621/
1183,CA13,33588197,Carbonic anhydrase 13 suppresses bone metastasis in breast cancer.,"['Yogosawa S', 'Nakayama J', 'Nishi M', 'Ryo A', 'Yoshida K']","['Animals', 'Biomarkers, Tumor/analysis/*metabolism', 'Bone Neoplasms/*genetics/mortality/secondary/therapy', 'Breast Neoplasms/genetics/mortality/*pathology/therapy', 'Carbonic Anhydrases/analysis/*metabolism', 'Cell Line, Tumor', 'Cell Movement/genetics', 'Disease-Free Survival', 'Female', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Macrophage Colony-Stimulating Factor/genetics', 'Mice', 'Neoplasm Invasiveness/genetics', 'Neoplasm Recurrence, Local/*epidemiology/genetics', 'Prognosis', 'Survival Rate', 'Vascular Endothelial Growth Factor A/genetics', 'Xenograft Model Antitumor Assays']",https://pubmed.ncbi.nlm.nih.gov/33588197/
1184,CA13,25429050,Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice.,"['Kortum B', 'Campregher C', 'Lang M', 'Khare V', 'Pinter M', 'Evstatiev R', 'Schmid G', 'Mittlbock M', 'Scharl T', 'Kucherlapati MH', 'Edelmann W', 'Gasche C']","['Animals', 'Anti-Inflammatory Agents, Non-Steroidal/pharmacology/*therapeutic use', 'Benzoquinones/pharmacology/*therapeutic use', 'Cell Proliferation/drug effects', 'Colorectal Neoplasms, Hereditary Nonpolyposis/genetics/pathology/*prevention & control', 'Disease Models, Animal', 'Female', 'Frameshift Mutation', 'HCT116 Cells', 'Humans', 'Intestinal Mucosa/metabolism', 'Male', 'Mesalamine/pharmacology/*therapeutic use', 'Mice', 'Microsatellite Instability/drug effects', 'MutS Homolog 2 Protein/*genetics/metabolism', 'Mutation Rate', 'Tumor Burden/drug effects']",https://pubmed.ncbi.nlm.nih.gov/25429050/
1185,CA13,33539623,Expression of reelin with age in the human hippocampal formation.,"['Despotovski V', 'Vivekanandarajah A', 'Waters KA', 'Machaalani R']","['Animals', 'Cerebral Cortex/metabolism', 'Child, Preschool', '*Hippocampus/metabolism', 'Humans', '*Nerve Tissue Proteins/metabolism', 'Neurogenesis', 'Neurons/physiology']",https://pubmed.ncbi.nlm.nih.gov/33539623/
1186,CA13,10662537,"Estrogen is more than just a ""sex hormone"": novel sites for estrogen action in the hippocampus and cerebral cortex.","['Shughrue PJ', 'Merchenthaler I']","['Animals', 'Cerebral Cortex/*physiology', 'Estrogen Receptor alpha', 'Estrogen Receptor beta', 'Estrogens/*physiology', 'Female', 'Hippocampus/*physiology', 'Humans', 'Neurodegenerative Diseases/physiopathology', 'Neurons/*physiology', 'Pyramidal Cells/physiology', 'Rats', 'Receptors, Estrogen/*genetics']",https://pubmed.ncbi.nlm.nih.gov/10662537/
1187,CA13,35056859,New Histamine-Related Five-Membered N-Heterocycle Derivatives as Carbonic Anhydrase I Activators.,"['Chiaramonte N', 'Gabellini A', 'Angeli A', 'Bartolucci G', 'Braconi L', 'Dei S', 'Teodori E', 'Supuran CT', 'Romanelli MN']","['Carbonic Anhydrase I/drug effects/*metabolism', 'Carbonic Anhydrase II/drug effects/metabolism', 'Carbonic Anhydrase V/drug effects/metabolism', 'Carbonic Anhydrases/drug effects/metabolism', 'Heterocyclic Compounds, 4 or More Rings/chemical synthesis/*chemistry/*pharmacology', 'Histamine/analogs & derivatives/chemical synthesis/*chemistry/*pharmacology', 'Humans', 'Imidazoles/chemistry', 'Protein Isoforms/drug effects/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35056859/
1188,CA13,39254209,Amygdala atrophies in specific subnuclei in preclinical Alzheimer's disease.,"['Salman Y', 'Gerard T', 'Huyghe L', 'Colmant L', 'Quenon L', 'Malotaux V', 'Ivanoiu A', 'Lhommel R', 'Dricot L', 'Hanseeuw BJ']","['Humans', '*Alzheimer Disease/pathology/diagnostic imaging', '*Amygdala/pathology/diagnostic imaging', 'Male', 'Female', '*Positron-Emission Tomography', 'Aged', '*Atrophy/pathology', '*Magnetic Resonance Imaging', '*tau Proteins/metabolism', 'Hippocampus/pathology/diagnostic imaging', 'Amyloid beta-Peptides/metabolism', 'Aged, 80 and over', 'Neuroimaging', 'Temporal Lobe/pathology/diagnostic imaging', 'Biomarkers']",https://pubmed.ncbi.nlm.nih.gov/39254209/
1189,CA13,39618045,Spike-In Proteome Enhances Data-Independent Acquisition for Thermal Proteome Profiling.,"['Wang Q', 'Chen Q', 'Lin Y', 'He D', 'Ji H', 'Tan CSH']","['*Proteome/analysis/metabolism', 'Humans', 'Proteomics/methods', 'Temperature']",https://pubmed.ncbi.nlm.nih.gov/39618045/
1190,CA13,16882331,Demonstration and characterization of mutations induced by Helicobacter pylori organisms in gastric epithelial cells.,"['Yao Y', 'Tao H', 'Park DI', 'Sepulveda JL', 'Sepulveda AR']","['Adaptor Proteins, Signal Transducing', 'Blotting, Western', 'Carrier Proteins/analysis', 'Cell Line', 'Coculture Techniques', 'DNA Methylation', 'DNA Mutational Analysis', 'Epithelial Cells/*microbiology', 'Escherichia coli', 'Gastric Mucosa/*microbiology', 'Genes, Reporter', 'Green Fluorescent Proteins/analysis/genetics', 'Helicobacter pylori/*pathogenicity', 'Humans', 'MutL Protein Homolog 1', 'MutS Homolog 2 Protein/analysis', '*Mutagenesis', 'Nuclear Proteins/analysis', 'Promoter Regions, Genetic', 'Transfection']",https://pubmed.ncbi.nlm.nih.gov/16882331/
1191,CA13,28883658,Running reorganizes the circuitry of one-week-old adult-born hippocampal neurons.,"['Sah N', 'Peterson BD', 'Lubejko ST', 'Vivar C', 'van Praag H']","['Action Potentials', 'Adult', 'Animals', 'Hippocampus/*physiology', 'Humans', 'Mice, Inbred C57BL', 'Nerve Net/*physiology', '*Neurogenesis', 'Neurons/*physiology', 'Patch-Clamp Techniques', '*Running']",https://pubmed.ncbi.nlm.nih.gov/28883658/
1192,CA13,39703113,"Causal Relationships Between Epilepsy, Anti-Epileptic Drugs, and Serum Vitamin D and Vitamin D Binding Protein: A Bidirectional and Drug Target Mendelian Randomization Study.","['Cheng Z', 'Zuo J', 'Peng X', 'Zhang H', 'Su W', 'Luan G', 'Guan Y']","['Humans', '*Mendelian Randomization Analysis', '*Epilepsy/blood/drug therapy/genetics', '*Vitamin D/blood/analogs & derivatives', '*Vitamin D-Binding Protein/genetics/blood', '*Anticonvulsants/therapeutic use', '*Genome-Wide Association Study', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/39703113/
1193,CA13,37606701,Albuminuria and markers for cardiovascular risk in 12-year-olds from the general Dutch population: a cross-sectional study.,"['Gracchi V', 'van den Belt SM', 'Corpeleijn E', 'Heerspink HJL', 'Verkade HJ']","['Pregnancy', 'Adult', 'Humans', 'Female', 'Child', '*Cardiovascular Diseases/diagnosis/epidemiology/etiology', 'Risk Factors', 'Cross-Sectional Studies', 'Albuminuria/epidemiology', '*Hypertension/etiology', 'Obesity/complications', 'Heart Disease Risk Factors', 'Creatinine/urine']",https://pubmed.ncbi.nlm.nih.gov/37606701/
1194,CA13,30742981,"Involvement of hippocampal subfields and anterior-posterior subregions in encoding and retrieval of item, spatial, and associative memories: Longitudinal versus transverse axis.","['Hrybouski S', 'MacGillivray M', 'Huang Y', 'Madan CR', 'Carter R', 'Seres P', 'Malykhin NV']","['Adult', 'Brain Mapping/methods', 'Female', 'Hippocampus/*physiology', 'Humans', 'Magnetic Resonance Imaging/methods', 'Male', 'Memory/*physiology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/30742981/
1195,CA13,17504134,"Characterization and inhibition of the recently discovered carbonic anhydrase isoforms CA XIII, XIV and XV.","['Hilvo M', 'Supuran CT', 'Parkkila S']","['Carbonic Anhydrase Inhibitors/*chemistry', 'Carbonic Anhydrases/*metabolism', 'Cell Compartmentation', 'Humans', '*Protein Isoforms', 'Sulfonamides/pharmacology', 'Tissue Distribution']",https://pubmed.ncbi.nlm.nih.gov/17504134/
1196,CA13,20819069,Recent advances in structural studies of the carbonic anhydrase family: the crystal structure of human CA IX and CA XIII.,"['Supuran CT', 'Di Fiore A', 'Alterio V', 'Monti SM', 'De Simone G']","['Antigens, Neoplasm/*chemistry/drug effects/metabolism', 'Carbonic Anhydrase IX', 'Carbonic Anhydrase Inhibitors/pharmacology', 'Carbonic Anhydrases/*chemistry/drug effects/metabolism', 'Crystallography, X-Ray/*methods', 'Drug Design', 'Humans', 'Isoenzymes/antagonists & inhibitors/chemistry/drug effects', 'Models, Molecular', '*Protein Structure, Quaternary']",https://pubmed.ncbi.nlm.nih.gov/20819069/
1197,CA13,39196261,Differential increase of hippocampal subfield volume after socio-affective mental training relates to reductions in diurnal cortisol.,"['Valk SL', 'Engert V', 'Puhlmann L', 'Linz R', 'Caldairou B', 'Bernasconi A', 'Bernasconi N', 'Bernhardt BC', 'Singer T']","['Humans', '*Hydrocortisone/metabolism', 'Male', 'Female', '*Hippocampus/physiology', 'Adult', '*Magnetic Resonance Imaging', 'Young Adult', 'Mindfulness', 'Circadian Rhythm/physiology', 'Stress, Psychological']",https://pubmed.ncbi.nlm.nih.gov/39196261/
1198,CA13,27083302,Dimethyl fumarate attenuates intracerebroventricular streptozotocin-induced spatial memory impairment and hippocampal neurodegeneration in rats.,"['Majkutewicz I', 'Kurowska E', 'Podlacha M', 'Myslinska D', 'Grembecka B', 'Rucinski J', 'Plucinska K', 'Jerzemowska G', 'Wrona D']","['Animals', 'Antibiotics, Antineoplastic/administration & dosage', 'Body Weight/drug effects', 'Cholinesterases/metabolism', 'Cytokines/metabolism', 'Dimethyl Fumarate/*therapeutic use', 'Disease Models, Animal', 'Eating/drug effects', 'Fluoresceins/metabolism', 'Hippocampus/*pathology', 'Immunosuppressive Agents/*therapeutic use', 'Injections, Intraventricular', 'Male', 'Maze Learning/drug effects', 'Memory Disorders/chemically induced/*drug therapy', 'Neurodegenerative Diseases/chemically induced/*drug therapy/*pathology', 'Rats', 'Rats, Wistar', 'Streptozocin/administration & dosage']",https://pubmed.ncbi.nlm.nih.gov/27083302/
1199,CA13,26261644,Association between interferon gamma 13-CA-repeats polymorphism and metastasis of nasopharyngeal carcinoma in a population of Northern China.,"['Hao K', 'Yan Z', 'Shuang Y', 'Sun J', 'Tao S', 'Fu W', 'Liu L']","['Asian People/*genetics', 'Carcinoma', 'Case-Control Studies', 'China', 'DNA Repeat Expansion', 'Female', 'Genetic Predisposition to Disease/*genetics', 'Genotype', 'Humans', 'Interferon-gamma/*genetics', 'Male', 'Middle Aged', 'Nasopharyngeal Carcinoma', 'Nasopharyngeal Neoplasms/*genetics/pathology', 'Neoplasm Invasiveness', 'Neoplasm Metastasis', 'Polymerase Chain Reaction', '*Polymorphism, Genetic/genetics', 'Retrospective Studies']",https://pubmed.ncbi.nlm.nih.gov/26261644/
1200,CA5B,32455435,Polarized Expression of Ion Channels and Solute Carrier Family Transporters on Heterogeneous Cultured Human Corneal Endothelial Cells.,"['Hamuro J', 'Deguchi H', 'Fujita T', 'Ueda K', 'Tokuda Y', 'Hiramoto N', 'Numa K', 'Nakano M', 'Bush J', 'Ueno M', 'Sotozono C', 'Kinoshita S']","['Cells, Cultured', 'Endothelial Cells/*metabolism', 'Endothelium, Corneal/*cytology', 'Humans', 'Ion Channels/*biosynthesis', 'Solute Carrier Proteins/*biosynthesis']",https://pubmed.ncbi.nlm.nih.gov/32455435/
1201,CA5B,21674123,Differential methylation hybridization profiling identifies involvement of STAT1-mediated pathways in breast cancer.,"['Kim JH', 'Kang HS', 'Kim TW', 'Kim SJ']","['Breast Neoplasms/*genetics/*metabolism', 'Cell Line, Tumor', 'CpG Islands', '*DNA Methylation', 'Epigenesis, Genetic', 'Female', 'Gene Expression Regulation, Neoplastic', 'Genome-Wide Association Study/methods', 'Humans', 'Hybridization, Genetic', 'Oligonucleotide Array Sequence Analysis/methods', 'Promoter Regions, Genetic', 'STAT1 Transcription Factor/*genetics/*metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/21674123/
1202,CA5B,26913920,Defective hepatic bicarbonate production due to carbonic anhydrase VA deficiency leads to early-onset life-threatening metabolic crisis.,"['Diez-Fernandez C', 'Rufenacht V', 'Santra S', 'Lund AM', 'Santer R', 'Lindner M', 'Tangeraas T', 'Unsinn C', 'de Lonlay P', 'Burlina A', 'van Karnebeek CD', 'Haberle J']","['Acidosis/*genetics/metabolism/pathology', 'Adolescent', 'Bicarbonates/metabolism', 'Carbonic Anhydrases/deficiency/*genetics/metabolism', 'Child', 'Child, Preschool', 'Humans', 'Hyperammonemia/*genetics/metabolism/pathology', 'Hypoglycemia/genetics/metabolism/pathology', 'Infant', 'Infant, Newborn', 'Lactic Acid/metabolism', 'Liver/enzymology/*metabolism/pathology', 'Mitochondria/genetics/metabolism/pathology', 'Mutation', 'Protein Isoforms']",https://pubmed.ncbi.nlm.nih.gov/26913920/
1203,CA5B,22820136,Differential gene expression analysis of peripheral blood mononuclear cells reveals novel test for early detection of pancreatic cancer.,"['Baine MJ', 'Menning M', 'Smith LM', 'Mallya K', 'Kaur S', 'Rachagani S', 'Chakraborty S', 'Sasson AR', 'Brand RE', 'Batra SK']","['Aged', 'Area Under Curve', 'CA-19-9 Antigen/genetics/metabolism', 'Carbonic Anhydrase V/genetics/metabolism', 'Case-Control Studies', 'DNA-Binding Proteins/genetics/metabolism', '*Early Detection of Cancer', 'Factor V/genetics/metabolism', 'Female', 'Growth Differentiation Factor 15/genetics/metabolism', 'Humans', 'Leukocytes, Mononuclear/*metabolism', 'Male', 'Middle Aged', 'Molecular Diagnostic Techniques', 'Multiplex Polymerase Chain Reaction', 'Pancreatic Neoplasms/*blood/diagnosis/genetics', 'ROC Curve', 'Real-Time Polymerase Chain Reaction', 'Transcription, Genetic', 'Transcriptome']",https://pubmed.ncbi.nlm.nih.gov/22820136/
1204,CA5B,34895312,Risk-focused differences in molecular processes implicated in SARS-CoV-2 infection: corollaries in DNA methylation and gene expression.,"['Konwar C', 'Asiimwe R', 'Inkster AM', 'Merrill SM', 'Negri GL', 'Aristizabal MJ', 'Rider CF', 'MacIsaac JL', 'Carlsten C', 'Kobor MS']","['Adaptor Proteins, Signal Transducing/genetics', 'Adolescent', 'Adult', 'Air Pollutants/adverse effects', 'Angiotensin-Converting Enzyme 2/genetics', 'Apoptosis Regulatory Proteins/genetics', 'COVID-19/*genetics/virology', 'Child', 'Child, Preschool', 'Chromosomes, Human, X', 'Co-Repressor Proteins/genetics', '*DNA Methylation', 'Female', '*Gene Expression', 'Genes, X-Linked', 'Glutathione Peroxidase/genetics', 'Humans', 'Infant', 'Infant, Newborn', 'Male', 'Middle Aged', 'Risk Factors', '*SARS-CoV-2', '*Sex Characteristics', 'Smoking/adverse effects', 'Sulfotransferases/genetics', 'Young Adult', 'beta-Arrestin 2/genetics', 'Glutathione Peroxidase GPX1']",https://pubmed.ncbi.nlm.nih.gov/34895312/
1205,CA5B,21347333,Transcriptional profiling of peripheral blood mononuclear cells in pancreatic cancer patients identifies novel genes with potential diagnostic utility.,"['Baine MJ', 'Chakraborty S', 'Smith LM', 'Mallya K', 'Sasson AR', 'Brand RE', 'Batra SK']","['Case-Control Studies', 'Female', 'Humans', 'Leukocytes, Mononuclear/*metabolism', 'Male', 'Middle Aged', 'Pancreatic Neoplasms/*diagnosis/*genetics/pathology', 'Reproducibility of Results', 'Sensitivity and Specificity', 'Transcription, Genetic/*genetics', '*Transcriptome']",https://pubmed.ncbi.nlm.nih.gov/21347333/
1206,CA5B,7459369,Cytotoxic liponucleotide analogs. II. Antitumor activity of CDP-diacylglycerol analogs containing the cytosine arabinoside moiety.,"['Turcotte JG', 'Srivastava SP', 'Steim JM', 'Calabresi P', 'Tibbetts LM', 'Chu MY']","['Animals', '*Antineoplastic Agents', 'Cell Line', 'Cytarabine/*analogs & derivatives/pharmacology', 'Cytidine Diphosphate Diglycerides/*pharmacology', 'Humans', 'Leukemia L5178/drug therapy', 'Leukemia P388/drug therapy', 'Mice', 'Neoplasms, Experimental/drug therapy', 'Nucleoside Diphosphate Sugars/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/7459369/
1207,CA5B,33351593,Systematic Analysis of Protein Targets Associated with Adverse Events of Drugs from Clinical Trials and Postmarketing Reports.,"['Smit IA', 'Afzal AM', 'Allen CHG', 'Svensson F', 'Hanser T', 'Bender A']","['Clinical Trials as Topic', 'Humans', 'Molecular Structure', 'Pharmaceutical Preparations/blood/*chemistry', 'Proteins/*analysis/antagonists & inhibitors', 'United States', 'United States Food and Drug Administration']",https://pubmed.ncbi.nlm.nih.gov/33351593/
1208,CA5B,39271758,Genetic investigations on singleton school aged children reveal novel variants and new candidate genes for hearing loss.,"['Khan H', 'Muzaffar F', 'Salman M', 'Bashir R', 'Seo GH', 'Naz S']","['Humans', 'Male', 'Child', 'Female', '*Hearing Loss/genetics', '*Exome Sequencing', '*Sulfate Transporters/genetics', 'Adolescent', 'Cadherin Related Proteins', 'Cadherins/genetics', 'Membrane Proteins/genetics', 'Connexin 26/genetics', 'Genetic Predisposition to Disease', 'Pakistan', 'Consanguinity', 'Connexins/genetics', 'Mutation, Missense', 'Myosins']",https://pubmed.ncbi.nlm.nih.gov/39271758/
1209,CA9,31442913,Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia.,"['Li Z', 'Jiang L', 'Chew SH', 'Hirayama T', 'Sekido Y', 'Toyokuni S']","['Antigens, Neoplasm/*genetics/*metabolism', 'Apoptosis/*genetics', 'Biomarkers', 'Carbonic Anhydrase IX/*genetics/*metabolism', 'Cell Line, Tumor', 'Ferroptosis/*genetics', 'Humans', 'Hypoxia/*metabolism', 'Lung Neoplasms/*genetics/*metabolism', 'Mesothelioma/*genetics/*metabolism', 'Mesothelioma, Malignant', 'Mitochondria/genetics/metabolism', 'Models, Biological', 'Reactive Oxygen Species/metabolism']",https://pubmed.ncbi.nlm.nih.gov/31442913/
1210,CA9,38701117,OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition.,"['Nan Y', 'Wu X', 'Luo Q', 'Chang W', 'Zhao P', 'Zhang L', 'Liu Z']","['Animals', 'Female', 'Humans', 'Mice', 'Antigens, Neoplasm/metabolism/genetics', '*Carbonic Anhydrase IX/metabolism/genetics', 'Cell Line, Tumor', 'Drug Resistance, Neoplasm/genetics/drug effects', 'Gene Expression Regulation, Neoplastic/drug effects', '*Gene Silencing', 'Glycolysis/drug effects', 'Hypoxia-Inducible Factor 1, alpha Subunit/metabolism/genetics', 'Metabolic Reprogramming', '*Mitochondria/metabolism/drug effects', '*Ovarian Neoplasms/genetics/metabolism/pathology/drug therapy', '*Thiolester Hydrolases/genetics']",https://pubmed.ncbi.nlm.nih.gov/38701117/
1211,CA9,29248440,JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.,"['Song X', 'Zhu S', 'Xie Y', 'Liu J', 'Sun L', 'Zeng D', 'Wang P', 'Ma X', 'Kroemer G', 'Bartlett DL', 'Billiar TR', 'Lotze MT', 'Zeh HJ', 'Kang R', 'Tang D']","['Adenocarcinoma/*drug therapy/genetics/metabolism/secondary', 'Aminoquinolines/*pharmacology', 'Animals', 'Antigens, Neoplasm/metabolism', 'Antineoplastic Agents/*pharmacology', 'Benzamides/*pharmacology', 'Biomarkers, Tumor/genetics/metabolism', 'Carbonic Anhydrase IX/metabolism', 'Cell Death/drug effects', 'Dose-Response Relationship, Drug', 'Female', 'Gene Expression Regulation, Neoplastic', 'HCT116 Cells', 'Humans', 'Hydrogen-Ion Concentration', 'Mice, Inbred C57BL', 'Mice, Nude', 'NF-kappa B/metabolism', 'Neoplastic Stem Cells/*drug effects/metabolism/pathology', 'Pancreatic Neoplasms/*drug therapy/genetics/metabolism/pathology', 'Signal Transduction/drug effects', 'Time Factors', 'Tumor Burden/drug effects', '*Tumor Microenvironment', 'Xenograft Model Antitumor Assays']",https://pubmed.ncbi.nlm.nih.gov/29248440/
1212,CA9,38227578,The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome.,"['Tsukuda S', 'Harris JM', 'Magri A', 'Balfe P', 'Siddiqui A', 'Wing PAC', 'McKeating JA']","['Animals', 'Humans', 'Mice', 'AlkB Homolog 5, RNA Demethylase/genetics/metabolism', 'Fucosyltransferases/genetics', '*Hepatitis B/genetics', '*Hepatitis B virus/metabolism', 'Hypoxia', 'Oxygen', 'RNA', 'Transcriptome']",https://pubmed.ncbi.nlm.nih.gov/38227578/
1213,CA9,25779969,Dual-pharmacophore DNA-encoded chemical libraries.,"['Scheuermann J', 'Neri D']","['Acetazolamide/chemical synthesis/pharmacology', 'Antigens, Neoplasm/*chemistry/metabolism', 'Antineoplastic Agents/*chemical synthesis/pharmacology', 'Carbonic Anhydrase IX', 'Carbonic Anhydrase Inhibitors/chemical synthesis/pharmacology', 'Carbonic Anhydrases/*chemistry/metabolism', 'Carcinoma, Renal Cell/drug therapy/enzymology/pathology', 'Combinatorial Chemistry Techniques', 'DNA/*chemistry/metabolism', 'Drug Discovery', 'Fluorescent Dyes/chemistry', 'Gene Expression', '*Gene Library', 'Humans', 'Kidney Neoplasms/drug therapy/enzymology/pathology', 'Small Molecule Libraries/chemical synthesis/*chemistry']",https://pubmed.ncbi.nlm.nih.gov/25779969/
1214,CA9,34083809,The role of HIF proteins in maintaining the metabolic health of the intervertebral disc.,"['Silagi ES', 'Schipani E', 'Shapiro IM', 'Risbud MV']","['Animals', 'Basic Helix-Loop-Helix Transcription Factors/metabolism/physiology', 'Humans', 'Hypoxia/metabolism', 'Hypoxia-Inducible Factor 1/metabolism/*physiology', 'Intervertebral Disc/*metabolism/physiology']",https://pubmed.ncbi.nlm.nih.gov/34083809/
1215,CA9,25647573,Targeting carbonic anhydrase IX activity and expression.,"['Mahon BP', 'Pinard MA', 'McKenna R']","['Antigens, Neoplasm/chemistry/*physiology', 'Antineoplastic Agents/*pharmacology', 'Carbonic Anhydrase IX', 'Carbonic Anhydrase Inhibitors/*pharmacology', 'Carbonic Anhydrases/chemistry/*physiology', 'Gene Expression', 'Gene Expression Regulation, Neoplastic', 'Gene Knockdown Techniques', 'Humans', 'Molecular Targeted Therapy', 'Neoplasms/enzymology/*therapy', 'Structural Homology, Protein']",https://pubmed.ncbi.nlm.nih.gov/25647573/
1216,CA9,29749469,"Association between SOX9 and CA9 in glioma, and its effects on chemosensitivity to TMZ.","['Xu X', 'Wang Z', 'Liu N', 'Cheng Y', 'Jin W', 'Zhang P', 'Wang X', 'Yang H', 'Liu H', 'Zhang Y', 'Tu Y']","['Antigens, Neoplasm/*genetics', 'Apoptosis/drug effects', 'Carbonic Anhydrase IX/antagonists & inhibitors/*genetics', 'Cell Line, Tumor', 'Cell Proliferation/drug effects', 'Dacarbazine/administration & dosage/adverse effects/*analogs & derivatives', 'Drug Resistance, Neoplasm/genetics', 'Enzyme Inhibitors/administration & dosage', 'Gene Expression Regulation, Neoplastic/drug effects', 'Glioma/*drug therapy/genetics/pathology', 'Humans', 'SOX9 Transcription Factor/antagonists & inhibitors/*genetics', 'Signal Transduction/drug effects', 'Temozolomide']",https://pubmed.ncbi.nlm.nih.gov/29749469/
1217,CA9,39656421,Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production.,"['Yang J', 'Tong X', 'Wang W', 'Yu X', 'Xu J', 'Shi S']","['Humans', '*Reactive Oxygen Species/metabolism', '*Pancreatic Neoplasms/pathology/metabolism/genetics', 'Animals', 'Cell Line, Tumor', '*Disease Progression', '*Carbonic Anhydrase IX/metabolism/genetics', 'Hydrogen-Ion Concentration', 'Cell Proliferation', 'Carcinoma, Pancreatic Ductal/pathology/metabolism/genetics', 'Mice', 'Lactic Acid/metabolism', 'Mice, Nude', 'Cell Movement', 'CA-19-9 Antigen/metabolism', 'Mice, Inbred BALB C', 'Mitochondria/metabolism', 'Gene Expression Regulation, Neoplastic', 'Antigens, Neoplasm']",https://pubmed.ncbi.nlm.nih.gov/39656421/
1218,CA9,20819065,Modulation of carbonic anhydrase 9 (CA9) in human brain cancer.,"['Said HM', 'Supuran CT', 'Hageman C', 'Staab A', 'Polat B', 'Katzer A', 'Scozzafava A', 'Anacker J', 'Flentje M', 'Vordermark D']","['Antigens, Neoplasm/*drug effects/metabolism', 'Antineoplastic Agents/*therapeutic use', 'Brain Neoplasms/*drug therapy/*enzymology', 'Carbonic Anhydrase IX', 'Carbonic Anhydrase Inhibitors/*therapeutic use', 'Carbonic Anhydrases/*drug effects/metabolism', 'Glycolysis/drug effects/genetics', 'Humans', 'Hypoxia/enzymology/genetics', 'Models, Biological', 'Sulfonamides/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/20819065/
1219,CA9,31819195,Carbonic anhydrase IX and acid transport in cancer.,['Becker HM'],"['Antigens, Neoplasm/*genetics/metabolism', 'Carbonic Anhydrase IX/*genetics/metabolism', 'Cell Movement/genetics', 'Cell Proliferation/genetics', 'Energy Metabolism/*genetics', 'Gene Expression Regulation, Neoplastic/genetics', 'Humans', 'Hydrogen-Ion Concentration', 'Neoplasm Invasiveness/genetics/pathology', 'Neoplasm Metastasis', 'Neoplasms/*genetics/metabolism/pathology']",https://pubmed.ncbi.nlm.nih.gov/31819195/
1220,CA9,23957913,Recent advances of immunohistochemistry for diagnosis of renal tumors.,"['Kuroda N', 'Tanaka A', 'Ohe C', 'Nagashima Y']","['Biomarkers, Tumor/*metabolism', 'Carcinoma, Renal Cell/classification/*diagnosis/genetics', 'Humans', 'Immunohistochemistry', 'Kidney Neoplasms/classification/*diagnosis/genetics', 'Translocation, Genetic']",https://pubmed.ncbi.nlm.nih.gov/23957913/
1221,CA9,31929132,Proliferation of Saos-2 and Ca9-22 cells on grooved and pillared titanium surfaces.,"['Kaga N', 'Akasaka T', 'Matsuura T', 'Yokoyama A', 'Yoshida Y']","['Bone-Implant Interface/physiology', 'Cell Adhesion/drug effects/*physiology', 'Cell Line', 'Cell Proliferation/drug effects/*physiology', 'Coated Materials, Biocompatible/chemical synthesis/*chemistry/pharmacology', '*Dental Implants', 'Epithelial Cells/drug effects/physiology', 'Humans', 'Materials Testing', 'Microtechnology', 'Osseointegration/drug effects/*physiology', 'Osteoblasts/drug effects/physiology', 'Surface Properties', 'Tissue Scaffolds/chemistry', 'Titanium/*chemistry']",https://pubmed.ncbi.nlm.nih.gov/31929132/
1222,CA9,39572570,Acid-exposed and hypoxic cancer cells do not overlap but are interdependent for unsaturated fatty acid resources.,"['Glowacka K', 'Ibanez S', 'Renoult O', 'Vermonden P', 'Giolito MV', 'Ozkan K', 'Degavre C', 'Aubert L', 'Guilbaud C', 'Laloux-Morris F', 'Richiardone E', 'Ambroise J', 'Bouzin C', 'Brusa D', 'Dehairs J', 'Swinnen J', 'Corbet C', 'Larondelle Y', 'Feron O']","['Humans', '*Stearoyl-CoA Desaturase/metabolism/genetics', 'Animals', 'Mice', '*Fatty Acids, Unsaturated/metabolism/pharmacology', '*Ferroptosis/drug effects', 'Cell Line, Tumor', '*Carbonic Anhydrase IX/metabolism/genetics', 'Cell Hypoxia/drug effects', 'Fatty Acids, Omega-3/metabolism/pharmacology', 'Neoplasms/metabolism/genetics/drug therapy/pathology', 'Spheroids, Cellular/drug effects/metabolism/pathology', 'Female', 'Organoids/metabolism/drug effects', 'Antigens, Neoplasm']",https://pubmed.ncbi.nlm.nih.gov/39572570/
1223,CA9,37973221,CA9 and PRELID2; hypoxia-responsive potential therapeutic targets for pancreatic ductal adenocarcinoma as per bioinformatics analyses.,"['Imanishi M', 'Inoue T', 'Fukushima K', 'Yamashita R', 'Nakayama R', 'Nojima M', 'Kondo K', 'Gomi Y', 'Tsunematsu H', 'Goto K', 'Miyamoto L', 'Funamoto M', 'Denda M', 'Ishizawa K', 'Otaka A', 'Fujino H', 'Ikeda Y', 'Tsuchiya K']","['Humans', 'Carbonic Anhydrase IX/genetics/metabolism', 'Antigens, Neoplasm/genetics/metabolism/therapeutic use', '*Carcinoma, Pancreatic Ductal/drug therapy/genetics', '*Pancreatic Neoplasms/drug therapy/genetics', 'Hypoxia/metabolism', 'RNA, Small Interfering', 'Computational Biology']",https://pubmed.ncbi.nlm.nih.gov/37973221/
1224,CA9,24146383,Carbonic anhydrase IX (CAIX) as a mediator of hypoxia-induced stress response in cancer cells.,"['McDonald PC', 'Dedhar S']","['Antigens, Neoplasm/*genetics/metabolism', 'Carbon Dioxide/metabolism', 'Carbonic Anhydrase IX', 'Carbonic Anhydrases/*genetics/metabolism', 'Carcinogenesis/genetics', 'Cell Hypoxia/genetics', 'Gene Expression Regulation, Neoplastic', 'Humans', '*Molecular Targeted Therapy', 'Neoplasms/*drug therapy/*enzymology/pathology', 'Stress, Physiological/genetics']",https://pubmed.ncbi.nlm.nih.gov/24146383/
1225,CA9,25721398,Targeting carbonic anhydrase IX with small organic ligands.,"['Wichert M', 'Krall N']","['Acetazolamide/analogs & derivatives/chemical synthesis/metabolism/*pharmacology', 'Animals', 'Antigens, Neoplasm/*chemistry/metabolism', 'Antineoplastic Agents/chemical synthesis/metabolism/*pharmacology', 'Carbonic Anhydrase IX', 'Carbonic Anhydrase Inhibitors/chemical synthesis/metabolism/*pharmacology', 'Carbonic Anhydrases/*chemistry/metabolism', 'Cell Line, Tumor', 'Colorectal Neoplasms/*drug therapy/enzymology/pathology', 'Humans', 'Ligands', 'Mice', 'Molecular Targeted Therapy', 'Protein Multimerization', 'Small Molecule Libraries/chemical synthesis/metabolism/*pharmacology', 'Xenograft Model Antitumor Assays']",https://pubmed.ncbi.nlm.nih.gov/25721398/
1226,CA9,35874663,Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid Tumors.,"['Tatari N', 'Zhang X', 'Chafe SC', 'McKenna D', 'Lawson KA', 'Subapanditha M', 'Shaikh MV', 'Seyfrid M', 'Savage N', 'Venugopal C', 'Moffat J', 'Singh SK']","['Adult', 'Antigens, Neoplasm/therapeutic use', '*Brain Neoplasms/metabolism', 'Carbonic Anhydrase IX/metabolism', '*Carbonic Anhydrases/metabolism/therapeutic use', '*Carcinoma, Renal Cell/therapy', '*Glioblastoma/therapy', 'Humans', 'Hypoxia', 'Immunotherapy', '*Kidney Neoplasms/therapy', 'T-Lymphocytes/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35874663/
1227,CA9,22289741,Recent developments in targeting carbonic anhydrase IX for cancer therapeutics.,"['McDonald PC', 'Winum JY', 'Supuran CT', 'Dedhar S']","['Animals', 'Antibodies, Monoclonal/therapeutic use', '*Antigens, Neoplasm/chemistry/genetics/immunology/physiology', 'Antineoplastic Agents/administration & dosage/*therapeutic use', 'Carbonic Anhydrase IX', '*Carbonic Anhydrases/chemistry/genetics/immunology/physiology', 'Gene Expression Regulation, Enzymologic/physiology', 'Gene Expression Regulation, Neoplastic/physiology', 'Humans', 'Medical Oncology/methods/*trends', 'Molecular Targeted Therapy/*methods/trends', 'Neoplasms/*drug therapy/genetics/pathology', 'Protein Conformation']",https://pubmed.ncbi.nlm.nih.gov/22289741/
1228,CA9,37463506,CA9 knockdown enhanced ionizing radiation-induced ferroptosis and radiosensitivity of hypoxic glioma cells.,"['Huang W', 'He Y', 'Yang S', 'Xue X', 'Qin H', 'Sun T', 'Yang W']","['Tumor Hypoxia', '*Glioma/genetics/radiotherapy', '*Ferroptosis', 'Radiation, Ionizing', '*Radiation Tolerance', '*Carbonic Anhydrase IX/genetics', 'Gene Knockdown Techniques', 'Cell Line, Tumor', 'Humans', 'Animals', 'Mice', 'Alarmins/metabolism', 'Lipid Peroxidation', 'Long-Chain-Fatty-Acid-CoA Ligase']",https://pubmed.ncbi.nlm.nih.gov/37463506/
1229,CA2,16115682,Ryanodine receptors.,['Hamilton SL'],"['Animals', 'Calcium/chemistry/physiology', 'Humans', 'Protein Structure, Secondary/genetics', 'Protein Structure, Tertiary/genetics', 'Ryanodine Receptor Calcium Release Channel/chemistry/metabolism/*physiology/ultrastructure']",https://pubmed.ncbi.nlm.nih.gov/16115682/
1230,CA2,24756715,TRPM2.,"['Faouzi M', 'Penner R']","['Animals', 'Cell Membrane Permeability', 'Gene Expression Regulation', 'Genetic Predisposition to Disease', 'Humans', 'Ion Channel Gating', 'Membrane Potentials', 'Mice', 'Mice, Knockout', 'Phenotype', 'Protein Conformation', 'Signal Transduction', 'Structure-Activity Relationship', 'TRPM Cation Channels/chemistry/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/24756715/
1231,CA2,38354239,A mechanism of lysosomal calcium entry.,"['Zajac M', 'Mukherjee S', 'Anees P', 'Oettinger D', 'Henn K', 'Srikumar J', 'Zou J', 'Saminathan A', 'Krishnan Y']","['Animals', 'Humans', '*Calcium/metabolism', 'Caenorhabditis elegans/metabolism', 'Calcium Channels/genetics/metabolism', 'Signal Transduction', 'Lysosomes/metabolism', 'Calcium Signaling', 'Mammals/metabolism', 'Antiporters/metabolism', '*Cation Transport Proteins/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38354239/
1232,CA2,24756718,TRPM5.,['Liman ER'],"['Animals', 'Gene Expression Regulation', 'Humans', 'Ion Channel Gating', 'Membrane Potentials', 'Protein Conformation', 'Signal Transduction', 'Structure-Activity Relationship', 'TRPM Cation Channels/chemistry/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/24756718/
1233,CA2,24961970,Photosensitive TRPs.,['Hardie RC'],"['Animals', 'Calcium/metabolism', 'Drosophila/physiology', 'Drosophila Proteins/physiology', 'Humans', 'Photoreceptor Cells/*physiology', 'Transient Receptor Potential Channels/chemistry/genetics/*physiology']",https://pubmed.ncbi.nlm.nih.gov/24961970/
1234,CA2,31172464,Mammalian NADPH Oxidases.,"['Buvelot H', 'Jaquet V', 'Krause KH']","['Animals', 'Gene Expression Regulation', 'Humans', 'Mammals', 'Mice', 'Models, Animal', 'Multigene Family', 'NADPH Oxidases/chemistry/*genetics/*metabolism', 'Oxidation-Reduction', 'Reactive Oxygen Species/*metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/31172464/
1235,CA2,22477146,Unraveling STIM2 function.,"['Lopez E', 'Salido GM', 'Rosado JA', 'Berna-Erro A']","['Amino Acid Sequence', 'Animals', 'Calcium/metabolism', 'Calcium Channels/metabolism/physiology', '*Calcium Signaling', 'Cell Adhesion Molecules/chemistry/genetics/metabolism/*physiology', 'Endoplasmic Reticulum/metabolism', 'Gene Expression', 'Humans', 'Molecular Sequence Data', 'Protein Isoforms/chemistry/genetics/metabolism/physiology', 'Protein Stability', 'Protein Structure, Tertiary', 'Stromal Interaction Molecule 2']",https://pubmed.ncbi.nlm.nih.gov/22477146/
1236,CA2,32574906,"Calsequestrin. Structure, function, and evolution.","['Wang Q', 'Michalak M']","['Amino Acid Sequence', 'Animals', 'Calsequestrin/*chemistry/*genetics/metabolism', 'Humans', 'Ions', 'Models, Biological', 'Phylogeny', 'Protein Isoforms/chemistry/genetics/metabolism', 'Sarcoplasmic Reticulum/metabolism']",https://pubmed.ncbi.nlm.nih.gov/32574906/
1237,CA2,29310803,Smoothelins and the Control of Muscle Contractility.,"['Murali M', 'MacDonald JA']","['Actin Cytoskeleton/metabolism', 'Amino Acid Sequence', 'Animals', 'Evolution, Molecular', 'Humans', 'Muscle Contraction/*physiology', 'Muscle Proteins/chemistry/genetics/*metabolism', 'Phylogeny']",https://pubmed.ncbi.nlm.nih.gov/29310803/
1238,CA2,15200142,Extracellular Ca2+-sensing receptors--an overview.,"['Chang W', 'Shoback D']","['Amino Acid Sequence', 'Animals', 'Calcium/*metabolism', 'Cations/chemistry/metabolism', 'Extracellular Space/metabolism', 'Homeostasis/genetics/physiology', 'Humans', 'Ligands', 'Mice', 'Mice, Knockout', 'Models, Biological', 'Molecular Sequence Data', 'Phylogeny', 'Receptors, Calcium-Sensing/agonists/genetics/*physiology', 'Receptors, G-Protein-Coupled/genetics/physiology', 'Sequence Homology, Amino Acid']",https://pubmed.ncbi.nlm.nih.gov/15200142/
1239,CA2,37254738,Notch3/Hes5 Induces Vascular Dysfunction in Hypoxia-Induced Pulmonary Hypertension Through ER Stress and Redox-Sensitive Pathways.,"['Morris HE', 'Neves KB', 'Nilsen M', 'Montezano AC', 'MacLean MR', 'Touyz RM']","['Animals', 'Mice', 'Basic Helix-Loop-Helix Transcription Factors/metabolism', '*Hypertension', '*Hypertension, Pulmonary/metabolism', 'Hypoxia/metabolism', 'Myocytes, Smooth Muscle/metabolism', 'Oxidation-Reduction', '*Pulmonary Arterial Hypertension/metabolism', 'Pulmonary Artery/metabolism', 'Reactive Oxygen Species/metabolism', 'Receptor, Notch3/genetics/metabolism', 'Repressor Proteins/metabolism', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/37254738/
1240,CA2,32712386,CatSper: The complex main gate of calcium entry in mammalian spermatozoa.,"['Rahban R', 'Nef S']","['Animals', 'Calcium/*metabolism', 'Calcium Channels/genetics/*physiology', 'Calcium Signaling/genetics', 'Humans', 'Male', 'Mice', 'Sperm Motility/genetics', 'Spermatozoa/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/32712386/
1241,CA2,24492007,Structure and closure of connexin gap junction channels.,['Oshima A'],"['Amino Acid Sequence', 'Animals', 'Connexins/*chemistry/genetics/metabolism', 'Humans', '*Molecular Dynamics Simulation', 'Molecular Sequence Data', 'Protein Conformation']",https://pubmed.ncbi.nlm.nih.gov/24492007/
1242,CA2,26603282,Calcium homeostasis modulator (CALHM) ion channels.,"['Ma Z', 'Tanis JE', 'Taruno A', 'Foskett JK']","['Animals', 'Calcium/*metabolism', 'Calcium Channels/chemistry/genetics/*metabolism', 'Connexins/chemistry/genetics/metabolism', 'Humans', '*Ion Channel Gating', 'Ion Channels/chemistry/genetics/*metabolism', 'Membrane Glycoproteins/chemistry/genetics/*metabolism', 'Sensory Receptor Cells/metabolism/physiology', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/26603282/
1243,CA2,33806823,Structure and Function of Ion Channels Regulating Sperm Motility-An Overview.,"['Nowicka-Bauer K', 'Szymczak-Cendlak M']","['Animals', 'Calcium/metabolism', 'Calcium Channels/chemistry/genetics/metabolism', 'Calcium Signaling', 'Chloride Channels/chemistry/genetics/metabolism', 'Humans', '*Ion Channel Gating', 'Ion Channels/*chemistry/genetics/*metabolism', 'Male', 'Potassium Channels/chemistry/genetics/metabolism', 'Sodium Channels/chemistry/genetics/metabolism', '*Sperm Motility', 'Spermatozoa/*physiology', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/33806823/
1244,CA2,26872338,Exploring the biophysical evidence that mammalian two-pore channels are NAADP-activated calcium-permeable channels.,"['Pitt SJ', ""Reilly-O'Donnell B"", 'Sitsapesan R']","['Animals', 'Calcium/metabolism/physiology', 'Calcium Channels/*physiology', 'Humans', 'Lysosomes/metabolism', 'NADP/*analogs & derivatives/physiology']",https://pubmed.ncbi.nlm.nih.gov/26872338/
1245,CA2,17217064,TRPM5 and taste transduction.,['Liman ER'],"['Animals', 'Biotransformation/drug effects', 'Gene Expression Regulation/genetics/physiology', 'Humans', 'Hydrogen-Ion Concentration', 'Ion Channel Gating/physiology', 'Ion Channels/metabolism/physiology', 'Signal Transduction/genetics/physiology', 'TRPM Cation Channels/agonists/antagonists & inhibitors/*genetics/*physiology', 'Taste/*physiology']",https://pubmed.ncbi.nlm.nih.gov/17217064/
1246,CA2,23224869,NCX1: mechanism of transport.,"['Ottolia M', 'Philipson KD']","['Animals', '*Calcium/chemistry/metabolism', 'Homeostasis/*physiology', 'Humans', 'Ion Transport/physiology', 'Mutation', 'Protein Structure, Secondary', '*Sodium/chemistry/metabolism', 'Sodium-Calcium Exchanger/*chemistry/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/23224869/
1247,CA2,28174082,"beta-Propeller phytases: Diversity, catalytic attributes, current developments and potential biotechnological applications.","['Kumar V', 'Yadav AN', 'Verma P', 'Sangwan P', 'Saxena A', 'Kumar K', 'Singh B']","['6-Phytase/chemistry/*genetics/metabolism', 'Bacillus/enzymology', '*Biotechnology', 'Calcium/metabolism', 'Catalysis', 'Enzyme Stability', 'Genetic Variation', 'Humans', 'Kinetics', 'Phytic Acid/*chemistry/metabolism', 'Substrate Specificity']",https://pubmed.ncbi.nlm.nih.gov/28174082/
1248,CA2,29716959,The phospholipase A(2) activity of peroxiredoxin 6.,['Fisher AB'],"['Animals', 'Disease', 'Humans', 'Peroxiredoxin VI/antagonists & inhibitors/chemistry/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/29716959/
1249,HRH4,19450133,Histamine pharmacogenomics.,"['Garcia-Martin E', 'Ayuso P', 'Martinez C', 'Blanca M', 'Agundez JA']","['Amine Oxidase (Copper-Containing)/*genetics', 'Amino Acid Substitution', 'Genetic Variation', 'Histamine/*genetics', 'Histamine N-Methyltransferase/*genetics', 'Histidine Decarboxylase/*genetics', 'Humans', 'Pharmacogenetics/methods', '*Polymorphism, Genetic', 'Promoter Regions, Genetic/genetics', 'Receptors, Histamine/*genetics']",https://pubmed.ncbi.nlm.nih.gov/19450133/
1250,HRH4,38871184,Single-cell RNA-sequencing of human eosinophils in allergic inflammation in the esophagus.,"['Ben-Baruch Morgenstern N', 'Rochman M', 'Kotliar M', 'Dunn JLM', 'Mack L', 'Besse J', 'Natale MA', 'Klingler AM', 'Felton JM', 'Caldwell JM', 'Barski A', 'Rothenberg ME']","['Humans', '*Eosinophils/immunology', '*Eosinophilic Esophagitis/genetics/immunology', '*Single-Cell Analysis', 'Male', 'Female', '*Esophagus/immunology/pathology', 'Adult', 'Sequence Analysis, RNA', 'Transcriptome', 'RNA-Seq']",https://pubmed.ncbi.nlm.nih.gov/38871184/
1251,HRH4,32607945,Emerging Therapeutic Options for Chronic Pruritus.,"['Reszke R', 'Krajewski P', 'Szepietowski JC']","['Analgesics, Opioid/pharmacology/therapeutic use', 'Antipruritics/therapeutic use', 'Basic Helix-Loop-Helix Transcription Factors/agonists', 'Biological Factors/therapeutic use', 'Chronic Disease/therapy', 'Clinical Trials as Topic', 'Humans', 'Janus Kinase Inhibitors/therapeutic use', 'Neurokinin-1 Receptor Antagonists/therapeutic use', 'Phototherapy/methods', 'Pruritus/*drug therapy/etiology/psychology', 'Quality of Life', 'Receptors, Aryl Hydrocarbon/agonists', 'Receptors, Histamine H4/antagonists & inhibitors', 'Receptors, Opioid, kappa/agonists', 'Receptors, Opioid, mu/antagonists & inhibitors', 'Skin/innervation/pathology', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/32607945/
1252,HRH4,27735066,Anti-inflammatory therapies in atopic dermatitis.,"['Heratizadeh A', 'Werfel T']","['Allergens/immunology', 'Anti-Inflammatory Agents/pharmacology/*therapeutic use', 'Clinical Trials as Topic', 'Cytokines/antagonists & inhibitors', 'Dermatitis, Atopic/*drug therapy/immunology/metabolism', 'Disease Management', 'Drug Discovery', 'Humans', 'Immunotherapy', 'Molecular Targeted Therapy', 'Receptors, Cytokine/antagonists & inhibitors', 'Receptors, Histamine H4/antagonists & inhibitors']",https://pubmed.ncbi.nlm.nih.gov/27735066/
1253,HRH4,35294861,IMPACT and OSBPL1A are two isoform-specific imprinted genes in bovines.,"['Dong Y', 'Jin L', 'Liu X', 'Li D', 'Chen W', 'Huo H', 'Zhang C', 'Li S']","['Alleles', 'Animals', 'Cattle/genetics', '*DNA Methylation', 'Female', '*Genomic Imprinting', 'Mice', 'Pregnancy', 'Promoter Regions, Genetic', 'Protein Isoforms/genetics']",https://pubmed.ncbi.nlm.nih.gov/35294861/
1254,HRH4,31500698,MRGPRX4 is a bile acid receptor for human cholestatic itch.,"['Yu H', 'Zhao T', 'Liu S', 'Wu Q', 'Johnson O', 'Wu Z', 'Zhuang Z', 'Shi Y', 'Peng L', 'He R', 'Yang Y', 'Sun J', 'Wang X', 'Xu H', 'Zeng Z', 'Zou P', 'Lei X', 'Luo W', 'Li Y']","['Bile Acids and Salts/*metabolism', 'Ganglia, Spinal/cytology', 'Humans', 'Pruritus/*chemically induced', 'Receptors, Cell Surface/*metabolism', 'Receptors, G-Protein-Coupled/*metabolism', 'Receptors, Histamine H4/metabolism', 'Sensory Receptor Cells/*drug effects/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/31500698/
1255,HRH4,21741967,The histamine H(4) receptor: targeting inflammatory disorders.,"['Walter M', 'Kottke T', 'Stark H']","['Animals', 'Humans', 'Inflammation/*drug therapy/*metabolism/pathology', 'Molecular Targeted Therapy/*methods', 'Protein Transport', 'Receptors, G-Protein-Coupled/chemistry/genetics/*metabolism', 'Receptors, Histamine/chemistry/genetics/*metabolism', 'Receptors, Histamine H4', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/21741967/
1256,HRH4,19413566,Advances in histamine pharmacology reveal new drug targets.,['Chazot PL'],"['Animals', 'Histamine Antagonists/*pharmacology/therapeutic use', 'Histamine H3 Antagonists/pharmacology/therapeutic use', 'Histidine Decarboxylase/antagonists & inhibitors', 'Humans', 'Models, Molecular', 'Receptors, G-Protein-Coupled/agonists/antagonists & inhibitors/*physiology', 'Receptors, Histamine/*physiology', 'Receptors, Histamine H3/*physiology', 'Receptors, Histamine H4']",https://pubmed.ncbi.nlm.nih.gov/19413566/
1257,HRH4,27063257,Monocyclic and Fused Azines and Azoles as Histamine H(4) Receptor Ligands.,"['Lazewska D', 'Dominguez-Alvarez E', 'Kaminska K', 'Kuder K', 'Kiec-Kononowicz K']","['Azoles/*chemistry/*metabolism/pharmacology', 'Humans', 'Hydrazines/*chemistry/*metabolism/pharmacology', 'Ligands', 'Receptors, G-Protein-Coupled/antagonists & inhibitors/*metabolism', 'Receptors, Histamine/*metabolism', 'Receptors, Histamine H4']",https://pubmed.ncbi.nlm.nih.gov/27063257/
1258,HRH4,26823878,Association between HRH4 polymorphisms and ankylosing spondylitis susceptibility.,"['Ran B', 'Wang Y', 'Zhang Y', 'Mao K', 'Wang Y']","['Adult', 'Case-Control Studies', 'Chi-Square Distribution', 'Female', 'Gene Frequency', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Haplotypes', 'Heterozygote', 'Homozygote', 'Humans', 'Linkage Disequilibrium', 'Male', 'Middle Aged', 'Odds Ratio', 'Phenotype', 'Polymerase Chain Reaction', 'Polymorphism, Genetic', 'Receptors, G-Protein-Coupled/*genetics', 'Receptors, Histamine/*genetics', 'Receptors, Histamine H4', 'Risk Assessment', 'Risk Factors', 'Spondylitis, Ankylosing/diagnosis/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/26823878/
1259,HRH4,39462031,Histamine stimulates human microglia to alter cellular prion protein expression via the HRH2 histamine receptor.,"['Pehar M', 'Hewitt M', 'Wagner A', 'Sandhu JK', 'Khalili A', 'Wang X', 'Cho JY', 'Sim VL', 'Kulka M']","['Humans', '*Microglia/metabolism/drug effects', '*Histamine/pharmacology/metabolism', 'Cell Line', '*Receptors, Histamine H2/metabolism/genetics', '*Calcium/metabolism', 'PrPC Proteins/metabolism/genetics', 'Cytokines/metabolism', 'Gene Expression Regulation/drug effects', 'Receptors, Histamine/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39462031/
1260,HRH4,27725312,Genetic variations within the promotor region of the human histamine H4 receptor gene in psoriasis patients.,"['Mommert S', 'Ratz L', 'Herwig K', 'Rost M', 'Gutzmer R', 'Werfel T']","['Female', 'Genetic Variation', 'Genotype', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Promoter Regions, Genetic', 'Psoriasis/*genetics/pathology', 'Receptors, Histamine H4/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27725312/
1261,HRH4,20636392,Histamine receptors and cancer pharmacology.,"['Medina VA', 'Rivera ES']","['Animals', 'Antineoplastic Agents/pharmacology', 'Cell Proliferation', '*Drug Delivery Systems', 'Drug Design', 'Histamine/metabolism', 'Humans', 'Neoplasms/drug therapy/*physiopathology', 'Receptors, G-Protein-Coupled/drug effects/metabolism', 'Receptors, Histamine/drug effects/*metabolism', 'Receptors, Histamine H4']",https://pubmed.ncbi.nlm.nih.gov/20636392/
1262,HRH4,25228262,Histamine H4 receptor ligands: future applications and state of art.,"['Correa MF', 'dos Santos Fernandes JP']","['Animals', '*Drug Discovery/methods', 'Humans', 'Imidazoles/chemistry/pharmacology', 'Indoles/chemistry/pharmacology', 'Inflammation/drug therapy/immunology', 'Ligands', 'Models, Molecular', 'Pyrimidines/chemistry/pharmacology', 'Quinazolines/chemistry/pharmacology', 'Quinoxalines/chemistry/pharmacology', 'Receptors, G-Protein-Coupled/*agonists/*antagonists & inhibitors/immunology', 'Receptors, Histamine/immunology', 'Receptors, Histamine H4', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/25228262/
1263,HRH4,30074739,[Histamime Receptor H4 as a New Therapeutic Target for Age-related Macular Degeneration].,['Kaneko H'],"['Aging', 'Animals', 'Gene Expression Regulation', 'Humans', 'Macular Degeneration/genetics/*metabolism/therapy', 'Receptors, Histamine H4/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/30074739/
1264,HRH4,23422377,Histamine H4 receptor polymorphism: a potential predictor of risperidone efficacy.,"['Wei Z', 'Wang L', 'Yu T', 'Wang Y', 'Sun L', 'Wang T', 'Huo R', 'Li Y', 'Wu X', 'Qin S', 'Xu Y', 'Feng G', 'He L', 'Xing Q']","['Adolescent', 'Adult', 'Analysis of Variance', 'Antipsychotic Agents/*therapeutic use', 'Asian People/genetics', 'China', 'Female', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Pharmacogenetics', 'Polymorphism, Single Nucleotide', 'Psychiatric Status Rating Scales', 'Receptors, G-Protein-Coupled/*genetics', 'Receptors, Histamine/*genetics', 'Receptors, Histamine H4', 'Risperidone/*therapeutic use', 'Schizophrenia/*drug therapy/genetics/physiopathology', 'Treatment Outcome', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/23422377/
1265,HRH4,29470609,[New aspects in systemic treatment of atopic dermatitis].,"['Werfel T', 'Wollenberg A', 'Pumnea T', 'Heratizadeh A']","['Antibodies, Monoclonal/therapeutic use', 'Antibodies, Monoclonal, Humanized/therapeutic use', 'Cyclosporine/*therapeutic use', 'Dermatitis, Atopic/*drug therapy', 'Glucocorticoids/*therapeutic use', 'Humans', 'Interleukins/antagonists & inhibitors', 'Janus Kinase Inhibitors/therapeutic use', 'Off-Label Use', 'Receptors, Histamine H4/antagonists & inhibitors', 'Receptors, Interleukin-13/antagonists & inhibitors']",https://pubmed.ncbi.nlm.nih.gov/29470609/
1266,HRH4,36288637,Transcriptional analyses provide novel insights into the transgenerational effects of Poly (I:C) on chickens.,"['Liu L', 'Wang D', 'Fu Y', 'Duan Z', 'Adetula AA', 'Liu H', 'Yu Y', 'Chu Q']","['Humans', 'Animals', 'Female', '*Chickens/genetics', '*Poly I-C/toxicity', 'Reproduction', 'Oviposition', 'Transcriptome']",https://pubmed.ncbi.nlm.nih.gov/36288637/
1267,HRH4,22201753,H(4) receptors in mast cells and basophils: a new therapeutic target for allergy?,"['Gibbs BF', 'Levi-Schaffer F']","['Basophils/*physiology', 'Histamine/physiology', 'Humans', 'Hypersensitivity/drug therapy/physiopathology', 'Inflammation Mediators/antagonists & inhibitors/physiology', 'Mast Cells/*physiology', 'Receptors, G-Protein-Coupled/antagonists & inhibitors/*physiology', 'Receptors, Histamine/*physiology', 'Receptors, Histamine H4']",https://pubmed.ncbi.nlm.nih.gov/22201753/
1268,HRH4,22653292,Asthma endophenotypes and polymorphisms in the histamine receptor HRH4 gene.,"['Simon T', 'Semsei AF', 'Ungvari I', 'Hadadi E', 'Virag V', 'Nagy A', 'Vangor MS', 'Laszlo V', 'Szalai C', 'Falus A']","['Adolescent', 'Asthma/etiology/*genetics', 'Base Sequence', 'Case-Control Studies', 'Child', 'Child, Preschool', 'Endophenotypes', 'Female', 'Gene Frequency', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Haplotypes', 'Humans', 'Infections/complications', 'Linkage Disequilibrium', 'Male', '*Polymorphism, Single Nucleotide', 'Receptors, G-Protein-Coupled/*genetics', 'Receptors, Histamine/*genetics', 'Receptors, Histamine H4', 'Risk Factors', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/22653292/
1269,CYSLTR1,39288219,The role of signaling pathways mediated by the GPCRs CysLTR1/2 in melanocyte proliferation and senescence.,"['Huber T', 'Horioka-Duplix M', 'Chen Y', 'Saca VR', 'Ceraudo E', 'Chen Y', 'Sakmar TP']","['*Receptors, Leukotriene/metabolism/genetics', 'Humans', '*Melanocytes/metabolism/cytology/pathology', '*Signal Transduction', '*Cellular Senescence', '*Cell Proliferation', 'Melanoma/metabolism/genetics/pathology', 'Animals', 'Mutation', 'Receptors, G-Protein-Coupled/metabolism/genetics', 'Uveal Neoplasms', 'Uveal Melanoma']",https://pubmed.ncbi.nlm.nih.gov/39288219/
1270,CYSLTR1,31742746,Generation and phenotype analysis of CysLTR1 L118F mutant mice.,"['Hu X', 'Mao J', 'Zhou B', 'Zhang H', 'Li B', 'Pang P', 'Shan H']","['Animals', '*Behavior, Animal', 'Calcium/*metabolism', 'Female', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Mutant Proteins/genetics/*metabolism', '*Mutation', 'Myocardium/*metabolism', 'Phenotype', '*Protein Interaction Domains and Motifs', 'Receptors, Leukotriene/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/31742746/
1271,CYSLTR1,29199960,Update on the Genetic Basis of Drug Hypersensitivity Reactions.,"['Jurado-Escobar R', 'Perkins JR', 'Garcia-Martin E', 'Isidoro-Garcia M', 'Dona I', 'Torres MJ', 'Cornejo-Garcia JA']","['Allergens/immunology', 'Anti-Inflammatory Agents, Non-Steroidal/adverse effects', 'Drug Hypersensitivity/diagnosis/*etiology/therapy', 'Genetic Association Studies', '*Genetic Predisposition to Disease', 'Humans', 'Pharmaceutical Preparations/classification']",https://pubmed.ncbi.nlm.nih.gov/29199960/
1272,CYSLTR1,27779086,Genetic Predictors of Drug Hypersensitivity.,"['Cornejo-Garcia JA', 'Oussalah A', 'Blanca M', 'Gueant-Rodriguez RM', 'Mayorga C', 'Waton J', 'Barbaud A', 'Gaeta F', 'Romano A', 'Gueant JL']","['Anti-Bacterial Agents/adverse effects/immunology/therapeutic use', 'Anti-Inflammatory Agents, Non-Steroidal/adverse effects/immunology/therapeutic use', 'Drug Hypersensitivity/drug therapy/*genetics/immunology', 'Humans', 'Immunoglobulin E/immunology']",https://pubmed.ncbi.nlm.nih.gov/27779086/
1273,CYSLTR1,16502481,Genetic markers for differentiating aspirin-hypersensitivity.,"['Kim SH', 'Park HS']","['Alleles', 'Anti-Inflammatory Agents, Non-Steroidal/*adverse effects', 'Aspirin/*adverse effects', 'Asthma/chemically induced/diagnosis/genetics', 'Drug Hypersensitivity/diagnosis/drug therapy/*genetics', 'Genetic Markers', 'Genetic Predisposition to Disease', 'Humans', 'Korea', 'Polymorphism, Single Nucleotide', 'Urticaria/chemically induced/diagnosis/genetics']",https://pubmed.ncbi.nlm.nih.gov/16502481/
1274,CYSLTR1,16771777,Determination of structure and transcriptional regulation of CYSLTR1 and an association study with asthma and rhinitis.,"['Zhang J', 'Migita O', 'Koga M', 'Shibasaki M', 'Arinami T', 'Noguchi E']","['Adolescent', 'Alternative Splicing', 'Amino Acid Sequence/genetics', 'Asthma/*genetics', 'Base Sequence/genetics', 'Child', 'Gene Expression Regulation/genetics', 'Genome Components/*genetics', 'Humans', 'Japan', 'Membrane Proteins/chemistry/*genetics', 'Molecular Sequence Data', 'Polymorphism, Genetic/genetics', 'Receptors, Leukotriene/chemistry/*genetics', 'Reverse Transcriptase Polymerase Chain Reaction', 'Rhinitis/*genetics', 'Transcription, Genetic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/16771777/
1275,CYSLTR1,33837837,The relevance of CYSLTR1 gene polymorphism to the severity of allergic rhinitis and clinical responsiveness of montelukast in children.,"['Zhao M', 'Li H', 'Li H']","['Acetates/therapeutic use', 'Anti-Asthmatic Agents/*therapeutic use', 'Child', 'Cyclopropanes', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Polymorphism, Single Nucleotide', '*Quinolines/therapeutic use', 'Receptors, Leukotriene/*genetics', '*Rhinitis, Allergic/drug therapy/genetics', 'Sulfides']",https://pubmed.ncbi.nlm.nih.gov/33837837/
1276,CYSLTR1,16505607,Pathogenesis of nonsteroidal antiinflammatory drug-induced asthma.,"['Kim SH', 'Park HS']","['Anti-Inflammatory Agents, Non-Steroidal/*adverse effects', 'Aspirin/*adverse effects', 'Asthma/*chemically induced/genetics', 'Female', 'Humans', 'Male']",https://pubmed.ncbi.nlm.nih.gov/16505607/
1277,CYSLTR1,32657253,Methylation of cysteinyl leukotriene receptor 1 genes associates with lung function in asthmatics exposed to traffic-related air pollution.,"['Rabinovitch N', 'Jones MJ', 'Gladish N', 'Faino AV', 'Strand M', 'Morin AM', 'MacIsaac J', 'Lin DTS', 'Reynolds PR', 'Singh A', 'Gelfand EW', 'Kobor MS', 'Carlsten C']","['*Air Pollution', '*Asthma/genetics', '*DNA Methylation', 'Humans', 'Leukocytes, Mononuclear', 'Lung', 'Receptors, G-Protein-Coupled', 'Receptors, Leukotriene/*genetics']",https://pubmed.ncbi.nlm.nih.gov/32657253/
1278,CYSLTR1,37659739,Development of bile acid activated receptors hybrid molecules for the treatment of inflammatory and metabolic disorders.,"['Fiorucci S', 'Sepe V', 'Biagioli M', 'Fiorillo B', 'Rapacciuolo P', 'Distrutti E', 'Zampella A']","['Humans', '*Bile Acids and Salts', 'Receptors, G-Protein-Coupled/metabolism', 'Receptors, Cytoplasmic and Nuclear', 'Liver/metabolism', '*Metabolic Diseases/drug therapy']",https://pubmed.ncbi.nlm.nih.gov/37659739/
1279,CYSLTR1,39504050,Cysteine Leukotriene Receptor Antagonist-Montelukast Effects on Diabetic Retinal Microvascular Endothelial Cells Curtail Autophagy.,"['Awad AM', 'Seetharaman ATM', 'Hossain MS', 'Elshaer SL', 'Abdelaziz RR', 'Nader MA', 'Gangaraju R']","['*Cyclopropanes/pharmacology', '*Acetates/pharmacology/therapeutic use', '*Quinolines/pharmacology/therapeutic use', '*Sulfides/pharmacology', '*Receptors, Leukotriene/metabolism/genetics', '*Autophagy/drug effects', '*Leukotriene Antagonists/pharmacology/therapeutic use', 'Humans', '*Retinal Vessels/pathology/drug effects', '*Diabetic Retinopathy/drug therapy/metabolism', 'Cells, Cultured', 'Endothelial Cells/metabolism/drug effects', 'Endothelium, Vascular/metabolism/drug effects', 'Capillary Permeability/drug effects', 'Diabetes Mellitus, Experimental', 'Blotting, Western']",https://pubmed.ncbi.nlm.nih.gov/39504050/
1280,CYSLTR1,33480040,Montelukast alleviates inflammation in experimental autoimmune encephalomyelitis by altering Th17 differentiation in a mouse model.,"['Han B', 'Zhang YY', 'Ye ZQ', 'Xiao Y', 'Rasouli J', 'Wu WC', 'Ye SM', 'Guo XY', 'Zhu L', 'Rostami A', 'Wang LB', 'Zhang Y', 'Li X']","['Acetates/*therapeutic use', 'Adoptive Transfer', 'Animals', 'Anti-Inflammatory Agents/*therapeutic use', 'Cell Differentiation', 'Cyclopropanes/*therapeutic use', 'Disease Models, Animal', 'Encephalomyelitis, Autoimmune, Experimental/*drug therapy', 'Female', 'Humans', 'Inflammation/*drug therapy', 'Leukotriene Antagonists/*therapeutic use', 'Mice', 'Mice, Inbred C57BL', 'Molecular Targeted Therapy', 'Multiple Sclerosis/*drug therapy', 'Quinolines/*therapeutic use', 'Receptors, Leukotriene/genetics/metabolism', 'Signal Transduction', 'Sulfides/*therapeutic use', 'Th17 Cells/*immunology']",https://pubmed.ncbi.nlm.nih.gov/33480040/
1281,CYSLTR1,19416143,Leukotriene pathway genetics and pharmacogenetics in allergy.,"['Duroudier NP', 'Tulah AS', 'Sayers I']","['5-Lipoxygenase-Activating Proteins', 'Arachidonate 5-Lipoxygenase/*physiology', 'Asthma/drug therapy/etiology/genetics', 'Carrier Proteins/genetics', 'Epoxide Hydrolases/genetics', 'Glutathione Transferase/genetics', 'Humans', 'Hypersensitivity/*drug therapy/etiology/genetics', 'Leukotriene Antagonists/therapeutic use', 'Leukotrienes/*physiology', 'Membrane Proteins/genetics', '*Pharmacogenetics', 'Polymorphism, Genetic', 'Receptors, Leukotriene/genetics/physiology', 'Receptors, Leukotriene B4/physiology', 'Signal Transduction/*physiology']",https://pubmed.ncbi.nlm.nih.gov/19416143/
1282,CYSLTR1,39358316,Cysteinyl Leukotriene Receptor Antagonism by Montelukast to Treat Visual Deficits.,"['Seetharaman ATM', 'Owens CE', 'Gangaraju R']","['Animals', 'Humans', '*Acetates/therapeutic use/pharmacology', '*Cyclopropanes/pharmacology/therapeutic use', '*Leukotriene Antagonists/therapeutic use/pharmacology', '*Quinolines/pharmacology/therapeutic use', 'Receptors, Leukotriene/metabolism', '*Sulfides/pharmacology/therapeutic use', 'Vision Disorders/drug therapy']",https://pubmed.ncbi.nlm.nih.gov/39358316/
1283,CYSLTR1,37731513,Identification of the shared gene signatures between pulmonary fibrosis and pulmonary hypertension using bioinformatics analysis.,"['Zhao H', 'Wang L', 'Yan Y', 'Zhao QH', 'He J', 'Jiang R', 'Luo CJ', 'Qiu HL', 'Miao YQ', 'Gong SG', 'Yuan P', 'Wu WH']","['Humans', '*Pulmonary Fibrosis/genetics', '*Hypertension, Pulmonary/genetics', 'Endothelial Cells', 'Genes, Regulator', 'Computational Biology', 'Proteins']",https://pubmed.ncbi.nlm.nih.gov/37731513/
1284,CYSLTR1,17397245,Treatment heterogeneity in asthma: genetics of response to leukotriene modifiers.,['Lima JJ'],"['Anti-Asthmatic Agents/therapeutic use', 'Asthma/*drug therapy/economics/epidemiology', 'Cost of Illness', '*Genetic Heterogeneity', 'Humans', 'Immunologic Factors/*therapeutic use', '*Leukotrienes/genetics', 'Models, Biological', 'Pharmacogenetics', 'Signal Transduction/genetics']",https://pubmed.ncbi.nlm.nih.gov/17397245/
1285,CYSLTR1,20046412,Update on recent advances in the management of aspirin exacerbated respiratory disease.,"['Palikhe NS', 'Kim JH', 'Park HS']","['Animals', 'Asthma, Aspirin-Induced/drug therapy/*genetics/*immunology', 'Eosinophils/metabolism', 'Genetic Predisposition to Disease/genetics', 'Humans', 'Leukotriene Antagonists/therapeutic use', 'Leukotrienes/metabolism', 'Models, Biological', 'Polymorphism, Genetic/genetics/physiology']",https://pubmed.ncbi.nlm.nih.gov/20046412/
1286,CYSLTR1,16825866,Genetic mechanism of aspirin-induced urticaria/angioedema.,"['Kim SH', 'Ye YM', 'Lee SK', 'Park HS']","['Angioedema/blood/*chemically induced/*genetics/immunology', 'Aspirin/*adverse effects', 'Drug Hypersensitivity/etiology/*genetics/immunology', 'HLA-DQ Antigens/genetics/immunology', 'HLA-DQ beta-Chains', 'HLA-DR Antigens/genetics/immunology', 'HLA-DRB1 Chains', 'Histamine/genetics/immunology', 'Humans', 'Urticaria/*chemically induced/*genetics/immunology/microbiology']",https://pubmed.ncbi.nlm.nih.gov/16825866/
1287,CYSLTR1,27221082,Expression of cysteinyl leukotriene receptor 1 and 2 (CysLTR1 and CysLTR2) in the lymphocytes of hyperplastic tonsils: comparison between allergic and nonallergic snoring children.,"['Paulucci BP', 'Pereira J', 'Picciarelli P', 'Levy D', 'Di Francesco RC']","['Adenoids/*metabolism/pathology', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Hyperplasia/genetics/metabolism', 'Hypersensitivity/genetics/metabolism/pathology', 'Lymphocytes/*metabolism', 'Male', 'Palatine Tonsil/*metabolism/pathology', 'RNA, Messenger/metabolism', 'Receptors, Leukotriene/*genetics', 'Snoring/genetics/metabolism/pathology']",https://pubmed.ncbi.nlm.nih.gov/27221082/
1288,CYSLTR1,21169002,Cysteinyl leukotriene antagonism inhibits bronchoconstriction in response to hypertonic saline inhalation in asthma.,"['Kazani S', 'Sadeh J', 'Bunga S', 'Wechsler ME', 'Israel E']","['Acetates/*administration & dosage', 'Administration, Inhalation', 'Adolescent', 'Adult', 'Aged', 'Asthma/drug therapy/genetics/*physiopathology', 'Bronchoconstriction/*drug effects/physiology', 'Cyclopropanes', 'Cysteine/*antagonists & inhibitors', 'Epidemiologic Methods', 'Female', 'Humans', 'Leukotriene Antagonists/*administration & dosage', 'Leukotrienes', 'Male', 'Middle Aged', 'Polymorphism, Genetic', 'Quinolines/*administration & dosage', 'Receptors, Leukotriene/*administration & dosage', 'Saline Solution, Hypertonic/*administration & dosage', 'Sulfides', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/21169002/
1289,CYP2C8,26721703,Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions.,"['Backman JT', 'Filppula AM', 'Niemi M', 'Neuvonen PJ']","['Antimalarials/pharmacology', 'Antineoplastic Agents/pharmacology', 'Cytochrome P-450 CYP2C8/*metabolism', 'Cytochrome P-450 CYP2C8 Inducers/*pharmacology', 'Drug Interactions/genetics/*physiology', 'Enzyme Repression/*drug effects', 'Humans', 'Hypoglycemic Agents/pharmacology', 'Hypolipidemic Agents/pharmacology', 'Pharmacogenetics']",https://pubmed.ncbi.nlm.nih.gov/26721703/
1290,CYP2C8,16646575,Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals.,"['Garcia-Martin E', 'Martinez C', 'Ladero JM', 'Agundez JA']","['Aryl Hydrocarbon Hydroxylases/*genetics', 'Cytochrome P-450 CYP2C8', 'Cytochrome P-450 CYP2C9', 'Ethnicity/*genetics', '*Genetic Variation', '*Health', 'Humans', 'Polymorphism, Genetic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/16646575/
1291,CYP2C8,34448113,"Variability of CYP2C8 Polymorphisms in Three Jordanian Populations: Circassians, Chechens and Jordanian-Arabs.","['Abudahab S', 'Hakooz N', 'Tobeh N', 'Gogazeh E', 'Gharaibeh M', 'Al-Eitan L', 'Zihlif M', 'Dajani R']","['*Arabs', 'Cytochrome P-450 CYP2C8/genetics', 'Gene Frequency', 'Genotype', 'Humans', 'Jordan/epidemiology', '*White People']",https://pubmed.ncbi.nlm.nih.gov/34448113/
1292,CYP2C8,37846548,Pharmacogenomics of chloroquine and hydroxychloroquine: current evidence and future implications.,"['Biswas M', 'Sukasem C']","['Humans', '*Hydroxychloroquine/adverse effects', '*Chloroquine/adverse effects', 'Cytochrome P-450 CYP2C8', 'Cytochrome P-450 CYP2D6/genetics', 'Pharmacogenetics']",https://pubmed.ncbi.nlm.nih.gov/37846548/
1293,CYP2C8,30636597,Effects of CYP2C8 and SLCO1B1 Genetic Polymorphisms on Repaglinide Pharmacokinetics: A Systematic Review and Meta-Analysis.,"['Zhou S', 'Xiang Q', 'Mu G', 'Ma L', 'Chen S', 'Xie Q', 'Zhang Z', 'Cui Y']","['Carbamates/metabolism/*pharmacokinetics', 'Cytochrome P-450 CYP2C8/*genetics/metabolism', 'Hypoglycemic Agents/metabolism/*pharmacokinetics', 'Liver-Specific Organic Anion Transporter 1/*genetics/metabolism', 'Piperidines/metabolism/*pharmacokinetics', '*Polymorphism, Genetic']",https://pubmed.ncbi.nlm.nih.gov/30636597/
1294,CYP2C8,17286541,CYP2C8 and antimalaria drug efficacy.,"['Gil JP', 'Gil Berglund E']","['Animals', 'Antimalarials/*therapeutic use', 'Aryl Hydrocarbon Hydroxylases/*genetics/metabolism', 'Cytochrome P-450 CYP2C8', 'Humans', 'Malaria/drug therapy/*enzymology/*genetics', 'Polymorphism, Genetic/drug effects/genetics', 'Substrate Specificity/drug effects']",https://pubmed.ncbi.nlm.nih.gov/17286541/
1295,CYP2C8,19442086,Polymorphic drug metabolism in anaesthesia.,"['Restrepo JG', 'Garcia-Martin E', 'Martinez C', 'Agundez JA']","['Anesthetics/*metabolism', 'Animals', 'Aryl Hydrocarbon Hydroxylases/genetics/physiology', 'Cytochrome P-450 CYP2A6', 'Cytochrome P-450 CYP2C8', 'Cytochrome P-450 CYP2C9', 'Cytochrome P-450 CYP3A/genetics/physiology', 'Humans', 'Pharmacogenetics', 'Polymorphism, Genetic']",https://pubmed.ncbi.nlm.nih.gov/19442086/
1296,CYP2C8,17092739,Pharmacogenetics of paclitaxel metabolism.,"['Spratlin J', 'Sawyer MB']","['Antineoplastic Agents, Phytogenic/*pharmacokinetics/pharmacology', 'Aryl Hydrocarbon Hydroxylases/drug effects/genetics', 'Cytochrome P-450 CYP2C8', 'Cytochrome P-450 Enzyme System/*drug effects/genetics', 'Humans', 'Paclitaxel/*pharmacokinetics/pharmacology', 'Polymorphism, Genetic']",https://pubmed.ncbi.nlm.nih.gov/17092739/
1297,CYP2C8,36178950,CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients.,"['Dalle Fratte C', 'Gagno S', 'Roncato R', 'Polesel J', 'Zanchetta M', 'Buzzo M', 'Posocco B', 'De Mattia E', 'Borsatti R', 'Puglisi F', 'Foltran L', 'Guardascione M', 'Buonadonna A', 'Cecchin E', 'Toffoli G']","['Humans', '*Cytochrome P-450 CYP2D6/genetics', 'Imatinib Mesylate/adverse effects/pharmacokinetics', 'Cytochrome P-450 CYP2C8/genetics', 'Pharmacogenetics', 'Cytochrome P-450 CYP2C9/genetics', 'Prospective Studies', 'Chromatography, Liquid', '*Gastrointestinal Stromal Tumors/drug therapy/genetics', 'Tandem Mass Spectrometry', 'Cytochromes/genetics', 'Genotype', 'Cytochrome P-450 CYP2C19/genetics']",https://pubmed.ncbi.nlm.nih.gov/36178950/
1298,CYP2C8,35892315,Pharmacogenetics of taxane-induced neurotoxicity in breast cancer: Systematic review and meta-analysis.,"['Guijosa A', 'Freyria A', 'Espinosa-Fernandez JR', 'Estrada-Mena FJ', 'Armenta-Quiroga AS', 'Ortega-Trevino MF', 'Catalan R', 'Antonio-Aguirre B', 'Villarreal-Garza C', 'Perez-Ortiz AC']","['Female', 'Humans', '*Breast Neoplasms/drug therapy/genetics', 'Cytochrome P-450 CYP2C8/genetics', 'Cytochrome P-450 CYP3A/genetics', 'Genetic Markers', 'Liver-Specific Organic Anion Transporter 1/genetics', '*Neurotoxicity Syndromes/genetics', 'Paclitaxel/adverse effects', '*Peripheral Nervous System Diseases/chemically induced/genetics/complications', 'Pharmacogenetics', 'Polymorphism, Single Nucleotide', '*Taxoids/adverse effects']",https://pubmed.ncbi.nlm.nih.gov/35892315/
1299,CYP2C8,31596164,Temsirolimus metabolic pathways revisited.,"['Shokati T', 'Hartmann M', 'Davari B', 'Klawitter J', 'Klawitter J', 'Christians U']","['Cytochrome P-450 CYP2C8/metabolism', 'Cytochrome P-450 CYP3A/metabolism', 'Cytochrome P-450 Enzyme System/metabolism', 'Humans', 'Hydroxylation', 'Mass Spectrometry', 'Metabolic Networks and Pathways', 'Microsomes, Liver/*metabolism', 'Sirolimus/*analogs & derivatives/metabolism']",https://pubmed.ncbi.nlm.nih.gov/31596164/
1300,CYP2C8,38404228,Mechanistic Determinants of Daprodustat Drug-Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B-CYP2C8 Interplay.,"['Bi YA', 'Jordan S', 'King-Ahmad A', 'West MA', 'Varma MVS']","['Adult', 'Animals', 'Female', 'Humans', 'Male', '*Cytochrome P-450 CYP2C8/metabolism', 'Cytochrome P-450 CYP2C8 Inhibitors/pharmacokinetics', '*Drug Interactions', 'Glycine/analogs & derivatives/pharmacokinetics', 'HEK293 Cells', '*Hepatocytes/metabolism/drug effects', 'Liver Diseases/metabolism', '*Liver-Specific Organic Anion Transporter 1/metabolism/antagonists & inhibitors', 'Macaca fascicularis', '*Renal Insufficiency, Chronic/metabolism', '*Rifampin/pharmacology', '*Solute Carrier Organic Anion Transporter Family Member 1B3/metabolism/antagonists & inhibitors']",https://pubmed.ncbi.nlm.nih.gov/38404228/
1301,CYP2C8,37993281,Genotype-guided new approach for dose optimisation of hydroxychloroquine administration in Chinese patients with SLE.,"['Xie H', 'Wen X', 'Wang Y', 'Huang X', 'Shu Q', 'Wang D', 'Geng L', 'Jin Z', 'Shen W', 'Ge W', 'Zhu Y', 'Sun L']","['Humans', 'Hydroxychloroquine/therapeutic use', '*Antirheumatic Agents/therapeutic use', 'Cytochrome P-450 CYP2C8', 'Cytochrome P-450 CYP2D6/genetics', 'East Asian People', '*Lupus Erythematosus, Systemic/drug therapy/genetics', 'Genotype']",https://pubmed.ncbi.nlm.nih.gov/37993281/
1302,CYP2C8,27548563,Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transporters.,"['Tornio A', 'Neuvonen PJ', 'Niemi M', 'Backman JT']","['Cytochrome P-450 CYP2C8/drug effects', 'Cytochrome P-450 CYP2C8 Inhibitors/metabolism/*pharmacology', 'Drug Interactions', 'Gemfibrozil/analogs & derivatives/metabolism/*pharmacology', 'Glucuronates/metabolism/pharmacology', 'Humans', 'Hypolipidemic Agents/metabolism/pharmacology', 'Membrane Transport Proteins/*drug effects']",https://pubmed.ncbi.nlm.nih.gov/27548563/
1303,CYP2C8,31849280,CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy.,"['Genvigir FDV', 'Campos-Salazar AB', 'Felipe CR', 'Tedesco-Silva H Jr', 'Medina-Pestana JO', 'Doi SQ', 'Cerda A', 'Hirata MH', 'Herrero MJ', 'Alino SF', 'Hirata RDC']","['Adult', 'Brazil/epidemiology', 'Cytochrome P-450 CYP2C8/*genetics', 'Cytochrome P-450 CYP3A/*genetics', 'Female', 'Genotype', 'Humans', 'Immunosuppression Therapy/methods', 'Immunosuppressive Agents/administration & dosage/*adverse effects/immunology', 'Kidney/drug effects/pathology', 'Kidney Transplantation/*adverse effects', 'Male', 'Middle Aged', 'Multidrug Resistance-Associated Protein 2', 'Polymorphism, Single Nucleotide/genetics', 'Tacrolimus/administration & dosage/*adverse effects/immunology', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/31849280/
1304,CYP2C8,27803446,"Genetic Polymorphisms and in Vitro Functional Characterization of CYP2C8, CYP2C9, and CYP2C19 Allelic Variants.",['Hiratsuka M'],"['Alleles', 'Animals', 'Cytochrome P-450 CYP2C19/*genetics/metabolism', 'Cytochrome P-450 CYP2C8/*genetics/metabolism', 'Cytochrome P-450 CYP2C9/*genetics/metabolism', 'Humans', 'Polymorphism, Genetic']",https://pubmed.ncbi.nlm.nih.gov/27803446/
1305,CYP2C8,21178300,Drug-induced idiosyncratic hepatotoxicity: prevention strategy developed after the troglitazone case.,['Ikeda T'],"['Adult', 'Aged', 'Aryl Hydrocarbon Hydroxylases/metabolism', 'Biotransformation/genetics', 'Chemical and Drug Induced Liver Injury/immunology/*prevention & control', 'Chromans/*adverse effects/metabolism', 'Cytochrome P-450 CYP2C8', 'Cytochrome P-450 CYP3A/biosynthesis', 'Female', 'Genes, MHC Class I/genetics', 'Glutathione Transferase/genetics', 'Hepatocytes/drug effects/metabolism', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Genetic', 'Safety-Based Drug Withdrawals', 'Thiazolidinediones/*adverse effects/metabolism', 'Troglitazone']",https://pubmed.ncbi.nlm.nih.gov/21178300/
1306,CYP2C8,30520341,Patients carrying CYP2C8*3 have shorter systemic paclitaxel exposure.,"['Marcath LA', 'Kidwell KM', 'Robinson AC', 'Vangipuram K', 'Burness ML', 'Griggs JJ', 'Poznak CV', 'Schott AF', 'Hayes DF', 'Henry NL', 'Hertz DL']","['Antineoplastic Agents, Phytogenic/administration & dosage/adverse effects', 'Cytochrome P-450 CYP2C8/*genetics', 'Female', 'Genetic Association Studies', 'Genotype', 'Humans', 'Liver-Specific Organic Anion Transporter 1/*genetics', 'Male', 'Middle Aged', 'Neoplasms/*drug therapy/genetics/pathology', 'Paclitaxel/administration & dosage/*adverse effects', 'Pharmacogenomic Variants/genetics', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/30520341/
1307,CYP2C8,16157296,Structural diversity of human xenobiotic-metabolizing cytochrome P450 monooxygenases.,"['Johnson EF', 'Stout CD']","['Amino Acid Sequence', 'Aryl Hydrocarbon Hydroxylases/*chemistry/metabolism', 'Cytochrome P-450 CYP2A6', 'Cytochrome P-450 CYP2C8', 'Cytochrome P-450 CYP2C9', 'Cytochrome P-450 CYP3A', 'Cytochrome P-450 Enzyme System/*chemistry/metabolism', 'Humans', 'Mixed Function Oxygenases/*chemistry/metabolism', 'Molecular Sequence Data', 'Xenobiotics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/16157296/
1308,CYP2C8,34304352,Drug-interaction between paclitaxel and goshajinkigan extract and its constituents.,"['Nakayama A', 'Tsuchiya K', 'Xu L', 'Matsumoto T', 'Makino T']","['*Carcinoma, Non-Small-Cell Lung', 'Cytochrome P-450 CYP2C8', 'Cytochrome P-450 CYP3A', 'Drug Interactions', '*Drugs, Chinese Herbal/pharmacology', 'Humans', '*Lung Neoplasms', 'Microsomes, Liver', 'Paclitaxel']",https://pubmed.ncbi.nlm.nih.gov/34304352/
1309,SLC22A11,39146184,Structural basis for the transport and substrate selection of human urate transporter 1.,"['He J', 'Liu G', 'Kong F', 'Tan Q', 'Wang Z', 'Yang M', 'He Y', 'Jia X', 'Yan C', 'Wang C', 'Qian H']","['Humans', '*Uric Acid/metabolism', '*Organic Anion Transporters/metabolism/chemistry', '*Organic Cation Transport Proteins/metabolism/chemistry', 'Substrate Specificity', '*Cryoelectron Microscopy', 'HEK293 Cells', 'Biological Transport', 'Models, Molecular', 'Organic Anion Transporters, Sodium-Independent']",https://pubmed.ncbi.nlm.nih.gov/39146184/
1310,SLC22A11,20613716,A 'complexity' of urate transporters.,"['Wright AF', 'Rudan I', 'Hastie ND', 'Campbell H']","['ATP Binding Cassette Transporter, Subfamily G, Member 2', 'ATP-Binding Cassette Transporters/genetics', 'Genome-Wide Association Study', 'Glucose Transport Proteins, Facilitative/genetics/physiology', 'Humans', 'Mutation', 'Neoplasm Proteins/genetics', 'Organic Anion Transporters/*physiology', 'Organic Cation Transport Proteins/physiology', 'Uric Acid/*metabolism', 'Uricosuric Agents/therapeutic use', 'Uromodulin/genetics']",https://pubmed.ncbi.nlm.nih.gov/20613716/
1311,SLC22A11,36274627,Circulating tumor-associated autoantibodies as novel diagnostic biomarkers in pancreatic adenocarcinoma.,"['Zhuang L', 'Huang C', 'Ning Z', 'Yang L', 'Zou W', 'Wang P', 'Cheng CS', 'Meng Z']","['Humans', '*Pancreatic Neoplasms/pathology', 'Autoantibodies', '*Adenocarcinoma/diagnosis', 'Biomarkers, Tumor', 'CA-19-9 Antigen', '*Pancreatitis, Chronic/diagnosis']",https://pubmed.ncbi.nlm.nih.gov/36274627/
1312,SLC22A11,33368618,27-Hydroxycholesterol regulates human SLC22A12 gene expression through estrogen receptor action.,"['Matsubayashi M', 'Sakaguchi YM', 'Sahara Y', 'Nanaura H', 'Kikuchi S', 'Asghari A', 'Bui L', 'Kobashigawa S', 'Nakanishi M', 'Nagata R', 'Matsui TK', 'Kashino G', 'Hasegawa M', 'Takasawa S', 'Eriguchi M', 'Tsuruya K', 'Nagamori S', 'Sugie K', 'Nakagawa T', 'Takasato M', 'Umetani M', 'Mori E']","['Gene Expression Regulation/*drug effects', 'Humans', 'Hydroxycholesterols/*pharmacology', 'Kidney/*metabolism', 'Organic Anion Transporters/*biosynthesis/genetics', 'Organic Cation Transport Proteins/*biosynthesis/genetics', 'Organoids/metabolism', 'Receptors, Estrogen/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/33368618/
1313,SLC22A11,25889045,An update on the genetic architecture of hyperuricemia and gout.,['Merriman TR'],"['ATP Binding Cassette Transporter, Subfamily G, Member 2', 'ATP-Binding Cassette Transporters/*genetics', 'Female', 'Genetic Predisposition to Disease/*epidemiology', '*Genome-Wide Association Study', 'Glucose Transport Proteins, Facilitative/*genetics', 'Gout/*genetics/physiopathology', 'Humans', 'Hyperuricemia/*genetics/physiopathology', 'Male', 'Neoplasm Proteins/*genetics', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/25889045/
1314,SLC22A11,17103332,Molecular insights into the structure-function relationship of organic anion transporters OATs.,"['Zhou F', 'You G']","['Animals', 'Humans', 'Mice', 'Mice, Knockout', 'Organic Anion Transporters/biosynthesis/*chemistry/genetics/*metabolism', 'Polymorphism, Genetic', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/17103332/
1315,SLC22A11,30415459,Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation.,"['Tron C', 'Lemaitre F', 'Verstuyft C', 'Petitcollin A', 'Verdier MC', 'Bellissant E']","['Animals', 'Humans', 'Immunosuppressive Agents/pharmacokinetics/*pharmacology', 'Membrane Transport Proteins/*genetics/metabolism', 'Multidrug Resistance-Associated Protein 2', '*Organ Transplantation', 'Polymorphism, Single Nucleotide', 'Tacrolimus/pharmacokinetics/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/30415459/
1316,SLC22A11,38222853,"Examining the Association of Rare Allelic Variants in Urate Transporters SLC22A11, SLC22A13, and SLC17A1 with Hyperuricemia and Gout.","['Vavra J', 'Pavelcova K', 'Masinova J', 'Hasikova L', 'Bubenikova E', 'Urbanova A', 'Mancikova A', 'Stiburkova B']","['Humans', '*Gout/genetics', '*Hyperuricemia/genetics', '*Organic Anion Transporters/genetics', '*Organic Anion Transporters, Sodium-Independent/genetics', 'Uric Acid/metabolism', '*Sodium-Phosphate Cotransporter Proteins, Type I/genetics']",https://pubmed.ncbi.nlm.nih.gov/38222853/
1317,SLC22A11,27103454,Research progress in the genetics of hyperuricaemia and gout.,"['Zheng M', 'Ma JW']","['Animals', 'Gene-Environment Interaction', 'Genetic Predisposition to Disease', 'Gout/etiology/*genetics', 'Humans', 'Hyperuricemia/etiology/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27103454/
1318,SLC22A11,29847376,The systems biology of uric acid transporters: the role of remote sensing and signaling.,"['Nigam SK', 'Bhatnagar V']","['Animals', '*Biological Transport', 'Humans', 'Intestinal Mucosa/metabolism', 'Ion Pumps/genetics/metabolism', 'Kidney/metabolism', 'Membrane Transport Proteins/*genetics/*metabolism', 'Multidrug Resistance-Associated Protein 2', 'Signal Transduction', 'Systems Biology', 'Uric Acid/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/29847376/
1319,SLC22A11,37894870,SLC22A11 Inserts the Uremic Toxins Indoxyl Sulfate and P-Cresol Sulfate into the Plasma Membrane.,"['Tust M', 'Muller JP', 'Fischer D', 'Grundemann D']","['Humans', 'Uremic Toxins', 'Indican/metabolism', 'Chromatography, Liquid', 'HEK293 Cells', 'Tandem Mass Spectrometry', '*Renal Insufficiency, Chronic/metabolism', 'Cresols/metabolism', '*Toxins, Biological/metabolism', 'Cell Membrane/metabolism', 'Organic Anion Transporters, Sodium-Independent']",https://pubmed.ncbi.nlm.nih.gov/37894870/
1320,SLC22A11,33832965,"Variants in urate transporters, ADH1B, GCKR and MEPE genes associate with transition from asymptomatic hyperuricaemia to gout: results of the first gout versus asymptomatic hyperuricaemia GWAS in Caucasians using data from the UK Biobank.","['Sandoval-Plata G', 'Morgan K', 'Abhishek A']","['ATP Binding Cassette Transporter, Subfamily G, Member 2/genetics', 'Adaptor Proteins, Signal Transducing/genetics', 'Aged', 'Alcohol Dehydrogenase/genetics', '*Asymptomatic Diseases', 'Disease Progression', 'Extracellular Matrix Proteins/genetics', 'Female', 'Genome-Wide Association Study', 'Glucose Transport Proteins, Facilitative/genetics', 'Glycoproteins/genetics', 'Gout/*genetics', 'Humans', 'Hyperuricemia/*genetics', 'Logistic Models', 'Male', 'Middle Aged', 'Mitochondrial Membrane Transport Proteins/genetics', 'Multifactorial Inheritance', 'Neoplasm Proteins/genetics', 'Organic Anion Transporters, Sodium-Independent/genetics', 'Phosphoproteins/genetics', 'Polymorphism, Single Nucleotide', 'Risk Factors', 'Serine Endopeptidases/genetics', 'White People']",https://pubmed.ncbi.nlm.nih.gov/33832965/
1321,SLC22A11,34948211,SLC22 Transporters in the Fly Renal System Regulate Response to Oxidative Stress In Vivo.,"['Zhang P', 'Azad P', 'Engelhart DC', 'Haddad GG', 'Nigam SK']","['Animals', 'Antioxidants/metabolism', 'Biological Transport/physiology', 'Drosophila melanogaster/*metabolism', 'Humans', 'Kidney/*metabolism', 'Organic Cation Transport Proteins/*metabolism', 'Oxidative Stress/*physiology', 'Signal Transduction/physiology']",https://pubmed.ncbi.nlm.nih.gov/34948211/
1322,SLC22A11,34842392,Plumbagin and Plumbago indica Differentially Modulated Cytochrome P450 and Transporter Profiles in BeWo and HepG2 Cells.,"['Chatuphonprasert W', 'Sukkasem N', 'Ellinger I', 'Jarukamjorn K']","['Cytochrome P-450 Enzyme System/*drug effects/pharmacology', 'Hep G2 Cells/*drug effects', 'Humans', 'Naphthoquinones/*pharmacology', 'Plumbaginaceae/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/34842392/
1323,SLC22A11,25496233,Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells.,"['Ebert R', 'Meissner-Weigl J', 'Zeck S', 'Maatta J', 'Auriola S', 'Coimbra de Sousa S', 'Mentrup B', 'Graser S', 'Rachner TD', 'Hofbauer LC', 'Jakob F']","['Antineoplastic Agents/pharmacology', 'Apoptosis/drug effects', 'Bone Neoplasms/drug therapy/metabolism', 'Breast Neoplasms/*drug therapy/metabolism', 'Caspase 3/metabolism', 'Caspase 7/metabolism', 'Cell Line, Tumor', 'Cell Survival/drug effects', 'Connexins/metabolism', 'Diphosphonates/*pharmacology', 'Etidronic Acid/analogs & derivatives/pharmacology', 'Female', 'Hemiterpenes/pharmacology', 'Humans', 'Ibandronic Acid', 'Imidazoles/pharmacology', 'MCF-7 Cells', 'Multidrug Resistance-Associated Proteins/metabolism', 'Nerve Tissue Proteins/metabolism', 'Organophosphorus Compounds/pharmacology', 'Osteoclasts/drug effects/metabolism', 'Phosphate Transport Proteins/metabolism', 'Probenecid/*pharmacology', 'Risedronic Acid', 'Zoledronic Acid']",https://pubmed.ncbi.nlm.nih.gov/25496233/
1324,SLC22A11,36398357,The impact of genetic variability in urate transporters on oxypurinol pharmacokinetics.,"['Hishe HZ', 'Stocker SL', 'Stamp LK', 'Dalbeth N', 'Merriman TR', 'Phipps-Green A', 'Wright DFB']","['Humans', 'Oxypurinol/pharmacokinetics', 'Uric Acid', '*Gout/drug therapy/genetics', 'Allopurinol/pharmacokinetics', '*Organic Anion Transporters/genetics', 'Organic Cation Transport Proteins/genetics', 'Glucose Transport Proteins, Facilitative/genetics']",https://pubmed.ncbi.nlm.nih.gov/36398357/
1325,SLC22A11,26086825,Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?,"['Lima A', 'Bernardes M', 'Azevedo R', 'Medeiros R', 'Seabra V']","['Adult', 'Aged', 'Antirheumatic Agents/pharmacokinetics/*therapeutic use', 'Arthritis, Rheumatoid/*drug therapy/genetics', 'Female', 'Humans', 'Male', 'Methotrexate/pharmacokinetics/*therapeutic use', 'Middle Aged', 'Multidrug Resistance-Associated Proteins/*genetics', 'Organic Anion Transporters, Sodium-Independent/*genetics', 'Pharmacogenetics', '*Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/26086825/
1326,SLC22A11,32363570,Multifaceted genome-wide study identifies novel regulatory loci in SLC22A11 and ZNF45 for body mass index in Indians.,"['Giri AK', 'Prasad G', 'Bandesh K', 'Parekatt V', 'Mahajan A', 'Banerjee P', 'Kauser Y', 'Chakraborty S', 'Rajashekar D', 'Sharma A', 'Mathur SK', 'Basu A', 'McCarthy MI', 'Tandon N', 'Bharadwaj D']","['Adolescent', 'Adult', 'Asian People/genetics', 'Body Mass Index', 'DNA Methylation', 'Female', 'Gene-Environment Interaction', 'Genetic Predisposition to Disease', '*Genome-Wide Association Study', 'Humans', 'Indians, North American/genetics', 'Kruppel-Like Transcription Factors/*genetics', 'Male', 'Obesity/*genetics/pathology', 'Organic Anion Transporters, Sodium-Independent/*genetics', 'Polymorphism, Single Nucleotide/genetics', 'Quantitative Trait Loci/genetics', 'Regulatory Sequences, Nucleic Acid/genetics', 'Repressor Proteins/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/32363570/
1327,SLC22A11,33617845,"Hyperosmolarity stimulates transporter-mediated insertion of estrone sulfate into the plasma membrane, but inhibits the uptake by SLC10A1 (NTCP).","['Muller JP', 'Keufgens L', 'Grundemann D']","['Cell Membrane/drug effects/*metabolism', 'Diuretics, Osmotic/administration & dosage', 'Dose-Response Relationship, Drug', 'Estrone/*analogs & derivatives/metabolism/pharmacology', 'HEK293 Cells', 'Humans', 'Mannitol/*administration & dosage', 'Organic Anion Transporters, Sodium-Dependent/*metabolism', 'Osmolar Concentration', 'Sucrose/*administration & dosage', 'Sweetening Agents/administration & dosage', 'Symporters/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/33617845/
1328,SLC22A8,38836423,"3,3',5-Triiodothyroacetic Acid Transporters.","['Chen Z', 'Yildiz S', 'Markova B', 'de Rooij LJ', 'Leeuwenburgh S', 'Hamers T', 'Peeters RP', 'Heuer H', 'Meima ME', 'Visser WE']","['Animals', '*Monocarboxylic Acid Transporters/metabolism/genetics', 'Humans', '*Symporters/metabolism/genetics', '*Blood-Brain Barrier/metabolism', 'Mice', '*Triiodothyronine/metabolism/analogs & derivatives', 'Chlorocebus aethiops', 'COS Cells', 'Zebrafish', 'Organic Anion Transporters/metabolism/genetics', 'Biological Transport', 'Muscle Hypotonia/metabolism/genetics', 'Mice, Knockout', 'Muscular Atrophy', 'X-Linked Intellectual Disability']",https://pubmed.ncbi.nlm.nih.gov/38836423/
1329,SLC22A8,29309257,"The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.",['Nigam SK'],"['Animals', 'Biological Transport/*drug effects', 'Humans', 'Metabolic Networks and Pathways/*drug effects', 'Organic Anion Transporters/*metabolism', 'Pharmaceutical Preparations/*administration & dosage/*metabolism', 'Renal Insufficiency, Chronic/drug therapy/metabolism', 'Signal Transduction/*drug effects']",https://pubmed.ncbi.nlm.nih.gov/29309257/
1330,SLC22A8,36206988,"OAT, OATP, and MRP Drug Transporters and the Remote Sensing and Signaling Theory.","['Nigam SK', 'Granados JC']","['Humans', '*Avena/metabolism', 'Remote Sensing Technology', 'Membrane Transport Proteins/metabolism', '*Organic Anion Transporters/metabolism', 'Adenosine Triphosphate']",https://pubmed.ncbi.nlm.nih.gov/36206988/
1331,SLC22A8,36123895,SLC22A8: An indicator for tumor immune microenvironment and prognosis of ccRCC from a comprehensive analysis of bioinformatics.,"['Xu K', 'Wu Y', 'Chi H', 'Li Y', 'She Y', 'Yin X', 'Liu X', 'He B', 'Li X', 'Du H']","['Biomarkers, Tumor/metabolism', '*Carcinoma, Renal Cell/pathology', 'Computational Biology', 'Humans', '*Kidney Neoplasms/pathology', 'Prognosis', 'Tumor Microenvironment/genetics']",https://pubmed.ncbi.nlm.nih.gov/36123895/
1332,SLC22A8,35081498,Systematic identification and characterization of cynomolgus macaque solute carrier transporters.,"['Uno Y', 'Yamazaki H']","['Amino Acid Sequence', 'Animals', 'Dogs', '*Liver/metabolism', 'Macaca fascicularis/metabolism', '*Membrane Transport Proteins/genetics/metabolism', 'Mice', 'Organic Cation Transporter 2/metabolism', 'Phylogeny', 'Rats']",https://pubmed.ncbi.nlm.nih.gov/35081498/
1333,SLC22A8,25540139,The organic anion transporter (OAT) family: a systems biology perspective.,"['Nigam SK', 'Bush KT', 'Martovetsky G', 'Ahn SY', 'Liu HC', 'Richard E', 'Bhatnagar V', 'Wu W']","['Gene Expression Regulation/*physiology', 'Humans', 'Organic Anion Transporters/chemistry/*genetics/*metabolism', 'Tissue Distribution']",https://pubmed.ncbi.nlm.nih.gov/25540139/
1334,SLC22A8,30931851,Methotrexate Disposition in Pediatric Patients with Acute Lymphoblastic Leukemia: What Have We Learnt From the Genetic Variants of Drug Transporters.,"['Hu YH', 'Zhou L', 'Wang SS', 'Jing X', 'Guo HL', 'Sun F', 'Zhang Y', 'Chen F', 'Xu J', 'Ji X']","['ATP-Binding Cassette Transporters/*genetics', 'Antimetabolites, Antineoplastic/pharmacokinetics/therapeutic use', 'Child', 'Humans', 'Methotrexate/*pharmacology/therapeutic use', 'Multidrug Resistance-Associated Protein 2', 'Organic Anion Transporters/*genetics', 'Polymorphism, Genetic', 'Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy/genetics']",https://pubmed.ncbi.nlm.nih.gov/30931851/
1335,SLC22A8,29847376,The systems biology of uric acid transporters: the role of remote sensing and signaling.,"['Nigam SK', 'Bhatnagar V']","['Animals', '*Biological Transport', 'Humans', 'Intestinal Mucosa/metabolism', 'Ion Pumps/genetics/metabolism', 'Kidney/metabolism', 'Membrane Transport Proteins/*genetics/*metabolism', 'Multidrug Resistance-Associated Protein 2', 'Signal Transduction', 'Systems Biology', 'Uric Acid/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/29847376/
1336,SLC22A8,35406626,Functional Characterization of Rare Variants in OAT1/SLC22A6 and OAT3/SLC22A8 Urate Transporters Identified in a Gout and Hyperuricemia Cohort.,"['Vavra J', 'Mancikova A', 'Pavelcova K', 'Hasikova L', 'Bohata J', 'Stiburkova B']","['Biological Transport', '*Gout/genetics/metabolism', 'HEK293 Cells', 'Humans', '*Hyperuricemia/genetics', '*Organic Anion Transport Protein 1/genetics', '*Organic Anion Transporters, Sodium-Independent/genetics', 'Uric Acid/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35406626/
1337,SLC22A8,17103332,Molecular insights into the structure-function relationship of organic anion transporters OATs.,"['Zhou F', 'You G']","['Animals', 'Humans', 'Mice', 'Mice, Knockout', 'Organic Anion Transporters/biosynthesis/*chemistry/genetics/*metabolism', 'Polymorphism, Genetic', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/17103332/
1338,SLC22A8,35393526,An Amish founder population reveals rare-population genetic determinants of the human lipidome.,"['Montasser ME', 'Aslibekyan S', 'Srinivasasainagendra V', 'Tiwari HK', 'Patki A', 'Bagheri M', 'Kind T', 'Barupal DK', 'Fan S', 'Perry J', 'Ryan KA', 'Shuldiner AR', 'Arnett DK', 'Beitelshees AL', 'Irvin MR', ""O'Connell JR""]","['*Amish/genetics', 'DNA-Binding Proteins/genetics', '*Founder Effect', '*Genetics, Population', 'Genome-Wide Association Study', 'Humans', '*Lipidomics', 'Lipids', 'Nuclear Proteins/genetics', 'Transcription Factors/genetics']",https://pubmed.ncbi.nlm.nih.gov/35393526/
1339,SLC22A8,32439376,Single-cell profiling reveals sex diversity in human renal proximal tubules.,"['Huang L', 'Liao J', 'He J', 'Pan S', 'Zhang H', 'Yang X', 'Cheng J', 'Chen Y', 'Mo Z']","['Animals', 'Female', 'Humans', 'Kidney/metabolism/*pathology', 'Kidney Tubules, Proximal/*metabolism/physiology', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Organic Anion Transport Protein 1/genetics/metabolism', 'Organic Anion Transporters, Sodium-Independent/genetics/metabolism', 'Sequence Analysis, RNA/methods', '*Sex Factors', 'Single-Cell Analysis/methods', 'Transcriptome/genetics']",https://pubmed.ncbi.nlm.nih.gov/32439376/
1340,SLC22A8,39201768,"The Biology and Biochemistry of Kynurenic Acid, a Potential Nutraceutical with Multiple Biological Effects.","['Alves LF', 'Moore JB', 'Kell DB']","['*Kynurenic Acid/metabolism', 'Humans', '*Dietary Supplements', 'Animals', 'Tryptophan/metabolism', 'Kynurenine/metabolism', 'Neuroprotective Agents/pharmacology', 'Antioxidants/metabolism/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/39201768/
1341,SLC22A8,24685584,Interaction of five anthraquinones from rhubarb with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8) and drug-drug interaction in rats.,"['Ma L', 'Zhao L', 'Hu H', 'Qin Y', 'Bian Y', 'Jiang H', 'Zhou H', 'Yu L', 'Zeng S']","['Animals', 'Anthraquinones/*pharmacology', 'Drug Interactions', 'Furosemide/blood/*pharmacokinetics', 'HEK293 Cells', 'Humans', 'Male', 'Organic Anion Transport Protein 1/*metabolism', 'Organic Anion Transporters, Sodium-Independent/*metabolism', 'Plant Extracts/*pharmacology', 'Rats, Sprague-Dawley', '*Rheum']",https://pubmed.ncbi.nlm.nih.gov/24685584/
1342,SLC22A8,16291576,The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics.,"['Erdman AR', 'Mangravite LM', 'Urban TJ', 'Lagpacan LL', 'Castro RA', 'de la Cruz M', 'Chan W', 'Huang CC', 'Johns SJ', 'Kawamoto M', 'Stryke D', 'Taylor TR', 'Carlson EJ', 'Ferrin TE', 'Brett CM', 'Burchard EG', 'Giacomini KM']","['Alleles', 'DNA Mutational Analysis', 'Ethnicity', '*Genetic Variation', 'Genetics, Population', 'Humans', 'Organic Anion Transporters, Sodium-Independent/*genetics/*physiology', 'Pharmaceutical Preparations/metabolism', 'Pharmacokinetics']",https://pubmed.ncbi.nlm.nih.gov/16291576/
1343,SLC22A8,24042472,Characteristics of pemetrexed transport by renal basolateral organic anion transporter hOAT3.,"['Kurata T', 'Iwamoto T', 'Kawahara Y', 'Okuda M']","['Biological Transport', 'Drug Interactions', 'Folic Acid Antagonists/*metabolism', 'Glutamates/*metabolism', 'Guanine/*analogs & derivatives/metabolism', 'HEK293 Cells', 'Humans', 'Kidney/drug effects/*metabolism', 'Kinetics', 'Methotrexate/metabolism', 'Organic Anion Transport Protein 1/genetics/metabolism', 'Organic Anion Transporters, Sodium-Independent/antagonists & inhibitors/*metabolism', 'Pemetrexed', 'Transfection']",https://pubmed.ncbi.nlm.nih.gov/24042472/
1344,SLC22A8,23506904,Transporter biology in drug approval: regulatory aspects.,"['Maeda K', 'Sugiyama Y']","['Drug Approval/*legislation & jurisprudence', 'Drug Interactions/*physiology', 'Humans', 'Membrane Transport Proteins/*metabolism', 'Models, Biological', 'Pharmaceutical Preparations/*metabolism', '*Pharmacokinetics', 'Risk Management']",https://pubmed.ncbi.nlm.nih.gov/23506904/
1345,SLC22A8,36316339,Drug transporters OAT1 and OAT3 have specific effects on multiple organs and gut microbiome as revealed by contextualized metabolic network reconstructions.,"['Jamshidi N', 'Nigam SK']","['Humans', '*Gastrointestinal Microbiome', 'Metabolic Networks and Pathways', 'Metabolomics', '*Organic Anion Transport Protein 1/metabolism', '*Organic Anion Transporters, Sodium-Independent/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36316339/
1346,ADRA1D,29180230,"Glucocorticoids, genes and brain function.","['Juszczak GR', 'Stankiewicz AM']","['Animals', 'Brain/*metabolism', '*Gene Expression', 'Glucocorticoids/*metabolism', 'Humans', 'Transcriptome']",https://pubmed.ncbi.nlm.nih.gov/29180230/
1347,ADRA1D,27382054,Endogenous N-terminal Domain Cleavage Modulates alpha1D-Adrenergic Receptor Pharmacodynamics.,"['Kountz TS', 'Lee KS', 'Aggarwal-Howarth S', 'Curran E', 'Park JM', 'Harris DA', 'Stewart A', 'Hendrickson J', 'Camp ND', 'Wolf-Yadlin A', 'Wang EH', 'Scott JD', 'Hague C']","['Hep G2 Cells', 'Humans', 'MCF-7 Cells', 'Neoplasm Proteins/genetics/*metabolism', 'PDZ Domains', '*Proteolysis', 'Receptors, Adrenergic, alpha-1/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/27382054/
1348,ADRA1D,37571902,Functional Involvement of ADRA1D in Cutaneous Melanoma Progression and Angiogenesis.,"['Wang J', 'Ning D', 'Xie D', 'Chen X', 'Cao X', 'Wan C']","['Humans', 'Mice', 'Animals', '*Melanoma/metabolism', 'Vascular Endothelial Growth Factor A/genetics/metabolism', '*Skin Neoplasms/genetics', 'Neovascularization, Pathologic/genetics/drug therapy/metabolism', 'Cell Line, Tumor', 'Hypoxia-Inducible Factor 1, alpha Subunit/genetics', 'Melanoma, Cutaneous Malignant']",https://pubmed.ncbi.nlm.nih.gov/37571902/
1349,ADRA1D,38622006,Bioinformatic Identification of Signaling Pathways and Hub Genes in Vascular Dementia.,"['Wu Y', 'Cai J', 'Pang B', 'Cao L', 'He Q', 'He Q', 'Zhang A']","['Animals', 'Rats', 'Humans', 'Aged', '*Dementia, Vascular/genetics', 'Ligands', '*Neurodegenerative Diseases', 'Amines', 'Signal Transduction/genetics', 'GTP-Binding Proteins', '*Aniline Compounds', '*Xanthenes']",https://pubmed.ncbi.nlm.nih.gov/38622006/
1350,ADRA1D,33208818,Patulin suppresses alpha(1)-adrenergic receptor expression in HEK293 cells.,"['Pillay Y', 'Nagiah S', 'Phulukdaree A', 'Krishnan A', 'Chuturgoon AA']","['AMP-Activated Protein Kinases/chemistry/metabolism', 'Adrenergic alpha-1 Receptor Agonists/pharmacology', 'Adrenergic alpha-1 Receptor Antagonists/*pharmacology', 'Epinephrine/pharmacology', 'Gene Expression Regulation/drug effects', 'HEK293 Cells', 'Humans', 'MAP Kinase Signaling System/drug effects', 'Metformin/pharmacology', 'Molecular Docking Simulation', 'Patulin/chemistry/metabolism/*pharmacology', 'Phosphatidylinositol 3-Kinases/metabolism', 'Proto-Oncogene Proteins c-akt/metabolism', 'Receptors, Adrenergic, alpha-1/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/33208818/
1351,ADRA1D,38729598,Genes related to neurotransmitter receptors as potential biomarkers for Alzheimer's disease.,"['Chen W', 'Zhang T', 'Zhang H']","['*Alzheimer Disease/genetics/metabolism', 'Humans', '*Receptors, Neurotransmitter/genetics/metabolism', '*Biomarkers/metabolism', 'Gene Regulatory Networks', 'Gene Expression Profiling/methods']",https://pubmed.ncbi.nlm.nih.gov/38729598/
1352,ADRA1D,33402011,Development of a Novel SNAP-Epitope Tag/Near-Infrared Imaging Assay to Quantify G Protein-Coupled Receptor Degradation in Human Cells.,"['Lee KS', 'Navaluna E', 'Marsh NM', 'Janezic EM', 'Hague C']","['Bortezomib/pharmacology', 'Cell Line, Tumor', 'Cycloheximide/pharmacology', 'Epithelial Cells/cytology/drug effects/metabolism', 'Gene Expression', 'HEK293 Cells', 'Half-Life', '*High-Throughput Screening Assays', 'Humans', 'Molecular Imaging/methods', 'Norepinephrine/pharmacology', 'Proteasome Endopeptidase Complex/drug effects/metabolism', 'Proteasome Inhibitors/pharmacology', 'Protein Isoforms/genetics/metabolism', 'Protein Synthesis Inhibitors/pharmacology', 'Proteolysis/drug effects', 'Receptor, Serotonin, 5-HT2A/genetics/*metabolism', 'Receptors, Adrenergic, alpha-1/genetics/*metabolism', 'Receptors, Interleukin-8A/genetics/*metabolism', 'Receptors, Somatostatin/genetics/*metabolism', 'Recombinant Fusion Proteins/*chemistry/genetics/metabolism', 'Spectroscopy, Near-Infrared/methods']",https://pubmed.ncbi.nlm.nih.gov/33402011/
1353,ADRA1D,33806345,Involvement of the Catecholamine Pathway in Glioblastoma Development.,"['Kraboth Z', 'Kajtar B', 'Galik B', 'Gyenesei A', 'Miseta A', 'Kalman B']","['Brain Neoplasms/*physiopathology', 'Catecholamines/*metabolism', 'Gene Expression Regulation, Neoplastic/*genetics', 'Glioblastoma/*physiopathology', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/33806345/
1354,ADRA1D,26381449,The association of DNA methylation and brain volume in healthy individuals and schizophrenia patients.,"['Liu J', 'Siyahhan Julnes P', 'Chen J', 'Ehrlich S', 'Walton E', 'Calhoun VD']","['Adult', 'Brain/*pathology', 'Cerebellum/pathology', 'CpG Islands/genetics', 'DNA Methylation/*genetics', 'Female', 'Genetic Association Studies', 'Genome, Human/*genetics', 'Humans', 'Image Processing, Computer-Assisted', 'Magnetic Resonance Imaging', 'Male', 'Middle Aged', 'Schizophrenia/*genetics/*pathology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/26381449/
1355,ADRA1D,29870805,Mineralocorticoid receptor antagonism reverses diabetes-related coronary vasodilator dysfunction: A unique vascular transcriptomic signature.,"['Brown SM', 'Meuth AI', 'Davis JW', 'Rector RS', 'Bender SB']","['Animals', 'Arterioles/*drug effects/metabolism/physiopathology', 'Coronary Artery Disease/*drug therapy/genetics/metabolism/physiopathology', 'Coronary Vessels/*drug effects/metabolism/physiopathology', 'Diabetes Mellitus, Type 2/*drug therapy/genetics/metabolism/physiopathology', 'Diabetic Angiopathies/*drug therapy/genetics/metabolism/physiopathology', 'Disease Models, Animal', 'Gene Expression Profiling/methods', 'Gene Regulatory Networks', 'High-Throughput Nucleotide Sequencing', 'Male', 'Mineralocorticoid Receptor Antagonists/*pharmacology', 'Rats, Inbred OLETF', 'Signal Transduction/drug effects', 'Spironolactone/*pharmacology', '*Transcriptome', 'Vasodilation/*drug effects']",https://pubmed.ncbi.nlm.nih.gov/29870805/
1356,ADRA1D,36776063,Acupuncture Therapy on Dementia: Explained with an Integrated Analysis on Therapeutic Targets and Associated Mechanisms.,"['Li D', 'Yang H', 'Lyu M', 'Wang J', 'Xu W', 'Wang Y']","['Humans', 'Molecular Docking Simulation', '*Alzheimer Disease/genetics', '*Dementia, Vascular', 'Gene Expression Profiling', '*Acupuncture Therapy']",https://pubmed.ncbi.nlm.nih.gov/36776063/
1357,ADRA1D,39046281,Identification and functionalization of thyrotropin receptor antibodies with different antigenic epitopes.,"['Zheng J', 'Duan H', 'Jiang Z', 'Chen L', 'You S', 'Huang L', 'Huang H']","['Humans', '*Receptors, Thyrotropin/immunology/genetics', '*Epitopes/immunology', '*Graves Disease/immunology/blood/diagnosis', 'Graves Ophthalmopathy/immunology/genetics/blood', 'Autoantibodies/immunology/blood', 'Female', 'Male', 'Immunoglobulins, Thyroid-Stimulating/blood/immunology', 'Thyroid Gland/immunology', 'Adult', 'Middle Aged', 'Cell Proliferation', 'Thyroiditis, Autoimmune/immunology/genetics', 'Hypothyroidism/immunology']",https://pubmed.ncbi.nlm.nih.gov/39046281/
1358,ADRA1D,17404580,Polymorphisms of norepinephrine transporter and adrenergic receptor alpha1D are associated with the response to beta-blockers in dilated cardiomyopathy.,"['Nonen S', 'Okamoto H', 'Fujio Y', 'Takemoto Y', 'Yoshiyama M', 'Hamaguchi T', 'Matsui Y', 'Yoshikawa J', 'Kitabatake A', 'Azuma J']","['Adrenergic beta-Antagonists/administration & dosage/*therapeutic use', 'Aged', 'Cardiomyopathy, Dilated/*drug therapy/*genetics', 'Female', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Norepinephrine Plasma Membrane Transport Proteins/*genetics', 'Polymorphism, Genetic/genetics', 'Receptors, Adrenergic, alpha-1/*genetics', 'Reverse Transcriptase Polymerase Chain Reaction']",https://pubmed.ncbi.nlm.nih.gov/17404580/
1359,ADRA1D,29655996,A Genomic-clinicopathologic Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer.,"['Wu SX', 'Huang J', 'Liu ZW', 'Chen HG', 'Guo P', 'Cai QQ', 'Zheng JJ', 'Qin HD', 'Zheng ZS', 'Chen X', 'Zhang RY', 'Chen SL', 'Lin TX']","['Aged', 'Female', '*Genomics', 'Humans', 'Lymphatic Metastasis', 'Male', 'Middle Aged', 'Neoplasm Invasiveness', '*Neoplasm Proteins/genetics/metabolism', 'Predictive Value of Tests', 'Preoperative Care', '*RNA, Messenger/genetics/metabolism', '*RNA, Neoplasm/genetics/metabolism', '*Urinary Bladder Neoplasms/genetics/metabolism/pathology']",https://pubmed.ncbi.nlm.nih.gov/29655996/
1360,ADRA1D,15464025,The elusive alpha(1D)-adrenoceptor: molecular and cellular characteristics and integrative roles.,"['Garcia-Sainz JA', 'Villalobos-Molina R']","['Adrenergic alpha-1 Receptor Antagonists', 'Animals', 'Antihypertensive Agents/pharmacology', 'Blood Vessels/physiopathology', 'Humans', 'Hypertension/drug therapy/physiopathology', 'Muscle, Smooth, Vascular/drug effects/physiopathology', 'Protein Kinase C/metabolism', 'Receptors, Adrenergic, alpha-1/*physiology']",https://pubmed.ncbi.nlm.nih.gov/15464025/
1361,ADRA1D,12442007,Molecular analysis of adrenergic receptor genes and interleukin-4/interleukin-4 receptor genes in patients with interstitial cystitis.,"['Sugaya K', 'Nishijima S', 'Yamada T', 'Miyazato M', 'Hatano T', 'Ogawa Y']","['Cystitis, Interstitial/*genetics', 'Female', 'Genotype', 'Humans', 'Interleukin-4/*genetics', 'Linkage Disequilibrium', 'Male', 'Middle Aged', 'Polymorphism, Genetic', 'Receptors, Adrenergic/*genetics', 'Receptors, Adrenergic, alpha-1/genetics', 'Receptors, Adrenergic, beta-2/genetics', 'Receptors, Adrenergic, beta-3/genetics', 'Receptors, Interleukin-4/*genetics']",https://pubmed.ncbi.nlm.nih.gov/12442007/
1362,ADRA1D,36648147,alpha1 Adrenoreceptor antagonism mitigates extracellular mitochondrial DNA accumulation in lung fibrosis models and in patients with idiopathic pulmonary fibrosis.,"['Ishikawa G', 'Peng X', 'McGovern J', 'Woo S', 'Perry C', 'Liu A', 'Yu S', 'Ghincea A', 'Kishchanka A', 'Fiorini V', 'Hu B', 'Sun Y', 'Sun H', 'Ryu C', 'Herzog EL']","['Mice', 'Animals', 'Humans', '*DNA, Mitochondrial/genetics/metabolism', '*Idiopathic Pulmonary Fibrosis/metabolism', 'Lung/metabolism', 'Signal Transduction', 'Fibroblasts/metabolism', 'Bleomycin/pharmacology', 'Adrenergic Agents/metabolism/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/36648147/
1363,ADRA1D,39541744,"Dissecting the association between blood pressure traits, hypertension, antihypertensive medications and epilepsy: A Mendelian randomization study.","['Yu C', 'Jiang S', 'Lv B', 'Deng X', 'Xu D']","['Humans', '*Mendelian Randomization Analysis', '*Epilepsy/genetics/drug therapy', '*Hypertension/genetics/drug therapy/complications', '*Blood Pressure/drug effects/genetics/physiology', '*Antihypertensive Agents/therapeutic use', '*Genome-Wide Association Study', '*Polymorphism, Single Nucleotide', 'Quantitative Trait Loci']",https://pubmed.ncbi.nlm.nih.gov/39541744/
1364,ADRA1D,39564730,"Blood Plasma Methylated DNA Markers in the Detection of Lymphoma: Discovery, Validation, and Clinical Pilot.","['Witzig TE', 'Taylor WR', 'Mahoney DW', 'Bamlet WR', 'Foote PH', 'Burger KN', 'Doering KA', 'Devens ME', 'Arndt JR', ""O'Connell MC"", 'Berger CK', 'Novak AJ', 'Cerhan JR', 'Hennek J', 'Katerov S', 'Allawi HT', 'Jevremovic D', 'Dao LN', 'Graham RP', 'Kisiel JB']","['Humans', '*DNA Methylation', '*Biomarkers, Tumor/blood', 'Female', 'Male', '*Lymphoma/blood/diagnosis/genetics', 'Pilot Projects', 'Middle Aged', 'Aged', 'Adult']",https://pubmed.ncbi.nlm.nih.gov/39564730/
1365,ADRA1D,34062902,Antidepressants Differentially Regulate Intracellular Signaling from alpha1-Adrenergic Receptor Subtypes In Vitro.,"['Chmielarz P', 'Kusmierczyk J', 'Rafa-Zablocka K', 'Chorazka K', 'Kowalska M', 'Satala G', 'Nalepa I']","['Animals', 'Antidepressive Agents/classification/*pharmacology', 'Citalopram/pharmacology', 'Depression/*drug therapy/etiology/genetics/pathology', 'Desipramine/pharmacology', 'Fluoxetine/pharmacology', 'Gene Expression Regulation/drug effects', 'Humans', 'Imipramine/pharmacology', 'Mianserin/pharmacology', 'Mice', 'PC12 Cells', 'Rats', 'Reboxetine/pharmacology', 'Receptors, Adrenergic, alpha-1/*genetics', 'Signal Transduction/drug effects']",https://pubmed.ncbi.nlm.nih.gov/34062902/
1366,HTR1F,35115687,"Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles.","['Hautakangas H', 'Winsvold BS', 'Ruotsalainen SE', 'Bjornsdottir G', 'Harder AVE', 'Kogelman LJA', 'Thomas LF', 'Noordam R', 'Benner C', 'Gormley P', 'Artto V', 'Banasik K', 'Bjornsdottir A', 'Boomsma DI', 'Brumpton BM', 'Burgdorf KS', 'Buring JE', 'Chalmer MA', 'de Boer I', 'Dichgans M', 'Erikstrup C', 'Farkkila M', 'Garbrielsen ME', 'Ghanbari M', 'Hagen K', 'Happola P', 'Hottenga JJ', 'Hrafnsdottir MG', 'Hveem K', 'Johnsen MB', 'Kahonen M', 'Kristoffersen ES', 'Kurth T', 'Lehtimaki T', 'Lighart L', 'Magnusson SH', 'Malik R', 'Pedersen OB', 'Pelzer N', 'Penninx BWJH', 'Ran C', 'Ridker PM', 'Rosendaal FR', 'Sigurdardottir GR', 'Skogholt AH', 'Sveinsson OA', 'Thorgeirsson TE', 'Ullum H', 'Vijfhuizen LS', 'Widen E', 'van Dijk KW', 'Aromaa A', 'Belin AC', 'Freilinger T', 'Ikram MA', 'Jarvelin MR', 'Raitakari OT', 'Terwindt GM', 'Kallela M', 'Wessman M', 'Olesen J', 'Chasman DI', 'Nyholt DR', 'Stefansson H', 'Stefansson K', 'van den Maagdenberg AMJM', 'Hansen TF', 'Ripatti S', 'Zwart JA', 'Palotie A', 'Pirinen M']","['Alleles', 'Cardiovascular System/metabolism', 'Case-Control Studies', 'Central Nervous System/metabolism', 'Genetic Loci', '*Genetic Predisposition to Disease', '*Genome-Wide Association Study', 'Humans', 'Migraine Disorders/*genetics', 'Migraine with Aura/genetics', 'Molecular Sequence Annotation', '*Polymorphism, Single Nucleotide', 'Quantitative Trait Loci']",https://pubmed.ncbi.nlm.nih.gov/35115687/
1367,HTR1F,38674857,Mendelian Randomization Analysis Identifies Inverse Causal Relationship between External Eating and Metabolic Phenotypes.,"['Timasheva Y', 'Balkhiyarova Z', 'Avzaletdinova D', 'Morugova T', 'Korytina GF', 'Nouwen A', 'Prokopenko I', 'Kochetova O']","['Humans', '*Mendelian Randomization Analysis', '*Phenotype', '*Diabetes Mellitus, Type 2/genetics/etiology', '*Feeding Behavior', 'Female', 'Male', 'Metabolic Syndrome/genetics/etiology', 'tRNA Methyltransferases/genetics', 'Glycated Hemoglobin/metabolism/analysis', 'Middle Aged', 'Body Mass Index', 'Adenylyl Cyclases/genetics', 'Genome-Wide Association Study', 'Polymorphism, Single Nucleotide', 'Adult', 'Waist Circumference', 'Genetic Variation', '*Ghrelin']",https://pubmed.ncbi.nlm.nih.gov/38674857/
1368,HTR1F,34207786,"Molecular Cloning and Functional Characterization of Three 5-HT Receptor Genes (HTR1B, HTR1E, and HTR1F) in Chickens.","['Sun C', 'Qiu Y', 'Ren Q', 'Zhang X', 'Cao B', 'Zou Y', 'Li J', 'Zhang J', 'Wang Y']","['Animals', 'Avian Proteins/*genetics/metabolism', 'Brain/metabolism', 'Cells, Cultured', 'Chickens/*genetics/metabolism', 'Cloning, Molecular', 'Colforsin/pharmacology', 'HEK293 Cells', 'Humans', 'MAP Kinase Signaling System', 'Pituitary Gland/drug effects/metabolism', 'Receptors, Serotonin, 5-HT1/*genetics/metabolism', 'Serotonin Receptor Agonists/pharmacology', 'Vasoactive Intestinal Peptide/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/34207786/
1369,HTR1F,33693534,Complete Freund's adjuvant-induced decrement of pruriceptor-mediated suppression of itch.,"['Yin W', 'Liu L', 'Zhou Y', 'Zhang Y', 'Kong D', 'Xu S', 'Tang D', 'Huang D', 'Wen D', 'Jiao Y', 'Fan Y', 'Gao P', 'Yu W']","['Animals', ""Freund's Adjuvant/*pharmacokinetics"", 'Male', 'Mice', 'Pruritus/*drug therapy/metabolism/pathology', 'TRPA1 Cation Channel/*metabolism', 'TRPV Cation Channels/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/33693534/
1370,HTR1F,9394293,Assignment of the human serotonin 1F receptor gene (HTR1F) to the short arm of chromosome 3 (3p13-p14.1).,"['Erdmann J', 'Shimron-Abarbanell D', 'Shridhar V', 'Smith DI', 'Propping P', 'Nothen MM']","['Animals', 'Chromosome Mapping', 'Chromosomes, Human, Pair 3/*genetics/ultrastructure', 'Cricetinae', 'Cricetulus', '*Genes', 'Humans', 'Hybrid Cells', 'Mice', 'Nerve Tissue Proteins/genetics', 'Receptors, Serotonin/*genetics', 'Species Specificity', 'Receptor, Serotonin, 5-HT1F']",https://pubmed.ncbi.nlm.nih.gov/9394293/
1371,HTR1F,16873768,Serotoninergic receptors on human airway epithelial cells.,"['Bayer H', 'Muller T', 'Myrtek D', 'Sorichter S', 'Ziegenhagen M', 'Norgauer J', 'Zissel G', 'Idzko M']","['Biological Transport, Active', 'Calcium/metabolism', 'Cells, Cultured', 'Dinoprostone/biosynthesis', 'Epithelial Cells/*metabolism', 'Humans', 'Interleukin-6/metabolism', 'Interleukin-8/metabolism', 'Receptors, Serotonin/*biosynthesis', 'Respiratory Mucosa/cytology/metabolism']",https://pubmed.ncbi.nlm.nih.gov/16873768/
1372,HTR1F,28270201,"Exploration of haplotype research consortium imputation for genome-wide association studies in 20,032 Generation Scotland participants.","['Nagy R', 'Boutin TS', 'Marten J', 'Huffman JE', 'Kerr SM', 'Campbell A', 'Evenden L', 'Gibson J', 'Amador C', 'Howard DM', 'Navarro P', 'Morris A', 'Deary IJ', 'Hocking LJ', 'Padmanabhan S', 'Smith BH', 'Joshi P', 'Wilson JF', 'Hastie ND', 'Wright AF', 'McIntosh AM', 'Porteous DJ', 'Haley CS', 'Vitart V', 'Hayward C']","['Blood Glucose/genetics', 'Cross-Sectional Studies', 'Electronic Health Records', 'Fasting', 'Female', 'Genes', 'Genome-Wide Association Study', '*Haplotypes', 'Heart Rate/genetics', 'Humans', 'Male', '*Polymorphism, Single Nucleotide', 'Prospective Studies', '*Quantitative Trait, Heritable', 'Scotland', 'Uric Acid/blood', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/28270201/
1373,HTR1F,33950983,MicroRNA-363-3p promote the development of acute myeloid leukemia with RUNX1 mutation by targeting SPRYD4 and FNDC3B.,"['Chen Y', 'Chen S', 'Lu J', 'Yuan D', 'He L', 'Qin P', 'Tan H', 'Xu L']","['Carcinogenesis/*genetics', 'Computational Biology', 'Core Binding Factor Alpha 2 Subunit/genetics', 'Datasets as Topic', 'Female', 'Fibronectins/*genetics', 'Gene Expression Regulation, Leukemic', 'Gene Regulatory Networks', 'Humans', 'Leukemia, Myeloid, Acute/*genetics/pathology', 'Male', 'MicroRNAs/*metabolism', 'Middle Aged', 'Mutation', 'Nuclear Proteins/*genetics', 'Protein Interaction Mapping', 'Protein Interaction Maps/genetics']",https://pubmed.ncbi.nlm.nih.gov/33950983/
1374,HTR1F,17763112,"Genome-wide linkage analysis for smoking-related regions, with replication in two ethnically diverse populations.","['Pomerleau OF', 'Pomerleau CS', 'Chu J', 'Kardia SL']","['Adult', 'Black People/*genetics', 'Chromosomes, Human, Pair 3/*genetics', 'Female', '*Genetic Linkage', '*Genetic Predisposition to Disease', 'Genome, Human', 'Humans', 'Male', 'Microsatellite Repeats', 'Middle Aged', 'Siblings', 'Smoking/genetics', 'Tobacco Use Disorder/*genetics', 'White People/*genetics']",https://pubmed.ncbi.nlm.nih.gov/17763112/
1375,HTR1F,31045513,Correlation of BRCA2 gene mutation and prognosis as well as variant genes in invasive urothelial carcinoma of the bladder.,"['Kuang S', 'Li H', 'Feng J', 'Xu S', 'Le Y']","['*Biomarkers, Tumor', 'Carcinoma, Transitional Cell/*genetics/*mortality/pathology', 'Gene Expression Regulation, Neoplastic', '*Genes, BRCA2', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Humans', '*Mutation', 'Neoplasm Invasiveness', 'Neoplasm Staging', 'Prognosis', 'Survival Analysis', 'Transcriptome', 'Urinary Bladder Neoplasms/*genetics/*mortality/pathology']",https://pubmed.ncbi.nlm.nih.gov/31045513/
1376,HTR1F,7910582,Chromosomal mapping of mouse genes expressed selectively within the central nervous system.,"['Danielson PE', 'Watson JB', 'Gerendasy DD', 'Erlander MG', 'Lovenberg TW', 'de Lecea L', 'Sutcliffe JG', 'Frankel WN']","['Animals', 'Brain/metabolism', 'Central Nervous System/*metabolism', '*Chromosome Mapping', 'Crosses, Genetic', 'Female', 'Gene Expression Regulation', 'Hybridization, Genetic', 'Male', 'Mice/*genetics/metabolism', 'Mice, Inbred C57BL', 'Muridae/genetics', 'Nerve Tissue Proteins/biosynthesis/*genetics', 'Organ Specificity', 'Polymorphism, Restriction Fragment Length']",https://pubmed.ncbi.nlm.nih.gov/7910582/
1377,HTR1F,20052562,Identification of a potential molecular link between the glucocorticoid and serotonergic signaling systems.,"['Falkenberg VR', 'Rajeevan MS']","['Animals', 'Base Sequence', 'Databases, Genetic', 'Evolution, Molecular', 'Glucocorticoids/*metabolism', 'HeLa Cells', 'Humans', 'Hypothalamo-Hypophyseal System/metabolism', 'Molecular Sequence Data', 'Pituitary-Adrenal System/metabolism', 'Promoter Regions, Genetic', 'Receptors, Glucocorticoid/metabolism', 'Receptors, Serotonin/metabolism', 'Serotonin/*metabolism', 'Signal Transduction/*physiology']",https://pubmed.ncbi.nlm.nih.gov/20052562/
1378,HTR1F,14970692,A refined comparative map between porcine chromosome 13 and human chromosome 3.,"['Van Poucke M', 'Yerle M', 'Chardon P', 'Jacobs K', 'Genet C', 'Mattheeuws M', 'Van Zeveren A', 'Peelman LJ']","['Animals', 'Chromosomes/*genetics', 'Chromosomes, Artificial, Bacterial/genetics', 'Chromosomes, Human, Pair 3/*genetics', 'Cytogenetic Analysis/methods/veterinary', 'Gene Library', 'Gene Order/genetics', 'Genetic Linkage/genetics', 'Humans', 'In Situ Hybridization, Fluorescence/methods/veterinary', 'Metaphase/genetics', 'Microsatellite Repeats/genetics', 'Molecular Sequence Data', 'Physical Chromosome Mapping/methods/veterinary', 'Polymerase Chain Reaction/methods/veterinary', 'Radiation Hybrid Mapping/methods/veterinary', 'Swine/*genetics']",https://pubmed.ncbi.nlm.nih.gov/14970692/
1379,HTR1F,21169892,"No association between polymorphisms in four serotonin receptor genes, serotonin transporter gene and alcohol-related suicide.","['Zupanc T', 'Pregelj P', 'Tomori M', 'Komel R', 'Paska AV']","['Adult', 'Aged', 'Alcoholism/complications/*genetics', 'Autopsy', 'Female', 'Genetic Predisposition to Disease', 'Humans', 'Introns/genetics', 'Male', 'Middle Aged', 'Minisatellite Repeats', 'Polymerase Chain Reaction', 'Polymorphism, Single Nucleotide', 'Promoter Regions, Genetic/genetics', 'Receptor, Serotonin, 5-HT1A/genetics', 'Receptor, Serotonin, 5-HT1B/genetics', 'Receptor, Serotonin, 5-HT2A/genetics', 'Receptors, Serotonin/*genetics', 'Serotonin Plasma Membrane Transport Proteins/*genetics', 'Suicide/psychology']",https://pubmed.ncbi.nlm.nih.gov/21169892/
1380,HTR1F,14970703,Genetic mapping of GBE1 and its association with glycogen storage disease IV in American Quarter horses.,"['Ward TL', 'Valberg SJ', 'Lear TL', 'Guerin G', 'Milenkovic D', 'Swinburne JE', 'Binns MM', 'Raudsepp T', 'Skow L', 'Chowdhary BP', 'Mickelson JR']","['1,4-alpha-Glucan Branching Enzyme/*genetics', 'Alleles', 'Americas', 'Animals', 'Chromosome Mapping/*methods/*veterinary', 'Genetic Linkage/genetics', 'Glycogen Storage Disease Type IV/*genetics/*veterinary', 'Horse Diseases/*genetics', 'Horses/*genetics', 'In Situ Hybridization, Fluorescence/methods/veterinary', 'Microsatellite Repeats/genetics', 'Radiation Hybrid Mapping/methods/veterinary', 'Sequence Analysis, DNA/methods/veterinary']",https://pubmed.ncbi.nlm.nih.gov/14970703/
1381,HTR1F,14753293,"Quantitative mRNA analysis of eight bovine 5-HT receptor subtypes in brain, abomasum, and intestine by real-time RT-PCR.","['Reist M', 'Pfaffl MW', 'Morel C', 'Meylan M', 'Hirsbrunner G', 'Blum JW', 'Steiner A']","['Abomasum/*metabolism', 'Animals', 'Brain/*metabolism', 'Cattle', 'DNA Primers/chemistry', 'DNA, Complementary/metabolism', 'Humans', 'Intestinal Mucosa/*metabolism', 'Models, Theoretical', 'RNA/chemistry', 'RNA, Messenger/*metabolism', 'Receptors, Serotonin/chemistry/*metabolism', 'Reverse Transcriptase Polymerase Chain Reaction/*methods']",https://pubmed.ncbi.nlm.nih.gov/14753293/
1382,HTR1F,12627464,Suicide and serotonin: study of variation at seven serotonin receptor genes in suicide completers.,"['Turecki G', 'Sequeira A', 'Gingras Y', 'Seguin M', 'Lesage A', 'Tousignant M', 'Chawky N', 'Vanier C', 'Lipp O', 'Benkelfat C', 'Rouleau GA']","['Alleles', 'Gene Frequency', 'Genotype', 'Humans', 'Polymorphism, Genetic', 'Protein Isoforms/genetics', 'Receptors, Serotonin/*genetics', '*Suicide']",https://pubmed.ncbi.nlm.nih.gov/12627464/
1383,HTR1F,19347865,Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.,"['Cody NA', 'Shen Z', 'Ripeau JS', 'Provencher DM', 'Mes-Masson AM', 'Chevrette M', 'Tonin PN']","['Alternative Splicing', 'Case-Control Studies', 'Cell Line, Tumor', 'Chromosomes, Human, Pair 3/*genetics', 'Cystadenocarcinoma, Serous/*genetics/pathology', 'DNA Methylation', 'DNA Primers/chemistry/genetics', 'Female', 'Genes, Tumor Suppressor/*physiology', 'Humans', 'Loss of Heterozygosity', 'Microsatellite Repeats', 'Ovarian Neoplasms/*genetics/pathology', 'Ovary/metabolism/pathology']",https://pubmed.ncbi.nlm.nih.gov/19347865/
1384,NR1I2,38067179,"AhR, PXR and CAR: From Xenobiotic Receptors to Metabolic Sensors.","['Rakateli L', 'Huchzermeier R', 'van der Vorst EPC']","['Humans', 'Pregnane X Receptor/metabolism', 'Constitutive Androstane Receptor', 'Receptors, Cytoplasmic and Nuclear/metabolism', '*Receptors, Steroid/metabolism', 'Receptors, Aryl Hydrocarbon/metabolism', 'Xenobiotics/metabolism', 'Carrier Proteins', '*Dyslipidemias']",https://pubmed.ncbi.nlm.nih.gov/38067179/
1385,NR1I2,39489412,Hepatocyte-specific SLC27A4 deletion ameliorates nonalcoholic fatty liver disease in mice via suppression of phosphatidylcholine-mediated PXR activation.,"['Shen C', 'Pan Z', 'Xie W', 'Zhao J', 'Miao D', 'Zhao L', 'Liu M', 'Zhong Y', 'Zhong C', 'Gonzalez FJ', 'Wang W', 'Gao Y', 'Liu C']","['Animals', '*Non-alcoholic Fatty Liver Disease/metabolism/genetics/pathology', '*Phosphatidylcholines/metabolism', 'Mice', '*Hepatocytes/metabolism', '*Pregnane X Receptor/genetics/metabolism', 'Male', 'Mice, Inbred C57BL', 'Fatty Acid Transport Proteins/genetics/metabolism', 'Diet, High-Fat/adverse effects', 'Mice, Knockout', 'Humans', 'Liver/metabolism/pathology']",https://pubmed.ncbi.nlm.nih.gov/39489412/
1386,NR1I2,38477509,Pregnane X Receptor Activation in Liver Macrophages Protects against Endotoxin-Induced Liver Injury.,"['Zhao T', 'Zhong G', 'Wang Y', 'Cao R', 'Song S', 'Li Y', 'Wan G', 'Sun H', 'Huang M', 'Bi H', 'Jiang Y']","['Animals', 'Humans', 'Male', 'Mice', 'Chemical and Drug Induced Liver Injury/metabolism/genetics', 'Disease Models, Animal', 'Endotoxemia/metabolism/genetics', '*Endotoxins', 'Lipopolysaccharides', 'Liver/metabolism', '*Macrophages/metabolism', 'Mice, Inbred C57BL', '*Pregnane X Receptor/metabolism/genetics', 'Signal Transduction', 'Female']",https://pubmed.ncbi.nlm.nih.gov/38477509/
1387,NR1I2,39475639,A comprehensive transcriptome characterization of individual nuclear receptor pathways in the human small intestine.,"['Willemsen S', 'Yengej FAY', 'Puschhof J', 'Rookmaaker MB', 'Verhaar MC', 'van Es J', 'Beumer J', 'Clevers H']","['Humans', '*Intestine, Small/metabolism', '*Receptors, Cytoplasmic and Nuclear/metabolism/genetics', '*Transcriptome', 'Receptors, Calcitriol/metabolism/genetics', 'Liver X Receptors/metabolism/genetics/agonists', 'Organoids/metabolism', 'Signal Transduction', 'Lipid Metabolism/genetics', 'Enterocytes/metabolism', 'Pregnane X Receptor/metabolism/genetics', 'Gene Expression Regulation/drug effects']",https://pubmed.ncbi.nlm.nih.gov/39475639/
1388,NR1I2,33300686,NR1I2 genetic polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity: A systematic review and meta-analysis.,"['Yang M', 'Qiu Y', 'Jin Y', 'Liu W', 'Wang Q', 'Yi H', 'Tang S']","['Animals', 'Antitubercular Agents/*adverse effects', 'Case-Control Studies', 'Chemical and Drug Induced Liver Injury/diagnosis/epidemiology/*genetics', 'Humans', 'Polymorphism, Single Nucleotide/*genetics', 'Pregnane X Receptor/*genetics', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/33300686/
1389,NR1I2,38654691,PXR Activation Relieves Deoxynivalenol-Induced Liver Oxidative Stress Via Malat1 LncRNA m(6)A Demethylation.,"['Feng Y', 'Shen J', 'Lin Z', 'Chen Z', 'Zhou M', 'Ma X']","['Animals', '*RNA, Long Noncoding/genetics/metabolism', '*Oxidative Stress/drug effects/genetics', 'Mice', '*Mice, Knockout', '*Trichothecenes/toxicity', '*Pregnane X Receptor/metabolism/genetics', '*Demethylation', 'Disease Models, Animal', 'Male', 'Mice, Inbred C57BL', 'Liver/metabolism/drug effects', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/38654691/
1390,NR1I2,38431091,Gut Clostridium sporogenes-derived indole propionic acid suppresses osteoclast formation by activating pregnane X receptor.,"['Peng R', 'Song C', 'Gou S', 'Liu H', 'Kang H', 'Dong Y', 'Xu Y', 'Hu P', 'Cai K', 'Feng Q', 'Guan H', 'Li F']","['Humans', 'Female', 'Mice', 'Animals', '*Osteoclasts/metabolism', 'Pregnane X Receptor/metabolism', '*Bone Resorption/metabolism', 'Osteogenesis', 'Estrogens/metabolism', 'Indoles/metabolism', 'Hydrogels', 'RANK Ligand/metabolism', 'Cell Differentiation', '*Clostridium', '*Propionates']",https://pubmed.ncbi.nlm.nih.gov/38431091/
1391,NR1I2,35159123,Nuclear Receptor PXR in Drug-Induced Hypercholesterolemia.,"['Karpale M', 'Hukkanen J', 'Hakkola J']","['*Atherosclerosis/metabolism', 'Cholesterol/metabolism', 'Humans', '*Hypercholesterolemia/chemically induced', 'Lipoproteins, LDL/metabolism', '*Pregnane X Receptor/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35159123/
1392,NR1I2,29199543,Genetic variations of the xenoreceptors NR1I2 and NR1I3 and their effect on drug disposition and response variability.,"['Mbatchi LC', 'Brouillet JP', 'Evrard A']","['Constitutive Androstane Receptor', 'Humans', 'Polymorphism, Genetic/*genetics', 'Pregnane X Receptor', 'Receptors, Cytoplasmic and Nuclear/*genetics', 'Receptors, Steroid/*genetics', 'Xenobiotics/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/29199543/
1393,NR1I2,33142929,Regulation of CAR and PXR Expression in Health and Disease.,"['Daujat-Chavanieu M', 'Gerbal-Chaloin S']","['Alternative Splicing', 'Animals', 'Biological Clocks', 'Constitutive Androstane Receptor', 'Energy Metabolism', '*Epigenesis, Genetic', '*Gene Expression Regulation, Developmental', 'Hepatocytes/physiology', 'Humans', 'Inactivation, Metabolic', 'Mice', 'Pregnane X Receptor/*physiology', 'Protein Isoforms', 'Receptors, Cytoplasmic and Nuclear/*physiology', 'Tissue Distribution', 'Transcription Factors']",https://pubmed.ncbi.nlm.nih.gov/33142929/
1394,NR1I2,28534176,Functions of pregnane X receptor in self-detoxification.,"['He L', 'Zhou X', 'Huang N', 'Li H', 'Li T', 'Yao K', 'Tian Y', 'Hu CA', 'Yin Y']","['Animals', 'Biomarkers, Pharmacological', 'Humans', 'Inactivation, Metabolic', 'Metabolic Diseases/*metabolism', 'Molecular Targeted Therapy', 'Pregnane X Receptor', 'Protein Processing, Post-Translational', 'Receptor Cross-Talk/*physiology', 'Receptors, Steroid/genetics/*metabolism', 'Signal Transduction/*physiology', 'Transcription Factors/genetics/metabolism/physiology', 'Xenobiotics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/28534176/
1395,NR1I2,29759961,The Roles of Xenobiotic Receptors: Beyond Chemical Disposition.,"['Mackowiak B', 'Hodge J', 'Stern S', 'Wang H']","['Animals', 'Cell Proliferation', 'Cell Transformation, Neoplastic/genetics/*metabolism/pathology', 'Constitutive Androstane Receptor', '*Energy Metabolism', 'Gene Expression Regulation, Neoplastic', 'Homeostasis', 'Humans', 'Neoplasms/genetics/*metabolism/pathology', 'Pregnane X Receptor/genetics/*metabolism', 'Receptors, Cytoplasmic and Nuclear/genetics/*metabolism', '*Signal Transduction', 'Xenobiotics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/29759961/
1396,NR1I2,27894906,Relationship between NR1I2 polymorphisms and inflammatory bowel disease risk: A systematic review and meta-analysis.,"['Sun MY', 'Lin JN']","['Colitis, Ulcerative/genetics', 'Crohn Disease/genetics', 'Genetic Predisposition to Disease/*genetics', 'Genotype', 'Humans', 'Inflammatory Bowel Diseases/*genetics', 'Linkage Disequilibrium/genetics', 'Polymorphism, Genetic/*genetics', 'Polymorphism, Single Nucleotide/genetics', 'Pregnane X Receptor', 'Receptors, Steroid/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27894906/
1397,NR1I2,29113993,PXR: More Than Just a Master Xenobiotic Receptor.,"['Oladimeji PO', 'Chen T']","['Animals', 'Apoptosis/physiology', 'Cell Movement/physiology', 'Cell Proliferation/physiology', 'DNA Damage', 'Humans', 'Inactivation, Metabolic', 'Inflammation/physiopathology', 'Pregnane X Receptor/*physiology', 'Xenobiotics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/29113993/
1398,NR1I2,39427444,Activation of nuclear receptor pregnane-X-receptor protects against abdominal aortic aneurysm by inhibiting oxidative stress.,"['Shen Z', 'Wang J', 'Chen Y', 'Fang P', 'Yuan A', 'Chen AF', 'Yan X', 'Lyu Y', 'Pu J']","['*Pregnane X Receptor/metabolism/genetics', '*Aortic Aneurysm, Abdominal/metabolism/prevention & control/pathology/genetics', '*Oxidative Stress/drug effects', 'Animals', 'Humans', 'Mice', '*Disease Models, Animal', 'Male', 'Myocytes, Smooth Muscle/metabolism/drug effects', 'Muscle, Smooth, Vascular/metabolism/cytology/drug effects']",https://pubmed.ncbi.nlm.nih.gov/39427444/
1399,NR1I2,15276713,CAR: detailing new models.,"['Goodwin B', 'Moore JT']","['Animals', 'Cholestasis/drug therapy/metabolism', 'Constitutive Androstane Receptor', 'Humans', 'Hyperbilirubinemia/drug therapy/metabolism', 'Obesity/drug therapy/metabolism', 'Pregnane X Receptor', 'Receptors, Cytoplasmic and Nuclear/agonists/*physiology', 'Receptors, Steroid/physiology', 'Transcription Factors/agonists/*physiology']",https://pubmed.ncbi.nlm.nih.gov/15276713/
1400,NR1I2,38744881,Chemical manipulation of an activation/inhibition switch in the nuclear receptor PXR.,"['Garcia-Maldonado E', 'Huber AD', 'Chai SC', 'Nithianantham S', 'Li Y', 'Wu J', 'Poudel S', 'Miller DJ', 'Seetharaman J', 'Chen T']","['*Pregnane X Receptor/metabolism/antagonists & inhibitors', 'Humans', 'Ligands', 'Crystallography, X-Ray', 'Hep G2 Cells', 'Models, Molecular', 'Protein Binding']",https://pubmed.ncbi.nlm.nih.gov/38744881/
1401,NR1I2,26045277,Nuclear receptor variants in liver disease.,"['Zimmer V', 'Liebe R', 'Lammert F']","['Constitutive Androstane Receptor', 'Genome-Wide Association Study', 'Humans', 'Liver Diseases/*genetics/*metabolism', 'Polymorphism, Single Nucleotide', 'Pregnane X Receptor', 'Receptors, Cytoplasmic and Nuclear/*genetics', 'Receptors, Steroid/genetics', 'Signal Transduction/genetics']",https://pubmed.ncbi.nlm.nih.gov/26045277/
1402,NR1I2,39004626,B3galt5 functions as a PXR target gene and regulates obesity and insulin resistance by maintaining intestinal integrity.,"['Zhang J', 'Huang Y', 'Li H', 'Xu P', 'Liu Q', 'Sun Y', 'Zhang Z', 'Wu T', 'Tang Q', 'Jia Q', 'Xia Y', 'Xu Y', 'Jing X', 'Li J', 'Mo L', 'Xie W', 'Qu A', 'He J', 'Li Y']","['Male', 'Animals', 'Mice', '*Pregnane X Receptor/agonists', '*Obesity/drug therapy/metabolism', '*Citrates/pharmacology/therapeutic use', '*Intestines/drug effects/metabolism', '*Galactosyltransferases/genetics/metabolism', '*Insulin Resistance', 'Diet, High-Fat', 'Gene Expression/drug effects', 'Inflammation/genetics', 'Gene Knockout Techniques', 'Humans', 'Drug Evaluation, Preclinical']",https://pubmed.ncbi.nlm.nih.gov/39004626/
1403,NR1I2,38032737,S-nitrosylation attenuates pregnane X receptor hyperactivity and acetaminophen-induced liver injury.,"['Cui Q', 'Jiang T', 'Xie X', 'Wang H', 'Qian L', 'Cheng Y', 'Li Q', 'Lu T', 'Yao Q', 'Liu J', 'Lai B', 'Chen C', 'Xiao L', 'Wang N']","['Animals', 'Humans', 'Mice', '*Acetaminophen/toxicity', '*Chemical and Drug Induced Liver Injury, Chronic/metabolism', 'Hepatocytes/metabolism', 'Pregnane X Receptor/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38032737/
